Citrus Sinensis ID: 023270

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280----
Protein Sequence
MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Secondary Structure (PSIPRED)
cccccccccccccccEEEccccccccccccccccEEEEEEEccccEEEEEEEcHHHHHHHHHHHHHHHHHHHHHHcccccEEccccEEEEccEEEEEEEEccccccHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEEccccEEcccccccccccccccccEEcccccccccHHEHHHHHHHHHHHccccccccccHHHHHHHHHcccEEccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccHHHEEEEEEEEEcccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHcccccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccEccccEcHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHccHHHHccccccccccc
Coil and Loop (DISEMBL)
mdtktaerednrkrewslqdfeigrplgkgkfgrVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQsslrhpnilrlygwfhddERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYChenhvihrdikpenllldhegrlkigdfgwsvqsrskrhtmcgtldylapemvenkehdyavdnwtlGILCYEflygappfeaesqkDTFRRIMKvdlsfpsapsiSAEAKHLISRLLVKDSSKRLSLQkimehpwiiknanprgtcdi
Flexible Loop (DISEMBL)
mdtktaerednrkrewslqdfeigrplgkgkfGRVYLVReveskhpvalkiiFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDfgwsvqsrskrHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLslqkimehpwiiknanprgtcdi
Low Complexity Region (SEG)
MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Disordered region (IsUnstruct)
*****************LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA*****TFRRIMKVDLSF**********KHLISRLLVK*****LSLQKIMEHPWIIK**********
Disordered Region (DISOPRED)
********************FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP******
Disordered Region (DISEMBL)
*************REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Disordered Region (DISPRO)
**************EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	284	2.2.26 [Sep-21-2011]
O64629	288	Serine/threonine-protein	yes	no	0.992	0.979	0.780	1e-133
Q9M077	294	Serine/threonine-protein	no	no	0.943	0.911	0.652	1e-107
Q683C9	282	Serine/threonine-protein	no	no	0.964	0.971	0.632	1e-105
Q2TA06	402	Aurora kinase A OS=Bos ta	yes	no	0.943	0.666	0.612	2e-99
P97477	395	Aurora kinase A OS=Mus mu	yes	no	0.940	0.675	0.614	1e-98
P59241	397	Aurora kinase A OS=Rattus	yes	no	0.961	0.687	0.601	8e-98
Q91820	407	Aurora kinase A-A OS=Xeno	N/A	no	0.957	0.668	0.6	8e-98
O14965	403	Aurora kinase A OS=Homo s	yes	no	0.957	0.674	0.596	2e-97
A5GFW1	402	Aurora kinase A OS=Sus sc	yes	no	0.954	0.674	0.598	3e-97
Q91819	408	Aurora kinase A-B OS=Xeno	N/A	no	0.957	0.666	0.6	3e-97

>sp|O64629|AUR3_ARATH Serine/threonine-protein kinase Aurora-3 OS=Arabidopsis thaliana GN=AUR3 PE=2 SV=1

 Score =  474 bits (1219), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 221/283 (78%), Positives = 252/283 (89%), Gaps = 1/283 (0%)

Query: 1   MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
           M  K+ E +  N +++WSL DFEIGRPLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct: 1   MSKKSTESDAGNTEKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
           YKI HQLRREMEIQ+SLRHPNILRL+GWFHD+ERIFLILEYAH GELY  L+++   TEQ
Sbjct: 61  YKIHHQLRREMEIQTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQ 120

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct: 121 QAATYIASLSQALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP 239
           LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+RI+K+DLSFP  P
Sbjct: 181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ++S EAK+LIS+LLVKD SKRLS++KIM+HPWI+KNA+P+G C
Sbjct: 241 NVSEEAKNLISQLLVKDPSKRLSIEKIMQHPWIVKNADPKGVC 283

Phosphorylates in vitro histone H3 at 'Ser-10' and 'Ser-28', but not at 'Thr-3' or 'Thr-11'. Colocalizes with phosphorylated histone H3 during mitosis. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9M077|AUR1_ARATH Serine/threonine-protein kinase Aurora-1 OS=Arabidopsis thaliana GN=AUR1 PE=1 SV=1

 Score =  388 bits (996), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 175/268 (65%), Positives = 223/268 (83%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           ++ W+L DF+IG+PLG+GKFG VYL RE  S H VALK++FK Q+++ +++HQLRRE+EI
Sbjct: 23  QKRWTLSDFDIGKPLGRGKFGHVYLAREKRSNHVVALKVLFKSQLQQSQVEHQLRREVEI 82

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+F+D +R++LILEYA RGELY++L+K + F+E++AATY+ASL  AL
Sbjct: 83  QSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKDLQKCKYFSERRAATYVASLARAL 142

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
            YCH  HVIHRDIKPENLL+  +G LKI DFGWSV + ++R TMCGTLDYL PEMVE+ E
Sbjct: 143 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 202

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           HD +VD W+LGILCYEFLYG PPFEA    DT+RRI++VDL FP  P ISA AK LIS++
Sbjct: 203 HDASVDIWSLGILCYEFLYGVPPFEAMEHSDTYRRIVQVDLKFPPKPIISASAKDLISQM 262

Query: 253 LVKDSSKRLSLQKIMEHPWIIKNANPRG 280
           LVK+SS+RL L K++EHPWI++NA+P G
Sbjct: 263 LVKESSQRLPLHKLLEHPWIVQNADPSG 290

Phosphorylates specifically 'Ser-10' of histone H3 in vitro and colocalizes with phosphorylated histone H3 during mitosis. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle. Might also colocalize with gamma-tubulin and function in microtubule organizing centers (MTOCs). In contrast with the mammalian B-type Aurora, AUR1 has no kinase activity toward 'Ser-28' of histone H3.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q683C9|AUR2_ARATH Serine/threonine-protein kinase Aurora-2 OS=Arabidopsis thaliana GN=AUR2 PE=2 SV=2

 Score =  383 bits (983), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 174/275 (63%), Positives = 226/275 (82%), Gaps = 1/275 (0%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           A  E  +KR W+  DF+IG+PLG+GKFG VYL RE  S H VALK++FK Q+++ +++HQ
Sbjct: 5   AASEAAQKR-WTTSDFDIGKPLGRGKFGHVYLAREKRSDHIVALKVLFKAQLQQSQVEHQ 63

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           LRRE+EIQS LRHPNILRLYG+F+D +R++LILEYA RGELY+EL+K + F+E++AATY+
Sbjct: 64  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAVRGELYKELQKCKYFSERRAATYV 123

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAP 185
           ASL  AL YCH  HVIHRDIKPENLL+  +G LKI DFGWSV + ++R TMCGTLDYL P
Sbjct: 124 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 183

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
           EMVE+ EHD +VD W+LGILCYEFLYG PPFEA    +T++RI++VDL FP  P +S+ A
Sbjct: 184 EMVESVEHDASVDIWSLGILCYEFLYGVPPFEAREHSETYKRIVQVDLKFPPKPIVSSSA 243

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 280
           K LIS++LVK+S++RL+L K++EHPWI++NA+P G
Sbjct: 244 KDLISQMLVKESTQRLALHKLLEHPWIVQNADPSG 278

Phosphorylates specifically 'Ser-10' of histone H3 in vitro. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle. Might colocalize with gamma-tubulin and function in microtubule organizing centers (MTOCs).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2TA06|AURKA_BOVIN Aurora kinase A OS=Bos taurus GN=AURKA PE=2 SV=1

 Score =  362 bits (928), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 166/271 (61%), Positives = 213/271 (78%), Gaps = 3/271 (1%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 121 EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 180

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 181 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYITEL 240

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 241 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 300

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E + HD  VD W+LG+LCYEFL G PPFEA++ ++T+RRI +V+ +FP    +   A+ 
Sbjct: 301 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEADTYQETYRRISRVEFTFPDC--VPEGARD 358

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           LISRLL  + S+R +L++++EHPWII N+ P
Sbjct: 359 LISRLLKHNPSQRPTLKEVLEHPWIIANSKP 389

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P97477|AURKA_MOUSE Aurora kinase A OS=Mus musculus GN=Aurka PE=1 SV=1

 Score =  359 bits (922), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 166/270 (61%), Positives = 212/270 (78%), Gaps = 3/270 (1%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ED +KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 112 EDTKKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKANVEHQLRR 171

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 172 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 231

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R TMCGTLDYL PEM
Sbjct: 232 ANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTMCGTLDYLPPEM 291

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T+RRI +V+ +FP    ++  A+ 
Sbjct: 292 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF--VTEGARD 349

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LISRLL  ++S+RL+L +++EHPWI  N++
Sbjct: 350 LISRLLKHNASQRLTLAEVLEHPWIKANSS 379

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P59241|AURKA_RAT Aurora kinase A OS=Rattus norvegicus GN=Aurka PE=1 SV=1

 Score =  357 bits (915), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 166/276 (60%), Positives = 214/276 (77%), Gaps = 3/276 (1%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
           T   + ED++KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  +
Sbjct: 108 TSIQKTEDSKKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGV 167

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
           +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ A
Sbjct: 168 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 227

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
           TYI  L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct: 228 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 287

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           Y  PEM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T+RRI +V+ +FP    +
Sbjct: 288 YQPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF--V 345

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           +  A+ LISRLL  +SS+RL+L +++EHPWI  N++
Sbjct: 346 TEGARDLISRLLKHNSSQRLTLAEVLEHPWIKANSS 381

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis GN=aurka-a PE=1 SV=1

 Score =  357 bits (915), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 165/275 (60%), Positives = 211/275 (76%), Gaps = 3/275 (1%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
           T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct: 122 TSAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
           +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct: 182 EHQLRREVEIQSHLRHPNILRLYGYFHDASRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
            YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct: 242 MYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+RRI KV+  +P  P +
Sbjct: 302 YLPPEMIEGRMHDETVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYP--PYV 359

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           S EA+ L+S+LL  + + RL L+ ++EHPWIIKN+
Sbjct: 360 SEEARDLVSKLLKHNPNHRLPLKGVLEHPWIIKNS 394

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Phosphorylates numerous target proteins. Important for microtubule formation and/or stabilization.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O14965|AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2

 Score =  355 bits (911), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 164/275 (59%), Positives = 212/275 (77%), Gaps = 3/275 (1%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 121 EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 180

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 181 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 240

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 241 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 300

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ 
Sbjct: 301 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARD 358

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           LISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 359 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 393

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A5GFW1|AURKA_PIG Aurora kinase A OS=Sus scrofa GN=AURKA PE=2 SV=1

 Score =  354 bits (909), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 164/274 (59%), Positives = 211/274 (77%), Gaps = 3/274 (1%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 121 EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKTQLEKAGVEHQLRR 180

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 181 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYITEL 240

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 241 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 300

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    +   A+ 
Sbjct: 301 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VPEGARD 358

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 281
           LISRLL  + S R +L++++EHPWI  N+ P  +
Sbjct: 359 LISRLLKHNPSHRPTLKEVLEHPWITANSKPASS 392

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91819|AURAB_XENLA Aurora kinase A-B OS=Xenopus laevis GN=aurka-b PE=2 SV=3

 Score =  354 bits (909), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 165/275 (60%), Positives = 211/275 (76%), Gaps = 3/275 (1%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
           T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct: 122 TLAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
           +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct: 182 EHQLRREVEIQSHLRHPNILRLYGYFHDACRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
            YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct: 242 LYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+RRI KV+  +P  P +
Sbjct: 302 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYP--PYV 359

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           S EAK L+S+LL  + + RL L+ ++EHPWI+KN+
Sbjct: 360 SEEAKDLVSKLLKHNPNHRLPLKGVLEHPWIVKNS 394

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Phosphorylates numerous target proteins. Important for microtubule formation and/or stabilization.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	284
356545969	332	PREDICTED: serine/threonine-protein kina	0.985	0.843	0.821	1e-136
224090609	283	predicted protein [Populus trichocarpa]	0.975	0.978	0.812	1e-136
356506339	276	PREDICTED: serine/threonine-protein kina	0.968	0.996	0.825	1e-135
225453778	281	PREDICTED: serine/threonine-protein kina	0.975	0.985	0.819	1e-135
15225495	288	serine/threonine-protein kinase aurora-3	0.992	0.979	0.780	1e-131
297828267	288	ATAUR3 [Arabidopsis lyrata subsp. lyrata	0.992	0.979	0.773	1e-129
449432227	285	PREDICTED: serine/threonine-protein kina	0.954	0.950	0.797	1e-129
357514781	305	Serine/threonine protein kinase Aurora-3	0.975	0.908	0.710	1e-122
255541356	260	Serine/threonine-protein kinase, putativ	0.838	0.915	0.852	1e-118
147781807	312	hypothetical protein VITISV_011428 [Viti	0.862	0.785	0.804	1e-116

>gi|356545969|ref|XP_003541405.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Glycine max]

 Score =  491 bits (1263), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 230/280 (82%), Positives = 253/280 (90%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           M ++    E+N KR WSL+DFEIG+PLG+GKFGRVY+ REV+SK  VALK+IFKEQI+KY
Sbjct: 34  MASQNPAEEENSKRHWSLEDFEIGKPLGRGKFGRVYVAREVKSKFVVALKVIFKEQIDKY 93

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           ++ HQLRREMEIQ+SLRH NILRLYGWFHD +R+FLILEYAH+GELY+ELRK    TE+Q
Sbjct: 94  RVHHQLRREMEIQTSLRHANILRLYGWFHDADRVFLILEYAHKGELYKELRKKGHLTEKQ 153

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL 180
           AATYI SLT ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQSRSKRHTMCGTL
Sbjct: 154 AATYILSLTKALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSRSKRHTMCGTL 213

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           DYLAPEMVENK HDYAVDNWTLGILCYEFLYGAPPFEAESQ DTF+RIMKVDLSFPS PS
Sbjct: 214 DYLAPEMVENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQSDTFKRIMKVDLSFPSTPS 273

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 280
           +S EAK+LISRLLVKDSS+RLSLQKIMEHPWIIKNA+  G
Sbjct: 274 VSIEAKNLISRLLVKDSSRRLSLQKIMEHPWIIKNADFVG 313

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224090609|ref|XP_002309033.1| predicted protein [Populus trichocarpa] gi|222855009|gb|EEE92556.1| predicted protein [Populus trichocarpa]

 Score =  490 bits (1261), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 225/277 (81%), Positives = 255/277 (92%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ++ + R+R WS+ DFEIG+PLG+GKFGRVY+ REV+SK+ VALK+IFKEQI+KY I HQL
Sbjct: 6   KKSEPRRRGWSIADFEIGKPLGRGKFGRVYVAREVKSKYIVALKVIFKEQIDKYNIHHQL 65

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           +REM+IQ+SL HPNILRLYGWFHDD+R+F+ILEYAH GEL++ELRK    +EQ+AATY+A
Sbjct: 66  KREMDIQTSLSHPNILRLYGWFHDDQRVFMILEYAHGGELFKELRKCGYLSEQKAATYVA 125

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           SL NALAYCHE  VIHRDIKPENLLLDHEGRLKI DFGWSVQSRSKRHTMCGTLDYLAPE
Sbjct: 126 SLANALAYCHEKDVIHRDIKPENLLLDHEGRLKIADFGWSVQSRSKRHTMCGTLDYLAPE 185

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           MVENK HDYAVDNWTLGILCYEFLYGAPPFEAESQ+DTFRRI+KVDL+FPS P +SAEAK
Sbjct: 186 MVENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQRDTFRRIVKVDLTFPSTPPVSAEAK 245

Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 283
           +LI+RLLVKDSSKRLSLQKI+EHPWIIKNANP GTCD
Sbjct: 246 NLITRLLVKDSSKRLSLQKILEHPWIIKNANPMGTCD 282

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356506339|ref|XP_003521942.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Glycine max]

 Score =  486 bits (1252), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 227/275 (82%), Positives = 249/275 (90%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           + N KREWSL DFEIG+PLGKGKFGRVY+ REV+SK  VALK+IFKEQ+EKY+I HQLRR
Sbjct: 2   DGNPKREWSLNDFEIGKPLGKGKFGRVYVAREVKSKFVVALKVIFKEQLEKYRIHHQLRR 61

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           EMEIQ SL+H N+LRLYGWFHD ER++LILEYAH GELY+EL K   F E+QAATYI SL
Sbjct: 62  EMEIQFSLQHQNVLRLYGWFHDSERVYLILEYAHNGELYKELSKKGHFNEKQAATYILSL 121

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
           T ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQSRSKRHTMCGTLDYLAPEMV
Sbjct: 122 TKALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSRSKRHTMCGTLDYLAPEMV 181

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           ENK HDYAVDNWTLGILCYEFLYGAPPFEAESQ DTF+RIMKVDLSFPS P++S EAK+L
Sbjct: 182 ENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQVDTFKRIMKVDLSFPSTPNVSLEAKNL 241

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 283
           ISRLLVKDSS+RLSLQ+IMEHPWI KNA+P+G C+
Sbjct: 242 ISRLLVKDSSRRLSLQRIMEHPWITKNADPKGVCN 276

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225453778|ref|XP_002270462.1| PREDICTED: serine/threonine-protein kinase Aurora-3 [Vitis vinifera] gi|296089088|emb|CBI38791.3| unnamed protein product [Vitis vinifera]

 Score =  486 bits (1250), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 227/277 (81%), Positives = 249/277 (89%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           E    ++++WSL DFEIG+PLG+GKFGRVYL RE++SK+ VALK+IFK QIEKY++ HQL
Sbjct: 4   EPSQKQQKQWSLDDFEIGKPLGRGKFGRVYLAREIKSKYVVALKVIFKAQIEKYRLHHQL 63

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           +REMEIQ+SL HPN+LRLYGWFHD ERIFLILEY + GELYRELRK    TE+QAATYIA
Sbjct: 64  KREMEIQTSLCHPNVLRLYGWFHDSERIFLILEYCYGGELYRELRKTGYLTEKQAATYIA 123

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           SLT ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGTLDYLAPE
Sbjct: 124 SLTQALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSTNKRRTMCGTLDYLAPE 183

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           MVENK HDYAVDNWTLGILCYEFLYG PPFEAESQ DTF+RIMKVDLSFPS P +SAEAK
Sbjct: 184 MVENKAHDYAVDNWTLGILCYEFLYGVPPFEAESQSDTFKRIMKVDLSFPSNPHVSAEAK 243

Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 283
           +LISRLLVKDSSKRLSLQKIMEHPWIIKNANP GTC+
Sbjct: 244 NLISRLLVKDSSKRLSLQKIMEHPWIIKNANPTGTCN 280

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15225495|ref|NP_182073.1| serine/threonine-protein kinase aurora-3 [Arabidopsis thaliana] gi|75318481|sp|O64629.1|AUR3_ARATH RecName: Full=Serine/threonine-protein kinase Aurora-3; Short=AtAur3; AltName: Full=Aurora-like kinase 3 gi|2979542|gb|AAC06151.1| putative protein kinase [Arabidopsis thaliana] gi|18491289|gb|AAL69469.1| At2g45490/F17K2.2 [Arabidopsis thaliana] gi|55467122|emb|CAH69534.1| aurora-like kinase 3 [Arabidopsis thaliana] gi|67845863|dbj|BAE00021.1| Aurora kinase [Arabidopsis thaliana] gi|330255467|gb|AEC10561.1| serine/threonine-protein kinase aurora-3 [Arabidopsis thaliana]

 Score =  474 bits (1219), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 221/283 (78%), Positives = 252/283 (89%), Gaps = 1/283 (0%)

Query: 1   MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
           M  K+ E +  N +++WSL DFEIGRPLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct: 1   MSKKSTESDAGNTEKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
           YKI HQLRREMEIQ+SLRHPNILRL+GWFHD+ERIFLILEYAH GELY  L+++   TEQ
Sbjct: 61  YKIHHQLRREMEIQTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQ 120

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct: 121 QAATYIASLSQALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP 239
           LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+RI+K+DLSFP  P
Sbjct: 181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ++S EAK+LIS+LLVKD SKRLS++KIM+HPWI+KNA+P+G C
Sbjct: 241 NVSEEAKNLISQLLVKDPSKRLSIEKIMQHPWIVKNADPKGVC 283

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297828267|ref|XP_002882016.1| ATAUR3 [Arabidopsis lyrata subsp. lyrata] gi|297327855|gb|EFH58275.1| ATAUR3 [Arabidopsis lyrata subsp. lyrata]

 Score =  467 bits (1201), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 219/283 (77%), Positives = 249/283 (87%), Gaps = 1/283 (0%)

Query: 1   MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
           M  ++ E +  + +++WSL DFEIG PLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct: 1   MSKRSTESDAGDTEKQWSLADFEIGGPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
           YKI HQLRREMEIQ+SL HPNILRL+GWF DDERIFLILEYAH GELY  L+K+   TEQ
Sbjct: 61  YKIHHQLRREMEIQTSLSHPNILRLFGWFDDDERIFLILEYAHGGELYGVLKKNGHLTEQ 120

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct: 121 QAATYIASLSEALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP 239
           LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+RI+K+DLSFP  P
Sbjct: 181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ++S EAK+LIS+LLVKD SKRLSL+KIM+HPWI+KNA+P+G C
Sbjct: 241 NVSEEAKNLISQLLVKDPSKRLSLEKIMQHPWIVKNADPKGVC 283

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449432227|ref|XP_004133901.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Cucumis sativus] gi|449519938|ref|XP_004166991.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Cucumis sativus]

 Score =  465 bits (1197), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 216/271 (79%), Positives = 244/271 (90%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+WSL+DF++G+PLGKGKFGRVYL REV SK+ VALK+IF+EQ++KY I  QL REMEI
Sbjct: 13  KRQWSLKDFDVGKPLGKGKFGRVYLAREVRSKYIVALKVIFREQMKKYGIHRQLMREMEI 72

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           Q+SLRHPNILRLYGWFHD ERIF+ILEYAHRGELYRELRK+   +E+QAATY+ SLT AL
Sbjct: 73  QTSLRHPNILRLYGWFHDAERIFMILEYAHRGELYRELRKNGHLSEKQAATYMLSLTQAL 132

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
           AYCHE  VIHRDIKPENLLLDHEGRLKIGDFGW+VQSRSKR+TMCGTLDYLAPEMVENK 
Sbjct: 133 AYCHEKDVIHRDIKPENLLLDHEGRLKIGDFGWAVQSRSKRYTMCGTLDYLAPEMVENKG 192

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           HD+A+DNWT+GILCYEFLYG PPFEAESQ DTF+RI KV+L+FPS P IS EA+ LI RL
Sbjct: 193 HDFAIDNWTMGILCYEFLYGVPPFEAESQSDTFQRIRKVELNFPSTPRISTEARDLIGRL 252

Query: 253 LVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 283
           LVKDSSKRLSLQ+I EHPWIIKNA+P G C+
Sbjct: 253 LVKDSSKRLSLQEIEEHPWIIKNADPSGICN 283

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357514781|ref|XP_003627679.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|358344449|ref|XP_003636302.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|358345551|ref|XP_003636840.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|355502237|gb|AES83440.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|355502775|gb|AES83978.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|355521701|gb|AET02155.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula]

 Score =  443 bits (1140), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 216/304 (71%), Positives = 241/304 (79%), Gaps = 27/304 (8%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ++   R+ EWS+ DFEIG+PLG+GKFGRVY+ REV+SK+ +ALK+IFKEQ+EKY I HQL
Sbjct: 2   DQNQKREHEWSINDFEIGKPLGRGKFGRVYVAREVKSKYVIALKVIFKEQLEKYNILHQL 61

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--- 123
           RREMEIQ SL+HPNILRLYGWFHD ER++LILEYAH GELY+ELRK   F+E+QAAT   
Sbjct: 62  RREMEIQISLKHPNILRLYGWFHDAERVYLILEYAHNGELYKELRKKGHFSEKQAATIDR 121

Query: 124 ------------------------YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK 159
                                   YI SLT ALAYCHE HVIHRDIKPENLLLDHEGRLK
Sbjct: 122 YRERERERERERERERERERDRERYILSLTKALAYCHEKHVIHRDIKPENLLLDHEGRLK 181

Query: 160 IGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
           I DFGWSVQS  KR TMCGTLDYLAPEMVENK HDYAVDNWTLGILCYEFLYG PPFEAE
Sbjct: 182 IADFGWSVQSVKKRKTMCGTLDYLAPEMVENKGHDYAVDNWTLGILCYEFLYGVPPFEAE 241

Query: 220 SQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
           SQ+DTF+RI  VDL+FP  P +S  AK+LISRLLVKDSSKRL LQKIMEHPWI +NAN  
Sbjct: 242 SQEDTFKRIRDVDLNFPPTPHVSKNAKNLISRLLVKDSSKRLPLQKIMEHPWIKENANHT 301

Query: 280 GTCD 283
           G C+
Sbjct: 302 GVCE 305

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255541356|ref|XP_002511742.1| Serine/threonine-protein kinase, putative [Ricinus communis] gi|223548922|gb|EEF50411.1| Serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  429 bits (1104), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 203/238 (85%), Positives = 221/238 (92%)

Query: 43  SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH 102
           SK+ VALK+IFKEQIEKY+I HQL+REMEIQ++L HPN+LRLYGWFHDDERIFLILEYA 
Sbjct: 19  SKYIVALKVIFKEQIEKYRIHHQLKREMEIQTNLCHPNVLRLYGWFHDDERIFLILEYAQ 78

Query: 103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
            GELY+EL+K     E+QAATYIASLTNAL+YCH+  VIHRDIKPENLLLDHEGRLKI D
Sbjct: 79  GGELYKELKKKGFLCEKQAATYIASLTNALSYCHKKDVIHRDIKPENLLLDHEGRLKIAD 138

Query: 163 FGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK 222
           FGWSVQSRSKRHTMCGTLDYLAPEMVENK HDYAVDNWTLGILCYEFLYGAPPFEAESQK
Sbjct: 139 FGWSVQSRSKRHTMCGTLDYLAPEMVENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQK 198

Query: 223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 280
           DTFRRIMKVDL+FPS P +SAEAK+LI+RLLVKDSSKRLSLQKI+EHPWIIKNA+P G
Sbjct: 199 DTFRRIMKVDLTFPSHPPVSAEAKNLITRLLVKDSSKRLSLQKILEHPWIIKNADPMG 256

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147781807|emb|CAN65449.1| hypothetical protein VITISV_011428 [Vitis vinifera]

 Score =  423 bits (1087), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 197/245 (80%), Positives = 218/245 (88%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           E    ++++WSL DFEIG+PLG+GKFGRVYL RE++SK+ VALK+IFK QIEKY++ HQL
Sbjct: 19  EXSQKQQKQWSLDDFEIGKPLGRGKFGRVYLAREIKSKYVVALKVIFKAQIEKYRLHHQL 78

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           +REMEIQ+SL HPN+LRLYGWFHD ERIFLILEY + GELYRELRK    TE+QAATYIA
Sbjct: 79  KREMEIQTSLCHPNVLRLYGWFHDSERIFLILEYCYGGELYRELRKTGYLTEKQAATYIA 138

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           SLT ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGTLDYLAPE
Sbjct: 139 SLTQALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSTNKRRTMCGTLDYLAPE 198

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           MVENK HDYAVDNWTLGILCYEFLYG PPFEAESQ DTF+RIMKVDLSFPS P +SAEAK
Sbjct: 199 MVENKAHDYAVDNWTLGILCYEFLYGVPPFEAESQSDTFKRIMKVDLSFPSNPHVSAEAK 258

Query: 247 HLISR 251
           +LISR
Sbjct: 259 NLISR 263

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	284
TAIR|locus:2043624	288	AUR3 "ataurora3" [Arabidopsis	0.992	0.979	0.780	1.1e-121
TAIR|locus:2134103	294	AUR1 "ataurora1" [Arabidopsis	0.943	0.911	0.652	5e-99
UNIPROTKB|Q2TA06	402	AURKA "Aurora kinase A" [Bos t	0.961	0.679	0.602	7.3e-91
UNIPROTKB|F1LN52	418	Aurka "Aurora kinase A" [Rattu	0.971	0.660	0.601	1.2e-90
UNIPROTKB|Q91820	407	aurka-a "Aurora kinase A-A" [X	0.957	0.668	0.6	1.9e-90
MGI|MGI:894678	395	Aurka "aurora kinase A" [Mus m	0.950	0.683	0.610	1.9e-90
RGD|628895	397	Aurka "aurora kinase A" [Rattu	0.971	0.695	0.597	5.1e-90
UNIPROTKB|Q91819	408	aurka-b "Aurora kinase A-B" [X	0.957	0.666	0.6	6.5e-90
UNIPROTKB|O14965	403	AURKA "Aurora kinase A" [Homo	0.964	0.679	0.592	1.7e-89
UNIPROTKB|A5GFW1	402	AURKA "Aurora kinase A" [Sus s	0.950	0.671	0.600	2.8e-89

TAIR|locus:2043624 AUR3 "ataurora3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
 Identities = 221/283 (78%), Positives = 252/283 (89%)

Query:     1 MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
             M  K+ E +  N +++WSL DFEIGRPLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct:     1 MSKKSTESDAGNTEKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query:    60 YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             YKI HQLRREMEIQ+SLRHPNILRL+GWFHD+ERIFLILEYAH GELY  L+++   TEQ
Sbjct:    61 YKIHHQLRREMEIQTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQ 120

Query:   120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
             QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct:   121 QAATYIASLSQALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query:   180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP 239
             LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+RI+K+DLSFP  P
Sbjct:   181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query:   240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
             ++S EAK+LIS+LLVKD SKRLS++KIM+HPWI+KNA+P+G C
Sbjct:   241 NVSEEAKNLISQLLVKDPSKRLSIEKIMQHPWIVKNADPKGVC 283

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000775 "chromosome, centromeric region" evidence=IDA

GO:0005819 "spindle" evidence=IDA

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0035175 "histone kinase activity (H3-S10 specific)" evidence=IDA

GO:0043987 "histone H3-S10 phosphorylation" evidence=IDA

GO:0043988 "histone H3-S28 phosphorylation" evidence=IDA

GO:0044022 "histone kinase activity (H3-S28 specific)" evidence=IDA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0009640 "photomorphogenesis" evidence=RCA

GO:0010388 "cullin deneddylation" evidence=RCA

GO:0016567 "protein ubiquitination" evidence=RCA

GO:0016571 "histone methylation" evidence=RCA

GO:0016579 "protein deubiquitination" evidence=RCA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2134103 AUR1 "ataurora1" [Arabidopsis thaliana (taxid:3702)]

 Score = 983 (351.1 bits), Expect = 5.0e-99, P = 5.0e-99
 Identities = 175/268 (65%), Positives = 223/268 (83%)

Query:    13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             ++ W+L DF+IG+PLG+GKFG VYL RE  S H VALK++FK Q+++ +++HQLRRE+EI
Sbjct:    23 QKRWTLSDFDIGKPLGRGKFGHVYLAREKRSNHVVALKVLFKSQLQQSQVEHQLRREVEI 82

Query:    73 QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
             QS LRHPNILRLYG+F+D +R++LILEYA RGELY++L+K + F+E++AATY+ASL  AL
Sbjct:    83 QSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKDLQKCKYFSERRAATYVASLARAL 142

Query:   133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
              YCH  HVIHRDIKPENLL+  +G LKI DFGWSV + ++R TMCGTLDYL PEMVE+ E
Sbjct:   143 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 202

Query:   193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
             HD +VD W+LGILCYEFLYG PPFEA    DT+RRI++VDL FP  P ISA AK LIS++
Sbjct:   203 HDASVDIWSLGILCYEFLYGVPPFEAMEHSDTYRRIVQVDLKFPPKPIISASAKDLISQM 262

Query:   253 LVKDSSKRLSLQKIMEHPWIIKNANPRG 280
             LVK+SS+RL L K++EHPWI++NA+P G
Sbjct:   263 LVKESSQRLPLHKLLEHPWIVQNADPSG 290

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005819 "spindle" evidence=IDA

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0035175 "histone kinase activity (H3-S10 specific)" evidence=IDA

GO:0005874 "microtubule" evidence=IDA

GO:0009504 "cell plate" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

UNIPROTKB|Q2TA06 AURKA "Aurora kinase A" [Bos taurus (taxid:9913)]

 Score = 906 (324.0 bits), Expect = 7.3e-91, P = 7.3e-91
 Identities = 167/277 (60%), Positives = 216/277 (77%)

Query:     7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
             + E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQL
Sbjct:   119 KNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 178

Query:    67 RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             RRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI 
Sbjct:   179 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYIT 238

Query:   127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAP 185
              L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL P
Sbjct:   239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298

Query:   186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
             EM+E + HD  VD W+LG+LCYEFL G PPFEA++ ++T+RRI +V+ +FP    +   A
Sbjct:   299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEADTYQETYRRISRVEFTFPDC--VPEGA 356

Query:   246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
             + LISRLL  + S+R +L++++EHPWII N+ P  +C
Sbjct:   357 RDLISRLLKHNPSQRPTLKEVLEHPWIIANSKP-SSC 392

GO:0004672 "protein kinase activity" evidence=ISS

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0031647 "regulation of protein stability" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1LN52 Aurka "Aurora kinase A" [Rattus norvegicus (taxid:10116)]

 Score = 904 (323.3 bits), Expect = 1.2e-90, P = 1.2e-90
 Identities = 169/281 (60%), Positives = 217/281 (77%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T   + ED++KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  +
Sbjct:   129 TSIQKTEDSKKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGV 188

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ A
Sbjct:   189 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 248

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
             TYI  L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   249 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 308

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
             YL PEM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T+RRI +V+ +FP    +
Sbjct:   309 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF--V 366

Query:   242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN--PRG 280
             +  A+ LISRLL  +SS+RL+L +++EHPWI  N++  P G
Sbjct:   367 TEGARDLISRLLKHNSSQRLTLAEVLEHPWIKANSSKPPTG 407

GO:0000278 "mitotic cell cycle" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0031647 "regulation of protein stability" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

UNIPROTKB|Q91820 aurka-a "Aurora kinase A-A" [Xenopus laevis (taxid:8355)]

 Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
 Identities = 165/275 (60%), Positives = 211/275 (76%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct:   122 TSAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct:   182 EHQLRREVEIQSHLRHPNILRLYGYFHDASRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
              YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   242 MYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
             YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+RRI KV+  +P  P +
Sbjct:   302 YLPPEMIEGRMHDETVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYP--PYV 359

Query:   242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             S EA+ L+S+LL  + + RL L+ ++EHPWIIKN+
Sbjct:   360 SEEARDLVSKLLKHNPNHRLPLKGVLEHPWIIKNS 394

GO:0000922 "spindle pole" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

GO:0005876 "spindle microtubule" evidence=IDA

GO:0008017 "microtubule binding" evidence=IDA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IMP

GO:0019894 "kinesin binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IMP

GO:0090307 "spindle assembly involved in mitosis" evidence=IMP

MGI|MGI:894678 Aurka "aurora kinase A" [Mus musculus (taxid:10090)]

 Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
 Identities = 168/275 (61%), Positives = 214/275 (77%)

Query:     9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
             ED +KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct:   112 EDTKKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKANVEHQLRR 171

Query:    69 EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
             E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct:   172 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 231

Query:   129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
              NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R TMCGTLDYL PEM
Sbjct:   232 ANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTMCGTLDYLPPEM 291

Query:   188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
             +E + HD  VD W+LG+LCYEFL G PPFEA + ++T+RRI +V+ +FP    ++  A+ 
Sbjct:   292 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF--VTEGARD 349

Query:   248 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN--PRG 280
             LISRLL  ++S+RL+L +++EHPWI  N++  P G
Sbjct:   350 LISRLLKHNASQRLTLAEVLEHPWIKANSSKPPTG 384

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000278 "mitotic cell cycle" evidence=IMP

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO

GO:0005819 "spindle" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030030 "cell projection organization" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=ISO

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0031647 "regulation of protein stability" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0051301 "cell division" evidence=IEA

RGD|628895 Aurka "aurora kinase A" [Rattus norvegicus (taxid:10116)]

 Score = 898 (321.2 bits), Expect = 5.1e-90, P = 5.1e-90
 Identities = 168/281 (59%), Positives = 216/281 (76%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T   + ED++KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  +
Sbjct:   108 TSIQKTEDSKKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGV 167

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ A
Sbjct:   168 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 227

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
             TYI  L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   228 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 287

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
             Y  PEM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T+RRI +V+ +FP    +
Sbjct:   288 YQPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF--V 345

Query:   242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN--PRG 280
             +  A+ LISRLL  +SS+RL+L +++EHPWI  N++  P G
Sbjct:   346 TEGARDLISRLLKHNSSQRLTLAEVLEHPWIKANSSKPPTG 386

GO:0000278 "mitotic cell cycle" evidence=ISO

GO:0000922 "spindle pole" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO;IDA

GO:0005819 "spindle" evidence=IDA

GO:0005874 "microtubule" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007049 "cell cycle" evidence=TAS

GO:0007067 "mitosis" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030030 "cell projection organization" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=ISO

GO:0031625 "ubiquitin protein ligase binding" evidence=ISO

GO:0031647 "regulation of protein stability" evidence=ISO

GO:0032355 "response to estradiol stimulus" evidence=IEP

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0051301 "cell division" evidence=IEA

UNIPROTKB|Q91819 aurka-b "Aurora kinase A-B" [Xenopus laevis (taxid:8355)]

 Score = 897 (320.8 bits), Expect = 6.5e-90, P = 6.5e-90
 Identities = 165/275 (60%), Positives = 211/275 (76%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct:   122 TLAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct:   182 EHQLRREVEIQSHLRHPNILRLYGYFHDACRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
              YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   242 LYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
             YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+RRI KV+  +P  P +
Sbjct:   302 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYP--PYV 359

Query:   242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             S EAK L+S+LL  + + RL L+ ++EHPWI+KN+
Sbjct:   360 SEEAKDLVSKLLKHNPNHRLPLKGVLEHPWIVKNS 394

GO:0000922 "spindle pole" evidence=ISS

GO:0004672 "protein kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0005876 "spindle microtubule" evidence=ISS

GO:0008017 "microtubule binding" evidence=ISS

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISS

GO:0019894 "kinesin binding" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

GO:0090307 "spindle assembly involved in mitosis" evidence=ISS

UNIPROTKB|O14965 AURKA "Aurora kinase A" [Homo sapiens (taxid:9606)]

 Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
 Identities = 164/277 (59%), Positives = 213/277 (76%)

Query:     7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
             + E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQL
Sbjct:   119 KNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 178

Query:    67 RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             RRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI 
Sbjct:   179 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 238

Query:   127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAP 185
              L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL P
Sbjct:   239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298

Query:   186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
             EM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A
Sbjct:   299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGA 356

Query:   246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
             + LISRLL  + S+R  L++++EHPWI  N++    C
Sbjct:   357 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 393

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=NAS

GO:0007051 "spindle organization" evidence=NAS

GO:0007049 "cell cycle" evidence=NAS

GO:0031647 "regulation of protein stability" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005813 "centrosome" evidence=IDA;TAS

GO:0030496 "midbody" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0046605 "regulation of centrosome cycle" evidence=TAS

GO:0045840 "positive regulation of mitosis" evidence=TAS

GO:0005819 "spindle" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0031145 "anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0005876 "spindle microtubule" evidence=IDA

GO:0031616 "spindle pole centrosome" evidence=IDA

UNIPROTKB|A5GFW1 AURKA "Aurora kinase A" [Sus scrofa (taxid:9823)]

 Score = 891 (318.7 bits), Expect = 2.8e-89, P = 2.8e-89
 Identities = 164/273 (60%), Positives = 211/273 (77%)

Query:     7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
             + E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQL
Sbjct:   119 KNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKTQLEKAGVEHQL 178

Query:    67 RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             RRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI 
Sbjct:   179 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYIT 238

Query:   127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAP 185
              L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL P
Sbjct:   239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298

Query:   186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
             EM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    +   A
Sbjct:   299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VPEGA 356

Query:   246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
             + LISRLL  + S R +L++++EHPWI  N+ P
Sbjct:   357 RDLISRLLKHNPSHRPTLKEVLEHPWITANSKP 389

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005815 "microtubule organizing center" evidence=IEA

GO:0000922 "spindle pole" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6BVA0	IPL1_DEBHA	2, ., 7, ., 1, 1, ., 1	0.5142	0.9612	0.6626	yes	no
P97477	AURKA_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6148	0.9401	0.6759	yes	no
Q8SRL5	IPL1_ENCCU	2, ., 7, ., 1, 1, ., 1	0.4942	0.9049	0.9448	yes	no
O01427	AIR2_CAEEL	2, ., 7, ., 1, 1, ., 1	0.5328	0.9014	0.8393	yes	no
Q54WX4	AURK_DICDI	2, ., 7, ., 1, 1, ., 1	0.5522	0.9330	0.6901	yes	no
O14965	AURKA_HUMAN	2, ., 7, ., 1, 1, ., 1	0.5963	0.9577	0.6749	yes	no
Q6C3J2	IPL1_YARLI	2, ., 7, ., 1, 1, ., 1	0.5247	0.9119	0.6981	yes	no
A5GFW1	AURKA_PIG	2, ., 7, ., 1, 1, ., 1	0.5985	0.9542	0.6741	yes	no
O59790	ARK1_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5855	0.9119	0.7295	yes	no
P59241	AURKA_RAT	2, ., 7, ., 1, 1, ., 1	0.6014	0.9612	0.6876	yes	no
Q2TA06	AURKA_BOVIN	2, ., 7, ., 1, 1, ., 1	0.6125	0.9436	0.6666	yes	no
Q61XD3	AIR2_CAEBR	2, ., 7, ., 1, 1, ., 1	0.5323	0.9154	0.8609	N/A	no
O64629	AUR3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7809	0.9929	0.9791	yes	no
Q755C4	IPL1_ASHGO	2, ., 7, ., 1, 1, ., 1	0.5115	0.9014	0.6975	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_VI0258 hypothetical protein (283 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	284
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-104
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-91
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-90
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-89
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-84
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-75
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-74
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-72
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-69
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-69
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-67
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-66
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-64
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-64
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-63
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-61
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-59
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-58
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-57
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-57
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-56
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-56
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-54
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-54
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-53
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-53
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-53
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-53
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-52
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-52
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-51
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-50
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-50
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-50
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-50
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-49
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-49
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-49
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-49
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-49
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-48
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-48
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-47
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-47
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-47
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-46
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-46
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-46
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-45
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-45
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-45
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-44
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-43
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-43
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-42
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-42
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-42
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-42
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-42
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-42
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-41
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-41
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-41
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-41
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-41
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-41
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-40
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-40
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-40
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-40
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-39
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-39
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-39
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-38
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-38
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-38
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-38
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-38
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-38
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-38
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-38
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-37
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-37
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-37
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-37
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-37
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-37
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-36
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-36
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-36
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-36
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-36
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-35
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-35
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-35
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-34
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-34
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-34
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-33
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-33
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-33
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-33
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-33
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-33
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-33
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-32
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-32
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-31
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-31
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-31
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-31
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-31
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-31
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-31
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-31
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-31
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-31
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-30
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-30
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-30
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-30
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-30
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-30
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-30
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-30
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-30
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-30
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-30
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-30
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-30
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-29
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-29
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-29
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-29
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-28
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-28
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-28
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-28
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-28
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-28
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-27
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-27
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-26
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-26
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-26
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-26
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-26
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-26
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-26
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-25
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-25
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-25
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-25
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-25
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-24
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-24
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-24
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-24
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-24
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-24
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-24
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-24
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-24
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-23
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-23
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-22
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-21
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-20
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-20
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-20
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-20
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-19
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-19
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-18
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-17
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-17
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-16
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-10
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  303 bits (779), Expect = e-104
 Identities = 106/256 (41%), Positives = 167/256 (65%), Gaps = 6/256 (2%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +EI   LG+G FG+VYL R+ ++   VA+K+I K++I+K +   ++ RE++I   L+HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+RLY  F D+++++L++EY   G+L+  L+K  R +E +A  Y+  + +AL Y H   +
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           +HRD+KPEN+LLD +G +K+ DFG +  +    K  T  GT +Y+APE++  K +  AVD
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 199 NWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDLSFPSA-PSISAEAKHLISRLLVKD 256
            W+LG++ YE L G PPF  + Q  + F++I K    FP     IS EAK LI +LLVKD
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238

Query: 257 SSKRLSLQKIMEHPWI 272
             KRL+ ++ ++HP+ 
Sbjct: 239 PEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  269 bits (691), Expect = 4e-91
 Identities = 109/251 (43%), Positives = 159/251 (63%), Gaps = 8/251 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG+V LVR+ ++    A+K++ K++I K K       E  I S + HP I++L+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F  +E+++L+LEYA  GEL+  L K  RF+E++A  Y A +  AL Y H   +I+RD+K
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 147 PENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
           PEN+LLD +G +K+ DFG +       S+ +T CGT +YLAPE++  K +  AVD W+LG
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL-- 261
           +L YE L G PPF AE +K+ + +I+K  L FP    +S EA+ LIS LL KD +KRL  
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE--FLSPEARDLISGLLQKDPTKRLGS 238

Query: 262 -SLQKIMEHPW 271
              ++I  HP+
Sbjct: 239 GGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  268 bits (687), Expect = 8e-90
 Identities = 114/258 (44%), Positives = 154/258 (59%), Gaps = 7/258 (2%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFE  + LG G FGRV LVR   S    ALKI+ K +I K K    +  E  I  S+RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P ++ LYG F DD  ++L++EY   GEL+  LRK  RF E  A  Y A +  AL Y H  
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
            +++RD+KPENLLLD +G +KI DFG++ + + + +T+CGT +YLAPE++ +K +  AVD
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVD 180

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS 258
            W LGIL YE L G PPF  ++    + +I++  + FPS    S +AK LI  LL  D +
Sbjct: 181 WWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAKDLIRNLLQVDLT 238

Query: 259 KRLSLQK-----IMEHPW 271
           KRL   K     I  HPW
Sbjct: 239 KRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  264 bits (677), Expect = 8e-89
 Identities = 102/261 (39%), Positives = 145/261 (55%), Gaps = 10/261 (3%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ R LG G FG VY  +   +   VA+KI+ K   +  K Q   RRE+ I   L HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ-TARREIRILRRLSHPN 59

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+RL   F D + ++L++EY   G+L+  L +    +E +A      +   L Y H N +
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           IHRD+KPEN+LLD  G +KI DFG + +   S S   T  GT  Y+APE ++    +   
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKD---TFRRIM--KVDLSFPSAPSISAEAKHLISR 251
           VD W+LG++ YE L G PPF  E+  D     RRI+   ++   P   S S EAK LI +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 252 LLVKDSSKRLSLQKIMEHPWI 272
            L KD SKR + ++I++HPW 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  252 bits (647), Expect = 7e-84
 Identities = 97/281 (34%), Positives = 152/281 (54%), Gaps = 30/281 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-R 77
            DF+ G+ +G+G F  V L +E E+    A+KI+ K Q+ K K    ++ E E+ + L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP I++LY  F D+E ++ +LEYA  GEL + +RK+    E+    Y A +  AL Y H 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----------------------QSRSKRH 174
             +IHRD+KPEN+LLD +  +KI DFG +                        ++R +  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
           +  GT +Y++PE++  K    + D W LG + Y+ L G PPF   ++  TF++I+K++ S
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 235 FPSAPSISAEAKHLISRLLVKDSSKRL----SLQKIMEHPW 271
           FP  P+   +AK LI +LLV D   RL       ++  HP+
Sbjct: 241 FP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  231 bits (591), Expect = 1e-75
 Identities = 104/256 (40%), Positives = 145/256 (56%), Gaps = 13/256 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G FGRV LV+        ALK + K  I +   Q  +  E EI     HP I++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F D + I++++EY   GEL+  LR    F E  A  YIA +  A  Y H   +I+RD+K
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 147 PENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGI 204
           PENLLLD  G +K+ DFG++  ++S  K  T CGT +Y+APE++ NK +D++VD W+LGI
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 205 LCYEFLYGAPPF--EAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKR 260
           L YE L G PPF  + E   + +  I+K +  L FP+   I   AK LI +LL ++  +R
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEER 238

Query: 261 LSLQK-----IMEHPW 271
           L   K     I +H W
Sbjct: 239 LGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  228 bits (583), Expect = 9e-74
 Identities = 100/291 (34%), Positives = 157/291 (53%), Gaps = 38/291 (13%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F+  + LGKG  GRV+LVR   +    ALK++ K+++ K     ++  E EI ++L H
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
           P +  LY  F  +  + L+++Y   GEL+R L++   +  +E+ A  Y A +  AL Y H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-------------------- 176
              +++RD+KPEN+LL   G + + DF  S QS  +   +                    
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 177 ------------CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT 224
                        GT +Y+APE++    H  AVD WTLGIL YE LYG  PF+  ++ +T
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQK----IMEHPW 271
           F  I+K +++FP +P +S+ A+ LI +LLVKD SKRL  ++    I +HP+
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  223 bits (570), Expect = 2e-72
 Identities = 93/260 (35%), Positives = 143/260 (55%), Gaps = 14/260 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           + KG +GRV+L ++  +    A+K+I K  + +     Q+  E +I S  + P +++LY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F   + ++L++EY   G+L   L       E  A  YIA +  AL Y H N +IHRD+K
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 147 PENLLLDHEGRLKIGDFGWS---VQSRSKR--------HTMCGTLDYLAPEMVENKEHDY 195
           P+N+L+D  G LK+ DFG S   +  R             + GT DY+APE++  + H  
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
            VD W+LG + YEFL G PPF  E+ ++ F+ I+   + +P    +S EA  LIS+LLV 
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240

Query: 256 DSSKRL---SLQKIMEHPWI 272
           D  KRL   S+++I  HP+ 
Sbjct: 241 DPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  215 bits (549), Expect = 1e-69
 Identities = 83/260 (31%), Positives = 136/260 (52%), Gaps = 15/260 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            FEI   +GKG FG VY  R   +   VA+K+I   ++E  + + ++  E++I    +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHP 57

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHEN 138
           NI++ YG +   + +++++E+   G L   L+  ++  TE Q A     L   L Y H N
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            +IHRDIK  N+LL  +G +K+ DFG S Q      R+TM GT  ++APE++  K +DY 
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK--VDLSFPSAPSI---SAEAKHLISR 251
            D W+LGI   E   G PP+     +    + +        P   +    S E K  + +
Sbjct: 178 ADIWSLGITAIELAEGKPPYS----ELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233

Query: 252 LLVKDSSKRLSLQKIMEHPW 271
            L K+  KR + +++++HP+
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  217 bits (555), Expect = 1e-69
 Identities = 100/262 (38%), Positives = 149/262 (56%), Gaps = 7/262 (2%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
            W L DFE+G  LG G FGRV + +   +    A+K + K +I K K    + +E  I  
Sbjct: 14  SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+ +   F D+ R++ +LE+   GEL+  LRK  RF    A  Y A L  A  Y
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            H   +I+RD+KPENLLLD++G +K+ DFG++ +   +  T+CGT +YLAPE++++K H 
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHG 193

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
            AVD WT+G+L YEF+ G PPF  ++    + +I+   L FP+       A+ L+  LL 
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQ 251

Query: 255 KDSSKRL-----SLQKIMEHPW 271
            D +KRL      +  +  HP+
Sbjct: 252 TDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  209 bits (534), Expect = 8e-67
 Identities = 101/259 (38%), Positives = 151/259 (58%), Gaps = 9/259 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
            D E  + +G G FGRV+LVR+  S+H  ALK++   E I   + QH +  E  +   + 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-VHNEKRVLKEVS 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP I+RL+   HD   +++++EY   GEL+  LR   RF+      Y + +  AL Y H 
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
             +++RD+KPEN+LLD EG +K+ DFG++ + R +  T+CGT +YLAPE++++K H+ AV
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAV 179

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           D W LGIL YE L G PPF  ++    + +I+   L FP    +   AK LI +LLV D 
Sbjct: 180 DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAKDLIKKLLVVDR 237

Query: 258 SKRLSLQK-----IMEHPW 271
           ++RL   K     +  H W
Sbjct: 238 TRRLGNMKNGADDVKNHRW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  206 bits (526), Expect = 5e-66
 Identities = 91/263 (34%), Positives = 147/263 (55%), Gaps = 15/263 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSSLR 77
            +EI + +GKG FG+VYLVR         LK I    +     + +     E++I   L 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI---DLSNMSEKEREDALNEVKILKKLN 57

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALA 133
           HPNI++ Y  F +  ++ +++EYA  G+L ++++K ++    F E+Q   +   L  AL 
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVEN 190
           Y H   ++HRDIKP+N+ L   G +K+GDFG S     +     T+ GT  YL+PE+ +N
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI-SAEAKHLI 249
           K ++Y  D W+LG + YE      PFE E+  +   +I+K    +P  PS  S+E ++L+
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPIPSQYSSELRNLV 235

Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
           S LL KD  +R S+ +I++ P+I
Sbjct: 236 SSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  202 bits (517), Expect = 1e-64
 Identities = 86/260 (33%), Positives = 145/260 (55%), Gaps = 11/260 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQLRREMEIQSSLRHP 79
           FE+ R +GKG FG+V +V++ ++K   A+K + K++ +EK  ++  +  E  I   L HP
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-NVLNERRILQELNHP 60

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            ++ L+  F D+E ++L+++    G+L   L +  +F+E+Q   +I  +  AL Y H   
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           +IHRDIKP+N+LLD +G + I DF  +  V   +   +  GT  Y+APE++  + +  AV
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDT---FRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
           D W+LG+  YE L G  P+   S+        +    D+ +P+  S   EA   I++LL 
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST--EAIDAINKLLE 238

Query: 255 KDSSKRLS--LQKIMEHPWI 272
           +D  KRL   L+ +  HP+ 
Sbjct: 239 RDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  201 bits (513), Expect = 1e-64
 Identities = 87/250 (34%), Positives = 129/250 (51%), Gaps = 41/250 (16%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG VYL R+ ++   VA+KII KE         +L RE+EI   L HPNI++LYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F D+  ++L++EY   G L   L+++  + +E +    +  +   L Y H N +IHRD+
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 146 KPENLLLDH-EGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENK-EHDYAVDNW 200
           KPEN+LLD   G++K+ DFG S    S +    T+ GT  Y+APE++  K  +    D W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR 260
           +LG++ YE                                   E K LI ++L KD  KR
Sbjct: 179 SLGVILYEL---------------------------------PELKDLIRKMLQKDPEKR 205

Query: 261 LSLQKIMEHP 270
            S ++I+EH 
Sbjct: 206 PSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  202 bits (516), Expect = 3e-63
 Identities = 101/288 (35%), Positives = 156/288 (54%), Gaps = 38/288 (13%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQLRREMEIQSSLRH 78
           DFE+ + +G+G FG V+LVR+ ++    A+K++ K   I++ +I H +R E +I +    
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADS 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P I++LY  F D+E ++L++EY   G+L   L +   F E+ A  YIA L  AL   H+ 
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG-----------WSVQSRS---------------- 171
             IHRDIKP+N+L+D +G +K+ DFG               + S                
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 172 -KRHTMC----GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR 226
            +R        GT DY+APE++    +    D W+LG++ YE LYG PPF +++ ++T+ 
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 227 RIM--KVDLSFPSAPSISAEAKHLISRLLVKDSSKRL-SLQKIMEHPW 271
           +I+  K  L FP  P +S EA  LI RLL  D   RL S ++I  HP+
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  194 bits (495), Expect = 3e-61
 Identities = 91/262 (34%), Positives = 132/262 (50%), Gaps = 13/262 (4%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLRH 78
           D E  + LG+G  G VY VR   +    ALK I      E    + QL RE++   S   
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCES 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS-LTNALAYCH- 136
           P +++ YG F+ +  I ++LEY   G L   L+K  +  E   A YIA  +   L Y H 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLHT 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAPEMVENKEH 193
           + H+IHRDIKP NLL++ +G +KI DFG S     +  + +T  GT+ Y++PE ++ + +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---RRIMKVDLSFPSAPSISAEAKHLIS 250
            YA D W+LG+   E   G  PF    Q   F   + I         A   S E +  IS
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237

Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
             L KD  KR S  ++++HP+I
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  189 bits (482), Expect = 4e-59
 Identities = 104/270 (38%), Positives = 156/270 (57%), Gaps = 20/270 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           +FE+ R LG G +G+V+LVR+V         A+K++ K  I +K K     R E ++  +
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 76  LRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +R  P ++ L+  F  D ++ LIL+Y + GEL+  L +   FTE +   YIA +  AL +
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVEN 190
            H+  +I+RDIK EN+LLD EG + + DFG S     +   + ++ CGT++Y+APE++  
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPF----EAESQKDTFRRIMKVDLSFPSAPSISAE 244
               HD AVD W+LG+L +E L GA PF    E  SQ +  RRI+K    FP   ++SAE
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--KTMSAE 238

Query: 245 AKHLISRLLVKDSSKRL---SLQKIMEHPW 271
           A+  I +LL KD  KRL      +I  HP+
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  186 bits (475), Expect = 2e-58
 Identities = 84/262 (32%), Positives = 138/262 (52%), Gaps = 11/262 (4%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++  G  LG+G FG VYL  + ++   +A+K +      + +++  L RE+ I SSL+HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE-ALEREIRILSSLQHP 59

Query: 80  NILRLYGWFHDDERIFL--ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           NI+R YG   D+E+  L   LEY   G L   L+K  +  E     Y   +   LAY H 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG-----WSVQSRSKRHTMCGTLDYLAPEMVENKE 192
           N ++HRDIK  N+L+D +G +K+ DFG       +++     ++ GT  ++APE++  +E
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 193 HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLIS 250
           +  A D W+LG    E   G PP+ E  +      +I       P  P  +S EAK  + 
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-PEIPEHLSEEAKDFLR 238

Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
           + L +D  KR +  ++++HP++
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  184 bits (470), Expect = 1e-57
 Identities = 91/255 (35%), Positives = 135/255 (52%), Gaps = 11/255 (4%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQL--RREMEIQSSLRHPNI 81
           +P+ KG FG VYL ++  +    A+K++ K + I K ++ +    R  M IQ     P +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYV 59

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
            +LY  F   + ++L++EY + G+    ++      E  A  YIA +   +   H+  +I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           HRDIKPENLL+D  G LK+ DFG S      +    GT DYLAPE +     D   D W+
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-FVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLISRLLVKDSSK 259
           LG + +EFL+G PPF AE+    F  I+   +++P       S EA  LI+RLL  D +K
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238

Query: 260 RLS---LQKIMEHPW 271
           RL     Q+I  HP+
Sbjct: 239 RLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  186 bits (473), Expect = 3e-57
 Identities = 94/244 (38%), Positives = 147/244 (60%), Gaps = 9/244 (3%)

Query: 25  RPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPN 80
           + LGKG +G+V+ VR+V         A+K++ K  I +  K     + E  I  +++HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ L   F    +++LILEY   GEL+  L +   F E  A  Y++ ++ AL + H+  +
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           I+RD+KPEN+LLD +G +K+ DFG    S+   +  HT CGT++Y+APE++    H  AV
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV 181

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           D W+LG L Y+ L GAPPF AE++K T  +I+K  L+ P  P ++ EA+ L+ +LL ++ 
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP--PYLTPEARDLLKKLLKRNP 239

Query: 258 SKRL 261
           S RL
Sbjct: 240 SSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  182 bits (464), Expect = 5e-56
 Identities = 101/254 (39%), Positives = 151/254 (59%), Gaps = 12/254 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H L     +Q++ RHP +  L 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y H   V++RD+
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEHDYAVDNWTL 202
           K ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ ++  AVD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL- 261
           G++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ LL KD  +RL 
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLG 239

Query: 262 ----SLQKIMEHPW 271
                 ++IMEH +
Sbjct: 240 GGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  183 bits (465), Expect = 6e-56
 Identities = 100/272 (36%), Positives = 151/272 (55%), Gaps = 8/272 (2%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQH 64
           + +E  RK +   +DF   R LG G FGRV L   + E   PVA+K   K +I K K   
Sbjct: 17  STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
            +  E +I + + HP  + LYG F D+  ++L+LE+   GE +  LR+++RF       Y
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY 136

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLA 184
            A +     Y    ++++RD+KPENLLLD +G +K+ DFG++    ++ +T+CGT +Y+A
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIA 196

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           PE++ N  H  A D WTLGI  YE L G PPF A      +++I++  + FP    +   
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF--LDNN 254

Query: 245 AKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
            KHL+ +LL  D +KR        Q + EHPW
Sbjct: 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  179 bits (455), Expect = 1e-54
 Identities = 89/253 (35%), Positives = 143/253 (56%), Gaps = 10/253 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L +        A+K++ K+ I K K Q  +  E  +   +++HP ++ L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   ++++ +L+Y + GEL+  L++ R F E +A  Y A + +AL Y H  ++I+RD+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG     ++      T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL- 261
           G + YE LYG PPF +    + +  I+   L     P+IS  A+HL+  LL KD +KRL 
Sbjct: 183 GAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLG 240

Query: 262 ---SLQKIMEHPW 271
                 +I  H +
Sbjct: 241 AKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  175 bits (445), Expect = 8e-54
 Identities = 83/256 (32%), Positives = 141/256 (55%), Gaps = 5/256 (1%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++G  +G+G FG VY    +E+   VA+K I  E+I++  ++  + +E+++  +L+HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI++  G     + +++ILEYA  G L + ++K   F E   A Y+  +   LAY HE  
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYA 196
           VIHRDIK  N+L   +G +K+ DFG + +         ++ GT  ++APE++E      A
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
            D W+LG    E L G PP+   +      RI++ D   P    IS E K  + +   KD
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKD 238

Query: 257 SSKRLSLQKIMEHPWI 272
            + R + +++++HPWI
Sbjct: 239 PNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  176 bits (448), Expect = 2e-53
 Identities = 86/257 (33%), Positives = 140/257 (54%), Gaps = 15/257 (5%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLRHPNI 81
           + LGKG FG+V L     +    A+K++ K+ I   +  +     +R + +    +HP +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
            +L+  F   +R+F ++EY + G+L   +++  RF E +A  Y A +   L + HE  +I
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           +RD+K +N+LLD EG +KI DFG     +       T CGT DY+APE++  + +  AVD
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS 258
            W LG+L YE L G  PFE + + + F+ I++ ++ +P    +S EAK ++   L K+  
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPE 236

Query: 259 KRLSL-----QKIMEHP 270
           KRL       Q I  HP
Sbjct: 237 KRLGCLPTGEQDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  175 bits (446), Expect = 3e-53
 Identities = 91/258 (35%), Positives = 157/258 (60%), Gaps = 18/258 (6%)

Query: 27  LGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSSLRHPNI 81
           LG+G FG+V+LVR++   ++    A+K++ K  +   K++ ++R +ME  I + + HP I
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFI 60

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           ++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + H   +I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           +RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + H  + D
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 180

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS 258
            W+ G+L +E L G+ PF+ + +K+T   I+K  L  P    +S EA+ L+  L  ++ +
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNPA 238

Query: 259 KRL-----SLQKIMEHPW 271
            RL      +++I  HP+
Sbjct: 239 NRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 5e-53
 Identities = 86/258 (33%), Positives = 142/258 (55%), Gaps = 6/258 (2%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+I   +G+G +G+V+L ++ ++   VALK + K  + K      +  E +I ++ +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            +++L   F DDE ++L +EY   G+    L      +E  A  Y+A +  A+   HE  
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
            IHRD+KPEN L+D  G +K+ DFG S    +  +++ G+ DY+APE++  K +D+ VD 
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPS----APSISAEAKHLISRLL 253
           W+LG + YEFL G PPF   +  +T+  +   K  L  P       ++S EA  LI++L+
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 254 VKDSSKRLSLQKIMEHPW 271
              S +  SL+ I  HP+
Sbjct: 242 NDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  174 bits (441), Expect = 5e-53
 Identities = 103/275 (37%), Positives = 159/275 (57%), Gaps = 22/275 (8%)

Query: 20  DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           +FE+ + LG G +G+V+LVR+V   +S    A+K++ K  I +K K     R E ++   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 76  LRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +R  P ++ L+  F  D ++ LIL+Y + GEL+  L +  RF EQ+   Y   +  AL +
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMVEN 190
            H+  +I+RDIK EN+LLD  G + + DFG S +       + ++ CGT++Y+AP++V  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPF----EAESQKDTFRRIMKVDLSFPSAPSISAE 244
            +  HD AVD W++G+L YE L GA PF    E  SQ +  RRI+K +  +P    +SA 
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSAL 238

Query: 245 AKHLISRLLVKDSSKRL-----SLQKIMEHPWIIK 274
           AK +I RLL+KD  KRL        +I +HP+  K
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  172 bits (437), Expect = 6e-52
 Identities = 101/252 (40%), Positives = 151/252 (59%), Gaps = 12/252 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++ RHP +  L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y H   V++RDI
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEHDYAVDNWTL 202
           K ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ ++  AVD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL- 261
           G++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ LL KD  +RL 
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLG 239

Query: 262 ----SLQKIMEH 269
                 +++MEH
Sbjct: 240 GGPSDAKEVMEH 251

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  171 bits (435), Expect = 6e-52
 Identities = 79/264 (29%), Positives = 138/264 (52%), Gaps = 11/264 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           +G+G  G VY   +  +   VA+K +  ++Q ++  I      E+ I    +HPNI+  Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-----EILIMKDCKHPNIVDYY 81

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRD 144
             +   + +++++EY   G L   + ++  R  E Q A     +   L Y H  +VIHRD
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRD 141

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           IK +N+LL  +G +K+ DFG++ Q    +SKR+++ GT  ++APE+++ K++   VD W+
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLLVKDSSKR 260
           LGI+C E   G PP+  E        I    +    +    S E K  +++ LVKD  KR
Sbjct: 202 LGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261

Query: 261 LSLQKIMEHPWIIKNANPRGTCDI 284
            S +++++HP++ K         +
Sbjct: 262 PSAEELLQHPFLKKACPKEEFAPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  174 bits (440), Expect = 7e-52
 Identities = 99/281 (35%), Positives = 143/281 (50%), Gaps = 31/281 (11%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + I R LG+G FG VYL R+   +  VALK++ K+   K K   +  RE++I +SL HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 80  -NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYC 135
            NI++LY +F D+  ++L++EY   G L   L+K  R    +E +A   +A + +AL Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 136 HENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSKR---------HTMCGTLDYLAP 185
           H   +IHRDIKPEN+LLD +G  +K+ DFG +                 T  GT  Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 186 EMVENKEH---DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           E++          + D W+LGI  YE L G PPFE E       + +K+           
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            LS  +   IS  A  L+ +LL KD   RLS    + H  +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  170 bits (431), Expect = 6e-51
 Identities = 97/271 (35%), Positives = 154/271 (56%), Gaps = 21/271 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           +FE+ + LG G +G+V+LVR+V   ++    A+K++ K  + +K K     R E  +   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 76  LRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +R  P ++ L+  F  + ++ LIL+Y   GE++  L +   F+E +   Y   +  AL +
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVEN 190
            H+  +++RDIK EN+LLD EG + + DFG S     + + + ++ CGT++Y+APE++  
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 191 KE-HDYAVDNWTLGILCYEFLYGAPPF----EAESQKDTFRRIMKVDLSFPSAPSISAEA 245
           K  H  AVD W+LGIL +E L GA PF    E  +Q +  RRI+K D  FP    I  EA
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPEA 238

Query: 246 KHLISRLLVKDSSKRL-----SLQKIMEHPW 271
           + L+ +LL KD  KRL        +I EHP+
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  168 bits (428), Expect = 1e-50
 Identities = 85/256 (33%), Positives = 144/256 (56%), Gaps = 13/256 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V L     +    A+K++ K+ I +   +   +  +  +  + +HP +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+F ++EY + G+L  ++++ R+F E ++  Y A +T AL + H + VI+RD+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N+LLD EG  K+ DFG   +         T CGT DY+APE+++  E+  +VD W L
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWAL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           G+L YE + G PPFEA+++ D F  I+  D+ +P    +S EA  ++   + K+ +KRL 
Sbjct: 183 GVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW--LSKEAVSILKAFMTKNPNKRLG 240

Query: 263 L-------QKIMEHPW 271
                     I +HP+
Sbjct: 241 CVASQGGEDAIKQHPF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  169 bits (428), Expect = 1e-50
 Identities = 100/254 (39%), Positives = 150/254 (59%), Gaps = 12/254 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LVRE  S    A+KI+ KE I  K ++ H L  E  +  + RHP +  L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTSLK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+  ++EY + GEL+  L + R F+E +   Y A + +AL Y H   +++RD+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEHDYAVDNWTL 202
           K ENL+LD +G +KI DFG   +  +   TM   CGT +YLAPE++E+ ++  AVD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL- 261
           G++ YE + G  PF  +  +  F  I+  D+ FP   ++SA+AK L+S LL+KD +KRL 
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLG 239

Query: 262 ----SLQKIMEHPW 271
                 ++IM H +
Sbjct: 240 GGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  168 bits (427), Expect = 2e-50
 Identities = 100/253 (39%), Positives = 152/253 (60%), Gaps = 13/253 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S RHP +  L 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH-ENHVIHRD 144
             F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y H E +V++RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 145 IKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           +K ENL+LD +G +KI DFG     ++  +   T CGT +YLAPE++E+ ++  AVD W 
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL 261
           LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L+S LL KD  +RL
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRL 239

Query: 262 -----SLQKIMEH 269
                  ++IM+H
Sbjct: 240 GGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  168 bits (426), Expect = 2e-50
 Identities = 95/252 (37%), Positives = 149/252 (59%), Gaps = 10/252 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           +GKG FG+V  VR+ +++   ALK I K  I  + ++ H L  E  + + +  P I+ L 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVPLK 59

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E+++L+L + + GEL+  L++  RF   +A  Y A L  AL   H+ +VI+RD+
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 146 KPENLLLDHEGRLKIGDFG---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD++G + + DFG    +++   K +T CGT +YLAPE++    +  AVD WTL
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           G+L YE L G PPF  E+  + +R+I++  L FP       +AK L+  LL +D ++RL 
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLG 237

Query: 263 L---QKIMEHPW 271
               Q+I  HP+
Sbjct: 238 YNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  166 bits (421), Expect = 1e-49
 Identities = 92/257 (35%), Positives = 147/257 (57%), Gaps = 12/257 (4%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILR 83
           R LGKG FG+V L R  ES    A+K++ K+ I +         E  I S  R HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           LY  F   +R+F ++E+ + G+L   ++K RRF E +A  Y A +T+AL + H+  +I+R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLDHEG  K+ DFG     + +     T CGT DY+APE+++   +  +VD W
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR 260
            +G+L YE L G  PFEAE++ D F  I+  ++ +P+   +S +A  ++   + K+ + R
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LSQDAVDILKAFMTKNPTMR 238

Query: 261 LSL------QKIMEHPW 271
           L        + I+ HP+
Sbjct: 239 LGSLTLGGEEAILRHPF 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  167 bits (424), Expect = 2e-49
 Identities = 98/299 (32%), Positives = 156/299 (52%), Gaps = 49/299 (16%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLRH 78
           DFE  + +G+G FG V LV++ ++ H  A+K + K E +EK ++ H +R E +I +   +
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADN 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++LY  F D+  ++LI+EY   G++   L K   FTE++   YIA    A+   H+ 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG---------------------------------- 164
             IHRDIKP+NLLLD +G +K+ DFG                                  
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 165 -------WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
                  W    R+  ++  GT DY+APE+     ++   D W+LG++ YE L G PPF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 218 AESQKDTFRRIM--KVDLSFPSAPSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 271
           +++ ++T+R+I+  K  L FP    +S EAK LI RL   ++ +RL    + +I  HP+
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  165 bits (419), Expect = 2e-49
 Identities = 85/239 (35%), Positives = 142/239 (59%), Gaps = 6/239 (2%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L R    +   A+K++ K+ I K K +  +  E  +   +++HP ++ L+
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   ++++ +L+Y + GEL+  L++ R F E +A  Y A + +AL Y H  ++++RD+
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG    +++      T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL 261
           G + YE LYG PPF + +  + +  I+   L     P+I+  A+HL+  LL KD +KRL
Sbjct: 183 GAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--KPNITNSARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  165 bits (419), Expect = 3e-49
 Identities = 83/266 (31%), Positives = 136/266 (51%), Gaps = 14/266 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF++   +G+G FG V +VRE  +    A+K++ K  +   +       E +I S    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
           P I +L   F D + ++L++EY   G+L   L ++  +F E  A  Y+A L  A+   H+
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM----CGTLDYLAPEMVE---- 189
              +HRDIKPEN+L+D  G +K+ DFG + +  + +        GT DY+APE++     
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 190 --NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSISAEA 245
                +    D W+LG++ YE +YG  PF   +   T+  IM  +  L FP  P +S++ 
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPW 271
             LI  LL     +RL  + +  HP+
Sbjct: 241 LDLIQSLLC-GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  163 bits (414), Expect = 5e-49
 Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 21/268 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII----FKEQIEKYKIQHQLRREMEIQS 74
           + F +   +GKG FG VY   +  +   VA+K+I     +++IE       +++E++  S
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE------DIQQEIQFLS 54

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
             R P I + YG F    ++++I+EY   G    +L K  +  E   A  +  +   L Y
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAFILREVLLGLEY 113

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENK 191
            HE   IHRDIK  N+LL  EG +K+ DFG S Q   + SKR+T  GT  ++APE+++  
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPSISAEAKHL 248
            +D   D W+LGI   E   G PP    S     R +  +  + P        S   K  
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPL---SDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           +S  L KD  +R S +++++H + IK A
Sbjct: 231 VSLCLNKDPKERPSAKELLKHKF-IKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  162 bits (413), Expect = 3e-48
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 20/259 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALK------IIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           LG+G FG+V L    ++    A+K      II ++++E    +   +R  E  +S RHP 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE---KRIFETANSERHPF 63

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++ L+  F  ++ +  ++EYA  G+L   +     F+E +A  Y A +   L Y HEN +
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKI 122

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           ++RD+K +NLLLD EG +KI DFG   +      +  T CGT ++LAPE++    +  AV
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           D W LG+L YE L G  PF  + +++ F  I+  ++ +P    +S EA  ++ RLL ++ 
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLRRNP 240

Query: 258 SKRL-----SLQKIMEHPW 271
            +RL       + + + P+
Sbjct: 241 ERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  160 bits (408), Expect = 3e-48
 Identities = 83/266 (31%), Positives = 132/266 (49%), Gaps = 23/266 (8%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           G  +G G FG+VY    +++   +A+K I + Q    K   ++  EM++   L+HPN+++
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            YG     E++++ +EY   G L   L   R   E     Y   L   LAY H + ++HR
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---------MCGTLDYLAPEMV---ENK 191
           DIKP N+ LDH G +K+GDFG +V  + K +T         + GT  Y+APE++   + K
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAV--KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----FRRIMKVDLSFPSAPSISAEAK 246
            H  A D W+LG +  E   G  P+   S+ D      F          P +  +S E K
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238

Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWI 272
             + R L  D  KR +  ++++HP++
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 3e-48
 Identities = 81/286 (28%), Positives = 144/286 (50%), Gaps = 38/286 (13%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E    LG+G +G VY  R+ ++   VALK I  +  E+  I     RE+ +   L+HPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPN 59

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENH 139
           I++L    H + +++L+ EY    +L + L K     +     + +  L   LAYCH + 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT---MCGTLDYLAPE-MVENKEH 193
           ++HRD+KP+N+L++ +G LK+ DFG +       + +T   +  TL Y APE ++ +K +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHY 176

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------DLSF 235
             AVD W++G +  E + G P F  +S+ D   +I ++                    +F
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236

Query: 236 PS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           P           P +  E   L+S++L  + +KR+S ++ ++HP+ 
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  160 bits (406), Expect = 2e-47
 Identities = 85/239 (35%), Positives = 134/239 (56%), Gaps = 6/239 (2%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L +        A+K++ K+ I K K Q+ +  E  +   +L+HP ++ L+
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E+++ +L+Y + GEL+  L++ R F E +A  Y A + +A+ Y H  ++I+RD+
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG     V+      T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL 261
           G + YE LYG PPF +      +  I+   L  P     +  A  L+  LL KD  +RL
Sbjct: 183 GAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP--GGKTVAACDLLVGLLHKDQRRRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  158 bits (401), Expect = 7e-47
 Identities = 84/286 (29%), Positives = 132/286 (46%), Gaps = 36/286 (12%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            ++I   +G+G  G V+  ++ E+   VALK +   ++E   I +Q  RE++   + +HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHEN 138
            +++L   F       L++EY     L   LR   R   E Q  +Y+  L   +AY H N
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTM---CGTLDYLAPEMVENKEH- 193
            ++HRD+KP NLL+  +G LKI DFG + + S  +         T  Y APE++      
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DLS 234
           D  VD W +G +  E L G+P F  E+  +    + +                     ++
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238

Query: 235 FPSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           FP +         P  S EA  L+  LLV D SKRLS  + + HP+
Sbjct: 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  159 bits (403), Expect = 7e-47
 Identities = 89/256 (34%), Positives = 147/256 (57%), Gaps = 12/256 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQL-RREMEIQSSLRH-PNILR 83
           +GKG FG+VY VR+ +++   A+K++ K++I  K ++ H +  R + +++ L   P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L   F  D  ++L+ +Y   GEL+  L+K  RF+E +A  YIA L  AL + H+  +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPE-MVENKEHDYAVDN 199
           D+KPEN+LLD  G + + DFG S  + +     +T CGT +YLAPE +++ K +   VD 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSK 259
           W+LG+L +E   G  PF AE  +  +R I    + FP    +S E +  +  LL ++   
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQH 239

Query: 260 RL----SLQKIMEHPW 271
           RL       ++ EHP+
Sbjct: 240 RLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  158 bits (402), Expect = 1e-46
 Identities = 85/263 (32%), Positives = 141/263 (53%), Gaps = 15/263 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE---QIEKYKIQHQLRREMEIQSSL 76
           DF     LGKG FG+V L     +    A+KI+ K+   Q +  +     +R + +    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-- 58

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           + P + +L+  F   +R++ ++EY + G+L   +++  +F E  A  Y A +   L + H
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
              +I+RD+K +N++LD EG +KI DFG    ++       T CGT DY+APE++  + +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             +VD W  G+L YE L G PPF+ E + + F+ IM+ ++S+P   S+S EA  +   LL
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLL 236

Query: 254 VKDSSKRLSL-----QKIMEHPW 271
            K  +KRL       + I EH +
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAF 259

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  155 bits (393), Expect = 6e-46
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 18/268 (6%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            D E    LG G  G V  V    +   +A+K I  E      IQ Q+ RE++I      
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNS 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGEL---YRELRKHRRFTEQQAATYIASLTNALAYC 135
           P I+  YG F+++  I + +EY   G L    +E++   R  E+       ++   L Y 
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG--RIPERILGKIAVAVLKGLTYL 116

Query: 136 HENH-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEH 193
           HE H +IHRD+KP N+L++  G++K+ DFG S Q   S   T  GT  Y+APE ++  ++
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDY 176

Query: 194 DYAVDNWTLGILCYE-----FLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS--ISAEAK 246
               D W+LG+   E     F Y       +   +  + I  V+   P  PS   S + +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--VNEPPPRLPSGKFSPDFQ 234

Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWIIK 274
             ++  L+KD  +R S ++++EHP+I K
Sbjct: 235 DFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 6e-46
 Identities = 90/258 (34%), Positives = 136/258 (52%), Gaps = 20/258 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLRH---PNI 81
           +G+G +G VY  + V +   VALKII       +   IQ    RE+ + S LR    PNI
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ----REVALLSQLRQSQPPNI 64

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
            + YG +    R+++I+EYA  G + R L K     E+  +  I  +  AL Y H+  VI
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV-ENKEHDYAV 197
           HRDIK  N+L+ + G +K+ DFG +    Q+ SKR T  GT  ++APE++ E K +D   
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPSISAEAKHLISRLLV 254
           D W+LGI  YE   G PP+   S  D FR +M +  S P        S   +  ++  L 
Sbjct: 184 DIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240

Query: 255 KDSSKRLSLQKIMEHPWI 272
           ++  +RLS +++++  WI
Sbjct: 241 EEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  152 bits (386), Expect = 7e-45
 Identities = 86/269 (31%), Positives = 132/269 (49%), Gaps = 20/269 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRH 78
           D+E+   +GKG FG V  VR       +  K I    + EK K Q  L  E+ I   L+H
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ--LVSEVNILRELKH 58

Query: 79  PNILRLYGWFHD--DERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNAL 132
           PNI+R Y    D  ++ +++++EY   G+L + ++K     +   E+     +  L  AL
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 133 AYCH-----ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             CH      N V+HRD+KP N+ LD    +K+GDFG +       S   T  GT  Y++
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI-SA 243
           PE + +  +D   D W+LG L YE    +PPF A +Q     +I   +  F   P   S+
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--EGKFRRIPYRYSS 236

Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           E   +I  +L  D  KR S +++++ P I
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  152 bits (385), Expect = 7e-45
 Identities = 78/259 (30%), Positives = 129/259 (49%), Gaps = 15/259 (5%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK---IIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           G  LG G FG VY    ++     A+K   +    Q  +  ++ QL +E+ + S L+HPN
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK-QLEQEIALLSKLQHPN 63

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++  G   +++ +++ LE    G L + L+K+  F E     Y   +   L Y H+ + 
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT--MCGTLDYLAPEMVENK-EHDYAV 197
           +HRDIK  N+L+D  G +K+ DFG + Q           G+  ++APE++  +  +  A 
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI----SAEAKHLISRLL 253
           D W+LG    E   G PP+   SQ +    + K+  S    P I    S EAK  I + L
Sbjct: 184 DIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRS-KELPPIPDHLSDEAKDFILKCL 239

Query: 254 VKDSSKRLSLQKIMEHPWI 272
            +D S R +  +++EHP++
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  154 bits (389), Expect = 7e-45
 Identities = 84/253 (33%), Positives = 140/253 (55%), Gaps = 10/253 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L +        A+K++ K+ +   K Q  +  E  +   +++HP ++ L+
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E+++ +L++ + GEL+  L++ R F E +A  Y A + +AL Y H  ++++RD+
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRH---TMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG   +  ++     T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           G + YE LYG PPF      + +  I+   L     P  S  A  ++  LL KD  +RL 
Sbjct: 183 GAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL--RPGASLTAWSILEELLEKDRQRRLG 240

Query: 263 LQ----KIMEHPW 271
            +    +I EHP+
Sbjct: 241 AKEDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  151 bits (383), Expect = 1e-44
 Identities = 82/257 (31%), Positives = 128/257 (49%), Gaps = 9/257 (3%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF++ + LGKG +G VY V+ +      ALK +        K +     E+ I +S+ HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYC 135
           NI+     F D  ++ +++EYA  G+L + + K     +   EQ+       L   L   
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGTLDYLAPEMVENKEHD 194
           HE  ++HRD+K  N+LL     +KIGD G S V  ++   T  GT  Y+APE+ + + + 
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI-SAEAKHLISRLL 253
           Y  D W+LG L YE    APPFEA S +D   ++ +    +P  P I S + ++ I  +L
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIPPIYSQDLQNFIRSML 237

Query: 254 VKDSSKRLSLQKIMEHP 270
                 R +  KI+  P
Sbjct: 238 QVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  150 bits (380), Expect = 2e-43
 Identities = 84/250 (33%), Positives = 138/250 (55%), Gaps = 7/250 (2%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V L     +    A+K + K+ + E   ++  +     +  +  HP +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E +F ++EY + G+L   ++   RF E +A  Y A +   L + H+  +I+RD+
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N+LLD +G +KI DFG    ++    K  T CGT DY+APE+++ ++++ +VD W+ 
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSF 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           G+L YE L G  PF  E + + F  I+     FP    IS EAK  +S+L  +D +KRL 
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--WISKEAKDCLSKLFERDPTKRLG 240

Query: 263 LQ-KIMEHPW 271
           +   I +HP+
Sbjct: 241 VDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  150 bits (380), Expect = 4e-43
 Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 22/293 (7%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
            + ++          SL + E    +G G  G VY V    +    ALK+I+    +   
Sbjct: 57  SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-- 114

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           ++ Q+ RE+EI   + HPN+++ +  F  +  I ++LE+   G L           EQ  
Sbjct: 115 VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFL 170

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--C-- 177
           A     + + +AY H  H++HRDIKP NLL++    +KI DFG    SR    TM  C  
Sbjct: 171 ADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFG---VSRILAQTMDPCNS 227

Query: 178 --GTLDYLAPEMVENKEHD-----YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK 230
             GT+ Y++PE +    +      YA D W+LG+   EF  G  PF    Q D    +  
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA 287

Query: 231 VDLSFPSAP--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 281
           + +S P     + S E +H IS  L ++ +KR S  ++++HP+I++    +G 
Sbjct: 288 ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQ 340

Length = 353

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  149 bits (378), Expect = 1e-42
 Identities = 93/276 (33%), Positives = 144/276 (52%), Gaps = 15/276 (5%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E   K     +DF++ + +G+G FG V LVR   SK   A+K++ K ++ K         
Sbjct: 33  EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E +I +      I++L+  F DD+ +++++EY   G+L   L  +    E+ A  Y A +
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEKWARFYTAEV 151

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLA 184
             AL   H    IHRD+KP+N+LLD  G LK+ DFG  ++  +     C    GT DY++
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYIS 211

Query: 185 PEMVENKEHD--YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSA 238
           PE+++++  D  Y    D W++G+  YE L G  PF A+S   T+ +IM  K  L+FP  
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271

Query: 239 PSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 271
             IS +AK LI   L  D   RL    + +I  HP+
Sbjct: 272 IEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  147 bits (373), Expect = 2e-42
 Identities = 84/248 (33%), Positives = 138/248 (55%), Gaps = 10/248 (4%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE---QIEKYKIQHQLRREMEIQSSL 76
           DF     LGKG FG+V L     +    A+KI+ K+   Q +  +     +R + +Q   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-- 58

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           + P + +L+  F   +R++ ++EY + G+L   +++  +F E QA  Y A ++  L + H
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKEH 193
              +I+RD+K +N++LD EG +KI DFG   +         T CGT DY+APE++  + +
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             +VD W  G+L YE L G PPF+ E + + F+ IM+ ++S+P   S+S EA  +   L+
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLM 236

Query: 254 VKDSSKRL 261
            K  SKRL
Sbjct: 237 TKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 2e-42
 Identities = 89/280 (31%), Positives = 141/280 (50%), Gaps = 38/280 (13%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-- 77
            FE+   +G+G +G+VY  R  ++   VA+KI+   + E+ +I+ +          LR  
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYN-------ILRKY 59

Query: 78  --HPNILRLYGWF-------HDDERIFLILEYAHRG---ELYRELRKH-RRFTEQQAATY 124
             HPNI   YG F       +DD+ ++L++E    G   +L + LRK  +R  E+  A  
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLD 181
           +      LAY HEN VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 182 YLAPEMVENKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
           ++APE++   E     +D   D W+LGI   E   G PP          R + K+  + P
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIPRNPP 235

Query: 237 ----SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
               S  + S +    IS  L+K+  +R  +++++EHP+I
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  145 bits (368), Expect = 3e-42
 Identities = 81/264 (30%), Positives = 139/264 (52%), Gaps = 20/264 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
           + F+I   LG+G +G VY     E+   VA+K++  +E ++      ++ +E+ I     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ------EIIKEISILKQCD 56

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYC 135
            P I++ YG +  +  +++++EY   G +  ++ K  ++  TE++ A  +      L Y 
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYL 115

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKE 192
           H N  IHRDIK  N+LL+ EG+ K+ DFG S Q   + +KR+T+ GT  ++APE+++   
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPS-ISAEAKHL 248
           ++   D W+LGI   E   G PP+   S     R I  +    P   S P   S E    
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF 232

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWI 272
           + + LVKD  +R S  ++++HP+I
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  145 bits (368), Expect = 4e-42
 Identities = 77/269 (28%), Positives = 139/269 (51%), Gaps = 22/269 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-----EIQSSLRHPNI 81
           +G+G  G V +  +  +   VA+K        K  ++ Q RRE+      I    +HPNI
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVK--------KMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           + +Y  +   + +++++E+   G L  ++  H R  E+Q AT   ++  AL++ H   VI
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVI 137

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +++LL  +GR+K+ DFG+  Q      +R ++ GT  ++APE++    +   VD
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPSISAEAKHLISRLLVK 255
            W+LGI+  E + G PP+  E      +RI   D   P   +   +S   +  + R+LV+
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR--DNLPPKLKNLHKVSPRLRSFLDRMLVR 255

Query: 256 DSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           D ++R +  +++ HP++ K   P     +
Sbjct: 256 DPAQRATAAELLNHPFLAKAGPPSSIVPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  144 bits (365), Expect = 6e-42
 Identities = 85/255 (33%), Positives = 133/255 (52%), Gaps = 7/255 (2%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E  R +G+G FG V+L R    +  V +K I  EQ+ K   +   + E ++   L HPN
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHEN 138
           I+  Y  F +D+ + +++EYA  G L   ++K       E     +   +  AL + H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 139 HVIHRDIKPENLLLD-HEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            ++HRD+K +N+LLD H+  +KIGDFG S  + S+SK +T+ GT  Y++PE+ E K ++ 
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
             D W LG + YE       FEA +      +IM    + P +   S + + LI  +L  
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLNL 239

Query: 256 DSSKRLSLQKIMEHP 270
           D SKR  L +IM  P
Sbjct: 240 DPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  144 bits (365), Expect = 1e-41
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 25/272 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-HQLRREMEIQSSLRH 78
           D+E+   +G G    VY    + +   VA+K I    +EK +    +LR+E++  S   H
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCNH 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALAY 134
           PN+++ Y  F   + ++L++ Y   G L  ++ K         E   AT +  +   L Y
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRSKRHTMCGTLDYLAPE- 186
            H N  IHRDIK  N+LL  +G +KI DFG S        ++R  R T  GT  ++APE 
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS------ 240
           M +   +D+  D W+ GI   E   GA P+           ++ +    PS  +      
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQNDPPSLETGADYKK 235

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            S   + +IS  L KD SKR + +++++H + 
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  143 bits (362), Expect = 2e-41
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 11/261 (4%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L +F+I + +GKG+F  VY    +     VALK +   ++   K +    +E+++   L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNAL 132
           HPN+++    F ++  + ++LE A  G+L R + KH     R   E+    Y   L +AL
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVE 189
            + H   ++HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE + 
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--DTFRRIMKVDLSFPSAPSISAEAKH 247
              +++  D W+LG L YE      PF  +        ++I K D     A   S E + 
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239

Query: 248 LISRLLVKDSSKRLSLQKIME 268
           L+SR +  D  KR  +  +++
Sbjct: 240 LVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  144 bits (364), Expect = 4e-41
 Identities = 81/246 (32%), Positives = 136/246 (55%), Gaps = 6/246 (2%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQLRREMEIQSSLRH 78
           DF     LGKG FG+V L     +    A+KI+ K+  I+   ++  +  +  +  S + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P + +L+  F   +R++ ++EY + G+L  ++++  RF E  A  Y A +   L + H  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            +I+RD+K +N++LD EG +KI DFG    ++       T CGT DY+APE++  + +  
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
           +VD W  G+L YE L G  PFE E + + F+ IM+ ++++P   S+S EA  +   L+ K
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTK 238

Query: 256 DSSKRL 261
              KRL
Sbjct: 239 HPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  142 bits (359), Expect = 5e-41
 Identities = 81/255 (31%), Positives = 137/255 (53%), Gaps = 15/255 (5%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR----EMEIQSSLRHPN 80
           R LGKG FG   L R  E    V    ++KE +   ++  + RR    E+ I S L+HPN
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLV----VWKE-VNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHEN 138
           I+  Y  F DD  + + +EYA+ G LY ++  +K + F E+    Y+  + +A++Y H+ 
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENKEHDY 195
            ++HRDIK  N+ L   G +K+GDFG S    S+     T+ GT  Y++PE+ +  ++++
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
             D W LG + YE L     F+A +  +   +I++ + + P     S+E   L+  LL +
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQ 239

Query: 256 DSSKRLSLQKIMEHP 270
           D  KR +  ++++ P
Sbjct: 240 DPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  141 bits (358), Expect = 5e-41
 Identities = 79/257 (30%), Positives = 128/257 (49%), Gaps = 9/257 (3%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFEI   +GKG FG V+ V     K   A+K I   ++ + + + +   E  + + L   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSS 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHE 137
            I+R Y  F D  ++ +++EYA  G+L++ L+    R   E Q   +   +   LA+ H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEH 193
             ++HRDIK  NL LD    +KIGD G     S  +     T+ GT  YL+PE+ E+K +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN-TIVGTPYYLSPELCEDKPY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           +   D W LG++ YE   G  PF+A +Q     +I++     P +   S +   LI + L
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQCL 237

Query: 254 VKDSSKRLSLQKIMEHP 270
            KD  +R    +++ +P
Sbjct: 238 TKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  145 bits (367), Expect = 5e-41
 Identities = 86/303 (28%), Positives = 146/303 (48%), Gaps = 54/303 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLRHP 79
           F   + +G G FG V LVR+V++    A+K + K + + + +  H ++ E +I +   + 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH-VKAERDILAEADNE 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            +++LY  F D + ++ +++Y   G++   L +   F E  A  YIA LT A+   H+  
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFG------W---------------------------- 165
            IHRDIKP+N+L+D +G +K+ DFG      W                            
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 166 -----SVQSRSKR-------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA 213
                 ++ R KR       H++ GT +Y+APE++    +    D W++G++ YE L G 
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Query: 214 PPFEAESQKDTFRRIM--KVDLSFPSAPSISAEAKHLISRLLVKDSSKRL---SLQKIME 268
           PPF A++  +T  +++  +  L  PS   +S EA  LI R L   +  RL      +I  
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKA 300

Query: 269 HPW 271
           HP+
Sbjct: 301 HPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 1e-40
 Identities = 81/269 (30%), Positives = 136/269 (50%), Gaps = 25/269 (9%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +D+E+ + +G G +G VY  R++ +   VA+K+I  E  + ++I   +++E+ +    R
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI---IQQEISMLKECR 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLT-NALA 133
           HPNI+  +G +   +++++++EY   G   ++Y+  R     +E Q A Y+   T   LA
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIA-YVCRETLKGLA 115

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV-E 189
           Y HE   IHRDIK  N+LL  +G +K+ DFG S Q   + +KR +  GT  ++APE+   
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 190 NKEHDY--AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK- 246
            ++  Y    D W LGI   E     PP          R +  +  S    P +  + K 
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPM---FDLHPMRALFLISKSNFPPPKLKDKEKW 232

Query: 247 -----HLISRLLVKDSSKRLSLQKIMEHP 270
                  I + L KD  KR +  K+++HP
Sbjct: 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  143 bits (362), Expect = 2e-40
 Identities = 93/296 (31%), Positives = 149/296 (50%), Gaps = 46/296 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLRH 78
           DFE  + +G+G FG V LV++ ++ H  A+KI+ K + +EK ++ H +R E +I      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAH-IRAERDILVEADG 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             +++++  F D   ++LI+E+   G++   L K    +E+    YIA    A+   H+ 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG---------------------------------- 164
             IHRDIKP+NLLLD +G +K+ DFG                                  
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 165 ----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
               W    R   ++  GT DY+APE+     ++   D W+LG++ YE L G PPF +E+
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 221 QKDTFRRIM--KVDLSFPSAPSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 271
            ++T+R++M  K  L FP    IS +AK LI R    DS  R+    +++I  HP+
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  140 bits (356), Expect = 2e-40
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 20/224 (8%)

Query: 25  RPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           + LG+G FG VY   L  +      VA+K + KE   + + +    +E  +   L HPN+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASE-EERKDFLKEARVMKKLGHPNV 58

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTNAL 132
           +RL G   ++E ++L+LEY   G+L   LRK R           + +   ++   +   +
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD-----YLAPEM 187
            Y      +HRD+   N L+  +  +KI DFG S       +    T       ++APE 
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 188 VENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           +++       D W+ G+L +E F  GA P+   S ++    + K
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  140 bits (355), Expect = 6e-40
 Identities = 75/250 (30%), Positives = 139/250 (55%), Gaps = 7/250 (2%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V+L     +    A+K + K+ +     ++  +  +  +  +  HP +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H   +++RD+
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N+LLD +G +KI DFG    ++   +K  T CGT DY+APE++  ++++ +VD W+ 
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSF 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           G+L YE L G  PF    +++ F+ I   +  +P    ++ EAK ++ +L V++  +RL 
Sbjct: 183 GVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRW--LTREAKDILVKLFVREPERRLG 240

Query: 263 LQ-KIMEHPW 271
           ++  I +HP+
Sbjct: 241 VKGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 8e-40
 Identities = 82/265 (30%), Positives = 137/265 (51%), Gaps = 19/265 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A KII    +E++E + +      E++I S  +
Sbjct: 7   WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV------EIDILSECK 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCH 136
           HPNI+ LY  +  + ++++++E+   G L   + +  R  TE Q       +  AL + H
Sbjct: 61  HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMV----- 188
            + VIHRD+K  N+LL  +G +K+ DFG S +++S   KR T  GT  ++APE+V     
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI-SAEAKH 247
           ++  +DY  D W+LGI   E     PP    +      +I+K +      PS  S+    
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
            +   LVKD   R +  ++++HP++
Sbjct: 241 FLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  141 bits (357), Expect = 1e-39
 Identities = 87/272 (31%), Positives = 146/272 (53%), Gaps = 13/272 (4%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           RK +   +D+++ + +G+G FG V LVR   S+   A+K++ K ++ K         E +
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           I +    P +++L+  F DD+ +++++EY   G+L   L  +    E+ A  Y A +  A
Sbjct: 96  IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLA 154

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEM 187
           L   H   +IHRD+KP+N+LLD  G LK+ DFG  ++        C    GT DY++PE+
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 188 VENKEHD----YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSI 241
           ++++  D       D W++G+  +E L G  PF A+S   T+ +IM  K  L+FP    I
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274

Query: 242 SAEAKHLISRLLVKDSSK--RLSLQKIMEHPW 271
           S  AK+LI   L     +  R  +++I +HP+
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 2e-39
 Identities = 92/272 (33%), Positives = 142/272 (52%), Gaps = 23/272 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E ++  +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   R  E  A  Y+A +  A+   H+
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--------WSVQSRSKRHTMCGTLDYLAPEM-- 187
              +HRDIKP+N+LLD  G +++ DFG         +VQS    +   GT DY++PE+  
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS----NVAVGTPDYISPEILQ 176

Query: 188 -VENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPS-APSI 241
            +E+ +  Y    D W+LG+  YE LYG  PF AES  +T+ +IM  K    FP     +
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236

Query: 242 SAEAKHLISRLLVKDSSK--RLSLQKIMEHPW 271
           S EAK LI RL+    ++  R  LQ   +HP+
Sbjct: 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  138 bits (349), Expect = 3e-39
 Identities = 87/274 (31%), Positives = 131/274 (47%), Gaps = 32/274 (11%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           E+ R LG+G  G V   R   +    ALK I  +      +Q Q+ RE+EI  S + P I
Sbjct: 5   ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTD--PNPDLQKQILRELEINKSCKSPYI 61

Query: 82  LRLYGWFHDDE--RIFLILEYAHRGEL---YRELRKHRRFTEQQAATYIA-SLTNALAYC 135
           ++ YG F D+    I + +EY   G L   Y++++K      ++    IA S+   L+Y 
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKE 192
           H   +IHRDIKP N+LL  +G++K+ DFG S   V S +   T  GT  Y+APE ++ K 
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKP 179

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL----------SFPSAPSI- 241
           +    D W+LG+   E      PF  E +      +  ++L               P   
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEP----PLGPIELLSYIVNMPNPELKDEPGNG 235

Query: 242 ---SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
              S E K  I + L KD ++R +   ++EHPWI
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  136 bits (346), Expect = 1e-38
 Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 45/292 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E    +G+G +G+VY  R  ++   VALK I  E  EK        RE+++   LRHPN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPN 59

Query: 81  ILRLYGWFHDDER--IFLILEYA-H--RGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           I+RL        +  I+++ EY  H   G L     K   FTE Q   Y+  L   L Y 
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYL 116

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG---WSVQSRSKRHT--MCGTLDYLAPEMV-E 189
           H N ++HRDIK  N+L++++G LK+ DFG      +  S  +T  +  TL Y  PE++  
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----DLSFP-------- 236
              +   VD W++G +  E   G P F+  ++ +   +I ++     D ++P        
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235

Query: 237 -------SAPS---------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                               I   A  L+ +LL  D  KR+S  + ++H + 
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 1e-38
 Identities = 82/285 (28%), Positives = 138/285 (48%), Gaps = 35/285 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++    +G+G +G VY  R+  +   VA+K I K + E   I     RE+++   L HPN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENH 139
           I++L   F     ++L+ E+    +LY+ ++  +R   E    +Y+  L   LA+CH + 
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC---GTLDYLAPE-MVENKEHDY 195
           ++HRD+KPENLL++ EG LK+ DFG +    S          T  Y APE ++ +K +  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DLSFP 236
            VD W++G +  E L   P F  +S+ D   +I +                      SFP
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238

Query: 237 SA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                      P+ S +A  L+S++L  D  KR++ ++ + HP+ 
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  138 bits (348), Expect = 2e-38
 Identities = 86/265 (32%), Positives = 141/265 (53%), Gaps = 13/265 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 195 ----YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSISAEAKHL 248
                  D W++G+  YE L G  PF A+S   T+ +IM  K  L+FP    IS EAK+L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281

Query: 249 ISRLLVKDSSK--RLSLQKIMEHPW 271
           I   L     +  R  +++I  H +
Sbjct: 282 ICAFLTDREVRLGRNGVEEIKRHLF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  136 bits (343), Expect = 3e-38
 Identities = 77/259 (29%), Positives = 140/259 (54%), Gaps = 12/259 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V + RE  S   VA+K++    + K + +  L  E+ I    +H N++ +Y 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   E +++++E+   G L  ++    R  E+Q AT   S+  AL Y H   VIHRDIK
Sbjct: 86  SYLVGEELWVLMEFLQGGAL-TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 147 PENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR ++ GT  ++APE++    +   VD W+LG
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS---ISAEAKHLISRLLVKDSSKR 260
           I+  E + G PP+ ++S     +R+   D   P   +   IS   +  + R+L ++  +R
Sbjct: 205 IMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPPKLKNAHKISPVLRDFLERMLTREPQER 262

Query: 261 LSLQKIMEHPWIIKNANPR 279
            + Q++++HP++++   P 
Sbjct: 263 ATAQELLDHPFLLQTGLPE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 4e-38
 Identities = 75/263 (28%), Positives = 134/263 (50%), Gaps = 20/263 (7%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH--QLRREMEIQSSLRHPNI 81
           G+ LG+G FGRVYL  +V++   +A+K +  +       +    L  E+++  +L+H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           ++ YG   DDE + + +EY   G +  +L+ +   TE     Y   +   + Y H N ++
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-HTMC----------GTLDYLAPEMVEN 190
           HRDIK  N+L D  G +K+GDFG      SKR  T+C          GT  +++PE++  
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI 249
           + +    D W++G    E L   PP+ E E+    F +I     +      +S +A++ +
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFL 240

Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            R  V+++ KR S ++++ H ++
Sbjct: 241 RRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  136 bits (343), Expect = 5e-38
 Identities = 76/266 (28%), Positives = 144/266 (54%), Gaps = 21/266 (7%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILR 83
           R +G+G + +V LV   +++   A+K+I KE +   +    ++ E  + +++  HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  F  + R+F ++E+   G+L   +++ R+  E+ A  Y A ++ AL + HE  +I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLD EG +K+ D+G     ++      T CGT +Y+APE++  +++ ++VD W
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDT---------FRRIMKVDLSFPSAPSISAEAKHLISR 251
            LG+L +E + G  PF+     D          F+ I++  +  P   S+S +A  ++  
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKG 238

Query: 252 LLVKDSSKRL------SLQKIMEHPW 271
            L KD  +RL        + I  HP+
Sbjct: 239 FLNKDPKERLGCHPQTGFRDIKSHPF 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  137 bits (345), Expect = 5e-38
 Identities = 87/275 (31%), Positives = 139/275 (50%), Gaps = 42/275 (15%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLR 77
           +DFE  + +G+G FG V LV++ ++ H  A+KI+ K + +EK ++ H +R E +I     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGH-IRAERDILVEAD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
              +++++  F D   ++LI+E+   G++   L K    TE++   YIA    A+   H+
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--------------------------------- 164
              IHRDIKP+NLLLD +G +K+ DFG                                 
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 165 -----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
                W    R    +  GT DY+APE+     ++   D W+LG++ YE L G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 220 SQKDTFRRIM--KVDLSFPSAPSISAEAKHLISRL 252
           + ++T++++M  K  L FP    IS +AK LI R 
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  135 bits (342), Expect = 5e-38
 Identities = 79/276 (28%), Positives = 138/276 (50%), Gaps = 22/276 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE  + +  G +G VYLVR  E++   A+K I K+ +       Q+  E +I +   +P
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            ++ ++  F     + +++EY   G+    L+         A  Y A    AL Y H   
Sbjct: 62  FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------------------MCGTLD 181
           ++HRD+KP+NLL+   G +K+ DFG S        T                  +CGT +
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA-PS 240
           Y+APE++  + +   VD W +GI+ YEFL G  PF  ++ ++ F +++  D+ +P    +
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241

Query: 241 ISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWII 273
           + A+A+ LISRLL ++  +RL      ++ +H + +
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  135 bits (341), Expect = 1e-37
 Identities = 75/250 (30%), Positives = 139/250 (55%), Gaps = 15/250 (6%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILR 83
           R +G+G + +V LVR  +++   A+K++ KE +   +    ++ E  + + +  HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y HE  +I+R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  +++ ++VD W
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDT---------FRRIMKVDLSFPSAPSISAEAKHLISR 251
            LG+L +E + G  PF+     D          F+ I++  +  P   S+S +A  ++  
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKS 238

Query: 252 LLVKDSSKRL 261
            L KD  +RL
Sbjct: 239 FLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 1e-37
 Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 45/283 (15%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  R+  +   VALK I  E  E   +     RE+ +   L HPNI+RL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHV 140
             H + +++L+ E+     L  +L+K+               +Y+  L   +AYCH + V
Sbjct: 66  VVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDY 195
           +HRD+KP+NLL+D EG LK+ DFG    + V  R+  H +  TL Y APE ++ ++++  
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYST 179

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------------DL--SFPS 237
            VD W++G +  E +   P F  +S+ D   RI +                 D   +FP 
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239

Query: 238 ---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                     P++  +   L+S++LV D +KR+S +  ++HP+
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (343), Expect = 2e-37
 Identities = 88/309 (28%), Positives = 146/309 (47%), Gaps = 58/309 (18%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLR 77
           +DF   + +GKG FG V LV++ ++    A+K + K E  +K ++ H ++ E ++ +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
            P ++ LY  F D + ++LI+E+   G+L   L K+  F+E     Y+A    A+   H+
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--------------------------------- 164
              IHRDIKP+N+L+D  G +K+ DFG                                 
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179

Query: 165 -----------------WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCY 207
                            W    R   ++  GT DY+APE+   + +    D W+LG + +
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239

Query: 208 EFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSISAEAKHLISRLLVKDSSKRL---S 262
           E L G PPF +E+  +T+R+I+  +  L FP    +S EA+ LI RL+  ++  RL    
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298

Query: 263 LQKIMEHPW 271
             +I  HP+
Sbjct: 299 AHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  134 bits (338), Expect = 3e-37
 Identities = 74/251 (29%), Positives = 139/251 (55%), Gaps = 13/251 (5%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILR 83
           R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +  +P ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  F    R+FL++EY + G+L   +++ R+  E+ A  Y A +  AL + HE  +I+R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLD +G +K+ D+G     +       T CGT +Y+APE++  +E+ ++VD W
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 201 TLGILCYEFLYGAPPF-------EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            LG+L +E + G  PF       +  ++   F+ I++  +  P    +S +A H++   L
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLKGFL 238

Query: 254 VKDSSKRLSLQ 264
            KD  +RL  Q
Sbjct: 239 NKDPKERLGCQ 249

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  132 bits (334), Expect = 3e-37
 Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 14/258 (5%)

Query: 22  EIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +G+ LG+G FG VY      +    +  VA+K + KE   + +I+ +  RE  I   L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIE-EFLREARIMRKLD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYC 135
           HPNI++L G   ++E + +++EY   G+L   LRK+R    +     ++   +   + Y 
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD----YLAPEMVENK 191
              + IHRD+   N L+     +KI DFG S       +           ++APE ++  
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
           +     D W+ G+L +E F  G  P+   S  +    + K     P  P+   E   L+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK-GYRLPKPPNCPPELYKLML 238

Query: 251 RLLVKDSSKRLSLQKIME 268
           +   +D   R +  +++E
Sbjct: 239 QCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  131 bits (333), Expect = 4e-37
 Identities = 63/257 (24%), Positives = 117/257 (45%), Gaps = 13/257 (5%)

Query: 22  EIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +G+ LG+G FG VY      +  + K  VA+K + ++  E+   +    RE  I   L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           HPN+++L G   ++E +++++EY   G+L   LRK+R + +     ++   +   + Y  
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD----YLAPEMVENKE 192
             + IHRD+   N L+     +KI DFG S       +           ++APE ++  +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 193 HDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
                D W+ G+L +E F  G  P+   S ++    +       P  P+   E   L+ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPPNCPPELYDLMLQ 238

Query: 252 LLVKDSSKRLSLQKIME 268
              +D   R +  +++E
Sbjct: 239 CWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  132 bits (335), Expect = 5e-37
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 42/288 (14%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRH 78
           +E G+ LG+G +  VY  R+ E+   VA+K I   + ++ K  I     RE+++   L+H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHE 137
           PNI+ L   F     I L+ E+    +L + ++ K    T     +Y+      L Y H 
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHD 194
           N ++HRD+KP NLL+  +G LK+ DFG +        K      T  Y APE++    H 
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH- 179

Query: 195 Y--AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------------------- 231
           Y   VD W++G +  E L   P    +S  D   +I +                      
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239

Query: 232 ------DLS--FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                  L   FP+A   S +A  L+ RLL  + +KR++ ++ +EHP+
Sbjct: 240 KPFPPTPLKQIFPAA---SDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  131 bits (332), Expect = 8e-37
 Identities = 78/257 (30%), Positives = 129/257 (50%), Gaps = 15/257 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   +   +    A K + K++++K K +     E +I   +    I+ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRD 144
            F   + + L++   + G+L   +       F E +A  Y A +   L + H+  +++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           +KPEN+LLD  G ++I D G +V+     K     GT  Y+APE+++ + +D++VD + L
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 203 GILCYEFLYGAPPF----EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS 258
           G   YE + G  PF    E   +++  RR +++ + +P     S EAK L   LL KD  
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPE 238

Query: 259 KRL-----SLQKIMEHP 270
           KRL     S  ++ EHP
Sbjct: 239 KRLGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  132 bits (333), Expect = 1e-36
 Identities = 77/251 (30%), Positives = 136/251 (54%), Gaps = 9/251 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V L          A+K + K+ +     ++  +  +  +  +  +P +  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E +F ++E+ + G+L   ++   RF   +A  Y A +   L + H   +I+RD+
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N++LD +G +KI DFG    +V   ++  T CGT DY+APE+++  ++ ++VD W+ 
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLISRLLVKDSSKRL 261
           G+L YE L G  PF  + + + F  I +VD   P  P  I+ E+K ++ +L  +D ++RL
Sbjct: 183 GVLLYEMLIGQSPFHGDDEDELFESI-RVDT--PHYPRWITKESKDILEKLFERDPTRRL 239

Query: 262 SLQ-KIMEHPW 271
            +   I  HP+
Sbjct: 240 GVVGNIRGHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  132 bits (334), Expect = 1e-36
 Identities = 84/268 (31%), Positives = 142/268 (52%), Gaps = 15/268 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E ++  +  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   R  E  A  Y+A +  A+   H+
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMVENKE- 192
            H +HRDIKP+N+L+D  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 193 ----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPS-APSISAEA 245
               +    D W+LG+  YE LYG  PF AES  +T+ +IM  K    FP+    +S +A
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240

Query: 246 KHLISRLLVKDSSK--RLSLQKIMEHPW 271
           K LI RL+     +  +  ++   +HP+
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPF 268

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  130 bits (328), Expect = 2e-36
 Identities = 76/259 (29%), Positives = 144/259 (55%), Gaps = 10/259 (3%)

Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +EI + +G+G FG++YL + + +S+H V  +I   +   K K   +  +E+ + + ++HP
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHE 137
           NI+  +  F ++ R+F+++EY   G+L + + + R   F+E Q  ++   ++  L + H+
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 138 NHVIHRDIKPENLLLDHEGRL-KIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEH 193
             ++HRDIK +N+ L   G + K+GDFG + Q   S    +T  GT  YL+PE+ +N+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           +   D W+LG + YE      PFE  +      +I +   + P +P+ S + + LIS+L 
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLF 238

Query: 254 VKDSSKRLSLQKIMEHPWI 272
                 R S+  I++ P++
Sbjct: 239 KVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  129 bits (327), Expect = 2e-36
 Identities = 75/252 (29%), Positives = 138/252 (54%), Gaps = 9/252 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG+  LV+  E      +K I   ++   K + + R+E+ + S+++HPNI++   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
            F ++  ++++++Y   G+LY+++   R   F E Q   +   +  AL + H+  ++HRD
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           IK +N+ L  +G +K+GDFG +    S      T  GT  YL+PE+ EN+ ++   D W 
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWA 186

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLISRLLVKDSSKR 260
           LG + YE       FEA + K+   +I++   S+P   S  S + ++L+S+L  ++   R
Sbjct: 187 LGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVSSHYSYDLRNLVSQLFKRNPRDR 244

Query: 261 LSLQKIMEHPWI 272
            S+  I+E  +I
Sbjct: 245 PSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  131 bits (331), Expect = 2e-36
 Identities = 85/248 (34%), Positives = 131/248 (52%), Gaps = 13/248 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFEI + +G+G FG V +V+   ++   A+KI+ K ++ K       R E  +  +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   R  E  A  YIA +  A+   H+
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KRHTMCGTLDYLAPEMVENKEH 193
            H +HRDIKP+N+LLD  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 194 DYA-----VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPS-APSISAEA 245
                    D W+LG+  YE LYG  PF AES  +T+ +IM  +    FPS    +S EA
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240

Query: 246 KHLISRLL 253
           K LI RL+
Sbjct: 241 KDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  128 bits (324), Expect = 1e-35
 Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 26/271 (9%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ----------LRREMEIQ 73
           G  +GKG +GRVYL   V +   +A+K +   ++                  LR E+E  
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQV---ELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
             L H NI++  G+   +E + + LEY   G +   LR + RF EQ    +   +   LA
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----SKRHTMCGTLDYLAPEMV 188
           Y H   ++HRD+K +NLL+D +G  KI DFG S +S       +  +M G++ ++APE++
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-----I 241
            +    Y+  VD W+LG +  E   G  P+  E       ++     S P  P      +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPPIPPDVSMNL 241

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           S  A   ++     +   R + +++++HP+I
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  126 bits (318), Expect = 7e-35
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 13/221 (5%)

Query: 21  FEIGRPLGKGKFGRVYL--VREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            E+G+ LG+G FG VY   ++         VA+K + KE   + + + +   E  I   L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASE-EEREEFLEEASIMKKL 58

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYC 135
            HPNI+RL G     E ++++ EY   G+L   LRKH    T +        +   + Y 
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD---YLAPEMVEN 190
              + +HRD+   N L+     +KI DFG S  +          G      ++APE +++
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
            +     D W+ G+L +E F  G  P+   S ++    +  
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219

Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  127 bits (319), Expect = 7e-35
 Identities = 74/256 (28%), Positives = 134/256 (52%), Gaps = 8/256 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 85  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 147 PENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R ++ GT  ++APE++    +   VD W+LG
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      + I   +     +   +S   K  + RLLV+D ++R +
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT 263

Query: 263 LQKIMEHPWIIKNANP 278
             ++++HP++ K   P
Sbjct: 264 AAELLKHPFLAKAGPP 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  126 bits (318), Expect = 1e-34
 Identities = 82/264 (31%), Positives = 135/264 (51%), Gaps = 25/264 (9%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA+K        +  +Q Q ++E+ I   L     +HPNI
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 137

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS----FPSAPSISAEAKHLISRLLV 254
            W+LGI+  E + G PP+  E   +  R +  +  +      +   +SA  +  ++R L 
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254

Query: 255 KDSSKRLSLQKIMEHPWIIKNANP 278
            D  KR S +++++HP+ +K A P
Sbjct: 255 MDVEKRGSAKELLQHPF-LKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 1e-34
 Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 41/287 (14%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +++ + LG G FG VYL R  E+   VA+K + K    K+    +     E++S  +   
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWEECMNLREVKSLRKLNE 56

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYR--ELRKHRRFTEQQAATYIASLTNALAYC 135
           HPNI++L   F +++ ++ + EY   G LY+  + RK + F+E    + I  +   LA+ 
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-HT-MCGTLDYLAPEMV-ENKE 192
           H++   HRD+KPENLL+     +KI DFG + + RS+  +T    T  Y APE++  +  
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DL 233
           +   VD W LG +  E     P F   S+ D   +I  V                     
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235

Query: 234 SFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            FP           P+ S EA  LI  +L  D  KR +  + ++HP+
Sbjct: 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  125 bits (315), Expect = 3e-34
 Identities = 78/256 (30%), Positives = 138/256 (53%), Gaps = 9/256 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +  E  +   VA+K   K  + K + +  L  E+ I     H N++ +Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q AT   S+  AL+Y H   VIHRDIK
Sbjct: 87  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 147 PENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR ++ GT  ++APE++    +   VD W+LG
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG 205

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      RRI   +      +  +S+  +  +  +LV++ S+R +
Sbjct: 206 IMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT 265

Query: 263 LQKIMEHPWIIKNANP 278
            Q++++HP+ +K A P
Sbjct: 266 AQELLQHPF-LKLAGP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  123 bits (309), Expect = 1e-33
 Identities = 75/261 (28%), Positives = 133/261 (50%), Gaps = 14/261 (5%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ---IEKYKIQHQLRREMEIQSSLRHPN 80
           G+ LG G F   Y  R+V++   +A+K +   +    E+ ++   LR+E+ + + L HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R+ G   +D    L +E+   G +   L K+  F E     Y   L   L+Y HEN +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 141 IHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSK-------RHTMCGTLDYLAPEMVENKE 192
           IHRD+K  NLL+D  G+ L+I DFG + +  +K       +  + GT+ ++APE++  ++
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPS-ISAEAKHLI 249
           +  + D W++G +  E     PP+ AE   +    I K+  +   PS P  +S   + + 
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVT 244

Query: 250 SRLLVKDSSKRLSLQKIMEHP 270
            R L      R   +++++HP
Sbjct: 245 LRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  124 bits (314), Expect = 1e-33
 Identities = 72/298 (24%), Positives = 127/298 (42%), Gaps = 55/298 (18%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL---R--REMEIQSS 75
           +E+ +P+G G +G V    +  +   VA+K I             +   R  RE+++   
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV------FDDLIDAKRILREIKLLRH 55

Query: 76  LRHPNILRLYGWFHDDER-----IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           LRH NI+ L              ++++ E     +L++ ++  +  T+     ++  +  
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILR 114

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLA 184
            L Y H  +VIHRD+KP N+L++    LKI DFG +        ++  +     T  Y A
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174

Query: 185 PE-MVENKEHDYAVDNWTLG-ILCYEFLYGAPPFEAESQKDTFRRIMKV-------DLSF 235
           PE ++ +  +  A+D W++G I   E L   P F      D    I++V       DL F
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFA-ELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 236 PSA----------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            ++                      P  S EA  L+ ++LV D  KR++  + + HP+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  121 bits (306), Expect = 5e-33
 Identities = 83/289 (28%), Positives = 139/289 (48%), Gaps = 45/289 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L HPN
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE------QQAATYIASLTNALAY 134
           I++L    H + +++L+ E+     L+++L+K    +           +Y+  L   LA+
Sbjct: 61  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVE 189
           CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y APE ++ 
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 174

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------ 231
            K +  AVD W+LG +  E +     F  +S+ D   RI +                   
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234

Query: 232 DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
             SFP           P +  + + L+S++L  D +KR+S +  + HP+
Sbjct: 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 5e-33
 Identities = 78/264 (29%), Positives = 123/264 (46%), Gaps = 12/264 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             +E+   +G+G +G V   R   +   VA+K  FKE  +   ++    RE+++   LRH
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRH 59

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA-TYIASLTNALAYCHE 137
            NI+ L   F    R++L+ EY  R  L   L          A  +YI  L  A+AYCH 
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRH--TMCGTLDYLAPE-MVENKE 192
           +++IHRDIKPEN+L+   G LK+ DFG+  ++++R          T  Y APE +V +  
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +   VD W +G +  E L G P F  +S  D    I K     P +      +    + +
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238

Query: 253 LVKDSSKRLSLQ----KIMEHPWI 272
              + S+  SL+      +  P +
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPAL 262

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  122 bits (306), Expect = 6e-33
 Identities = 87/276 (31%), Positives = 138/276 (50%), Gaps = 33/276 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII-----FKEQIE-KYKIQHQLRREMEIQS 74
           +EI   +GKG +G+VY V   +     A+KI+       E+IE +Y I         +QS
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI---------LQS 74

Query: 75  SLRHPNILRLYGWFHDDER-----IFLILEYAHRG---ELYREL-RKHRRFTEQQAATYI 125
              HPN+++ YG F+  ++     ++L+LE  + G   EL + L    +R  E   +  +
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDY 182
                 L + H N +IHRD+K  N+LL  EG +K+ DFG S Q   +R +R+T  GT  +
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 183 LAPEMVE-NKEHDYAVDN----WTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVDLSFP 236
           +APE++   +++DY+ D     W+LGI   E   G PP F+    K  F+       +  
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                     H IS+ L+KD   R S+  ++EHP+I
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  121 bits (305), Expect = 7e-33
 Identities = 82/270 (30%), Positives = 139/270 (51%), Gaps = 19/270 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E++I +S  
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV------EIDILASCD 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HPNI++L   F+ +  +++++E+   G +    L   R  TE Q          AL Y H
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMV----- 188
           EN +IHRD+K  N+L   +G +K+ DFG S ++     +R +  GT  ++APE+V     
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKH 247
           +++ +DY  D W+LGI   E     PP    +      +I K +    + PS  S+E K 
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
            + + L K+   R +  ++++HP++  N+N
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  121 bits (304), Expect = 8e-33
 Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 18/265 (6%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK------IIFKEQIEKYKIQHQLRREMEIQSSLR 77
           G  +G G FG VYL     S   +A+K      +    +  K  +   L RE+ +   L+
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H NI++  G   D + + + LEY   G +   L  +  F E     ++  +   L Y H 
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMV 188
             +IHRDIK  N+L+D++G +KI DFG S          ++   R ++ G++ ++APE+V
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKH 247
           +   +    D W+LG L  E L G  PF   +Q     +I +   + P  PS IS+EA  
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE--NASPEIPSNISSEAID 242

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
            + +    D +KR +  ++++HP++
Sbjct: 243 FLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  120 bits (303), Expect = 1e-32
 Identities = 81/256 (31%), Positives = 131/256 (51%), Gaps = 9/256 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V+   +V +   VA+K I    ++K   +  +  E+ +   L++PNI+    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F   + +F+++EY   G L  ++       E Q A        AL + H N VIHRDIK
Sbjct: 84  SFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD W+LG
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E+       I          P  +S   +  ++R L  D  KR S
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS 262

Query: 263 LQKIMEHPWIIKNANP 278
            +++++HP+ +K A P
Sbjct: 263 AKELLQHPF-LKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  120 bits (301), Expect = 2e-32
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 26/263 (9%)

Query: 25  RPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRRE-------MEIQSSL 76
           R +GKG +G V LVR   + K  V         I+K  +++  RRE        ++ S L
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYV---------IKKLNLRNASRRERKAAEQEAQLLSQL 56

Query: 77  RHPNILRLY-GWFHDDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALA 133
           +HPNI+     W  +D  +++++ +   G+LY +L+  K +   E Q   +   +  AL 
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVEN 190
           Y HE H++HRD+K +N+ L     +K+GD G +    ++     T+ GT  Y++PE+  N
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLI 249
           K ++Y  D W LG   YE       F A+       RI++  L  P  P   S E   LI
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--PPMPKDYSPELGELI 234

Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
           + +L K   KR S++ I+  P+I
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  117 bits (295), Expect = 1e-31
 Identities = 70/253 (27%), Positives = 126/253 (49%), Gaps = 8/253 (3%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + + R +G+G FGR  LV+ V S    A+K I +       ++   R+E  + + ++HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDS-RKEAVLLAKMKHP 58

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALAYCHE 137
           NI+     F  D  +++++EY   G+L ++++  + + F E     +   +   + + HE
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHD 194
             V+HRDIK +N+ L   G++K+GDFG +       +   T  GT  Y+ PE+ EN  ++
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
              D W+LG + YE      PF+A S K+   ++ +     P     S E + LI ++  
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFK 237

Query: 255 KDSSKRLSLQKIM 267
           ++   R S   I+
Sbjct: 238 RNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  117 bits (295), Expect = 1e-31
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 13/254 (5%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L +F I + +G+G+F  VY    +    PVALK +    +   K +    +E+++   L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELR---KHRRFT-EQQAATYIASLTNALA 133
           HPN+++ Y  F +D  + ++LE A  G+L R ++   K +R   E+    Y   L +AL 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVEN 190
           + H   V+HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--DTFRRIMKVDLSFPSAPS--ISAEAK 246
             +++  D W+LG L YE      PF  +        ++I + D  +P  PS   S E +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELR 238

Query: 247 HLISRLLVKDSSKR 260
            L++  +  D  KR
Sbjct: 239 QLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  118 bits (298), Expect = 1e-31
 Identities = 85/301 (28%), Positives = 146/301 (48%), Gaps = 55/301 (18%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSS 75
           S+ ++E    + +G +G VY  R+ ++   VALK +  +++ E + I     RE+ I   
Sbjct: 3   SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL--REINILLK 60

Query: 76  LRHPNILRL----YGWFHDDERIFLILEYAHRGELYRELR-----KHRRFTEQQAATYIA 126
           L+HPNI+ +     G   D   I++++EY     +  +L+       + F + +    + 
Sbjct: 61  LQHPNIVTVKEVVVGSNLDK--IYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLML 113

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-MCGTLDYL 183
            L + +A+ H+N ++HRD+K  NLLL++ G LKI DFG +    S  K +T +  TL Y 
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS----- 237
           APE ++  KE+  A+D W++G +  E L   P F  +S+ D   +I K  L  P+     
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK-LLGTPTEKIWP 232

Query: 238 --------------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                                     A S+S     L++RLL  D +KR+S +  ++HP+
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Query: 272 I 272
            
Sbjct: 293 F 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  121 bits (306), Expect = 1e-31
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 33/287 (11%)

Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
            A  ++  K+ W      I R LG G  G V   + V    P A+K++    +E      
Sbjct: 24  EATAKEQAKKYW------ISRVLGSGATGTVLCAKRVSDGEPFAVKVV---DMEGMSEAD 74

Query: 65  QLRREMEIQSSLR--HPNILRLYGWF-HDDER-------IFLILEYAHRGELYRELRKH- 113
           + R + E+   L     +I++ +  F   D R       I L+L+YA+ G+L +E++   
Sbjct: 75  KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA 134

Query: 114 ---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---- 166
              R F E +A      +  A+ + H  H+IHRDIK  N+LL   G +K+GDFG+S    
Sbjct: 135 KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194

Query: 167 -VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF 225
              S     T CGT  Y+APE+   K +    D ++LG+L YE L    PF+ E+ ++  
Sbjct: 195 ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254

Query: 226 RRIM--KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
            + +  + D   P  PSIS E + +++ LL  D  +R S  K++  P
Sbjct: 255 HKTLAGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  117 bits (294), Expect = 3e-31
 Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 19/261 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   ++ +   VA+K        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVI 137

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLISRLLVKDS 257
            W+LGI+  E + G PP+  E+       I          P  +SA  +  ++R L  D 
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDV 257

Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            +R S +++++HP+ +K A P
Sbjct: 258 DRRGSAKELLQHPF-LKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 4e-31
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 57/297 (19%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +E    +G+G +G VY  R++ +   VALK          K++  L  E    S+LR   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALK----------KVRVPLSEEGIPLSTLREIA 50

Query: 78  ---------HPNILRLYGWFH--DDER---IFLILEYAHRGELYRELRKH--RRFTEQQA 121
                    HPNI+RL    H    +R   + L+ E+  + +L   L K        +  
Sbjct: 51  LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI 109

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-GT 179
              +  L   + + H + ++HRD+KP+N+L+  +G++KI DFG + + S     T    T
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------- 231
           L Y APE++    +   VD W++G +  E     P F   S+ D   +I  V        
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229

Query: 232 --------DLSFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                     SFPS          P I  E   L+ ++L  +  KR+S  + ++HP+
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  116 bits (292), Expect = 4e-31
 Identities = 83/259 (32%), Positives = 137/259 (52%), Gaps = 19/259 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  E+ E  +I+  +++E+ + S    P + + YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G     LR    F E Q AT +  +   L Y H    IHRDIK
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 188

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSISAE----AKHLISRLLVKDS 257
           I   E   G PP       ++    M+V    P  + P+++ E     K  I   L KD 
Sbjct: 189 ITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241

Query: 258 SKRLSLQKIMEHPWIIKNA 276
           S R + +++++H +I+KNA
Sbjct: 242 SFRPTAKELLKHKFIVKNA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  116 bits (292), Expect = 4e-31
 Identities = 82/257 (31%), Positives = 132/257 (51%), Gaps = 17/257 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH----PNIL 82
           +G+G FG VY  R+ ++    A+K + K++I K K    L     I  SL      P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
            +   FH  +++  IL+  + G+L+  L +H  F+E++   Y   +   L + H   V++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNW 200
           RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++    +D + D +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWF 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDTF---RRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           +LG + ++ L G  PF     KD     R  + V++  P   S S E K L+  LL +D 
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD--SFSPELKSLLEGLLQRDV 238

Query: 258 SKRLSL-----QKIMEH 269
           SKRL       Q++ EH
Sbjct: 239 SKRLGCLGRGAQEVKEH 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  116 bits (293), Expect = 5e-31
 Identities = 80/267 (29%), Positives = 136/267 (50%), Gaps = 19/267 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG +G VY V    +   +A+K I + ++++ K   Q+  E++I      P I+  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFN-QIIMELDILHKAVSPYIVDFYG 66

Query: 87  WFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTNALAYCHENH-VIH 142
            F  +  +++ +EY   G   +LY          E        ++   L +  E H +IH
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVE----NKEHDY 195
           RD+KP N+L++  G++K+ DFG S   V S +K  T  G   Y+APE ++    N+   Y
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNIGCQSYMAPERIKSGGPNQNPTY 184

Query: 196 AV--DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDLSFPSAPS-ISAEAKHLISR 251
            V  D W+LG+   E   G  P+  E+  + F ++   VD   P+ PS  S +A+  +++
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK 244

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANP 278
            L K  ++R +  +++EHPW++K  N 
Sbjct: 245 CLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  116 bits (292), Expect = 6e-31
 Identities = 83/267 (31%), Positives = 134/267 (50%), Gaps = 19/267 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E+EI ++  
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV------EIEILATCN 67

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HP I++L G F+ D ++++++E+   G +    L   R  TE Q       +  AL Y H
Sbjct: 68  HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV----- 188
              +IHRD+K  N+LL  +G +K+ DFG S   V++  +R +  GT  ++APE+V     
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKH 247
           ++  +DY  D W+LGI   E     PP    +      +I K +    S PS  S E + 
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIK 274
            +   L K    R S  +++EHP++  
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  115 bits (289), Expect = 1e-30
 Identities = 86/264 (32%), Positives = 128/264 (48%), Gaps = 29/264 (10%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-LRREMEIQSSLRHPNILRLY 85
           LGKG +G VY  R++ ++    ++I  KE  E+     Q L  E+ + S L+H NI++  
Sbjct: 16  LGKGTYGIVYAARDLSTQ----VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIH 142
           G   ++    + +E    G L   LR      +  EQ    Y   +   L Y H+N ++H
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 143 RDIKPENLLLD-HEGRLKIGDFGWSVQSRSKR--------HTMCGTLDYLAPEMVENKEH 193
           RDIK +N+L++ + G +KI DFG      SKR         T  GTL Y+APE+++    
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFG-----TSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 194 DY--AVDNWTLGILCYEFLYGAPPFE--AESQKDTFRRIM-KVDLSFPSAPSISAEAKHL 248
            Y    D W+LG    E   G PPF    E Q   F+  M K+    P   S+SAEAK+ 
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--SLSAEAKNF 244

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWI 272
           I R    D  KR S   +++ P++
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  115 bits (290), Expect = 1e-30
 Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 26/276 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH- 78
           D E+   LG+G +G V  +R V +   +A+K I +  +     Q Q R  M++  S+R  
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVN---SQEQKRLLMDLDISMRSV 57

Query: 79  --PNILRLYG-WFHD-DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNALA 133
             P  +  YG  F + D  I + +      + Y+++        +     IA S+  AL 
Sbjct: 58  DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 134 YCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTM-CGTLDYLAPEMV 188
           Y H    VIHRD+KP N+L++  G++K+ DFG S   V S +K  T+  G   Y+APE +
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPERI 175

Query: 189 ----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDLSFPSAP--SI 241
                 K +D   D W+LGI   E   G  P+  +S K  F+++ + V+   P  P    
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQLPAEKF 233

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           S E +  +++ L K+  +R +  ++++HP+   + +
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 1e-30
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 16/270 (5%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHEN 138
           ++ L   +   + + L+L   + G+L   +    +  F E++A  Y A +T  L   H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHDYA 196
            +++RD+KPEN+LLD  G ++I D G +V+           GT+ Y+APE+V+N+ + ++
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQK----DTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
            D W LG L YE + G  PF    +K    +  RR+ +    +      S  A+ +  +L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQL 239

Query: 253 LVKDSSKRLSLQK-----IMEHPWIIKNAN 277
           L KD   RL  +      +  HP   + AN
Sbjct: 240 LTKDPGFRLGCRGEGAEEVKAHP-FFRTAN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  115 bits (289), Expect = 1e-30
 Identities = 80/259 (30%), Positives = 133/259 (51%), Gaps = 17/259 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH----PNIL 82
           +G+G FG VY  R+ ++    A+K + K++I K K    L     I  SL      P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
            +   FH  +++  IL+  + G+L+  L +H  F+E +   Y A +   L + H   V++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK-EHDYAVDNW 200
           RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++    +D + D +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDTF---RRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           +LG + ++ L G  PF     KD     R  + + +  P   S S E + L+  LL +D 
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDV 238

Query: 258 SKRLSL-----QKIMEHPW 271
           ++RL       Q++ EHP+
Sbjct: 239 NRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  115 bits (290), Expect = 1e-30
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 47/284 (16%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           LG+G +  VY  R   +   VALK I    +E      I     RE+ +   L+H NI+R
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIVR 62

Query: 84  LYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTE-QQAATYIASLTNALAYCHENHVI 141
           L+   H + ++ L+ EY  +  + Y +    R   +     ++   L   +A+CHEN V+
Sbjct: 63  LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPE-MVENKEHD 194
           HRD+KP+NLL++  G LK+ DFG +      V + S       TL Y AP+ ++ ++ + 
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLGSRTYS 179

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----DLSFPSA----------- 238
            ++D W++G +  E + G P F   + +D   +I ++     + ++P             
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239

Query: 239 -----------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                      P        L+ RLL  +   R+S    ++HPW
Sbjct: 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  115 bits (291), Expect = 2e-30
 Identities = 88/309 (28%), Positives = 135/309 (43%), Gaps = 58/309 (18%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSS 75
            L+D+EI   LG+G FG VY  R++++   VALK I+   + + + I     RE++I   
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63

Query: 76  LRHPNILRLYGWF---HDDER-----IFLILEY-AHRGELYRELRKHR-RFTEQQAATYI 125
           L+HPN++ L        D  +     ++++  Y  H  +L   L     + TE Q   Y+
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH--DLSGLLENPSVKLTESQIKCYM 121

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQSRS 171
             L   + Y HENH++HRDIK  N+L+D++G LKI DFG                     
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 172 KRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK 230
           K   +  T  Y  PE++   + +  AVD W +G +  E     P  + +S  D    I K
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241

Query: 231 V--------------------DLSFPSAPSISAE--AKH------LISRLLVKDSSKRLS 262
           +                      SF + P    E   K       L+S+LL  D  KRL+
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301

Query: 263 LQKIMEHPW 271
               +EHP+
Sbjct: 302 ASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  114 bits (288), Expect = 2e-30
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 20/271 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D E    LG G  G V  V+ + +   +A K++      K  ++ Q+ RE++I    R 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRS 62

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH-E 137
           P I+  YG F ++  I + +E+   G L R  +K      +       ++   L Y +  
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           + ++HRDIKP N+L++  G++K+ DFG S +   S   T  GT  Y++PE ++  ++   
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQK-----------DTFRRIMKVDLSFPSAPS--ISA 243
            D W+LGI   E   G  PF   +             D  ++I  V    P  PS     
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI--VQEPPPRLPSSDFPE 240

Query: 244 EAKHLISRLLVKDSSKRLSLQKIME-HPWII 273
           + +  +   L+KD ++R + Q++    P+I 
Sbjct: 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  114 bits (287), Expect = 2e-30
 Identities = 80/257 (31%), Positives = 130/257 (50%), Gaps = 19/257 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG VY   +  +K  VA+KII  E+ E  +I+  +++E+ + S    P I R YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDSPYITRYYG 69

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G    +L K     E   AT +  +   L Y H    IHRDIK
Sbjct: 70  SYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D+  D W+LG
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG 188

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSISAEA----KHLISRLLVKDS 257
           I   E   G PP             M+V    P  S P++  +     K  +   L KD 
Sbjct: 189 ITAIELAKGEPPNSDLHP-------MRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241

Query: 258 SKRLSLQKIMEHPWIIK 274
             R + +++++H +I +
Sbjct: 242 RFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  114 bits (286), Expect = 3e-30
 Identities = 76/260 (29%), Positives = 133/260 (51%), Gaps = 15/260 (5%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           G+ LG+G FGRVYL  +V++   +A K +    E  E  K    L  E+++  +L+H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 82  LRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           ++ YG   D  ++ + + +EY   G +  +L+ +   TE     Y   +   ++Y H N 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEH 193
           ++HRDIK  N+L D  G +K+GDFG S        S +   ++ GT  +++PE++  + +
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Query: 194 DYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLISR 251
               D W+LG    E L   PP+ E E+    F+  +    + P  PS IS  A+  +  
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--IATQPTNPQLPSHISEHARDFLGC 244

Query: 252 LLVKDSSKRLSLQKIMEHPW 271
           + V ++  R S ++++ HP+
Sbjct: 245 IFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  114 bits (286), Expect = 4e-30
 Identities = 76/260 (29%), Positives = 131/260 (50%), Gaps = 18/260 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   +   +    A K + K++++K K       E  I + +    I+ L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 87  WFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
            F     + L++   + G+L    Y    ++  F E +A  Y A + + L + H+  +I+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           RD+KPEN+LLD++G ++I D G +V+    +SK     GT  ++APE+++ +E+D++VD 
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180

Query: 200 WTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
           + LG+  YE +    PF A  +    K+  +RI+   +++P     S  +K     LL K
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAK 238

Query: 256 DSSKRLSLQ-----KIMEHP 270
           D  KRL  +      +  HP
Sbjct: 239 DPEKRLGFRDGNCDGLRTHP 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  114 bits (286), Expect = 5e-30
 Identities = 76/291 (26%), Positives = 139/291 (47%), Gaps = 46/291 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D+     +G+G +G VY  R  ++   VA+K I  E  E+  +     RE+ +   L+HP
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH-------RRFTEQQAATYIASLTNAL 132
           NI+ L      + R++LI E+     L  +L+K+       +    +   +Y+  +   +
Sbjct: 60  NIVCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-M 187
            +CH   V+HRD+KP+NLL+D++G +K+ DFG    + +  R   H +  TL Y APE +
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVL 173

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV---------------- 231
           + +  +   VD W++G +  E     P F  +S+ D   RI ++                
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 232 --DLSFP---------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
               +FP         +  ++  +   L+ ++L+ D +KR+S +K + HP+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  116 bits (291), Expect = 5e-30
 Identities = 83/305 (27%), Positives = 142/305 (46%), Gaps = 54/305 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   + LG G FG V L R+V++K   A+K + K+ +        ++ E +I +   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++RLY  F D + ++ +++Y   G++   L +   F E  A  YIA LT A+   H+   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG------WS---------------------------- 166
           IHRDIKP+N+L+D +G +K+ DFG      W+                            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 167 ---------VQSRSKR-------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
                    ++ R+ R       H++ GT +Y+APE++    +    D W++G++ YE L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 211 YGAPPFEAESQKDTFRRIMK--VDLSFPSAPSISAEAKHLISRLL--VKDSSKRLSLQKI 266
            G PPF A++  +T  +++     L  P    +S EA  LI +L    +D   +    +I
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302

Query: 267 MEHPW 271
             HP+
Sbjct: 303 KAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  114 bits (286), Expect = 6e-30
 Identities = 82/293 (27%), Positives = 142/293 (48%), Gaps = 46/293 (15%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +  +E    +G+G +G VY  R+  +   +ALK I  EQ E   +     RE+ +   ++
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA------ATYIASLTNA 131
           H NI+RL    H ++R++L+ EY     L  +L+KH   +   A       TY+  +   
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 132 LAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE 186
           +AYCH + V+HRD+KP+NLL+D     LK+ DFG    + +  R+  H +  TL Y APE
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPE 173

Query: 187 -MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------- 231
            ++ ++ +   VD W++G +  E +   P F  +S+ D   +I ++              
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233

Query: 232 ----DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 +FP           P++      L+S++L  D SKR++ +  +EH +
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  115 bits (289), Expect = 7e-30
 Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 52/280 (18%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G FG V L  +V++    A+K + K+ +        ++ E +I +   +  +++L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y  F D + ++ +++Y   G++   L +   F E  A  YIA LT A+   H+   IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 145 IKPENLLLDHEGRLKIGDFG------W--------------------------------- 165
           IKP+N+L+D +G +K+ DFG      W                                 
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 166 ----SVQSRSKR-------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP 214
               +++ R+ +       H++ GT +Y+APE++  K +    D W++G++ +E L G P
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246

Query: 215 PFEAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRL 252
           PF A +  +T  +++  +  L  P    +S EA  LI++L
Sbjct: 247 PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  112 bits (282), Expect = 1e-29
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 13/256 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           LGKG FG VYLV++ ++     LK++ +  + +      ++   E Q  S L HP I++ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 85  YGWFHDDERIFLILEYAHRGEL---YRELRKH-RRFTEQQAATYIASLTNALAYCHENHV 140
           +  F + +   +I EY    +L     EL+   +  +E Q   +   L   + Y H+  +
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           +HRD+K +N+ L     LKIGDFG S   + S     T  GT  Y++PE ++++ +D   
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKD 256
           D W+LG + YE    A  FE ++      RI++     PS P + S +   ++  +L KD
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--PSLPETYSRQLNSIMQSMLNKD 244

Query: 257 SSKRLSLQKIMEHPWI 272
            S R S  +I+ +P+I
Sbjct: 245 PSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  112 bits (283), Expect = 1e-29
 Identities = 73/271 (26%), Positives = 133/271 (49%), Gaps = 30/271 (11%)

Query: 18  LQDFEIGRPLG--KGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ------HQLRRE 69
           L++ EI + L    GKFG+V ++     KH    K+  ++ I+           HQL ++
Sbjct: 13  LKNCEIVKKLKLIDGKFGKVSVL-----KHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKD 67

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
                   +PN ++LY      +   LI++Y   G+L+  L+K  + +E +    I  L 
Sbjct: 68  --------NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLV 119

Query: 130 NALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
            AL   H++++IH DIK EN+L D  + R+ + D+G   +         GTLDY +PE +
Sbjct: 120 EALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-CKIIGTPSCYDGTLDYFSPEKI 178

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRRIMKVDLSFPSAPSISAE 244
           +   +D + D W +G+L YE L G  PF+ +  ++    +  +  +  L F    ++S  
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK--NVSKN 236

Query: 245 AKHLISRLLVKDSSKRL-SLQKIMEHPWIIK 274
           A   +  +L  + + RL +  +I++HP++  
Sbjct: 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  113 bits (285), Expect = 1e-29
 Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 41/292 (14%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+ +FE    +G+G +G VY  R+  S   VALK +  +  E+  I     RE+ +  +L
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNL 63

Query: 77  RHPNILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALA 133
           RHPNI+ L         + IFL++EY  + +L   L      F+E Q    +  L   L 
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPEMV-E 189
           Y HEN +IHRD+K  NLLL  +G LKI DFG +         M     TL Y APE++  
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-------------SFP 236
              +  A+D W +G +  E L   P    +S+ +     + + L               P
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD--LIIQLLGTPNESIWPGFSDLP 240

Query: 237 SA-----------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                              P +S     L++ LL+ D  KR + ++ +E  +
Sbjct: 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  112 bits (281), Expect = 2e-29
 Identities = 81/261 (31%), Positives = 130/261 (49%), Gaps = 19/261 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA        I +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVA--------IRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLISRLLVKDS 257
            W+LGI+  E + G PP+  E+       I          P  +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258

Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  110 bits (276), Expect = 7e-29
 Identities = 71/253 (28%), Positives = 129/253 (50%), Gaps = 11/253 (4%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L +F+I + +G+G+F  VY    +  + PVALK +   ++   K +    +E+++   L 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNALA 133
           HPN+++    F +D  + ++LE A  G+L + +    ++ R   E+    Y   L +A+ 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVEN 190
           + H   V+HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-LSFPSAPS--ISAEAKH 247
             +++  D W+LG L YE      PF  + + + F    K++   +P  P+   S + + 
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239

Query: 248 LISRLLVKDSSKR 260
           L+S  +  D  +R
Sbjct: 240 LVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  111 bits (281), Expect = 7e-29
 Identities = 92/307 (29%), Positives = 145/307 (47%), Gaps = 54/307 (17%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L+ +EI + LGKG +G V+   +  +K  VALK IF         Q   R  M +Q    
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 78  HPNILRLYGWFH--DDERIFLILEYAHRGELYRELRK------HRRFTEQQAATYIASLT 129
           HPNI++L       +D+ I+L+ EY    +L+  +R       H+R+   Q       L 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQ-------LL 117

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCGTLDYLA--- 184
            AL Y H  +VIHRD+KP N+LL+ + R+K+ DFG   S+    +        DY+A   
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 185 ---PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------DL 233
              PE ++ +  +   VD W++G +  E L G P F   S  +   +I++V       D+
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 234 -------------SFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                        S PS          P  S +A  L+ +LLV + +KRL+ ++ +EHP+
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 272 IIKNANP 278
           + +  NP
Sbjct: 298 VAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  110 bits (277), Expect = 9e-29
 Identities = 80/274 (29%), Positives = 137/274 (50%), Gaps = 29/274 (10%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HP 79
           +EI   +GKG +G+V+ V   ++    A+KI+  + I  + I  ++  E  I  +L  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPI--HDIDEEIEAEYNILKALSDHP 75

Query: 80  NILRLYGWFH-----DDERIFLILEYAHRGELYR----ELRKHRRFTEQQAATYIASLTN 130
           N+++ YG ++     + ++++L+LE  + G +       L++  R  E   A  +     
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H N  IHRD+K  N+LL  EG +K+ DFG S Q   +R +R+T  GT  ++APE+
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 188 VE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---P 239
           +      +  +D   D W+LGI   E   G PP    +     R + K+  + P     P
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNPPPTLHQP 252

Query: 240 SI-SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            + S E    I + L KD  KR ++  +++H +I
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  110 bits (275), Expect = 1e-28
 Identities = 79/259 (30%), Positives = 133/259 (51%), Gaps = 19/259 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  E+ E  +I+  +++E+ + S    P + + YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 70  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 188

Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSI----SAEAKHLISRLLVKDS 257
           I   E   G PP             MKV    P  + P++    S   K  +   L K+ 
Sbjct: 189 ITAIELAKGEPPHSELHP-------MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241

Query: 258 SKRLSLQKIMEHPWIIKNA 276
           S R + +++++H +I++ A
Sbjct: 242 SFRPTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  110 bits (275), Expect = 1e-28
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 17/266 (6%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHEN 138
           ++ L   +   + + L+L   + G+L   +    +  F E++A  Y A +   L   H  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++RD+KPEN+LLD  G ++I D G +V   +  S R  + GT+ Y+APE++ N+ +  
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTL 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQK----DTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           + D W LG L YE + G  PF    +K    +  RR+++ +  + +    S EAK +   
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA--KFSEEAKSICKM 238

Query: 252 LLVKDSSKRLSLQ-----KIMEHPWI 272
           LL KD  +RL  Q     ++  HP+ 
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  109 bits (275), Expect = 2e-28
 Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 16/276 (5%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D +K    L D E    +G G  G+VY +R  ++ H +A+K + +    K + +  L   
Sbjct: 6   DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDL 64

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIAS 127
             +  S   P I++ YG+F  D  +F+ +E         +L K  +    E        +
Sbjct: 65  DVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA 122

Query: 128 LTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           +  AL Y  E H VIHRD+KP N+LLD  G +K+ DFG S   V S++K  +  G   Y+
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYM 181

Query: 184 APEMVE----NKEHDYAVDNWTLGILCYEFLYGAPPFE-AESQKDTFRRIMKVDL-SFPS 237
           APE ++    N ++D   D W+LGI   E   G  P++  +++ +   +I++ +  S P 
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241

Query: 238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII 273
               S +    +   L KD  KR   +++++HP+I 
Sbjct: 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  109 bits (273), Expect = 3e-28
 Identities = 71/279 (25%), Positives = 134/279 (48%), Gaps = 37/279 (13%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V+  +  E+   VALK +  +  +   +     RE+ +   L+H NI+RLY 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA-TYIASLTNALAYCHENHVIHRDI 145
             H D+++ L+ EY  + +L +         + +   +++  L   LA+CH ++V+HRD+
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125

Query: 146 KPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNW 200
           KP+NLL++  G LK+ DFG    + +  R     +  TL Y  P+ +   K +  ++D W
Sbjct: 126 KPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMW 184

Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRIMKV-----DLSFPS----------------- 237
           + G +  E    G P F      D  +RI ++     + S+P                  
Sbjct: 185 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATT 244

Query: 238 -----APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 P +++  + L+  LLV +  +R+S ++ ++HP+
Sbjct: 245 SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  109 bits (273), Expect = 3e-28
 Identities = 75/258 (29%), Positives = 128/258 (49%), Gaps = 13/258 (5%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIH 142
              +   + + L+L   + G+L   +       F E +A  Y A +   L   H+  +++
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHDYAVDNW 200
           RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+V+N+ + ++ D W
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 185

Query: 201 TLGILCYEFLYGAPPFEAESQK---DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            LG L YE + G  PF+   +K   +   R++K ++    +   S +A+ L   LL KD 
Sbjct: 186 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLCKMLLCKDP 244

Query: 258 SKRL-----SLQKIMEHP 270
            +RL       +++ EHP
Sbjct: 245 KERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  108 bits (272), Expect = 4e-28
 Identities = 73/223 (32%), Positives = 116/223 (52%), Gaps = 9/223 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G+G +G V   R  E+K  VA+K  FK+  E  +++    RE+++  +L+  N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRG--ELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           I+ L   F    +++L+ EY  +   EL  E+        ++  +YI  L  A+ +CH+N
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHKN 119

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            ++HRDIKPENLL+ H   LK+ DFG+    S  S +       T  Y +PE++    + 
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
            AVD W++G +  E   G P F  ES+ D    I KV    P+
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  107 bits (268), Expect = 3e-27
 Identities = 77/299 (25%), Positives = 124/299 (41%), Gaps = 40/299 (13%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V  V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  E        ++   L Y  E H
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119

Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQS 179

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD-------------TFRRIMKVDLSFPSAPS---- 240
           D W+LG+   E   G  P      K+                    V    P +P     
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239

Query: 241 -------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 280
                               S E +  + + L K+  +R  L+++ +HP+I +      
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  105 bits (264), Expect = 4e-27
 Identities = 70/265 (26%), Positives = 134/265 (50%), Gaps = 15/265 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +G+ LG+G FGRVYL  + ++   +A+K +    E  E  K  + L  E+++  +L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           H  I++ YG   D  +  + + +E+   G +  +L+ +   TE     Y   +   ++Y 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ------SRSKRHTMCGTLDYLAPEMVE 189
           H N ++HRDIK  N+L D  G +K+GDFG S +      S +   ++ GT  +++PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPS-ISAEAKH 247
            + +    D W++G    E L   PP+ E E+    F+  +    + P  P  +S   + 
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPVLPPHVSDHCRD 240

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
            + R+ V ++  R S  +++ H ++
Sbjct: 241 FLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  107 bits (269), Expect = 1e-26
 Identities = 68/222 (30%), Positives = 116/222 (52%), Gaps = 14/222 (6%)

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRE----LRKHRRFTEQQAA 122
           R E+   ++  H  I++ +  F  D+++ LI+EY   G+L ++    L++H  F E +  
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMC 177
                +  AL   H   ++HRD+K  N+ L   G +K+GDFG+S Q     S     + C
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSF 235
           GT  YLAPE+ E K +    D W+LG++ YE L    PF+  SQ++  ++++  K D   
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--- 289

Query: 236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           P    +S+  K L+  LL K+ + R + Q+++   ++   AN
Sbjct: 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVAN 331

Length = 478

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  104 bits (261), Expect = 1e-26
 Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 19/268 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G G +G+VY  R V++    A+K++     E+ +I+ ++     ++    H N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM---LKKYSHHRN 64

Query: 81  ILRLYGWFHD------DERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNAL 132
           I   YG F        D++++L++E+   G +   ++  K     E+  A     +   L
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVE 189
           ++ H++ VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  ++APE++ 
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 190 NKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
             E     +D+  D W+LGI   E   GAPP            I +       +   S +
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244

Query: 245 AKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            +  I   LVK+ S+R + +++M+HP+I
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  104 bits (261), Expect = 2e-26
 Identities = 79/265 (29%), Positives = 127/265 (47%), Gaps = 14/265 (5%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V   +   +    A K + K++I+K K +     E  I   +    ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIH 142
              +   + + L+L   + G+L   +    +  F EQ+A  Y A L   L       +++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           RD+KPEN+LLD  G ++I D G +VQ           GT+ Y+APE++ N+++ ++ D W
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWW 185

Query: 201 TLGILCYEFLYGAPPFEAESQK---DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            LG L YE + G  PF    ++   +   R +K D    S    S +AK +   LL K+ 
Sbjct: 186 GLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE-KFSEDAKSICRMLLTKNP 244

Query: 258 SKRLSLQ-----KIMEHPWIIKNAN 277
            +RL  +      + +HP I KN N
Sbjct: 245 KERLGCRGNGAAGVKQHP-IFKNIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  104 bits (260), Expect = 2e-26
 Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 20/266 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFE+ + +G G +G VY  R V +    A+K+I  E  E + +  Q   E+ +    +H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKH 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            NI+  +G +   +++++ +E+   G L          +E Q A         L Y H  
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM--VENK-E 192
             +HRDIK  N+LL   G +K+ DFG S Q   + +KR +  GT  ++APE+  VE K  
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 193 HDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVDLSFPSAPSISAEAK----- 246
           ++   D W +GI   E     PP F+    +  F   +    +F   P +  + K     
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNF-QPPKLKDKMKWSNSF 241

Query: 247 -HLISRLLVKDSSKRLSLQKIMEHPW 271
            H +   L K+  KR + +K+++HP+
Sbjct: 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  103 bits (259), Expect = 3e-26
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 35/276 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G G +G+VY  R V++    A+K++   + E+ +I+ ++     ++    H N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM---LKKYSHHRN 74

Query: 81  ILRLYGWF-------HDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNA 131
           I   YG F       HDD+ ++L++E+   G +   ++  +     E   A     +   
Sbjct: 75  IATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV 188
           LA+ H + VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  ++APE++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 189 ENKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
              E     +DY  D W+LGI   E   GAPP             M+     P  P    
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPPPKL 246

Query: 244 EAK-------HLISRLLVKDSSKRLSLQKIMEHPWI 272
           ++K         I   LVK+   R S +++++HP+I
Sbjct: 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  103 bits (259), Expect = 3e-26
 Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 16/206 (7%)

Query: 27  LGKGKFGRVYLVREVESKHP-VALKIIF-------KEQIEKYKIQHQLRREME-IQSSLR 77
           LG G FG VY VR+  +    +ALK I        K++ E+ K    +  E+  I+  LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 78  HPNILRLYGWFHDDERIFLILEY---AHRGELYRELR-KHRRFTEQQAATYIASLTNALA 133
           HPNI+R Y  F +++R++++++    A  GE +  L+ K +RFTE++       +  AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 134 YCH-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVEN 190
           Y H E  ++HRD+ P N++L  + ++ I DFG + Q +  SK  ++ GT+ Y  PE+V+N
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPF 216
           + +    D W  G + Y+     PPF
Sbjct: 188 EPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  104 bits (262), Expect = 4e-26
 Identities = 81/321 (25%), Positives = 139/321 (43%), Gaps = 67/321 (20%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--------------IQHQLRR 68
            G  LG+G +G+V    +  +   VA+K   K +I +                I     R
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIK---KVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E++I + ++H NI+ L   + + + I L+++     +L + + +  R TE Q    +  +
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQI 128

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--------VQSRSKRHTMCG-- 178
            N L   H+ + +HRD+ P N+ ++ +G  KI DFG +          + SK  TM    
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 179 -------TLDYLAPE--MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                  TL Y APE  M   K H  AVD W++G +  E L G P F  E++ D   RI 
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHF-AVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247

Query: 230 KV-----DLSFPSA---------------------PSISAEAKHLISRLLVKDSSKRLSL 263
           ++     + ++P A                     P+ S +A  L+  LL  +  +R+S 
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307

Query: 264 QKIMEHPWIIKNANPRGTCDI 284
           ++ ++H +   +  P   CD 
Sbjct: 308 KEALKHEYFKSDPLP---CDP 325

Length = 335

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  103 bits (259), Expect = 7e-26
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 7/214 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFE    LG G  G V  V+   S   +A K+I  E   K  I++Q+ RE+++      
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNS 62

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P I+  YG F+ D  I + +E+   G L + L++ +R  E+       ++   LAY  E 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 139 H-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           H ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +   
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182

Query: 197 VDNWTLGILCYEFL---YGAPPFEAESQKDTFRR 227
            D W++G+   E     Y  PP +A+  +  F R
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  102 bits (257), Expect = 8e-26
 Identities = 87/272 (31%), Positives = 126/272 (46%), Gaps = 24/272 (8%)

Query: 18  LQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSS 75
           L+D  EIGR    G FG V  +    S   +A+K I     EK   Q +L  +++ +  S
Sbjct: 6   LKDLGEIGR----GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRS 59

Query: 76  LRHPNILRLYG-WFHD-DERIFLILEYAHRGELYR--ELRKHRRFTEQQAATYIASLTNA 131
              P I++ YG  F + D  I + L      + Y+           E+       +   A
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 132 LAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEM 187
           L Y  E   +IHRD+KP N+LLD  G +K+ DFG S   V S +K     G   Y+APE 
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPER 178

Query: 188 VENKEHD-YAV--DNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVD---LSFPSAPS 240
           ++    D Y V  D W+LGI  YE   G  P+    S  D   +++K D   LS      
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            S    + I+  L+KD SKR   ++++EHP+I
Sbjct: 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  101 bits (252), Expect = 3e-25
 Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 14/264 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           QD +    LG G  G VY    + ++  +A+K+I  +     ++Q Q+  E+EI      
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDS 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P I+  YG F  + RI +  E+   G L      +R+  E        ++   L Y    
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G++K+ DFG S Q   S   T  GT  Y+APE +  +++    
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-----VDLSFPSAP--SISAEAKHLIS 250
           D W+LGI   E   G  P+    +       ++     VD   P  P    S +  H I+
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIK 274
           + + K   +R + + +M+HP+I++
Sbjct: 235 QCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 3e-25
 Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 47/286 (16%)

Query: 26  PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---YKIQHQLRREMEIQSSLRHPNIL 82
            LG+G +  VY  R   +   VALK I  E  E      I     RE  +   L+H NI+
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDLKHANIV 66

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE-QQAATYIASLTNALAYCHENHVI 141
            L+   H  + + L+ EY    +L + +              ++  L   LAYCH+  V+
Sbjct: 67  TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL+   G LK+ DFG     SV S++  + +  TL Y  P+ ++ + E+  +
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTS 184

Query: 197 VDNWTLGILCYEFLYGAPPF----EAESQKDTFRRIM----------------KVDLSFP 236
           +D W +G + YE   G P F    + E Q     R++                    SFP
Sbjct: 185 LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244

Query: 237 ---------SAPSIS--AEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                     AP +      + L  + L  +  KR+S  + M+HP+
Sbjct: 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  101 bits (253), Expect = 4e-25
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 6/196 (3%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHR 143
            G +  +   +L++EY   G     L  H++   E + A         LAY H +++IHR
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNW 200
           D+K  N+LL   G +K+GDFG S    +  +   GT  ++APE++   +  ++D  VD W
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198

Query: 201 TLGILCYEFLYGAPPF 216
           +LGI C E     PP 
Sbjct: 199 SLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 4e-25
 Identities = 69/265 (26%), Positives = 136/265 (51%), Gaps = 15/265 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKII--FKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +G+ LG+G FG VYL  + ++   +A+K +    +  E  K  + L  E+++  +LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 78  HPNILRLYGWFHDDE--RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           H  I++ YG   D E  ++ + +EY   G +  +L+ +   TE     Y   +   ++Y 
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ------SRSKRHTMCGTLDYLAPEMVE 189
           H N ++HRDIK  N+L D  G +K+GDFG S +      S +   ++ GT  +++PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAP-SISAEAKH 247
            + +    D W++     E L   PP+ E E+    F+  +    + P  P  +S   + 
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK--IATQPTKPMLPDGVSDACRD 240

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
            + ++ V++  +R + + ++ HP++
Sbjct: 241 FLKQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  102 bits (254), Expect = 4e-25
 Identities = 80/299 (26%), Positives = 134/299 (44%), Gaps = 48/299 (16%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 63

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123

Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 183

Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRRIMKVDLSF------------------- 235
           D W++G+   E   G    PP +A+  +  F   ++ D +                    
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243

Query: 236 --------------------PSAPSI--SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                               P  PS    AE +  +++ L+K+ ++R  L+++M H +I
Sbjct: 244 DSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  101 bits (252), Expect = 4e-25
 Identities = 81/293 (27%), Positives = 135/293 (46%), Gaps = 56/293 (19%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLY 85
           +G+G +G+VY  R+  +   VALK    E +++  I     RE+ +   L     I+RL 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 86  GWFHDDER-----IFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNA 131
              H +E+     ++L+ EY     L  +L+K          R    +   +++  L   
Sbjct: 68  DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 132 LAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE 186
           +A+CH++ V+HRD+KP+NLL+D + G LKI D G    +S+  +S  H +  TL Y APE
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPE 181

Query: 187 MVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------- 231
           ++    H    VD W++G +  E     P F  +S+      I K+              
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241

Query: 232 -------------DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                        DLS  + P +S E   L+ ++L  D +KR+S +  + HP+
Sbjct: 242 LRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =   99 bits (249), Expect = 6e-25
 Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 14/262 (5%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPN 80
           G  LGKG +G VY          +A+K +       +   K   +L+ E+++  SL+H N
Sbjct: 5   GEVLGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++  G   DD  I + +E+   G +   L +     E     Y   + + +AY H N V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG------WSVQSRSKRH---TMCGTLDYLAPEMVENK 191
           +HRDIK  N++L   G +K+ DFG      W     +  +   +M GT  ++APE++   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLIS 250
            +    D W++G   +E   G PP  +  +      I       P  P S SA A   ++
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243

Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
             L +D  +R S  +++ H ++
Sbjct: 244 SCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  103 bits (258), Expect = 9e-25
 Identities = 90/300 (30%), Positives = 147/300 (49%), Gaps = 41/300 (13%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E  L ++E+ + +G G+FG V+LV+   ++     K I    + K + + QL  E+ +  
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMR 67

Query: 75  SLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK-HRRF--TEQQAATYIA-SL 128
            L+H NI+R    F +  ++++++++E+   G+L R ++K ++ F   E+ A   I   L
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 129 TNALAYCHE-------NHVIHRDIKPENLLLD----HEGRL-------------KIGDFG 164
            +ALAYCH          V+HRD+KP+N+ L     H G++             KIGDFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 165 WS--VQSRSKRHTMCGTLDYLAPEMV--ENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
            S  +   S  H+  GT  Y +PE++  E K +D   D W LG + YE   G  PF    
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH--- 244

Query: 221 QKDTFRRIMKVDLSFPSAP--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           + + F +++      P  P    S E   LI  LL   + +R S  + + +  IIKN  P
Sbjct: 245 KANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ-IIKNVGP 303

Length = 1021

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  100 bits (249), Expect = 1e-24
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 46/283 (16%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  V+  R   +++ VALK I  E  E         RE+ +   L+H NI+ L+ 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI--REVSLLKDLKHANIVTLHD 71

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-----FTEQQAATYIASLTNALAYCHENHVI 141
             H D+ + L+ EY     L ++L+++        +      ++  +   LAYCH   V+
Sbjct: 72  IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++  G LK+ DFG     SV +++  + +  TL Y  P+ ++ + E+   
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DLSFPS 237
           +D W +G + +E   G P F   + +D    I ++                   + +FP 
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPK 245

Query: 238 ---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                    AP +  E   L+++ L  +S KR+S ++ M+H +
Sbjct: 246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 99.4 bits (248), Expect = 1e-24
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 36/279 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V+  R  E+   VA+K  F E  +   I+    RE+ +   L+HPN++ L  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F    ++ L+ EY     L  EL K+ R   E      I     A+ +CH+++ IHRD+
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126

Query: 146 KPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC-GTLDYLAPEM-VENKEHDYAVDNWT 201
           KPEN+L+  +G++K+ DFG++  +      +T    T  Y APE+ V + ++   VD W 
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWA 186

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DLSFPSA---- 238
           +G +  E L G P +  +S  D    I K                     LS P      
Sbjct: 187 IGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246

Query: 239 ------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 P+IS+ A   +   L  D ++RLS ++++EHP+
Sbjct: 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 99.1 bits (247), Expect = 3e-24
 Identities = 77/307 (25%), Positives = 131/307 (42%), Gaps = 56/307 (18%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +  +  F+I   +G+G +G+VY  R+ ++   VALK +  +  EK        RE++I  
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILR 61

Query: 75  SLRHPNILRLYGWFHDD----------ERIFLILEYAHRGELYRELR-KHRRFTEQQAAT 123
            L H NI+ L     D              +L+ EY    +L   L      F+E    +
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKS 120

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGT 179
           ++  L   L YCH+ + +HRDIK  N+LL+++G++K+ DFG    ++ +          T
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180

Query: 180 LDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAES------------------ 220
           L Y  PE++  +E +  A+D W+ G +  E     P F+A                    
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240

Query: 221 ---------------QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQK 265
                           K  +RR ++ + SF     I   A  L+  +L  D SKR + ++
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSF-----IPTPALDLLDHMLTLDPSKRCTAEE 295

Query: 266 IMEHPWI 272
            +  PW+
Sbjct: 296 ALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 3e-24
 Identities = 81/317 (25%), Positives = 138/317 (43%), Gaps = 69/317 (21%)

Query: 21  FEIGRPLGKGKFGRVYLVR--EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +EI   +G+G +GRVY  +    +     A+K    ++ +   I     RE+ +   L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 79  PNILRLYGWF--HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY-IASLT----NA 131
            N++ L   F  H D+ ++L+ +YA   +L++ ++ HR+          + SL     N 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 132 LAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWSVQSRSKRHTMCG------TLD 181
           + Y H N V+HRD+KP N+L+       G +KIGD G +    +    +        T+ 
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 182 YLAPEMVENKEHDY--AVDNWTLGILCYEFLYGAPPF---EAES------QKDTFRRIMK 230
           Y APE++    H Y  A+D W +G +  E L   P F   EA+       Q+D   RI +
Sbjct: 181 YRAPELLLGARH-YTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239

Query: 231 VDLSFPSA---PSI---------------------------------SAEAKHLISRLLV 254
           V L  P+    P I                                  ++   L+ +LL 
Sbjct: 240 V-LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298

Query: 255 KDSSKRLSLQKIMEHPW 271
            D +KR++ ++ +EHP+
Sbjct: 299 YDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  101 bits (253), Expect = 4e-24
 Identities = 57/180 (31%), Positives = 102/180 (56%), Gaps = 3/180 (1%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F I +P+ +G FG+VYL R+  +    A+K++ K  +    + HQ++ E +  +  
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           + P I+ LY        ++L++EY   G++   L  +  F E+ A  YI+ +  AL Y H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            + +IHRD+KP+N+L+ +EG +K+ DFG S  + ++   M   L    P M + K +DY+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILT--TPSMAKPK-NDYS 178

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 98.7 bits (246), Expect = 5e-24
 Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 42/283 (14%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           +P+G G FG V   R+  +   VA+K I K       +  +  RE+++   LRH NI+ L
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 85  YGWF-HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
              F    E I+ + E     +L+R L   R   +Q    ++  +   L Y H   V+HR
Sbjct: 75  SDIFISPLEDIYFVTELLGT-DLHR-LLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDN 199
           D+KP N+L++    LKI DFG +   R +   M G   T  Y APE M+  +++D  VD 
Sbjct: 133 DLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDI 189

Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--------------------- 238
           W+ G +  E L G P F  +   + F  I  + L  P                       
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL-LGTPPDDVINTICSENTLRFVQSLPKR 248

Query: 239 ---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                     +    A  L+ ++LV D  KR+S  + + HP++
Sbjct: 249 EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 97.7 bits (243), Expect = 5e-24
 Identities = 66/252 (26%), Positives = 123/252 (48%), Gaps = 9/252 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V  V+   +    A K + K++++K   +     E EI   +  P I+ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
            F     + L++   + G+L   +     R    ++   Y A +T  + + H   +++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENKEHDYAVDNWTL 202
           +KPEN+LLD +G  ++ D G +V+ +  +      GT  Y+APE+++ + + Y VD + +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 203 GILCYEFLYGAPPF----EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS 258
           G   YE + G  PF    E  ++++  RR ++ ++ F    + + E+K +    L K   
Sbjct: 181 GCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ-NFTEESKDICRLFLAKKPE 239

Query: 259 KRLSLQKIMEHP 270
            RL  ++  + P
Sbjct: 240 DRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 97.9 bits (244), Expect = 6e-24
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 36/279 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V   +  E+   VA+K  F E  +   ++    RE+ +   LRH N++ L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F   +R++L+ E+     L  +L K+     E +   Y+  +   + +CH +++IHRDI
Sbjct: 68  VFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126

Query: 146 KPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-MCGTLDYLAPEM-VENKEHDYAVDNWT 201
           KPEN+L+   G +K+ DFG++  + +  + +T    T  Y APE+ V + ++  AVD W 
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWA 186

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMK-------------------VDLSFPSA---- 238
           +G L  E L G P F  +S  D    I+K                     +  P      
Sbjct: 187 VGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIE 246

Query: 239 ------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 P +S     L  + L  D   R S  +++ H +
Sbjct: 247 PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 97.8 bits (243), Expect = 7e-24
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 46/283 (16%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  V+  R   +++ VALK I  E  E         RE+ +  +L+H NI+ L+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI--REVSLLKNLKHANIVTLHD 70

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVI 141
             H +  + L+ EY     L  +L+++        +      ++  L   L+YCH+  ++
Sbjct: 71  IIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ +G LK+ DFG     SV +++  + +  TL Y  P+ ++ + E+   
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DLSFPS 237
           +D W +G + YE   G P F   + K+    I ++                      FP 
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQ 244

Query: 238 ---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                    AP +  +   L+S LL+ ++  R+S +  + H +
Sbjct: 245 YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 8e-24
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 9/217 (4%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           + ++ ++G  +GKG+FG V L         VA+K +  +             E  + ++L
Sbjct: 4   NSKELKLGATIGKGEFGDVML--GDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTL 57

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAY 134
           RHPN+++L G       ++++ EY  +G L   LR   R   T  Q   +   +   + Y
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
             E + +HRD+   N+L+  +   K+ DFG + ++   + +    + + APE +  K+  
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFS 177

Query: 195 YAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
              D W+ GIL +E + +G  P+     KD    + K
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 98.1 bits (245), Expect = 9e-24
 Identities = 73/316 (23%), Positives = 132/316 (41%), Gaps = 56/316 (17%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + D ++   P+G G +G+V    + ++   VA+K +   F+  I      
Sbjct: 3   RQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI------ 56

Query: 64  HQLR--REMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   + H N++ L   F     +      +L+       +L   + K ++
Sbjct: 57  HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIV-KCQK 114

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            ++      +  +   L Y H   +IHRD+KP N+ ++ +  LKI DFG +  +  +   
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174

Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--- 231
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  +RIM +   
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234

Query: 232 ---------------------------DLS--FPSAPSISAEAKHLISRLLVKDSSKRLS 262
                                      D    F  A   +  A  L+ ++LV D  KR++
Sbjct: 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA---NPLAIDLLEKMLVLDPDKRIT 291

Query: 263 LQKIMEHPWIIKNANP 278
             + + HP++ +  +P
Sbjct: 292 AAEALAHPYLAEYHDP 307

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 97.6 bits (243), Expect = 9e-24
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 16/264 (6%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           R +G G FG VY  R+V +   VA+K +    K+  EK++    + +E+     LRHPN 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQQLRHPNT 77

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHV 140
           +   G +  +   +L++EY   G     L  H++   E + A         LAY H +  
Sbjct: 78  IEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAV 197
           IHRDIK  N+LL   G +K+ DFG S    S  ++  GT  ++APE++   +  ++D  V
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI--SAEAKHLISRLLVK 255
           D W+LGI C E     PP    +       I + D   P+  S   S   ++ +   L K
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWSDYFRNFVDSCLQK 253

Query: 256 DSSKRLSLQKIMEHPWIIKNANPR 279
               R S +++++H ++++   P 
Sbjct: 254 IPQDRPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 97.9 bits (244), Expect = 1e-23
 Identities = 78/305 (25%), Positives = 129/305 (42%), Gaps = 62/305 (20%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +E+ + LG+G +G V   R  E+     VA+K I     +K   +  LR    ++    H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 79  PNILRLYGWFHDDERIFLILEYAHRG-ELYREL---------RKHRRFTEQQAATYIASL 128
            NI  LY    D + +F           LY EL         R  +  T+    ++I  +
Sbjct: 62  KNITCLY----DMDIVF---PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI 114

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------VQSRSKRHTMCGTLD 181
              L Y H  +V+HRD+KP NLL++ +  LKI DFG +        ++         T  
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 182 YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES---------------QKDTF 225
           Y APE M+  + +  A+D W++G +  E L   P F+ +                 ++T 
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234

Query: 226 RRI-----------------MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
            RI                    +  FP+A   +  A  L+ +LL  D +KR+S+++ +E
Sbjct: 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNA---NPLALDLLEKLLAFDPTKRISVEEALE 291

Query: 269 HPWII 273
           HP++ 
Sbjct: 292 HPYLA 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.5 bits (242), Expect = 2e-23
 Identities = 70/257 (27%), Positives = 127/257 (49%), Gaps = 12/257 (4%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           R +G G FG VY  R+V +   VA+K +    K+  EK++    + +E++    ++HPN 
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVKFLQRIKHPNS 87

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHV 140
           +   G +  +   +L++EY   G     L  H++   E + A         LAY H +++
Sbjct: 88  IEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAV 197
           IHRDIK  N+LL   G++K+ DFG S    S  ++  GT  ++APE++   +  ++D  V
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG-SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           D W+LGI C E     PP    +       I + +     +   S   ++ +   L K  
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265

Query: 258 SKRLSLQKIMEHPWIIK 274
             R + +++++H ++++
Sbjct: 266 QDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 97.1 bits (242), Expect = 2e-23
 Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 61/298 (20%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++K  VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 86  -------GWFHDDERIFLILEY-AHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCH 136
                   +       +L+ E+  H  +L   L  K+ +FT  +    +  L N L Y H
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH--DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCG---TLDYLAPEMVE 189
            N ++HRD+K  N+L+  +G LK+ DFG    +S+   SK +       TL Y  PE++ 
Sbjct: 137 RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196

Query: 190 NKEHDY--AVDNWTLGILCYEFLYGAPPFEAESQK------------------------D 223
             E DY   +D W  G +  E    +P  +  +++                        +
Sbjct: 197 G-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255

Query: 224 TFR---------RIMKVDLSFPSAPSIS-AEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            F+         R +K  L     P +    A  LI +LLV D +KR+     + H +
Sbjct: 256 LFKKMELPQGQKRKVKERLK----PYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 96.6 bits (241), Expect = 2e-23
 Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 42/281 (14%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILR 83
           +G+G F  V   +  ++    A+K +     + +K   Q+    EIQ+  R   HPNILR
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 84  LYGWFHDDE--RIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHV 140
           L     D +  R+ L+ E      LY  ++  +R   E++  +Y+  L  +L + H N +
Sbjct: 63  LIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG--WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAV 197
            HRDIKPEN+L+  +  LK+ DFG    + S+        T  Y APE ++ +  +   +
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM 180

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------DLSFPSA- 238
           D W +G + +E L   P F   ++ D   +I  V                  + +FPS  
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKK 240

Query: 239 --------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                   P+ SAE   L+ +LL  D  +R++ ++ + HP+
Sbjct: 241 GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 95.9 bits (238), Expect = 5e-23
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 6/262 (2%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G FG VY      +   VA+K +     +  +    + +E++    L+HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +  +   +L++EY   G     L  H++   E + A         LAY H +++IHRDI
Sbjct: 89  CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNWTL 202
           K  N+LL   G++K+ DFG S    S  ++  GT  ++APE++   +  ++D  VD W+L
Sbjct: 148 KAGNILLTEPGQVKLADFG-SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206

Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           GI C E     PP    +       I + D     +   +   +  +   L K   +R +
Sbjct: 207 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA 266

Query: 263 LQKIMEHPWIIKNANPRGTCDI 284
             +++ H ++ ++   R   D+
Sbjct: 267 SAELLRHDFVRRDRPARVLIDL 288

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.4 bits (235), Expect = 9e-23
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 25  RPLGKGKFGRVYLVR-EVESKHP---VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + LG+G FG+V L R +    +    VA+K +     E++  +    RE+EI  +L H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHEN 67

Query: 81  ILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
           I++  G         + LI+EY   G L   L++HR +   ++   + + +   + Y   
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGTLD-----YLAPEMVENK 191
              IHRD+   N+L++ E  +KI DFG + V    K +            + APE +   
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 192 EHDYAVDNWTLGILCYE-FLYGAP 214
           +   A D W+ G+  YE F YG P
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 93.9 bits (233), Expect = 1e-22
 Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 14/261 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            D+E+ + +G G +G VY  R + +    A+KII  E  + + +   +++E+ +    +H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKH 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            NI+  +G +   E++++ +EY   G L          +E Q A         LAY H  
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV---ENKE 192
             +HRDIK  N+LL   G +K+ DFG + +   + +KR +  GT  ++APE+    +N  
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 193 HDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVDLSFPS---APSISAEAKHL 248
           ++   D W +GI   E     PP F+    +  F  + K +   P        S+   + 
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNFQPPKLKDKTKWSSTFHNF 244

Query: 249 ISRLLVKDSSKRLSLQKIMEH 269
           +   L K+  KR + ++++ H
Sbjct: 245 VKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 93.3 bits (232), Expect = 2e-22
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 18/221 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++F + R LG G FG V+          VA+KI+  + + K   Q   ++E++    LRH
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRV-RVAIKILKSDDLLK---QQDFQKEVQALKRLRH 61

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT-----YIAS-LTNAL 132
            +++ L+      E +++I E   +G L   LR      E Q         +A  +   +
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS----PEGQVLPVASLIDMACQVAEGM 117

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT---LDYLAPEMVE 189
           AY  E + IHRD+   N+L+  +   K+ DFG +   +   +          + APE   
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177

Query: 190 NKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIM 229
           +       D W+ GIL YE F YG  P+   +  + + +I 
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 93.9 bits (233), Expect = 2e-22
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 46/283 (16%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  VY  R   + + VALK I  E  E         RE+ +   L+H NI+ L+ 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI--REVSLLKDLKHANIVTLHD 71

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVI 141
             H ++ + L+ EY     L ++L+++               ++  L   L YCH   V+
Sbjct: 72  IIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++  G LK+ DFG     S+ +++  + +  TL Y  P+ ++ + ++   
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DLSFPS 237
           +D W +G + YE   G P F   + ++    I ++                     ++P 
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK 245

Query: 238 ---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                    AP + ++   L+S+LL  +  KR+S ++ M+HP+
Sbjct: 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 93.2 bits (232), Expect = 6e-22
 Identities = 71/302 (23%), Positives = 133/302 (44%), Gaps = 49/302 (16%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++    +G G +G V    +  S   VA+K I     +   +  +  RE++I    +H N
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-AFDVPTLAKRTLRELKILRHFKHDN 65

Query: 81  ILRLYGWFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +         D + ++++++     +L+  +   +  TE+    ++  L   L Y H
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTM-----CGTLDYLAPE-MV 188
             +VIHRD+KP NLL++ +  L+IGDFG    + S    H         T  Y APE ++
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 189 ENKEHDYAVDNWTLGILCYEFL---------------------YGAPPFE--AESQKDTF 225
              E+  A+D W++G +  E L                      G+P  E       D  
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV 244

Query: 226 RRIMKVDLSFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           R+ ++   + P           P  S EA  L+S++L  D  +R+++++ ++HP++ +  
Sbjct: 245 RKYIQ---NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301

Query: 277 NP 278
           +P
Sbjct: 302 DP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.5 bits (225), Expect = 2e-21
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 21/219 (9%)

Query: 27  LGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           LG G FG   +VR  E          VA+K +  +++    I     +E  I  SL H N
Sbjct: 3   LGDGSFG---VVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHEN 57

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHEN 138
           ++RLYG       + ++ E A  G L   LRK     F       Y   + N + Y    
Sbjct: 58  LIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD----YLAPEMVENKE 192
             IHRD+   N+LL  + ++KIGDFG    +      + M   L     + APE +  + 
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 193 HDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
             +A D W  G+  +E F YG  P+   S     ++I K
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.6 bits (225), Expect = 2e-21
 Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 13/261 (4%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           E   +D  +GR +G+G+FG VY    +     K  VA+K   K        +  L+ E  
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSVREKFLQ-EAY 59

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTN 130
           I     HP+I++L G   ++  +++++E A  GEL   L+ ++          Y   L+ 
Sbjct: 60  IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DYLAPE 186
           ALAY      +HRDI   N+L+     +K+GDFG S  ++  S      G L   ++APE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 187 MVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
            +  +    A D W  G+  +E L  G  PF+     D   RI   +   P  P+     
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL 237

Query: 246 KHLISRLLVKDSSKRLSLQKI 266
             L+++    D SKR    ++
Sbjct: 238 YSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 91.0 bits (226), Expect = 6e-21
 Identities = 79/297 (26%), Positives = 128/297 (43%), Gaps = 50/297 (16%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D E  RP+G G FG V+ V +      VALK +     +      ++ RE+++    +H 
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHD 59

Query: 80  NILR--------LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           N+L             F +   I+++ E     +L++ +   +  +      ++  +   
Sbjct: 60  NVLSALDILQPPHIDPFEE---IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCG---TLDYLAPEM 187
           L Y H   ++HRDIKP NLL++    LKI DFG + V+   +   M     T  Y APE+
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175

Query: 188 VENKEHDY--AVDNWTLGILCYEFLYGAPPFEAES---QKDTF----------------- 225
           +    H Y  AVD W++G +  E L     F+A+S   Q D                   
Sbjct: 176 LMGSRH-YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234

Query: 226 ---RRIMKVDLSFPSAPSI-------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                I++     PS P +       + EA HL+ R+LV D  KR+S    + HP++
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 9e-21
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 14/214 (6%)

Query: 21  FEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            E  + LG G FG VY    + E E  K PVA+K++ +E     K   ++  E  + +S+
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASV 66

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYC 135
            HP+++RL G      ++ LI +    G L   +R H+     Q    +   +   ++Y 
Sbjct: 67  DHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVEN 190
            E  ++HRD+   N+L+     +KI DFG +  +    K +   G    + ++A E + +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 191 KEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKD 223
           + + +  D W+ G+  +E + +GA P+E     +
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 2e-20
 Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 15/201 (7%)

Query: 27  LGKGKFGRV----YLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG G FG V    YL++  +    VA+K + +E I   K   +  RE  + + L HP I+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEV-EVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIV 59

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           RL G     E + L++E A  G L + L+K R             +   +AY    H +H
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGT--LDYLAPEMVENKEHDYA 196
           RD+   N+LL +  + KI DFG S      S   R T  G   L + APE +   +    
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178

Query: 197 VDNWTLGILCYE-FLYGAPPF 216
            D W+ G+  +E F YGA P+
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 77/312 (24%), Positives = 136/312 (43%), Gaps = 48/312 (15%)

Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + + ++   P+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 3   RQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY 62

Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   ++H N++ L   F       +   ++L+      G     + K ++ +
Sbjct: 63  ----RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLS 116

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     I  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 117 DEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV 176

Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
            T  Y APE++ N  H +  VD W++G +  E L G   F      D  +RIM+V +  P
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV-VGTP 235

Query: 237 SAP---SISAE---------------------------AKHLISRLLVKDSSKRLSLQKI 266
           S      IS+E                           A  L+ ++LV DS KR+S  + 
Sbjct: 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295

Query: 267 MEHPWIIKNANP 278
           + HP+  +  +P
Sbjct: 296 LAHPYFSQYHDP 307

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 76/303 (25%), Positives = 136/303 (44%), Gaps = 44/303 (14%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE-QIEKYKIQHQ 65
           R++  K  W + D +   + +G G +G V    +  +   VA+K +++  Q E +    +
Sbjct: 3   RQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFA--KR 60

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRKHRRFTEQ 119
             RE+ +   ++H N++ L   F  D  +      +L++ +   G    +L KH + +E 
Sbjct: 61  AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSED 118

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           +    +  +   L Y H   +IHRD+KP NL ++ +  LKI DFG + Q+ S+      T
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVT 178

Query: 180 LDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA 238
             Y APE++ N  H    VD W++G +  E L G P F+     D    IMKV  + PS 
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT-PSK 237

Query: 239 ------------------------------PSISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                         P+ +  A +++ ++LV D+  R++  + + 
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297

Query: 269 HPW 271
           HP+
Sbjct: 298 HPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 87.1 bits (215), Expect = 6e-20
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 9/217 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E    LG+G +  VY  +   +   VALK+I  ++ E         RE  +   L+H N
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHAN 64

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENH 139
           I+ L+   H  E + L+ EY H  +L + + KH      +    ++  L   L+Y H+ +
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDY 195
           ++HRD+KP+NLL+   G LK+ DFG +       HT      TL Y  P+ ++ + E+  
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 196 AVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKV 231
            +D W +G +  E + G   F   +  +D   RI  V
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV 220

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 6e-20
 Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 33/242 (13%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVY--LVREVESKH---PVALKIIF-----KEQIEKYKIQH 64
           E   +   + R LG+G FG VY  L + V        VA+K +      +E+IE      
Sbjct: 2   ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN--- 58

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---RF----- 116
               E  +       +++RL G     +   +++E   +G+L   LR  R          
Sbjct: 59  ----EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114

Query: 117 --TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRS 171
             T Q+     A + + +AY      +HRD+   N ++  +  +KIGDFG +    ++  
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 174

Query: 172 KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
            R    G L   ++APE +++       D W+ G++ +E       P++  S ++  + +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234

Query: 229 MK 230
           + 
Sbjct: 235 ID 236

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 81/315 (25%), Positives = 143/315 (45%), Gaps = 58/315 (18%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           + K  + + NR      + +++G  +G G FG VY    +++   VA+K + ++   +YK
Sbjct: 52  EEKMIDNDINRS---PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYK 106

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFH------DDERIFL--ILEYAHRGELYRELRKH 113
                 RE+ I  +L H NI+ L  +++      +++ IFL  ++E+  +  +++ ++ +
Sbjct: 107 -----NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHY 160

Query: 114 RRFTEQQ----AATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQ 168
            R            Y   L  ALAY H   + HRD+KP+NLL+D +   LK+ DFG +  
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220

Query: 169 ----SRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
                RS  + +C    Y APE M+    +   +D W+LG +  E + G P F  +S  D
Sbjct: 221 LLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278

Query: 224 TFRRIMKV-----------------DLSFPSAPS----------ISAEAKHLISRLLVKD 256
              RI++V                 D+ FP                 +A + IS+ L  +
Sbjct: 279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338

Query: 257 SSKRLSLQKIMEHPW 271
             KRL+  + +  P+
Sbjct: 339 PLKRLNPIEALADPF 353

Length = 440

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 10/210 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  VY      +   VALK+I  +  E   +     RE  +   L+H NI+ L+ 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHD 70

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
             H  E +  + EY H  +L + + +H           ++  L   LAY H  H++HRD+
Sbjct: 71  IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWT 201
           KP+NLL+ + G LK+ DFG +        T      TL Y  P+ ++   ++  A+D W 
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWG 189

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKV 231
            G +  E L G P F   S  D F ++ K+
Sbjct: 190 AGCIFIEMLQGQPAFPGVS--DVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 2e-19
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 10/211 (4%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
             +GKG FG VY    ++    VA+K          K +    +E EI     HPNI++L
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRK--FLQEAEILKQYDHPNIVKL 57

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHR 143
            G     + I++++E    G L   LRK + R T ++           + Y    + IHR
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLAPEMVENKEHDYAVD 198
           D+   N L+     LKI DFG S +     +T+   L      + APE +    +    D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 199 NWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
            W+ GIL +E F  G  P+   S + T  RI
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 78/311 (25%), Positives = 136/311 (43%), Gaps = 60/311 (19%)

Query: 21  FEIGR------PLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--RE 69
           FE+        P+G+G +G V   +  E+   VA+K I   F  +I+        R  RE
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA------KRTLRE 54

Query: 70  MEIQSSLRHPNILRLYGWFHDDER-----IFLILEYAHRGELYRELRKHRRFTEQQAATY 124
           +++   L H N++ +        R     ++++ E     +L++ +R  +  ++     +
Sbjct: 55  IKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLD 181
           +  L   L Y H  +V+HRD+KP NLLL+    LKI DFG +  +  K   M     T  
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW 173

Query: 182 YLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------DL 233
           Y APE++ N  E+  A+D W++G +  E L   P F  +      + I ++       DL
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 234 SF---PSA-------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            F     A                   P  +  A  L+ ++LV D SKR+++++ + HP+
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Query: 272 IIK----NANP 278
           +      +  P
Sbjct: 294 LASLHDPSDEP 304

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 85.7 bits (212), Expect = 3e-19
 Identities = 80/312 (25%), Positives = 135/312 (43%), Gaps = 63/312 (20%)

Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           RE+  K  W L + +   + +G G +G V    +  +   VA+K +   F+ +I      
Sbjct: 3   REEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FA 58

Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHR--R 115
            +  RE+ +   ++H N++ L   F       + +  +L++ Y     +  +L+K     
Sbjct: 59  KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHP 113

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            +E +    +  +   L Y H   +IHRD+KP NL ++ +  LKI DFG    +R     
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL---ARHADAE 170

Query: 176 MCG---TLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV 231
           M G   T  Y APE++ N  H +  VD W++G +  E L G   F+ +   D   +I+KV
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230

Query: 232 ------------------------------DLS--FPSAPSISAEAKHLISRLLVKDSSK 259
                                         D S  FP A   S +A  L+ ++L  D  K
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKA---SPQAVDLLEKMLELDVDK 287

Query: 260 RLSLQKIMEHPW 271
           RL+  + +EHP+
Sbjct: 288 RLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 83.4 bits (206), Expect = 6e-19
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PN++ L+ +   ++ +FL+L++A  G+L+  + K     E+    + A +  AL   H  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG-WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++ RD+ P N+LLD  G +++  F  WS    S        + Y APE+    E   A 
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-YCAPEVGGISEETEAC 163

Query: 198 DNWTLGILCYEFLYGAPPFEAES---QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
           D W+LG + +E L G    E         T        L+ P    +S EA+ L+ +LL 
Sbjct: 164 DWWSLGAILFELLTGKTLVECHPSGINTHT-------TLNIPEW--VSEEARSLLQQLLQ 214

Query: 255 KDSSKRL-----SLQKIMEHPW 271
            + ++RL      ++ I  HP+
Sbjct: 215 FNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 82.6 bits (204), Expect = 2e-18
 Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 27/266 (10%)

Query: 27  LGKGKFGRVY------LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           LG G FG VY      ++        VA+K + K   ++ K +    +E  + S+  HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE--FLKEAHLMSNFNHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-------TNALA 133
           I++L G    +E  ++I+E    G+L   LR  R          +  L            
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGR-----LKIGDFG-----WSVQSRSKRHTMCGTLDYL 183
           Y  + H IHRD+   N L+  +G      +KIGDFG     +      K       + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           APE + + +     D W+ G+L +E L  G  P+ A + ++  + +           +  
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQKPENCP 239

Query: 243 AEAKHLISRLLVKDSSKRLSLQKIME 268
            +   L++    +D S+R +  +I E
Sbjct: 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 5/148 (3%)

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E  I  ++ HP+I++L G F  ++   LIL   ++ +LY  L   R            S+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNIAICDILAIERSV 191

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLA 184
             A+ Y HEN +IHRDIK EN+ ++H G + +GDFG +      + +K +   GT+   A
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNA 251

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYG 212
           PE++    +  AVD W+ GI+ +E    
Sbjct: 252 PELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.7 bits (202), Expect = 4e-18
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 25  RPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           R LG+G FG+V+L     +     K  VA+K + KE       +    RE E+ ++ +H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASN-DARKDFEREAELLTNFQHE 68

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--------------RRFTEQQA---A 122
           NI++ YG   + +   ++ EY   G+L + LR H                 T  Q    A
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RSKRHTM 176
             IAS    + Y    H +HRD+   N L+ ++  +KIGDFG S  V +    R   HTM
Sbjct: 129 VQIAS---GMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
              + ++ PE +  ++     D W+ G++ +E F YG  P+
Sbjct: 186 L-PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.5 bits (201), Expect = 4e-18
 Identities = 71/271 (26%), Positives = 119/271 (43%), Gaps = 29/271 (10%)

Query: 25  RPLGKGKFGRVYLVREV----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           R LG+G FG+V L R       +   VA+K +  E    +     L++E+EI  +L H N
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHEN 67

Query: 81  ILRLYGWFHDD--ERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHE 137
           I++  G   +D    I LI+E+   G L   L R   +   +Q   Y   +   + Y   
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCGTLD----YLAPEMVENK 191
              +HRD+   N+L++ E ++KIGDFG   ++++  + +T+   LD    + APE +   
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 192 EHDYAVDNWTLGILCYE--------------FLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
           +   A D W+ G+  YE              FL    P   +       R+++     P 
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247

Query: 238 APSISAEAKHLISRLLVKDSSKRLSLQKIME 268
            P+   E   L+ +      SKR + Q ++E
Sbjct: 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 83.4 bits (206), Expect = 6e-18
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
           GT DYLAPE++  K H  AVD W LG+  +EFL G PPF  E+ +  F+ I+  D+ +P 
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 238 A-PSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
               +S  A++ I  LL  D +KR  L+++ +HP
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 81.2 bits (200), Expect = 7e-18
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 37/282 (13%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILR 83
           +G G +G VY  R+  S H VALK + + Q  +  +     RE+ +   L    HPNI+R
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 84  LY---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           L         D    + L + H  +    Y +         +     +      L + H 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-MCGTLDYLAPEMVENKEHDY 195
           N ++HRD+KPEN+L+   G++K+ DFG + + S     T +  TL Y APE++    +  
Sbjct: 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYAT 186

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSFPSA------ 238
            VD W++G +  E     P F   S+ D   +I  +           D++ P        
Sbjct: 187 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRG 246

Query: 239 --------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                   P I      L+  +L  +  KR+S  + ++HP+ 
Sbjct: 247 PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.4 bits (198), Expect = 9e-18
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 9/210 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V+    ++ K PVA+K   ++  ++ KI+     E  I     HPNI++L G
Sbjct: 3   LGKGNFGEVF-KGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIG 59

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDI 145
                + I++++E    G+    LRK +     +Q   +       +AY    + IHRD+
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPEMVENKEHDYAVDNWT 201
              N L+     LKI DFG S Q     ++  G     + + APE +    +    D W+
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179

Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
            GIL +E F  G  P+   + +    ++ K
Sbjct: 180 YGILLWETFSLGVCPYPGMTNQQAREQVEK 209

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 9e-18
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 12/218 (5%)

Query: 23  IGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I + +G G+FG V   R          VA+K +     +K ++      E  I     HP
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQFDHP 65

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NI+RL G       + +I EY   G L + LR++  +FT  Q    +  + + + Y  E 
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCG--TLDYLAPEMVENKEH 193
           + +HRD+   N+L++     K+ DFG S +         T  G   + + APE +  ++ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMK 230
             A D W+ GI+ +E + YG  P+   S +D  + +  
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 29/224 (12%)

Query: 19  QDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  +   LG+G FG+V+L         + K  VA+K + KE  E  +   Q  RE E+ 
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQ--REAELL 61

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTE 118
           + L+H +I+R YG   +   + ++ EY   G+L R LR H                + T 
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG 178
            Q     + + + + Y    H +HRD+   N L+     +KIGDFG S    S  +   G
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 179 -----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                 + ++ PE +  ++     D W+ G++ +E F YG  P+
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 80.9 bits (199), Expect = 1e-17
 Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 36/245 (14%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           G  +G+G +G VY  +  + K      +   +QIE   I     RE+ +   L+HPN++ 
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYAL---KQIEGTGISMSACREIALLRELKHPNVIA 62

Query: 84  LYGWF--HDDERIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTNAL 132
           L   F  H D +++L+ +YA   +L+  ++ HR         +       + +  + + +
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 133 AYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWS------VQSRSKRHTMCGTLDY 182
            Y H N V+HRD+KP N+L+  E    GR+KI D G++      ++  +    +  T  Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 183 LAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK---------DTFRRIMKVD 232
            APE++    H   A+D W +G +  E L   P F    +          D   RI  V 
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV- 240

Query: 233 LSFPS 237
           + FP+
Sbjct: 241 MGFPA 245

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)

Query: 19  QDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG+V+L     +   + K  VA+K +    +   K     +RE E+ 
Sbjct: 5   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELL 61

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFT 117
           ++L+H +I++ YG   D + + ++ EY   G+L + LR H                    
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RS 171
             Q     + + + + Y    H +HRD+   N L+     +KIGDFG S  V S    R 
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
             HTM   + ++ PE +  ++     D W+ G++ +E F YG  P+
Sbjct: 182 GGHTML-PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 79.6 bits (196), Expect = 2e-17
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   + +  +S+  VA+KI+ K       ++ +L RE  +   L +P I+R+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
            G   + E   L++E A  G L + L+K++  TE+     +  ++  + Y  E + +HRD
Sbjct: 62  IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAVD 198
           +   N+LL  +   KI DFG S    +  +           + + APE +   +     D
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD 180

Query: 199 NWTLGILCYE-FLYGAPPF 216
            W+ G+L +E F YG  P+
Sbjct: 181 VWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 50/194 (25%), Positives = 90/194 (46%), Gaps = 15/194 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + + + L  G  GRV++  +     PV LKI  K           L   M +Q+ + HP+
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQN-VNHPS 118

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHENH 139
           ++R+           ++L + +  +LY  L ++ R     QA      +   L Y H   
Sbjct: 119 VIRMKDTLVSGAITCMVLPH-YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           +IHRD+K EN+ ++   ++ IGD G + Q          + GT++  APE++   +++  
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK 236

Query: 197 VDNWTLGILCYEFL 210
            D W+ GI+ +E L
Sbjct: 237 ADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 80/318 (25%), Positives = 134/318 (42%), Gaps = 77/318 (24%)

Query: 24  GRPLGKGKFGRVYLVREVESK--HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           G  +G+G +G VY  +  + K     ALK     QIE   I     RE+ +   L+HPN+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELKHPNV 60

Query: 82  LRLYGWF--HDDERIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTN 130
           + L   F  H D +++L+ +YA   +L+  ++ HR         +       + +  + +
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 131 ALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWS------VQSRSKRHTMCGTL 180
            + Y H N V+HRD+KP N+L+  E    GR+KI D G++      ++  +    +  T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 181 DYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK---------DTFRRIMK 230
            Y APE++    H   A+D W +G +  E L   P F    +          D   RI  
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239

Query: 231 VDLSFPS---------APSIS----------------------------AEAKHLISRLL 253
           V + FP+          P  S                            ++A HL+ +LL
Sbjct: 240 V-MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 254 VKDSSKRLSLQKIMEHPW 271
             D  KR++ ++ M+ P+
Sbjct: 299 TMDPIKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.7 bits (196), Expect = 3e-17
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 25/229 (10%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNI 81
           R LG+G FG+V+L  E  +  P   KI+   +  K      +    RE E+ ++L+H +I
Sbjct: 11  RELGEGAFGKVFLA-ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH-------------RRFTEQQAATYIASL 128
           ++ YG   + + + ++ EY   G+L + LR H                T+ Q       +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RSKRHTMCGTLDY 182
              + Y    H +HRD+   N L+     +KIGDFG S  V S    R   HTM   + +
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRW 188

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           + PE +  ++     D W+LG++ +E F YG  P+   S  +    I +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 3e-17
 Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 10/249 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG V+  R      PVA+K   +E +    ++ +  +E  I     HPNI+RL G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPP-DLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
                + I++++E    G+    LR    R   ++    + +    + Y    H IHRD+
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLAPEMVENKEHDYAVDNW 200
              N L+  +  LKI DFG S +     +   G +      + APE +    +    D W
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVW 180

Query: 201 TLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSK 259
           + GIL +E F  GA P+   S + T R  ++  +  P           L+ R    D  +
Sbjct: 181 SFGILLWEAFSLGAVPYANLSNQQT-REAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239

Query: 260 RLSLQKIME 268
           R S   + +
Sbjct: 240 RPSFSTVHQ 248

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.7 bits (196), Expect = 3e-17
 Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 36/252 (14%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVRE--VESKHP-----VALKIIFKEQIEK 59
           E  ++ + E+S     +G+PLG+G FG+V +     ++   P     VA+K++  +  EK
Sbjct: 3   ELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62

Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 63  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120

Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  ++Q       + TY   +   + Y      IHRD+   N+L+     +KI
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKI 178

Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 239 PYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 17/213 (7%)

Query: 42  ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY--GWFHDDERIFLILE 99
            + H VA+K++  +  E+   + + RRE  + + L HPNI+ L   G       +F + E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFE 59

Query: 100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEG 156
           Y     L   L         +    +  + +ALA  H   ++HRD+KP+N+++       
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119

Query: 157 RLKIGDFGWS----------VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILC 206
             K+ DFG            V + ++   + GT  Y APE +  +      D +  G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 207 YEFLYGAPPFEAESQKDT-FRRIMKVDLSFPSA 238
            E L G    +  S  +  ++++  VD+S P  
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPW 212

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.1 bits (192), Expect = 7e-17
 Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 13/221 (5%)

Query: 16  WSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   +  +      E  + 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLA-----EASVM 53

Query: 74  SSLRHPNILRLYGWFHDDE-RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
           + LRH N+++L G   +++  ++++ EY  +G L   LR   R          +   +  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
           A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 173

Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           K+     D W+ GIL +E + +G  P+     KD   R+ K
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 7e-17
 Identities = 70/311 (22%), Positives = 131/311 (42%), Gaps = 46/311 (14%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQ 65
           R++  K  W + + ++   P+G G +G V    + ++     L++  K+    ++ I H 
Sbjct: 5   RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT----GLRVAVKKLSRPFQSIIHA 60

Query: 66  LR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
            R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++ T
Sbjct: 61  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLT 118

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           +      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +     
Sbjct: 119 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 178

Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD---- 232
            T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++     
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238

Query: 233 ----------------LSFPSAPSISAE---------AKHLISRLLVKDSSKRLSLQKIM 267
                            S    P ++           A  L+ ++LV DS KR++  + +
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298

Query: 268 EHPWIIKNANP 278
            H +  +  +P
Sbjct: 299 AHAYFAQYHDP 309

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.1 bits (192), Expect = 9e-17
 Identities = 70/292 (23%), Positives = 125/292 (42%), Gaps = 42/292 (14%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 59

Query: 75  SLRHPNILRLYGW---FHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 60  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              L + H + V+HRD+KP+N+L+   G++K+ DFG    +S Q      ++  TL Y A
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVTLWYRA 177

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DL 233
           PE++    +   VD W++G +  E     P F   S  D   +I+ V           D+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 234 SFPSA--------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           + P                  I    K L+ + L  + +KR+S    + HP+
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 77.8 bits (192), Expect = 1e-16
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 32/232 (13%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLR 67
           EW L      +G+PLG+G FG+V     V   +P     VA+K++  +  EK      L 
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD--LV 63

Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------R 115
            EME+   + +H NI+ L G    +  +++++EYA  G L   LR  R           R
Sbjct: 64  SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 116 FTEQQAATY-IASLTNALA----YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
             E+      + S    +A    +      IHRD+   N+L+  +  +KI DFG +    
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183

Query: 171 SK---RHTMCGTLDY--LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                R T  G L    +APE + ++ + +  D W+ G+L +E F  G  P+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 77.2 bits (190), Expect = 1e-16
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 11/216 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++   L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSH 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHE 137
             +++LYG       I+++ EY   G L   LR+H +RF   Q       +   +AY   
Sbjct: 59  EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEH 193
              IHRD+   N L+D +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178

Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T  ++
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.2 bits (190), Expect = 1e-16
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 23/214 (10%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K    +   Q+    ++E+ I  +L H NI+
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   +   + + LI+EY   G L   L KH+     Q   +   +   +AY H  H 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQHY 128

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY------------LAPEMV 188
           IHRD+   N+LLD++  +KIGDFG +      +    G   Y             A E +
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLA------KAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK 222
           +  +  YA D W+ G+  YE L      ++  +K
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 72/304 (23%), Positives = 131/304 (43%), Gaps = 63/304 (20%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ---LR--REMEIQ 73
             ++    +G+G +G V       +   VA+K     +I  +  +HQ    R  RE++I 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPF--EHQTFCQRTLREIKIL 57

Query: 74  SSLRHPNILRL--------YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
              +H NI+ +        +  F+D   ++++ E     +LY+ ++  +  +      ++
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFND---VYIVQELMET-DLYKLIKT-QHLSNDHIQYFL 112

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD---- 181
             +   L Y H  +V+HRD+KP NLLL+    LKI DFG + +     H   G L     
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA-RIADPEHDHTGFLTEYVA 171

Query: 182 ---YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------ 231
              Y APE M+ +K +  A+D W++G +  E L   P F  +        I+ V      
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231

Query: 232 -DL-------------SFPSAPSIS---------AEAKHLISRLLVKDSSKRLSLQKIME 268
            DL             S P  P +           +A  L+ ++L  +  KR+++++ + 
Sbjct: 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291

Query: 269 HPWI 272
           HP++
Sbjct: 292 HPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.9 bits (189), Expect = 2e-16
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 13/217 (5%)

Query: 23  IGRPLGKGKFGRVYLVR-EVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I + +G G+FG V   R ++  K   PVA+K +     EK +       E  I     HP
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + ++ EY   G L   LRKH  +FT  Q    +  + + + Y  + 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S          +T  G    + + APE +  ++
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
              A D W+ GI+ +E + YG  P+   S +D  + I
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 76.1 bits (187), Expect = 3e-16
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 11/208 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   +E K  VA+K I     E    +     E ++   L HP +++LYG
Sbjct: 12  IGSGQFGLVWLGYWLE-KRKVAIKTIR----EGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R +F+++        +   +AY   ++VIHRD+
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+    ++    D W+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRI 228
            G+L +E F  G  P+E  S  +    I
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEVVETI 214

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.0 bits (187), Expect = 3e-16
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 11/212 (5%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G+FG V+L  +  ++  VA+K I     E    +     E ++   L HP +++L
Sbjct: 10  KELGSGQFGVVHL-GKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHR 143
           YG     + ++++ E+   G L   LR+ + + ++    +    +   + Y   N  IHR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDN 199
           D+   N L+   G +K+ DFG +       +T   G    + +  PE+    ++    D 
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 200 WTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           W+ G+L +E F  G  PFE +S  +    I +
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.3 bits (188), Expect = 4e-16
 Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 21/215 (9%)

Query: 22  EIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSSLR 77
            + R LG G FG VY  L R  +    V L++  K   E    Q +    ME  I S   
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGD-AVELQVAVKTLPESCSEQDESDFLMEALIMSKFN 67

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-------TN 130
           H NI+RL G   +    F++LE    G+L   LR++R   E+ ++  +  L         
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEG--RL-KIGDFGWS---VQSRSKRHTMCGTL--DY 182
              Y  ENH IHRDI   N LL  +G  R+ KI DFG +    ++   R      L   +
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
           + PE   +       D W+ G+L +E F  G  P+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 39/272 (14%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q ++I R +GKG  G VYL  +      VALK I ++  E   ++ +  RE +I + L 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASL---- 128
           HP I+ +Y    D + ++  + Y   G   + L K     E         T + +     
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 129 ---TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV---------------QSR 170
                 + Y H   V+HRD+KP+N+LL   G + I D+G ++               +  
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 171 SKRHTM------CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT 224
               +M       GT DY+APE +       + D + LG++ Y+ L  + P+    ++  
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY----RRKK 235

Query: 225 FRRIMKVD-LSFPSAPSISAEAKHLISRLLVK 255
            R+I   D +  P   +   E    +S++ +K
Sbjct: 236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMK 267

Length = 932

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.4 bits (185), Expect = 7e-16
 Identities = 61/280 (21%), Positives = 116/280 (41%), Gaps = 34/280 (12%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR---REMEIQSSL 76
           +  +G+ LG+G+FG+V        K       +  + +++     +LR    E  +   +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--------------------- 115
            HP++++LYG    D  + LI+EYA  G L   LR+ R+                     
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 116 ---FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----- 167
               T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI DFG S      
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFR 226
            S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+   + +  F 
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF- 239

Query: 227 RIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKI 266
            ++K         + S E  +L+     ++  KR +   I
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 67/298 (22%), Positives = 121/298 (40%), Gaps = 51/298 (17%)

Query: 21  FEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + I   L  G  G V++      E +  V +K +   +           RE++I  ++ H
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISH 145

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+ L   +     + +++   ++ +L+  + +      +QA T    L  ALAY H  
Sbjct: 146 RAIINLIHAYRWKSTVCMVMPK-YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR 204

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMCGTLDYLAPEMVENKEH 193
            +IHRD+K EN+ LD      +GDFG + +        + +   GTL+  +PE++    +
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264

Query: 194 DYAVDNWTLGILCYEF------LYGAPPFEAESQKDTFRRIMKV-DLSFP---------- 236
               D W+ G++ +E       L+G     + SQ  +  R M+V  L FP          
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH 324

Query: 237 ------------SAPSI------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                       + P +        + ++LI+++L  D   R S Q I+  P   K  
Sbjct: 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382

Length = 392

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 17/199 (8%)

Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LGKG FG V L R    +  +   VA+K   K Q    +      RE+EI  SL+H NI+
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 83  RLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           +  G  +   R  + L++EY   G L   L+KHR R   ++   Y + +   + Y     
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPEMVENKEH 193
            +HRD+   N+L++ E R+KIGDFG + V  + K +          + + APE +   + 
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188

Query: 194 DYAVDNWTLGILCYE-FLY 211
             A D W+ G++ YE F Y
Sbjct: 189 SVASDVWSFGVVLYELFTY 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 59/244 (24%), Positives = 109/244 (44%), Gaps = 21/244 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL---RREMEIQSSLRHPNILR 83
           LG+G+FG V+L +    +      ++  + ++K K ++     RRE+++   L H N++R
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE------ 137
           L G   + E  ++ILEY   G+L + LR  +   E+     +++    +A C +      
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST-KQKVALCTQIALGMD 131

Query: 138 ----NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMV 188
                  +HRD+   N L+  +  +K+     S    +      R+ +   L +LAPE V
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAV 190

Query: 189 ENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +  +     D W+ G+L +E F  G  PF   S ++   R+    L  P      +    
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYK 250

Query: 248 LISR 251
           L++R
Sbjct: 251 LMTR 254

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 63/244 (25%), Positives = 112/244 (45%), Gaps = 32/244 (13%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQ 65
           K E S     +G+PLG+G FG+V +   +  +   P     VA+K++  +  +K      
Sbjct: 6   KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSD 63

Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---------- 114
           L  EME+   + +H NI+ L G    D  +++++EYA +G L   LR  R          
Sbjct: 64  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123

Query: 115 -RFTEQQAA-----TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
            +  E+Q       +    +   + Y      IHRD+   N+L+  +  +KI DFG +  
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 169 SRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQK 222
             +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243

Query: 223 DTFR 226
           + F+
Sbjct: 244 ELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 69/303 (22%), Positives = 121/303 (39%), Gaps = 51/303 (16%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           RPLG G  G V+   + +    VA+K I     +  K      RE++I   L H NI+++
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVKV 67

Query: 85  YGWF-------HDDERIFLILEYAHRGELY-----RELRKHRRFTEQQAATYIASLTNAL 132
           Y           +D      L   +  + Y       + +    +E+ A  ++  L   L
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGL 127

Query: 133 AYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
            Y H  +V+HRD+KP N+ ++ E   LKIGDFG +         K +   G +   Y +P
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187

Query: 186 EMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEA------------------ESQKDTFR 226
            ++ +  +   A+D W  G +  E L G P F                    E  ++   
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247

Query: 227 RIMKV----DLSFPSAP------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
            ++      D   P  P       ++ EA   + ++L  +   RL+ ++ + HP++   +
Sbjct: 248 NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307

Query: 277 NPR 279
            P 
Sbjct: 308 CPF 310

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           E  L        LG+G FG+VY   L    E     ++ I   ++  + K+Q + R+E E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           + S L+HPNI+ L G    ++   ++ EY   G+L+  L ++   ++  A +   ++ ++
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 132 LA----------------YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--------- 166
           L                 Y   +H +HRD+   N L+     +KI DFG S         
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 167 -VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
            VQS+S        + ++ PE +   +     D W+ G++ +E F YG  P+   S ++ 
Sbjct: 181 RVQSKSLL-----PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235

Query: 225 FRRI 228
              I
Sbjct: 236 IEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 21/213 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
              IG+         V+L +   +   VA+K I  +   K  ++  L++E+     L+HP
Sbjct: 3   LTLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA----SLTNALAYC 135
           NIL     F  D  ++++      G     L+ H  F E      IA     + NAL Y 
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYI 117

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTM--------CGTLDYLAP 185
           H    IHR +K  ++LL  +G++ +    +SV      KR  +           L +L+P
Sbjct: 118 HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 186 EMVENKEHDYAV--DNWTLGILCYEFLYGAPPF 216
           E+++     Y    D +++GI   E   G  PF
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 73.8 bits (181), Expect = 3e-15
 Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 16/254 (6%)

Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V    L    + +  VA+K +     EK +       E  I     HPNI+ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIH 69

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           L G       + +I E+   G L   LR++  +FT  Q    +  +   + Y  E + +H
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD------YLAPEMVENKEHD 194
           RD+   N+L++     K+ DFG S  ++  +   T   +L       + APE +  ++  
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            A D W+ GI+ +E + YG  P+   S +D    I + D   P           L+    
Sbjct: 190 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPMDCPTALHQLMLDCW 248

Query: 254 VKDSSKRLSLQKIM 267
            KD + R    +I+
Sbjct: 249 QKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 3e-15
 Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 35/235 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+   + E  R +G+G FGRV+  R       E    VA+K++ KE+     +Q   +RE
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASA-DMQADFQRE 58

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL- 128
             + +   HPNI++L G     + + L+ EY   G+L   LR      +   +   +S  
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 129 ---------------------TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
                                   +AY  E   +HRD+   N L+     +KI DFG S 
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 168 QSRSKRHTMCGTLD-----YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
              S  +      D     ++ PE +    +    D W  G++ +E F YG  P+
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.5 bits (178), Expect = 5e-15
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 11/215 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +    + LG G+FG V+L  +   K  VA+K+I +  + +         E ++   L HP
Sbjct: 5   ELTFLKELGSGQFGVVHL-GKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           N+++LYG       IF++ EY   G L   LR+ + +   +      + +  A+ Y   N
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEHD 194
             IHRD+   N L+  +  +K+ DFG +      ++T   GT   + +  PE+ +     
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 195 YAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
              D W+ G+L +E F  G  P+E  S  +    +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 72.6 bits (178), Expect = 5e-15
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 23/217 (10%)

Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREME 71
           W ++  D  +   LG G++G VY    V  K+   VA+K + ++ +E      +  +E  
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVY--EGVWKKYSLTVAVKTLKEDTME----VEEFLKEAA 54

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-----FTEQQAATYIA 126
           +   ++HPN+++L G    +   ++I E+   G L   LR+  R           AT I+
Sbjct: 55  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDY 182
           S   A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + +
Sbjct: 115 S---AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 171

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEF-LYGAPPFEA 218
            APE +   +     D W  G+L +E   YG  P+  
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 6e-15
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-LRREMEIQSS 75
           +LQ   +G  +G+G+FG V        K  VA+K I      K  +  Q    E  + + 
Sbjct: 4   NLQKLTLGEIIGEGEFGAVLQGEYTGQK--VAVKNI------KCDVTAQAFLEETAVMTK 55

Query: 76  LRHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRRF--TEQQAATYIASLTNAL 132
           L H N++RL G   H+   +++++E   +G L   LR   R   +  Q   +   +   +
Sbjct: 56  LHHKNLVRLLGVILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
            Y     ++HRD+   N+L+  +G  K+ DFG +             + + APE +++K+
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKK 173

Query: 193 HDYAVDNWTLGILCYE-FLYGAPPFEAESQKD 223
                D W+ G+L +E F YG  P+   S K+
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.7 bits (178), Expect = 9e-15
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 38/237 (16%)

Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V +   +  + + P     VA+K++  +  EK      L  EME+   
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 79

Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   LR  R                + + 
Sbjct: 80  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 196

Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 13/213 (6%)

Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V+   L      +  VA+K +     EK +       E  I     H NI+R
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           L G     +   +I EY   G L + LR H   F+  Q    +  +   + Y  + + +H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLAPEMVENKEHDYA 196
           RD+   N+L++     K+ DFG S          +T  G    + + APE +  ++   A
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190

Query: 197 VDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
            D W+ GI+ +E + +G  P+   S  +  + I
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.7 bits (173), Expect = 3e-14
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 29/234 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSSLRHPNILRL 84
           +G G FG+V L  E       A +++ KE         QL   +E++    L HPN+L+ 
Sbjct: 3   IGNGWFGKVLL-GEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHR--------RFTEQQAATYIASLTNALAYCH 136
            G   +     L+LE+   G+L   LR +R        +   Q+ A  +AS    L + H
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS---GLLWLH 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----LDYLAPEMVENK 191
           +   IH D+   N  L  +  +KIGD+G +++   + + +        L +LAPE+VE +
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 192 EHDYAVDN-------WTLGILCYE-FLYGAPPFEAESQKDTFRR-IMKVDLSFP 236
             D    +       W+LG+  +E F     P+   S +   ++ + + D+  P
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 28/232 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
           K E+      +G+PLG+G FG+V     Y + +      V + +   +     K    L 
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65

Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------R 115
            EME+   + +H NI+ L G    +  +++I+EYA +G L   LR  R           +
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 116 FTEQQAA-----TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV--- 167
             E+Q +     +    +   + Y      IHRD+   N+L+  +  +KI DFG +    
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 168 QSRSKRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                + T  G L   ++APE + ++ + +  D W+ GIL +E F  G  P+
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 70.1 bits (171), Expect = 5e-14
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 12/216 (5%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E   +  ++ + LG G+FG V++     S   VA+K +   +     +Q  L  E  +  
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTL---KPGTMSVQAFLE-EANLMK 56

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
           +L+H  ++RLY     +E I++I EY  +G L   L+     +    +   + A +   +
Sbjct: 57  TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMV 188
           AY    + IHRD++  N+L+      KI DFG +        + R      + + APE +
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKD 223
                    D W+ GIL YE + YG  P+   S  D
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   +GKG +G V    +  +   VA+K I  +  E      ++ RE+++   LRHP+
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 81  ILRLYGW--------FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           I+ +           F D   +F ++E     +L++ ++ +   T +    ++  L  AL
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL------APE 186
            Y H  +V HRD+KP+N+L + + +LKI DFG +  + +   T     DY+      APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 187 MVENKEHDY--AVDNWTLGILCYEFLYGAPPF 216
           +  +    Y  A+D W++G +  E L G P F
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 66/307 (21%), Positives = 130/307 (42%), Gaps = 60/307 (19%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q    +      RE+ +  
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLLK 75

Query: 75  SLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
            + H NI+ L   F       + + ++L++E      L + +  H     ++ +  +  +
Sbjct: 76  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--HMELDHERMSYLLYQM 132

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAP 185
              + + H   +IHRD+KP N+++  +  LKI DFG + ++      M     T  Y AP
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTACTNFMMTPYVVTRYYRAP 191

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------- 231
           E++    +   VD W++G +  E + G+  F+     D + ++++               
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251

Query: 232 ----------------------DLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSLQK 265
                                 D  FPS        +++A+ L+S++LV D  KR+S+ +
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311

Query: 266 IMEHPWI 272
            + HP+I
Sbjct: 312 ALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 3e-13
 Identities = 54/199 (27%), Positives = 84/199 (42%), Gaps = 12/199 (6%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LG G+FG V+      +  PVA+K +    ++          E +I   LRHP +++L
Sbjct: 12  RKLGAGQFGEVWEGLWNNTT-PVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQL 66

Query: 85  YGWFHDDERIFLILEYAHRGEL--YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           Y     +E I+++ E    G L  Y +    R     Q     A + + +AY    + IH
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPEMVENKEHDYAVD 198
           RD+   N+L+      K+ DFG + V          G    + + APE           D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 199 NWTLGILCYEFL-YGAPPF 216
            W+ GIL  E + YG  P+
Sbjct: 187 VWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 67.8 bits (166), Expect = 3e-13
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 7/229 (3%)

Query: 46  PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DE--RIFLILEYA 101
            V ++   K       +      E++    +   NIL++YG+  D  D+  R+ LILEY 
Sbjct: 45  EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104

Query: 102 HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKI 160
            RG L   L K +  + +            L   ++  +  ++++   + L+    +LKI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164

Query: 161 GDFGWSVQSRSKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEA 218
              G      S        + Y + +M+ +   E+    D ++LG++ +E   G  PFE 
Sbjct: 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224

Query: 219 ESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIM 267
            + K+ +  I+  + S         E K ++      DS KR ++++I+
Sbjct: 225 LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 22/273 (8%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE------SKHPVALKIIFKEQIEKYKIQH 64
           + K E+   +   G+ LG G FG+V     VE      SK    +K+  K          
Sbjct: 27  DLKWEFPRNNLSFGKTLGAGAFGKV-----VEATAYGLSKSDAVMKVAVKMLKPTAHSSE 81

Query: 65  Q--LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQ 119
           +  L  E++I S L  H NI+ L G       I +I EY   G+L   LR+ R    T +
Sbjct: 82  REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE 141

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC 177
              ++   +   +A+    + IHRD+   N+LL H   +KI DFG +  + + S      
Sbjct: 142 DLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG 201

Query: 178 GT---LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDL 233
                + ++APE + N  + +  D W+ GIL +E F  G+ P+        F +++K   
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261

Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKI 266
                    AE   ++      D  KR + ++I
Sbjct: 262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 27  LGKGKFGRVYL-VREVESKH-PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   V ++  K   VA+K++ K + EK  ++ ++ RE EI   L +P I+R+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEK-SVRDEMMREAEIMHQLDNPYIVRM 60

Query: 85  YGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            G   + E + L++E A  G L + L  K    T       +  ++  + Y    + +HR
Sbjct: 61  IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 144 DIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCG-TLDYLAPEMVENKEHDYAV 197
           D+   N+LL ++   KI DFG S       S  K  +     L + APE +  ++     
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 198 DNWTLGILCYE-FLYGAPPFE 217
           D W+ GI  +E F YG  P++
Sbjct: 180 DVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 23/227 (10%)

Query: 25  RPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           R LG+G FG VY  + + V    P   VA+K + +    + +I+     E  +       
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCH 69

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT---------- 129
           +++RL G     +   +I+E   RG+L   LR  R   E        SL           
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLD--YLA 184
           + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R    G L   +++
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMK 230
           PE +++       D W+ G++ +E    A  P++  S +   R +M+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 56/252 (22%), Positives = 115/252 (45%), Gaps = 15/252 (5%)

Query: 20  DFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +F+  + LG G FG VY    + E E  K PVA+K +   +    K   ++  E  + +S
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMAS 65

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAY 134
           + +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y
Sbjct: 66  VDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVE 189
             E  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + 
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 190 NKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           ++ + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   +
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMI 243

Query: 249 ISRLLVKDSSKR 260
           + +  + D+  R
Sbjct: 244 MVKCWMIDADSR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 64.7 bits (157), Expect = 4e-12
 Identities = 61/262 (23%), Positives = 121/262 (46%), Gaps = 17/262 (6%)

Query: 18  LQDFEIGRP--LGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREME 71
           L++ E+ R   LG G FG VY    V E E+ K PVA+KI+ +    K  ++     E  
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEAL 61

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTN 130
           I +S+ HP+++RL G       I L+ +    G L   + +H+     Q    +   +  
Sbjct: 62  IMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAP 185
            + Y  E  ++HRD+   N+L+     +KI DFG +  ++   K +   G    + ++A 
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++  +  D W+ G+  +E + +G  P++    ++    + K +   P  P  + +
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQPPICTID 239

Query: 245 AKHLISRLLVKDSSKRLSLQKI 266
              ++ +  + D+  R   +++
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 23/217 (10%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----KIQHQLRREMEI 72
           S Q F+I   LG+G FG+V    + + K   A+KI+    + KY    KI+ Q   ++  
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKIEIQFMEKVRQ 184

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
                   ++++  +F ++     I+   +   L   + KH  F+ +  A  I     AL
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 133 AYCH-ENHVIHRDIKPENLLLDHEG----------------RLKIGDFGWSVQSRSKRHT 175
            Y H E H++H D+KPEN+L++                   R++I D G     R  R  
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG 212
           +  T  Y +PE+V      Y+ D W++G + YE   G
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 5e-12
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 14/218 (6%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH-PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            ++ R LG G+FG V++     +    VA+K + K      +      +E +I   LRH 
Sbjct: 8   LKLERKLGAGQFGEVWM--GTWNGTTKVAVKTL-KPGTMSPE---AFLQEAQIMKKLRHD 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHE 137
            +++LY    ++E I+++ EY  +G L   L+    ++    Q     A +   +AY   
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKEH 193
            + IHRD+   N+L+      KI DFG +        + R      + + APE       
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181

Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               D W+ GIL  E   YG  P+   + ++   ++ +
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 24/220 (10%)

Query: 19  QDFEIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +D +    +G+G FG+V   ++++   K   A+K++  ++            E+E+   L
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEVLCKL 59

Query: 77  -RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQ 119
             HPNI+ L G   +   +++ +EYA  G L   LRK R                  T Q
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           Q   + + +   + Y  E   IHRD+   N+L+      KI DFG S           G 
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR 179

Query: 180 LD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           L   ++A E +    +    D W+ G+L +E +  G  P+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.8 bits (152), Expect = 2e-11
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 26/213 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR---EMEIQSSL-RHPNIL 82
           +G+G FG+V  ++    K  + +    K ++++Y  +   R    E+E+   L  HPNI+
Sbjct: 3   IGEGNFGQV--LKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIA 126
            L G       ++L +EYA  G L   LRK R                  + QQ   + A
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD--YLA 184
            +   + Y  +   IHRD+   N+L+      KI DFG S           G L   ++A
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
            E +    +    D W+ G+L +E +  G  P+
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 50/178 (28%), Positives = 74/178 (41%), Gaps = 35/178 (19%)

Query: 19  QDFEIGRPLGKGKFGRVYL------VREVESKHP----------VALKIIFKEQIEKYKI 62
           Q       LG+G+FG V+L          E              VA+K++  +  +  + 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA- 121
                +E++I S L  PNI RL G    D  + +I+EY   G+L + L+KH   T   A 
Sbjct: 65  D--FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 122 -------------ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                        AT IAS    + Y    + +HRD+   N L+     +KI DFG S
Sbjct: 123 NSKSLSFSTLLYMATQIAS---GMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 28/229 (12%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNIL 82
           + +G G FG+V L  EV S +  A +++ KE      +Q Q++   E Q   SL+H N+L
Sbjct: 1   KEIGNGWFGKVIL-GEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRR--------FTEQQAATYIASLTNALAY 134
           +  G   +     L++E+   G+L   LR  R+         T Q+ A  IA     L +
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL---GLLH 115

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----LDYLAPEMVE 189
            H+N+ IH D+   N LL  +  +KIGD+G S     + + +        L ++APE+V+
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 190 NKEHDYAV-------DNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               +  V       + W+LG+  +E F  G+ P+   S +      ++
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.6 bits (149), Expect = 5e-11
 Identities = 56/241 (23%), Positives = 105/241 (43%), Gaps = 29/241 (12%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E +L        LG+ +FG+VY          E    VA+K + K++ E   ++ + + E
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAE-GPLREEFKHE 58

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL--------------RKHRR 115
             ++S L+HPNI+ L G    ++ + +I  Y    +L+  L               K  +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 116 FTEQQAATY--IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRS 171
            T + A     +  +   + +   +HV+H+D+   N+L+  +  +KI D G    V +  
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Query: 172 KRHTMCGTL---DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRR 227
               M  +L    +++PE +   +     D W+ G++ +E F YG  P+   S +D    
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238

Query: 228 I 228
           I
Sbjct: 239 I 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 69/326 (21%), Positives = 136/326 (41%), Gaps = 75/326 (23%)

Query: 13  KREWSLQDFEIG-------------RPLGKGKFGRVYLVREVESKHPVALKII---FKEQ 56
           KR+ +    EIG             +P+G G  G V    +   +  VA+K +   F+ Q
Sbjct: 5   KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ 64

Query: 57  IEKYKIQHQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYR 108
               +      RE+ +   + H NI+ L   F       + + +++++E   A+  ++ +
Sbjct: 65  THAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 120

Query: 109 ELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
               H R +       +  +   + + H   +IHRD+KP N+++  +  LKI DFG +  
Sbjct: 121 MELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175

Query: 169 SRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR 226
           + +         T  Y APE++    +   VD W++G +  E + G   F      D + 
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235

Query: 227 RIMKV------------------------------------DLSFPSAPS----ISAEAK 246
           ++++                                     D+ FP+        +++A+
Sbjct: 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 295

Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWI 272
            L+S++LV D+SKR+S+ + ++HP+I
Sbjct: 296 DLLSKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 13/217 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++ + LG G+FG V++     +KH    K+  K              E  +  +L+H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMA--TYNKHT---KVAVKTMKPGSMSVEAFLAEANVMKTLQH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASLTNALAYCH 136
             +++L+      E I++I E+  +G L   L+      +   +   + A +   +A+  
Sbjct: 61  DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKE 192
           + + IHRD++  N+L+      KI DFG +        + R      + + APE +    
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
                D W+ GIL  E + YG  P+   S  +  R +
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 32/202 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQ--LRREMEIQSSLR 77
           F I R L  G  G V+     ES HP    +++ K       +     LRR       L 
Sbjct: 171 FAIHRALTPGSEGCVF-----ESSHPDYPQRVVVKAGWYASSVHEARLLRR-------LS 218

Query: 78  HPNILRLYGWFHDDERIF-----LILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNA 131
           HP +L L      D R+      L+L   +R +LY  L  + R     Q       L +A
Sbjct: 219 HPAVLALL-----DVRVVGGLTCLVLP-KYRSDLYTYLGARLRPLGLAQVTAVARQLLSA 272

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPE 186
           + Y H   +IHRDIK EN+L++    + +GDFG +  +R    T     + GT+D  APE
Sbjct: 273 IDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE 332

Query: 187 MVENKEHDYAVDNWTLGILCYE 208
           ++    +  +VD W+ G++ +E
Sbjct: 333 VLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 21/208 (10%)

Query: 25  RPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           R +GKG FG VY   L+     K   A+K +   +I   +   Q  +E  I     HPN+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 82  LRLYGWFHDDERIFLI-LEYAHRGELYRELRKHRRF-TEQQAATYIASLTNALAYCHENH 139
           L L G     E   L+ L Y   G+L   +R      T +    +   +   + Y     
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFG----------WSVQSRSKRHTMCGTLDYLAPEMVE 189
            +HRD+   N +LD    +K+ DFG          +SV   +        + ++A E ++
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH--NHTGAKL-PVKWMALESLQ 175

Query: 190 NKEHDYAVDNWTLGILCYEFLY-GAPPF 216
            ++     D W+ G+L +E +  GAPP+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 32/227 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVES--KHPVALKIIFKEQIEKYKIQHQLRR---E 69
           EW+  D +    +G+G FG+V   R  +   +   A+K     ++++Y  +   R    E
Sbjct: 5   EWN--DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-----RMKEYASKDDHRDFAGE 57

Query: 70  MEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-------------- 114
           +E+   L  HPNI+ L G       ++L +EYA  G L   LRK R              
Sbjct: 58  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117

Query: 115 --RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
               + QQ   + A +   + Y  +   IHRD+   N+L+      KI DFG S      
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177

Query: 173 RHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
                G L   ++A E +    +    D W+ G+L +E +  G  P+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 14/211 (6%)

Query: 19  QDFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
            +    + LG G FG V+    + E +S K PVA+K I  +     +   ++   M    
Sbjct: 7   TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMG 64

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALA 133
           SL H  I+RL G       + L+ + +  G L   +R+HR     Q+   +   +   + 
Sbjct: 65  SLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC---GTLDYLAPEMV 188
           Y  E+ ++HR++   N+LL  +  ++I DFG +  +    K++        + ++A E +
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEA 218
               + +  D W+ G+  +E + YGA P+  
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)

Query: 30  GKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           G FGR++   L+ E   K         K+   + ++   L+    +   L H NIL +  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQNILPILH 75

Query: 87  -WFHDDERIFLILEYAHRGELYRELRK--------HRRFTEQQAATYIASLTNALAYCHE 137
               D E  F++  Y + G L   L++         +  + QQ       +   ++Y H+
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR----SKRHTMCGT----LDYLAPEMVE 189
             VIH+DI   N ++D E ++KI D   +  SR       H +       + ++A E + 
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 190 NKEHDYAVDNWTLGILCYEF--LYGAP-----PFEAESQ-KDTFR 226
           NKE+  A D W+ G+L +E   L   P     PFE  +  KD +R
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 66/308 (21%), Positives = 131/308 (42%), Gaps = 62/308 (20%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q    +      RE+ +  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMK 71

Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 126

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 265 KIMEHPWI 272
           + ++HP+I
Sbjct: 307 EALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 58.8 bits (142), Expect = 5e-10
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 21/212 (9%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           EIGR  G      VYL R   +   V ++I   E   +  ++  L+ E+ +    RHPNI
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLK-ALQNEVVLSHFFRHPNI 61

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL----TNALAYCHE 137
           +  +  F     +++I  +   G     L+ +  F E  +   I ++       L Y H+
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--WSVQSRSKRHTMC--------GTLDYLAPEM 187
           N  IHR+IK  ++L+  +G + +      +S+    ++  +           L +L+PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 188 VENKEHDYAV--DNWTLGILCYEFLYGAPPFE 217
           +    + Y V  D +++GI   E   G  PF+
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.3 bits (141), Expect = 5e-10
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 29/227 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           +G G FG+V L+ E+ +   VA +++ KE       K Q++  ++ +    L+HPNIL+ 
Sbjct: 3   IGNGWFGKV-LLSEIYTDTGVA-RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRK---HRRFTE----QQAATYIASLTNALAYCHE 137
            G   +     L+ EY   G+L   L +   HRR ++    Q+ A  IA+    + + H+
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA---GVTHMHK 117

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM------CGTLDYLAPEMVENK 191
           ++ +H D+   N  L  +  +K+GD+G    SR K   +      C  L +LAPE+V   
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGP-SRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 192 -------EHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                  E     + W LG+  +E F   A P+   S ++    ++K
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 11/215 (5%)

Query: 23  IGRPLGKGKFGRV---YLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I R LG G+FG +    L    + + PVA+  +     +K   +     E        H 
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ--RRGFLAEALTLGQFDHS 66

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NI+RL G       + ++ EY   G L   LRKH  +    Q    +  L + + Y  E 
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYL--APEMVENKEHD 194
             +H+ +    +L++ +   KI  F    + +S+    TM G    L  APE ++     
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
            A D W+ GI+ +E + YG  P+   S +D  + +
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 26/177 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVE-------------SKHPVALKIIFKEQIEKYK 61
           E+  Q   +   LG+G+FG V+L  E E                PV + +          
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVHLC-EAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT 59

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
            ++   +E++I S L++PNI+RL G    D+ + +I EY   G+L + L +    +    
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 122 ATYIASLTNA------------LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
           A  I S++ A            + Y    + +HRD+   N L+ +   +KI DFG S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 22/217 (10%)

Query: 21  FEIGRPLGKGKFGRV---YLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           F +GR LGKG+FG V    L  E  S   VA+K++  +      I+ +  RE        
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59

Query: 78  HPNILRLYG---WFHDDERI---FLILEYAHRGELYRELRKHR------RFTEQQAATYI 125
           HPN+++L G         R+    +IL +   G+L+  L   R          Q    ++
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----L 180
             + + + Y    + IHRD+   N +L+    + + DFG S +  S  +   G      +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
            +LA E + +  +    D W  G+  +E +  G  P+
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 29/167 (17%)

Query: 27  LGKGKFGRVYLVR--------------EVESKHP--VALKIIFKEQIEKYKIQHQLRREM 70
           LG+G+FG V+L                +V    P  VA+K++ +E   K   ++   +E+
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANK-NARNDFLKEI 70

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------RFTEQQ 120
           +I S L+ PNI+RL       + + +I EY   G+L + L +H                 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 121 AATYIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
              ++A+ + + + Y    + +HRD+   N L+     +KI DFG S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 54/255 (21%), Positives = 118/255 (46%), Gaps = 15/255 (5%)

Query: 25  RPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + LG G FG VY    + + E+ K PVA+K++ +E     K   ++  E  + + +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSP-KANKEILDEAYVMAGVGSPY 70

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           + RL G       + L+ +    G L   +R+++ R   Q    +   +   ++Y  E  
Sbjct: 71  VCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGT--LDYLAPEMVENKEHD 194
           ++HRD+   N+L+     +KI DFG +       ++ H   G   + ++A E + ++   
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           +  D W+ G+  +E + +GA P++    ++    +++     P  P  + +   ++ +  
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLLEKGERLPQPPICTIDVYMIMVKCW 248

Query: 254 VKDSSKRLSLQKIME 268
           + DS  R   +++++
Sbjct: 249 MIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 55.2 bits (133), Expect = 6e-09
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 13/199 (6%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G+FG V++         VA+K + +  +           E  +   L+HP ++RL
Sbjct: 12  KKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRL 66

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIH 142
           Y      E I++I EY   G L   L+     + T  +     A +   +A+    + IH
Sbjct: 67  YAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      KI DFG +        + R      + + APE +         D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 199 NWTLGILCYEFL-YGAPPF 216
            W+ GIL  E + YG  P+
Sbjct: 186 VWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 63/302 (20%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSSLRHPNIL 82
           +P+G G  G V    +  +   VA+K   K       + H  R  RE+ +   + H NI+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNII 78

Query: 83  RLYGWFHDDER------IFLILEY--AHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L   F   +       ++L++E   A+  ++ +    H R +       +  +   + +
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKH 133

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPEMVENK 191
            H   +IHRD+KP N+++  +  LKI DFG + ++      M     T  Y APE++   
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPEVILGM 192

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------- 231
            +   VD W++G +  E + G   F      D + +I++                     
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV 252

Query: 232 ----------------DLSFPSAPS-----ISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
                           D+ FP          +++A+ L+S++LV D  KR+S+   ++HP
Sbjct: 253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312

Query: 271 WI 272
           +I
Sbjct: 313 YI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 54/230 (23%)

Query: 27  LGKGKFGRVYLVREVESKHP-----------------VALKIIFKEQIEKYKIQHQLRRE 69
           LG+G+FG V+L  EV +                    VA+KI+  +  +  +  +   +E
Sbjct: 13  LGEGQFGEVHLC-EVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR--NDFLKE 69

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ---------- 119
           ++I S L+ PNI+RL G   D++ + +I EY   G+L + L  H    ++          
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 120 --------QAATYIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---- 166
                    +  ++A  + + + Y    + +HRD+   N L+     +KI DFG S    
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 167 ------VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
                 +Q R+        + ++A E +   +   A D W  G+  +E L
Sbjct: 190 AGDYYRIQGRAVL-----PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 33/231 (14%)

Query: 25  RPLGKGKFGRVY--LVREVESKHP---VALKII-----FKEQIEKYKIQHQLRREMEIQS 74
           R LG+G FG VY    R++        VA+K +      +E+IE          E  +  
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-------FLNEASVMK 64

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE----------QQAATY 124
                +++RL G     +   +++E    G+L   LR  R   E          Q+    
Sbjct: 65  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTL- 180
            A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R    G L 
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 181 -DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIM 229
             ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 34/212 (16%)

Query: 23  IGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-------IQ 73
           +G+ LG+G+FG V    + + +S   VA+K +        KI    R EME         
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM--------KIAICTRSEMEDFLSEAVCM 54

Query: 74  SSLRHPNILRLYG-WFHDDER-----IFLILEYAHRGELYRELRKHR------RFTEQQA 121
               HPN++RL G      E        +IL +   G+L+  L   R          Q  
Sbjct: 55  KEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML 114

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL- 180
             ++  + + + Y      IHRD+   N +L+    + + DFG S +  +  +   G + 
Sbjct: 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174

Query: 181 ----DYLAPEMVENKEHDYAVDNWTLGILCYE 208
                ++A E + ++ +    D W+ G+  +E
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.9 bits (127), Expect = 3e-08
 Identities = 61/262 (23%), Positives = 106/262 (40%), Gaps = 30/262 (11%)

Query: 27  LGKGKFGRVYL-VREVESKHPVALKIIFKEQIEK-----YKIQHQLRREMEIQSSLRHPN 80
           LG+G F  +Y  V  V+S   +         + K     ++          + S L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNALAYCHENH 139
           +++LYG    DE I ++ EY   G L   L + +          +A  L +AL Y  +  
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 140 VIHRDIKPENLLLDHEGR-------LKIGDFGW--SVQSRSKRHTMCGTLDYLAPEMVEN 190
           ++H ++  +N+L+   G        +K+ D G   +V SR +R      + ++APE + N
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RIPWIAPECIRN 178

Query: 191 --KEHDYAVDNWTLGILCYEFLYGAP-PFEA--ESQKDTFRRIMKVDLSFPSAPSISAEA 245
                  A D W+ G    E       P      S+K+ F +     L  P    ++   
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR-LPMPDCAELAN-- 235

Query: 246 KHLISRLLVKDSSKRLSLQKIM 267
             LI++    D +KR S + I+
Sbjct: 236 --LINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 13/217 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++ + LG G+FG V++         VA+K +    +           E +I   LRH
Sbjct: 6   ESLQLIKKLGNGQFGEVWM-GTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALAYCH 136
             +++LY     +E I+++ EY  +G L   L+  + R           A +   +AY  
Sbjct: 61  DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKE 192
             + IHRD++  N+L+      KI DFG +        + R      + + APE      
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 193 HDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRI 228
                D W+ GIL  E +  G  P+   + ++   ++
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 43/204 (21%), Positives = 83/204 (40%), Gaps = 9/204 (4%)

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYI 125
           +E ++   LRH  +++LY     +E I+++ EY  +G L   L+    +     Q     
Sbjct: 50  QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 108

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLD 181
           A + + +AY    + +HRD++  N+L+      K+ DFG +        + R      + 
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 168

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           + APE           D W+ GIL  E    G  P+     ++   ++ +     P  P 
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPE 227

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQ 264
                  L+ +   K+  +R + +
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.2 bits (127), Expect = 5e-08
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 23/216 (10%)

Query: 18  LQDFEIGRPLGKGKFGRVYL------VREVESKHPVALKIIFKEQ----IEKY-----KI 62
           L  F +   L  G FG++++        E E++  V      K +    I K      + 
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI---LEYAHRGELYRE-LRKHRRFTE 118
             QL  E+     L H NIL++      +   ++I    ++     +Y E      R   
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----H 174
           +Q    +  L  A+ Y H+  +IHRDIK EN+ L+ +G++ +GDFG ++    +R    +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
              GT+   +PE++    +    D W+ G++  + L
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 48/234 (20%), Positives = 102/234 (43%), Gaps = 29/234 (12%)

Query: 27  LGKGKFGRVY----LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG+  FG++Y     +  ++    VA+K +  + I   +   + ++E  + + L HPNI+
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 83  RLYGWFHDDERIFLILEYAHRGELY-----RELRKHRRFTEQQAATYIASLTN------- 130
            L G    ++ + ++ EY ++G+L+     R        +  +  T  +SL +       
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 131 -----ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----L 180
                 + Y   +  +H+D+   N+L+  +  +KI D G S +  S  +          +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDL 233
            ++ PE +   +     D W+ G++ +E F +G  P+   S ++    + K  L
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 52.1 bits (125), Expect = 7e-08
 Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 21  FEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            ++G+ LG+G+FG V    L ++  S+  VA+K + K  I  Y    +   E        
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59

Query: 78  HPNILRLYG---WFHDDERI---FLILEYAHRGELYRELRKHR------RFTEQQAATYI 125
           HPN+++L G        ++I    +IL +   G+L+  L   R      +   Q    ++
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL----- 180
             +   + Y    + IHRD+   N +L  +  + + DFG S +  S  +   G +     
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
            ++A E + ++ +    D W  G+  +E  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 51.6 bits (123), Expect = 9e-08
 Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 17/211 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++            K+  K       +     +E +I   LRH  ++ LY 
Sbjct: 14  LGQGCFGEVWM-----GTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 87  WFHDDERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ E+  +G L   L+    K+ +    Q     A + + +AY    + IH
Sbjct: 69  VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP--QLVDMAAQIADGMAYIERMNYIH 125

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      KI DFG +        + R      + + APE           D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRI 228
            W+ GIL  E +  G  P+     ++   ++
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 32/160 (20%)

Query: 76  LRHPNILRLYGWFHDDERIFLILEY---AHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           L+HPNI++L G    ++  +LI EY    +  E+ R L   RR   ++ A  IA    AL
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERR---RKIAIGIAK---AL 793

Query: 133 AYCHEN---HVIHRDIKPENLLLD--HEGRLKIG-------DFGWSVQSRSKRHTMCGTL 180
            + H      V+  ++ PE +++D   E  L++        D    + S           
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA---------- 843

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
            Y+APE  E K+     D +  G++  E L G  P +AE 
Sbjct: 844 -YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882

Length = 968

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 1e-05
 Identities = 30/146 (20%), Positives = 52/146 (35%), Gaps = 13/146 (8%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
             + L  G   RVYL+          LKI    +           RE+ I   L    + 
Sbjct: 2   SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGA-----DREREVAILQLLARKGLP 54

Query: 83  --RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
             ++      D   +L++E+     L     + +    +Q A  +A L           +
Sbjct: 55  VPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV----L 110

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS 166
            H D+ P N+L+D    L I D+ ++
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 35/139 (25%), Positives = 61/139 (43%), Gaps = 14/139 (10%)

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMVENK 191
           IHRD+   N+LL     +KI DFG +         V+    R      L ++APE + ++
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL----PLKWMAPETIFDR 256

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            +    D W+ G+L +E F  GA P+      + F R +K      +    + E    + 
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316

Query: 251 RLLVKDSSKRLSLQKIMEH 269
                + S+R +  +++EH
Sbjct: 317 DCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 8/135 (5%)

Query: 141 IHRDIKPENLLLDHEGRL-KIGDFGWSVQSRSKRHTMCG-----TLDYLAPEMVENKEHD 194
           IHRD+   N+LL H GR+ KI DFG +   R+  + +        + ++APE + N  + 
Sbjct: 236 IHRDLAARNILLTH-GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYT 294

Query: 195 YAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           +  D W+ GIL +E F  G+ P+        F +++K      S     +E   ++    
Sbjct: 295 FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCW 354

Query: 254 VKDSSKRLSLQKIME 268
             D  KR + ++I++
Sbjct: 355 DADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 42/185 (22%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +  +   DF +G+ LG+G FG VY    V  +     K + K+  E Y         +EI
Sbjct: 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE-YG-------AVEI 177

Query: 73  --QSSLRH--PNILR--LYGWFH-----DDERIFLILEYAHRGELYRELRKHRRF----- 116
                +R   PN     +YG+        ++  +L+  Y     L  +L + + F     
Sbjct: 178 WMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLA-DLMQSKEFPYNVE 236

Query: 117 -------------TEQQAA---TYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLK 159
                         E++     T +  +  AL   H   ++HRD+KP+N++     G  K
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFK 296

Query: 160 IGDFG 164
           I D G
Sbjct: 297 IIDLG 301

Length = 566

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 14/86 (16%)

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMVENK 191
           IHRD+   N+LL     +KI DFG +         V+  S R      L ++APE + +K
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL----PLKWMAPESIFDK 251

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPF 216
            +    D W+ G+L +E F  GA P+
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 9e-05
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 71  EIQSSLR---HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT------EQQA 121
           E  S +R   H +I+ LYG    D    ++ E+   G L  +L  HR+        + + 
Sbjct: 53  ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKFKV 110

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-------LKIGDFGWSVQSRSKRH 174
           A  +AS   AL+Y  +  ++H ++  +N+LL  EG        +K+ D G  +   S R 
Sbjct: 111 AKQLAS---ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-RQ 166

Query: 175 TMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLY-GAPPFEAE--SQKDTF--RRI 228
                + ++APE VE+ K    A D W+ G   +E  Y G  P + +  ++K+ F   + 
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226

Query: 229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIM 267
           M         PS    A  L++  +  D ++R   + IM
Sbjct: 227 M------LVTPSCKELAD-LMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 18/32 (56%), Positives = 25/32 (78%)

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
           H   ++HRDIKPENLL+  +G++KI DFG +V
Sbjct: 326 HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAV 357

Length = 507

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 37/222 (16%)

Query: 27  LGKGKFGRVY--LVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREME-------I 72
           LG+G F +++  + REV       K  V LK++ K            R   E       +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----------RNYSESFFEAASM 52

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNA 131
            S L H +++  YG     +   ++ EY   G L   L+K++          +A  L  A
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR--------LKIGDFGWSVQSRSKRHTMCGTLDYL 183
           L +  +  + H ++  +N+LL  E          +K+ D G S+    K   +   + ++
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-EILLERIPWV 171

Query: 184 APEMVENKEH-DYAVDNWTLGILCYE-FLYGAPPFEA-ESQK 222
            PE +EN ++   A D W+ G   +E F  G  P  A +SQK
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 14/100 (14%)

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMVENK 191
           IHRD+   N+LL     +KI DFG +         V+    R      L ++APE + +K
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL----PLKWMAPESIFDK 250

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
            +    D W+ G+L +E F  GA P+      + F R +K
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 18/184 (9%)

Query: 96  LILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH 154
           ++ E+   G L   LRK + R       T    L +AL+Y  + +++H ++  +N+LL  
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152

Query: 155 EGR-------LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILC 206
            G        +K+ D G S  + S R      + ++APE V        A D W+ G   
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTALS-REERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211

Query: 207 YEFLY-GAPPFEAE--SQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
            E  + G  P +    S+K+ F    K  L  PS   ++     LIS+ L  + ++R S 
Sbjct: 212 LEICFDGEVPLKERTPSEKERFYE-KKHRLPEPSCKELAT----LISQCLTYEPTQRPSF 266

Query: 264 QKIM 267
           + I+
Sbjct: 267 RTIL 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 8/110 (7%)

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRL-KIGDFGWSVQ-SRSKRHTMCGT----LD 181
           + N + +    + +HRD+   N+L+  EG+L KI DFG +    R   +   G+    L 
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           ++APE + N  +    D W+ GIL +E F  G  P+      + F   +K
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK 356

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 35/166 (21%), Positives = 72/166 (43%), Gaps = 14/166 (8%)

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAAT 123
           L+ E+ +     HPNI+     F  D  ++++  +   G     +  H     +E   A 
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF--GWSVQSRSKRHTM----- 176
            +  +  AL Y H    +HR +K  ++L+  +G++ +       S+ +  +R  +     
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165

Query: 177 ---CGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFE 217
                 L +L+PE+++   + +D   D +++GI   E   G  PF+
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.002
 Identities = 36/143 (25%), Positives = 59/143 (41%), Gaps = 11/143 (7%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           N K E+   + + G+ LG G FG+V     + + + ++   VA+K++ K      + +  
Sbjct: 30  NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDE-REA 87

Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
           L  E++I S L +H NI+ L G       + +I EY   G+L   LRK            
Sbjct: 88  LMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMAL 147

Query: 125 IASLTNALAY---CHENHVIHRD 144
                 +  Y     E   I  D
Sbjct: 148 PEISETSSDYKNITLEKKYIRSD 170

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 8/115 (6%)

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTM 176
           ++   +   + +    + +HRD+   N+LL     +KI DFG +          SK  T 
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
              + ++APE + +  +    D W+ GIL +E F  G  P+       TF   +K
Sbjct: 301 L-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.4 bits (87), Expect = 0.003
 Identities = 31/153 (20%), Positives = 57/153 (37%), Gaps = 18/153 (11%)

Query: 131 ALAYCHEN----HVIHRDIKPENLLLDHEGRLKI-GDFGWSVQSRSKRHTMCGTLDYLAP 185
             A C +       +HR  K  N+LL  +G LK+ G   +    +S+         ++AP
Sbjct: 19  IWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRPDPY-----FMAP 73

Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMK-------VDLSFPS 237
           E+++ + +    D ++LGI  YE L Y  P  E          ++         D S   
Sbjct: 74  EVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLE 133

Query: 238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
             S +   +  +     +   +R +    + H 
Sbjct: 134 GVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	284
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
smart00090	237	RIO RIO-like kinase.	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG1243	690	consensus Protein kinase [General function predict	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.59
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.56
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
KOG3087	229	consensus Serine/threonine protein kinase [General	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
COG4248	637	Uncharacterized protein with protein kinase and he	99.37
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.33
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.23
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.1
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.06
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	99.01
PRK09902	216	hypothetical protein; Provisional	99.0
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.7
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.69
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.43
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.42
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.39
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.28
PLN02876	822	acyl-CoA dehydrogenase	98.25
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.25
KOG2270	520	consensus Serine/threonine protein kinase involved	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.1
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.08
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.06
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.9
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.9
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.89
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.78
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.75
PRK05231	319	homoserine kinase; Provisional	97.66
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.56
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.33
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.3
PLN02756	418	S-methyl-5-thioribose kinase	97.16
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.06
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.05
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.03
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.97
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.96
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.95
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.92
PRK12396	409	5-methylribose kinase; Reviewed	96.85
PLN02236	344	choline kinase	96.79
PRK11768	325	serine/threonine protein kinase; Provisional	96.48
PRK10593	297	hypothetical protein; Provisional	96.4
PTZ00384	383	choline kinase; Provisional	95.95
PTZ00296	442	choline kinase; Provisional	95.76
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.75
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.62
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.55
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.17
PRK10271	188	thiK thiamine kinase; Provisional	95.06

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-58  Score=392.79  Aligned_cols=259  Identities=38%  Similarity=0.747  Sum_probs=246.7

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|...+.||.|||+.+|.+++..+|..||+|++.+.........+.+.+|+++-+.|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999988887788899999999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~  175 (284)
                      |.|+.++|.+++++.+++++.+++.+++||+.|+.|||+++|+|+|||..|++++.+-+|||+|||++....   +....
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            999999999999999999999999999999999999999999999999999999999999999999996654   56677


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .+|||-|.|||++....++..+||||+||+||-|++|++||+..+-.+++..+......+|.  .++.++++||+++|++
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~  255 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRP  255 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcC
Confidence            89999999999999999999999999999999999999999999999999999998877777  8999999999999999


Q ss_pred             CCCCCCCHHhhhcCccccccCCCC
Q 023270          256 DSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      ||.+|||++++|.|+||.++-.|.
T Consensus       256 ~P~~Rpsl~~vL~h~Ff~~g~~p~  279 (592)
T KOG0575|consen  256 NPSERPSLDEVLDHPFFKSGFTPA  279 (592)
T ss_pred             CcccCCCHHHHhcCHhhhCCCcCC
Confidence            999999999999999998876654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-58  Score=379.60  Aligned_cols=260  Identities=35%  Similarity=0.574  Sum_probs=230.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH----HHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----KIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...-|.+.+.||+|+||.|-+|..+.+++.||||++.+......    .....+++|+++|++++||||++++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34458888999999999999999999999999999987655431    12345679999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC---CCEEEeeccccccc
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQS  169 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~---~~~~l~d~~~~~~~  169 (284)
                      ..|+|+||++||.|.+.+-.++.+.++.-+.++.|++.|+.|||+.||+|+||||+|||+..+   ..+||+|||++...
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999876   78999999999777


Q ss_pred             C--CCCccccCCCcccCccccCCCCC--C-chhhHhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCC--CCCCC
Q 023270          170 R--SKRHTMCGTLDYLAPEMVENKEH--D-YAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKVDLSFP--SAPSI  241 (284)
Q Consensus       170 ~--~~~~~~~~~~~y~aPE~~~~~~~--~-~~~Di~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~--~~~~~  241 (284)
                      +  +-....+|||.|.|||++.+...  . .+.|+||+||++|-+++|.+||....... ..+++.++.+.+.  .+..+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            4  44467789999999999987653  3 47899999999999999999998776655 8888888766554  45689


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +.+..+||++||..||++|||++++|+||||+..+
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999999999999999999999764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-57  Score=369.60  Aligned_cols=265  Identities=32%  Similarity=0.478  Sum_probs=236.8

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...+...+.+.++.||+|..|+|++|.++.+++.+|+|++...  ......+++.+|+++++..+||||+.+++.|..++
T Consensus        73 ~~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   73 DNGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             ccccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            3456777999999999999999999999999999999999332  23345688899999999999999999999999998


Q ss_pred             -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       .+.++||||++|||..++...+.+++..+..++.++++||.|||+ ++|+||||||+|||++..|.|||+|||.+....
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence             599999999999999999998999999999999999999999995 899999999999999999999999999985543


Q ss_pred             -CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          171 -SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-----SQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                       +......||..|+|||.+.+..++.++||||||++++|+++|+.||...     +.-+++..+..+..+......+|++
T Consensus       231 nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e  310 (364)
T KOG0581|consen  231 NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE  310 (364)
T ss_pred             hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence             3457788999999999999999999999999999999999999999875     6678888888754333333359999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      ++.||+.||.+||.+|||+.|+++|||+++-.++.
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            99999999999999999999999999999876653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-54  Score=349.90  Aligned_cols=259  Identities=39%  Similarity=0.710  Sum_probs=241.5

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .....+|++++.||.|+||+||+|+...+++.||+|++.+.........+..+.|..++.+++||.|++++..|.+++.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            57789999999999999999999999999999999999998888877889999999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CC
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RS  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~  171 (284)
                      |+|+||+.||.|...|++.+.++++.+.-++..|+.||.|||+.||+||||||+|||++.+|+++|+|||++...   +.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998533   34


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      .....+||+.|+|||++.+..++..+|.||||+++|+|++|.+||.+.+....++++.++....+ +..++.+.+++++.
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~-p~~ls~~ardll~~  259 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP-PGYLSEEARDLLKK  259 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC-CccCCHHHHHHHHH
Confidence            55667899999999999999999999999999999999999999999999999999998863222 22589999999999


Q ss_pred             hcccCCCCCC----CHHhhhcCccccc
Q 023270          252 LLVKDSSKRL----SLQKIMEHPWIIK  274 (284)
Q Consensus       252 ~l~~~p~~Rp----s~~~il~~~~~~~  274 (284)
                      +|..||++|.    .+++|-+||||..
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCccccc
Confidence            9999999996    8999999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-53  Score=358.86  Aligned_cols=259  Identities=37%  Similarity=0.663  Sum_probs=237.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDER   93 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~   93 (284)
                      .-..+||...+.||+|+|++|++|++..+++.||||++.+.-+..+.-.+-+..|=..|..| .||.|++++-.|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            56788999999999999999999999999999999999888777766667777788888888 89999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--  171 (284)
                      +|+|+||+++|.|.++|..-+.+++..++.++.+|+.||+|||++||+|+||||+|||++.|++++|.|||.+.....  
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998733211  


Q ss_pred             ----------CC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 023270          172 ----------KR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS  237 (284)
Q Consensus       172 ----------~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  237 (284)
                                ..    ...+||..|.+||++.....++.+|||+|||++|+|+.|.+||.+.+.-.+.++++.-...++.
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence                      11    2356889999999999999999999999999999999999999999999999999987666655


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                        .+++.+++||+++|..||.+|++++||.+||||...
T Consensus       309 --~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  309 --GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             --CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence              899999999999999999999999999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-53  Score=332.20  Aligned_cols=258  Identities=41%  Similarity=0.751  Sum_probs=248.7

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      .++++|++++.||.|+||+|-+++++.++..||+|++.+...-.....+...+|-.+++.+.||.++++++.+.+.+++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            78999999999999999999999999999999999999988888888899999999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcc
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  175 (284)
                      +||||.+||.|.+++++.+.+++..++-++.+|+.|++|||..+|+++|+||+|||++.+|.+||+|||++....+....
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T  200 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT  200 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999888999


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .+|||.|+|||++....+..++|.||||+++|||+.|.+||...+...+++++..+...+|.  .+++++++||+.+|+.
T Consensus       201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~--~fs~~~kdLl~~LL~v  278 (355)
T KOG0616|consen  201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS--YFSSDAKDLLKKLLQV  278 (355)
T ss_pred             ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc--ccCHHHHHHHHHHHhh
Confidence            99999999999999999999999999999999999999999999999999999999888877  7999999999999999


Q ss_pred             CCCCCC-----CHHhhhcCcccccc
Q 023270          256 DSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      |-.+|.     -..+|.+||||+..
T Consensus       279 D~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  279 DLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             hhHhhhcCcCCCccccccCcccccc
Confidence            999993     57789999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-52  Score=356.80  Aligned_cols=262  Identities=38%  Similarity=0.710  Sum_probs=238.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ....|++.+|.+.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++..+
T Consensus        11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            56788999999999999999999999999999999999999776554445567788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +..++||||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999876555


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..+....+  ..++..+++|+++
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~  248 (329)
T PTZ00263        171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP--NWFDGRARDLVKG  248 (329)
T ss_pred             CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC--CCCCHHHHHHHHH
Confidence            55556789999999999999899999999999999999999999999888888888877655443  3589999999999


Q ss_pred             hcccCCCCCCC-----HHhhhcCcccccc
Q 023270          252 LLVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      ||..||.+||+     +++++.||||++.
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999997     7999999999874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.7e-52  Score=352.85  Aligned_cols=265  Identities=38%  Similarity=0.630  Sum_probs=243.5

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ..+.+++..+|++++.||+|+||.||+|+-+.+|+.||+|++.+...........++.|=.+|.....+++|+++..|.+
T Consensus       133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD  212 (550)
T KOG0605|consen  133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD  212 (550)
T ss_pred             hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence            34557889999999999999999999999999999999999999988888889999999999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      .+++|+||||.+||++..+|.+-+.|+++.++-++.+++-||..+|+.|++|+||||+|+|++..|++||+|||++....
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999861100


Q ss_pred             -------------------------CC-----C--------------------ccccCCCcccCccccCCCCCCchhhHh
Q 023270          171 -------------------------SK-----R--------------------HTMCGTLDYLAPEMVENKEHDYAVDNW  200 (284)
Q Consensus       171 -------------------------~~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~  200 (284)
                                               ..     .                    ...+|||.|+|||++.+..++..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence                                     00     0                    124689999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHhhhcCcccccc
Q 023270          201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKN  275 (284)
Q Consensus       201 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~  275 (284)
                      ||||||||++.|.+||.+.++.++++++..-.  ..++....+++++++||.+||+ ||.+|.   .++||.+||||+..
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            99999999999999999999999999998865  6667777899999999999998 999998   69999999999975


Q ss_pred             C
Q 023270          276 A  276 (284)
Q Consensus       276 ~  276 (284)
                      +
T Consensus       452 ~  452 (550)
T KOG0605|consen  452 D  452 (550)
T ss_pred             C
Confidence            3

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-53  Score=336.48  Aligned_cols=255  Identities=27%  Similarity=0.495  Sum_probs=221.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      |..|..+.++|+|+||+|++++++.+|+.||||+|.-+. +.+...+...+|++++++++|+|+|.++++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            467999999999999999999999999999999996544 3345677889999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---C
Q 023270           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~  173 (284)
                      +|||+. ++.+.++.. ..++.+.+..++.|++.|+.|+|+++++|+||||+||+++.+|.+||||||++.....+   .
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999987 555555554 57899999999999999999999999999999999999999999999999998655433   3


Q ss_pred             ccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------------
Q 023270          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---------------  237 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------  237 (284)
                      ..+.-|-+|.|||.+.+ ..|....||||+||++.||++|.+.|.+.++-+.+..+.+.......               
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            34556889999999987 77999999999999999999999999999888877766654222211               


Q ss_pred             --------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          238 --------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       238 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                                    -+.++..+.+|+..||..||.+|++++|+|.||||.+
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence                          1345677899999999999999999999999999954

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-52  Score=354.64  Aligned_cols=258  Identities=40%  Similarity=0.761  Sum_probs=235.4

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH--HHHHHHHHHHHHHHHhCC-CCcccceeeEEecC
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK--YKIQHQLRREMEIQSSLR-HPNILRLYGWFHDD   91 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~   91 (284)
                      .....+|.+.+.||.|+||+|+.+.+..++..||+|++.......  ....+.+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            456779999999999999999999999999999999776642221  134567778999999999 99999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeeccccccc-
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQS-  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~~~~~~-  169 (284)
                      ..+++||||+.+|.|.+++.+.+.+.+..+..+++|++.|+.|||++||+|+||||+||+++.+ +++||+|||++... 
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999999999999998899999999999999999999999999999999999999999 99999999999655 


Q ss_pred             --CCCCccccCCCcccCccccCCCC-CC-chhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC-CHH
Q 023270          170 --RSKRHTMCGTLDYLAPEMVENKE-HD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI-SAE  244 (284)
Q Consensus       170 --~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  244 (284)
                        .......+|++.|+|||++.+.. ++ .++||||+|+++|.|++|..||...+...+...+..+....+.  .+ +++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~--~~~S~~  250 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS--YLLSPE  250 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC--CcCCHH
Confidence              34556778999999999999877 75 7999999999999999999999999999999998888777766  45 999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ++.|+++||.+||.+|+|+.+|++||||+.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-53  Score=322.82  Aligned_cols=263  Identities=65%  Similarity=1.145  Sum_probs=248.5

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .....|.+.+|.+.+.||.|.||.||+|+.+.++-.||+|++.+++.......+++++|+++.+.++||||++++++|.+
T Consensus        14 ~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   14 RATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             ccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            34578999999999999999999999999999999999999999999888889999999999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           91 DERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ....|+++||.+.|++...+.  ....+++.....++.|++.|+.|+|..+++|+||+|+|+|++.+|.+|+.|||++..
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            999999999999999999998  556799999999999999999999999999999999999999999999999999976


Q ss_pred             c-CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          169 S-RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       169 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      . .+.....+||..|.|||...+...+...|+|++|++.|+++.|.+||+..+..++++++.+....++  +.++.++.+
T Consensus       174 ~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p--~~is~~a~d  251 (281)
T KOG0580|consen  174 APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP--STISGGAAD  251 (281)
T ss_pred             cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC--cccChhHHH
Confidence            6 4555667899999999999999999999999999999999999999999999999999999877777  489999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +|.+|+..+|.+|.+..|+++|||++.+
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=338.71  Aligned_cols=263  Identities=35%  Similarity=0.656  Sum_probs=237.0

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|.+.+.||+|+||+||+++++.++..||||.+.+.... ....+.+..|+.+++.++|+||+.+++++..++.+|+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            467899999999999999999999999999999999877543 3456788899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC------CCEEEeecccccccC
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE------GRLKIGDFGWSVQSR  170 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~------~~~~l~d~~~~~~~~  170 (284)
                      |||||+||+|.+++.+.+.+++..++.++.||+.|+++||+++|+|+||||.|||++.+      -.+||.|||+++...
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875      469999999996654


Q ss_pred             C--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-CCCCHHHHH
Q 023270          171 S--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA-PSISAEAKH  247 (284)
Q Consensus       171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~  247 (284)
                      +  -....+|+|-|+|||++....|+-|+|+||+|+++|++++|+.||...+..++...+.++....+.. ..++.+..+
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~  246 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRE  246 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhh
Confidence            3  3356789999999999999999999999999999999999999999999999999888765444443 356777889


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCccccccCCCCC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  280 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (284)
                      ++-..+..+|.+|-+..+-+.|+++..++-.+.
T Consensus       247 Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~~  279 (429)
T KOG0595|consen  247 LLISLLQRNPKDRISFEDFFDHPFLAANPQDRA  279 (429)
T ss_pred             hhhHHHhcCccccCchHHhhhhhhcccCccccc
Confidence            999999999999999999999999988765443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-51  Score=345.47  Aligned_cols=255  Identities=38%  Similarity=0.706  Sum_probs=230.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997655444445567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccC
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG  178 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  178 (284)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...........|
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g  160 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG  160 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence            99999999999998888999999999999999999999999999999999999999999999999998665554455678


Q ss_pred             CCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 023270          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       179 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (284)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......++.  .+++.+++++++||..||.
T Consensus       161 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~  238 (291)
T cd05612         161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAKDLIKKLLVVDRT  238 (291)
T ss_pred             ChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc--cCCHHHHHHHHHHcCCCHH
Confidence            99999999999888999999999999999999999999999888888888777654443  6789999999999999999


Q ss_pred             CCCC-----HHhhhcCcccccc
Q 023270          259 KRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       259 ~Rps-----~~~il~~~~~~~~  275 (284)
                      +||+     ++++++||||+..
T Consensus       239 ~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         239 RRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HccCCccCCHHHHhcCccccCC
Confidence            9995     9999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-50  Score=347.10  Aligned_cols=263  Identities=37%  Similarity=0.666  Sum_probs=235.6

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCC-ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ....++...+|++.+.||.|+||.||+|.+..++ ..|++|++...........+.+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            3456778899999999999999999999876655 689999987655444445567889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      .++..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999998665


Q ss_pred             CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                      ........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......++  ..+++++.+++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li  259 (340)
T PTZ00426        182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP--KFLDNNCKHLM  259 (340)
T ss_pred             CCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHH
Confidence            5555556789999999999988899999999999999999999999999988888888877655443  46899999999


Q ss_pred             HHhcccCCCCCC-----CHHhhhcCcccccc
Q 023270          250 SRLLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       250 ~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      ++||..||++|+     +++++++||||++.
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999995     89999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-50  Score=343.74  Aligned_cols=257  Identities=33%  Similarity=0.563  Sum_probs=229.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.++..++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997765554445677888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccC
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG  178 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  178 (284)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........|
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g  160 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG  160 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999998766555556678


Q ss_pred             CCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCC----CCCCHHHHHHHHHh
Q 023270          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSA----PSISAEAKHLISRL  252 (284)
Q Consensus       179 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~l~~li~~~  252 (284)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.......  +..    ..+++++.+++.+|
T Consensus       161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  240 (333)
T cd05600         161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL  240 (333)
T ss_pred             CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHH
Confidence            999999999999899999999999999999999999999988877776665432211  111    14689999999999


Q ss_pred             cccCCCCCCCHHhhhcCcccccc
Q 023270          253 LVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       253 l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |..+|.+||+++++++||||.+.
T Consensus       241 l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         241 INDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             hhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-51  Score=342.44  Aligned_cols=260  Identities=29%  Similarity=0.460  Sum_probs=224.5

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~   92 (284)
                      -.+.+.+|.++++||.|+||.||+|+...++..||||.++.....-.+.  .-.+|+..+++++ ||||+++.+++.+.+
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            3456789999999999999999999999999999999998766543322  2347999999998 999999999998888


Q ss_pred             -eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 -RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       .+|+|||||+. .|..+++.. ..+++..++.|+.||++||+|+|++|++|+|+||+|||+..+..+||.|||+++...
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence             99999999975 999999765 579999999999999999999999999999999999999999999999999996554


Q ss_pred             --CCCccccCCCcccCccccC-CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 023270          171 --SKRHTMCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP-----------  236 (284)
Q Consensus       171 --~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  236 (284)
                        .+...++-|-+|+|||++. .+-|+.+.|+|++||+++|+++-++.|.+.+.-+.+.++......+.           
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence              3445567788999999875 55699999999999999999999999999888887777665311111           


Q ss_pred             --------C---------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          237 --------S---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       237 --------~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                              .         .+..+.++.++|.+|+.+||.+|||++|+|+|||||.+.
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                    1         123678999999999999999999999999999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-51  Score=335.55  Aligned_cols=257  Identities=32%  Similarity=0.554  Sum_probs=223.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC--eEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE--RIF   95 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~--~~~   95 (284)
                      ..++...+.||.|+||+||++.+..+|...|||.+.......   .+.+.+|++++++++|+|||+.++.....+  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            466889999999999999999999999999999986653222   577899999999999999999999744443  699


Q ss_pred             EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEeecccccccCC--
Q 023270           96 LILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRS--  171 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~--  171 (284)
                      ++|||+++|+|.+++++.+ .+++..++.+.+|+++||.|||++|++|+||||+|||++. ++.+||.|||.+.....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999987 7999999999999999999999999999999999999999 79999999998854442  


Q ss_pred             ----CCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          172 ----KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       172 ----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                          ......|++.|+|||+..++ ...+++|||||||++.+|+||+.||.. ....+.+-.+......+..+..+|.++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence                22345689999999999853 344699999999999999999999988 555665666665555556667899999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ++|+..|+..||++|||++++|+|||.++...
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999988765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-52  Score=327.72  Aligned_cols=257  Identities=30%  Similarity=0.519  Sum_probs=224.9

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceee-EEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG-WFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~-~~~~~~   92 (284)
                      ..-.+.+|+|+++||.|.||+||+|....+++.+|.|.+.....+. ...+....|+.++++++||||+++++ .+.++.
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~-k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDA-KARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccH-HHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            4556788999999999999999999999999999999997555444 44677889999999999999999998 454444


Q ss_pred             -eEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCCeEecCCCCEEEeec
Q 023270           93 -RIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHE--NH--VIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~--~g--i~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                       .+++|||+|+.|+|..+++..    +.+++..+|.++.|++.||..+|.  ..  +.|+||||.||+++.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence             499999999999999998653    468999999999999999999998  34  899999999999999999999999


Q ss_pred             ccccccCCC---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          164 GWSVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       164 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      |++....+.   ....+|||.|++||.+...+++.+|||||+||++|+|+.-.+||.+.+-.++.+++.++...+....-
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence            998655433   35678999999999999999999999999999999999999999999999999999998665444457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .|.+++.+|+.|+++||+.||+.     +|++++.+
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence            88999999999999999999986     56665543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.6e-50  Score=313.76  Aligned_cols=259  Identities=29%  Similarity=0.501  Sum_probs=225.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|...+++|+|.||.||+|++..+|+.||||++....... .......+|++.++.++|+||+.++++|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            57899999999999999999999999999999997765432 33456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccc-
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-  176 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-  176 (284)
                      ||++ .+|...++.. ..++..++..++.+++.|++|||++.|+|+||||+|+|++++|.+||.|||+++...++.... 
T Consensus        81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            9997 5999998765 478999999999999999999999999999999999999999999999999997766554333 


Q ss_pred             --cCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCC-------------
Q 023270          177 --CGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSA-------------  238 (284)
Q Consensus       177 --~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~-------------  238 (284)
                        +.+-+|.|||.+.+.. |+...|+||.||++.||+-+.+.|.+.++-+.+..+......+  ..+             
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence              4678899999998765 8999999999999999999999999999988888877642211  111             


Q ss_pred             -----------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          239 -----------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       239 -----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                                 +..++++.+|+..|+..||.+|+|+.|+|+|+||+..+-|-
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence                       23467789999999999999999999999999999876553

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-49  Score=339.64  Aligned_cols=249  Identities=39%  Similarity=0.644  Sum_probs=222.3

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      +.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997765544445567778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCCc
Q 023270          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLD  181 (284)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~  181 (284)
                      +|...+...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            999999988889999999999999999999999999999999999999999999999999875432   22233458999


Q ss_pred             ccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       182 y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      |+|||++.+..++.++||||||+++++|++|..||...+.......+......++  ..+++++.++|++||..||++||
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcC
Confidence            9999999999999999999999999999999999998888887777776654443  47899999999999999999999


Q ss_pred             -----CHHhhhcCcccccc
Q 023270          262 -----SLQKIMEHPWIIKN  275 (284)
Q Consensus       262 -----s~~~il~~~~~~~~  275 (284)
                           ++.++++||||+..
T Consensus       239 ~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         239 GGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCCCCCHHHHHcCCCcCCC
Confidence                 89999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.6e-49  Score=340.74  Aligned_cols=257  Identities=32%  Similarity=0.567  Sum_probs=223.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||+|+||+||+|.+..+++.||+|++.............+..|+.++..++|++|+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997765555555677888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~------  172 (284)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999987432110      


Q ss_pred             --------------------------------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC
Q 023270          173 --------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES  220 (284)
Q Consensus       173 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~  220 (284)
                                                      .....|++.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                            012368899999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHhhhcCcccccc
Q 023270          221 QKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVK--DSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       221 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~~il~~~~~~~~  275 (284)
                      ..+....+....  ..++....+++++++++.+|+..  ++..||++++|++||||+..
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence            888888777633  33333346889999999997752  23356899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-49  Score=343.18  Aligned_cols=256  Identities=37%  Similarity=0.694  Sum_probs=229.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|.+.+.||.|+||+||+|.+..+++.||+|++.............+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997765544445677889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~------  172 (284)
                      ||+++++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......      
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999987543322      


Q ss_pred             --------------------------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 023270          173 --------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR  226 (284)
Q Consensus       173 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~  226 (284)
                                                .....|++.|+|||.+.+..++.++||||||+++++|++|..||...+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                      123458899999999999999999999999999999999999999988888777


Q ss_pred             HHHh--cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHhhhcCcccccc
Q 023270          227 RIMK--VDLSFPSAPSISAEAKHLISRLLVKDSSKRLS-LQKIMEHPWIIKN  275 (284)
Q Consensus       227 ~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~il~~~~~~~~  275 (284)
                      .+..  .....+....+++++.++|.+||. +|.+||+ ++++++||||++.
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            7776  444445545579999999999997 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=328.91  Aligned_cols=268  Identities=29%  Similarity=0.479  Sum_probs=233.5

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      .....+.....+|.+...||.|..++||+|.....+..||||++..+.-...  .+.+++|++.++.++||||++.+..|
T Consensus        16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sF   93 (516)
T KOG0582|consen   16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSF   93 (516)
T ss_pred             cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEE
Confidence            3445566778899999999999999999999999999999999977665543  68999999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      ..++.+++||.|+.+||+.++++..  ..+++..+..+++++++||.|||++|.+|||||+.|||++.+|.|+|+|||.+
T Consensus        94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence            9999999999999999999999875  46899999999999999999999999999999999999999999999999976


Q ss_pred             cc---cCCCC----ccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 023270          167 VQ---SRSKR----HTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS  237 (284)
Q Consensus       167 ~~---~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  237 (284)
                      -.   .+...    ....|++.|+|||++..  ..|+.|+||||||++..||.+|..||....+...+...+++..+.+.
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            21   11111    33478999999999654  34899999999999999999999999999888877777776554222


Q ss_pred             C--------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          238 A--------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       238 ~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .        ..++..+++++..||..||++|||++++|.|+||++.+.+
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            1        2456789999999999999999999999999999998654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-50  Score=343.42  Aligned_cols=254  Identities=34%  Similarity=0.601  Sum_probs=237.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +++|.+...||+|.||+||+++.+.+.+.||+|.+.+....+ ...+.+++|+++++.++||||+.+++.|+...++++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            578999999999999999999999999999999998765444 4568899999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCc---
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---  174 (284)
                      .|||.| +|..+++.++.++++.+..++.+++.||.|||+.+|.|+|+||.||+++.+|++|++|||+++.+..+..   
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999975 9999999999999999999999999999999999999999999999999999999999999987766553   


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...|+|.|+|||+..++.++..+|+||+||++||+++|++||-..+...+.+.+......++.  ..+..+.+|+..+|.
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~  236 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLI  236 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhh
Confidence            456999999999999999999999999999999999999999999999999999988766666  799999999999999


Q ss_pred             cCCCCCCCHHhhhcCcccccc
Q 023270          255 KDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +||.+|.|..+++.|||.+..
T Consensus       237 kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  237 KDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             cChhhcccHHHHhcChHHhhh
Confidence            999999999999999998764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-50  Score=346.69  Aligned_cols=260  Identities=33%  Similarity=0.622  Sum_probs=240.5

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..-|++.+.||.|+-|.|-+|++..+|+.+|||++.+...-+......+.+|+-+|+.+.|||++++++++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            44578899999999999999999999999999999876444445567889999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC--CCCcc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHT  175 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~--~~~~~  175 (284)
                      .||+++|.|.+++...+++++.++...++||+.|+.|+|..+|+|+|+||+|+|++..+++||.|||++....  .--..
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999985443  34467


Q ss_pred             ccCCCcccCccccCCCCCC-chhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      .+|+|-|.+||+..+..|+ .++||||-|+|+|.|+||++||.+.+...++.+..++.+..+.  .+++++++||++||+
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLD  248 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhc
Confidence            7899999999999999975 6999999999999999999999999999999999999877775  899999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      .||.+|.|.++|+.|||++......
T Consensus       249 VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  249 VDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             cCccccccHHHHhhCchhhcCCCCC
Confidence            9999999999999999999887654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-49  Score=333.47  Aligned_cols=247  Identities=38%  Similarity=0.635  Sum_probs=220.5

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||+|+||.||++.+..++..||+|++.............+.+|+.++..++|+||+++++++..++..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999998765544444556778899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCCccc
Q 023270          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYL  183 (284)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~y~  183 (284)
                      .+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            9999888889999999999999999999999999999999999999999999999999875422   2223446899999


Q ss_pred             CccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC--
Q 023270          184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL--  261 (284)
Q Consensus       184 aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--  261 (284)
                      |||++.+..++.++||||||+++++|++|..||...+..+...........++  ..+++++.+++.+||..||.+||  
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~~~  238 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP--DGFDRDAKDLLIGLLSRDPTRRLGY  238 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC--CcCCHHHHHHHHHHcCCCHHHcCCC
Confidence            99999999999999999999999999999999999888888887776654443  47899999999999999999997  


Q ss_pred             -CHHhhhcCcccccc
Q 023270          262 -SLQKIMEHPWIIKN  275 (284)
Q Consensus       262 -s~~~il~~~~~~~~  275 (284)
                       ++.+++.||||.+.
T Consensus       239 ~~~~e~l~hp~~~~~  253 (312)
T cd05585         239 NGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCHHHHHcCCCcCCC
Confidence             57999999999974

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-49  Score=339.79  Aligned_cols=256  Identities=35%  Similarity=0.626  Sum_probs=225.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++.............+.+|+.++..++|+||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            48999999999999999999999999999999997765444455667889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~------  172 (284)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||++......      
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999987432110      


Q ss_pred             -----------------------------------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCC
Q 023270          173 -----------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE  217 (284)
Q Consensus       173 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~  217 (284)
                                                         .....|++.|+|||++.+..++.++|||||||++++|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                               012358899999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCC---HHhhhcCcccccc
Q 023270          218 AESQKDTFRRIMKVDLS--FPSAPSISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  275 (284)
Q Consensus       218 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  275 (284)
                      ..+..+....+......  .+....+++++.++|.+|+. +|.+|++   ++++++||||.+.
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            98888877777654332  23333578999999999996 9999998   9999999999764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-48  Score=338.62  Aligned_cols=266  Identities=33%  Similarity=0.543  Sum_probs=230.4

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      +.....+....+|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++|+||+++++++
T Consensus        33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          33 EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             HhhccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            44556778889999999999999999999999999999999999765444444456677899999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ..++..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||++..
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         113 QDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            9999999999999999999988664 588999999999999999999999999999999999999999999999999854


Q ss_pred             cCCC----CccccCCCcccCccccCCC----CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCC
Q 023270          169 SRSK----RHTMCGTLDYLAPEMVENK----EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPSA  238 (284)
Q Consensus       169 ~~~~----~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~  238 (284)
                      ....    .....|++.|+|||.+.+.    .++.++|+||||+++|+|++|..||...+....+.++....  ..++..
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD  271 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence            3321    2334689999999998653    37889999999999999999999999998888888877643  333444


Q ss_pred             CCCCHHHHHHHHHhcccCCCC--CCCHHhhhcCcccccc
Q 023270          239 PSISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  275 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  275 (284)
                      ..++.++.++|++||..+|.+  |+|++++++||||++.
T Consensus       272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            468999999999999999987  9999999999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-48  Score=332.56  Aligned_cols=249  Identities=39%  Similarity=0.655  Sum_probs=221.6

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      +.||+|+||.||++.+..++..||+|++.............+.+|+++++.++||||+++++.+..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997765444445567778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCccccCCCc
Q 023270          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLD  181 (284)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~  181 (284)
                      +|..++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   ......|++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            9999998888899999999999999999999999999999999999999999999999998754221   2223458899


Q ss_pred             ccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       182 y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      |+|||++.+..++.++||||||+++|+|++|..||...+...............+  ..+++++.++|.+||..||++||
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHccCCHHHhC
Confidence            9999999998999999999999999999999999998888887777776554443  37899999999999999999998


Q ss_pred             -----CHHhhhcCcccccc
Q 023270          262 -----SLQKIMEHPWIIKN  275 (284)
Q Consensus       262 -----s~~~il~~~~~~~~  275 (284)
                           ++.++++||||.+.
T Consensus       239 ~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         239 GGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCCCCCHHHHHcCCCcCCC
Confidence                 99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-48  Score=339.06  Aligned_cols=257  Identities=30%  Similarity=0.532  Sum_probs=222.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +.|.+++.||.|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++.+++.+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999997766555555678899999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-------  171 (284)
                      ||+++++|.+++.+.+.+++..+..++.|++.||.|||..||+|+||||+||+++.+++++|+|||++.....       
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999998632100       


Q ss_pred             -------------------------------------------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHH
Q 023270          172 -------------------------------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE  208 (284)
Q Consensus       172 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  208 (284)
                                                                 ......|++.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                       0012358899999999998889999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHhhhcCcccccc
Q 023270          209 FLYGAPPFEAESQKDTFRRIMKV--DLSFPSAPSISAEAKHLISRLL--VKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       209 l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l--~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |++|..||...+..+....+...  ....+....+++++.+||.+|+  ..++..||+++++++||||++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999988877766666542  2333444468999999999965  4556669999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-49  Score=332.93  Aligned_cols=257  Identities=30%  Similarity=0.490  Sum_probs=222.4

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~   94 (284)
                      ....|..+.+||+|+||.||+|++..+|+.||+|++...... .+....+.+||.+|++++||||+++.+++.+.  +.+
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            455699999999999999999999999999999999765533 34567788999999999999999999999877  689


Q ss_pred             EEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           95 FLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      |+|+|||+. +|.-++.+.+ .+++.++..++.||+.||.|+|.+|++|+|||.+|||++.+|++||.|||++...... 
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999999986 8888887753 7999999999999999999999999999999999999999999999999999743322 


Q ss_pred             ---CccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCC--------
Q 023270          173 ---RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--DLSFPSA--------  238 (284)
Q Consensus       173 ---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~--------  238 (284)
                         ....+.|.+|.|||++.+.. |+.+.|+||.||||.||++|++.|.+.+..+.+..+.+.  ......+        
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence               23345789999999998875 999999999999999999999999999999988887763  1111111        


Q ss_pred             -----------------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          239 -----------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       239 -----------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                                       ..+++...+|+..||..||.+|.|+.++|+++||...
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence                             1367888999999999999999999999999999443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=330.71  Aligned_cols=255  Identities=29%  Similarity=0.479  Sum_probs=228.5

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCce-EEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ....+...+..+.+.||.|+||+||++...  |+. ||+|++.....+... .+.+.+|+.++.+++||||+++++++.+
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            556777888899999999999999998874  444 999999877666554 7899999999999999999999999998


Q ss_pred             CC-eEEEEEeecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCeEecCCC-CEEEeeccc
Q 023270           91 DE-RIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENH-VIHRDIKPENLLLDHEG-RLKIGDFGW  165 (284)
Q Consensus        91 ~~-~~~~v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~lh~~g-i~H~dl~p~nil~~~~~-~~~l~d~~~  165 (284)
                      +. .+++||||+++|+|.+++..  ...++...++.++.||+.|+.|||+.+ |+|+||||+|||++.++ ++||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            87 79999999999999999988  578999999999999999999999999 99999999999999997 999999999


Q ss_pred             ccccCC---CCccccCCCcccCccccC--CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          166 SVQSRS---KRHTMCGTLDYLAPEMVE--NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       166 ~~~~~~---~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      +.....   ......||+.|+|||++.  ...++.++||||||+++|+|+||..||..................+..+..
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~  270 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE  270 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            965543   233367899999999999  568999999999999999999999999999997777777777777777777


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .++.+..++..||..||..||++.+|+.-
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~  299 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVSR  299 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence            99999999999999999999999998753

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-48  Score=331.06  Aligned_cols=254  Identities=33%  Similarity=0.596  Sum_probs=223.9

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC-CcccceeeEEecCCeEEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h-~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...........+.+..|.+++..+.| ++++++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999976554444445677788888888876 46888999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~  175 (284)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999888889999999999999999999999999999999999999999999999999875322   22234


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..|++.|+|||++.+..++.++|+||+|+++++|++|..||...+..+....+.......+  ..+++++.+++++||..
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~  238 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP--KSLSKEAVSICKGLLTK  238 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhhc
Confidence            4589999999999999999999999999999999999999999998888888877654433  47899999999999999


Q ss_pred             CCCCCCCH-----HhhhcCcccccc
Q 023270          256 DSSKRLSL-----QKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rps~-----~~il~~~~~~~~  275 (284)
                      ||.+|+++     +++++||||+..
T Consensus       239 ~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         239 HPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999987     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-48  Score=332.66  Aligned_cols=249  Identities=38%  Similarity=0.645  Sum_probs=221.0

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      +.||.|+||.||++.+..+++.||+|++.............+.+|+++++.++|+||+++.+.+..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997665444445567788999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCCc
Q 023270          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLD  181 (284)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~  181 (284)
                      +|...+.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            999999888889999999999999999999999999999999999999999999999999875422   12233458899


Q ss_pred             ccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       182 y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      |+|||.+.+..++.++||||||+++++|++|..||...+..+....+......+  +..+++++.++|++||..||++|+
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~  238 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF--PRTLSADAKSLLSGLLIKDPNKRL  238 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccC--CCCCCHHHHHHHHHHcCCCHHHcC
Confidence            999999998889999999999999999999999999888877777766554443  347899999999999999999997


Q ss_pred             -----CHHhhhcCcccccc
Q 023270          262 -----SLQKIMEHPWIIKN  275 (284)
Q Consensus       262 -----s~~~il~~~~~~~~  275 (284)
                           +++++++||||...
T Consensus       239 ~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         239 GGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCCCCHHHHhcCCCcCCC
Confidence                 89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-48  Score=338.86  Aligned_cols=256  Identities=33%  Similarity=0.576  Sum_probs=222.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++++.||.|+||+||++.+..+++.||+|++...........+.+.+|+++++.++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999987665545555678889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~------  172 (284)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999987421100      


Q ss_pred             --------------------------------------------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHH
Q 023270          173 --------------------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE  208 (284)
Q Consensus       173 --------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  208 (284)
                                                                  .....|++.|+|||++.+..++.++|||||||++++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                                                        001358899999999998889999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHhhhcCcccccc
Q 023270          209 FLYGAPPFEAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKR---LSLQKIMEHPWIIKN  275 (284)
Q Consensus       209 l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~il~~~~~~~~  275 (284)
                      |++|..||...+..+....+....  ..++....++.++.+||++||. +|.+|   +++.+++.||||+..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999888877777766532  3333334588999999999997 66665   599999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.1e-48  Score=329.40  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=221.7

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      +...+|++.+.||.|+||.||++.+..++..|++|.+.....  ......+.+|+++++.++|+||+++++++..++..+
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            567899999999999999999999999999999999865421  223467889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecccccccC-CCC
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SKR  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-~~~  173 (284)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.... ...
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            9999999999999999888899999999999999999999985 69999999999999999999999999875432 223


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------------
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-----------------------  230 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----------------------  230 (284)
                      ....+++.|+|||++.+..++.++||||||+++++|++|..||...+..+.......                       
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            345688999999999988899999999999999999999999987665544322111                       


Q ss_pred             -----------------------cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          231 -----------------------VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       231 -----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                             ..........+++++++||++||..||++|||++++++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                                   11111112247889999999999999999999999999999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-48  Score=320.64  Aligned_cols=266  Identities=38%  Similarity=0.642  Sum_probs=243.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .....+.+++|+++++||+|.-|+||+|....++..+|+|++.+.......-...+..|-++|..++||.++.++..++.
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            34567788999999999999999999999999999999999999988887778888899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      +...|++||||+||+|..+.+++  +.+++..++-++..++-||+|||-.||+++||||+|||+.++|++.|+||.++..
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999999999999998876  4699999999999999999999999999999999999999999999999998511


Q ss_pred             cC----------------------------------C-C------------------------CccccCCCcccCccccC
Q 023270          169 SR----------------------------------S-K------------------------RHTMCGTLDYLAPEMVE  189 (284)
Q Consensus       169 ~~----------------------------------~-~------------------------~~~~~~~~~y~aPE~~~  189 (284)
                      ..                                  . .                        ....+||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            00                                  0 0                        01123667799999999


Q ss_pred             CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHh
Q 023270          190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS----LQK  265 (284)
Q Consensus       190 ~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~  265 (284)
                      +...+.+.|.|+||+++|||+.|..||.+.+..++...++.....++..+.++..+++||+++|.+||++|.-    +++
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e  388 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE  388 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence            9999999999999999999999999999999999999999999999998899999999999999999999998    999


Q ss_pred             hhcCccccccC
Q 023270          266 IMEHPWIIKNA  276 (284)
Q Consensus       266 il~~~~~~~~~  276 (284)
                      |-+||||+..+
T Consensus       389 IK~HpFF~gVn  399 (459)
T KOG0610|consen  389 IKRHPFFEGVN  399 (459)
T ss_pred             hhcCccccCCC
Confidence            99999998764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=338.61  Aligned_cols=254  Identities=31%  Similarity=0.544  Sum_probs=227.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|....+||+|+.|.||.|....+++.||||.+.......   .+-+.+|+.+|+..+|+||+.+++.+..++.+++||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            45888999999999999999999999999999997765544   357889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~  175 (284)
                      ||+++|+|.+.+.... +++.++..+++.++.||+|||.+||+|+|||.+|||++.+|.+||+|||++...   ......
T Consensus       350 Eym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             eecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            9999999999887644 899999999999999999999999999999999999999999999999998443   334566


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..|||.|+|||+.....|+++.||||||++++||+.|.+||-..++- .++.-...+......++.+|+++++|+.+||+
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            78999999999999999999999999999999999999999865554 44444455677777788999999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .|+++|+|+.++|+||||+...
T Consensus       509 ~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  509 VDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             cchhcCCCHHHHhcChhhhhcC
Confidence            9999999999999999996653

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.3e-48  Score=324.88  Aligned_cols=256  Identities=28%  Similarity=0.434  Sum_probs=217.1

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|++.+.||.|+||.||++.+..+++.||+|.+.............+.+|+.+++.++|++++++++.+..++..++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999876554443444567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCcc
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~~  175 (284)
                      |+++++|...+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999998887643  3689999999999999999999999999999999999999999999999999855322  2234


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCCCCCCCCHHHHHHHHHhc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK--VDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ..|+..|+|||++.+..++.++||||||+++++|++|..||..............  .......+..+++++.+|+++||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            4688999999999999999999999999999999999999987654322222211  11122334468999999999999


Q ss_pred             ccCCCCCCC-----HHhhhcCcccccc
Q 023270          254 VKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       254 ~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      +.||++||+     ++++++||||.+.
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999997     8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.2e-48  Score=337.74  Aligned_cols=256  Identities=32%  Similarity=0.563  Sum_probs=223.7

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|.+++.||.|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999997765544555678889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-------  171 (284)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.....       
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999998632100       


Q ss_pred             -------------------------------------------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHH
Q 023270          172 -------------------------------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE  208 (284)
Q Consensus       172 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  208 (284)
                                                                 ......|++.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                       0012357899999999999899999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHhhhcCcccccc
Q 023270          209 FLYGAPPFEAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  275 (284)
Q Consensus       209 l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  275 (284)
                      |++|..||...+..+....+....  ...+....+++++.++|.+|+ .+|++|++   ++++++||||+..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999999999888877776666532  333444568999999999986 59999997   9999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-48  Score=330.62  Aligned_cols=249  Identities=37%  Similarity=0.650  Sum_probs=219.4

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||+|+||+||+|.+..+++.||+|++...........+.+..|..++..+ +|+||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999999999999999998765443334455666777777766 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|..++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223446899


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.......+  ..+++++.+++++||..||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R  238 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLSQDAVDILKAFMTKNPTMR  238 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcccCHHHC
Confidence            99999999988899999999999999999999999999999888888877654433  3689999999999999999999


Q ss_pred             CCH------HhhhcCcccccc
Q 023270          261 LSL------QKIMEHPWIIKN  275 (284)
Q Consensus       261 ps~------~~il~~~~~~~~  275 (284)
                      |++      ++++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         239 LGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CCCCCCCCHHHHHcCCCcCCC
Confidence            998      999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-48  Score=338.93  Aligned_cols=256  Identities=32%  Similarity=0.562  Sum_probs=223.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++++.||.|+||.||+|++..+++.||+|++.............+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999997655544445567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-------  171 (284)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....       
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999998631100       


Q ss_pred             ---------------------------------------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC
Q 023270          172 ---------------------------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG  212 (284)
Q Consensus       172 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg  212 (284)
                                                             ......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                   00123588999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHhhhcCcccccc
Q 023270          213 APPFEAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKN  275 (284)
Q Consensus       213 ~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~  275 (284)
                      ..||...+..+....+....  ...+....+++++.++|.+|+ .+|.+|+   +++++++||||+..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999888877766655432  223334468999999999976 5999999   99999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-49  Score=316.90  Aligned_cols=263  Identities=30%  Similarity=0.486  Sum_probs=225.9

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~   94 (284)
                      ++..|+.+.+|++|+||.||+|+++.+++.||+|+++.+. ......-.-.+|+.++.+.+|+||+.+-++....  +.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            4567999999999999999999999999999999986544 2222333456899999999999999999987654  479


Q ss_pred             EEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           95 FLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      |+|||||+. +|.+++.+.+ ++...++..++.|++.|++|||.+.|+|+||||+|+|++..|.+|++|||+++..+++ 
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999999985 9999998875 8999999999999999999999999999999999999999999999999999877766 


Q ss_pred             --CccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCCC--------
Q 023270          173 --RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--DLSFPSAP--------  239 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~--------  239 (284)
                        ......|.+|.|||++.+.. ++...|+||+|||+.+++++++.|.+.+..+.+.++.+.  ......++        
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence              34456789999999998776 899999999999999999999999999888888777663  11111111        


Q ss_pred             --------------------CCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCCC
Q 023270          240 --------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  281 (284)
Q Consensus       240 --------------------~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (284)
                                          .++....+|++.+|..||.+|.|+++.|.|+||.+.+.|.++
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P  373 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP  373 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence                                145888999999999999999999999999999998776543

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-48  Score=325.99  Aligned_cols=253  Identities=29%  Similarity=0.473  Sum_probs=211.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|+||+||++.+..+++.|++|++...... ....+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999998654322 233456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC----Cc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----RH  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~----~~  174 (284)
                      ||++++++..+......++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......    ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            99998766655555567899999999999999999999999999999999999999999999999998543221    12


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------CC
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-------------------SF  235 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------------~~  235 (284)
                      ...+++.|+|||++.+..++.++|+||||+++++|++|.+||...+..+....+.....                   ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            34578899999999988899999999999999999999999988765544333222100                   00


Q ss_pred             CC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 PS-----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 ~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +.           ...+++++.+|+.+||.+||++|||++++|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00           11367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-48  Score=333.56  Aligned_cols=256  Identities=33%  Similarity=0.600  Sum_probs=224.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|.+.+.||+|+||+||++.+..+++.||+|++...........+.+.+|+.+++.++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998766544455677889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----  173 (284)
                      ||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999886 679999999999999999999999999999999999999999999999999985433221    


Q ss_pred             ccccCCCcccCccccC------CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCHHH
Q 023270          174 HTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPSAPSISAEA  245 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  245 (284)
                      ....+++.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+....  ..++..+.+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            2235789999999986      4557889999999999999999999999888887777766543  2334445689999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      .+|+..||. +|.+|||+++++.||||++.
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            999999997 99999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=311.99  Aligned_cols=256  Identities=33%  Similarity=0.616  Sum_probs=232.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++-..||+|.|+.|+++.+..+|+.+++|.+....+... .-+.+.+|+++-+.++||||+++.+.+.+.+..|+|+
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            469999999999999999999999999999999877666554 3468899999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeecccccccC--CCC
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWSVQSR--SKR  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~--~~~  173 (284)
                      |+++|+.|-.-|-..--.++..+-..++||+++|.|+|.+||+|+|++|.|+++-.   ...+||+|||++...+  ...
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~  169 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW  169 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence            99999999777766566789999999999999999999999999999999999943   4579999999985544  344


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHH
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLISR  251 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  251 (284)
                      ....|+|.|+|||++...+++..+|||+-|+++|-|+.|.+||.+.+...++++++++...++.  ++.++++.++|+++
T Consensus       170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvrr  249 (355)
T KOG0033|consen  170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRR  249 (355)
T ss_pred             ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHH
Confidence            5677999999999999999999999999999999999999999999999999999999777766  67899999999999


Q ss_pred             hcccCCCCCCCHHhhhcCcccccc
Q 023270          252 LLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||..||.+|.|+.+.|+|||+.+-
T Consensus       250 ML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  250 MLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HhccChhhhccHHHHhCCchhcch
Confidence            999999999999999999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=329.85  Aligned_cols=264  Identities=34%  Similarity=0.655  Sum_probs=231.6

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH-----------HHHHHHHHHHHHHHhCCCC
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-----------KIQHQLRREMEIQSSLRHP   79 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~h~   79 (284)
                      .......+++|.+.+.||+|.||.|.+|.+..+++.||||++.+......           ...+..++|+.++++++|+
T Consensus        89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            34455678999999999999999999999999999999999876544221           1135889999999999999


Q ss_pred             cccceeeEEecC--CeEEEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC
Q 023270           80 NILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (284)
Q Consensus        80 ~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~  156 (284)
                      |||+++++..+.  +.+|+|+|||+.|.+.+ ....+. ++..+++.++++++.||.|||.+||+||||||+|+|++.+|
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            999999998765  58999999999888764 333344 89999999999999999999999999999999999999999


Q ss_pred             CEEEeecccccccC--------CCCccccCCCcccCccccCCCC----CCchhhHhhHHHHHHHHHhCCCCCCCCChHHH
Q 023270          157 RLKIGDFGWSVQSR--------SKRHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (284)
Q Consensus       157 ~~~l~d~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~  224 (284)
                      +|||+|||.+....        .......|||.|+|||...++.    .+.+.||||+|++||.|+.|..||.+....++
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            99999999875331        1113467999999999987643    35789999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ..++....+.++..+.+..++++||.+||++||.+|.+..+|..|||..+.
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            999999999999988899999999999999999999999999999999877

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.1e-48  Score=324.78  Aligned_cols=254  Identities=28%  Similarity=0.493  Sum_probs=213.1

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      -++.+|++.+.||.|+||+||++.+..++..||+|++......  .....+.+|+++++.++|+||+++++++..++..+
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3578999999999999999999999999999999998643221  12345678999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---
Q 023270           96 LILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---  171 (284)
                      +|+||+++ +|.+++...+ .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99999985 8888887654 578999999999999999999999999999999999999999999999998754322   


Q ss_pred             CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 023270          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS----------------  234 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------------  234 (284)
                      ......+++.|+|||.+.+ ..++.++||||+|+++++|++|..||.+.+..+.+..+......                
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2223456889999998865 45899999999999999999999999887776655544331100                


Q ss_pred             ---C---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          235 ---F---------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       235 ---~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                         .         ...+.+++++.+|+++||.+||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence               0         0113567899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-48  Score=334.12  Aligned_cols=267  Identities=31%  Similarity=0.548  Sum_probs=228.4

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      .++.........+|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          32 VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             HHHHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34455667778899999999999999999999999999999999876544444445667889999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      +..++..++||||+++++|.+++... .++...+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++.
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         112 FQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            99999999999999999999988664 58999999999999999999999999999999999999999999999999985


Q ss_pred             ccCCC----CccccCCCcccCccccCCCC----CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCC
Q 023270          168 QSRSK----RHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL--SFPS  237 (284)
Q Consensus       168 ~~~~~----~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~  237 (284)
                      .....    .....|++.|+|||++.+..    ++.++|+||+|+++|+|++|..||...+......++.....  .++.
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  270 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE  270 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence            54322    13456899999999986543    77899999999999999999999999988888888776443  3333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCC--CCCHHhhhcCcccccc
Q 023270          238 APSISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  275 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  275 (284)
                      ...+++.+++++..||..++.+  |++++++++||||++.
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            3357999999999999855543  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.2e-48  Score=328.48  Aligned_cols=252  Identities=33%  Similarity=0.609  Sum_probs=219.2

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHH---HHhCCCCcccceeeEEecCCeEEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI---QSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~---~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      |++++.||+|++|.||++.+..+++.||+|++...........+.+..|.++   ++.++|+||+++++++..++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            7899999999999999999999999999999976554333344556566554   4567899999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~  174 (284)
                      |||+++++|...+.. +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   ....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999887754 568999999999999999999999999999999999999999999999999875322   2223


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+  ..+++++.+++++||.
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~L~  237 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--RFLSREAISIMRRLLR  237 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhh
Confidence            45688999999999998999999999999999999999999999988888888777654433  4689999999999999


Q ss_pred             cCCCCCC-----CHHhhhcCcccccc
Q 023270          255 KDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       255 ~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      .||.+||     +++++++||||++.
T Consensus       238 ~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         238 RNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999999     79999999999874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6e-48  Score=328.55  Aligned_cols=248  Identities=35%  Similarity=0.629  Sum_probs=219.2

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||.|+||.||+|.+..+++.||+|++...........+.+..|.+++..+ +|++|+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999765544444455666788888765 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223345789


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||++.+..++.++||||||+++++|++|..||...+..+....+.......+  ..+++++.+++.+||..||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~ll~~~L~~dp~~R  238 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP--VWLSKEAVSILKAFMTKNPNKR  238 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhccCHHHc
Confidence            99999999988999999999999999999999999999999888888887654443  3689999999999999999999


Q ss_pred             C-------CHHhhhcCccccc
Q 023270          261 L-------SLQKIMEHPWIIK  274 (284)
Q Consensus       261 p-------s~~~il~~~~~~~  274 (284)
                      |       +++++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         239 LGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CCCCCCCCCHHHHhcCCccCC
Confidence            9       9999999999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.5e-48  Score=327.60  Aligned_cols=254  Identities=33%  Similarity=0.583  Sum_probs=223.3

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +|.+.+.||+|+||.||++.+..++..||+|++................+..++..+ +|++++++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            689999999999999999999999999999999765543333445566677777766 5799999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~  175 (284)
                      ||+++++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999875432   22234


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..|++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+......++  ..++.++.+++.+||..
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~l~~  238 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAICKGLMTK  238 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CcCCHHHHHHHHHHccc
Confidence            5688999999999999999999999999999999999999999998888888877655444  36899999999999999


Q ss_pred             CCCCCCCH-----HhhhcCcccccc
Q 023270          256 DSSKRLSL-----QKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rps~-----~~il~~~~~~~~  275 (284)
                      +|.+|+++     .++++||||+..
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         239 HPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             CHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            99999985     899999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4e-48  Score=330.20  Aligned_cols=249  Identities=38%  Similarity=0.642  Sum_probs=220.2

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      +.||.|+||.||++.+..++..||+|++.............+..|++++..++|+||+++.+.+..++..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997765444444566778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      +|..++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888889999999999999999999997 799999999999999999999999999875322   2223345899


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||++.+..++.++||||||+++++|++|..||...+.......+.......+  ..+++++.+++++||..||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R  238 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLSPEAKSLLSGLLKKDPKQR  238 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhhcCHHHh
Confidence            99999999998999999999999999999999999998888777777666544443  4689999999999999999999


Q ss_pred             C-----CHHhhhcCcccccc
Q 023270          261 L-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       261 p-----s~~~il~~~~~~~~  275 (284)
                      +     ++.++++||||.+.
T Consensus       239 ~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         239 LGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCCCCHHHHhcCCCcCCC
Confidence            7     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.4e-48  Score=333.35  Aligned_cols=256  Identities=34%  Similarity=0.602  Sum_probs=224.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||+|+||+||+|.+..+++.||+|++.............++.|+.++..++|++++++++.+..++.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997665545555678888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~------  172 (284)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999986422110      


Q ss_pred             --------------------------------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC
Q 023270          173 --------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES  220 (284)
Q Consensus       173 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~  220 (284)
                                                      .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                            112358899999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHhhhcCcccccc
Q 023270          221 QKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKN  275 (284)
Q Consensus       221 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~  275 (284)
                      .......+....  ..++....++++++++|.+|+ .+|.+|+   +++++++||||++.
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            888877776532  233333357899999999987 4999998   58999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-47  Score=325.65  Aligned_cols=249  Identities=34%  Similarity=0.611  Sum_probs=219.6

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||.|+||+||++.+..+++.||+|++.............+..|..++..+ +|+||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999776544444456667788888777 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875421   2223345789


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||.+.+..++.++|+||||+++++|++|..||...+.......+.......  +..+++++.+++++||..||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~dP~~R  238 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY--PRWLSKEAKSILKSFLTKNPEKR  238 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--CCcCCHHHHHHHHHHccCCHHHc
Confidence            9999999999999999999999999999999999999888888877776655443  33689999999999999999999


Q ss_pred             CCH-----HhhhcCcccccc
Q 023270          261 LSL-----QKIMEHPWIIKN  275 (284)
Q Consensus       261 ps~-----~~il~~~~~~~~  275 (284)
                      ||+     .++++||||++.
T Consensus       239 ~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         239 LGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCCCHHHHhcCCCcCCC
Confidence            999     999999999874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-47  Score=325.01  Aligned_cols=249  Identities=30%  Similarity=0.575  Sum_probs=215.8

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh-CCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||.|+||.||++.+..+++.||+|++................|..++.. .+|++++++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999976543322334455667777664 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~~~~~~  180 (284)
                      ++|..++.....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...   ........|++
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            999999988888999999999999999999999999999999999999999999999999987532   22233456899


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||++.+..++.++||||||+++++|++|..||...+..+....+.......+  ..++.++++++++||..||++|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~R  238 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP--RWITKESKDILEKLFERDPTRR  238 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHccCCHHHc
Confidence            99999999999999999999999999999999999998888887777766544333  3689999999999999999999


Q ss_pred             CCH-HhhhcCcccccc
Q 023270          261 LSL-QKIMEHPWIIKN  275 (284)
Q Consensus       261 ps~-~~il~~~~~~~~  275 (284)
                      |++ +++++||||.+.
T Consensus       239 ~~~~~~~~~h~~f~~~  254 (316)
T cd05620         239 LGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CCChHHHHcCCCcCCC
Confidence            998 589999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=314.56  Aligned_cols=260  Identities=28%  Similarity=0.473  Sum_probs=219.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-----C
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-----D   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-----~   91 (284)
                      ....|...+.||.|++|.|..|.+..+|+.||||++.... ......+...+|+++++.++|+||+.+.+++..     -
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3445666899999999999999999999999999996433 333445667789999999999999999999865     3


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-  170 (284)
                      +.+|+|+|+++ .+|...+++++.|+.+.+..++.|++.||+|+|+.+++|+|+||+|++++.++.+|++|||+++... 
T Consensus        99 ~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen   99 NDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             ceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence            46899999995 5999999998889999999999999999999999999999999999999999999999999996663 


Q ss_pred             ----CCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 023270          171 ----SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--------  237 (284)
Q Consensus       171 ----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  237 (284)
                          .-...+.-|-+|.|||++.+ ..++.+.||||+|||+.||++|++.|.+.+..+.+..++.....++.        
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence                22245667889999998754 45999999999999999999999999987766655555443222211        


Q ss_pred             ---------------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          238 ---------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       238 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                           -+..++...+|+.+||..||.+|+|++|+|+|||+..-.+|
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                                 13578899999999999999999999999999999876544

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-47  Score=324.23  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=209.6

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      +..+|++.+.||.|+||+||+|.+..+++.||+|++.......  ....+.+|+.+++.++|+||+++++++..++..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            4578999999999999999999999999999999986433211  12356689999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---C
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---K  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~  172 (284)
                      ||||++ ++|.+++... +.++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....   .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999996 5777777654 5689999999999999999999999999999999999999999999999998754322   2


Q ss_pred             CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCC---------------
Q 023270          173 RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSF---------------  235 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~---------------  235 (284)
                      .....+++.|+|||++.+ ..++.++||||+|+++++|++|..||.+.... +.+..+.......               
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            233457889999999865 45788999999999999999999999875432 2222221100000               


Q ss_pred             ------C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          236 ------P---------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       236 ------~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                            .         .....++++.+|+++||+.||++|||++++++||||++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                  0         00124578899999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.1e-47  Score=318.45  Aligned_cols=256  Identities=43%  Similarity=0.731  Sum_probs=230.3

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|++|.||++.+..+++.+++|++.............+.+|+++++.++|+||+++++++.+++..++|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999987655544455677889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccC
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG  178 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  178 (284)
                      ||+++++|.+++...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...........+
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  160 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG  160 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence            99999999999998889999999999999999999999999999999999999999999999999998666555555568


Q ss_pred             CCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 023270          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       179 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (284)
                      ++.|+|||.+.+...+.++|+||||+++++|++|..||...+..........+....  +..++..+.+++.+||..||.
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~  238 (290)
T cd05580         161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF--PSFFSPDAKDLIRNLLQVDLT  238 (290)
T ss_pred             CccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC--CccCCHHHHHHHHHHccCCHH
Confidence            899999999988888999999999999999999999998888777777766554433  346799999999999999999


Q ss_pred             CCC-----CHHhhhcCccccccC
Q 023270          259 KRL-----SLQKIMEHPWIIKNA  276 (284)
Q Consensus       259 ~Rp-----s~~~il~~~~~~~~~  276 (284)
                      +|+     +++++++||||+..+
T Consensus       239 ~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         239 KRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HccCcccCCHHHHHcCcccccCC
Confidence            999     999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.9e-47  Score=329.99  Aligned_cols=265  Identities=32%  Similarity=0.551  Sum_probs=227.5

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ........++|++.+.||.|+||.||++.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            45567788999999999999999999999999999999999876544444445667889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ++..++||||+++++|.+++... .++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            99999999999999999988764 58899999999999999999999999999999999999999999999999985443


Q ss_pred             CC----CccccCCCcccCccccCCCC----CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCCCC
Q 023270          171 SK----RHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPSAPS  240 (284)
Q Consensus       171 ~~----~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  240 (284)
                      ..    .....|++.|+|||++.+..    ++.++||||||+++|+|++|..||...+.......+....  ..++....
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence            21    22446899999999986543    7889999999999999999999999998888888777643  33444457


Q ss_pred             CCHHHHHHHHHhcccCCCC--CCCHHhhhcCccccccC
Q 023270          241 ISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~~  276 (284)
                      ++.+++++|..||..++.+  |++++++++||||++.+
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            8999999999999844433  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-47  Score=324.83  Aligned_cols=250  Identities=38%  Similarity=0.688  Sum_probs=219.0

Q ss_pred             eeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHH-HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           24 GRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      ++.||.|+||.||++.+.   .+++.||+|++...... .......+..|+.+++.++|+||+++++.+..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   46788999998765432 22334567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccc
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTM  176 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~  176 (284)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   ......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999875322   222334


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD  256 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (284)
                      .|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..+....  ++.+++++.+++.+||..+
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL--PPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHcccC
Confidence            68899999999998889999999999999999999999999998888888887765433  4478999999999999999


Q ss_pred             CCCCC-----CHHhhhcCcccccc
Q 023270          257 SSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       257 p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      |++||     +++++++||||+..
T Consensus       239 p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         239 PSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999     89999999999763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.2e-47  Score=326.10  Aligned_cols=249  Identities=30%  Similarity=0.602  Sum_probs=214.2

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||.|+||.||++.+..+++.||+|++...........+.+..|..++..+ +|+||+++++++..++.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999999876555555566788899998888 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~~~~~~  180 (284)
                      ++|..++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...   ........|++
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999987532   22233456899


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE---------SQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      .|+|||++.+..++.++|+||||+++|+|++|..||...         ........+......  .+..++.++.+++++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~  238 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKASSVLKG  238 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence            999999999999999999999999999999999999632         112233344444333  334689999999999


Q ss_pred             hcccCCCCCCC------HHhhhcCcccccc
Q 023270          252 LLVKDSSKRLS------LQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps------~~~il~~~~~~~~  275 (284)
                      ||..||.+|++      ++++++||||.+.
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         239 FLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999997      7899999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=326.70  Aligned_cols=257  Identities=39%  Similarity=0.696  Sum_probs=235.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~   96 (284)
                      -..|.+.+.||.|.||.||.++...+|+.+|+|++.+...........+.+|+++|+++. |||++.+.+.++....+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            346999999999999999999999999999999998877655445678999999999998 9999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC----CCEEEeecccccccCC-
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWSVQSRS-  171 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~----~~~~l~d~~~~~~~~~-  171 (284)
                      |||+|.||.|.+.+... .+++.++..++.|++.++.|||+.|++|+|++|+|+|+...    +.++++|||++..... 
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            99999999999999876 49999999999999999999999999999999999999654    4799999999966654 


Q ss_pred             -CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHH
Q 023270          172 -KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHL  248 (284)
Q Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l  248 (284)
                       ......|++.|+|||++....++...|+||+|+++|.|++|.+||.+.+......++..+...+..  ++.++..++++
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~  272 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF  272 (382)
T ss_pred             ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence             456678999999999999999999999999999999999999999999999999999998765544  56899999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |+.||..||.+|+|+.++|+|||++..
T Consensus       273 i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  273 IRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHhcccCcccCCCHHHHhcCccccCC
Confidence            999999999999999999999999975

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.8e-47  Score=323.61  Aligned_cols=249  Identities=33%  Similarity=0.584  Sum_probs=214.7

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh-CCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||+|+||.||+|.+..+++.||+|++...........+....+..++.. .+|+||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999976544333334444555666554 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|..++.....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999985432   2223446899


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||.+.+..++.++||||||+++++|++|..||.+.+..+....+......  .+..++.++.+++++||..+|.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ll~~~l~~~P~~R  238 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH--FPRWISKEAKDCLSKLFERDPTKR  238 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHccCCHHHc
Confidence            999999999888999999999999999999999999998888888777655433  334689999999999999999999


Q ss_pred             CCH-HhhhcCcccccc
Q 023270          261 LSL-QKIMEHPWIIKN  275 (284)
Q Consensus       261 ps~-~~il~~~~~~~~  275 (284)
                      |++ +++++||||...
T Consensus       239 ~~~~~~l~~h~~~~~~  254 (316)
T cd05592         239 LGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CCChHHHHcCcccCCC
Confidence            986 589999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-47  Score=325.50  Aligned_cols=249  Identities=36%  Similarity=0.660  Sum_probs=216.1

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHH-HHHhCCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~-~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||+|+||+||++.+..+++.|++|++.............+..+.. +++.++|+||+++++.+..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999997655433333344444444 56789999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|..++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223345889


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||++.+..++.++||||||+++++|++|..||...+..+....+.......  .+.+++++.++|.+||..||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R  238 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL--KPNISVSARHLLEGLLQKDRTKR  238 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHHhC
Confidence            9999999999999999999999999999999999999988888888777664433  34689999999999999999999


Q ss_pred             CCH----HhhhcCcccccc
Q 023270          261 LSL----QKIMEHPWIIKN  275 (284)
Q Consensus       261 ps~----~~il~~~~~~~~  275 (284)
                      |++    .++++||||...
T Consensus       239 ~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         239 LGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             CCCCCCHHHHHcCCCcCCC
Confidence            988    699999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.3e-47  Score=322.04  Aligned_cols=254  Identities=33%  Similarity=0.592  Sum_probs=222.8

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +|.+.+.||.|+||+||+|.+..+++.||+|++...........+.+..|..++..+. |++++++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5889999999999999999999999999999997655444344556677888888776 577888999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~  175 (284)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            999999999999888889999999999999999999999999999999999999999999999999875422   12233


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..|++.|+|||++.+..++.++|+||+|+++++|++|..||...+.......+.......+  ..++.++.+++.+||..
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~l~~  238 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP--KSLSKEAVSICKGLMTK  238 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHHHHHHHHHccc
Confidence            4588999999999988899999999999999999999999999988888888877655443  36899999999999999


Q ss_pred             CCCCCCC-----HHhhhcCcccccc
Q 023270          256 DSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      +|.+|++     .+++++||||+..
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         239 HPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             CHhhCCCCCCCCHHHHhcCcccCCC
Confidence            9999997     4789999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-48  Score=318.35  Aligned_cols=254  Identities=36%  Similarity=0.671  Sum_probs=236.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|.+.+.||.|.||.|-+|.....|..||||.+.+..+...+..-.+++|+++|+.++||||+.++++|++.+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            47999999999999999999999999999999999988888888889999999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHTM  176 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~~~  176 (284)
                      ||..+|.|.+++...+.|++.+++.+++||+.|+.|+|+++++|+|||.+|||++.++++||.|||++.....  -....
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF  212 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF  212 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence            9999999999999999999999999999999999999999999999999999999999999999999844433  33567


Q ss_pred             cCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      +|+|-|.+||+.++.+| .+..|-||||+++|-|..|.+||.+.+...+.+++..+.+..+.   .|.+..-||+.||-.
T Consensus       213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmV  289 (668)
T KOG0611|consen  213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMV  289 (668)
T ss_pred             cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhc
Confidence            89999999999999987 58999999999999999999999999999999999998765554   567889999999999


Q ss_pred             CCCCCCCHHhhhcCcccccc
Q 023270          256 DSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||++|.|+++|-.|=|+-=.
T Consensus       290 NP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  290 NPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             CcccchhHHHHhhhheeecc
Confidence            99999999999999887533

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.1e-47  Score=324.29  Aligned_cols=249  Identities=31%  Similarity=0.610  Sum_probs=212.4

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||+|+||.||++.+..+++.||+|++...........+.+..|+.++..+ +|+||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999776544444556777888887766 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|...+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223456889


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE---------SQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      .|+|||++.+..++.++|+||||+++++|++|..||...         ........+......  .+..++.++.+++++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~  238 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKS  238 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--CCCCCCHHHHHHHHH
Confidence            999999999999999999999999999999999999521         122233334443333  334789999999999


Q ss_pred             hcccCCCCCCC------HHhhhcCcccccc
Q 023270          252 LLVKDSSKRLS------LQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps------~~~il~~~~~~~~  275 (284)
                      ||..||++||+      ++++++||||++.
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         239 FLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999998      5799999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9e-47  Score=322.74  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=218.2

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      +..++|++.++||.|+||.||++.+..++..+++|.+.....  ......+.+|+++++.++|+||+++++++..++..+
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            556899999999999999999999999999999998755321  123457889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecccccccCC-CC
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KR  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~~  173 (284)
                      +||||+++++|.+++...+.++...+..++.+++.|+.|||.. +++|+||+|+||+++.++.++|+|||++..... ..
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  159 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence            9999999999999999888899999999999999999999975 799999999999999999999999998754322 22


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------------
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRI-------------------------  228 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~-------------------------  228 (284)
                      ....++..|+|||++.+..++.++|+||||++++++++|..||............                         
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            3346788999999999888999999999999999999999999765543332111                         


Q ss_pred             -------------------HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          229 -------------------MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       229 -------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                         ............++.++.+|+.+||..||.+|||+++++.||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                               111111111124678999999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.4e-47  Score=320.99  Aligned_cols=249  Identities=31%  Similarity=0.591  Sum_probs=215.3

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh-CCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||+|+||+||++.+..+++.||+|++................|..++.. .+||||+++++++..++.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999876543322333455566667765 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~~~~~~  180 (284)
                      ++|...+.....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...   ........|++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            999999988888999999999999999999999999999999999999999999999999987542   12223445889


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+.......  +..++.++.+++.+||..||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R  238 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY--PRWLTREAKDILVKLFVREPERR  238 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CccCCHHHHHHHHHHhccCHhhc
Confidence            9999999998889999999999999999999999999988888777766554332  33688999999999999999999


Q ss_pred             CCHH-hhhcCcccccc
Q 023270          261 LSLQ-KIMEHPWIIKN  275 (284)
Q Consensus       261 ps~~-~il~~~~~~~~  275 (284)
                      |++. ++++||||++.
T Consensus       239 ~~~~~~l~~h~~~~~~  254 (316)
T cd05619         239 LGVKGDIRQHPFFREI  254 (316)
T ss_pred             CCChHHHHcCcccCCC
Confidence            9996 99999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-46  Score=310.70  Aligned_cols=254  Identities=28%  Similarity=0.513  Sum_probs=222.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH--HHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .+|++.+.||.|++|.||++.+..++..|++|.+.....  ......+.+.+|+.++++++|+||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            469999999999999999999999999999999864332  222335678899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---  173 (284)
                      ++|++++++|.+++...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999874332211   


Q ss_pred             ---ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       174 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                         ....++..|+|||.+.+...+.++||||||++++++++|+.||...+.................+..++.++.++++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR  241 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence               22346778999999999889999999999999999999999998877776666655554455555678999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccc
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +||..+|.+|||+.++++||||
T Consensus       242 ~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         242 RTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-47  Score=325.04  Aligned_cols=256  Identities=26%  Similarity=0.436  Sum_probs=209.3

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----CeE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----ERI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----~~~   94 (284)
                      +|++.+.||.|+||.||++.+..++..|++|.+....... .....+.+|+.+++.++|+||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            6999999999999999999999999999999986432221 2234677899999999999999999987543     358


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      |+||||++ ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999996 689999988888999999999999999999999999999999999999999999999999998543211  


Q ss_pred             ----CccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------------
Q 023270          173 ----RHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV---------------  231 (284)
Q Consensus       173 ----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---------------  231 (284)
                          .....+++.|+|||++.+  ..++.++||||||+++++|++|..||...+.......+...               
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                123457899999999865  56899999999999999999999999876543322211110               


Q ss_pred             -----------CCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          232 -----------DLSFP---SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       232 -----------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                 ....+   ..+.+++++.+++.+||..||++|||++++++||||++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                       00000   01246788999999999999999999999999999977543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.4e-47  Score=322.71  Aligned_cols=254  Identities=38%  Similarity=0.651  Sum_probs=214.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHH-HHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~   94 (284)
                      +|++.+.||+|+||+||++.+.   .++..||+|++...... .....+.+..|+.++..+ +|++|+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998864   46889999998654432 223445677899999999 489999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---  171 (284)
                      ++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++.....   
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            99999999999999998888899999999999999999999999999999999999999999999999998754321   


Q ss_pred             -CCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          172 -KRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       172 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                       ......|++.|+|||.+.+.. ++.++||||||+++++|++|..||...    ........+....  ...+..+++.+
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  238 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGPEA  238 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHH
Confidence             222346899999999987654 788999999999999999999999643    2333444444333  33344789999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHhhhcCcccccc
Q 023270          246 KHLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      .+++.+||..||++||     +++++++||||++.
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999999     88899999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-46  Score=320.07  Aligned_cols=257  Identities=33%  Similarity=0.552  Sum_probs=218.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|+||+||++.+..+++.||+|++...........+.+.+|..++..++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997655444445567888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----
Q 023270           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----  173 (284)
                      ||+++++|.+++.+ ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999976 4578999999999999999999999999999999999999999999999999874432211    


Q ss_pred             ccccCCCcccCccccCC-----CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CCCCCHHH
Q 023270          174 HTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---APSISAEA  245 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  245 (284)
                      ....|++.|+|||++..     ..++.++||||+|+++|+|++|..||...+..+....+.........   ...+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            22358999999999863     44788999999999999999999999988887777776654322222   23579999


Q ss_pred             HHHHHHhcccCCC--CCCCHHhhhcCcccccc
Q 023270          246 KHLISRLLVKDSS--KRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       246 ~~li~~~l~~~p~--~Rps~~~il~~~~~~~~  275 (284)
                      ++++++||..+++  .|++++++++||||...
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            9999999865443  37899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-46  Score=314.34  Aligned_cols=247  Identities=30%  Similarity=0.467  Sum_probs=209.8

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||+|+||+||++.+..+++.|++|.+...........+.+..|+.+++.++|++++++.+++..++..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999998765554444456677899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---CccccCC
Q 023270          107 YRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGT  179 (284)
Q Consensus       107 ~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~  179 (284)
                      ...+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......   .....++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            887743    356899999999999999999999999999999999999999999999999987543221   2234678


Q ss_pred             CcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||.......    ........  ....++.+++++.+++.+||+.
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~  238 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLAK  238 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhcC
Confidence            89999999999999999999999999999999999997654322    22222222  2223346899999999999999


Q ss_pred             CCCCCC-----CHHhhhcCcccccc
Q 023270          256 DSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      ||++||     +++++++||||+..
T Consensus       239 ~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         239 DPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             CHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-46  Score=314.42  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=217.7

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|++.+.||.|+||+||++.+..+++.||+|++.............+.+|+.+++.++|++|+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999999999999999866544443344566789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCcc
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~~  175 (284)
                      |+++++|.+.+...  ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999888654  4689999999999999999999999999999999999999999999999998854322  2223


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ..+++.|+|||.+.+..++.++|+||+|+++|++++|..||.+..............  .....+..++..+.+|+.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            467899999999998889999999999999999999999998776544333332211  122233468999999999999


Q ss_pred             ccCCCCCC-----CHHhhhcCcccccc
Q 023270          254 VKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       254 ~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      ..||.+||     +++++++||||.+.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            99999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-46  Score=325.73  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=210.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ..+...+|++.+.||.|+||.||+|.+..+++.||+|....         ..+.+|+++++.++||||+++++++..++.
T Consensus        87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            34566789999999999999999999999999999997522         345689999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---  170 (284)
                      .++|+|++. ++|..++.....++...++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....   
T Consensus       158 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        158 TCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             eEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            999999996 6898888887889999999999999999999999999999999999999999999999999985322   


Q ss_pred             -CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHh------------
Q 023270          171 -SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-------QKDTFRRIMK------------  230 (284)
Q Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~-------~~~~~~~~~~------------  230 (284)
                       .......|++.|+|||++.+..++.++||||||+++|+|++|..||-...       ....+..+..            
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence             22233468999999999998899999999999999999999997764321       1111111110            


Q ss_pred             --------------cCCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          231 --------------VDLSFP-------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       231 --------------~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                    .....+       ....++.++.+||.+||..||++|||++++|+||||++.+.|
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                          000000       001356789999999999999999999999999999997665

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-47  Score=313.63  Aligned_cols=251  Identities=37%  Similarity=0.676  Sum_probs=214.8

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |++++.||+|+||+||++.+..+++.||+|++......... .....+|+..+++++|+||+++++++...+..+++||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999877655543 23345599999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc---cCCCCcccc
Q 023270          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMC  177 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~---~~~~~~~~~  177 (284)
                      +++++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..   .........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99889999999888899999999999999999999999999999999999999999999999999864   233344556


Q ss_pred             CCCcccCccccC-CCCCCchhhHhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHH
Q 023270          178 GTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAES---QKDTFRRIMKVDLSFPS--APSISAEAKHLISR  251 (284)
Q Consensus       178 ~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  251 (284)
                      +++.|.|||.+. +...+.++|+||+|+++++|++|..||....   ......+..........  ....+.++.+++.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            788999999998 7889999999999999999999999999873   33333333322111111  11234899999999


Q ss_pred             hcccCCCCCCCHHhhhcCccc
Q 023270          252 LLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ||+.||++|||+.++++||||
T Consensus       240 ~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGSTTHHHHHTSGGG
T ss_pred             HccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=331.28  Aligned_cols=259  Identities=34%  Similarity=0.609  Sum_probs=237.7

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~   92 (284)
                      ..+.+.+|.+++.||.|.||+|+++..+.+++.||||++++..+-.....+..+.|-+++.... ||.++.++..|...+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            5788999999999999999999999999999999999999988877777788888888887775 999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc---c
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---S  169 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~---~  169 (284)
                      ++|+||||..||++.. +...+.+++..+.-++..++.||.|||++||+++|||.+|||+|.+|++||.|||++..   .
T Consensus       443 ~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            9999999999999443 44447799999999999999999999999999999999999999999999999999854   3


Q ss_pred             CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                      ++.+...+|||.|+|||++.+..|+.+.|.||||++||+|+.|..||.+.+.+++-..++.....++.  .+|.+..+++
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~--~ls~ea~~il  599 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSKEAIAIM  599 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--cccHHHHHHH
Confidence            45667788999999999999999999999999999999999999999999999999999988776666  6999999999


Q ss_pred             HHhcccCCCCCCC-----HHhhhcCcccccc
Q 023270          250 SRLLVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       250 ~~~l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      +++|..+|++|.-     +++|..||||+.-
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            9999999999994     6899999999863

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-46  Score=317.23  Aligned_cols=259  Identities=39%  Similarity=0.672  Sum_probs=227.7

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||+|++|+||+|.+..+++.|++|.+...........+.+..|++.++.++|+||+++++.+..++..++++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999997765554445677889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC----
Q 023270           99 EYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~----  172 (284)
                      ||+.+++|.+++...  ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......    
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764  46899999999999999999999999999999999999999999999999986432111    


Q ss_pred             ----------------------------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHH
Q 023270          173 ----------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (284)
Q Consensus       173 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~  224 (284)
                                                  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                        1123467789999999988899999999999999999999999998888877


Q ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHhhhcCccccccCC
Q 023270          225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS----LQKIMEHPWIIKNAN  277 (284)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~~~~~  277 (284)
                      ...........+....++.++.+++.+||..+|++|||    +++++.||||++.+-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~  297 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW  297 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence            77777665555555558999999999999999999999    999999999998643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-47  Score=322.64  Aligned_cols=249  Identities=35%  Similarity=0.658  Sum_probs=217.6

Q ss_pred             eeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           24 GRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      ++.||+|+||.||++.+.   .+++.|++|++........ ....+..|++++++++|+||+++++++..++..|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            367999999999998864   5788999999976544332 234567789999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Ccccc
Q 023270          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMC  177 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~  177 (284)
                      +++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   .....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            999999999988888999999999999999999999999999999999999999999999999987543322   23346


Q ss_pred             CCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCC
Q 023270          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS  257 (284)
Q Consensus       178 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  257 (284)
                      |++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......  +..+++++.+++++||+.||
T Consensus       160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~li~~~l~~~P  237 (318)
T cd05582         160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM--PQFLSPEAQSLLRALFKRNP  237 (318)
T ss_pred             CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCH
Confidence            7899999999998889999999999999999999999999988888888777665443  34689999999999999999


Q ss_pred             CCCCC-----HHhhhcCcccccc
Q 023270          258 SKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       258 ~~Rps-----~~~il~~~~~~~~  275 (284)
                      ++||+     +++++.||||++.
T Consensus       238 ~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         238 ANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             hHcCCCCCCCHHHHhCCCCcCCC
Confidence            99999     7779999999763

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=324.25  Aligned_cols=251  Identities=25%  Similarity=0.443  Sum_probs=221.8

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++....++.++.||+|-||.||.+... ....|++|.+.......    +.+.+|+++|++++|++|+++++++..+
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            345566667889999999999999999974 44589999987654443    4677999999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +.++|||||++.|+|.++|+.  ...++..+.+.++.||++|++||++++++|+||..+|||++.+..+||+|||+++..
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence            999999999999999999987  457999999999999999999999999999999999999999999999999999743


Q ss_pred             CCCCc----cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RSKRH----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      .....    ...-+..|+|||.+..+.++.+|||||||++|+|++| |+.|+.+.+..+.++.+.++ ...+.++.+|++
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-yRlp~P~~CP~~  432 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-YRLPRPEGCPDE  432 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-CcCCCCCCCCHH
Confidence            32221    1123567999999999999999999999999999998 99999999999999998887 477778899999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.+++..||..+|++|||++.+..
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999997654

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-46  Score=320.72  Aligned_cols=249  Identities=34%  Similarity=0.628  Sum_probs=215.3

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHH-HHHhCCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~-~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||.|+||+||++.+..+++.|++|++.............+..|.. +++.++|+||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999987654433333344444544 56779999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|...+.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223445889


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||.+.+..++.++||||||+++++|++|..||...+..+...........  ..+..+.++.+++++||..+|.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ll~~~p~~R  238 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV--LRPGASLTAWSILEELLEKDRQRR  238 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCcc--CCCCCCHHHHHHHHHHhccCHHhc
Confidence            999999999999999999999999999999999999998888888877765433  334689999999999999999999


Q ss_pred             CCH----HhhhcCcccccc
Q 023270          261 LSL----QKIMEHPWIIKN  275 (284)
Q Consensus       261 ps~----~~il~~~~~~~~  275 (284)
                      |++    +++++||||...
T Consensus       239 ~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         239 LGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             CCCCCCHHHHhcCCCcCCC
Confidence            977    599999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.4e-46  Score=318.72  Aligned_cols=248  Identities=34%  Similarity=0.609  Sum_probs=214.4

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHH-HHHHhCCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-EIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~-~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||.|+||.||+|.+..+++.|++|++.............+..|. .+++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999765544333334444554 467889999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|...+.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223345789


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......  .++..+.++.+++.+||..+|.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R  238 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGLLHKDQRRR  238 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHccCCHhhc
Confidence            999999999888999999999999999999999999998888777777765433  334688999999999999999999


Q ss_pred             CCH----HhhhcCccccc
Q 023270          261 LSL----QKIMEHPWIIK  274 (284)
Q Consensus       261 ps~----~~il~~~~~~~  274 (284)
                      |++    .++++|+||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         239 LGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCCCCCHHHHhCCCCcCC
Confidence            976    49999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.8e-46  Score=324.45  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=214.1

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----eE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----RI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----~~   94 (284)
                      +|++.+.||.|+||.||++.+..+++.||+|.+....... ...+.+.+|+.+++.++|+||+++++++..++     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch-HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            5889999999999999999999999999999985432222 23456778999999999999999999998776     78


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      ++|+||+. ++|...+.....++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999997 588888888888999999999999999999999999999999999999999999999999988543221  


Q ss_pred             --CccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------------
Q 023270          173 --RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------  231 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------------------  231 (284)
                        .....+++.|+|||.+.+.. ++.++||||+|+++++|++|+.||...+.......+...                  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence              12234678899999987754 789999999999999999999999887766554443221                  


Q ss_pred             -----CCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          232 -----DLSF-------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       232 -----~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                           ....       ......++++.+||.+||..||++|||++++|+||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  297 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLR  297 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcch
Confidence                 0000       1123457899999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-48  Score=302.81  Aligned_cols=260  Identities=33%  Similarity=0.578  Sum_probs=232.7

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-----HHHHHHHHHHHHHHHHHhC-CCCcccceeeEE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSL-RHPNILRLYGWF   88 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~   88 (284)
                      ....+.|.-.++||.|..++|-++.+..+++.+++|++.....     ......+.-++|+.+++++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3456789999999999999999999999999999998753221     1344566777899999988 599999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      +.+...++|+|.|+.|.|.+++.+--.++++..+++++|+++++.|||..+|+|+|+||+|||++++-+++|+|||+++.
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence            99999999999999999999999988999999999999999999999999999999999999999999999999999966


Q ss_pred             cC--CCCccccCCCcccCccccC------CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 023270          169 SR--SKRHTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--  238 (284)
Q Consensus       169 ~~--~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  238 (284)
                      ..  ..-...+|||+|+|||.+.      ...++...|+|+.|++||-|+.|.+||...-..-.++-++.+...+.++  
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            54  3445678999999999884      3457889999999999999999999999998888999999998877664  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      .+++.+.++||++||+.||.+|.|++++|+||||++
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            589999999999999999999999999999999943

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.3e-46  Score=317.85  Aligned_cols=249  Identities=30%  Similarity=0.582  Sum_probs=213.6

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||+|+||.||++.+..+++.||+|++...........+.+.+|..++.++ +|++|+++++.+...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876555555567788898888888 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~~~~~~  180 (284)
                      ++|...+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...   ........|++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            999999988888999999999999999999999999999999999999999999999999987542   22223456899


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC------C-hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE------S-QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      .|+|||++.+..++.++|+||||+++++|++|..||...      . .......+.....  ..+..++..+.+++++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L  238 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFLSVKASHVLKGFL  238 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHh
Confidence            999999999999999999999999999999999999532      1 2223333333322  234468899999999999


Q ss_pred             ccCCCCCCC------HHhhhcCcccccc
Q 023270          254 VKDSSKRLS------LQKIMEHPWIIKN  275 (284)
Q Consensus       254 ~~~p~~Rps------~~~il~~~~~~~~  275 (284)
                      ..||++|++      ++++++||||+..
T Consensus       239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         239 NKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             ccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            999999998      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.7e-46  Score=320.28  Aligned_cols=257  Identities=23%  Similarity=0.399  Sum_probs=209.1

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC---
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE---   92 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~---   92 (284)
                      ...++|++.+.||.|+||.||++.+..++..||+|++....... .....+.+|+.+++.++|+||+++++++...+   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            35689999999999999999999999999999999986543222 23456678999999999999999999886443   


Q ss_pred             ---eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           93 ---RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        93 ---~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                         ..++||||+++ +|...+..  .++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               57999999975 66665543  4788999999999999999999999999999999999999999999999998543


Q ss_pred             CC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------------
Q 023270          170 RS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD---------------  232 (284)
Q Consensus       170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------------  232 (284)
                      ..  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+....+.......               
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            22  2233467889999999999999999999999999999999999998776544333222110               


Q ss_pred             -------CCCC------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          233 -------LSFP------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       233 -------~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                             ...+                  .....++++++||.+||..||++|||++++|+||||+.-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence                   0000                  0112467899999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.2e-46  Score=315.09  Aligned_cols=259  Identities=27%  Similarity=0.478  Sum_probs=214.7

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      -++.+|.+.+.||.|+||.||++.+..++..|++|.+.......  ....+.+|+.+++.++|+|++++++++..++..+
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            46788999999999999999999999999999999986443221  2235667999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      +||||+++ +|..++... ..++...+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......  
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99999975 787777654 45899999999999999999999999999999999999999999999999987543222  


Q ss_pred             -CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 023270          173 -RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS----------------  234 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------------  234 (284)
                       .....+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+......                
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence             223456888999998865 45889999999999999999999999887765554443321100                


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          235 ------------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       235 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                  ....+.+++++.++|.+||..||.+|||++++++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence                        0111357889999999999999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.1e-46  Score=317.77  Aligned_cols=248  Identities=35%  Similarity=0.659  Sum_probs=214.1

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHH-HHHHhCCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-EIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~-~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||+|+||+||+|.+..+++.|++|++.............+..+. .+++.++|+||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999765443333333444443 456788999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875322   2223446899


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      .|+|||++.+..++.++||||||+++++|++|..||...+..+.+..+......  ..+.+++.+.+++++||..+|.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R  238 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR  238 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC--CCCCCCHHHHHHHHHHcccCHHHC
Confidence            999999999999999999999999999999999999998888887777665433  334789999999999999999999


Q ss_pred             CCHH----hhhcCccccc
Q 023270          261 LSLQ----KIMEHPWIIK  274 (284)
Q Consensus       261 ps~~----~il~~~~~~~  274 (284)
                      |++.    ++++|+||..
T Consensus       239 ~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         239 LGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCCHHHHhcCcccCC
Confidence            9876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-46  Score=323.42  Aligned_cols=259  Identities=31%  Similarity=0.506  Sum_probs=213.2

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ....+.+|++.+.||.|+||.||++.+..+++.|++|++....  .......+.+|+++++.++|+||+++++++..++.
T Consensus        69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  146 (353)
T PLN00034         69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE  146 (353)
T ss_pred             CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence            4456788999999999999999999999999999999985433  22334678899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--  171 (284)
                      +++|+||+++++|...    ...++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....  
T Consensus       147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999999999888643    2346788889999999999999999999999999999999999999999998754322  


Q ss_pred             -CCccccCCCcccCccccCC-----CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCCCCCCC
Q 023270          172 -KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---TFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       172 -~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (284)
                       ......|+..|+|||.+..     ...+.++||||||+++|+|++|+.||......+   ....... .........++
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  301 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-SQPPEAPATAS  301 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-cCCCCCCCccC
Confidence             2234568899999998743     223568999999999999999999997443322   2222221 22233344788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      .++.+||.+||..||++|||++++++||||.+.+.+.
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~  338 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ  338 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCCccc
Confidence            9999999999999999999999999999999986654

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=321.14  Aligned_cols=248  Identities=35%  Similarity=0.609  Sum_probs=212.7

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC---CCCcccceeeEEecCCeEEEEEeecCC
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l---~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      ||+|+||+||+|.+..+++.||+|++................+..++...   +|++|+++++.+..++..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999998765443333333444555555544   699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCccccCCC
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~  180 (284)
                      ++|...+...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875322   2223456899


Q ss_pred             cccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 023270          181 DYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSK  259 (284)
Q Consensus       181 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  259 (284)
                      .|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+..+....+. ..+++++.+++++||..||.+
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~  239 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-NVLSDEGRQFVKGLLNRNPQH  239 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCCCHHH
Confidence            99999998765 4789999999999999999999999998888888877766554443 357899999999999999999


Q ss_pred             CC----CHHhhhcCcccccc
Q 023270          260 RL----SLQKIMEHPWIIKN  275 (284)
Q Consensus       260 Rp----s~~~il~~~~~~~~  275 (284)
                      ||    +++++++||||.+.
T Consensus       240 R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         240 RLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCCCCCHHHHhcCccccCC
Confidence            98    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-47  Score=321.42  Aligned_cols=255  Identities=28%  Similarity=0.519  Sum_probs=234.8

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe-EE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER-IF   95 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~-~~   95 (284)
                      .+.+|.+++.+|.|+||.+++++++.+++.|++|.+......... .+...+|+.++++++||||+.+.+.|.+++. .+
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            367899999999999999999999999999999999776655544 3477899999999999999999999999887 99


Q ss_pred             EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC
Q 023270           96 LILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  173 (284)
                      |||+||+||++...+.+.+  .++++.+..++.|++.|+.|||++.|+|+||++.||+++.++.|+|+|||++....+..
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999998764  68999999999999999999999999999999999999999999999999997665543


Q ss_pred             ---ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       174 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                         ....||+.|++||.+.+.+|..++|||||||++|++++-+++|...+...+..++.... ..+.+...+.+++.+|+
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence               55679999999999999999999999999999999999999999999999999999987 55566689999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCcccc
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      .||..+|+.||++.++|.+|..+
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhh
Confidence            99999999999999999998776

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.3e-46  Score=309.58  Aligned_cols=256  Identities=20%  Similarity=0.248  Sum_probs=222.2

Q ss_pred             hcccccccCcEee--eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           12 RKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        12 ~~~~~~~~~y~~~--~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ....+...+++..  ..||+|+++.||++.+  +++.||+|++...........+.+.+|+.++++++|+||+++++++.
T Consensus        11 ~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~   88 (283)
T PHA02988         11 DIKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII   88 (283)
T ss_pred             cceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence            3445566666666  7799999999999987  68899999997665545455678889999999999999999999987


Q ss_pred             c----CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecc
Q 023270           90 D----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        90 ~----~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                      +    ....++|+||+++|+|.+++.+.+.++....+.++.+++.|+.+||+. +++|+||+|+||+++.++.+||+|||
T Consensus        89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988         89 DIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             ecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccc
Confidence            6    347899999999999999999888899999999999999999999984 99999999999999999999999999


Q ss_pred             cccccCCCCccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          165 WSVQSRSKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      ++...........++..|+|||.+.+  ..++.++||||||+++|+|++|..||...+..+...........+..+...+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (283)
T PHA02988        169 LEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP  248 (283)
T ss_pred             hHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCc
Confidence            98655444445567889999999976  6789999999999999999999999999888888887766655555555789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++.+++.+||+.||++|||++++++.
T Consensus       249 ~~l~~li~~cl~~dp~~Rps~~ell~~  275 (283)
T PHA02988        249 LEIKCIVEACTSHDSIKRPNIKEILYN  275 (283)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            999999999999999999999999863

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-45  Score=315.60  Aligned_cols=257  Identities=32%  Similarity=0.556  Sum_probs=219.3

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|+||+||++.+..+++.|++|++.............+..|+.++..++|++++++++.+..++.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987654444444566788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC----CC
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KR  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~----~~  173 (284)
                      ||+++++|.+++.+. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.....    ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            999999999999874 6789999999999999999999999999999999999999999999999998743221    11


Q ss_pred             ccccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CCCCCHHH
Q 023270          174 HTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---APSISAEA  245 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  245 (284)
                      ....|++.|+|||++.     ...++.++||||||+++|+|++|..||...+..+....+.........   ...+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            2346899999999986     345788999999999999999999999998888888877665433222   23579999


Q ss_pred             HHHHHHhcccCCC--CCCCHHhhhcCcccccc
Q 023270          246 KHLISRLLVKDSS--KRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       246 ~~li~~~l~~~p~--~Rps~~~il~~~~~~~~  275 (284)
                      ++|+++||..++.  .|++++++++||||+..
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            9999999965443  47899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-45  Score=315.93  Aligned_cols=257  Identities=32%  Similarity=0.541  Sum_probs=219.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.............+.+|..++..++|++|+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987654444444566788899999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----
Q 023270           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----  173 (284)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999987 4678999999999999999999999999999999999999999999999999875433221    


Q ss_pred             ccccCCCcccCccccCC-----CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CCCCCHHH
Q 023270          174 HTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---APSISAEA  245 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  245 (284)
                      ....|++.|+|||++.+     +.++.++|+||||+++|+|++|..||...+..+....+.........   ...++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            22458999999999865     45788999999999999999999999988888777777654332222   23578999


Q ss_pred             HHHHHHhcccCCCC--CCCHHhhhcCcccccc
Q 023270          246 KHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  275 (284)
Q Consensus       246 ~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  275 (284)
                      ++++.+||...+++  |++++++++||||+..
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            99999999865544  5699999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.7e-46  Score=312.00  Aligned_cols=252  Identities=26%  Similarity=0.434  Sum_probs=204.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEec-CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh---CCCCcccceeeEEe-----
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS---LRHPNILRLYGWFH-----   89 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~---l~h~~i~~~~~~~~-----   89 (284)
                      ++|++.+.||.|+||+||+|.+.. ++..||+|.+........ ....+.+|+..++.   ++|+||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            589999999999999999999854 467899998864332211 11233445555554   47999999999875     


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ....+++|+|+++ ++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456899999997 5898888764  358999999999999999999999999999999999999999999999999985


Q ss_pred             ccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 023270          168 QSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---------  236 (284)
Q Consensus       168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  236 (284)
                      ....  ......+++.|+|||.+.+..++.++||||||+++++|++|.+||.+.+..+.+..+........         
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            4332  22344578999999999888899999999999999999999999999888777766654211000         


Q ss_pred             ----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          237 ----------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       237 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                      ..+.+++.+.+++.+||..||++|||+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                            013567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-46  Score=308.09  Aligned_cols=255  Identities=32%  Similarity=0.489  Sum_probs=221.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|++|.||++.+..+++.|++|.+......  .....+.+|+++++.++|+|++++++++.++...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            4799999999999999999999999999999998654322  23456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Ccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~  175 (284)
                      |++++++|.+++... .++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   ...
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999998875 7899999999999999999999999999999999999999999999999987554322   233


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..+++.|+|||.+.+..++.++|+||||++++++++|..||...+.......+............++.++.+++.+||..
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence            45678899999999888999999999999999999999999887766666555554332222223789999999999999


Q ss_pred             CCCCCCCHHhhhcCccccccC
Q 023270          256 DSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +|.+|||++++++||||++..
T Consensus       238 ~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         238 DPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             ChhhCcCHHHHhhChhhcCCC
Confidence            999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-46  Score=318.56  Aligned_cols=260  Identities=25%  Similarity=0.437  Sum_probs=214.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC----
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD----   91 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~----   91 (284)
                      -...+|++.+.||.|+||+||++.+..+++.||+|.+....... .....+.+|+.+++.++|+||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34578999999999999999999999999999999986543322 2335567899999999999999999987533    


Q ss_pred             --CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 --ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 --~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                        ...+++++++ +++|..++.. ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence              3579999998 5688877654 56899999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 023270          170 RSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-------------  235 (284)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  235 (284)
                      ........+++.|+|||++.+ ..++.++||||||+++++|++|..||...+..+.+..+.......             
T Consensus       169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence            555555678999999999877 468899999999999999999999998776655444433211000             


Q ss_pred             ----------CC------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          236 ----------PS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       236 ----------~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                +.      ....++.+.+|+.+||..||.+|||++++|+||||.+...+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                      00      01356678999999999999999999999999999986554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-46  Score=324.29  Aligned_cols=253  Identities=28%  Similarity=0.456  Sum_probs=220.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-C-----CcccceeeEEecCCe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-H-----PNILRLYGWFHDDER   93 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h-----~~i~~~~~~~~~~~~   93 (284)
                      +|.|++.||.|+||.|.+|.+..+++.||||+++....    ..++...|+.+|..++ |     -|+++++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            79999999999999999999999999999999966442    3355667888888886 3     489999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC--CEEEeeccccccc
Q 023270           94 IFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG--RLKIGDFGWSVQS  169 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~--~~~l~d~~~~~~~  169 (284)
                      +|+|+|..+ .+|.++++.++  .++...++.++.||+.||..||+.||+|+||||+|||+...+  .+|++|||.++..
T Consensus       263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999999997 59999999874  689999999999999999999999999999999999997654  6999999999888


Q ss_pred             CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------------
Q 023270          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS------------  237 (284)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------  237 (284)
                      ......+..+-.|+|||++.+.+++.+.||||||||++||++|.+.|.+.+..+.+..+......++.            
T Consensus       342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf  421 (586)
T KOG0667|consen  342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF  421 (586)
T ss_pred             CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence            87777888899999999999999999999999999999999999999998888877776654221111            


Q ss_pred             -------------------------------------CC------------CCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          238 -------------------------------------AP------------SISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       238 -------------------------------------~~------------~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                                                           .+            .-...+.+||.+||.+||.+|+|+.++|+
T Consensus       422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                                                 00            01235789999999999999999999999


Q ss_pred             CccccccCC
Q 023270          269 HPWIIKNAN  277 (284)
Q Consensus       269 ~~~~~~~~~  277 (284)
                      ||||+....
T Consensus       502 Hpfl~~~~~  510 (586)
T KOG0667|consen  502 HPFLTGTSL  510 (586)
T ss_pred             Ccccccccc
Confidence            999995433

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-45  Score=326.43  Aligned_cols=254  Identities=26%  Similarity=0.450  Sum_probs=206.8

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC----
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD----   91 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~----   91 (284)
                      ....+|++.+.||+|+||.||+|.+..++..||||++....       ....+|+.+++.++|+||+++++++...    
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            34568999999999999999999999999999999885432       1234688999999999999999876432    


Q ss_pred             ----CeEEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEee
Q 023270           92 ----ERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGD  162 (284)
Q Consensus        92 ----~~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d  162 (284)
                          ..+++||||+++ ++..++.    ....++...++.++.||+.||.|||+.||+|+||||+||+++.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence                257799999975 7766664    345789999999999999999999999999999999999998765 799999


Q ss_pred             cccccccC--CCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------
Q 023270          163 FGWSVQSR--SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL------  233 (284)
Q Consensus       163 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------  233 (284)
                      ||++....  .......+++.|+|||++.+. .++.++|||||||++++|++|.+||.+.+..+.+.++.....      
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            99985432  222345678999999998764 589999999999999999999999998877665555443110      


Q ss_pred             -----------CCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          234 -----------SFP----------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       234 -----------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                 .++          .+...++++.+||++||..||.+|||+.++|+||||++..+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                       001          11246789999999999999999999999999999987644

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.1e-45  Score=308.44  Aligned_cols=257  Identities=30%  Similarity=0.566  Sum_probs=224.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|+||.||++.+..+++.|++|.+.............+.+|+.+++.++|+||+++++.+..++..++|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987655444444567888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-------
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-------  171 (284)
                      ||+++++|.+++...+.+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.....       
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999998642110       


Q ss_pred             -----------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-C
Q 023270          172 -----------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA-P  239 (284)
Q Consensus       172 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~  239 (284)
                                 ......++..|+|||.+.+..++.++|+||||++++++++|..||.+.+..+............+.. .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                       0011245778999999988889999999999999999999999999888888777776654443333 2


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---HHhhhcCcccccc
Q 023270          240 SISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  275 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  275 (284)
                      .+++++.+++.+||..+|.+||+   +.++|+||||+..
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            57899999999999999999997   7999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-45  Score=328.69  Aligned_cols=254  Identities=26%  Similarity=0.481  Sum_probs=220.9

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecC-CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      ....|.+.+.||.|++|.||+|.+..+ +..|++|.+.....   .....++.|+..++.++|+||+++++++..++..|
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            344599999999999999999998877 77888987744322   23356778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           96 LILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +||||+++++|.+.+..    ..++++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999987754    34689999999999999999999999999999999999999999999999999854332


Q ss_pred             C-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          172 K-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       172 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      .     .....|++.|+|||++.+..++.++||||||+++++|++|..||...+..+.+.....+... +.+..+++++.
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~  300 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMK  300 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHH
Confidence            2     23345899999999999999999999999999999999999999998888888887765443 23346889999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ++|..||..+|++||++++++.|||++.
T Consensus       301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        301 ALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            9999999999999999999999999864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-45  Score=311.44  Aligned_cols=260  Identities=28%  Similarity=0.494  Sum_probs=216.0

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      -++.+|.+.+.||.|++|.||++.+..++..|++|.+.......  ....+.+|+..++.++|+||+++++++..++..+
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            46789999999999999999999999999999999985433211  1235667999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      +|+||++ ++|..++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            9999997 5888887654 56899999999999999999999999999999999999999999999999987543221  


Q ss_pred             -CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 023270          173 -RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS----------------  234 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------------  234 (284)
                       .....+++.|+|||.+.+. .++.++||||||+++++|++|.+||...+..+....+......                
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence             1233467889999988654 4788999999999999999999999887766555443321100                


Q ss_pred             ---CC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          235 ---FP---------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       235 ---~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                         .+         ..+.+++++.+||.+||..||++|||++++++||||+...++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence               00         113578899999999999999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-46  Score=303.53  Aligned_cols=259  Identities=29%  Similarity=0.478  Sum_probs=221.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc-ccceeeEEecCC----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDE----   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~-i~~~~~~~~~~~----   92 (284)
                      +..|..+++||+|+||+||+|+...+|+.||+|++...... +.......+|+.+++.++|+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            67789999999999999999999999999999998665432 223456678999999999999 999999998777    


Q ss_pred             --eEEEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           93 --RIFLILEYAHRGELYRELRKHR----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        93 --~~~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                        .+++|+||++. +|..++....    .++...++.+++||+.|+.|||++||+|+||||.||+++++|.+||+|||++
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999975 9999998765    5788899999999999999999999999999999999999999999999998


Q ss_pred             cccCCC---CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCC--
Q 023270          167 VQSRSK---RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSA--  238 (284)
Q Consensus       167 ~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~--  238 (284)
                      ....-+   .....+|.+|+|||++.+. .++...||||+||++++|+++...|.+.+..+++..+......+  ..+  
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            654422   2344578899999999988 58999999999999999999999999999988888776642111  111  


Q ss_pred             ------------------------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          239 ------------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       239 ------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                              +..+++..+++.+||+.+|.+|.|++.+|.||||+....+
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence                                    1223578999999999999999999999999999998654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.6e-45  Score=300.84  Aligned_cols=251  Identities=31%  Similarity=0.499  Sum_probs=220.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+....... .....+.+|+++++.++|+|++++++++..++..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            5899999999999999999999999999999986544333 334678889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---c
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---H  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~  174 (284)
                      |+++++|.+++...  ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999999775  578999999999999999999999999999999999999999999999999875433221   2


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||...+............... ....++.++.+++.+||+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~  238 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLT  238 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcc
Confidence            3357788999999999889999999999999999999999999888777777766654333 333688999999999999


Q ss_pred             cCCCCCCCHHhhhcCccc
Q 023270          255 KDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~  272 (284)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         239 KDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCcccCcCHHHHhhCCCC
Confidence            999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-45  Score=329.21  Aligned_cols=262  Identities=30%  Similarity=0.485  Sum_probs=224.8

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ..+.+....+|++.+.||+|+||+||++.+..+++.||+|++....... .....+.+|+..+..++|++++++++.+..
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            3445556689999999999999999999999999999999986654433 234567789999999999999998887643


Q ss_pred             CC--------eEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCE
Q 023270           91 DE--------RIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        91 ~~--------~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~  158 (284)
                      .+        .+++|+||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence            22        478999999999999988653    468999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCC-----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 023270          159 KIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL  233 (284)
Q Consensus       159 ~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  233 (284)
                      +|+|||++.....     ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+.......+..
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~  262 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY  262 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            9999999754321     22345689999999999999999999999999999999999999999988888887776543


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      . +.++.+++++.+++.+||..||.+||++.++++|||++.
T Consensus       263 ~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        263 D-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             C-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            3 344578999999999999999999999999999999875

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-45  Score=310.41  Aligned_cols=258  Identities=28%  Similarity=0.411  Sum_probs=216.3

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|+||.||++.+..++..+++|.+.....  ......+.+|+++++.++|+||+++++.+..++..++|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            479999999999999999999999999999999864322  223456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccCC-CCccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTM  176 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~~~~~  176 (284)
                      ||+++++|.+++...+.++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  158 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence            999999999999988889999999999999999999997 5999999999999999999999999998744322 22344


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------------------
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD------------------------  232 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------------------  232 (284)
                      .++..|+|||.+.+..++.++|+||||++++++++|..||...+............                        
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            57889999999988889999999999999999999999997655433222211110                        


Q ss_pred             ------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          233 ------------LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       233 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                  ........++.++.+++.+||..+|.+|||++++++||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                        0000111367889999999999999999999999999999987544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-45  Score=307.95  Aligned_cols=248  Identities=26%  Similarity=0.433  Sum_probs=207.6

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||.|+||+||++.+..+++.|++|.+.............+..|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999998654443333334556789999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--CccccCCCcc
Q 023270          107 YRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDY  182 (284)
Q Consensus       107 ~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~y  182 (284)
                      .+.+....  .++...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++......  .....+++.|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            98886543  5889999999999999999999999999999999999999999999999987543322  1234578899


Q ss_pred             cCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 023270          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       183 ~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (284)
                      +|||++.+..++.++|+||+|+++|+|++|..||.....    .............. ....+++++++++++||+.||.
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~  239 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPE  239 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHHhccCHh
Confidence            999999988899999999999999999999999976433    23333333322222 2236899999999999999999


Q ss_pred             CCCCH----HhhhcCcccccc
Q 023270          259 KRLSL----QKIMEHPWIIKN  275 (284)
Q Consensus       259 ~Rps~----~~il~~~~~~~~  275 (284)
                      +||++    ++++.||||+..
T Consensus       240 ~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         240 DRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hCCCCccchhhhhcChhhcCC
Confidence            99999    778899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-45  Score=305.18  Aligned_cols=251  Identities=32%  Similarity=0.566  Sum_probs=220.7

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||++.+..+++.|++|++...........+.+.+|++.+++++|+|++++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999998999999999976655444556788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--Ccccc
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMC  177 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~  177 (284)
                      |+.+++|.+.+....+++...+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++......  .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            9999999999988778999999999999999999999999999999999999999999999999987544332  23345


Q ss_pred             CCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       178 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ++..|+|||.+.+...+.++|+||||++++++++|..||...+.   .........  .....++..+.++.++|++||.
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHcc
Confidence            77889999999888899999999999999999999999987764   333333322  3344445788999999999999


Q ss_pred             cCCCCCCCH--HhhhcCccc
Q 023270          255 KDSSKRLSL--QKIMEHPWI  272 (284)
Q Consensus       255 ~~p~~Rps~--~~il~~~~~  272 (284)
                      .||.+||++  .++++||||
T Consensus       239 ~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         239 RDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CChhHcCCccHHHHhcCCCC
Confidence            999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=319.65  Aligned_cols=254  Identities=29%  Similarity=0.462  Sum_probs=226.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|.....||.|.||.||++.+..+++.||+|++.......  ....+++|+.++..++++||.+.++.+..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            45777799999999999999999999999999997665433  3578889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~  175 (284)
                      |||.+|++.+.++....+++..+..++++++.|+.|||.++.+|+||++.||++..+|.++|.|||.+....   .....
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999985443   33366


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..|||.|+|||+.....|+.++||||||++.++|.+|.+|+....+...+.-+.+..++.- ...+++.+++||..||+.
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L-~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL-DGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc-ccccCHHHHHHHHHHhhc
Confidence            7899999999999988999999999999999999999999999888655555554433222 237899999999999999


Q ss_pred             CCCCCCCHHhhhcCcccccc
Q 023270          256 DSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||+.||||.++|.|+|+++.
T Consensus       250 ~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  250 NPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             CcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999983

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-45  Score=303.81  Aligned_cols=252  Identities=30%  Similarity=0.502  Sum_probs=217.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH------HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE------KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      +|.+.+.||.|++|.||+|.+..+++.|++|.+......      .....+.+.+|+.++++++|+|++++++++..++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            578899999999999999999889999999988543221      22344678899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      .++++||+++++|.+++.+.+.++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            9999999999999999988888999999999999999999999999999999999999999999999999987443311 


Q ss_pred             --------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          173 --------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       173 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                              .....++..|+|||.+.+..++.++|+||+|+++++|++|..||...+........... .....+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-CCCcCCcccCHH
Confidence                    11234678899999999888999999999999999999999999887766655554442 223334468899


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +.+++++||+++|.+||+++++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-45  Score=327.62  Aligned_cols=254  Identities=26%  Similarity=0.439  Sum_probs=204.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC------CCcccceeeEEec
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR------HPNILRLYGWFHD   90 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~------h~~i~~~~~~~~~   90 (284)
                      ..++|++++.||.|+||+||+|.+..+++.||||++.....    ..+....|+++++.++      |.+++++++++..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            45789999999999999999999999999999999854221    1223344555555554      4568888888875


Q ss_pred             C-CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCC------------
Q 023270           91 D-ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEG------------  156 (284)
Q Consensus        91 ~-~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~------------  156 (284)
                      + +++++|+|++ +++|.+++...+.++...+..++.||+.||.|||. .||+|+||||+|||++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            5 5789999998 56898888888889999999999999999999998 5999999999999998765            


Q ss_pred             ----CEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 023270          157 ----RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD  232 (284)
Q Consensus       157 ----~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  232 (284)
                          .+||+|||.+...........+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+....
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence                4999999987655555556678999999999999999999999999999999999999998877655444332211


Q ss_pred             CCCC-------------------------C---------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          233 LSFP-------------------------S---------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       233 ~~~~-------------------------~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ..++                         .               ....++.+.+||.+||..||++|||++|+|+||||
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence            1000                         0               00113567899999999999999999999999999


Q ss_pred             ccc
Q 023270          273 IKN  275 (284)
Q Consensus       273 ~~~  275 (284)
                      ++.
T Consensus       442 ~~~  444 (467)
T PTZ00284        442 LKY  444 (467)
T ss_pred             ccc
Confidence            984

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.2e-47  Score=307.52  Aligned_cols=252  Identities=34%  Similarity=0.536  Sum_probs=215.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----e
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----R   93 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----~   93 (284)
                      -.|...+.+|+|+||.||++...++++.||||++....-..       -+|+++|+.++||||+++..+|....     .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            45889999999999999999999999999999985543222       26889999999999999998885321     4


Q ss_pred             EEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeecccccc
Q 023270           94 IFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQ  168 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~~~~~  168 (284)
                      ..+|+||++. +|...++.    +..++...++-+..||+.||.|||..||+|+||||.|+|++.+ |.+||+|||.+..
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            6789999985 99888874    5678999999999999999999999999999999999999987 9999999999854


Q ss_pred             c--CCCCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 023270          169 S--RSKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--------  237 (284)
Q Consensus       169 ~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  237 (284)
                      .  +++...+.++-.|+|||.+.+.. |+.+.||||.||++.||+-|.+.|.+.+..+++..+.+-...+..        
T Consensus       176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            3  34445667888999999988765 899999999999999999999999999888887777664211111        


Q ss_pred             -------------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          238 -------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       238 -------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                         ....++++.+|++++|..+|.+|.++.+++.||||...-+|
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                               23578999999999999999999999999999999988776

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.1e-45  Score=303.10  Aligned_cols=248  Identities=40%  Similarity=0.672  Sum_probs=219.3

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||.|++|.||++.+..+++.|++|++...........+.+.+|+.+++.++|+|++++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999989999999999766555445567889999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--CccccCCCcccC
Q 023270          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA  184 (284)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~y~a  184 (284)
                      .+++.+...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......  .....+++.|+|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            999988888999999999999999999999999999999999999999999999999998554332  233457888999


Q ss_pred             ccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 023270          185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES--QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS  262 (284)
Q Consensus       185 PE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  262 (284)
                      ||.+.+..++.++|+||+|++++++++|..||....  ......+...+......+...++++.+++.+||..+|.+||+
T Consensus       161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence            999988889999999999999999999999998776  666666666444444455566899999999999999999999


Q ss_pred             -----HHhhhcCccccc
Q 023270          263 -----LQKIMEHPWIIK  274 (284)
Q Consensus       263 -----~~~il~~~~~~~  274 (284)
                           ++++++||||.+
T Consensus       241 ~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         241 NLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             CcccCHHHHhcChhhhC
Confidence                 999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.6e-45  Score=304.50  Aligned_cols=256  Identities=29%  Similarity=0.432  Sum_probs=217.7

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|+..+.||.|+||+||++.+..+++.||+|.+.............+.+|+++++.++|++++++.+.+..++..++++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999866544443344566789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCcc
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~~  175 (284)
                      |+++++|.+.+...  ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999999888654  3689999999999999999999999999999999999999999999999998754322  2233


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ..++..|+|||.+.+..++.++|+||+|++++++++|..||................  ........++.++.+|+..||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            467899999999988889999999999999999999999998876654433333211  122334468899999999999


Q ss_pred             ccCCCCCCC-----HHhhhcCcccccc
Q 023270          254 VKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       254 ~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      ..||++||+     +.++++|+||++-
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         241 TKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             cCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999     8899999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.5e-45  Score=301.93  Aligned_cols=254  Identities=27%  Similarity=0.498  Sum_probs=215.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH--HHHHHHHHHHHHHHHHHhCCCCcccceeeEEec--CCeE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERI   94 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~--~~~~   94 (284)
                      .+|++.+.||+|++|.||++.+..++..|++|.+.....  ........+.+|+.+++.++|+|++++++++..  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            579999999999999999999999999999998754322  222345678889999999999999999998865  3678


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---  171 (284)
                      ++++||+++++|.+++...+.++....+.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....   
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999998743221   


Q ss_pred             ---CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       172 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                         ......++..|+|||.+.+..++.++|+||+|++++++++|..||..........+..........+..+++.++++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence               11223467889999999988899999999999999999999999988776666655544333333344678889999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      + +||..+|++||+++++++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 57778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-45  Score=306.49  Aligned_cols=255  Identities=30%  Similarity=0.479  Sum_probs=214.8

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|++.+.||.|+||.||++.+..+++.|++|.+.............+..|+.+++.++|++++++++.+..++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999866544433334566789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCcc
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~~  175 (284)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999999888654  3589999999999999999999999999999999999999999999999998754322  2223


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCCCCCCHHHHHHHHHh
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---DTFRRIMKVDLSFPSAPSISAEAKHLISRL  252 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (284)
                      ..++..|+|||.+.+..++.++|+||+|+++++|++|..||......   .......... .......+++++.+|+++|
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  239 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARSLCKML  239 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHHHHHHH
Confidence            46789999999999888999999999999999999999999865432   2222222211 1223346889999999999


Q ss_pred             cccCCCCCCC-----HHhhhcCcccccc
Q 023270          253 LVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       253 l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      |+.||++|||     ++++++||||.+.
T Consensus       240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         240 LCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             hhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-44  Score=300.26  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=214.6

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH---HHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      +|++.+.||.|+||+||++.. .++..+++|.+.....   ........+.+|+..++.++|+|++++++++.+++..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999976 4788899998754321   222334678899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC------
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR------  170 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~------  170 (284)
                      ++||+++++|.+++.+..+++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....      
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999874321      


Q ss_pred             ---CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCCCCCCHHHH
Q 023270          171 ---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-DLSFPSAPSISAEAK  246 (284)
Q Consensus       171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  246 (284)
                         .......++..|+|||.+.+..++.++|+||||++++++++|..||...+........... ......+..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence               1112345778899999999888999999999999999999999999876655544433332 222334456899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +++.+||..+|.+||++.+++.||||
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.8e-45  Score=315.40  Aligned_cols=255  Identities=23%  Similarity=0.393  Sum_probs=210.8

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----   91 (284)
                      ..++|++.+.||+|+||.||++.+..+++.|+||++....... .....+.+|+.+++.++|+||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            4689999999999999999999999999999999986543222 2235667899999999999999999987543     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       ...|+||||+++ +|...+..  .++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             357999999975 77776654  47889999999999999999999999999999999999999999999999986543


Q ss_pred             CC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 023270          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP------------  236 (284)
Q Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------------  236 (284)
                      ..  .....+++.|+|||++.+..++.++||||||+++++|++|..||...+..+.+..+........            
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            32  2334678999999999999999999999999999999999999988777665555443211000            


Q ss_pred             ----------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          237 ----------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       237 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                                                  .....+.++++||.+||..||.+|||++++|+||||...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                                        001235678999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-44  Score=297.32  Aligned_cols=251  Identities=29%  Similarity=0.546  Sum_probs=215.9

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-CCeEEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DERIFLIL   98 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-~~~~~~v~   98 (284)
                      +|++.+.||.|++|.||++.+..+++.|++|.+....... ...+.+.+|+.+++.++|+|++++++.+.. +..+++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999986544332 234567889999999999999999988764 44689999


Q ss_pred             eecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CC
Q 023270           99 EYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~  173 (284)
                      ||+++++|.+++...  ..+++.+++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999998764  4589999999999999999999999999999999999999999999999998754322   22


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ....+++.|+|||.+.+..++.++|+||+|++++++++|..||...+..........+... ..+..+++++.+++.+|+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l  238 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYSPELGELIATML  238 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHh
Confidence            3345788999999999999999999999999999999999999888777766666555432 234468899999999999


Q ss_pred             ccCCCCCCCHHhhhcCccc
Q 023270          254 VKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~  272 (284)
                      +.+|.+||++.+++.||||
T Consensus       239 ~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         239 SKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ccCcccCCCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.4e-45  Score=315.12  Aligned_cols=257  Identities=22%  Similarity=0.380  Sum_probs=209.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC----
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD----   91 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~----   91 (284)
                      ....+|++.+.||.|+||.||++.+..+++.|++|++....... .....+.+|+.+++.++|+||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            35689999999999999999999999999999999986543222 2345667899999999999999999988543    


Q ss_pred             --CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 --ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 --~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                        ...++||||+++ ++...+..  .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999975 67666644  4788999999999999999999999999999999999999999999999998654


Q ss_pred             CCC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--------------
Q 023270          170 RSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL--------------  233 (284)
Q Consensus       170 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------  233 (284)
                      ...  .....+++.|+|||++.+..++.++||||||+++++|++|..||.+.+..+..........              
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            332  2334678999999999998999999999999999999999999987765444333222100              


Q ss_pred             --------CC------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          234 --------SF------------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       234 --------~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                              ..                  ......+.++++||.+||..||++|||++++|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                    00                  00112356789999999999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-45  Score=313.22  Aligned_cols=253  Identities=23%  Similarity=0.406  Sum_probs=206.7

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeE
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~   87 (284)
                      +++...+|++.+.||.|+||.||+|.+.     .++..||+|++.....  ....+.+.+|+.++..+ +|+||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            4566679999999999999999999753     3456799999864322  12345688899999999 89999999998


Q ss_pred             EecC-CeEEEEEeecCCCchHHHHHhc-----------------------------------------------------
Q 023270           88 FHDD-ERIFLILEYAHRGELYRELRKH-----------------------------------------------------  113 (284)
Q Consensus        88 ~~~~-~~~~~v~e~~~~~~L~~~l~~~-----------------------------------------------------  113 (284)
                      +... +.++++|||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8654 4689999999999999998653                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-----CccccCC
Q 023270          114 ---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGT  179 (284)
Q Consensus       114 ---------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~  179 (284)
                               ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......     .....++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                     23778888999999999999999999999999999999999999999999988543211     1122345


Q ss_pred             CcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 023270          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (284)
                      +.|+|||++.+..++.++||||||+++|+|++ |..||......+..............+...++++.+++.+||..||.
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            78999999998889999999999999999997 99999876654444444443333444557889999999999999999


Q ss_pred             CCCCHHhhhc
Q 023270          259 KRLSLQKIME  268 (284)
Q Consensus       259 ~Rps~~~il~  268 (284)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.8e-45  Score=302.93  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=211.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|++|.||++.+..++..|++|.+.....  ....+.+.+|+.++.+++|+|++++++++..++..++|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            478999999999999999999999999999999854322  223457888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-CCcccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMC  177 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~  177 (284)
                      ||+++++|..+    ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            99999888654    3468889999999999999999999999999999999999999999999998854332 233456


Q ss_pred             CCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-------DTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       178 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      ++..|+|||.+.+..++.++|+||||++++++++|..||......       ...................++++.+++.
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT  234 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence            788999999999888999999999999999999999999653221       2222222222222223357889999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      +||..+|.+||+++++++||||++...
T Consensus       235 ~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         235 QCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHhhCChhhCCCHHHHhcCcccccccC
Confidence            999999999999999999999988743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-44  Score=304.56  Aligned_cols=254  Identities=29%  Similarity=0.494  Sum_probs=219.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|++|+||++.+..+++.|++|.+......   ..+.+.+|+..++.++|+|++++++++..++..++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            5699999999999999999999999999999998543322   2356778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Ccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~  175 (284)
                      ||+++++|..++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            99999999998865 46899999999999999999999999999999999999999999999999987543221   223


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-LSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..++..|+|||.+.+..++.++|+||||++++++++|..||...+............ .....+..+++.+.+++.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            457788999999988889999999999999999999999998887766555444322 2223344688999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .+|.+||++.+++.||||+.+.
T Consensus       255 ~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         255 MDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             cChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.1e-45  Score=306.45  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=202.6

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHH---hCCCCcccceeeEEec-----C
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS---SLRHPNILRLYGWFHD-----D   91 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~---~l~h~~i~~~~~~~~~-----~   91 (284)
                      +|++.+.||.|+||+||+|.+..+++.|++|.+....... .....+.+|+..++   .++|+||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            6999999999999999999999999999999886432211 11122334444444   4579999999998754     3


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      ...++++|++++ +|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            468999999974 888888764  35899999999999999999999999999999999999999999999999987543


Q ss_pred             CCC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----C-------
Q 023270          170 RSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-----F-------  235 (284)
Q Consensus       170 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~-------  235 (284)
                      ...  .....++..|+|||.+.+..++.++||||+|+++++|++|.+||..........++......     +       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            322  22345788899999999888999999999999999999999999887776655554431100     0       


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 -------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                   ...+.++.++.+++.+||..||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         0113567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-44  Score=305.05  Aligned_cols=255  Identities=28%  Similarity=0.472  Sum_probs=218.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++.+.||.|++|.||++.+..++..|++|.+.......   ...+.+|+.+++.+.|+|++++++.+..+...++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            358999999999999999999999999999999986543332   35677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Cc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~  174 (284)
                      +||+++++|.+++.+ ..++..++..++.|++.||.|||..|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            999999999998865 45799999999999999999999999999999999999999999999999987543221   22


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHhc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-DLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ...+++.|+|||.+.+...+.++|+||||++++++++|..||...+........... ......+..+++.+.+++.+||
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence            345788999999998888999999999999999999999999877765444433322 2222334468899999999999


Q ss_pred             ccCCCCCCCHHhhhcCccccccC
Q 023270          254 VKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ..+|.+||+++++++||||..+.
T Consensus       255 ~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         255 DMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             cCCcccCcCHHHHhhChhhhccC
Confidence            99999999999999999998863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.8e-45  Score=306.24  Aligned_cols=261  Identities=30%  Similarity=0.502  Sum_probs=218.2

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH--HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +|++.+.||.|++|.||++.+..+++.|++|.+......  .......+..|+..++.++|+|++++++++..++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999998654432  122345667899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---
Q 023270           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---  173 (284)
                      +||+ +++|.+++.... .++...++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 789999998776 79999999999999999999999999999999999999999999999999985543321   


Q ss_pred             ccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------------
Q 023270          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP----------------  236 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------------  236 (284)
                      ....+++.|.|||.+.+ ..++.++|+||||++++++++|.++|...+..+.+.+.........                
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            22345678999998855 4578999999999999999999888887776655555433210000                


Q ss_pred             ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCCC
Q 023270          237 ----------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  281 (284)
Q Consensus       237 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (284)
                                .....+.++.+++.+||.++|++|||+.+++.||||++.+.|.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~  294 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP  294 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence                      012357889999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-44  Score=296.51  Aligned_cols=251  Identities=31%  Similarity=0.533  Sum_probs=221.6

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||.+++..++..+++|.+....... ...+.+.+|++++++++|+|++++++++.+++..++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            6999999999999999999999999999999986544333 234567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---c
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---H  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~  174 (284)
                      |+++++|.+++...  ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999875  468999999999999999999999999999999999999999999999999875443222   3


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...+++.|.|||.+.+...+.++|+||||++++++++|..||...+..+....+..+..... .+.++.++.+++.+||.
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~  238 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV-VSVYSSELISLVHSLLQ  238 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-ccccCHHHHHHHHHHcc
Confidence            34578899999999888889999999999999999999999998888888877776554432 35689999999999999


Q ss_pred             cCCCCCCCHHhhhcCccc
Q 023270          255 KDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~  272 (284)
                      .+|.+|||++++++|||+
T Consensus       239 ~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         239 QDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cCcccCCCHHHHhhCcCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-44  Score=300.06  Aligned_cols=252  Identities=29%  Similarity=0.478  Sum_probs=216.2

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|++|+||++....++..+++|++.......  ..+.+.+|+..++.++|+|++++++.+..++..++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998899999999986443322  4567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--
Q 023270           99 EYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--  173 (284)
                      |++++++|.+++...   ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   458999999999999999999999999999999999999999999999999874332211  


Q ss_pred             -----ccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----CCCCH
Q 023270          174 -----HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----PSISA  243 (284)
Q Consensus       174 -----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  243 (284)
                           ....++..|+|||.+... ..+.++|+||||+++++|++|..||...+......+...........    ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                 223477889999998776 68899999999999999999999998877766666655543221111    25788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ++.+++.+||..||.+|||+++++.||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.9e-45  Score=306.49  Aligned_cols=257  Identities=28%  Similarity=0.472  Sum_probs=218.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++++.||.|++|.||++.+..++..|++|.+.......   .+.+.+|+.+++.++|+|++++++++..++..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            378999999999999999999999999999999986533222   35677889999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Cc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~  174 (284)
                      +||+++++|.+++.. ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            999999999998865 45789999999999999999999999999999999999999999999999987543222   12


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHhc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ...+++.|+|||.+.+..++.++|+||||++++++++|..||...+.......... +......+..+++.+.+++.+||
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL  253 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence            34577889999999988899999999999999999999999987665443332222 22222234467889999999999


Q ss_pred             ccCCCCCCCHHhhhcCccccccCCC
Q 023270          254 VKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ..+|.+||+++++++||||+.....
T Consensus       254 ~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         254 EMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             cCChhhCcCHHHHhcCchhcccccc
Confidence            9999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-44  Score=301.95  Aligned_cols=254  Identities=30%  Similarity=0.520  Sum_probs=216.3

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |++.+.||.|++|.||++.+..++..+++|.+.....   ...+.+.+|+.+++.++|+|++++++++..++..++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            6889999999999999999999999999999854332   2345677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCccc
Q 023270          101 AHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTM  176 (284)
Q Consensus       101 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~~  176 (284)
                      +++++|...+.+ ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....   .....
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999888765 45789999999999999999999999999999999999999999999999998743322   12334


Q ss_pred             cCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHH
Q 023270          177 CGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLIS  250 (284)
Q Consensus       177 ~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  250 (284)
                      .+++.|+|||.+.     +..++.++|+||+|+++++|++|..||...+............. ....+..++.++.+++.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            5788999999873     34577899999999999999999999988877766666655432 22233467899999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      +||..+|.+||+++++++||||+....
T Consensus       244 ~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHccCChhhCcCHHHHhcCCCEeccCC
Confidence            999999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-45  Score=304.13  Aligned_cols=255  Identities=31%  Similarity=0.527  Sum_probs=218.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|++|.||++.+..++..+++|.+....   ....+.+..|+.+++.++|+|++++++++..++..++||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            46999999999999999999998899999999985432   223456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCc
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~  174 (284)
                      ||+++++|.+++... ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.....   ...
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999999999998764 5789999999999999999999999999999999999999999999999998743322   222


Q ss_pred             cccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 023270          175 TMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHL  248 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  248 (284)
                      ...+++.|+|||.+.     ...++.++|+||||+++|++++|..||...+............. ....+..++.++.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence            345788899999874     34467899999999999999999999998877766666655432 222334678999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +.+||..+|.+|||++++++||||.+.-
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHhccChhhCcCHHHHhcChhhcccc
Confidence            9999999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-44  Score=298.51  Aligned_cols=254  Identities=26%  Similarity=0.492  Sum_probs=215.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhh--HHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~   94 (284)
                      .+|++.+.||+|+||.||++.+..++..|++|.+....  .......+.+.+|+..++.++|+|++++++++.++  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            68999999999999999999999999999999875322  12223456788899999999999999999988764  468


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---  171 (284)
                      ++++||+++++|.+++.+.+.++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999999999999998888889999999999999999999999999999999999999999999999998753321   


Q ss_pred             ---CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       172 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                         ......++..|+|||.+.+...+.++|+||||+++++|++|..||...+......+..........+..++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF  241 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence               12223477889999999888899999999999999999999999987766666655554433333444678889999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      +++|+. +|++||+++++++|||+.
T Consensus       242 i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         242 LKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHhc-ChhhCCCHHHHhcCcccC
Confidence            999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2e-44  Score=298.22  Aligned_cols=255  Identities=34%  Similarity=0.519  Sum_probs=222.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+......  .....+.+|+..+..++|+|++++++++..++..++++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4799999999999999999999999999999998665432  34567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccCCCCc---
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---  174 (284)
                      ||+++++|.+++.....++...++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999988889999999999999999999999 9999999999999999999999999998754432221   


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCCCC-CCHHHHHHHH
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE---SQKDTFRRIMKVDLSFPSAPS-ISAEAKHLIS  250 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~  250 (284)
                      ...++..|.|||.+.+..++.++|+||||++++++++|..||...   ...+....+..... ...... ++..+.+++.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  237 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP-PSLPAEEFSPEFRDFIS  237 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC-CCCCcccCCHHHHHHHH
Confidence            345678899999999888999999999999999999999999777   44555555554433 233334 8899999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +||.++|.+||+++++++||||++..
T Consensus       238 ~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         238 ACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHccCChhhCCCHHHHHhCHHHHhcc
Confidence            99999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.4e-44  Score=302.50  Aligned_cols=257  Identities=29%  Similarity=0.485  Sum_probs=217.3

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|++++.||.|++|.||++.+..++..+++|.+....   ....+.+.+|+..++.++|+|++++++.+..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            55999999999999999999999999999999986543   223466788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Cc
Q 023270           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~  174 (284)
                      ||+++++|...+.+ ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99999999887755 457899999999999999999999999999999999999999999999999987443221   22


Q ss_pred             cccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 023270          175 TMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHL  248 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  248 (284)
                      ...+++.|+|||.+.     ...++.++|+||||+++|+|++|..||...+......+...... .......++.++.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF  248 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence            345678899999885     34467899999999999999999999988776666655554322 222334678899999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +.+||..+|++||+++++++||||......
T Consensus       249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         249 LKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             HHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            999999999999999999999999875543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-44  Score=303.18  Aligned_cols=253  Identities=29%  Similarity=0.513  Sum_probs=211.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|++|.||++.+..+++.|++|++....... ...+.+.+|+.+++.++|+|++++++++..++..++|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            47999999999999999999999999999999985432111 22345678999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---cc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~  175 (284)
                      ||+++++|..++.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......   ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999988888877777789999999999999999999999999999999999999999999999999885443322   23


Q ss_pred             ccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------CC
Q 023270          176 MCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-------------------SF  235 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------------~~  235 (284)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+.....                   ..
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            446788999999876 4578899999999999999999999987766554443322100                   00


Q ss_pred             CC----------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 PS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 ~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +.          .+.++..+.+|+.+||.++|.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00          12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-44  Score=297.06  Aligned_cols=253  Identities=29%  Similarity=0.485  Sum_probs=218.6

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH--HHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +|+..+.||+|++|.||++.+..++..|++|.+.....  ......+.+.+|+..++.++|+|++++++++..++..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            57888999999999999999988999999999854332  1223456788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--Ccc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHT  175 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~  175 (284)
                      +||+++++|.+++.+.+.++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......  ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999987543322  234


Q ss_pred             ccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..++..|+|||.+.... ++.++|+||||++++++++|..||.....................++.+++++.+++++||.
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            45788899999987776 89999999999999999999999987776555555544333334455788999999999999


Q ss_pred             cCCCCCCCHHhhhcCccc
Q 023270          255 KDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~  272 (284)
                      .+|.+||++++++.|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=311.43  Aligned_cols=259  Identities=36%  Similarity=0.682  Sum_probs=235.8

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      =|.+.+.||+|-|+.|.+|++.-+|+.||||++.+...+.-. ...+.+|++-|+.++||||++++++......+|+|.|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            389999999999999999999999999999999988777644 3567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe-cCCCCEEEeeccccccc--CCCCcc
Q 023270          100 YAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL-DHEGRLKIGDFGWSVQS--RSKRHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~-~~~~~~~l~d~~~~~~~--~~~~~~  175 (284)
                      .-++|+|.++|-.+ ..++++.+..++.||+.|+.|+|+.-++|+||||+||.+ ..-|-|||.|||++...  +.....
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence            99999999999776 579999999999999999999999999999999999877 45699999999998444  334456


Q ss_pred             ccCCCcccCccccCCCCCC-chhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      .+|+..|.|||++.+..|+ ++.||||||+|+|-|.+|.+||...++.+.+..++.=.+..+.  -++.+.++||.+||.
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs--hvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS--HVSKECRDLIQSMLV  255 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch--hhhHHHHHHHHHHHh
Confidence            7899999999999999986 6899999999999999999999999999999999987766665  799999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCCCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANPRGT  281 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (284)
                      .||++|.|.++|..++|+|-.+.+.+|
T Consensus       256 RdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  256 RDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             cCchhhccHHHHhccccccCCCCCccc
Confidence            999999999999999999999887765

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.4e-45  Score=301.58  Aligned_cols=254  Identities=31%  Similarity=0.490  Sum_probs=216.0

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+......  .....+.+|+..++.++|+|++++++.+..++..++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            4788999999999999999999999999999998664332  33467788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccCCC-Ccc
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-RHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-~~~  175 (284)
                      |++++++|.+++... ..++...+..++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence            999989999999876 788999999999999999999999 99999999999999999999999999987433211 112


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-----SQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      ..++..|+|||.+.+..++.++|+||||++++++++|..||...     ...+.................++.++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN  238 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence            56778899999998889999999999999999999999999654     2333444444332222222237899999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccc
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      +||..+|.+|||+.+++.||||++
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         239 LCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHcCCCchhCcCHHHHhhCchhhc
Confidence            999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-44  Score=309.19  Aligned_cols=253  Identities=19%  Similarity=0.339  Sum_probs=206.6

Q ss_pred             eeeeeccC--CCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           23 IGRPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        23 ~~~~lg~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      ++++||.|  ++++||++.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            56789999  78899999999999999999986544322 3356778899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-------
Q 023270          101 AHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (284)
Q Consensus       101 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-------  171 (284)
                      +++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++||+.......       
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999999763  4589999999999999999999999999999999999999999999999975422111       


Q ss_pred             ---CCccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 023270          172 ---KRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-----------  235 (284)
Q Consensus       172 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----------  235 (284)
                         ......++..|+|||.+.+  ..++.++||||||+++++|++|..||..............+....           
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               0112235567999999876  458899999999999999999999998765544333332221110           


Q ss_pred             ---------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          236 ---------------------------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       236 ---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                                       +....+++++.+|+++||..||++|||++++++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                             01113567899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.9e-44  Score=296.27  Aligned_cols=251  Identities=29%  Similarity=0.567  Sum_probs=219.3

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|+||.+|++.+..+++.|++|.+....... ...+.+.+|+..++.++|+|++++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            6999999999999999999999999999999986543332 234577889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---c
Q 023270          100 YAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---H  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~  174 (284)
                      |+++++|.+.+....  .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++.......   .
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999887643  57899999999999999999999999999999999999999999999999875433221   2


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...+++.|+|||.+.+...+.++|+||||++++++++|..||...+..+.......+... ..+..++.++.+++.+||.
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~  238 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFK  238 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhh
Confidence            234678899999998888999999999999999999999999988887777777665433 2344689999999999999


Q ss_pred             cCCCCCCCHHhhhcCccc
Q 023270          255 KDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~  272 (284)
                      .+|.+||++.++++||||
T Consensus       239 ~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         239 RNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CChhhCcCHHHHhhCcCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-44  Score=298.48  Aligned_cols=254  Identities=28%  Similarity=0.513  Sum_probs=215.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH---HHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      +|+..+.||+|++|.||++.+..+++.|++|++.....   ......+.+..|++.++.++|+|++++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58889999999999999999999999999999864321   122345788899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccCCC---
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~---  172 (284)
                      |+||+++++|.+++.+.+++++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+......   
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998776 5999999987443221   


Q ss_pred             ----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCCCCCCHHH
Q 023270          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---DTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       173 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                          .....++..|+|||.+.+..++.++|+||+|++++++++|..||......   ....+..........++.+++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL  240 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence                12235678899999998888999999999999999999999999754432   23333333333344445688999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      .+++.+||..+|.+||++.++++||||+
T Consensus       241 ~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         241 RDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.6e-44  Score=301.32  Aligned_cols=252  Identities=37%  Similarity=0.676  Sum_probs=222.0

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ++|.+.+.||+|++|.||++.+..+++.|++|++...........+.+..|..+++.+. |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999997755444444577888999999998 99999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----  173 (284)
                      ||++++++|.+++.....++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999998889999999999999999999999999999999999999999999999999874432211    


Q ss_pred             -------------------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 023270          174 -------------------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS  234 (284)
Q Consensus       174 -------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  234 (284)
                                         ....++..|+|||.+.+...+.++|+||||++++++++|..||...+............. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  239 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY-  239 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC-
Confidence                               122356789999999888899999999999999999999999998887666666654333 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCH----HhhhcCccc
Q 023270          235 FPSAPSISAEAKHLISRLLVKDSSKRLSL----QKIMEHPWI  272 (284)
Q Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~il~~~~~  272 (284)
                       ..+..+++.+.+++.+||+.+|.+|||+    ++++.||||
T Consensus       240 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         240 -SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             3344789999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-44  Score=300.54  Aligned_cols=254  Identities=27%  Similarity=0.448  Sum_probs=213.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ....++|++.+.||.|++|.||+|.+..+++.|++|.+......   ....+.+|+.+++.++|+|++++++.+..++..
T Consensus         5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence            34456899999999999999999999999999999998554322   234567899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---  171 (284)
                      ++++||+++++|.+++...+.+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999998743322   


Q ss_pred             CCccccCCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CCCCCHHH
Q 023270          172 KRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---APSISAEA  245 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  245 (284)
                      ......+++.|+|||.+.   ...++.++|+||||+++++|++|..||...................+.   ...++..+
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence            223346788999999874   455788999999999999999999998765554444333333222221   12467889


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCcc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPW  271 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~  271 (284)
                      .+++.+||..+|++|||++++++|||
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-44  Score=296.38  Aligned_cols=250  Identities=31%  Similarity=0.507  Sum_probs=215.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|++|.||++.+..+++.+++|++......   ..+.+.+|+.+++.++|+|++++++++..++.++++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            5799999999999999999999989999999998654322   3467889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCc
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~  174 (284)
                      ||+++++|.+++... ..++...++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++.....   ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999998776 7899999999999999999999999999999999999999999999999998754332   122


Q ss_pred             cccCCCcccCccccCCC---CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCCCCCHHHHHH
Q 023270          175 TMCGTLDYLAPEMVENK---EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPSISAEAKHL  248 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  248 (284)
                      ...++..|+|||.+.+.   .++.++|+||||+++++|++|..||...+................   .....+.++.++
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            34567889999998776   788999999999999999999999988776665555444322221   223467889999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPW  271 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~  271 (284)
                      +++||..+|.+|||+++++.|+|
T Consensus       240 i~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         240 IKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.4e-44  Score=298.45  Aligned_cols=253  Identities=29%  Similarity=0.496  Sum_probs=213.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH-------HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-------KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+......       .....+.+.+|+..++.++|+|++++++++..++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            688999999999999999999889999999987532221       1123456788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..++|+||+++++|.+++...+.++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999987543321


Q ss_pred             -----CccccCCCcccCccccCCCC--CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCCCC
Q 023270          173 -----RHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP----SAPSI  241 (284)
Q Consensus       173 -----~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  241 (284)
                           .....++..|+|||.+....  ++.++|+||||++++++++|..||..........+.........    ....+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence                 12234678899999987654  78899999999999999999999977666554444333222222    22356


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +.++.+++.+||.++|.+|||++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-44  Score=301.58  Aligned_cols=251  Identities=28%  Similarity=0.513  Sum_probs=207.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||++.+..++..|++|++....... .....+.+|+.+++.++|+|++++++++..++..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            6899999999999999999999999999999986533221 223567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---
Q 023270          100 YAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---  173 (284)
Q Consensus       100 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---  173 (284)
                      |++ ++|..++...   ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            997 5888887653   468999999999999999999999999999999999999999999999999875432221   


Q ss_pred             ccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------
Q 023270          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-------------------  233 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------------  233 (284)
                      ....+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+.............                   
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            223457889999988654 478899999999999999999999987665443333221100                   


Q ss_pred             --C------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          234 --S------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       234 --~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                        .      ......+++++.++|++||+.||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence              0      00123478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-44  Score=296.14  Aligned_cols=251  Identities=35%  Similarity=0.601  Sum_probs=212.4

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHH-HHhCCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~-~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +.||.|++|.||+|.+..+++.|++|++.............+..+... ....+|+|++++++++..++..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            579999999999999999999999999865543332223333444433 4455899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCCCccc
Q 023270          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL  183 (284)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~  183 (284)
                      ++|.+++...+.++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....+++.|+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~y~  160 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKKFVGTPDYL  160 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-cccCCCCcCcc
Confidence            99999999888899999999999999999999999999999999999999999999999998754332 23345778899


Q ss_pred             CccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       184 aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      |||.+.+..++.++|+||||++++++++|..||...+..............++  ....+++++.+++.+||..+|.+||
T Consensus       161 ~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  240 (260)
T cd05611         161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL  240 (260)
T ss_pred             ChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHcc
Confidence            99999888889999999999999999999999998888877776665543333  2235789999999999999999999


Q ss_pred             ---CHHhhhcCccccccC
Q 023270          262 ---SLQKIMEHPWIIKNA  276 (284)
Q Consensus       262 ---s~~~il~~~~~~~~~  276 (284)
                         ++++++.||||++..
T Consensus       241 ~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         241 GANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             CCCcHHHHHcChHhhcCC
Confidence               558999999998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-44  Score=299.83  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=211.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++.+.||.|+||.||++.+..+++.|++|++......   ....+.+|+.+++.++|+|++++++.+..++..++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            345799999999999999999999999999999998643322   23467789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---C
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~  173 (284)
                      |+||+++++|.+++.....++...+..++.|++.|+.|||+.|++|+|++|+||+++.++.++|+|||++......   .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999988543221   2


Q ss_pred             ccccCCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CCCCCHHHHH
Q 023270          174 HTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---APSISAEAKH  247 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~  247 (284)
                      ....+++.|+|||.+.   ...++.++|+||+|+++++|++|..||...........+.......+.   ...++..+.+
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            3345778899999874   344788999999999999999999999765544433332222222221   2356889999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCcc
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPW  271 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~  271 (284)
                      ++++||..+|.+|||++++++|+|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.8e-44  Score=303.40  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=218.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      -..|++.+.||+|++|+||++.+..+++.|++|++...........+.+.+|+.+++.++|+|++++.+++..++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            35699999999999999999999999999999998654443444456788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccc
Q 023270           98 LEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM  176 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~  176 (284)
                      +||+. +++.+.+.. .+.++...+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-~~~~  171 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-ANSF  171 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-CCCc
Confidence            99997 577777654 45789999999999999999999999999999999999999999999999998754332 2334


Q ss_pred             cCCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          177 CGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       177 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      .+++.|+|||.+.   ...++.++||||||++++++++|..||...+.....................+.++.+++.+||
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  251 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCL  251 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence            5778899999874   4558889999999999999999999998877766655554433222223356889999999999


Q ss_pred             ccCCCCCCCHHhhhcCccccccCC
Q 023270          254 VKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ..+|.+||++.+++.||||++...
T Consensus       252 ~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         252 QKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             cCChhhCcCHHHHhcChhhcccCC
Confidence            999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.5e-44  Score=299.28  Aligned_cols=256  Identities=28%  Similarity=0.518  Sum_probs=219.3

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|...+.||.|++|.||++.+..++..+++|++.....   ...+.+.+|+.+++.++|+|++++++++..++..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            56667899999999999999989999999998854322   223567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCccc
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTM  176 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~~  176 (284)
                      |+++++|.+++.. ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....   .....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999999887 6789999999999999999999999999999999999999999999999997643322   12234


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS-APSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~  255 (284)
                      .+++.|+|||.+.+..++.++|+||||++++++++|..||...+................. ...++..+.+++.+||..
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence            5788999999998888999999999999999999999999888777776666654322221 224789999999999999


Q ss_pred             CCCCCCCHHhhhcCccccccCCCC
Q 023270          256 DSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      +|++|||++++++||||+++.++.
T Consensus       256 ~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         256 DPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             ChhhCcCHHHHccCcccccCCCcc
Confidence            999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.5e-44  Score=295.57  Aligned_cols=249  Identities=30%  Similarity=0.526  Sum_probs=214.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||.|++|.||++....++..|++|.+.....     .+.+.+|++.++.++|+|++++++++..++..++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            579999999999999999999988899999999855432     467889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Cc
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~  174 (284)
                      |++++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            999999999999764 57899999999999999999999999999999999999999999999999987543322   22


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHhc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-LSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ...++..|+|||.+.+..++.++|+||||+++++|++|..||...+............ .....+..++.++.+++.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            3346788999999988889999999999999999999999998766655444333221 122223357789999999999


Q ss_pred             ccCCCCCCCHHhhhcCccc
Q 023270          254 VKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~  272 (284)
                      ..+|.+|||++++|+||||
T Consensus       238 ~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         238 VKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hcChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.2e-44  Score=296.99  Aligned_cols=248  Identities=37%  Similarity=0.667  Sum_probs=219.7

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||.|++|.||++.+..+++.+++|++.............+.+|++.++.++|+|++++++.+..++..++++|++++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999888999999999766554445567888999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-----------Ccc
Q 023270          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----------RHT  175 (284)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----------~~~  175 (284)
                      .+++.+.+.+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......           ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            999988788999999999999999999999999999999999999999999999999987433222           123


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..++..|+|||...+...+.++|+||||++++++++|..||......+.......+...++....+++++.+++.+||+.
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence            34677899999998888999999999999999999999999988888887777765555555444599999999999999


Q ss_pred             CCCCCCCH---HhhhcCccccc
Q 023270          256 DSSKRLSL---QKIMEHPWIIK  274 (284)
Q Consensus       256 ~p~~Rps~---~~il~~~~~~~  274 (284)
                      +|.+|||+   .++|+||||.+
T Consensus       241 ~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         241 DPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CHhhcCCCccHHHHhcCccccC
Confidence            99999999   99999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-44  Score=298.95  Aligned_cols=250  Identities=29%  Similarity=0.497  Sum_probs=210.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC------
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD------   91 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~------   91 (284)
                      ..|++.+.||.|+||.||++.+..+++.|++|.+......    ...+.+|+..+..+ +|+|++++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4688999999999999999999999999999998654322    24567888888888 699999999998643      


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      ...++++||+++++|.+++...  ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999998864  36899999999999999999999999999999999999999999999999997543


Q ss_pred             C---CCCccccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          170 R---SKRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       170 ~---~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      .   .......+++.|+|||++.     +..++.++|+||+|+++++|++|..||........................+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            2   2223345788899999986     3357889999999999999999999998776665555544443333344467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +.++.+|+.+||..+|.+|||+++++.||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-44  Score=332.75  Aligned_cols=266  Identities=29%  Similarity=0.508  Sum_probs=219.7

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ....++.+.+|.+++.||.|+||+||+|.+..++..+++|++....... .....+..|+.++..++|+||+++++++..
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            3567788899999999999999999999999999999999986544333 234677889999999999999999998854


Q ss_pred             --CCeEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCCeEecCC--
Q 023270           91 --DERIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHEN-------HVIHRDIKPENLLLDHE--  155 (284)
Q Consensus        91 --~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~-------gi~H~dl~p~nil~~~~--  155 (284)
                        ...+|+||||+++++|..+|...    ..+++..++.++.||+.||.|||..       +|+|+||+|+|||++.+  
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              35789999999999999998753    5799999999999999999999985       49999999999999642  


Q ss_pred             ---------------CCEEEeecccccccCC--CCccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCC
Q 023270          156 ---------------GRLKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPF  216 (284)
Q Consensus       156 ---------------~~~~l~d~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~  216 (284)
                                     +.++|+|||++.....  ......+++.|+|||++.+  ..++.++|||||||++|+|++|..||
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                           3599999999854432  2233468999999999864  44789999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          217 EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ...+....+..........+ ....+.++.+||..||..+|.+||++.++|.||||+....|
T Consensus       244 ~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        244 HKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             CcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            76655544444444332222 23578999999999999999999999999999999877554

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-44  Score=301.40  Aligned_cols=253  Identities=27%  Similarity=0.482  Sum_probs=211.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|++|.||++.+..+++.|++|.+....... ...+.+.+|+++++.++|+|++++++++..++..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999998899999999986543322 33456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Ccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~  175 (284)
                      ||+++++|..+......++...++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99999888887777667999999999999999999999999999999999999999999999999987543221   122


Q ss_pred             ccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------------C
Q 023270          176 MCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-------------------F  235 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------------~  235 (284)
                      ..++..|+|||.+.+ ..++.++||||||+++++|++|.+||...+..+....+......                   .
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            346788999998865 34778999999999999999999999876655444333321000                   0


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 ----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                ...+.++..+.+++.+||..+|.+||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                      0123568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-44  Score=301.33  Aligned_cols=260  Identities=26%  Similarity=0.445  Sum_probs=219.9

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      ++.++|++.+.||+|++|+||++.+..+++.|++|++....  .......+.+|+++++.++|+|++++++++...+.++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            35678999999999999999999999899999999875432  1233567889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccC-CCC
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SKR  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-~~~  173 (284)
                      +|+||+++++|.+++...+.++...+..++.+++.++.|||+ .|++|+||+|+||+++.++.++|+|||++.... ...
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~  159 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence            999999999999999888889999999999999999999997 699999999999999999999999999874332 222


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCCCCCCCC
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-----------DTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~  242 (284)
                      ....++..|+|||.+.+..++.++|+||||++++++++|..||......           +.................++
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            3446788999999998888999999999999999999999999865542           23333333322222223478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .++.+|+.+||..||.+|||++++++|+||.+...
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            89999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-43  Score=294.11  Aligned_cols=252  Identities=30%  Similarity=0.590  Sum_probs=214.1

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||++.+..++..|++|.+...... ....+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            699999999999999999999889999999998665433 3456788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC------
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------  173 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~------  173 (284)
                      |+++++|.+++.....++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......      
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            99999999999887778999999999999999999999999999999999999999999999999875432221      


Q ss_pred             -ccccCCCcccCccccCCCC---CCchhhHhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhc-CCCCCCCCCCCHHHHH
Q 023270          174 -HTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKV-DLSFPSAPSISAEAKH  247 (284)
Q Consensus       174 -~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~  247 (284)
                       ....+++.|+|||.+.+..   .+.++|+||||++++++++|..||....... ........ ....+....+++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             1234678899999988766   8899999999999999999999997653332 22222221 2222233345899999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCccc
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ++.+||..+|.+|||+++++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-43  Score=292.80  Aligned_cols=252  Identities=31%  Similarity=0.538  Sum_probs=219.6

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIFLI   97 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~~~v   97 (284)
                      +|++.+.||+|++|.||++.+..+++.|++|++...... ....+.+.+|+..+++++|+|++++++.+...  +..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999989999999998665433 23457888999999999999999999999988  899999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-----
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----  172 (284)
                      +|++++++|.+++.+...++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......     
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999987554433     


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      .....++..|.|||.+.+...+.++|+||||++++++++|..||.... .................+..++.++.+++.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            234457888999999988889999999999999999999999998766 3333333333233344455779999999999


Q ss_pred             hcccCCCCCCCHHhhhcCccc
Q 023270          252 LLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~  272 (284)
                      |+..+|.+||++.+++.||||
T Consensus       240 ~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         240 CLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             hCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-44  Score=302.82  Aligned_cols=251  Identities=26%  Similarity=0.541  Sum_probs=205.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||+|.+..+|+.|++|.+....... .....+.+|+.+++.++|+|++++++++.+.+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            5899999999999999999999999999999986533221 223456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Ccc
Q 023270          100 YAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~  175 (284)
                      |+++ +|.+++.+ ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9974 78777765 467899999999999999999999999999999999999999999999999987543322   123


Q ss_pred             ccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCC--------------C---C-
Q 023270          176 MCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDL--------------S---F-  235 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~~--------------~---~-  235 (284)
                      ..+++.|+|||.+.+.. ++.++||||||+++++|++|..|+ ...+..+.+..+.+...              .   . 
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            34678899999987654 689999999999999999988875 44444444333322100              0   0 


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 ---------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                               ...+.++++++++|.+||..||.+|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                     0113468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.3e-44  Score=298.84  Aligned_cols=252  Identities=33%  Similarity=0.533  Sum_probs=212.8

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||+|.+..++..|++|++....... .....+.+|+.+++.++|+|++++++++..++..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            6899999999999999999999999999999986544322 234577889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC----Cc
Q 023270          100 YAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----RH  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~----~~  174 (284)
                      |+ +++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......    ..
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 88999988654 57899999999999999999999999999999999999999999999999987544332    22


Q ss_pred             cccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 023270          175 TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF------------------  235 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------------------  235 (284)
                      ...++..|+|||.+.+.. ++.++||||+|++++++++|.++|...+..+............                  
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            345788899999986544 6899999999999999999999898777666555544321110                  


Q ss_pred             -C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          236 -P---------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       236 -~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                       .         ..+..+.++.+++.+||..+|.+|||+++++.||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             0         0124578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.4e-44  Score=293.05  Aligned_cols=251  Identities=33%  Similarity=0.505  Sum_probs=218.3

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....... .....+.+|+++++.++|+|++++++.+..++..++|+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            6899999999999999999999999999999987654333 235678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccCCC--Cc
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSK--RH  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~--~~  174 (284)
                      |+++++|.+++...  ..+++..+..++.+++.++.+||++|++|+||+|+||+++.++ .++|+|||.+......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999999764  3589999999999999999999999999999999999998654 6899999988544322  23


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...++..|+|||.+.+...+.++|+||||++++++++|..||...+.............. .....++.++.+++.+||.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~  238 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLN  238 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHcc
Confidence            345788999999998888899999999999999999999999988877777666654332 3344689999999999999


Q ss_pred             cCCCCCCCHHhhhcCccc
Q 023270          255 KDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~  272 (284)
                      .+|.+|||++++++||||
T Consensus       239 ~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         239 LDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CChhhCCCHHHHhhCCCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-44  Score=299.60  Aligned_cols=258  Identities=27%  Similarity=0.462  Sum_probs=215.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++++.||.|++|.||++.+..++..|++|.+......  .....+.+|+.+++.++|+|++++++.+..++..++|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            3789999999999999999999999999999988543211  22356778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccC-CCC
Q 023270           99 EYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SKR  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-~~~  173 (284)
                      ||+++++|..++...   ..+++..+..++.+++.|+.|||. .|++|+||+|+||+++.++.++|+|||.+.... ...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            999999999888764   378999999999999999999997 599999999999999999999999999875432 222


Q ss_pred             ccccCCCcccCccccCCCC------CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCCCCCCCCHHH
Q 023270          174 HTMCGTLDYLAPEMVENKE------HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK--VDLSFPSAPSISAEA  245 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  245 (284)
                      ....+++.|+|||.+.+..      ++.++|+||||++++++++|..||..............  .......++.+++++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            3345778899999985443      47899999999999999999999977655544333222  112233344689999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .+++.+||..+|.+||+++++++||||.+...+
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            999999999999999999999999999887544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.8e-44  Score=301.23  Aligned_cols=258  Identities=28%  Similarity=0.506  Sum_probs=218.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|.....||+|+||.||++.+..++..|+||.+....   ....+.+.+|+..++.++|+|++++++.+..++..++|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            44666788999999999999998899999999985432   223456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~  175 (284)
                      ||+++++|.+++.. +.++...+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            99999999988754 4689999999999999999999999999999999999999999999999998743321   1223


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..++..|+|||.+.+..++.++|+||||++++++++|..||...+............. .......++..+.+++..||.
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence            4578889999999888899999999999999999999999988777665555443321 222233578899999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANPRG  280 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~~~  280 (284)
                      .+|.+|||++++++||||.....|.+
T Consensus       258 ~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         258 REPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             CChhHCcCHHHHhhChhhhccCCccc
Confidence            99999999999999999998877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.1e-44  Score=302.87  Aligned_cols=264  Identities=31%  Similarity=0.467  Sum_probs=217.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~   94 (284)
                      .+.+|++.+.||.|++|.||++.+..+++.|++|.+....... .......+|+.++++++|+|++++++++.+.  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            5688999999999999999999999999999999985433221 1122445789999999999999999998755  568


Q ss_pred             EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           95 FLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      ++|+||+++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999974 888888764 57899999999999999999999999999999999999999999999999988554322 


Q ss_pred             --CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------------
Q 023270          173 --RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS---------------  234 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------------  234 (284)
                        .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+..+....+......               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence              122234677999999865 45789999999999999999999999988887776655442110               


Q ss_pred             ----CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCCCC
Q 023270          235 ----FPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC  282 (284)
Q Consensus       235 ----~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  282 (284)
                          ...         ....++++.++|.+||.+||++|||++++++||||++.+.|.-+|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~  303 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPE  303 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCC
Confidence                000         012578899999999999999999999999999999998886555

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-44  Score=309.00  Aligned_cols=248  Identities=24%  Similarity=0.407  Sum_probs=200.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|.+++.||.|+||.||+|.+..++..|++|+....         ....|+.+++.++|+||+++++++..++..++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            345799999999999999999999999999999985332         22357889999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC--CCC
Q 023270           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKR  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~--~~~  173 (284)
                      |+|++. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....  ...
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            999996 578777765 4678999999999999999999999999999999999999999999999999985432  222


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHhcC----CCCC---
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQ---------KDTFRRIMKVD----LSFP---  236 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~-~p~~~~~~---------~~~~~~~~~~~----~~~~---  236 (284)
                      ....|++.|+|||++.+..++.++||||||+++|+|+++. .+|.....         ...+..+....    ..++   
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            3456889999999999989999999999999999999844 44443211         11111111100    0000   


Q ss_pred             -------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          237 -------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       237 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                                               ....++.++.+||.+||+.||++|||++++|+||||++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                     01135667888999999999999999999999999986

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=297.91  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=212.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|++|.||++.+..+++.|++|++...... ....+.+.+|+++++.++|+|++++++++..++..++++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            4799999999999999999999999999999998654322 233467889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC----Cc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----RH  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~----~~  174 (284)
                      ||++++.+..+..+...++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......    ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            99998777666666677999999999999999999999999999999999999999999999999987544332    22


Q ss_pred             cccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------C
Q 023270          175 TMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-------------------S  234 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------------~  234 (284)
                      ...++..|+|||.+.+. .++.++|+||||++++++++|..||...+..+..........                   .
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            34567889999999887 789999999999999999999999987665544433222100                   0


Q ss_pred             C-----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          235 F-----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       235 ~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      .           .....++.++.+|+.+||..+|++|||+++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0           0011348889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.8e-44  Score=297.54  Aligned_cols=254  Identities=29%  Similarity=0.461  Sum_probs=212.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEe----
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH----   89 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~----   89 (284)
                      .-....|++.+.||.|+||.||++.+..+++.+++|++.....    ....+..++.+++.+ +|+|++++++++.    
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            3345789999999999999999999999999999999854321    224567788888888 6999999999884    


Q ss_pred             --cCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccc
Q 023270           90 --DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        90 --~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                        .++..+++|||+++++|.+++...  ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence              346789999999999999998764  3578888999999999999999999999999999999999999999999998


Q ss_pred             ccccC---CCCccccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 023270          166 SVQSR---SKRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS  237 (284)
Q Consensus       166 ~~~~~---~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  237 (284)
                      +....   .......+++.|+|||.+.     +..++.++|+||||+++++|++|..||.....................
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  247 (282)
T cd06636         168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK  247 (282)
T ss_pred             hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence            75432   2223345788999999875     345778999999999999999999999877666555554444333334


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ...++.++.++|++||..||.+||++.++++||||
T Consensus       248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            44688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-43  Score=293.71  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=213.0

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      +...+|++.+.||.|+||.||++.+.   ..+..|++|.+......  .....+.+|+..+..++|+|++++++++..++
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            45678999999999999999999765   34568999998654322  23457888999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999999775 5789999999999999999999999999999999999999999999999998644322


Q ss_pred             CC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          172 KR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       172 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      ..    ....++..|+|||.+.+..++.++||||||++++++++ |..||...+..+....+..+. ..+.+..++..+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-RLPAPRNCPNLLH  238 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCCCCCCCCHHHH
Confidence            11    11223567999999999999999999999999999775 999999888887777665543 3445567899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhc
Q 023270          247 HLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +++.+||..+|.+||++++|++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-43  Score=292.10  Aligned_cols=251  Identities=32%  Similarity=0.530  Sum_probs=216.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec--CCeEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERIFLI   97 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~--~~~~~~v   97 (284)
                      +|++.+.||.|++|.||++.+..++..+++|++....... ...+.+..|++.++.++|+|++++++++..  +...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            6899999999999999999999999999999986543332 234567889999999999999999997753  4578999


Q ss_pred             EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCH-----ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh-----~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      +||+++++|.+++..    ..+++...++.++.+++.||.+||     +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999876    357899999999999999999999     89999999999999999999999999998855


Q ss_pred             cCCCC---ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          169 SRSKR---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       169 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      .....   ....+++.|+|||.+.+...+.++|+||||++++++++|..||...+..........+.. ...+...+.++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  238 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-RRIPYRYSSEL  238 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-CCCccccCHHH
Confidence            43322   234578899999999988899999999999999999999999998887666666555433 33445788999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      .+++.+||..+|.+||+++++++|||+
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.8e-44  Score=297.36  Aligned_cols=251  Identities=23%  Similarity=0.392  Sum_probs=215.2

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCC-----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      +.+++|++.+.||.|++|.||++.+...+     ..|++|.+.....  ......+.+|+..+..++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            45779999999999999999999876655     6799999864332  2334678899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC
Q 023270           91 DERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~  154 (284)
                      .+..++++||+++++|.+++...                ..++...++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999999764                35788999999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 023270          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRI  228 (284)
Q Consensus       155 ~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  228 (284)
                      ++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++++|++ |..||.+.+..+....+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987543221     123345678999999988889999999999999999998 99999988888777766


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .... ....+..+|+++.+|+.+||+.||.+||++.+++++
T Consensus       240 ~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6543 334456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-43  Score=296.50  Aligned_cols=255  Identities=31%  Similarity=0.484  Sum_probs=218.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|+..+.||.|++|.||++.+..++..|++|.+......  .....+.+|+..++.+.|+|++++++.+.++...++|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4688999999999999999999999999999998654322  23467888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Ccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~  175 (284)
                      ||+++++|.+++.. ++++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||.+......   ...
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999998875 56899999999999999999999999999999999999999999999999987443221   122


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..++..|+|||.+.+...+.++|+||||++++++++|..||...+........... ........++.++.+++.+||..
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-NPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-CCCCCchhhhHHHHHHHHHHccc
Confidence            34677899999998888999999999999999999999999887766555544332 22333346788999999999999


Q ss_pred             CCCCCCCHHhhhcCccccccCC
Q 023270          256 DSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      +|.+||++++++.||||.+...
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         240 DPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             CcccCcCHHHHHhChHhhhcch
Confidence            9999999999999999988743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-43  Score=297.00  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=208.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHH-HHHhCCCCcccceeeEEecCCeEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~-~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+........  ...+..++. .++..+|+|++++++++..++..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            479999999999999999999999999999999865432221  123334444 46677899999999999999999999


Q ss_pred             EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      +||++ ++|.+++..    ...+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 588777754    24689999999999999999999997 9999999999999999999999999987543322


Q ss_pred             C--ccccCCCcccCccccCC----CCCCchhhHhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          173 R--HTMCGTLDYLAPEMVEN----KEHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       173 ~--~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      .  ....++..|+|||.+.+    ..++.++|+||||++++++++|..||... ...+.+...............+|.++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF  237 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence            1  22457788999998865    34688999999999999999999999753 33344444444332222334688999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .+++.+||..+|.+||+++++++||||++...+
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.5e-43  Score=296.10  Aligned_cols=253  Identities=31%  Similarity=0.505  Sum_probs=210.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~----   91 (284)
                      ...+|.+.+.||+|++|.||++.+..+++.+++|++......    ...+.+++.++..+ +|+|++++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            467899999999999999999999999999999998543222    24566788888888 799999999998643    


Q ss_pred             -CeEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           92 -ERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        92 -~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                       +..++|+||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence             368999999999999998753    357899999999999999999999999999999999999999999999999987


Q ss_pred             cccCC---CCccccCCCcccCccccCCCC-----CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCC
Q 023270          167 VQSRS---KRHTMCGTLDYLAPEMVENKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPS  237 (284)
Q Consensus       167 ~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~  237 (284)
                      .....   ......++..|+|||.+....     ++.++|+||||+++++|++|..||..........++..... ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  255 (291)
T cd06639         176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH  255 (291)
T ss_pred             hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence            54322   122345678899999875432     67899999999999999999999988777666655544322 2223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      .+..+..+.+++.+||..+|.+||++.++++||||+
T Consensus       256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            345778899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=295.62  Aligned_cols=251  Identities=31%  Similarity=0.517  Sum_probs=210.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC-----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD-----   91 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~-----   91 (284)
                      -++|++.+.||.|++|.||+|.+..++..+++|++.....    ..+.+.+|+.+++.+ .|+|++++++++...     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            3789999999999999999999988999999999865432    235678899999998 699999999998654     


Q ss_pred             -CeEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           92 -ERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        92 -~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                       ..+++|+||+++++|.+++..    ...++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence             458999999999999998865    347899999999999999999999999999999999999999999999999987


Q ss_pred             cccCC---CCccccCCCcccCccccCC-----CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC
Q 023270          167 VQSRS---KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-PS  237 (284)
Q Consensus       167 ~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~  237 (284)
                      .....   ......++..|+|||.+..     ..++.++||||||++++++++|..||..........++....... ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence            44322   2233457888999998753     346788999999999999999999998776666666555543222 22


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ....+.++++++++||..||.+|||++++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22377899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-44  Score=312.55  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEe--cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      +...+|.+++.||.|+||.||++...  ..+..|++|.+...        ....+|+++++.++|+||+++++++...+.
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            34457999999999999999999754  35677999988543        234578999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      .+++||++. ++|..++.....+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++...... 
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            999999996 588888877788999999999999999999999999999999999999999999999999987543321 


Q ss_pred             ----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcC-------------
Q 023270          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---KDTFRRIMKVD-------------  232 (284)
Q Consensus       173 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~-------------  232 (284)
                          .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+...   ...+..+.+..             
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence                1234689999999999998999999999999999999999999965432   11222111100             


Q ss_pred             ------------CC--CCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          233 ------------LS--FPS-----APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       233 ------------~~--~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                  ..  ...     ...++.++.++|++||..||++|||+.++|.||||++.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                        00  000     113567899999999999999999999999999999864

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8e-44  Score=299.98  Aligned_cols=258  Identities=29%  Similarity=0.543  Sum_probs=219.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .-|.....||.|+||.||++.+..++..|++|.+......   ..+.+.+|+..+..++|+|++++++++..++..++++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            3466677899999999999999989999999998543322   2356778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~  175 (284)
                      ||+++++|..++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99999999887755 5689999999999999999999999999999999999999999999999998743222   1223


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..... .......++.++.+++++||.
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence            4578899999999888899999999999999999999999988777666665544322 122234678899999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANPRG  280 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~~~  280 (284)
                      .+|.+||+++++++||||.++..|.|
T Consensus       257 ~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         257 REPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             CCcccCcCHHHHhhChhhccCCCccc
Confidence            99999999999999999999977654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.9e-43  Score=291.55  Aligned_cols=251  Identities=21%  Similarity=0.361  Sum_probs=216.7

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      +++...+|.+.+.||+|++|.||++.+..+++.|++|.+.....    ....+.+|++.++.++|+|++++++++..++.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   76 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence            35677889999999999999999999999999999999864332    23567789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           94 IFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      .++++||+++++|.+++...  ..++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999999998764  3589999999999999999999999999999999999999999999999998754433


Q ss_pred             CCc----cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          172 KRH----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       172 ~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      ...    ....+..|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+... .....+..++.++.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVY  235 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHH
Confidence            221    1223567999999988889999999999999999998 99999988877776666543 34455567899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcC
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++.+||..+|.+|||+.++++.
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHHH
Confidence            99999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-43  Score=293.00  Aligned_cols=252  Identities=27%  Similarity=0.498  Sum_probs=211.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.+|++.+.||.|+||.||++.+..+++.|++|.+.............+.+|+.+++.++|+|++++++++..++..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            46899999999999999999999999999999987553333334456778899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC
Q 023270           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  173 (284)
                      +||+++++|.+++..    ...++...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988853    3457899999999999999999999999999999999999999999999999875433221


Q ss_pred             ---ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES--QKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       174 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                         ....+++.|+|||.+.+...+.++|+||+|++++++++|..||....  .......+.............+..+.++
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL  240 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence               23457788999999988889999999999999999999999986543  2344444443333333334678899999


Q ss_pred             HHHhcccCCCCCCCHHhhhcC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.+||..+|.+||+++++++.
T Consensus       241 i~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         241 VSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.7e-44  Score=299.57  Aligned_cols=258  Identities=29%  Similarity=0.466  Sum_probs=218.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .....+|.+.+.||+|+||.||++.+..+++.|++|.+.....   ...+.+.+|+..++.++|+|++++++++..++..
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            3345789999999999999999999988999999999854322   2235678899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      ++|+||+++++|.+++.+. .++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999999999988764 5789999999999999999999999999999999999999999999999986433221  


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCCCCCCCCCCCHHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  250 (284)
                       .....+++.|+|||.+.+..++.++|+||||++++++++|..||...+.......... .......+..++..+.++++
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence             2233577889999999888899999999999999999999999987766544433322 22223334467889999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +||..+|.+||++.+++.||||++..
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999999774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-43  Score=296.85  Aligned_cols=251  Identities=30%  Similarity=0.535  Sum_probs=208.2

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++++.||.|++|.||+|.+..+++.|++|.+....... .....+.+|++++++++|+|++++++++.+++..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            5899999999999999999999999999999886433221 223567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Cc
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~  174 (284)
                      |++ ++|.+++...  ..++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 5888888653  46899999999999999999999999999999999999999999999999987543221   12


Q ss_pred             cccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 023270          175 TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF------------------  235 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------------------  235 (284)
                      ...+++.|+|||.+.+.. ++.++|+||||+++++++||..||...+..+...+........                  
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            234577899999887654 6889999999999999999999998776655444433211100                  


Q ss_pred             C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 P---------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +         ..+.++++++++|.+||..||.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0         012468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.7e-44  Score=309.12  Aligned_cols=255  Identities=25%  Similarity=0.423  Sum_probs=209.7

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEE-----ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      .+++..++|++.+.||.|+||.||+|..     ..++..||+|++......  ...+.+.+|++++..+ +||||+++++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeee
Confidence            3445566899999999999999999974     345668999998643322  2245678899999999 8999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcC----------------------------------------------------
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHR----------------------------------------------------  114 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------------------------------------------  114 (284)
                      ++..++..++||||+++|+|.+++....                                                    
T Consensus       107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (375)
T cd05104         107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR  186 (375)
T ss_pred             eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence            9999999999999999999999886421                                                    


Q ss_pred             -----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270          115 -----------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus       115 -----------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                                             .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                                   367888999999999999999999999999999999999999999999999854332


Q ss_pred             CC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          172 KR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       172 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ..     ....++..|+|||.+.+..++.++||||||++++++++ |..||..........+..........+...+.++
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  346 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM  346 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence            21     11234567999999999999999999999999999997 8999987665544444444433444445678999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+|+.+||+.||++|||+.++++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.6e-43  Score=298.15  Aligned_cols=255  Identities=25%  Similarity=0.447  Sum_probs=217.4

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |...+.||+|++|+||++++..++..|++|.+.............+.+|+..++.++|+|++++++++.++...++|+||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999999999999999998654443334445778899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCC
Q 023270          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT  179 (284)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  179 (284)
                      +. +++.+.+... .+++...++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++.... ......++
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-~~~~~~~~  180 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-PANSFVGT  180 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-CCCCcccc
Confidence            96 5777777653 578999999999999999999999999999999999999999999999999875432 22345678


Q ss_pred             CcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 023270          180 LDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD  256 (284)
Q Consensus       180 ~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (284)
                      ..|+|||.+.   +..++.++|+||||+++++|++|..||...+..................+.++..+.+++.+||+.+
T Consensus       181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  260 (313)
T cd06633         181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI  260 (313)
T ss_pred             ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence            8899999974   4568889999999999999999999998887766666665544444444567889999999999999


Q ss_pred             CCCCCCHHhhhcCccccccCC
Q 023270          257 SSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       257 p~~Rps~~~il~~~~~~~~~~  277 (284)
                      |.+||++++++.||||+..+-
T Consensus       261 P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         261 PQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             hhhCcCHHHHhcCcccCCCch
Confidence            999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=288.17  Aligned_cols=251  Identities=33%  Similarity=0.593  Sum_probs=220.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||++.+..+++.|++|.+....... ...+.+.+|++++++++|+|++++++++..++..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            6899999999999999999999899999999997655432 345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---ccc
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTM  176 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~~  176 (284)
                      ++++++|.+++.....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            99999999999888889999999999999999999999999999999999999999999999999885544322   234


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD  256 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (284)
                      .++..|+|||...+...+.++|+|++|++++++++|..||...+........... .....++.++.++.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHHhCC
Confidence            5678899999998888899999999999999999999999877766555554433 233344578899999999999999


Q ss_pred             CCCCCCHHhhhcCccc
Q 023270          257 SSKRLSLQKIMEHPWI  272 (284)
Q Consensus       257 p~~Rps~~~il~~~~~  272 (284)
                      |++|||+++++.||||
T Consensus       239 p~~R~~~~~~l~~~~~  254 (254)
T cd06627         239 PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-43  Score=295.04  Aligned_cols=251  Identities=30%  Similarity=0.458  Sum_probs=210.1

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||.|+||+||+|.+..+++.|++|.+.............+..|+.+++.++|+|++++++++...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999998765443333445667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCccccCCCcc
Q 023270          107 YRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHTMCGTLDY  182 (284)
Q Consensus       107 ~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~y  182 (284)
                      .+++.+.+  .+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.....  ......++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99998765  789999999999999999999999999999999999999999999999998754322  22234567889


Q ss_pred             cCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--DLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       183 ~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      +|||.+.+..++.++|+||+|+++++|++|..||...........+...  ......++.+++++.+++++||..+|.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            9999998888999999999999999999999999776542222222211  11223344689999999999999999999


Q ss_pred             C-----CHHhhhcCccccccCC
Q 023270          261 L-----SLQKIMEHPWIIKNAN  277 (284)
Q Consensus       261 p-----s~~~il~~~~~~~~~~  277 (284)
                      |     ++.++++||||.+-+-
T Consensus       241 ~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         241 LGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             cCCCcccHHHHHhChhhhcCCh
Confidence            9     8888999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-43  Score=312.21  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ....|.+.+.||.|+||.||++.+..++..|++|....         ..+.+|+++++.++|+||+++++++..++..++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            35579999999999999999999999999999997422         234579999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---  172 (284)
                      |+|++. ++|..++... ..+++..++.++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++......   
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            999996 5888887664 46999999999999999999999999999999999999999999999999998543221   


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCC-CCC-------ChHHHHHHHHhcCCC---CC---
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-EAE-------SQKDTFRRIMKVDLS---FP---  236 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~-~~~-------~~~~~~~~~~~~~~~---~~---  236 (284)
                        .....|+..|+|||++.+..++.++||||||+++|+|++|..++ ...       ....+.+.+......   ++   
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence              12345899999999999999999999999999999999876543 221       112222222211110   00   


Q ss_pred             --------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          237 --------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       237 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                                                ....++.++.+||++||..||++|||++|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                      00134568999999999999999999999999999975

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.2e-43  Score=289.06  Aligned_cols=251  Identities=36%  Similarity=0.637  Sum_probs=220.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||++.+..++..|++|++....... ...+.+.+|++.++.++|+|++++.+.+..++..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh-HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            6899999999999999999999999999999986644322 334577889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---
Q 023270          100 YAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (284)
Q Consensus       100 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---  172 (284)
                      ++++++|.+.+.+.    ..++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999999774    67899999999999999999999999999999999999999999999999987544332   


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHh
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL  252 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (284)
                      .....+++.|+|||.+.+..++.++|+||+|++++++++|..||...+............. ...+..++.++.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~  238 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY-PPIPSQYSSELRNLVSSL  238 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHH
Confidence            2234577889999999888899999999999999999999999988887777777665542 333447889999999999


Q ss_pred             cccCCCCCCCHHhhhcCccc
Q 023270          253 LVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       253 l~~~p~~Rps~~~il~~~~~  272 (284)
                      |..+|.+|||++++|+||||
T Consensus       239 l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         239 LQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             cCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.1e-43  Score=295.92  Aligned_cols=255  Identities=29%  Similarity=0.536  Sum_probs=219.8

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .-..|++...||+|++|.||++.+..++..|++|++.....    ....+.+|++.++.++|+|++++++.+..++..++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            34559999999999999999999998999999999865432    34567789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---
Q 023270           97 ILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---  172 (284)
                      ++||+++++|.+++...+ .++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            999999999999998876 8999999999999999999999999999999999999999999999999987433221   


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-FPSAPSISAEAKHLISR  251 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  251 (284)
                      .....++..|+|||.+.+..++.++|+||||++++++++|..||...+.............. ......++.++.+++++
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence            12234678899999998888999999999999999999999999887776655554443222 22223478999999999


Q ss_pred             hcccCCCCCCCHHhhhcCcccccc
Q 023270          252 LLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||+.+|.+|||+.++++|+||++.
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.1e-43  Score=287.45  Aligned_cols=249  Identities=33%  Similarity=0.586  Sum_probs=216.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|.+.+.||.|++|.||++.+..+++.+++|++.....   .....+.+|+..++.++|++++++++.+..++..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            68999999999999999999988999999999865443   235678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--ccc
Q 023270          100 YAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTM  176 (284)
Q Consensus       100 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~  176 (284)
                      |+++++|.+++... ..++...+..++.+++.++.+||..|++||||+|+||+++.++.++|+|||.+.......  ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999999999876 578999999999999999999999999999999999999999999999999875544332  445


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .++..|+|||.+.+...+.++|+||||++++++++|..||...+............. .......++.++.+++.+||..
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence            678889999999888899999999999999999999999988766555554443222 2222223489999999999999


Q ss_pred             CCCCCCCHHhhhcCcc
Q 023270          256 DSSKRLSLQKIMEHPW  271 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~  271 (284)
                      ||.+|||+.++++|||
T Consensus       238 ~p~~R~t~~~~l~~~~  253 (253)
T cd05122         238 NPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ChhhCCCHHHHhcCCC
Confidence            9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=294.96  Aligned_cols=255  Identities=29%  Similarity=0.496  Sum_probs=213.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC---CCcccceeeEEecCCeEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERIF   95 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~---h~~i~~~~~~~~~~~~~~   95 (284)
                      +.|++.+.||.|++|.||++.+..++..|++|.+......  .....+.+|+.+++.++   |+|++++++++..+...+
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            3588999999999999999999999999999998543221  22346678888888886   999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---  172 (284)
                      +|+||+++++|.+++.. ..++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus        79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            99999999999998866 47899999999999999999999999999999999999999999999999987543322   


Q ss_pred             CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      .....++..|+|||.+.++ .++.++|+||||+++++|++|..||........................++.++.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA  237 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence            2234577889999988654 468899999999999999999999987766555443333222222222378899999999


Q ss_pred             hcccCCCCCCCHHhhhcCccccccC
Q 023270          252 LLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ||..||.+||++++++.|+||++..
T Consensus       238 ~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         238 CLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HcCCCcccCcCHHHHhhChHhhccc
Confidence            9999999999999999999998875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=288.66  Aligned_cols=244  Identities=43%  Similarity=0.716  Sum_probs=217.4

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||.|++|.||++.+..+++.+++|.+.............+..|+.+++.++|+|++++++.+..++..+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999888999999998776555444567888999999999999999999999999999999999988999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---CccccCCCccc
Q 023270          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYL  183 (284)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~y~  183 (284)
                      .+++.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   .....++..|.
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999998888999999999999999999999999999999999999999999999999987554332   33455788899


Q ss_pred             CccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023270          184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL  263 (284)
Q Consensus       184 aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  263 (284)
                      |||...+...+.++|+||||++++++++|..||...+............  ...+...++++.+++.+||..||.+||++
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~R~~~  238 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKDPTKRLGS  238 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence            9999988889999999999999999999999998888776666666533  44444679999999999999999999999


Q ss_pred             ---HhhhcCccc
Q 023270          264 ---QKIMEHPWI  272 (284)
Q Consensus       264 ---~~il~~~~~  272 (284)
                         +++++||||
T Consensus       239 ~~~~~l~~~~~f  250 (250)
T cd05123         239 GGAEEIKAHPFF  250 (250)
T ss_pred             ccHHHHHhCCCC
Confidence               999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-43  Score=307.72  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=210.7

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecC-----CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      .+.+...+|++.+.||.|+||.||++.+...     +..||+|.+.......  ....+.+|+++++.+ +|+||+++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEee
Confidence            3445567899999999999999999986543     3579999986543222  245678899999999 8999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhc-----------------------------------------------------
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKH-----------------------------------------------------  113 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~-----------------------------------------------------  113 (284)
                      .+..++..++||||+++++|.+++...                                                     
T Consensus       110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            999999999999999999999988542                                                     


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCc--
Q 023270          114 -----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH--  174 (284)
Q Consensus       114 -----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--  174 (284)
                                       ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........  
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                             1367888999999999999999999999999999999999999999999999754322211  


Q ss_pred             ---cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          175 ---TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       175 ---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                         ...++..|+|||++.+..++.++||||||+++++|++ |..||.....................+..+++++.+++.
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK  349 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence               1224567999999988889999999999999999997 999998776655555555544444455567899999999


Q ss_pred             HhcccCCCCCCCHHhhhc
Q 023270          251 RLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~  268 (284)
                      +||+.||.+|||++++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         350 MCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-43  Score=289.12  Aligned_cols=253  Identities=25%  Similarity=0.504  Sum_probs=217.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhh--hHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~   94 (284)
                      .+|++.+.||+|++|.||++.+..++..|++|.+...  ..........+.+|+..++.++|+|++++++++.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999999999999999987432  112233456888999999999999999999988654  468


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---  171 (284)
                      ++++||+++++|.+++.+.+.++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....   
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999998754321   


Q ss_pred             ---CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       172 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                         ......++..|+|||.+.+..++.++|+||||++++++++|..||..........+..........++.+++++.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  241 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF  241 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence               11233577889999999988899999999999999999999999988777666666555444444566789999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +.+||. +|..||++.+++.|||+
T Consensus       242 i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         242 LKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHhc-CcccCccHHHHhcCCCC
Confidence            999998 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=292.69  Aligned_cols=265  Identities=38%  Similarity=0.645  Sum_probs=245.2

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      +.....++.+++|..++.||.|.||.|.+++.+.+++.||+|++.++-+........-..|-++++..+||.+..+...|
T Consensus       158 ~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  158 EAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             cccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            44556678999999999999999999999999999999999999988887777777888899999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ...+.+|+||||..||.|...+.+...++++..+-+...|+.||.|||+++|+++|+|.+|.|++.+|++||.|||+...
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence            99999999999999999999898888999999999999999999999999999999999999999999999999999844


Q ss_pred             c---CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          169 S---RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       169 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      .   +......+|+|.|+|||++....+..+.|.|.+|++||+|++|++||...+...+..-++.....++.  .++++.
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr--~ls~eA  395 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR--TLSPEA  395 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc--cCCHHH
Confidence            3   34456678999999999999999999999999999999999999999999999999989988888877  799999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHhhhcCcccccc
Q 023270          246 KHLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      +.|+..+|..||.+|.     .+.+|.+|+||...
T Consensus       396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            9999999999999998     78999999999753

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.7e-43  Score=294.25  Aligned_cols=249  Identities=30%  Similarity=0.493  Sum_probs=201.6

Q ss_pred             eeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHH---HHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM---EIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~---~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      .||+|+||.||++.+..+++.+++|.+...............++.   ..+...+|++++.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999988654332211112222333   34444579999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-CCccccCCCc
Q 023270          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLD  181 (284)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~  181 (284)
                      +++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ......++..
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  160 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcC
Confidence            999999998888899999999999999999999999999999999999999999999999998754322 2223457899


Q ss_pred             ccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 023270          182 YLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       182 y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (284)
                      |+|||.+.+ ..++.++|+||+|+++++|++|..||......  ....... .......++.+++++.+++++||..||.
T Consensus       161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (279)
T cd05633         161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQRDVS  239 (279)
T ss_pred             ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence            999998864 55889999999999999999999999754321  2222221 1223334457899999999999999999


Q ss_pred             CCC-----CHHhhhcCcccccc
Q 023270          259 KRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       259 ~Rp-----s~~~il~~~~~~~~  275 (284)
                      +||     |+.++++||||+.-
T Consensus       240 ~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         240 KRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HhcCCCCCCHHHHHhCccccCC
Confidence            999     69999999999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.3e-43  Score=296.00  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=204.6

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEec----------------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCC
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVE----------------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP   79 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~   79 (284)
                      +..++|++.++||+|+||.||+|.+..                ++..||+|.+......  .....+.+|+.++.+++|+
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCC
Confidence            445789999999999999999997532                3446999998654322  2346788999999999999


Q ss_pred             cccceeeEEecCCeEEEEEeecCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023270           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-------------------RFTEQQAATYIASLTNALAYCHENHV  140 (284)
Q Consensus        80 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~~i~~~l~~lh~~gi  140 (284)
                      ||+++++++.+.+..++||||+++++|.+++....                   .++...++.++.|++.||.|||+.|+
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999886532                   35778899999999999999999999


Q ss_pred             cccCCCCCCeEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh--CC
Q 023270          141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GA  213 (284)
Q Consensus       141 ~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~  213 (284)
                      +|+||+|+||+++.++.++|+|||++.......     ....++..|+|||.+.+..++.++||||||+++++|++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            999999999999999999999999885432211     22334678999999988889999999999999999986  66


Q ss_pred             CCCCCCChHHHHHHHHhc------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          214 PPFEAESQKDTFRRIMKV------DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       214 ~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .||...+..+........      ......++.++..+.+++.+||..+|++|||+++|.+
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            788877666555443221      1112233467899999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.5e-43  Score=288.08  Aligned_cols=247  Identities=29%  Similarity=0.520  Sum_probs=214.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||++.+..++..|++|.+......  ...+.+.+|+.+++.++|+|++++++.+..++.+++++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            689999999999999999999999999999998543322  234677789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Cc
Q 023270          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~  174 (284)
                      |+++++|.+++...  ..++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+......   ..
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            99999999988653  45799999999999999999999999999999999999999999999999987543322   22


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..........+... +.+..++..+.+++.+||+
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~  237 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFK  237 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHh
Confidence            345788899999998888999999999999999999999999988877777776655433 2334688999999999999


Q ss_pred             cCCCCCCCHHhhhcC
Q 023270          255 KDSSKRLSLQKIMEH  269 (284)
Q Consensus       255 ~~p~~Rps~~~il~~  269 (284)
                      .||.+|||+.+++.-
T Consensus       238 ~~P~~Rp~~~~il~~  252 (255)
T cd08219         238 RNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCCCHHHHhhc
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-44  Score=294.68  Aligned_cols=244  Identities=32%  Similarity=0.580  Sum_probs=204.0

Q ss_pred             EeeeeeccCCCeEEEEEEEe----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           22 EIGRPLGKGKFGRVYLVREV----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      .+.+.||.|.||.||+|...    ..+..|+||.+....  .....+.+.++++.+++++|+||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence            46789999999999999988    456679999994432  222357888999999999999999999999988889999


Q ss_pred             EeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---
Q 023270           98 LEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---  172 (284)
                      +||+++++|.+++...  ..++...++.++.|++.||.|||+.+++|++|+++||+++.++.+||+|||+.......   
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999887  67999999999999999999999999999999999999999999999999998655221   


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                        .........|+|||.+.+..++.++||||||++++++++ |..||...+..+....+..+. ..+.+..++..+.+++
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-RLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-ETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cceeccchhHHHHHHH
Confidence              122335678999999988889999999999999999999 789999998888888875543 3445557899999999


Q ss_pred             HHhcccCCCCCCCHHhhhc
Q 023270          250 SRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~  268 (284)
                      .+||..+|++|||+.++++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.8e-43  Score=290.69  Aligned_cols=251  Identities=29%  Similarity=0.521  Sum_probs=211.5

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.+|++.+.||.|++|.||++.+..++..+++|.+.............+.+|+.+++.++|+|++++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            36899999999999999999999999999999988654444444456788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      +|++++++|.+++..    ...+++..++.++.+++.++.|||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998864    346899999999999999999999999999999999999999999999999987443222 


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ--KDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                        .....++..|+|||.+.+...+.++|+||||+++++|++|..||.....  ...................++.++.++
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL  240 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence              1234578889999999888899999999999999999999999975443  233333333332323334688899999


Q ss_pred             HHHhcccCCCCCCCHHhhhc
Q 023270          249 ISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~  268 (284)
                      +.+||..+|.+|||++++++
T Consensus       241 i~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         241 VNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHhcCCCcccCCCHHHHHH
Confidence            99999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.2e-43  Score=288.45  Aligned_cols=249  Identities=22%  Similarity=0.413  Sum_probs=213.3

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      +.+...+|++.++||+|++|.||++.+ .++..|++|.+......    .+.+.+|+.+++.++|+|++++++.+..++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            356788999999999999999999986 45677999987543322    3577889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           94 IFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      .++++||+++++|.+++...  ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            99999999999999999764  4678899999999999999999999999999999999999999999999999854432


Q ss_pred             CC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          172 KR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       172 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      ..    ....++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.......+... ...+....++.++.
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELY  234 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHH
Confidence            11    12234567999999988889999999999999999998 99999988877777766654 33444457899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhc
Q 023270          247 HLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +++.+||..+|++||+++++++
T Consensus       235 ~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         235 DIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.5e-43  Score=291.26  Aligned_cols=253  Identities=30%  Similarity=0.481  Sum_probs=216.6

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |++.+.||.|+||.||++.+..++..|++|.+......  ...+.+.+|+..++.++|+|++++++.+..++..++|+||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            77889999999999999999889999999987543322  2346788899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Ccccc
Q 023270          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMC  177 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~  177 (284)
                      +++++|.+++.. ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++......   .....
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence            999999988865 46899999999999999999999999999999999999999999999999987433221   12235


Q ss_pred             CCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCC
Q 023270          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS  257 (284)
Q Consensus       178 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  257 (284)
                      ++..|+|||.+.+..++.++|+||||++++++++|..||...........+.... .......++.++.+++.+||..+|
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p  241 (277)
T cd06641         163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP  241 (277)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCCh
Confidence            6788999999988889999999999999999999999998777666555543332 222334678999999999999999


Q ss_pred             CCCCCHHhhhcCccccccCC
Q 023270          258 SKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       258 ~~Rps~~~il~~~~~~~~~~  277 (284)
                      .+||++.+++.||||.+...
T Consensus       242 ~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         242 SFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             hhCcCHHHHHhCHHHhhhhh
Confidence            99999999999999998644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.3e-43  Score=287.57  Aligned_cols=251  Identities=29%  Similarity=0.589  Sum_probs=217.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|.+.+.||.|++|.||++.+..++..+++|.+....... ...+.+.+|+.+++.++|+|++++++.+..++..++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999986643322 234567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccCCCC---
Q 023270          100 YAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSKR---  173 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~---  173 (284)
                      |+++++|.+++....  .+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++ .++|+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999987653  478999999999999999999999999999999999998886 46999999875443322   


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ....+++.|+|||.+.+..++.++|+||||++++++++|..||...+..+........... ...+.++.++.+++.+||
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l  238 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLF  238 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHh
Confidence            2234778899999998888999999999999999999999999888777777666654432 334468899999999999


Q ss_pred             ccCCCCCCCHHhhhcCccc
Q 023270          254 VKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~  272 (284)
                      ..+|++|||+.+++.||||
T Consensus       239 ~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         239 KVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ccChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-43  Score=295.99  Aligned_cols=254  Identities=30%  Similarity=0.465  Sum_probs=216.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|++.+.||.|++|.||++.+..++..|++|.+......  ...+.+.+|+..++.++|+|++++++.+..++..++|+|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            477889999999999999999889999999998643322  234678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---ccc
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTM  176 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~~  176 (284)
                      |+++++|.+++.. ..++...+..++.+++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            9999999988865 568999999999999999999999999999999999999999999999999874433211   223


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD  256 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (284)
                      .++..|+|||.+.+..++.++|+||||++++++++|..|+...........+.... ........+.++.+++.+||..+
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKD  240 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCC
Confidence            46788999999998889999999999999999999999998766655554433332 22233467889999999999999


Q ss_pred             CCCCCCHHhhhcCccccccCC
Q 023270          257 SSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       257 p~~Rps~~~il~~~~~~~~~~  277 (284)
                      |.+||++.++++||||++...
T Consensus       241 p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         241 PRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             cccCcCHHHHHHhHHHHHHhh
Confidence            999999999999999987643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.8e-43  Score=301.70  Aligned_cols=257  Identities=23%  Similarity=0.400  Sum_probs=209.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----   91 (284)
                      ..++|++.+.||+|++|.||++.+..+++.|++|.+....... .....+.+|+.+++.++|+|++++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4688999999999999999999999999999999986432222 2234566899999999999999999987543     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       ...++|+||++ ++|...+...  ++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             35799999997 4888877654  8999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC--ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 023270          171 SKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-------------  235 (284)
Q Consensus       171 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  235 (284)
                      ...  ....++..|+|||.+.+..++.++||||||+++++|++|..||...+....+..+.......             
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            322  23346788999999999999999999999999999999999998776544443332210000             


Q ss_pred             -----------------------CC-----CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          236 -----------------------PS-----APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       236 -----------------------~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                             +.     ....+++++++|.+||..||++|||+.++|+||||++--+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                                   00     1124667899999999999999999999999999975433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-42  Score=295.70  Aligned_cols=258  Identities=25%  Similarity=0.441  Sum_probs=221.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|...+.||+|+||.||++.+..++..+++|.+.............+.+|++.++.++|+|++++++++..++..++|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34889999999999999999999999999999986544333344567888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcccc
Q 023270           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC  177 (284)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  177 (284)
                      ||+.+ ++.+.+.. ..+++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++.... ......
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~  182 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-PANSFV  182 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-Cccccc
Confidence            99975 77777754 4578999999999999999999999999999999999999999999999999874432 223445


Q ss_pred             CCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       178 ~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      +++.|+|||.+.   .+.++.++|+||||+++++|++|..||...+.....................++.+.+++.+||.
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  262 (317)
T cd06635         183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ  262 (317)
T ss_pred             CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHcc
Confidence            788899999873   45688999999999999999999999988877777777766555455555788999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .+|.+||++.++++|+|+......
T Consensus       263 ~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         263 KIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             CCcccCcCHHHHHhChhhhccCcc
Confidence            999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.6e-43  Score=292.41  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=207.4

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEe-----c
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH-----D   90 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~-----~   90 (284)
                      ...+|++.+.||+|++|.||++.+..+++.+++|++......    ...+..|+.+++.+ +|+|++++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            557899999999999999999999999999999987543221    24566788888888 6999999999873     4


Q ss_pred             CCeEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           91 DERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      ++..++||||+++++|.+++..    ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            4679999999999999988753    246889999999999999999999999999999999999999999999999987


Q ss_pred             cccCC---CCccccCCCcccCccccCC-----CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCC
Q 023270          167 VQSRS---KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-LSFPS  237 (284)
Q Consensus       167 ~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~  237 (284)
                      .....   ......+++.|+|||.+..     ..++.++|+||+|+++++|++|..||................ .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            54322   2223457889999998753     447889999999999999999999998776655444433322 12222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +...+.++.+++.+||..+|.+|||+.++++|+||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            33467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-42  Score=290.87  Aligned_cols=257  Identities=32%  Similarity=0.476  Sum_probs=210.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIFL   96 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~~~   96 (284)
                      .+|.+.++||.|++|.||++.+..+++.+++|.+......  .....+.+|++.++.++|+||+++++++...  +.+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            4789999999999999999999999999999998654322  2346778899999999999999999988643  47899


Q ss_pred             EEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           97 ILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ||||+++++|.+++..    ...++...+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    245889999999999999999999999999999999999999999999999987443222


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCC-CCCC----CCC
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-----SQKDTFRRIMKVDLS-FPSA----PSI  241 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~-~~~~----~~~  241 (284)
                       .....++..|+|||.+.+..++.++|+||||+++++|++|..||...     ...+....+...... ....    ...
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd06621         159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW  238 (287)
T ss_pred             ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence             12344678899999999889999999999999999999999999765     223333333321111 1110    134


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ++++.+++.+||..+|.+|||+.+++.||||++...
T Consensus       239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             HHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            678999999999999999999999999999977644

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.5e-43  Score=296.92  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=209.9

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCce--EEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHP--VALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~   91 (284)
                      .+.+++|++.+.||.|+||.||+|.+..++..  +++|.+....  .......+.+|+.++.++ +|+|++++++++..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            46778999999999999999999998877765  4666654321  223346778899999999 899999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~  155 (284)
                      +..++|+||+++++|.+++....                .++...++.++.|++.|+.|||+.|++|+||+|+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999997542                47899999999999999999999999999999999999999


Q ss_pred             CCEEEeecccccccCCCC--ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 023270          156 GRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVD  232 (284)
Q Consensus       156 ~~~~l~d~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  232 (284)
                      +.++|+|||++.......  .....+..|+|||.+.+..++.++||||||+++++++| |..||...+..+........ 
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-  239 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-  239 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-
Confidence            999999999874322111  11223567999999988889999999999999999998 99999887777666655443 


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .....+..+++++.+++.+||..+|.+||++++++.+
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2333344678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-43  Score=301.35  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=218.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----eE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----RI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----~~   94 (284)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+..... .....+.+.+|+..++.++|+|++++.+++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            69999999999999999999988999999999865432 2233467888999999999999999999987765     78


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      |+++||++ ++|..++.+...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999997 589999988778999999999999999999999999999999999999999999999999988544332  


Q ss_pred             ----CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 023270          173 ----RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP-----------  236 (284)
Q Consensus       173 ----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  236 (284)
                          .....++..|+|||.+.+. .++.++|+||||++++++++|..||...+..+....+........           
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence                2234567889999999887 789999999999999999999999988877666555444211111           


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          237 ------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       237 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                        ..+.++.++.+++.+||+.+|.+||++++++.||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                              012468889999999999999999999999999999988766

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.9e-43  Score=290.38  Aligned_cols=248  Identities=28%  Similarity=0.515  Sum_probs=204.2

Q ss_pred             ccCcEeeeee--ccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHH-hCCCCcccceeeEEecCCeE
Q 023270           18 LQDFEIGRPL--GKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS-SLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        18 ~~~y~~~~~l--g~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~-~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .++|.+.+.+  |.|+||.||++.+..++..+++|.+........        ++.... ..+|+|++++++.+..++..
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            4577777776  999999999999999999999999865432221        111111 12699999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccCCCC
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSKR  173 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~  173 (284)
                      ++||||+++++|.+++.+...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+...... 
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-  163 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-  163 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence            99999999999999998888899999999999999999999999999999999999999998 9999999987544322 


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHhc-CCCCCCCCCCCHHHHHHHHH
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-RRIMKV-DLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~  251 (284)
                      ....++..|+|||.+.+..++.++|+||+|+++++|++|..||......... ...... .......+.+++.+.++|.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  243 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS  243 (267)
T ss_pred             ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence            2345788999999999888999999999999999999999999865443321 111111 12223344689999999999


Q ss_pred             hcccCCCCCCC-HHhhhcCccccc
Q 023270          252 LLVKDSSKRLS-LQKIMEHPWIIK  274 (284)
Q Consensus       252 ~l~~~p~~Rps-~~~il~~~~~~~  274 (284)
                      ||+.+|.+||+ ++++|+||||.+
T Consensus       244 ~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        244 MLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HhccChhhCCchHHHHhcCCcccC
Confidence            99999999996 699999999974

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.5e-43  Score=295.55  Aligned_cols=253  Identities=29%  Similarity=0.476  Sum_probs=209.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIF   95 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~~   95 (284)
                      +.+|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+..++.++|+|++++++++..+  +..+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            46899999999999999999999989999999998654332 22234566799999999999999999998877  8999


Q ss_pred             EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           96 LILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      +|+||++ ++|.+++.... .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9999997 48988887654 5899999999999999999999999999999999999999999999999987544332  


Q ss_pred             -CccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 023270          173 -RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS----------------  234 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------------  234 (284)
                       .....+++.|+|||.+.+.. .+.++|+||+|+++++|++|..||...+......++......                
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence             22344678899999887654 688999999999999999999999887766655544321100                


Q ss_pred             -------------CCCCCC-CCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          235 -------------FPSAPS-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       235 -------------~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                   ...... +++.+.++|.+||..+|++|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         000111 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-42  Score=288.16  Aligned_cols=255  Identities=30%  Similarity=0.493  Sum_probs=208.0

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      +...+.+.....||+|+||.||++.+..++..|++|.+......   ..+.+.+|+.+++.++|+||+++++++..++..
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            34455666667899999999999999889999999987554322   235778899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEeecccccccC
Q 023270           95 FLILEYAHRGELYRELRKH-RRF--TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSR  170 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~-~~l--~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~  170 (284)
                      ++++||+++++|.+++... ..+  +...+..++.|++.|+.|||+.|++|+||+|+||+++. ++.++|+|||.+....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            9999999999999999765 445  78889999999999999999999999999999999976 6799999999874432


Q ss_pred             C---CCccccCCCcccCccccCCCC--CCchhhHhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCHH
Q 023270          171 S---KRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       171 ~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      .   ......+++.|+|||.+.+..  ++.++|+||+|+++++|++|..||....... ..............+..++++
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE  240 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence            2   122335788999999986543  7889999999999999999999997644322 222111111222233468899


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +++++.+||..+|.+|||+++++.||||
T Consensus       241 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         241 AKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-42  Score=286.49  Aligned_cols=246  Identities=21%  Similarity=0.382  Sum_probs=210.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++.+.||.|+||.||++... ++..+++|.+......    ...+.+|+.+++.++|+|++++++++..++..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            4578999999999999999999764 5568999987644322    2467789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--  173 (284)
                      ||||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999998754 468999999999999999999999999999999999999999999999999875432211  


Q ss_pred             --ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          174 --HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       174 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                        ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+..+.. ...+...+.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~  235 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-LYRPKLASMTVYEVMY  235 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHH
Confidence              12234567999999988889999999999999999999 9999998888888777766542 3334467889999999


Q ss_pred             HhcccCCCCCCCHHhhhc
Q 023270          251 RLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~  268 (284)
                      +||..+|.+|||++++++
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.7e-43  Score=297.45  Aligned_cols=259  Identities=26%  Similarity=0.454  Sum_probs=218.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|+..+.||.|++|.||++++..++..+++|.+...........+.+.+|+++++.++|+|++++++++..+...++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44888999999999999999999999999999986433333333456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcccc
Q 023270           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC  177 (284)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  177 (284)
                      ||+. +++.+.+.. ...++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~~~~~  172 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANXFV  172 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-ccccc
Confidence            9997 577777654 45689999999999999999999999999999999999999999999999998754432 23345


Q ss_pred             CCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       178 ~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      +++.|+|||.+.   ....+.++||||||++++++++|..||...+..+.................++..+.++|++||.
T Consensus       173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  252 (308)
T cd06634         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  252 (308)
T ss_pred             CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhh
Confidence            788999999874   34578899999999999999999999988776666666555544444445688999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      .+|.+||++++++.|||+.+...+.
T Consensus       253 ~~P~~Rp~~~~ll~~~~~~~~~~~~  277 (308)
T cd06634         253 KIPQDRPTSEVLLKHRFVLRERPPT  277 (308)
T ss_pred             CCcccCCCHHHHhhCccccccCChh
Confidence            9999999999999999999975543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-42  Score=285.04  Aligned_cols=247  Identities=23%  Similarity=0.435  Sum_probs=214.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .+..++|++.+.||.|++|.||++..  .++.|++|.+.....    ..+.+.+|+.+++.++|+|++++++++..++..
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            46788999999999999999999986  478899999865543    346788899999999999999999999989999


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ++|+||+++++|.+++....  .+++..+..++.|++.|+.|||..|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999999998765  6899999999999999999999999999999999999999999999999988655433


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      ......+..|.|||.+.+..++.++|+||||++++++++ |..||...+..+........ .....+..+++++.+++.+
T Consensus       156 ~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         156 QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCccCCCHHHHHHHHH
Confidence            333344667999999988889999999999999999997 99999888877766655543 2333445688999999999


Q ss_pred             hcccCCCCCCCHHhhhc
Q 023270          252 LLVKDSSKRLSLQKIME  268 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~  268 (284)
                      ||..+|.+|||++++++
T Consensus       235 ~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         235 CWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-43  Score=292.64  Aligned_cols=253  Identities=29%  Similarity=0.513  Sum_probs=204.8

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ++.+|++.+.||.|++|.||++.+..+++.|++|.+.......  ....+.+|+.+++.++|+||+++++++..++..++
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            5689999999999999999999998899999999985433211  12345679999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--  173 (284)
                      |+||+++ +|.+++... ..++...++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9999985 898888765 468999999999999999999999999999999999999999999999999875432111  


Q ss_pred             -ccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCC-----------------
Q 023270          174 -HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFRRIMKVDL-----------------  233 (284)
Q Consensus       174 -~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~-----------------  233 (284)
                       ....++..|+|||.+.+ ..++.++||||+|+++++|++|..||.... ..+....+.....                 
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence             12235778999998865 457899999999999999999999997655 2222222111000                 


Q ss_pred             ----CC-------CCCCCCC--HHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          234 ----SF-------PSAPSIS--AEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       234 ----~~-------~~~~~~~--~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                          ..       ...+.++  .++.+++.+||.++|++|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                00       0001234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-42  Score=284.97  Aligned_cols=251  Identities=32%  Similarity=0.522  Sum_probs=218.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....... .....+.+|+..++.++|+|++++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999986644333 234566789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-CCc
Q 023270          100 YAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRH  174 (284)
Q Consensus       100 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~~~  174 (284)
                      |+++++|.+++..    ...++...++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  159 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK  159 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence            9999999998866    34689999999999999999999999999999999999999999999999998744332 222


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...+++.|+|||.+.+..++.++|+||||++++++++|..||...+..+........... ......+.++.+++.+||.
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcC
Confidence            345778899999999888999999999999999999999999988887766666554433 2334788999999999999


Q ss_pred             cCCCCCCCHHhhhcCccc
Q 023270          255 KDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~  272 (284)
                      .+|.+|||++++++||++
T Consensus       239 ~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         239 VKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCcccCCCHHHHhcCCCC
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-42  Score=290.64  Aligned_cols=250  Identities=24%  Similarity=0.444  Sum_probs=214.0

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      +..++|.+.+.||+|++|.||++....     ++..|++|.+......  ...+.+.+|+++++.++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            346789999999999999999998743     3578999998654332  234678899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC
Q 023270           91 DERIFLILEYAHRGELYRELRKHR--------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~  156 (284)
                      ++..++||||+++++|.+++...+              .++...+..++.|++.++.+||+.|++|+||+|+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            999999999999999999997642              478889999999999999999999999999999999999999


Q ss_pred             CEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 023270          157 RLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMK  230 (284)
Q Consensus       157 ~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~  230 (284)
                      .++|+|||++......     .....+++.|+|||.+.+..++.++||||||++++++++ |..||...+..+....+..
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            9999999987543221     122234678999999999999999999999999999998 9999988888887777776


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.... .+..++.++.+++.+||..||.+||+++++++
T Consensus       240 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 GRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            54433 33478999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.9e-43  Score=296.30  Aligned_cols=243  Identities=29%  Similarity=0.542  Sum_probs=189.5

Q ss_pred             eeeeccCCCeEEEEEEEe--cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec--CCeEEEEEe
Q 023270           24 GRPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERIFLILE   99 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~--~~~~~~v~e   99 (284)
                      .++||.|+||+||+|.+.  .++..|++|.+......     ..+.+|+++++.++|+||+++++++..  +...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999865  46788999998654322     345689999999999999999998854  457899999


Q ss_pred             ecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe----cCCCCEEEeecccc
Q 023270          100 YAHRGELYRELRKH---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS  166 (284)
Q Consensus       100 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~----~~~~~~~l~d~~~~  166 (284)
                      |++ ++|.+++...         ..++...++.++.|++.||.|||+.|++|+||+|+||++    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            996 4888877532         248899999999999999999999999999999999999    45578999999998


Q ss_pred             cccCCC------CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHh
Q 023270          167 VQSRSK------RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------DTFRRIMK  230 (284)
Q Consensus       167 ~~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------~~~~~~~~  230 (284)
                      ......      .....+++.|+|||++.+. .++.++||||+|+++++|++|.+||......         ..+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            543221      1234578899999998774 5899999999999999999999999653321         11111111


Q ss_pred             cCC--------------------------CC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          231 VDL--------------------------SF----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       231 ~~~--------------------------~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ...                          ..          ......+.++.+||.+||.+||.+|||++++|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            000                          00          0001234678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1e-42  Score=292.54  Aligned_cols=253  Identities=28%  Similarity=0.499  Sum_probs=214.7

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      -..+||.|++|.||++....++..|++|++....   ......+.+|+..++.++|+|++++++.+..++..++++||++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3467999999999999999999999999974332   2234568889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---CccccCC
Q 023270          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGT  179 (284)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~  179 (284)
                      +++|.+++.. ..++...+..++.|++.++.+||+.|++||||+|+||+++.++.++|+|||.+......   .....++
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            9999987654 46899999999999999999999999999999999999999999999999986433221   2234577


Q ss_pred             CcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHhcccCCC
Q 023270          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~  258 (284)
                      +.|+|||.+.+..++.++|+||+|++++++++|..||...+..+.......... .......+++.+.+++.+||..+|.
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~  259 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA  259 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence            889999999888889999999999999999999999988776665554443321 2223346789999999999999999


Q ss_pred             CCCCHHhhhcCccccccCCCC
Q 023270          259 KRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       259 ~Rps~~~il~~~~~~~~~~~~  279 (284)
                      +||+++++++||||.+...|.
T Consensus       260 ~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         260 QRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             cCcCHHHHhcChHHhccCCCc
Confidence            999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.3e-42  Score=286.50  Aligned_cols=250  Identities=29%  Similarity=0.506  Sum_probs=210.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||.|++|.||++.+..+++.|++|.+...........+.+.+|++++++++|++++++++.+..++..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            58999999999999999999999899999999886433333334567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           99 EYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      ||+++++|.+++...    ..++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            999999999988642    45899999999999999999999999999999999999999999999999987433221  


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES--QKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                       .....+++.|.|||.+.+..++.++|+||||++++++++|..||....  ....................++.++.+++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence             223457788999999988889999999999999999999999996543  23344444443333323336788999999


Q ss_pred             HHhcccCCCCCCCHHhhhc
Q 023270          250 SRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~  268 (284)
                      .+||.++|.+|||+.+|++
T Consensus       242 ~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=292.07  Aligned_cols=250  Identities=30%  Similarity=0.547  Sum_probs=208.6

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |++.+.||.|++|.||++.+..+++.|++|++....... .....+.+|+..++.++|+|++++++++.+++..++++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            688999999999999999999999999999986543222 2234567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---cc
Q 023270          101 AHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HT  175 (284)
Q Consensus       101 ~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~  175 (284)
                      ++ ++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            96 58999988765  78999999999999999999999999999999999999999999999999875432211   22


Q ss_pred             ccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------------------
Q 023270          176 MCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL---------------------  233 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---------------------  233 (284)
                      ..++..|+|||.+.+. .++.++|+||||+++++|++|..||...+......+......                     
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            3457889999987664 478899999999999999999999988776554444332100                     


Q ss_pred             C------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          234 S------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       234 ~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      .      ....+.++.++.+++.+||+++|.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0      01123577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-42  Score=290.01  Aligned_cols=248  Identities=30%  Similarity=0.462  Sum_probs=202.1

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecC--CeEEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDD--ERIFLI   97 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~--~~~~~v   97 (284)
                      |++++.||.|++|.||++.+..++..|++|.+........ . ....+|+..+.++. |+|++++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7889999999999999999999999999999865432221 1 23346777888775 99999999999887  899999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--Cc
Q 023270           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~  174 (284)
                      +||+++ ++.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||++......  ..
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            999974 787777664 57899999999999999999999999999999999999999 99999999988543322  12


Q ss_pred             cccCCCcccCccccC-CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------CC--
Q 023270          175 TMCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL----------------SF--  235 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----------------~~--  235 (284)
                      ...++..|+|||.+. +...+.++|+||+|+++++|++|..||...+..+..........                .+  
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            344678899999764 45578899999999999999999999988776554444332110                00  


Q ss_pred             C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 P---------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +         ..+.++.++.+++.+||.++|.+||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0         012468899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-42  Score=291.76  Aligned_cols=257  Identities=29%  Similarity=0.523  Sum_probs=210.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +++|++.+.||.|++|+||++.+..+++.|++|.+....... ...+.+.+|+++++.++|+|++++++++..++..++|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            468999999999999999999999999999999986543221 2335677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEeecccccccCCC--
Q 023270           98 LEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~--  172 (284)
                      +||++ ++|...+....  .++...++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||++......  
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            99997 47877776654  3578888999999999999999999999999999999985 457999999988543221  


Q ss_pred             -CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 023270          173 -RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-----------------  233 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----------------  233 (284)
                       .....+++.|+|||.+.+. .++.++|+||+|+++++|+||..||...+..+...+......                 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence             1223457889999988664 478899999999999999999999988776665554432100                 


Q ss_pred             ----CCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          234 ----SFP------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       234 ----~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                          .+.      ..+.+++++.+++.+||+.+|++||+++++++||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                000      1235788999999999999999999999999999999864

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-44  Score=301.64  Aligned_cols=264  Identities=25%  Similarity=0.447  Sum_probs=210.8

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEe
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFH   89 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~   89 (284)
                      .....++.+.|++++.||+||.+.||+|... +...||+|++.....+. ....-+..|+.+|.+++ |.+|+++++|-.
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~-qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADN-QTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCH-HHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            4567888999999999999999999999874 44556666664444333 56789999999999996 899999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      .++.+|+|||+-+ .+|..+|++... .+.-.++.++.|++.|+.++|++||+|.||||.|+++ ..|.+||+|||++..
T Consensus       431 ~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  431 TDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             cCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            9999999999975 699999987653 3334888999999999999999999999999999999 789999999999855


Q ss_pred             cCCCC-----ccccCCCcccCccccCCCC-----------CCchhhHhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc
Q 023270          169 SRSKR-----HTMCGTLDYLAPEMVENKE-----------HDYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFRRIMKV  231 (284)
Q Consensus       169 ~~~~~-----~~~~~~~~y~aPE~~~~~~-----------~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~  231 (284)
                      .....     ....||+.|++||.+....           .++++||||||||+|+|+.|++||..-. ....+..+...
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P  588 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP  588 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence            54333     3457999999999885322           4678999999999999999999997544 33333334333


Q ss_pred             CCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          232 DLSFPSAPS-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       232 ~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .-..+.+.. -+.++.++++.||..||++|||+.++|+|||++-.+.|
T Consensus       589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~  636 (677)
T KOG0596|consen  589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP  636 (677)
T ss_pred             CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence            221222221 23349999999999999999999999999999865443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-42  Score=297.72  Aligned_cols=258  Identities=25%  Similarity=0.438  Sum_probs=213.8

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----   92 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~----   92 (284)
                      ...+|++++.||.|++|.||++.+..++..|++|++..... .......+.+|+.+++.++|+||+++++++..++    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            45679999999999999999999999999999999854322 2223456778999999999999999999886553    


Q ss_pred             --eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 --RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                        .+++|+|++ +++|..++.. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              468999999 5688887764 568999999999999999999999999999999999999999999999999986655


Q ss_pred             CCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Q 023270          171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--------------  235 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------  235 (284)
                      .......+++.|+|||.+.+ ..++.++|+||||++++++++|..||...+......++.......              
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07880         170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK  249 (343)
T ss_pred             cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence            44445567889999998876 357899999999999999999999998776655444433321110              


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          236 ---------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       236 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                     ...+.+++++.+++.+||..||.+|||+.+++.||||+..-+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                           011357888999999999999999999999999999988643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.5e-43  Score=298.35  Aligned_cols=261  Identities=27%  Similarity=0.438  Sum_probs=213.5

Q ss_pred             ccCcEe-eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH-----------HHHHHHHHHHHHHHhCCCCccccee
Q 023270           18 LQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-----------KIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        18 ~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      .++|.. .+.||.|++|+||++.+..+++.|++|++........           .....+.+|+++++.++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356764 5779999999999999999999999999854332210           0112467899999999999999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccc
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      +++..++..++++|+++ ++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            99999999999999997 58999998878899999999999999999999999999999999999999999999999998


Q ss_pred             ccccC-----------------CCCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023270          166 SVQSR-----------------SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRR  227 (284)
Q Consensus       166 ~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~  227 (284)
                      +....                 .......+++.|+|||.+.+.. ++.++|+||||++++++++|..||...+..+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            74433                 1111223567899999987644 68899999999999999999999998887766555


Q ss_pred             HHhcCCCCC--------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          228 IMKVDLSFP--------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       228 ~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      +........                          ..+..+.++.++|.+||+.+|++|||++++|.||||+..+.+-
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~  323 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC  323 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence            433111000                          0123578899999999999999999999999999999886653

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-42  Score=285.44  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=212.2

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++...+|++.+.||.|++|.||++.+. +++.|++|.+......    .+.+.+|+..+++++|+|++++++++..++..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            456678999999999999999999864 5578999998654322    34677899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ++++|++++++|.+++....  .++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999998899999997654  6899999999999999999999999999999999999999999999999987544321


Q ss_pred             C----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .    .....+..|+|||.+.+..++.++|+||||+++++|++ |..||...+.......+... ...+.....+.++.+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  235 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYD  235 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence            1    11122457999999998889999999999999999999 99999988887777766554 233445578999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhc
Q 023270          248 LISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+|+..+|.+||++.++++
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.5e-43  Score=299.17  Aligned_cols=262  Identities=23%  Similarity=0.404  Sum_probs=216.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ..-..++|++.+.||.|++|.||++.+..+++.|++|++....... .....+.+|+.+++.++|+|++++.+++..++.
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            3335778999999999999999999999999999999986543222 233556779999999999999999998766554


Q ss_pred             ------EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           94 ------IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        94 ------~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                            .++|+|+++ ++|.+++.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          89 LEDFQDVYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccccccEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence                  899999995 689888876 568999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 023270          168 QSRSKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP----------  236 (284)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  236 (284)
                      ..........++..|+|||.+.+. ..+.++||||||++++++++|..||...+....+..+.......+          
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         167 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             cccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            655444455678889999988653 578899999999999999999999987776655554433211100          


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          237 -------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       237 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                         .....++++.+++++||+.+|.+|||+++++.||||++-.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                               012358899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=284.93  Aligned_cols=242  Identities=25%  Similarity=0.465  Sum_probs=212.9

Q ss_pred             eeeccCCCeEEEEEEEecC---CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeec
Q 023270           25 RPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYA  101 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~  101 (284)
                      +.||.|+||.||++.+...   +..|++|.+.......  ..+.+.+|++.+..++|+|++++++++..++..++++||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4689999999999999876   8899999987654333  4577889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270          102 HRGELYRELRKH---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus       102 ~~~~L~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ++++|.+++...         ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999885         67899999999999999999999999999999999999999999999999998554432


Q ss_pred             -----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          173 -----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       173 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                           .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||...+..+.......+ .....+..++.++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCccCChHHH
Confidence                 233446788999999988889999999999999999998 69999998888777777653 34445557899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcC
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++.+||..+|.+|||+++++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-42  Score=291.03  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=202.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++++.||.|++|.||++.+..++..|++|++.......  ....+.+|+..++.++|+|++++++++..++..++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999999999999999985433211  123456789999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CC
Q 023270           98 LEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~  173 (284)
                      +||+. +++.+++.. ...++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 577666654 35678889999999999999999999999999999999999999999999998754322   12


Q ss_pred             ccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcC-------------------
Q 023270          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVD-------------------  232 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~-------------------  232 (284)
                      ....+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+.. +.+.+.....                   
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            233467889999998754 4788999999999999999999999765432 2222211100                   


Q ss_pred             --CCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          233 --LSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       233 --~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                        .....         .-..+.++.+++.+|+..||++|||+++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              00000         00235789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-42  Score=290.75  Aligned_cols=250  Identities=29%  Similarity=0.539  Sum_probs=208.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      +|++.+.||.|++|.||++.+..++..|++|++......  .....+.+|+.+++.++|+|++++++++...+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999998654322  123456678999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---C
Q 023270          100 YAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (284)
Q Consensus       100 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~  173 (284)
                      |+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9985 888888654   35899999999999999999999999999999999999999999999999987533221   1


Q ss_pred             ccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 023270          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-----------------  235 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----------------  235 (284)
                      ....++..|+|||.+.+. .++.++|+||||++++++++|..||...+..+...++.......                 
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            233467889999988654 46889999999999999999999998877666555443221000                 


Q ss_pred             -C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 -P---------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 -~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                       +         ..+.+++++.+++..||+.||.+||+++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence             0         012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-42  Score=290.08  Aligned_cols=249  Identities=24%  Similarity=0.453  Sum_probs=211.4

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      +.-++|.+.+.||.|+||.||++...     .++..+++|.+....   ......+.+|+.++++++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45578999999999999999999853     345568999885433   2234568889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC
Q 023270           91 DERIFLILEYAHRGELYRELRKHR-------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR  157 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~  157 (284)
                      ++..++|+||+++++|.+++...+             .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999997543             3899999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 023270          158 LKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKV  231 (284)
Q Consensus       158 ~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  231 (284)
                      ++|+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+....+..+
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999885432211     12234668999999998889999999999999999998 99999988888777777665


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ... .....++.++.+++.+||+.+|.+|||++++++
T Consensus       239 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         239 RVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            432 333468899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=276.49  Aligned_cols=255  Identities=27%  Similarity=0.422  Sum_probs=214.6

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      .+-.+.-+||++.+.||.|||+-|++++...+++.||+|++......   ..+..++|++..++++|||+++++++...+
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~---~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE---DIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH---HHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            34456778999999999999999999999999999999999876633   356788999999999999999999886544


Q ss_pred             C-----eEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCCCCEEE
Q 023270           92 E-----RIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKI  160 (284)
Q Consensus        92 ~-----~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~~~~~l  160 (284)
                      .     ..|++++|...|+|.+.+...    ..+++.+++.++.++.+||++||+..  +.|+||||.||++..++.+++
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence            3     489999999999999999764    26899999999999999999999999  999999999999999999999


Q ss_pred             eecccccccCCCC------------ccccCCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCC--ChHH
Q 023270          161 GDFGWSVQSRSKR------------HTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAE--SQKD  223 (284)
Q Consensus       161 ~d~~~~~~~~~~~------------~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~--~~~~  223 (284)
                      .|||.++...-.-            ....++..|+|||.+.   +...+.++|||||||++|.++.|..||+..  ....
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            9999874432111            1234688999999985   445789999999999999999999999632  2222


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.-....+...++....+|..+.++|++||+.||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2333444567777778899999999999999999999999999875

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-42  Score=285.50  Aligned_cols=247  Identities=23%  Similarity=0.406  Sum_probs=210.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++.+.||.|++|+||++... ++..+++|.+......    ...+.+|+..++.++|+||+++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            5678999999999999999999764 3456999988644322    2457789999999999999999999998899999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--  173 (284)
                      +|||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999999765 468999999999999999999999999999999999999999999999999875332211  


Q ss_pred             --ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          174 --HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       174 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                        ....++..|.|||.+.+..++.++|+||||+++++|++ |..||...+..+.......... .......+..+.+++.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~  235 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYRPHLASEKVYAIMY  235 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHH
Confidence              12234567999999988889999999999999999998 9999988887777776665533 3334467899999999


Q ss_pred             HhcccCCCCCCCHHhhhcC
Q 023270          251 RLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~  269 (284)
                      +||..+|.+||++.+++++
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-42  Score=290.82  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=208.2

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCc--eEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~   95 (284)
                      ++|++.+.||.|+||.||++.+..++.  .+++|.+....  .....+.+.+|+.++.++ +|+|++++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999998877765  36788775321  112245678899999999 7999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEE
Q 023270           96 LILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~  159 (284)
                      +++||+++++|.+++....                .++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999997542                478899999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCCcc--ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 023270          160 IGDFGWSVQSRSKRHT--MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFP  236 (284)
Q Consensus       160 l~d~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  236 (284)
                      |+|||++.........  ...+..|+|||.+.+..++.++||||||+++++|++ |..||...+..+......... ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-~~~  238 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RME  238 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCC
Confidence            9999987533221111  123457999999988889999999999999999997 999999888888777766542 333


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+..++.++.+|+.+||..+|.+|||++++++.
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            445689999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-42  Score=288.69  Aligned_cols=248  Identities=29%  Similarity=0.496  Sum_probs=203.2

Q ss_pred             eeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHH---HHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL---RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~---~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      .||.|+||.||++.+..+++.|++|.+..............   ...++.++...|++++++.+++..++..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999865433221111112   223345556689999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-CCccccCCCc
Q 023270          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLD  181 (284)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~  181 (284)
                      +++|..++...+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..... ......++..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence            999999998888899999999999999999999999999999999999999999999999998754322 2234467899


Q ss_pred             ccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCC
Q 023270          182 YLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAES---QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS  257 (284)
Q Consensus       182 y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  257 (284)
                      |+|||.+.++ .++.++|+||+|+++++|++|..||....   ..........  .....+..+++++.+++.+||..+|
T Consensus       161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            9999998754 58899999999999999999999998763   2332222222  2233344679999999999999999


Q ss_pred             CCCC-----CHHhhhcCcccccc
Q 023270          258 SKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       258 ~~Rp-----s~~~il~~~~~~~~  275 (284)
                      .+||     +++++++||||++.
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCC
Confidence            9999     99999999999775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-42  Score=290.65  Aligned_cols=253  Identities=29%  Similarity=0.467  Sum_probs=205.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCe----
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDER----   93 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~----   93 (284)
                      .+|++.+.||.|++|.||++.+..+++.|++|.+...... ......+.+|+.+++.+. |+|++++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            4799999999999999999999999999999997553221 122346778999999995 6999999999876665    


Q ss_pred             -EEEEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEeecccc
Q 023270           94 -IFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWS  166 (284)
Q Consensus        94 -~~~v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d~~~~  166 (284)
                       .|+++||+++ +|..++...     ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999985 788877543     35799999999999999999999999999999999999998 889999999987


Q ss_pred             cccCC---CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Q 023270          167 VQSRS---KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-------  235 (284)
Q Consensus       167 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------  235 (284)
                      .....   ......+++.|.|||.+.+ ..++.++|+||||+++++|++|..||...+..+...++.......       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            53322   1122345778999998865 447899999999999999999999998877666555443311000       


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          236 -------------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       236 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                                         ...+.++.++.++|.+||.+||.+||++++++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                               00135788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-42  Score=286.86  Aligned_cols=248  Identities=23%  Similarity=0.410  Sum_probs=214.1

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      -.-.+|++.+.||.|++|.||++.+.. +..+++|.+......   ....+..|+.+++.++|+|++++++++..++..+
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            345679999999999999999999877 889999998654332   2356788999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC
Q 023270           96 LILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  173 (284)
                      +|+||+++++|.+++...  ..++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999999999764  468999999999999999999999999999999999999999999999999875432221


Q ss_pred             ---ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       174 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                         ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+........ ...+.+..+++++.+++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCCCCCCCHHHHHHH
Confidence               12234567999999988889999999999999999998 89999988887777776654 34455568899999999


Q ss_pred             HHhcccCCCCCCCHHhhhc
Q 023270          250 SRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~  268 (284)
                      .+||..||.+|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         238 LECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-43  Score=304.42  Aligned_cols=262  Identities=34%  Similarity=0.620  Sum_probs=240.4

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...-+...|.+.+.||.|.|++|.++.+..++..||||.+++........ +.+.+|++++..++||||++++.+.+.+.
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            34456778999999999999999999999999999999998888776554 44889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc--C
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS--R  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~--~  170 (284)
                      .+|+||||+.++.+.+++.+++...+..+..++.|++.|++|||+++|+|+|||++||+++.+-++||+|||++...  .
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999998544  3


Q ss_pred             CCCccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          171 SKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                      ......+|++.|.|||++.+..+ .+..|+||+|+++|.|++|.+||.+.+..++....+.+.+..+.  .++-+.+++|
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~--~ms~dce~lL  286 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF--YMSCDCEDLL  286 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--eeechhHHHH
Confidence            44467789999999999998886 58999999999999999999999999999999999998887777  6899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      +++|..+|.+|+++++++.|.|.-...+
T Consensus       287 rk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  287 RKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             HHhhccCccccCCHHHhhhhcccchhhh
Confidence            9999999999999999999999865543

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-42  Score=287.41  Aligned_cols=253  Identities=19%  Similarity=0.328  Sum_probs=213.6

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCC-----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      +++..++|++.+.||.|+||.||++.+....     ..|++|.+......  .....+.+++.+++.++|+|++++++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence            3567789999999999999999999886544     78999998544322  2235677899999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCE
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHR----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~  158 (284)
                      ..++..++|+||+++++|.+++....          .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence            99999999999999999999986532          36788899999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 023270          159 KIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVD  232 (284)
Q Consensus       159 ~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  232 (284)
                      +|+|||++......     .....++..|.|||.+.+...+.++||||||++++++++ |..||...+..+........ 
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-  237 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-  237 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-
Confidence            99999987543221     122335678999999988889999999999999999998 99999988887777766643 


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .....+...+.++.+++.+||..+|++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            3344455689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.6e-42  Score=287.56  Aligned_cols=259  Identities=20%  Similarity=0.354  Sum_probs=213.9

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      +++...+|++.+.||.|+||.||++....     .+..|++|.+......  .....+.+|+..++.++|+|++++++++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            35667899999999999999999987542     3557999987543322  2234567899999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCE
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~  158 (284)
                      ...+..++||||+++++|.+++...          ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence            9999999999999999999999753          234677889999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 023270          159 KIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVD  232 (284)
Q Consensus       159 ~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  232 (284)
                      +|+|||++.......     ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+..+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999875322111     11234567999999988889999999999999999998 789998888777766665543


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc------Ccccccc
Q 023270          233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME------HPWIIKN  275 (284)
Q Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~------~~~~~~~  275 (284)
                      . ...+...++.+.+++.+||+.+|++|||+.++++      ||||+..
T Consensus       239 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         239 Y-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            2 2233467899999999999999999999999998      8999764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.7e-42  Score=287.94  Aligned_cols=251  Identities=19%  Similarity=0.366  Sum_probs=211.0

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEe----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREV----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      +.+.+|++.+.||+|+||+||++...    .++..+++|.+......  .....+.+|+.+++.++|+|++++++++..+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            45789999999999999999999853    35577999998643322  2345778899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC
Q 023270           92 ERIFLILEYAHRGELYRELRKH-----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~  154 (284)
                      +..+++|||+++++|.+++...                 ..++...++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999998532                 24788889999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 023270          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRI  228 (284)
Q Consensus       155 ~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  228 (284)
                      ++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+.....
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998543221     122234567999999988889999999999999999998 99999887776666655


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .... ..+.+..+++++.+++.+||+.+|.+||++.+++++
T Consensus       240 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5433 344455789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=303.13  Aligned_cols=256  Identities=26%  Similarity=0.439  Sum_probs=226.7

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCc---e-EEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKH---P-VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~-v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      .+++.-.+-.+.++||+|+||.||++.....+.   . ||+|..............++.+|++++++++|+||++++|+.
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            355666667778999999999999998876533   3 899998764544556678999999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .....+++|||+|.+|+|.++|+..+ .++..+...++.+.+.||.|||+.+++|+||..+|+|++.++.+||+|||++.
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999999999987 59999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCCc---cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          168 QSRSKRH---TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       168 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      .......   ...-+..|+|||.+..+.++.++||||||+++||+++ |..||.+....+...++.......+.+...|.
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence            5531111   1134678999999999999999999999999999998 89999999999999999887778888888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++..++.+|+..+|++|||+.++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999999998865

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=282.95  Aligned_cols=252  Identities=34%  Similarity=0.598  Sum_probs=216.3

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEEEeecC
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      ...||+|+++.|-.+....++..||||++.+....   ....+.+|++++.+.+ |+||+.++++|+++..+|+|||.+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            45689999999999999999999999999776322   3467778999999985 9999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---CEEEeecccccccC---------
Q 023270          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSR---------  170 (284)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~---------  170 (284)
                      ||+|...|...+.+++.++.+++.+|+.||.+||.+||.|+|+||+|||....+   .+||+||.+.....         
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            999999999999999999999999999999999999999999999999997665   59999998852211         


Q ss_pred             -CCCccccCCCcccCccccC---C--CCCCchhhHhhHHHHHHHHHhCCCCCCCCC---------------hHHHHHHHH
Q 023270          171 -SKRHTMCGTLDYLAPEMVE---N--KEHDYAVDNWTLGILCYEFLYGAPPFEAES---------------QKDTFRRIM  229 (284)
Q Consensus       171 -~~~~~~~~~~~y~aPE~~~---~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~---------------~~~~~~~~~  229 (284)
                       .....++|+..|+|||+..   +  ..|+.+.|+||||+++|-|+.|++||.+.-               ...+.+.+.
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence             1112355777899999763   3  237899999999999999999999997642               234566677


Q ss_pred             hcCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          230 KVDLSFPS--APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       230 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .+.+.++.  +..+|.+.+++++.+|..++.+|.++.++++|||++.+...
T Consensus       320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            77777776  34799999999999999999999999999999999988654

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.6e-43  Score=299.15  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=211.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe----cCCeE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH----DDERI   94 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~----~~~~~   94 (284)
                      .+|++.+.||.|++|.||++.+..+++.|++|++..... .......+.+|+.+++.++|+||+++++++.    .....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            789999999999999999999999999999999865322 1223456678999999999999999999875    33578


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC-
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-  173 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-  173 (284)
                      ++|+||+. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999996 5899999888889999999999999999999999999999999999999999999999999874332111 


Q ss_pred             ------ccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh----------------
Q 023270          174 ------HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK----------------  230 (284)
Q Consensus       174 ------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----------------  230 (284)
                            ....++..|.|||.+.+ ..++.++|+||||+++++|++|..||...+....+..+..                
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                  23357788999998765 4588999999999999999999999977654332221111                


Q ss_pred             -------cCCCCCC------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          231 -------VDLSFPS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       231 -------~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                             .......      .+..++++.++|.+||+.+|.+|||+++++.||||.+-+.+-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                   0000000      134688999999999999999999999999999998776553

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=308.50  Aligned_cols=253  Identities=28%  Similarity=0.485  Sum_probs=220.8

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |.|+..||.|+||.||+|..+.++-..|.|++..   .+.+.+..+.-|+.++..++||+|+++++.|.-++.++++.||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            6788999999999999999998888888998843   3445578888999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCccc
Q 023270          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTM  176 (284)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~~  176 (284)
                      |+||-....+..- ..|++.++..++.|++.||.|||+++|+|+||+..|||++.+|.++|.|||.+...   .......
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence            9999998877654 57999999999999999999999999999999999999999999999999987332   2233456


Q ss_pred             cCCCcccCcccc-----CCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CCCCCHHHHHHHH
Q 023270          177 CGTLDYLAPEMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS-APSISAEAKHLIS  250 (284)
Q Consensus       177 ~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~  250 (284)
                      .|+|.|+|||+.     ...+|+.++||||||+++.+|..+.+|....++...+-++-+..++.-. +..-+..+.+|+.
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk  270 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK  270 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence            799999999986     4677899999999999999999999999888888777777665433322 3356778999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .||..||+.||+++++|+||||++.+
T Consensus       271 ~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  271 RCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHhcCCccCCCHHHHhhCcccccCC
Confidence            99999999999999999999999764

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-42  Score=297.57  Aligned_cols=259  Identities=26%  Similarity=0.442  Sum_probs=211.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----C
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----E   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----~   92 (284)
                      .++|++.+.||.|++|+||++.+..+++.|++|.+....... .....+.+|+.+++.++|+|++++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            457999999999999999999999999999999986532222 2234566799999999999999999987644     3


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..++++||+. ++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999996 689999988888999999999999999999999999999999999999999999999999988544322


Q ss_pred             ---CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----------------
Q 023270          173 ---RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------------  231 (284)
Q Consensus       173 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----------------  231 (284)
                         .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+...                 
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence               123456788999998765 45889999999999999999999999776543322221110                 


Q ss_pred             ------CCC------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          232 ------DLS------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       232 ------~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                            ...      ....+.+++++.+++.+||+.+|++|||++++++||||....++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                  000      00123578899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-42  Score=283.84  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=213.0

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecC---CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ..++|++.+.||+|+||+||+|....+   ...|++|.+.....  ......+.+|+..++.++|+|++++++++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            457899999999999999999988654   45789998865432  2234567889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++++||+++++|.+++... +.++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999999765 47899999999999999999999999999999999999999999999999998554311


Q ss_pred             C-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          173 R-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       173 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      .     ....++..|+|||.+.+..++.++|+||||++++++++ |..||......+....+.... ..+.+...++.+.
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  238 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLPPPMDCPSALY  238 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHH
Confidence            1     11223567999999998889999999999999999997 999998888877777666543 3334457899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcC
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++.+||..+|++||++++++++
T Consensus       239 ~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         239 QLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.7e-42  Score=287.04  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=211.2

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      +..++|++.+.||+|++|.||+|.+..     ++..|++|.+......  .....+..|+.+++.++|+|++++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            445779999999999999999999877     6778999988543322  223567789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---CEEE
Q 023270           91 DERIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKI  160 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~~~l  160 (284)
                      .+..++|+||+++++|.+++....       .+++..++.++.||+.++.|||+.|++|+||+|+||+++.++   .++|
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999999997653       488999999999999999999999999999999999998765   5999


Q ss_pred             eecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 023270          161 GDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLS  234 (284)
Q Consensus       161 ~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  234 (284)
                      +|||++.......     .....+..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+... ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~  239 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR  239 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence            9999875432111     12223467999999988889999999999999999996 99999988877766655443 33


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...+..++.++.+++.+||..+|.+|||++++++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            44455789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.1e-42  Score=282.24  Aligned_cols=241  Identities=25%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      +.||+|+||.||++.+..+++.|++|.+.....  ......+.+|+++++.++|+||+++++++..++..++|+||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            468999999999999999999999998754321  223457888999999999999999999999999999999999999


Q ss_pred             chHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCc-----cccC
Q 023270          105 ELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH-----TMCG  178 (284)
Q Consensus       105 ~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~~~  178 (284)
                      +|.+++...+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........     ....
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999997654 689999999999999999999999999999999999999999999999998754322111     1122


Q ss_pred             CCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCC
Q 023270          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS  257 (284)
Q Consensus       179 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  257 (284)
                      +..|+|||.+.++.++.++|+||||++++++++ |..||...+........... .....+...+..+.+++.+||..+|
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCcccCCHHHHHHHHHHcCCCh
Confidence            456999999988889999999999999999997 99999887776665555543 2334455788999999999999999


Q ss_pred             CCCCCHHhhhc
Q 023270          258 SKRLSLQKIME  268 (284)
Q Consensus       258 ~~Rps~~~il~  268 (284)
                      .+|||+.++++
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.3e-42  Score=317.65  Aligned_cols=252  Identities=25%  Similarity=0.404  Sum_probs=207.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +++|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+++++.++|||++++++++.+++..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            47899999999999999999999999999999998654433344456788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           98 LEYAHRGELYRELRKH-----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      |||+++++|.+++.+.           ..++...++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988642           23456778899999999999999999999999999999999999999999987


Q ss_pred             cccCC---------------------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHH
Q 023270          167 VQSRS---------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF  225 (284)
Q Consensus       167 ~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~  225 (284)
                      .....                     ......|++.|+|||.+.+..++.++||||||+++++|+||..||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            54310                     011235899999999999999999999999999999999999999876554433


Q ss_pred             HHHH-hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          226 RRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       226 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .... ...........+|+.+.+++.+||..||++||+..+.+..
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2211 1111112223688999999999999999999876665543

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.7e-42  Score=282.67  Aligned_cols=246  Identities=24%  Similarity=0.427  Sum_probs=210.2

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe-cCCe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH-DDER   93 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~-~~~~   93 (284)
                      -+.+.+|++.+.||+|++|.||++..  .+..+++|.+....     ..+.+.+|+.+++.++|++++++++++. .++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            35678999999999999999999875  47789999985432     1346788999999999999999999754 5567


Q ss_pred             EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           94 IFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      .++++||+++++|.+++...+  .++...++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            899999999999999997654  478999999999999999999999999999999999999999999999998865444


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      .......+..|+|||++.+..++.++||||||+++++|++ |..||...+..+....+... ......+.+++.+.+++.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         155 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHH
Confidence            3334445678999999988889999999999999999997 99999888777776666554 233445578999999999


Q ss_pred             HhcccCCCCCCCHHhhhc
Q 023270          251 RLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~  268 (284)
                      +||..+|++|||++++++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         234 QCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.9e-42  Score=285.80  Aligned_cols=252  Identities=21%  Similarity=0.356  Sum_probs=209.5

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      .+.-++|++.+.||+|++|.||++.+..     ++..|++|++......  .....+.+|+.+++.++|+|++++++++.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3456789999999999999999987643     3567999998543221  22356778999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEE
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~  159 (284)
                      .++..++|+||+++++|.+++.+..          .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            9999999999999999999987532          357788899999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 023270          160 IGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDL  233 (284)
Q Consensus       160 l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  233 (284)
                      |+|||++.......     ....+++.|+|||.+.+..++.++|+||||++++++++ |..||...+..+..........
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999875332211     12234677999999998889999999999999999998 7899988887777766555432


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                       ...+...++.+.+++.+||..+|++|||+.+++++
T Consensus       240 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 -LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             23344688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-42  Score=292.49  Aligned_cols=254  Identities=26%  Similarity=0.453  Sum_probs=202.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----   92 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~----   92 (284)
                      .+.+|++.+.||+|++|.||+|.+..+++.|++|.+....... .....+.+|++++++++|+|++++++++...+    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            4568999999999999999999999999999999885433221 11234567899999999999999999886543    


Q ss_pred             ----eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           93 ----RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        93 ----~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                          ..++|+||+++ +|...+... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence                45999999974 788777654 378999999999999999999999999999999999999999999999999874


Q ss_pred             ccCCCC-------ccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 023270          168 QSRSKR-------HTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-----  234 (284)
Q Consensus       168 ~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----  234 (284)
                      ......       ....++..|+|||.+.+.. ++.++|+||||+++++|++|..||...+.......+......     
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            332111       1234577899999886654 688999999999999999999999877665443332221000     


Q ss_pred             --------------CCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          235 --------------FPS-----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       235 --------------~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                    .+.           ....+..+.++|.+||..||.+|||++++|+||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                          000           00135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-42  Score=296.26  Aligned_cols=254  Identities=24%  Similarity=0.422  Sum_probs=206.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeE
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~   87 (284)
                      +++...+|++.+.||.|+||.||+|.+..     +++.|++|++......  ...+.+.+|+.++.++ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeee
Confidence            34445599999999999999999997543     3578999998643322  2235667899999999 79999999998


Q ss_pred             EecC-CeEEEEEeecCCCchHHHHHhc-----------------------------------------------------
Q 023270           88 FHDD-ERIFLILEYAHRGELYRELRKH-----------------------------------------------------  113 (284)
Q Consensus        88 ~~~~-~~~~~v~e~~~~~~L~~~l~~~-----------------------------------------------------  113 (284)
                      +... ..+++++||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            7644 5789999999999999988542                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-----CccccCCC
Q 023270          114 --------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTL  180 (284)
Q Consensus       114 --------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~  180 (284)
                              ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......     .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    25788999999999999999999999999999999999999999999999988543211     11223456


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSK  259 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  259 (284)
                      .|+|||.+.+..++.++||||||++++++++ |..||......+..............+...++++.+++.+||+.+|++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            7999999999999999999999999999998 999998765544444444443344444567899999999999999999


Q ss_pred             CCCHHhhhcC
Q 023270          260 RLSLQKIMEH  269 (284)
Q Consensus       260 Rps~~~il~~  269 (284)
                      ||+++++++|
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-42  Score=289.67  Aligned_cols=256  Identities=28%  Similarity=0.432  Sum_probs=207.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~   96 (284)
                      ..+|...+.||.|+||.||++.+..++..|++|.+......  .....+.+|+..+.++. |+|++++++++..++..++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            45778889999999999999999999999999998654333  23456778888888886 9999999999999999999


Q ss_pred             EEeecCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           97 ILEYAHRGELYRELR-----KHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        97 v~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ++|+++. ++.++..     ....+++..+..++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999864 5554332     235789999999999999999999975 99999999999999999999999999874332


Q ss_pred             C--CCccccCCCcccCccccCCC---CCCchhhHhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCC---CCCCCCC
Q 023270          171 S--KRHTMCGTLDYLAPEMVENK---EHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDLS---FPSAPSI  241 (284)
Q Consensus       171 ~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~---~~~~~~~  241 (284)
                      .  ......++..|+|||.+.+.   .++.++|+||+|++++++++|..||..... .+...+.......   ...+..+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            2  22233578889999998776   588999999999999999999999976542 2223333222111   1112247


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +.++.+|+++||..+|.+|||+++++.||||++..
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            89999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.5e-42  Score=288.03  Aligned_cols=250  Identities=24%  Similarity=0.450  Sum_probs=211.7

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ++..+|.+.+.||+|++|.||++.+..     ++..+++|.+.....   ...+.+.+|+..++.++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            567889999999999999999998543     445688998854332   223567889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC
Q 023270           91 DERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~  154 (284)
                      ++..++||||+++++|.+++....                .+++..++.++.||+.|+.+||++|++|+||+|+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999997643                3788999999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 023270          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRI  228 (284)
Q Consensus       155 ~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  228 (284)
                      ++.++|+|||++......     .....++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+.....
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999988543322     122335678999999998889999999999999999998 99999888887777766


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ..+... ......+..+.+++.+||..+|.+|||+.++++.
T Consensus       239 ~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         239 TQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             hCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            554332 2334678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=283.90  Aligned_cols=247  Identities=22%  Similarity=0.404  Sum_probs=210.1

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++.+.||.|++|.||++.+. ++..+++|.+.......    ..+.+|+.+++.++|+|++++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            4568999999999999999999875 56789999985433222    356679999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--  173 (284)
                      |+||+++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999999999764 468999999999999999999999999999999999999999999999999875433221  


Q ss_pred             --ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          174 --HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       174 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                        ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+........ .....+...+.++.+++.
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  235 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKLAPTEVYTIMY  235 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHH
Confidence              11123457999999998889999999999999999998 89999888877777666554 333444568999999999


Q ss_pred             HhcccCCCCCCCHHhhhcC
Q 023270          251 RLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~  269 (284)
                      +||..+|++|||++++++.
T Consensus       236 ~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         236 SCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHhcCChhhCcCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.8e-42  Score=299.79  Aligned_cols=255  Identities=23%  Similarity=0.392  Sum_probs=210.7

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecC-----CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCccccee
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLY   85 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~   85 (284)
                      ..+++...+|++.+.||.|+||.||++.+...     +..||+|++......  ...+.+.+|+++++.+. ||||++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            45677788899999999999999999987433     346999998643322  23467889999999996 99999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhc----------------------------------------------------
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKH----------------------------------------------------  113 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------------------------------------------  113 (284)
                      +++...+..++||||+++++|.+++..+                                                    
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            9999999999999999999999887542                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270          114 --------------------------------------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus       114 --------------------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                                                                  ..++...+..++.|++.||.|||+.|++|+||+|+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        136778889999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      |+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99999999999999997543221     122345678999999988889999999999999999997 999998765554


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .................++.++.+++.+||..+|++|||+.++.+
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            444444444444555678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=306.12  Aligned_cols=253  Identities=23%  Similarity=0.405  Sum_probs=219.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ...+++-..+..+..+||+|.||+||++.+-+   .||||++........ ..+.|+.|+..+++-+|.||+-+.|++..
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            46788888999999999999999999998754   599999977655543 68999999999999999999999999998


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      ++. .||+-+|+|.+|...+.-. -++.....+.|++|+++|+.|||.++|+|+|||.+||++..++.|||+|||++...
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence            887 9999999999999998765 46899999999999999999999999999999999999999999999999998443


Q ss_pred             C-----CCCccccCCCcccCccccCC---CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---C
Q 023270          170 R-----SKRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---A  238 (284)
Q Consensus       170 ~-----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~  238 (284)
                      .     .......|...|+|||+++.   .+|++.+||||||+++|||++|..||.....+.++...-++......   .
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~  618 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR  618 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence            2     22344567788999999864   45899999999999999999999999987777777766666333322   3


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ...++++++|+..||..++++||++.+||.
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            467889999999999999999999999998

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.7e-42  Score=283.27  Aligned_cols=248  Identities=21%  Similarity=0.397  Sum_probs=208.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++..++|++.++||.|++|.||+|.+..+ ..|++|.+......    ...+.+|+++++.++|+|++++++.+. ++..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   75 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence            45567899999999999999999987655 46999998653322    245778999999999999999999774 4568


Q ss_pred             EEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ++|+||+++++|.+++...  ..++...++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999999999764  35789999999999999999999999999999999999999999999999987543222


Q ss_pred             C----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .    ....++..|+|||...+..++.++|+||||++++++++ |..||......+......... ..+....++..+.+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  234 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHD  234 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCCccccCHHHHH
Confidence            1    12335667999999988889999999999999999999 899999888877777665543 33344578999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+|+..+|.+||+++++++.
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~~  256 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQAF  256 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHHH
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-43  Score=314.36  Aligned_cols=256  Identities=24%  Similarity=0.437  Sum_probs=228.9

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR   83 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~   83 (284)
                      .+....++..++-...+.||+|.||.||+++-.+     ....||||.++...  +....++|++|++++..++|+|||+
T Consensus       476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVr  553 (774)
T KOG1026|consen  476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVR  553 (774)
T ss_pred             CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEE
Confidence            4566778889999999999999999999998654     33459999986544  3345689999999999999999999


Q ss_pred             eeeEEecCCeEEEEEeecCCCchHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           84 LYGWFHDDERIFLILEYAHRGELYRELRKHR----------R----FTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        84 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------~----l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      ++|+|.+++..++|+||+..|+|.++|....          .    |+..+.+.|+.||+.|+.||-++.+||+||..+|
T Consensus       554 LlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN  633 (774)
T KOG1026|consen  554 LLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN  633 (774)
T ss_pred             EEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence            9999999999999999999999999996532          2    8899999999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCCCCc-----cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      +|+.++-.|||+|||+++..-+...     ...-+.+|+|||.+..+.++.+|||||+|++|||+++ |..||.+.+..+
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E  713 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE  713 (774)
T ss_pred             ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence            9999999999999999966544332     2334678999999999999999999999999999997 999999999999


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhh
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIM  267 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il  267 (284)
                      .++-+..+.. ++.+..+|.++.+|+..||+.+|++|||+.+|=
T Consensus       714 VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  714 VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            9999999987 888889999999999999999999999999873

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.6e-42  Score=291.72  Aligned_cols=261  Identities=29%  Similarity=0.466  Sum_probs=213.1

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-CCeEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DERIF   95 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-~~~~~   95 (284)
                      .-++|++.+.||.|+||.||++.+..+++.|++|++....... ...+.+..|+.+++.++|||++++.+++.. ++..+
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            4568999999999999999999999999999999875432221 234567789999999999999999998865 55789


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcc
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  175 (284)
                      +++||++ ++|..++.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  164 (328)
T cd07856          87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG  164 (328)
T ss_pred             EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence            9999995 588877764 46788899999999999999999999999999999999999999999999998655444444


Q ss_pred             ccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----------------------
Q 023270          176 MCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------------------  231 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----------------------  231 (284)
                      ..+++.|+|||.+.+ ..++.++|+||||++++++++|..||...........+...                       
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            567888999998766 56899999999999999999999999776543221111100                       


Q ss_pred             ---CCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCC
Q 023270          232 ---DLSFP---SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  280 (284)
Q Consensus       232 ---~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (284)
                         ....+   ..+.+++++.+++.+||+.+|++|||+++++.||||++.+.|..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~  299 (328)
T cd07856         245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD  299 (328)
T ss_pred             ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence               00000   11346789999999999999999999999999999998887754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=295.16  Aligned_cols=257  Identities=25%  Similarity=0.454  Sum_probs=206.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----C
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----E   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----~   92 (284)
                      ..+|++.+.||.|++|.||++.+..+++.|++|.+....  .......+.+|+.+++.++|+|++++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            368999999999999999999999999999999985322  122345567899999999999999999987544     3


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..++++|++++ +|...+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999974 78776644 57899999999999999999999999999999999999999999999999987443221


Q ss_pred             C------ccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------
Q 023270          173 R------HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL------------  233 (284)
Q Consensus       173 ~------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------  233 (284)
                      .      ....+++.|+|||.+.+ ..++.++||||+|+++++|++|..||...+.......+.....            
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            1      22356788999998654 4688999999999999999999999976654333222211000            


Q ss_pred             ----------CC-C------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          234 ----------SF-P------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       234 ----------~~-~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                .. .      ..+..++++.+++.+||+.+|++|||+.++++||||.+..++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                      00 0      012467889999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=288.03  Aligned_cols=250  Identities=31%  Similarity=0.524  Sum_probs=209.2

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeEEEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIFLIL   98 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~~~v~   98 (284)
                      |++.+.||.|++|.||++.+..+++.+++|++.... ........+.+|+.+++.++|+|++++++++...  +..++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            789999999999999999999999999999997653 2223345677899999999999999999999888  8999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----  173 (284)
                      ||+++ +|.+++... ..+++..++.++.|++.|+.+||..|++|+||+|+||+++.++.++|+|||.+.......    
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99974 888888765 578999999999999999999999999999999999999999999999999885443322    


Q ss_pred             ccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----C----------
Q 023270          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP-----S----------  237 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~----------  237 (284)
                      ....++..|+|||.+.+ ..++.++||||||++++++++|..||...+.......+........     .          
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            23345778999998765 4578999999999999999999999988777665555443211000     0          


Q ss_pred             --------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          238 --------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       238 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                    ...+++++.+++.+||..+|.+||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          01138889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=293.44  Aligned_cols=252  Identities=27%  Similarity=0.504  Sum_probs=201.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEec--CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--CeEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIF   95 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~~~   95 (284)
                      +|++.+.||+|++|.||+|.+..  ++..||+|.+...........+.+.+|+.+++.++|+|++++++++...  +.++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  8899999998763311222234567889999999999999999999888  7899


Q ss_pred             EEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC----CCCEEEeecccc
Q 023270           96 LILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH----EGRLKIGDFGWS  166 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~----~~~~~l~d~~~~  166 (284)
                      +|+||+++ ++.+.+...     ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.    ++.++|+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 677666432     26899999999999999999999999999999999999999    899999999987


Q ss_pred             cccCCCC------ccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHH---------HHHHHHh
Q 023270          167 VQSRSKR------HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------TFRRIMK  230 (284)
Q Consensus       167 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~---------~~~~~~~  230 (284)
                      .......      ....+++.|+|||.+.+. .++.++|+||||+++++|++|..||.......         .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            5432221      223457789999988764 47899999999999999999999997654322         1111100


Q ss_pred             ------------------------c--CCCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          231 ------------------------V--DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       231 ------------------------~--~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                              .  ....+.         ....+.++.+++.+||.+||++|||++++++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                    0  000000         01456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=312.15  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=217.9

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceee-EEe
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYG-WFH   89 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~-~~~   89 (284)
                      ...++.-.+++|.+.|.+|||+.||+|.+...+..||+|++...   .+..++.+++|+.+|+.|+ |+|||.+++ ...
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            45566777899999999999999999999988899999998655   3456789999999999997 999999999 322


Q ss_pred             ----cC--CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCCCCEE
Q 023270           90 ----DD--ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        90 ----~~--~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~~~~~  159 (284)
                          .+  -.++++||||.++.|.+++...  ..|++.++++|+.++++|+.+||..+  |+|||||.+|||+..+|+.|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence                11  2579999999999999999754  46999999999999999999999998  99999999999999999999


Q ss_pred             EeecccccccCCCC------------ccccCCCcccCcccc---CCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHH
Q 023270          160 IGDFGWSVQSRSKR------------HTMCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (284)
Q Consensus       160 l~d~~~~~~~~~~~------------~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~  224 (284)
                      |||||.++......            -...-|+.|+|||.+   .+..+++|+|||+|||+||.|+....||+....-  
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--  264 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--  264 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence            99999984433222            112358899999965   5778999999999999999999999999876443  


Q ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                        .++.+.+.++..+..+..+.+||+.||++||.+||++-|++++-+--
T Consensus       265 --aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  265 --AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             --eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence              45567788888889999999999999999999999999999875433

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.4e-42  Score=291.34  Aligned_cols=251  Identities=20%  Similarity=0.352  Sum_probs=210.4

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCce----EEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHP----VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .+..++|++.+.||+|+||.||++.+..++..    |++|++.....  ....+.+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            45678999999999999999999998666554    89999864322  2234577889999999999999999998876


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      + ..+++++++++|+|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence            4 577999999999999999875 46889999999999999999999999999999999999999999999999998644


Q ss_pred             CCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          170 RSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       170 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ....     .....+..|+|||.+.+..++.++||||||+++|++++ |..||.+....+... ........+..+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTI  238 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCCCCCCCH
Confidence            3221     11223567999999999999999999999999999997 999998877665543 4444445555567889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+++.+||..+|.+||++.+++.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-42  Score=282.09  Aligned_cols=248  Identities=23%  Similarity=0.426  Sum_probs=213.3

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++...+|.+.+.||.|++|.||++.+. ++..+++|.+......    ...+.+|+..++.++|+|++++++++..+...
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            567789999999999999999999864 5578999998654332    24677899999999999999999999988999


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ++++|++++++|.+++....  .++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999999997653  6899999999999999999999999999999999999999999999999987544321


Q ss_pred             C----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .    .....+..|+|||.+.+...+.++|+||+|++++++++ |..||...+.......+.... ..+.+...+.++.+
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPRPPNCPEELYD  235 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence            1    12224567999999998889999999999999999998 999999888887777776542 34444567899999


Q ss_pred             HHHHhcccCCCCCCCHHhhhc
Q 023270          248 LISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+||..+|.+||+++++++
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=320.95  Aligned_cols=267  Identities=35%  Similarity=0.581  Sum_probs=236.1

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ......+.+..||.|++.||.|+||.|.+++++.+++.||.|++.+-.......-..|+.|=.+|..-+.+=|+.++..|
T Consensus        65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF  144 (1317)
T ss_pred             HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence            34556677888999999999999999999999999999999999775444444456778888888888889999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      .++.++|+||||++||+|..++.....++++.++-++..|+.||..+|+.|++|+||||+|||++..|++||.|||.+..
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence            99999999999999999999999998999999999999999999999999999999999999999999999999998754


Q ss_pred             cCC----CCccccCCCcccCccccC----C-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCC
Q 023270          169 SRS----KRHTMCGTLDYLAPEMVE----N-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--DLSFPS  237 (284)
Q Consensus       169 ~~~----~~~~~~~~~~y~aPE~~~----~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~  237 (284)
                      ...    .....+|||.|.+||++.    + +.|++..|.||+|+++|+|+.|..||-..+-.+++.+++.-  .+.+|.
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~  304 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD  304 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence            432    235567999999999984    3 56889999999999999999999999999999999999876  445554


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCC---HHhhhcCccccccC
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKNA  276 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~  276 (284)
                      ...+|.+.++||.+.++ +|+.|..   ++++..||||.+-+
T Consensus       305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence            46799999999999995 8899998   99999999998753

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-44  Score=303.37  Aligned_cols=250  Identities=25%  Similarity=0.457  Sum_probs=225.9

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      .+....+++-|..-..++.||.|+.|.||+++.  .++.||||++..          .-..+|+.|++|+|+||+.|.++
T Consensus       113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGV  180 (904)
T KOG4721|consen  113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGV  180 (904)
T ss_pred             hhhhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeee
Confidence            344567888888889999999999999999986  567899999832          12367888999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      |...-.+|||||||..|.|...|+...+++......|..+|+.|+.|||.++|+|+|||.-|||++.+..|||+|||-+.
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999773


Q ss_pred             ccC--CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          168 QSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       168 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ...  ...-...||..|+|||++.+.+.++|.||||||++||+|+||..||.+-+...++.-.-...+..+.+..+|+.+
T Consensus       261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF  340 (904)
T ss_pred             hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence            322  333345799999999999999999999999999999999999999999988888887777778888888999999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +-|+++||...|++|||+.|||.|
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHH
Confidence            999999999999999999999999

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-42  Score=293.82  Aligned_cols=259  Identities=24%  Similarity=0.427  Sum_probs=211.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----   91 (284)
                      ...+|.+.+.||+|+||.||++.+..+++.|++|++....... ...+.+.+|+.++++++|+||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            4488999999999999999999999999999999986533222 2245677899999999999999999987543     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       ...+++++++ +++|.+++.. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             3478888887 5688887755 468999999999999999999999999999999999999999999999999986655


Q ss_pred             CCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------
Q 023270          171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL----------------  233 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----------------  233 (284)
                      .......++..|+|||.+.+ ..++.++|+||||++++++++|..||...+.......+.....                
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (345)
T cd07877         172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  251 (345)
T ss_pred             ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence            54445567889999998866 4588899999999999999999999987665544433322110                


Q ss_pred             -------CCCC------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          234 -------SFPS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       234 -------~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                             ..+.      ....++++.++|.+||..||.+||++.++++||||++.-.|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                   0000      11357889999999999999999999999999999975443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-41  Score=281.09  Aligned_cols=241  Identities=24%  Similarity=0.379  Sum_probs=204.1

Q ss_pred             eeeccCCCeEEEEEEE--ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           25 RPLGKGKFGRVYLVRE--VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      +.||+|+||.||++.+  ..++..+++|++...... ....+.+..|+.+++.++|+|++++++++. ++..++|+||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            3689999999999864  456788999998654322 234567888999999999999999999875 556799999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC------ccc
Q 023270          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------HTM  176 (284)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~------~~~  176 (284)
                      +++|.+++.....++...+..++.|++.|+.+||+.|++|+||+|.||+++.++.++|+|||.+.......      ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            99999999888889999999999999999999999999999999999999999999999999875443221      112


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .++..|+|||.+.+..++.++|+||||++++++++ |..||......+....+..+. ..+.+..+++++.++|.+||+.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~~~~  237 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RMECPQRCPPEMYDLMKLCWTY  237 (257)
T ss_pred             CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHhcc
Confidence            23468999999988889999999999999999998 999999888777777666543 3445557899999999999999


Q ss_pred             CCCCCCCHHhhhc
Q 023270          256 DSSKRLSLQKIME  268 (284)
Q Consensus       256 ~p~~Rps~~~il~  268 (284)
                      ||.+||++++|.+
T Consensus       238 ~p~~Rp~~~~i~~  250 (257)
T cd05116         238 GVDERPGFAVVEL  250 (257)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-41  Score=280.57  Aligned_cols=242  Identities=25%  Similarity=0.451  Sum_probs=208.0

Q ss_pred             eeeccCCCeEEEEEEEec-CCc--eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeec
Q 023270           25 RPLGKGKFGRVYLVREVE-SKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYA  101 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~-~~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~  101 (284)
                      +.||.|++|.||++.+.. +++  .|++|.+......  ...+.+.+|+..+++++|+|++++++++.. ...++++|++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999998865 333  5899998765543  456788899999999999999999999988 8899999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC------C
Q 023270          102 HRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------R  173 (284)
Q Consensus       102 ~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~------~  173 (284)
                      ++++|.+++.+..  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......      .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999998764  6899999999999999999999999999999999999999999999999987543321      1


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHh
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL  252 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (284)
                      ....++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+..............+...|..+.+++.+|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC  237 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence            12345678999999998889999999999999999998 99999888888777776654445555557889999999999


Q ss_pred             cccCCCCCCCHHhhhcC
Q 023270          253 LVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       253 l~~~p~~Rps~~~il~~  269 (284)
                      |..+|++|||++++++.
T Consensus       238 l~~~p~~Rps~~~~~~~  254 (257)
T cd05040         238 WAHNPADRPTFAALREF  254 (257)
T ss_pred             CCCCcccCCCHHHHHHH
Confidence            99999999999999863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.5e-42  Score=285.35  Aligned_cols=249  Identities=24%  Similarity=0.444  Sum_probs=210.9

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      +...+|++.+.||+|+||.||++...     .++..+++|.+.....   .....+.+|++.++.++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH---HHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            56788999999999999999999642     3566788998754332   234578889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC
Q 023270           91 DERIFLILEYAHRGELYRELRKHR---------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~  155 (284)
                      ++..++++||+++++|.+++...+               .++...++.++.|++.|+.|||+.|++|+||+|+||+++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999997653               47889999999999999999999999999999999999999


Q ss_pred             CCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 023270          156 GRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIM  229 (284)
Q Consensus       156 ~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~  229 (284)
                      +.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+......
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            99999999987533221     112234678999999998889999999999999999998 999998887777776665


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          230 KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .+. ....+..+++.+.+++.+||..||.+||+++++++
T Consensus       239 ~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            543 23344578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=287.34  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=212.6

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      .+++..++|.+.+.||.|+||.||++.+.     .++..+++|.+......  ...+.+.+|+.+++++ +|+||+++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            45566678999999999999999999753     34557999988654322  2346788999999999 7999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecc
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                      ++...+..++++||+++++|.+++....  .++..++..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999999997643  38999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 023270          165 WSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSA  238 (284)
Q Consensus       165 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
                      .+.......     ....++..|+|||.+.+..++.++||||+|++++++++ |..||......+...+...........
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP  266 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence            875432211     12234677999999998889999999999999999998 999998877666555555444444444


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ...++++.+++.+||.++|.+|||+.++++
T Consensus       267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-42  Score=294.67  Aligned_cols=255  Identities=25%  Similarity=0.459  Sum_probs=208.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC------C
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------E   92 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~------~   92 (284)
                      .+|.+.+.||.|++|.||+|.+..+++.|++|++....... .....+.+|+++++.++|+||+++++++...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            58999999999999999999999999999999986532222 2235677899999999999999999988654      3


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .+++|+||+.. +|...+  ...++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            56999999864 676654  246899999999999999999999999999999999999999999999999998655444


Q ss_pred             CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 023270          173 RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL------------------  233 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------------  233 (284)
                      .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+.....                  
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07879         171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY  250 (342)
T ss_pred             CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence            444566788999999876 4588999999999999999999999988765554443332100                  


Q ss_pred             -----CCCC------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          234 -----SFPS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       234 -----~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                           ..+.      .+..++++.++|++||+.||.+||++++++.||||+...+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                 0000      1246788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.4e-42  Score=290.57  Aligned_cols=243  Identities=28%  Similarity=0.525  Sum_probs=188.4

Q ss_pred             eeeeccCCCeEEEEEEEec--CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe--cCCeEEEEEe
Q 023270           24 GRPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH--DDERIFLILE   99 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~--~~~~~~~v~e   99 (284)
                      ..+||.|+||+||+|.+..  ++..|++|.+......     ..+.+|+.+++.++|+|++++++++.  .+...++|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            3689999999999998654  5678999988543322     34668999999999999999999885  3567899999


Q ss_pred             ecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe----cCCCCEEEeecccc
Q 023270          100 YAHRGELYRELRKH---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS  166 (284)
Q Consensus       100 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~----~~~~~~~l~d~~~~  166 (284)
                      |+++ +|.+++...         ..+++..++.++.|++.||.|||+.|++|+||+|+||++    +.++.++|+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9974 777777532         247889999999999999999999999999999999999    45679999999998


Q ss_pred             cccCCC------CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHh
Q 023270          167 VQSRSK------RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------DTFRRIMK  230 (284)
Q Consensus       167 ~~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------~~~~~~~~  230 (284)
                      ......      .....+++.|+|||.+.+. .++.++||||||+++++|+||.+||......         ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            543322      1234568889999998764 4789999999999999999999999653321         11111110


Q ss_pred             cCC--------------------------C----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          231 VDL--------------------------S----------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       231 ~~~--------------------------~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ...                          .          .......+..+.+|+.+||..||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000                          0          00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.4e-42  Score=282.00  Aligned_cols=247  Identities=22%  Similarity=0.402  Sum_probs=209.5

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++...+|+++++||+|+||.||+|.. .+++.|++|.+.......    ..+.+|+.+++.++|+|++++++++. .+..
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAVVT-QEPI   75 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcH----HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence            45667899999999999999999985 467889999986544332    46778999999999999999999874 5678


Q ss_pred             EEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ++++|++.+++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999999998764  36889999999999999999999999999999999999999999999999987543311


Q ss_pred             C----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .    ....++..|+|||.+....++.++|+||||++++++++ |..||...+..+....+... ...+.+...+.++.+
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPRPDNCPEELYE  234 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence            1    12234568999999988889999999999999999998 99999988877776665544 344555678899999


Q ss_pred             HHHHhcccCCCCCCCHHhhhc
Q 023270          248 LISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+||..+|++||+++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-41  Score=286.86  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCC----------------ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCC
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESK----------------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP   79 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----------------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~   79 (284)
                      +..++|++++.||+|+||.||++.+...+                ..|++|.+......  .....+.+|+++++.++|+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCC
Confidence            35679999999999999999999876543                45799998654322  3356788999999999999


Q ss_pred             cccceeeEEecCCeEEEEEeecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        80 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      |++++++++..++..++++|++++++|.+++....           .++...++.++.|++.||.|||+.|++|+||+|+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999997765           6899999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh--CCCCCCCCCh
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GAPPFEAESQ  221 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~~~  221 (284)
                      ||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||++++++++  +..||...+.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999987543221     122335678999999988889999999999999999998  7888988777


Q ss_pred             HHHHHHHHhc------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          222 KDTFRRIMKV------DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       222 ~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ...+......      ....+..+.++.++.+++.+||+.+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            7666655432      1122233457899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.5e-42  Score=293.88  Aligned_cols=256  Identities=26%  Similarity=0.438  Sum_probs=206.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------   91 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~------   91 (284)
                      ..+|.+.+.||.|++|.||++.+..+++.|++|.+.....   ...+.+.+|+++++.++|+|++++++.+...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            3789999999999999999999999999999999855433   2345677899999999999999999876543      


Q ss_pred             --------CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEee
Q 023270           92 --------ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGD  162 (284)
Q Consensus        92 --------~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d  162 (284)
                              ...++|+||++ ++|.+++.. ..+++..++.++.|+++||.|||+.|++|+||+|+||+++. ++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    35799999997 588887754 46899999999999999999999999999999999999975 56789999


Q ss_pred             cccccccCCC------CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-
Q 023270          163 FGWSVQSRSK------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-  234 (284)
Q Consensus       163 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-  234 (284)
                      ||.+......      .....++..|.|||.+.. ..++.++||||||+++++|++|..||...+..+........... 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9987543211      122346778999998754 45788999999999999999999999877665554444332100 


Q ss_pred             ---------------------CC------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          235 ---------------------FP------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       235 ---------------------~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                           ..      ..+.++.++.+|+.+||..||++|||+++++.||||+.-..|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence                                 00      012477889999999999999999999999999999854333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.3e-42  Score=290.04  Aligned_cols=257  Identities=28%  Similarity=0.493  Sum_probs=209.6

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-   92 (284)
                      .+...++|++.+.||.|++|.||++.+..+++.|++|.+....... .....+.+|+++++.++|+|++++++++.+.. 
T Consensus         2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            3456789999999999999999999999999999999986432211 12345678999999999999999999887654 


Q ss_pred             ---------eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           93 ---------RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        93 ---------~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                               .+++|+||+++ ++...+.+. ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                     79999999986 677767654 4689999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC----ccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--
Q 023270          163 FGWSVQSRSKR----HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--  235 (284)
Q Consensus       163 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--  235 (284)
                      ||.+.......    ....++..|+|||.+.+. .++.++||||||++++++++|.+||...+..+.+..+.......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99875432211    122346789999988654 47889999999999999999999998777665555444321100  


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 --------------------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                                .....+|+.+.+++.+||..+|.+|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                      0112468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-41  Score=285.98  Aligned_cols=255  Identities=39%  Similarity=0.673  Sum_probs=211.9

Q ss_pred             CcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHH-HHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~   94 (284)
                      +|++.+.||.|+||.||+|.+.   .++..|++|++...... .....+.+.+|++++..+ +|++|+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999875   47889999998654332 223346677899999999 589999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      ++|+||+++++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999987543221  


Q ss_pred             --CccccCCCcccCccccCCC--CCCchhhHhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCCCCCCHH
Q 023270          173 --RHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                        .....++..|+|||.+.+.  ..+.++|+||||++++++++|..||.....    .+.........  .+.+..+++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  238 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSAL  238 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--CCCCccCCHH
Confidence              1234478889999998753  467899999999999999999999974332    33333333322  2334468899


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHhhhcCccccccC
Q 023270          245 AKHLISRLLVKDSSKRL-----SLQKIMEHPWIIKNA  276 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~~  276 (284)
                      +.+++++||..+|.+||     ++++++.||||++..
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            99999999999999997     899999999998863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=287.10  Aligned_cols=250  Identities=30%  Similarity=0.533  Sum_probs=209.1

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |++.+.||+|++|.||++.+..+++.+++|.+....... .....+..|+..++.++|+|++++++++..++..++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            678899999999999999998899999999986544332 2345777899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---ccc
Q 023270          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTM  176 (284)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~~  176 (284)
                      +++ ++.+.+... ..++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            975 787777663 578999999999999999999999999999999999999999999999999875443322   223


Q ss_pred             cCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------------
Q 023270          177 CGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--------------------  235 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------------  235 (284)
                      .++..|.|||.+.+. ..+.++|+||||++++++++|..||...+..+............                    
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            467789999998776 68999999999999999999999998877655444433211000                    


Q ss_pred             --------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 --------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                              ...+.++.++.+++.+||.+||.+||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                    0112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7e-42  Score=286.19  Aligned_cols=252  Identities=20%  Similarity=0.371  Sum_probs=212.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecC-----CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ++.+.+|++.+.||.|+||.||++.+..+     +..|++|++......  .....+..|+.++..++|+||+++++++.
T Consensus         1 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~   78 (283)
T cd05091           1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVT   78 (283)
T ss_pred             CCCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            35678899999999999999999987543     577999998654322  23456788999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec
Q 023270           90 DDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD  153 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~  153 (284)
                      ..+..++++||+.+++|..++...                ..++...++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF  158 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence            999999999999999999998532                2478888999999999999999999999999999999999


Q ss_pred             CCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 023270          154 HEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRR  227 (284)
Q Consensus       154 ~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~  227 (284)
                      .++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999875432211     22334678999999988889999999999999999998 8899988888877777


Q ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          228 IMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +..... .+.+..++..+.+++.+||+.+|.+||++.+|+..
T Consensus       239 i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            666543 33445789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-41  Score=281.26  Aligned_cols=247  Identities=22%  Similarity=0.405  Sum_probs=208.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++...+|++.++||.|++|.||++.+. ++..+++|.+.......    +.+.+|+.+++.++|++++++++++. .+..
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI   75 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence            456678999999999999999999764 56679999986544322    45788999999999999999999875 4568


Q ss_pred             EEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      +++|||+++++|.+++...  ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            9999999999999998764  35899999999999999999999999999999999999999999999999998543221


Q ss_pred             C----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .    ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+... ...+.+...+.++.+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHE  234 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence            1    12234567999999988889999999999999999999 99999888887777766553 334445578899999


Q ss_pred             HHHHhcccCCCCCCCHHhhhc
Q 023270          248 LISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+||..+|.+|||++++++
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=279.70  Aligned_cols=240  Identities=24%  Similarity=0.387  Sum_probs=203.8

Q ss_pred             eeeccCCCeEEEEEEEecCC---ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeec
Q 023270           25 RPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYA  101 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~  101 (284)
                      ++||+|+||.||+|.+...+   ..+++|.+......  ...+.+.+|++.++.++|+|++++++++. .+..++|+||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999876655   68999998765443  23467888999999999999999999875 55689999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcc------
Q 023270          102 HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------  175 (284)
Q Consensus       102 ~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~------  175 (284)
                      ++++|.+++.....+++..+..++.|++.++.+||..|++|+||+|+||+++.++.++|+|||.+.........      
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999998888999999999999999999999999999999999999999999999999987543222211      


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+.... ....+..++..+.+++.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhc
Confidence            112357999999998889999999999999999998 999998888776666655443 334555788999999999999


Q ss_pred             cCCCCCCCHHhhhc
Q 023270          255 KDSSKRLSLQKIME  268 (284)
Q Consensus       255 ~~p~~Rps~~~il~  268 (284)
                      ++|++||++.++++
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-41  Score=286.13  Aligned_cols=261  Identities=27%  Similarity=0.482  Sum_probs=210.9

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEec
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD   90 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~   90 (284)
                      ....+...+|++.+.||.|++|.||++.+..+++.|++|.+.......  ....+..++..+... .|+|++++++++..
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            445778899999999999999999999998889999999986543222  223445566655555 49999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           91 DERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      +...++++||++ +++.+++.. ...+++..+..++.+++.++.|||+ .|++|+||+|+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          86 DSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             CCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            999999999986 477777655 3578999999999999999999997 5999999999999999999999999998754


Q ss_pred             cCC--CCccccCCCcccCccccCCCC----CCchhhHhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCC-CCCCCCC
Q 023270          169 SRS--KRHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDL-SFPSAPS  240 (284)
Q Consensus       169 ~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~-~~~~~~~  240 (284)
                      ...  ......++..|+|||.+.+..    ++.++|+||||+++++|++|..||..... .+.+........ ..+....
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06618         165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG  244 (296)
T ss_pred             ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence            322  122334677899999986553    78899999999999999999999976433 344444444332 2222234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ++.++.+++.+||..||.+||++++++.||||++.
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            78999999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-42  Score=308.82  Aligned_cols=259  Identities=22%  Similarity=0.346  Sum_probs=195.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCce-EEEE--------------ehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALK--------------IIFKEQIEKYKIQHQLRREMEIQSSLRHPNI   81 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-v~iK--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i   81 (284)
                      ...+|++++.||+|+||+||++........ .+.|              .+.+...........+.+|+.++++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            457899999999999999999876433221 1111              1111111122334567899999999999999


Q ss_pred             cceeeEEecCCeEEEEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC
Q 023270           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (284)
Q Consensus        82 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~  156 (284)
                      +++++++..++..|++++++. ++|.+++...     .......++.++.|++.||.|||+.||+|+||||+|||++.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            999999999999999999986 4777666442     2234667888999999999999999999999999999999999


Q ss_pred             CEEEeecccccccCCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCC-CCCC--ChHHHHHHHH
Q 023270          157 RLKIGDFGWSVQSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAE--SQKDTFRRIM  229 (284)
Q Consensus       157 ~~~l~d~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p-~~~~--~~~~~~~~~~  229 (284)
                      .++|+|||++......    .....|+..|+|||++.+..++.++||||||+++++|++|..+ +...  .....+.++.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            9999999998544322    1234689999999999999999999999999999999998754 4322  2222222222


Q ss_pred             hcCC----CCC--------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          230 KVDL----SFP--------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       230 ~~~~----~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ....    .++                          ....++.++.+++.+||..||.+|||+.++|+||||....
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            1100    000                          0113566788899999999999999999999999998764

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-41  Score=283.21  Aligned_cols=250  Identities=24%  Similarity=0.437  Sum_probs=214.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ..+|++.+.||.|+||.||++....     +.+.+++|.+.....  ....+.+.+|+++++.++|+|++++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            4689999999999999999999754     346689998855332  223467888999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeec
Q 023270           93 RIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                      ..++|+||+++++|.+++....         .++...+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998765         6899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 023270          164 GWSVQSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSA  238 (284)
Q Consensus       164 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
                      |++......    .....++..|+|||.+.+...+.++||||||++++++++ |..||..................+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            987433221    122334667999999988888999999999999999998 889998877777777776666666666


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ..++..+.+++.+||..+|.+|||+.+++..
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            6789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-41  Score=287.29  Aligned_cols=254  Identities=24%  Similarity=0.444  Sum_probs=211.4

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecC-------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~   84 (284)
                      .+++...+|.+.+.||+|+||.||++.+...       ...+++|.+......  .....+..|+.++..+ +|+|++++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            4555568999999999999999999986542       346999998654221  2235677899999999 79999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++++..++..++|+||+++++|.+++....                .++...++.++.|++.||.|||+.|++|+||+|+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999997642                4788999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.++|+|||.+......     .....+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999999999999999987543221     111223467999999988889999999999999999998 89999887776


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +......... ....+..++.++.+++.+||..+|.+|||+.+++++
T Consensus       250 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            6666555443 334455789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.6e-41  Score=279.36  Aligned_cols=247  Identities=22%  Similarity=0.389  Sum_probs=207.5

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++...+|.+...||.|++|.||++.+..+ ..+++|.+......    .+.+.+|+++++.++|++++++++++. .+..
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            34567899999999999999999987554 46999987553322    245778999999999999999999875 4568


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      +++|||+++++|.+++....  .++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            99999999999999997643  4789999999999999999999999999999999999999999999999988543222


Q ss_pred             C----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .    ....++..|+|||...+...+.++|+||||++++++++ |..||......+....+... ...+.+...+..+.+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHE  234 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHH
Confidence            1    12234567999999988889999999999999999999 99999988887777666554 333444578899999


Q ss_pred             HHHHhcccCCCCCCCHHhhhc
Q 023270          248 LISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++++||..+|.+||+++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-41  Score=280.89  Aligned_cols=249  Identities=26%  Similarity=0.419  Sum_probs=210.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCc---eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ...+|++.+.||.|+||.||++.+..++.   .+++|.+......  ...+.+.+|+..++.++|+|++++++++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            46789999999999999999998865443   6899988653322  234678889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++|+||+++++|.+++... +.++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999765 46899999999999999999999999999999999999999999999999987543322


Q ss_pred             Cc------cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          173 RH------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       173 ~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ..      ...++..|+|||.+.+..++.++|+||||++++++++ |..||......+....+... ...+....+++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAAL  238 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHH
Confidence            11      1112457999999998889999999999999999886 99999888777666666554 3444555789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .+++.+|++.+|.+||+++++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         239 HQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=286.32  Aligned_cols=254  Identities=24%  Similarity=0.455  Sum_probs=213.3

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCC-----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      ..++..++|++.+.||+|++|.||++......     ..+++|.+......  .....+.+|+.++..+ +|+|++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            34566788999999999999999999876443     67899998653322  2335678899999999 7999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~ni  150 (284)
                      ++..++..+++|||+++++|.+++...                ..++...++.++.|++.||.|||+.|++|+||+|+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999998642                4588999999999999999999999999999999999


Q ss_pred             EecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHH
Q 023270          151 LLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT  224 (284)
Q Consensus       151 l~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~  224 (284)
                      +++.++.++|+|||++.......     ....++..|+|||.+.+..++.++||||||++++++++ |..||......+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            99999999999999875433211     11224567999999988889999999999999999997 9999988877776


Q ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....... .....+...+.++.+|+.+||..+|.+|||+.+++++
T Consensus       244 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6665554 3344455788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-42  Score=285.82  Aligned_cols=250  Identities=31%  Similarity=0.570  Sum_probs=209.9

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |++.+.||.|++|.||+++...+++.|++|++.... ......+.+..|+..++.++|+|++++++++.+.+..++|+|+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999987654 1222345667899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---ccc
Q 023270          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTM  176 (284)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~~  176 (284)
                      ++ ++|.+++.+. ..++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            97 5899999887 579999999999999999999999999999999999999999999999999875443222   223


Q ss_pred             cCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------CC--
Q 023270          177 CGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL------------------SF--  235 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------------~~--  235 (284)
                      ..+..|+|||.+.+. .++.++|+||||++++++++|..||...+..+.+.++.....                  ..  
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            346779999998776 789999999999999999999999988776655544432100                  00  


Q ss_pred             -------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 -------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                             ...+.++.++.+++++||..+|++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                   0112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.5e-41  Score=279.79  Aligned_cols=250  Identities=23%  Similarity=0.382  Sum_probs=212.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCc---eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      +..++|+..+.||+|++|.||+|.+..++.   .+++|.+......  ...+.+..|+++++.++|+|++++.+++...+
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            556789999999999999999999876655   6899988543222  23456788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ..++||||+++++|.+++... +.++...+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999998764 5789999999999999999999999999999999999999999999999998754332


Q ss_pred             CCc------cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          172 KRH------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       172 ~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ...      ....+..|+|||.+.+..++.++|+||||++++++++ |..||...+..+....+... ...+.....+.+
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~  238 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPSA  238 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCHH
Confidence            111      1112456999999988889999999999999999997 99999888887777777654 344445578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.+++.+||..+|.+||+++++++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=285.47  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecC--------------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVES--------------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI   81 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~--------------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i   81 (284)
                      +.-++|++.+.||+|+||.||++.+...              ...|++|.+.....  ......+.+|+++++.++|+|+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i   79 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNI   79 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence            4457999999999999999999887543              23489999865322  2234578899999999999999


Q ss_pred             cceeeEEecCCeEEEEEeecCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKHR------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        82 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      +++++++..++..++||||+++++|.+++....            .++...++.++.|++.|+.|||+.|++|+||+|+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            999999999999999999999999999986532            36788899999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh--CCCCCCCCChH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GAPPFEAESQK  222 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~~~~  222 (284)
                      |+++.++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++++|++  +..||...+..
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            999999999999999875432111     12234568999999988889999999999999999988  67888887776


Q ss_pred             HHHHHHHh------cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          223 DTFRRIMK------VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       223 ~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.......      .......++..++.+.+|+.+||..+|.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            65554332      11112234467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=284.27  Aligned_cols=250  Identities=28%  Similarity=0.481  Sum_probs=204.7

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC---CCCcccceeeEEecCCe----
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDER----   93 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l---~h~~i~~~~~~~~~~~~----   93 (284)
                      |++.+.||.|++|.||++.+..+++.|++|++....... .....+.+|+.+++++   +|+|++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            789999999999999999998889999999986433222 1223444566555544   69999999999987776    


Q ss_pred             -EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           94 -IFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        94 -~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       .++++|++++ +|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999974 8888887753  58999999999999999999999999999999999999999999999999874432


Q ss_pred             CC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----C-------
Q 023270          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-----P-------  236 (284)
Q Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~-------  236 (284)
                      ..  .....++..|+|||.+.+..++.++|+||||+++++|++|.+||...+..+...++.......     +       
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            22  223346788999999998889999999999999999999999999888777666655421100     0       


Q ss_pred             -------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          237 -------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       237 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                   ..+.+++.+.+++.+||+.||.+||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                         011346788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.1e-42  Score=291.74  Aligned_cols=253  Identities=22%  Similarity=0.368  Sum_probs=204.9

Q ss_pred             eeeccC--CCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           25 RPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        25 ~~lg~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      ..||.|  ++|+||++.+..+++.|++|++....... ...+.+.+|+.+++.++|+||+++++++..++..++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456666  99999999999999999999986543322 334688889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---C-----
Q 023270          103 RGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---K-----  172 (284)
Q Consensus       103 ~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~-----  172 (284)
                      ++++.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++||+.......   .     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999998875  3589999999999999999999999999999999999999999999999975421111   0     


Q ss_pred             --CccccCCCcccCccccCCC--CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------------
Q 023270          173 --RHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL---------------  233 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---------------  233 (284)
                        .....++..|+|||++.+.  .++.++|+||+|++++++++|..||.................               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence              0111235569999998764  478999999999999999999999987765554443332211               


Q ss_pred             ------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          234 ------------------------------SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       234 ------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                                    ..+....+++++.+|+++||..||.+|||++++|+||||.+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                          011112356789999999999999999999999999999987543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.4e-41  Score=280.04  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=211.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCc---eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ..++|++.+.||.|+||.||+|....+++   .|++|.+....  .......+..|+..++.++|+|++++++++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            46789999999999999999999887665   59999986532  12234678899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++|+||+++++|.+++... +.++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999998764 56899999999999999999999999999999999999999999999999987433221


Q ss_pred             Cc--c---cc---CCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          173 RH--T---MC---GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       173 ~~--~---~~---~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ..  .   ..   .+..|+|||.+.+..++.++||||||++++++++ |..||...+..+....+... ...+.+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~  238 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPPPMDCPT  238 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCcccCCH
Confidence            11  0   11   1346999999998889999999999999999886 99999888877776666443 34455567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+.+++.+||..+|.+||++++++..
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         239 ALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.7e-42  Score=292.62  Aligned_cols=259  Identities=32%  Similarity=0.514  Sum_probs=210.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC--Ce
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD--ER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~--~~   93 (284)
                      ..++|++.+.||.|++|.||++.+..+++.+++|++....... .....+.+|+.+++++ +|+||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4578999999999999999999998899999999885432222 2234566799999999 999999999988654  36


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      .++|+||++ ++|..++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            899999997 5898888775 7889999999999999999999999999999999999999999999999987433221 


Q ss_pred             -------CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 023270          173 -------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF---------  235 (284)
Q Consensus       173 -------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------  235 (284)
                             .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||......+....+.......         
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                   122356788999998755 457889999999999999999999998766655444332221100         


Q ss_pred             --------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          236 --------------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       236 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                          ...+.++.++.+++..||..+|.+|||+.++++||||++.+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                                0112368899999999999999999999999999999887443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.7e-41  Score=278.30  Aligned_cols=244  Identities=23%  Similarity=0.417  Sum_probs=208.1

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .+++|++.+.||+|+||.||++.  .+++.|++|.+....     ....+.+|+..++.++|+|++++++++..+ ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            46789999999999999999886  477889999985432     124677899999999999999999988655 4799


Q ss_pred             EEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCc
Q 023270           97 ILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH  174 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  174 (284)
                      ++||+++++|.+++....  .++...++.++.|++.|+.+||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~  155 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD  155 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence            999999999999997653  578999999999999999999999999999999999999999999999998755433333


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ....+..|.|||.+.+..++.++|+||||+++++|++ |..||...+..+........ ........++..+.+++.+||
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l  234 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLMTSCW  234 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHc
Confidence            3344677999999988889999999999999999997 99999988887776666554 333445578999999999999


Q ss_pred             ccCCCCCCCHHhhhcC
Q 023270          254 VKDSSKRLSLQKIMEH  269 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~  269 (284)
                      ..+|.+||+++++++.
T Consensus       235 ~~~p~~Rp~~~~l~~~  250 (254)
T cd05083         235 ETEPKKRPSFHKLREK  250 (254)
T ss_pred             CCChhhCcCHHHHHHH
Confidence            9999999999999863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-41  Score=280.73  Aligned_cols=251  Identities=29%  Similarity=0.483  Sum_probs=208.9

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH--HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +|.+.+.||.|++|.||++.+...+..+++|++......  .......+..|+.+++.++|+|++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            689999999999999999998877777777765432221  111223456788899999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      +||+++++|.+++..    ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++. +.++|+|||.+...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988854    356899999999999999999999999999999999999964 67999999987443221 


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                        .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..........+. ....+..++.++.+++.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-CCCCcchhcHHHHHHHH
Confidence              223456788999999988888999999999999999999999998877777666665542 22234468899999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccc
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      +||..+|.+||+++++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         239 SMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.8e-41  Score=280.59  Aligned_cols=250  Identities=20%  Similarity=0.371  Sum_probs=208.7

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCc----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .+...+|++.+.||.|+||+||+|.+..++.    +|++|++......  .....+.+|+..++.++|+|++++++++..
T Consensus         3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            3567899999999999999999999877766    4799988644322  234567889999999999999999998865


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                       ...+++++++++++|.+++... +.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence             4578999999999999999774 46899999999999999999999999999999999999999999999999987543


Q ss_pred             CCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          170 RSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       170 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ....     ....+++.|+|||...+..++.++||||||++++++++ |..||...........+.. ....+.....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQPPICTI  238 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCCccCCH
Confidence            2211     12234567999999988889999999999999999998 9999987776665554443 333444557899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+++.+||..||.+||++.++++
T Consensus       239 ~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         239 DVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999994

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.8e-41  Score=277.59  Aligned_cols=245  Identities=25%  Similarity=0.464  Sum_probs=211.8

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCC----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESK----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      +++.+.||.|+||.||++.+..++    ..|++|.+.......  ..+.+..|+..+..++|+|++++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467889999999999999998766    889999986543321  34678899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCc
Q 023270           97 ILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH  174 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  174 (284)
                      ++|++++++|.+++.....  +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999977654  89999999999999999999999999999999999999999999999999854433211


Q ss_pred             ----cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          175 ----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       175 ----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                          ...+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+............. .......+.++.+++
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i  237 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-LPKPENCPPEIYKLM  237 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCcCCHHHHHHH
Confidence                1225678999999988889999999999999999998 8999988888777777766543 334456899999999


Q ss_pred             HHhcccCCCCCCCHHhhhc
Q 023270          250 SRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~  268 (284)
                      .+||..+|++|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      238 LQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHCcCChhhCcCHHHHHh
Confidence            9999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=299.76  Aligned_cols=253  Identities=27%  Similarity=0.466  Sum_probs=225.0

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |.=++.||+|+||.||-|.+..+...||||++....-.+.+--+.+.+|++.+++++|||.+.+-+.+..+...++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            66678899999999999999999999999999765555444446778899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCC
Q 023270          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT  179 (284)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  179 (284)
                      |- ||-.+++.-. +++.+.++..|..+.+.||.|||+++.+|+|||..|||++..|.|||.|||.+.... +.+..+||
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-PAnsFvGT  185 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-PANSFVGT  185 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-chhcccCC
Confidence            95 6999998876 579999999999999999999999999999999999999999999999999885543 44567899


Q ss_pred             CcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 023270          180 LDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD  256 (284)
Q Consensus       180 ~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (284)
                      |.|+|||++.   .+.|+-+.||||||++..+|...++|.-..+....+..+-+...+.-..+.-+..+++||..||..-
T Consensus       186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKi  265 (948)
T KOG0577|consen  186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI  265 (948)
T ss_pred             ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhC
Confidence            9999999874   6779999999999999999999999988888888887777765555555567889999999999999


Q ss_pred             CCCCCCHHhhhcCcccccc
Q 023270          257 SSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       257 p~~Rps~~~il~~~~~~~~  275 (284)
                      |.+|||++++|.|+|++..
T Consensus       266 pqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  266 PQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             cccCCcHHHHhhcchhccC
Confidence            9999999999999999875

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=281.51  Aligned_cols=249  Identities=32%  Similarity=0.509  Sum_probs=205.2

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEEEe
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      |++.+.||+|++|+||+|....+++.|++|.+........  .....+|+..+..++ |+|++++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            7889999999999999999988999999999865432211  123346888888998 9999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--Ccc
Q 023270          100 YAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~  175 (284)
                      |+ +++|.+.+....  .++...++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+......  ...
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            99 678988887764  7899999999999999999999999999999999999999999999999988544332  223


Q ss_pred             ccCCCcccCccccC-CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------------
Q 023270          176 MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP------------------  236 (284)
Q Consensus       176 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------------------  236 (284)
                      ..++..|+|||.+. +..++.++|+||||+++++|++|..||...+..+...+.........                  
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            45678899999875 44578999999999999999999999987766555444332111100                  


Q ss_pred             ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          237 ----------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       237 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                ..+..+.++.++++.||..+|++|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                      011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.5e-41  Score=282.33  Aligned_cols=246  Identities=24%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             CcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      +|++.+.||+|+||.||++.+..     ....+++|.+......  .....+.+|+..++.+.|+||+++++.+..++..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     2346888887644322  2246788899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 023270           95 FLILEYAHRGELYRELRKH------------------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~ni  150 (284)
                      ++++||+.+++|.+++...                        ..++...++.++.|++.||.|||+.|++|+||+|+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478889999999999999999999999999999999


Q ss_pred             EecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHH
Q 023270          151 LLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT  224 (284)
Q Consensus       151 l~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~  224 (284)
                      +++.++.++|+|||++......     .....++..|+|||.+.+..++.++||||||+++++|++ |..||.+......
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999987543211     122234567999999988889999999999999999998 9999988887776


Q ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ....... .....+...+.++.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         239 FNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHhCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            6655443 344445578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.9e-41  Score=284.00  Aligned_cols=254  Identities=24%  Similarity=0.446  Sum_probs=213.4

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEec-------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~   84 (284)
                      .+++...+|.+.+.||.|+||.||++....       ++..|++|.+.....  ....+.+.+|+..++.+ +|+||+++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchhe
Confidence            467888999999999999999999997532       344689998864321  22346788899999999 79999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++++..++..++++||+++++|.+++.+.                ..++...++.++.|++.||.|||+.|++|+||+|+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence            99999999999999999999999999764                24678889999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.++|+|||.+......     .....++..|+|||++.+..++.++||||||++++++++ |..||...+..
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            999999999999999998544321     112234567999999988889999999999999999998 88999888887


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +....+.... ....+..++.++.+++.+||..+|.+|||+.++++.
T Consensus       247 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            7777665543 333445788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-41  Score=287.99  Aligned_cols=254  Identities=31%  Similarity=0.518  Sum_probs=203.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----   91 (284)
                      ...+|++.+.||.|++|.||++.+..+++.+++|.+....... .....+.+|++.++.++|+||+++++++.+.     
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            3689999999999999999999999999999999985433211 1123456799999999999999999987543     


Q ss_pred             ---CeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           92 ---ERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        92 ---~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                         ..+++|+||++. ++...+.. ...++...+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence               357999999975 67666654 3579999999999999999999999999999999999999999999999999874


Q ss_pred             ccCCCCc--------------cccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 023270          168 QSRSKRH--------------TMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD  232 (284)
Q Consensus       168 ~~~~~~~--------------~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  232 (284)
                      .......              ...+++.|+|||.+.+. .++.++||||||+++++|++|.+||.+.+.......+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            3322111              11346779999987654 47899999999999999999999998877766555443311


Q ss_pred             CCCC---------------------C-------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          233 LSFP---------------------S-------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       233 ~~~~---------------------~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ....                     .       ...+++.+.+++.+||..||++|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            1000                     0       01345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=272.48  Aligned_cols=261  Identities=25%  Similarity=0.466  Sum_probs=217.6

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEe
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFH   89 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~   89 (284)
                      .+......++.+.+..||.|+.|+|+++....+|+.+|||.+......  +..+.+...+.++...+ .|+|++.+++|.
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            344556677788889999999999999999999999999999765533  34566777777766554 799999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .+...++.||.+. ..+..++++. +++++..+-.+...+++||.||.+ +|++|+|+||+|||++..|++||+|||++.
T Consensus       162 ~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsG  240 (391)
T KOG0983|consen  162 TNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISG  240 (391)
T ss_pred             eCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccc
Confidence            9999999999986 3667766665 578999999999999999999985 599999999999999999999999999984


Q ss_pred             ccC--CCCccccCCCcccCccccCCC---CCCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCC-C
Q 023270          168 QSR--SKRHTMCGTLDYLAPEMVENK---EHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVDLSFPSAP-S  240 (284)
Q Consensus       168 ~~~--~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~-~  240 (284)
                      ...  .......|-+.|+|||.+...   .|+..+||||||+++++|.||..||.+ .++.+.+.+++....+.-... .
T Consensus       241 rlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g  320 (391)
T KOG0983|consen  241 RLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG  320 (391)
T ss_pred             eeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence            332  333556788999999998644   588899999999999999999999987 566788888887543222222 4


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      +++.+++|+..||..|+++||.+.++|+|||+..
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence            8999999999999999999999999999999875

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-41  Score=280.94  Aligned_cols=247  Identities=25%  Similarity=0.425  Sum_probs=198.5

Q ss_pred             cCc-EeeeeeccCCCeEEEEEEE----ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--
Q 023270           19 QDF-EIGRPLGKGKFGRVYLVRE----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--   91 (284)
Q Consensus        19 ~~y-~~~~~lg~g~~~~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--   91 (284)
                      .+| ++.+.||.|+||+||++..    ..++..|++|.+......  .....+.+|++.++.++|+|++++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 9999999999999987653    346778999998654321  2335677899999999999999999987653  


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ...+++|||+++++|.+++... .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999998764 589999999999999999999999999999999999999999999999999754332


Q ss_pred             CC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH--------------HHHHHHHhc
Q 023270          172 KR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------DTFRRIMKV  231 (284)
Q Consensus       172 ~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~--------------~~~~~~~~~  231 (284)
                      ..      ....++..|+|||.+.+...+.++||||||+++++|++|..||......              ....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            11      1123456699999998888999999999999999999999998643321              111111222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ....+.+..++.++.+++.+||.++|++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2233334567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.9e-41  Score=281.82  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=210.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      +..++|++.+.||.|+||.||+|.+..     ++..|++|.+.....  ......+.+|+..++.+.|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            445789999999999999999998753     577899999865432  2234678889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           91 DERIFLILEYAHRGELYRELRKHR----------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++..++++||+++++|.+++....                      .++...++.++.|++.||.+||+.|++|+||+|+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            999999999999999999986432                      3678889999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.++|+|||.+......     ......+..|+|||.+.+..++.++|+||||+++++|++ |..||.+.+..
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999987533211     112234567999999988889999999999999999997 88899888887


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +....+..+.. .+.++.++.++.+++.+||..+|.+|||++++++
T Consensus       240 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77776665443 2334468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.1e-41  Score=280.84  Aligned_cols=254  Identities=40%  Similarity=0.679  Sum_probs=210.6

Q ss_pred             CcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHH-HHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~   94 (284)
                      +|++.+.||.|++|.||++.+.   .+++.|++|++...... .......+..|++++.++ +|++++++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   36788999998654332 233446678899999999 599999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      ++|+||+++++|.+++.....++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            999999999999999988788999999999999999999999999999999999999999999999999987443221  


Q ss_pred             --CccccCCCcccCccccCCCC--CCchhhHhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAES----QKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                        .....++..|+|||.+.+..  .+.++|+||||+++++|++|..||....    ..+.........  .+.+..++.+
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  238 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAE  238 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCcccCHH
Confidence              12234788999999987655  7889999999999999999999996432    223333333332  3344468899


Q ss_pred             HHHHHHHhcccCCCCCCC---HHhhhcCcccccc
Q 023270          245 AKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  275 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  275 (284)
                      +.+++.+||+.+|++|||   +.++|+||||++.
T Consensus       239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            999999999999999998   5678999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.3e-41  Score=275.61  Aligned_cols=247  Identities=22%  Similarity=0.398  Sum_probs=210.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++.+.||.|++|.||++.+. ++..+++|.+.......    ..+.+|++.++.++|++++++++++......++
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            4578999999999999999999875 46789999986544332    357789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--  173 (284)
                      |+||+++++|.+++... ..++++.++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999999999998765 468999999999999999999999999999999999999999999999999875432221  


Q ss_pred             --ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          174 --HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       174 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                        ....++..|+|||.+.+..++.++|+||||++++++++ |..||...........+..+. ....+...+.++.+|+.
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-RLYKPRLASQSVYELMQ  235 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-CCCCCCCCCHHHHHHHH
Confidence              12234568999999988889999999999999999998 999999888877777766543 22333457899999999


Q ss_pred             HhcccCCCCCCCHHhhhcC
Q 023270          251 RLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~  269 (284)
                      +||..+|.+|||++++++.
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.5e-41  Score=287.09  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=206.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecC--CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEec----CC
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVES--KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD----DE   92 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~----~~   92 (284)
                      +|++.+.||+|+||.||++.+..+  +..|++|.+..... .....+.+.+|+.+++.+ +|+||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  88999999754221 122245667788999888 59999999987532    24


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..++++++++ ++|.+++.....++...++.++.|++.||.|||..|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6789999986 589999988888999999999999999999999999999999999999999999999999987533211


Q ss_pred             -------CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 023270          173 -------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-----------  233 (284)
Q Consensus       173 -------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----------  233 (284)
                             .....+++.|+|||.+.+ ..++.++|+||+|++++++++|.+||...+.......+.....           
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence                   123357888999998765 4588999999999999999999999987665443332222100           


Q ss_pred             -----------------C-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          234 -----------------S-FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       234 -----------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                       . ....+..+.++.+++.+||..||++|||+.+++.||||++.-+|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                             0 00123467899999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-41  Score=279.11  Aligned_cols=247  Identities=19%  Similarity=0.339  Sum_probs=206.6

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCC---ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe----
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER----   93 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~----   93 (284)
                      |++.+.||+|+||.||+|....++   ..|++|.+....... .....+.+|+..++.++|+|++++++++...+.    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            678999999999999999876543   779999986543322 234578889999999999999999998865554    


Q ss_pred             --EEEEEeecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccc
Q 023270           94 --IFLILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        94 --~~~v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                        .++++||+++++|..++...      ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888542      3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 023270          166 SVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAP  239 (284)
Q Consensus       166 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
                      +.......     .....+..|+|||.+.+..++.++||||||++++++++ |..||......+....+..+. ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCc
Confidence            75432221     11234567999999988889999999999999999999 999998888777776666543 344455


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .++.++.+++.+||..||.+|||+.+++++
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-42  Score=291.59  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=198.5

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-eEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-RIFLI   97 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-~~~~v   97 (284)
                      ++|.-...||+|+||+||++.... +..||||++.......   .++|.+|+.++.+++|+|+++++|||.+++ ..++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            578888899999999999998754 4899999886654332   345999999999999999999999999998 59999


Q ss_pred             EeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCeEecCCCCEEEeecccccccCC-
Q 023270           98 LEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENH---VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~g---i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-  171 (284)
                      +||++.|+|.+.+....  +++|..+.+|+.+++.||+|||...   |+|+||||+|||+|.+.++||+|||++..... 
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999997764  8999999999999999999999864   99999999999999999999999999844433 


Q ss_pred             CCcc--c-cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhc-CCCCCCC---
Q 023270          172 KRHT--M-CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES------QKDTFRRIMKV-DLSFPSA---  238 (284)
Q Consensus       172 ~~~~--~-~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~------~~~~~~~~~~~-~~~~~~~---  238 (284)
                      ....  . .|+.+|+|||+...+..+.++||||||++++|++||+.+.....      ..+........ .......   
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            2222  2 78999999999999999999999999999999999998776432      11211122221 1111111   


Q ss_pred             --CCCC--HH---HHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          239 --PSIS--AE---AKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       239 --~~~~--~~---l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                        ...+  .+   +..+...|+..+|++||++.++++.
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence              1223  22   5577779999999999999997543

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.2e-41  Score=293.15  Aligned_cols=257  Identities=23%  Similarity=0.400  Sum_probs=213.2

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccce
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRL   84 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~   84 (284)
                      ...+++...+|.+.+.||.|+||.||+|.+.     .++..||+|++.......  ..+.+.+|+.++..+. |+||+++
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~  106 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNL  106 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEE
Confidence            3447778888999999999999999999854     345679999996543222  2356788999999997 9999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcC--------------------------------------------------
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHR--------------------------------------------------  114 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--------------------------------------------------  114 (284)
                      ++++..++..++|+||+++++|.+++..++                                                  
T Consensus       107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            999999999999999999999999986532                                                  


Q ss_pred             ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023270          115 ------------------------------------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (284)
Q Consensus       115 ------------------------------------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~  146 (284)
                                                                      .++...++.++.|++.||.|||+.|++|+||+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk  266 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA  266 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence                                                            25667788899999999999999999999999


Q ss_pred             CCCeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCC
Q 023270          147 PENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES  220 (284)
Q Consensus       147 p~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~  220 (284)
                      |+||+++.++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||++++++++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999998543211     122345678999999988889999999999999999998 889998766


Q ss_pred             hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ..+..............+..++.++.+++.+||..+|.+||++.+|++.
T Consensus       347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6555555444444444555789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.3e-41  Score=286.53  Aligned_cols=254  Identities=24%  Similarity=0.453  Sum_probs=212.2

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecC-------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~   84 (284)
                      .+++...+|++.+.||+|+||.||+|.+...       ...|++|.+......  ...+.+.+|+++++++ +|+||+++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeee
Confidence            4566667899999999999999999986532       235899988643222  2346788899999999 79999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++++..++..++++||+++++|.+++....                .++...+..++.|++.||.|||+.|++|+||+|+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999987532                3678889999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.++|+|||++.......     ....++..|+|||.+.+..++.++||||||+++++|++ |..||...+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999875433211     11223467999999999889999999999999999998 89999888877


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +....+.... ........+.++.+++.+||..+|.+|||+.+++++
T Consensus       244 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ELFKLLKEGH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7776665543 333445688999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=277.80  Aligned_cols=250  Identities=22%  Similarity=0.382  Sum_probs=211.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCc----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .++..+|++.+.||+|+||+||++.+..++.    .+++|.......  ......+.+|+..+..++|+|++++++++..
T Consensus         3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            4677899999999999999999999876655    588998765432  2334677889999999999999999999876


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                       +..++|+||+++++|.+++.+. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence             7899999999999999999875 46899999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCc-----cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          170 RSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       170 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      .....     ...++..|+|||.+.+..++.++|+||||++++++++ |..||......+....+... ...+.+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  238 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQPPICTI  238 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCCCCCCCH
Confidence            32211     1113467999999988889999999999999999998 99999988877766666543 33444556889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+++.+||..+|.+||++.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-41  Score=288.73  Aligned_cols=254  Identities=23%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeE
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~   87 (284)
                      +.+...+|++.+.||.|+||.||+|.+.     .+++.||+|.+......  ...+.+.+|+.++.++ +|+|+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            3455569999999999999999999853     45678999998653322  2245677899999999 68999999998


Q ss_pred             EecC-CeEEEEEeecCCCchHHHHHhc-----------------------------------------------------
Q 023270           88 FHDD-ERIFLILEYAHRGELYRELRKH-----------------------------------------------------  113 (284)
Q Consensus        88 ~~~~-~~~~~v~e~~~~~~L~~~l~~~-----------------------------------------------------  113 (284)
                      +... ...++++||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            7654 5689999999999999998642                                                     


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-----Cc
Q 023270          114 --------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RH  174 (284)
Q Consensus       114 --------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----~~  174 (284)
                                    ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......     ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          13577888899999999999999999999999999999999999999999987543211     11


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ...++..|+|||.+.+..++.++|+||||++++++++ |..||.....................+...++++.+++..||
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence            2234567999999988889999999999999999997 999997655433333333333333444457889999999999


Q ss_pred             ccCCCCCCCHHhhhcC
Q 023270          254 VKDSSKRLSLQKIMEH  269 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~  269 (284)
                      ..+|.+|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-40  Score=274.61  Aligned_cols=248  Identities=21%  Similarity=0.396  Sum_probs=208.9

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      +++-..+|++.+.||+|+||.||++.+ ..+..+++|.+.....    ..+.+.+|+.+++.++|+|++++++++.. +.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence            356678999999999999999999975 4566799998864322    23567889999999999999999999877 77


Q ss_pred             EEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           94 IFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      .++++||+++++|.+++...  ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            89999999999999999764  3578889999999999999999999999999999999999999999999998743321


Q ss_pred             C----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          172 K----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       172 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      .    .....++..|+|||.+....++.++|+||||++++++++ |..||...+.......+... ...+.....+.++.
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  233 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELY  233 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCCCcccCCHHHH
Confidence            1    112234567999999988889999999999999999998 99999988777666655544 34444567899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhc
Q 023270          247 HLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +++.+|+..+|++||++.++++
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.3e-41  Score=276.02  Aligned_cols=229  Identities=25%  Similarity=0.396  Sum_probs=192.7

Q ss_pred             CCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCchHHH
Q 023270           30 GKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRE  109 (284)
Q Consensus        30 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~  109 (284)
                      |.++.||+|.+..+++.|++|.+......        .++...+....|+|++++++++.+++..+++|||+++++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~--------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY--------SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhh--------hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            89999999999999999999999664321        2233444455799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCCCcccCccccC
Q 023270          110 LRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVE  189 (284)
Q Consensus       110 l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (284)
                      +.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+...........++..|+|||...
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence            98888899999999999999999999999999999999999999999999999998755444444445567899999998


Q ss_pred             CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----H
Q 023270          190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL-----Q  264 (284)
Q Consensus       190 ~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~  264 (284)
                      +..+++++|+||+|++++++++|..|+.......      ........++.+++.+++++++||+.||.+||++     +
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            8889999999999999999999998875432211      1111222334688999999999999999999986     9


Q ss_pred             hhhcCccc
Q 023270          265 KIMEHPWI  272 (284)
Q Consensus       265 ~il~~~~~  272 (284)
                      +++.||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.5e-41  Score=277.97  Aligned_cols=247  Identities=19%  Similarity=0.344  Sum_probs=203.8

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCc--eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC------C
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------E   92 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~------~   92 (284)
                      |.+.+.||.|+||.||++.+..++.  .+++|.+....... ...+.+..|+..++.++|+|++++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4578899999999999999877765  58999875532222 3346778899999999999999999986432      2


Q ss_pred             eEEEEEeecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           93 RIFLILEYAHRGELYRELRK------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      ..++++||+++++|..++..      ...++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            57899999999999988742      134789999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          167 VQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       167 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      .......     .....++.|+|||.+.+..++.++|+||||++++++++ |..||...........+..+. .....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCC
Confidence            5433211     12234667999999999899999999999999999999 899998887777766665543 3334457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++..+.+++.+||+.+|.+|||+++++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=274.45  Aligned_cols=251  Identities=31%  Similarity=0.615  Sum_probs=213.3

Q ss_pred             cccCcEee-eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHH-HhCCCCcccceeeEEec----
Q 023270           17 SLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHD----   90 (284)
Q Consensus        17 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~-~~l~h~~i~~~~~~~~~----   90 (284)
                      ...+|++. ++||.|-.|.|-.+.++.+++.+|+|++...        +..++|+++- ..-.|+||+.+++++++    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            34567775 4689999999999999999999999998432        2445666543 23369999999998853    


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeeccc
Q 023270           91 DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGW  165 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~~~  165 (284)
                      ...+.+|||.++||.|.+.++..+  .+++.++..|+.||..|+.|||+.+|.|+||||+|+|.+.   |..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            357899999999999999998875  4999999999999999999999999999999999999964   56899999999


Q ss_pred             ccccC--CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCC-
Q 023270          166 SVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES----QKDTFRRIMKVDLSFPSA-  238 (284)
Q Consensus       166 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~-  238 (284)
                      +....  ......+.||.|.|||++....++...|+||+|++||-|++|.+||-...    .....+++..+.+.++.+ 
T Consensus       211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE  290 (400)
T KOG0604|consen  211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE  290 (400)
T ss_pred             ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence            96655  44456678999999999999999999999999999999999999996543    344566677777776664 


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          239 -PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       239 -~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                       +.+|.+.+++|+.+|..+|.+|.|++++++|||+.+.
T Consensus       291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence             5899999999999999999999999999999999764

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=285.50  Aligned_cols=251  Identities=28%  Similarity=0.478  Sum_probs=217.9

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |.++.+||+|+||.||+|.++++|+.+|||.+....     .++++.+|+.++.+++.++++++++.+.....+++||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            889999999999999999999999999999985543     356888999999999999999999999888999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCccc
Q 023270          101 AHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTM  176 (284)
Q Consensus       101 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~~  176 (284)
                      |.-|+..+.++. +++|+++++..+++..+.+|+|||...-+|+||+..|||++.+|++||.|||.+...   ....+.-
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence            999999999864 578999999999999999999999999999999999999999999999999987433   3344556


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .|+|-|+|||++..-.|+-++||||||++..+|..|++||.+-.+...+.-+.. ....+..+..-+.++.+|+++||..
T Consensus       190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK  269 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIK  269 (502)
T ss_pred             ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence            799999999999988899999999999999999999999987666433322211 1122222334577899999999999


Q ss_pred             CCCCCCCHHhhhcCccccccC
Q 023270          256 DSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +|++|.|+.++++|||+++.+
T Consensus       270 ~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  270 KPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             CHHHHHHHHHHhhhhhhcCCC
Confidence            999999999999999999984

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-40  Score=277.66  Aligned_cols=251  Identities=19%  Similarity=0.322  Sum_probs=206.0

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCc----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .+...+|++.+.||.|+||+||++.+..++.    .+++|.+....  .......+..++..+..+.|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-   79 (279)
T cd05111           3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-   79 (279)
T ss_pred             cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence            4567899999999999999999999877766    47777774322  1223356777888889999999999999875 


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +...++++|++++++|.+++... +.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            45678899999999999999764 57899999999999999999999999999999999999999999999999988543


Q ss_pred             CCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          170 RSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       170 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ...     .....++..|+|||.+.+..++.++||||||+++|++++ |..||.+.........+.. ....+.+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-GERLAQPQICTI  238 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCCCCCCH
Confidence            211     112335678999999988889999999999999999998 9999988776654443333 333344445778


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+++.+|+..+|.+|||++++++.
T Consensus       239 ~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         239 DVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            89999999999999999999999873

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-40  Score=283.04  Aligned_cols=253  Identities=23%  Similarity=0.423  Sum_probs=210.0

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEec-------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~   85 (284)
                      +.+...+|.+.+.||+|++|.||++.+..       ....+++|.+.....  ......+..|+.+++.+ +|+||++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLL   84 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence            45556789999999999999999997632       344689998764322  22345678899999999 599999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      +++..++..++++||+++++|.+++...                ..++...+..++.|++.||.|||++|++|+||+|+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            9999999999999999999999999763                247889999999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      |+++.++.++|+|||.+......     .....++..|+|||.+.+..++.++|+||||++++++++ |..||...+..+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998543321     111223457999999988889999999999999999998 899998888777


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....+.... ....+..++.++.+++.+||..+|++|||+.++++.
T Consensus       245 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         245 LFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            776665543 233445788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-40  Score=275.93  Aligned_cols=251  Identities=27%  Similarity=0.461  Sum_probs=209.7

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecC---CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ++...+|.+.+.||.|++|.||+|.+...   ...|++|.......  ....+.+.+|+..++.++|+|++++++++.. 
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   78 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-   78 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence            35567899999999999999999987544   34689998865432  2234678889999999999999999998865 


Q ss_pred             CeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      +..++|+||+++++|.+++.+.. .++...++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            55789999999999999998754 58999999999999999999999999999999999999999999999999875432


Q ss_pred             CCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          171 SKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       171 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ...    ....++..|+|||.+....++.++|+||||++++++++ |..||...+..+....+..+. ..+.++.++.++
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  237 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL  237 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHH
Confidence            221    12223467999999988889999999999999999886 999999888777766655543 334456789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+++.+|+..+|.+|||+.++++.
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=273.23  Aligned_cols=240  Identities=27%  Similarity=0.407  Sum_probs=204.5

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      ++||.|++|.||++.+.. ++.|++|.+......  .....+.+|++++++++|+||+++++++...+..++|+|+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999877 999999988654433  23467888999999999999999999999999999999999999


Q ss_pred             chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC-----ccccC
Q 023270          105 ELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCG  178 (284)
Q Consensus       105 ~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~  178 (284)
                      +|.+++... ..++...+..++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......     .....
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999998664 468999999999999999999999999999999999999999999999999875433111     11123


Q ss_pred             CCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCC
Q 023270          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS  257 (284)
Q Consensus       179 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  257 (284)
                      +..|+|||.+.++.++.++|+||||++++++++ |..||............... .....+...+.++.+++.+||..+|
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHhccCh
Confidence            456999999988889999999999999999999 89999887776666555443 3344455788999999999999999


Q ss_pred             CCCCCHHhhhc
Q 023270          258 SKRLSLQKIME  268 (284)
Q Consensus       258 ~~Rps~~~il~  268 (284)
                      .+|||++++++
T Consensus       237 ~~Rp~~~ell~  247 (251)
T cd05041         237 ENRPSFSEIYN  247 (251)
T ss_pred             hhCcCHHHHHH
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-41  Score=279.85  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=200.7

Q ss_pred             CcEeeeeeccCCCeEEEEEEE----ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC--Ce
Q 023270           20 DFEIGRPLGKGKFGRVYLVRE----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ER   93 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~--~~   93 (284)
                      -|++++.||+|+||.||++..    ..++..|++|.+.....  ......+.+|+.+++.+.|+|++++.+++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            478999999999999999974    45678899999865432  22345788999999999999999999988765  57


Q ss_pred             EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++|+||+++++|.+++.+. ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            89999999999999999765 36899999999999999999999999999999999999999999999999987543221


Q ss_pred             C------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHHhcC
Q 023270          173 R------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES--------------QKDTFRRIMKVD  232 (284)
Q Consensus       173 ~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~--------------~~~~~~~~~~~~  232 (284)
                      .      ....++..|+|||.+.+..++.++||||||+++++++++..|.....              ............
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            1      12345667999999988889999999999999999999776542211              111111222222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...+....++.++.+|+.+||+.+|.+|||++++++.
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            3344455789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=300.39  Aligned_cols=247  Identities=32%  Similarity=0.542  Sum_probs=215.0

Q ss_pred             eeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCc
Q 023270           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGE  105 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~  105 (284)
                      +||.|.||+||.+++..+...+|||.+.-...   ...+-+.+|+.+-++++|.||++.+|.+.+++++-|.||-.+|||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            58999999999999999999999999855432   234678899999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEeecccccccCC---CCccccC
Q 023270          106 LYRELRKH-RRF--TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRS---KRHTMCG  178 (284)
Q Consensus       106 L~~~l~~~-~~l--~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~---~~~~~~~  178 (284)
                      |.+++++- +++  ++..+..+..||++||.|||++.|+|+|||-+||+++. .|.+||+|||-+....+   -+....|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            99999876 566  77888889999999999999999999999999999965 69999999998754432   3345679


Q ss_pred             CCcccCccccCCCC--CCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          179 TLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       179 ~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      |..|+|||++..++  |.+++|||||||++.+|.||++||-. .++...+.+.-.-+..++.+..++.+.+.||.+|+.+
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            99999999998665  88999999999999999999999954 4555555555445556667778899999999999999


Q ss_pred             CCCCCCCHHhhhcCcccccc
Q 023270          256 DSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||.+||++.++|+.||++.+
T Consensus       819 d~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CcccCccHHHhccCcccccC
Confidence            99999999999999999988

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=277.40  Aligned_cols=242  Identities=24%  Similarity=0.383  Sum_probs=200.6

Q ss_pred             eeeccCCCeEEEEEEEecCCce--EEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEEeec
Q 023270           25 RPLGKGKFGRVYLVREVESKHP--VALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYA  101 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~e~~  101 (284)
                      +.||.|+||.||++.+..++..  +++|.+....  .....+.+.+|+.++.++ +|+|++++++++...+..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            3689999999999998877764  5788875322  112345678899999999 7999999999999999999999999


Q ss_pred             CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccc
Q 023270          102 HRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus       102 ~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      ++++|.+++....                .++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999987542                478899999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCC--ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          166 SVQSRSKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       166 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      +.......  .....+..|+|||++.+..++.++|+||||+++++|++ |..||...+..+....+.... .......++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  237 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCD  237 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CCCCCCcCC
Confidence            74322111  11223567999999988889999999999999999997 999998887777766665432 333344678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .++.+++.+|+..+|.+|||+++++..
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         238 DEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-42  Score=295.24  Aligned_cols=253  Identities=26%  Similarity=0.472  Sum_probs=220.8

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-HHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe--EEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER--IFLI   97 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~--~~~v   97 (284)
                      .+...+||.|+|-+||+|.|..+|-.||=--+..... ......+.+..|+.+|+.|+|+||+++++++.+...  +-+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            3456679999999999999999998887433322222 234556889999999999999999999999987765  8889


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCC-CCEEEeecccccccCCCCc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRSKRH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~  174 (284)
                      +|.+..|+|..++++.+..+.+.+..|++||+.||.|||++.  |+|+|||-+||+++-+ |.|||+|+|+++.......
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            999999999999999999999999999999999999999996  9999999999999755 8999999999977665554


Q ss_pred             cc-cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHh
Q 023270          175 TM-CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL  252 (284)
Q Consensus       175 ~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (284)
                      .. .|||.|+|||.+. ..|++..|||||||+|+||.|+..|| +..+.-.++++...+..+......-.+++++||..|
T Consensus       202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC  280 (632)
T KOG0584|consen  202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC  280 (632)
T ss_pred             ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence            44 7999999999986 77999999999999999999999999 567888888888888766555555578999999999


Q ss_pred             cccCCCCCCCHHhhhcCcccccc
Q 023270          253 LVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       253 l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |.. .++|||+.++|.||||+..
T Consensus       281 l~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  281 LAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hcC-chhccCHHHHhhChhhccc
Confidence            998 9999999999999999986

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-40  Score=280.40  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=203.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEec----------------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVE----------------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI   81 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i   81 (284)
                      -++|++.+.||.|+||.||++.+..                ++..+++|.+.....  ......+.+|+..++.++|+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence            3579999999999999999985432                344689999864321  2234678899999999999999


Q ss_pred             cceeeEEecCCeEEEEEeecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 023270           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (284)
Q Consensus        82 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~ni  150 (284)
                      +++++++..++..++++||+++++|.+++....           .++...+..++.|++.||.|||+.|++|+||+|+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999987642           366778999999999999999999999999999999


Q ss_pred             EecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh--CCCCCCCCChHH
Q 023270          151 LLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GAPPFEAESQKD  223 (284)
Q Consensus       151 l~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~~~~~  223 (284)
                      +++.++.++|+|||++.......     .....+..|+|||...++.++.++|+||||+++|++++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999975432211     12233567999999888889999999999999999998  778998777666


Q ss_pred             HHHHHHh------cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          224 TFRRIMK------VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       224 ~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .......      .....+.+..+++.+.+++.+||..||.+||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5543321      11122334467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.3e-41  Score=283.80  Aligned_cols=247  Identities=22%  Similarity=0.354  Sum_probs=197.9

Q ss_pred             CCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCchHHHH
Q 023270           31 KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL  110 (284)
Q Consensus        31 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  110 (284)
                      +++.||.++...+++.||+|++....... ...+.+.+|+..++.++|+||+++++++..++..++++||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            44566666777799999999986542222 34567899999999999999999999999999999999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC----------CccccC
Q 023270          111 RKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----------RHTMCG  178 (284)
Q Consensus       111 ~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~----------~~~~~~  178 (284)
                      ...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++||+.+......          .....+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            764  46889999999999999999999999999999999999999999999999976432211          112335


Q ss_pred             CCcccCccccCCC--CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------------
Q 023270          179 TLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF---------------------  235 (284)
Q Consensus       179 ~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------------------  235 (284)
                      +..|+|||.+...  .++.++|+||+|++++++++|..||...+......+...+....                     
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            6679999998663  47889999999999999999999998765544333222211000                     


Q ss_pred             -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          236 -----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       236 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                 .....++.++.+|+.+||..||.+|||++++|+||||++..++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence                       0011234678999999999999999999999999999987544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-40  Score=306.92  Aligned_cols=149  Identities=33%  Similarity=0.628  Sum_probs=138.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.+|.+.++||.|+||+||++.+..+++.||+|++.............+..|+..+..++|+||+++++.+...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            67999999999999999999999999999999999765544444556788899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      |||+.+++|.+++...+.++...++.++.||+.||.|||..||+|+||+|+|||++.++.++|+|||++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            999999999999988888999999999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-40  Score=277.06  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=209.6

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEec----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVE----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .+...+|++.+.||+|+||.||++.+..    ++..|++|.+....  .......+.+|+..++.++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3566789999999999999999999876    35778999875332  22335677889999999999999999998765


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEe
Q 023270           91 -DERIFLILEYAHRGELYRELRKH--------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (284)
Q Consensus        91 -~~~~~~v~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~  161 (284)
                       +...+++++|+++++|.+++...        ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             46789999999999999998664        358899999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 023270          162 DFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSF  235 (284)
Q Consensus       162 d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~  235 (284)
                      |||++.......     ....++..|+|||.+.+..++.++||||||++++++++ |..||...+..+........ ...
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~  238 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRL  238 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCC
Confidence            999985432111     12234567999999988889999999999999999998 99999888777666555443 333


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .....+++++.+++.+||..+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            444567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-40  Score=271.07  Aligned_cols=241  Identities=24%  Similarity=0.403  Sum_probs=203.7

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      ++||+|++|.||++.. .++..+++|.+......  .....+.+|+..++.++|+|++++++++...+..++|+||++++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            4689999999999985 47889999998654322  22346788999999999999999999999999999999999999


Q ss_pred             chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----ccccCC
Q 023270          105 ELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT  179 (284)
Q Consensus       105 ~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~  179 (284)
                      +|.+++... ..+++..+..++.+++.+|.++|+.|++|+||+|+||+++.++.++|+|||++.......    .....+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999998764 467899999999999999999999999999999999999999999999999875432211    112335


Q ss_pred             CcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 023270          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  258 (284)
                      ..|+|||.+.+..++.++|+||||++++++++ |..||................ ....+..++.++.+++.+|+..+|.
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-RMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccCcc
Confidence            67999999988889999999999999999998 999998887777666665543 3344457899999999999999999


Q ss_pred             CCCCHHhhhcC
Q 023270          259 KRLSLQKIMEH  269 (284)
Q Consensus       259 ~Rps~~~il~~  269 (284)
                      +||++.++++.
T Consensus       237 ~Rp~~~~l~~~  247 (250)
T cd05085         237 NRPKFSELQKE  247 (250)
T ss_pred             cCCCHHHHHHH
Confidence            99999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=324.62  Aligned_cols=257  Identities=29%  Similarity=0.508  Sum_probs=227.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+++....||.|.||.||.+.+..+|...|+|.+.-.... ....+.+.+|+.++..++|||+++++++=...+..+|.|
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4677888999999999999999999999999998665544 455678889999999999999999999988999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC-----
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-----  173 (284)
                      |||++|+|.+.++...-.++.....+..|++.|+.|||++||||+||||.||+++.+|.+|++|||.+....++.     
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            999999999999988888888889999999999999999999999999999999999999999999986655443     


Q ss_pred             --ccccCCCcccCccccCCCC---CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          174 --HTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       174 --~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                        +...||+.|+|||++++..   ...+.|||||||++.||+||+.||...+..-.+.-.....-.+..+..++++.++|
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHH
Confidence              3467999999999997654   45799999999999999999999988877766666666555666677899999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      |.+||..||++|+++.||++|-|-.-+.
T Consensus      1474 le~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             HHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            9999999999999999999999866553

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.7e-40  Score=276.76  Aligned_cols=249  Identities=26%  Similarity=0.439  Sum_probs=200.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEE----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec--C
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--D   91 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~--~   91 (284)
                      -++|++.+.||.|+||.||++.    +..++..|++|.+.....   ...+.+.+|+++++.++|+|++++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            4689999999999999999987    445788999999855432   234677889999999999999999998653  3


Q ss_pred             CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ...++|+||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4689999999999999999765 468999999999999999999999999999999999999999999999999875432


Q ss_pred             CCCc------cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH---------------HHHHHHH
Q 023270          171 SKRH------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------------DTFRRIM  229 (284)
Q Consensus       171 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------------~~~~~~~  229 (284)
                      ....      ...++..|+|||.+.+..++.++|+||||+++++|++|..++......               ..+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            2111      112234599999998888999999999999999999987665433211               1112223


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          230 KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ......+....++.++.+|+.+||..+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            3333444455788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-40  Score=272.17  Aligned_cols=240  Identities=24%  Similarity=0.372  Sum_probs=199.8

Q ss_pred             eeccCCCeEEEEEEEe--cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           26 PLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      .||.|+||.||++...  ..+..|++|++.....  ....+.+.+|+.++++++|+||+++++++. .+..++|+||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            4899999999998765  3445689999865432  233467889999999999999999999875 4578999999999


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC------ccc
Q 023270          104 GELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------HTM  176 (284)
Q Consensus       104 ~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~------~~~  176 (284)
                      ++|.+++... ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.......      ...
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            9999998753 578999999999999999999999999999999999999999999999999874322211      111


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .++..|+|||.+.+..++.++|+||||++++++++ |..||......+......++. ....++..++++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHcCC
Confidence            22467999999988889999999999999999996 999999888877776665543 3344456799999999999999


Q ss_pred             CCCCCCCHHhhhcC
Q 023270          256 DSSKRLSLQKIMEH  269 (284)
Q Consensus       256 ~p~~Rps~~~il~~  269 (284)
                      +|++||+++++.+.
T Consensus       238 ~~~~Rp~~~~i~~~  251 (257)
T cd05115         238 KWEDRPNFAKVEER  251 (257)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-40  Score=277.36  Aligned_cols=250  Identities=24%  Similarity=0.423  Sum_probs=207.1

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEec----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec--
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVE----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--   90 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~--   90 (284)
                      ...+|++.+.||.|+||.||++....    ++..+++|.+......  .....+.+|++.++.+.|+|++++++++..  
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            35678999999999999999998653    4788999998755433  335678899999999999999999998877  


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +...++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            557999999999999999997764 6899999999999999999999999999999999999999999999999988554


Q ss_pred             CCCCc------cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH--------------HHHHHHH
Q 023270          170 RSKRH------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------DTFRRIM  229 (284)
Q Consensus       170 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~--------------~~~~~~~  229 (284)
                      .....      ...++..|+|||.+.+..++.++|+||||+++++|++|..|+......              .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            42211      123345699999998888999999999999999999999988653221              2223333


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          230 KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ......+....++.++.+++.+||..+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            344445555577899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=293.22  Aligned_cols=249  Identities=33%  Similarity=0.562  Sum_probs=216.4

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCC
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      .+.||.|.||+||-+++..+|+.||||++.+..+.+.+ ...+++|++++..++||+|+.+--.|+..+..|+|||.+. 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence            46799999999999999999999999999887766544 3789999999999999999999999999999999999996 


Q ss_pred             CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC---CCEEEeecccccccCCCCcc--c
Q 023270          104 GELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHT--M  176 (284)
Q Consensus       104 ~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~--~  176 (284)
                      |++.+.|.+.  +.|++....-++.||+.||.|||-.+|+|+||||+|||+...   -++||+|||+++..++....  -
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV  726 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV  726 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence            4777777554  579999999999999999999999999999999999999654   37999999999887765543  4


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHhcc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~  254 (284)
                      .|+|.|+|||++.+..+...-|+||+|+++|.-++|..||+...+  +-.++....+++  ..+..++++..+||+.+|+
T Consensus       727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~AidlIn~LLq  804 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQ  804 (888)
T ss_pred             cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHHHHHHHHH
Confidence            599999999999999999999999999999999999999975433  233333333333  3455899999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ..-++|.|.+..|.|||+|+-|
T Consensus       805 Vkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  805 VKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999865

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=251.10  Aligned_cols=255  Identities=25%  Similarity=0.514  Sum_probs=218.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +.|.-.++||+|.+|+||+++..++++.||+|.+.....++ .......+|+-+++.++|.||++++++...+..+.+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            56788899999999999999999999999999986654332 33456678999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCc---
Q 023270           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---  174 (284)
                      |||+. .|..+..+ ++.++.+.++.++.|++.++.++|++++.|+|++|.|.+++.+|.+||.|||++...+-+..   
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            99975 88888765 47899999999999999999999999999999999999999999999999999866554432   


Q ss_pred             cccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC--CCCCCC------------
Q 023270          175 TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVD--LSFPSA------------  238 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~--~~~~~~------------  238 (284)
                      ....+.+|.||.++.+.. ++...|+||.||++.++.. |.+.|.+.+-.+.+.++....  .....+            
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            234688999999998877 7889999999999999985 889999999888888776531  111111            


Q ss_pred             -------------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       239 -------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                                   +.++..-++++..+|.-+|.+|.++++.|+||||.+.
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                         2344567899999999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=290.72  Aligned_cols=265  Identities=38%  Similarity=0.604  Sum_probs=245.0

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ......+.+++++++..||.||||.|-++........+|+|.+++.-+-.....+.+..|-++|...+.+.|++++-.|.
T Consensus       411 ~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr  490 (732)
T KOG0614|consen  411 AEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR  490 (732)
T ss_pred             HhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence            34667889999999999999999999999987776678999998877666566778888999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..+.|++||-|=||.++..++..+.++...++-++..+++|+.|||++||+++||||+|.+++.+|-+||.|||++...
T Consensus       491 d~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  491 DSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             cchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999665


Q ss_pred             CC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          170 RS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      ..  .+-..+|||.|.|||++.+..++.+.|.||||+++++|++|.+||.+.++..++..++++......+..++....+
T Consensus       571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~  650 (732)
T KOG0614|consen  571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD  650 (732)
T ss_pred             ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence            43  4455679999999999999999999999999999999999999999999999999999998888888899999999


Q ss_pred             HHHHhcccCCCCCCC-----HHhhhcCccccc
Q 023270          248 LISRLLVKDSSKRLS-----LQKIMEHPWIIK  274 (284)
Q Consensus       248 li~~~l~~~p~~Rps-----~~~il~~~~~~~  274 (284)
                      +|+++...+|.+|.-     +.+|-.|.||-.
T Consensus       651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            999999999999995     899999999964

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.4e-40  Score=273.29  Aligned_cols=250  Identities=27%  Similarity=0.492  Sum_probs=209.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEec-CCceEEEEehhhhhH-------HHHHHHHHHHHHHHHHHh-CCCCcccceeeEEec
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQI-------EKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHD   90 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~-------~~~~~~~~~~~~~~~~~~-l~h~~i~~~~~~~~~   90 (284)
                      .|++.+.||.|++|.||++.+.. +++.+++|.+.....       ........+.+|+.++.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999887 678899998753211       122334556678877764 789999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeeccc
Q 023270           91 DERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      ++..++++||+++++|.+++..    ...++...++.++.|++.++.+||. .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743    3468999999999999999999996 6899999999999999999999999998


Q ss_pred             ccccCCC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          166 SVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       166 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      +......  .....++..|+|||.+.+..++.++|+||||++++++++|..||........................+++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            7543332  23345788899999999888999999999999999999999999888777777766665444333346889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+++.+||..||.+||++.++.++
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            99999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=281.37  Aligned_cols=260  Identities=32%  Similarity=0.489  Sum_probs=230.0

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ..+..+.|+.=++||.||||.|+.++-..+|+-||.|.+.+.......-..-...|-+++.+++.+.||.+-..|+..+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            55677889999999999999999999999999999999988877776666777889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-
Q 023270           94 IFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-  170 (284)
                      +++|+..|+||+|.--|.+.+  .+++..++-++.+|+-||.+||+.+||++|+||+|||+|+.|+++|+|+|+++... 
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999998888775  79999999999999999999999999999999999999999999999999996543 


Q ss_pred             -CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCCCCCCCHHH
Q 023270          171 -SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----DTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                       .+.....||.+|+|||++.+..|+...|.|||||++|+|+.|..||...-..    ++-+..+...  ...++.+|+++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~--~ey~~kFS~ea  417 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP--EEYSDKFSEEA  417 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--hhcccccCHHH
Confidence             3334458999999999999999999999999999999999999999775443    3333333333  33346899999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHhhhcCcccccc
Q 023270          246 KHLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      +++.+.+|..||++|.     .++++.+||||+..
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            9999999999999998     77899999999875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=305.37  Aligned_cols=251  Identities=24%  Similarity=0.414  Sum_probs=220.7

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCc-----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      .+.-..-...+.||.|.||.||.+.......     .|++|.+....  +.+....|.+|..+|+.++||||+++++++.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            3556678889999999999999998765433     38888875433  3445678999999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           90 DDERIFLILEYAHRGELYRELRKH-------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                      +.+..+|++|||++|+|..+|++.       ..|+..+++.++.|+++|+.||++.+++|+||..+|+|++....|||.|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence            999999999999999999999876       2589999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC-cc----ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 023270          163 FGWSVQSRSKR-HT----MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFP  236 (284)
Q Consensus       163 ~~~~~~~~~~~-~~----~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  236 (284)
                      ||++++..... ..    ..-+..|+|||.+..+.++.++||||||+++||++| |..||...+..+++...+.+. ..+
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~  924 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD  924 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence            99997432221 11    123568999999999999999999999999999998 999999999999999777776 777


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .+..+|..+.+++.+||..+|++||++..|++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            77799999999999999999999999999987

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-41  Score=271.04  Aligned_cols=261  Identities=27%  Similarity=0.507  Sum_probs=208.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCc----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-C
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-D   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-~   91 (284)
                      .+..|.+.+.||+|++|.||+|...+++.    .||||.|..+...+ ..-...-+|+.+++.++|+|++.+..++.. +
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            35679999999999999999997665543    68999997663222 122345589999999999999999999877 7


Q ss_pred             CeEEEEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC----CCEEEee
Q 023270           92 ERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGD  162 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~----~~~~l~d  162 (284)
                      ..+++++||.+. +|+..|+-+     ..++...+.+++.||++|+.|||++=+.|+||||.|||+.-+    |.|||.|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            899999999975 999988543     468999999999999999999999999999999999999888    8999999


Q ss_pred             cccccccCCCCcc------ccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 023270          163 FGWSVQSRSKRHT------MCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQ---------KDTFR  226 (284)
Q Consensus       163 ~~~~~~~~~~~~~------~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~---------~~~~~  226 (284)
                      +|+++...++-..      -+.|.+|.|||.+.+.. ++++.|+|++||++.||+|-.+.|.+...         .+.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9998665544322      23578899999999877 89999999999999999999888865321         12222


Q ss_pred             HHHhc--CCCCCCCC---------------------------------CCCHHHHHHHHHhcccCCCCCCCHHhhhcCcc
Q 023270          227 RIMKV--DLSFPSAP---------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPW  271 (284)
Q Consensus       227 ~~~~~--~~~~~~~~---------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  271 (284)
                      ++...  ......++                                 .-++...+|+..||+.||.+|.|++|+|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            22221  11111111                                 12445789999999999999999999999999


Q ss_pred             ccccCCCC
Q 023270          272 IIKNANPR  279 (284)
Q Consensus       272 ~~~~~~~~  279 (284)
                      |++-+.|.
T Consensus       340 F~~d~lpp  347 (438)
T KOG0666|consen  340 FTEDPLPP  347 (438)
T ss_pred             cccCCCCC
Confidence            99997774

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=290.81  Aligned_cols=244  Identities=34%  Similarity=0.569  Sum_probs=210.1

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHH-HhCCCCcccceeeEEecCCeEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~-~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      ...+|.+...+|.|+|+.+-.+.+..+++.+++|++..+..+       ..+|+.++ ..-+|+|++++.+.+.++.+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence            467789999999999999999999999999999999665222       22455333 3447999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe-cCCCCEEEeecccccccCCCCc
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL-DHEGRLKIGDFGWSVQSRSKRH  174 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~-~~~~~~~l~d~~~~~~~~~~~~  174 (284)
                      +|||.+.++-+.+.+...+... ..+..|+.+|+.|+.|||++|++|||++|+|||+ +..++++|+|||.+........
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~  471 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD  471 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence            9999999998888887766545 7778899999999999999999999999999999 6889999999999866655545


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ..+.+..|.|||++....+++++|+||||+++|+|++|..||.....+ +++..+..+.+    ...+|+++++||++||
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~----s~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF----SECVSDEAKDLLQQLL  547 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc----ccccCHHHHHHHHHhc
Confidence            556788899999999999999999999999999999999999877666 45544444322    2589999999999999


Q ss_pred             ccCCCCCCCHHhhhcCccc
Q 023270          254 VKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~  272 (284)
                      +.||.+||++.+++.||||
T Consensus       548 ~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  548 QVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cCChhhCcChhhhccCcch
Confidence            9999999999999999999

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-39  Score=275.26  Aligned_cols=251  Identities=21%  Similarity=0.384  Sum_probs=207.4

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCc----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .++-.+|++.+.||+|++|.||++.+..++.    .+++|.+......  .....+.+|+.+++.++|+|++++++++..
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            4567889999999999999999999877776    4688887543322  223467789999999999999999998865


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      + ..++++||+++++|.+++.... .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence            4 4679999999999999987754 6899999999999999999999999999999999999999999999999998543


Q ss_pred             CCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          170 RSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       170 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ...     .....++..|+|||.+.+..++.++||||||++++++++ |..||.+........ +.......+..+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLPQPPICTI  238 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCH
Confidence            221     112234568999999988889999999999999999997 899998776555443 3344444455556789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+.+++..|+..+|++||+++++++.
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-39  Score=271.56  Aligned_cols=238  Identities=23%  Similarity=0.324  Sum_probs=191.7

Q ss_pred             eeeccCCCeEEEEEEEecC------------------------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc
Q 023270           25 RPLGKGKFGRVYLVREVES------------------------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN   80 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~------------------------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~   80 (284)
                      .+||+|+||.||++....+                        ...|++|++.....   .....+.+++.+++.++|+|
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCC
Confidence            3699999999999875322                        23488898854322   23456778889999999999


Q ss_pred             ccceeeEEecCCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---
Q 023270           81 ILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---  156 (284)
Q Consensus        81 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---  156 (284)
                      |+++++++..+...++||||+++++|..++.. .+.++...+..++.|++.||.|||+.|++|+||+|+||+++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999998876 45789999999999999999999999999999999999997644   


Q ss_pred             ----CEEEeecccccccCCCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHh
Q 023270          157 ----RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMK  230 (284)
Q Consensus       157 ----~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~  230 (284)
                          .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++++++ +|..||......+.......
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  236 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK  236 (274)
T ss_pred             CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence                4899999987433222 22346778999998865 55899999999999999985 79999987766554333222


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                       ..  ..+...++++.+++.+||..+|.+|||+++++++
T Consensus       237 -~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 -KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             11  2223456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-39  Score=269.18  Aligned_cols=235  Identities=23%  Similarity=0.372  Sum_probs=193.5

Q ss_pred             eeeccCCCeEEEEEEEecCC----------ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           25 RPLGKGKFGRVYLVREVESK----------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      +.||+|+||.||++.+..++          ..+++|.+......    ...+.+++.+++.++|+|++++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998776          34777876443321    4677889999999999999999999887 778


Q ss_pred             EEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-------CEEEeecccc
Q 023270           95 FLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-------RLKIGDFGWS  166 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-------~~~l~d~~~~  166 (284)
                      ++|+||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++       .++|+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 789999999999999999999999999999999999999887       7999999988


Q ss_pred             cccCCCCccccCCCcccCccccCCC--CCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          167 VQSRSKRHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ..... .....++..|+|||.+.+.  .++.++|+||||++++++++ |..||...+..+........ ...+.  ....
T Consensus       156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~  231 (259)
T cd05037         156 ITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM--PDCA  231 (259)
T ss_pred             ccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC--CCch
Confidence            65443 2233456789999998876  68899999999999999998 68888776544443333322 11111  2347


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+++.+||..+|.+|||+.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            8999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.8e-40  Score=271.54  Aligned_cols=238  Identities=21%  Similarity=0.340  Sum_probs=193.7

Q ss_pred             eeeccCCCeEEEEEEEecCCc-------eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           25 RPLGKGKFGRVYLVREVESKH-------PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~-------~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.||.|+||.||++.+...+.       .+++|.+....   ....+.+.+++.+++.++|+|++++++++..++..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            368999999999998865543       37788774332   23345677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC--------EEEeecccccc
Q 023270           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--------LKIGDFGWSVQ  168 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~--------~~l~d~~~~~~  168 (284)
                      |||+++++|..++...+ .++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.        ++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997754 5899999999999999999999999999999999999987764        69999998754


Q ss_pred             cCCCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          169 SRSKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      ... .....++..|+|||.+.+. .++.++|+||||+++|++++| ..|+...+........ ...  ...+...+.++.
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~  233 (258)
T cd05078         158 VLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDR--HQLPAPKWTELA  233 (258)
T ss_pred             cCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcc--ccCCCCCcHHHH
Confidence            432 2234567889999998764 478999999999999999998 5676665555443322 222  223335678999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcC
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++.+||+.+|.+|||++++++.
T Consensus       234 ~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         234 NLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-39  Score=270.67  Aligned_cols=241  Identities=25%  Similarity=0.422  Sum_probs=200.2

Q ss_pred             eeeccCCCeEEEEEEEecCC------ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           25 RPLGKGKFGRVYLVREVESK------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +.||+|++|.||++.+....      ..+++|.+.....  ......+.+|+..++.++|+||+++++++...+..++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            46899999999999876433      6789998754321  122456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-----CEEEeecccc
Q 023270           99 EYAHRGELYRELRKH-------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----RLKIGDFGWS  166 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-----~~~l~d~~~~  166 (284)
                      ||+++++|.+++...       ..++...++.++.|++.+|.|||+.|++|+||+|+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998653       2478899999999999999999999999999999999999887     8999999987


Q ss_pred             cccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          167 VQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       167 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      ......     .....++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+... .....+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCccc
Confidence            433221     112234678999999999999999999999999999998 99999887776665554433 23344457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +|..+.+++.+||..+|.+||++.++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-39  Score=267.62  Aligned_cols=238  Identities=22%  Similarity=0.345  Sum_probs=192.0

Q ss_pred             eeeccCCCeEEEEEEEecC------------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           25 RPLGKGKFGRVYLVREVES------------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~------------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      +.||.|+||.||++.....            ...+++|++....   ......+.+++.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3689999999999975322            2358889875432   233456778899999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC-------EEEeecc
Q 023270           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-------LKIGDFG  164 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~-------~~l~d~~  164 (284)
                      ..++++||+++++|..++... ..++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999999888764 56899999999999999999999999999999999999987664       8999999


Q ss_pred             cccccCCCCccccCCCcccCccccC-CCCCCchhhHhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          165 WSVQSRSKRHTMCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      ++...... ....++..|+|||.+. +..++.++||||||+++|+++ +|..||......+... ......  ......+
T Consensus       158 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~--~~~~~~~  233 (262)
T cd05077         158 IPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC--MLVTPSC  233 (262)
T ss_pred             CCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc--cCCCCCh
Confidence            87543322 2334678899999886 456889999999999999997 5888887765544332 222222  2223457


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++.+|+.+||+.||.+||++.+|+++
T Consensus       234 ~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         234 KELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.4e-39  Score=268.00  Aligned_cols=242  Identities=23%  Similarity=0.378  Sum_probs=193.5

Q ss_pred             eeeccCCCeEEEEEEEec--CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           25 RPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      +.||.|+||.||++....  ....+++|.+.....  ......+.+|+..++.++|+||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            468999999999996533  345688888754322  2234567789999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-----C
Q 023270          103 RGELYRELRKHR-----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----K  172 (284)
Q Consensus       103 ~~~L~~~l~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-----~  172 (284)
                      +++|.+++....     ..+...++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.....     .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999997653     246778889999999999999999999999999999999999999999998743211     1


Q ss_pred             CccccCCCcccCccccC-------CCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC-CC---CCCCC
Q 023270          173 RHTMCGTLDYLAPEMVE-------NKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDL-SF---PSAPS  240 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~-~~---~~~~~  240 (284)
                      .....++..|+|||++.       ....+.++||||||+++++|++ |..||......+.......... ..   .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            12234567799999874       2346789999999999999998 8899988877766666544322 11   12236


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++..+.+++..|+ .||++|||++++++.
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            7888999999998 599999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.3e-39  Score=266.29  Aligned_cols=242  Identities=21%  Similarity=0.364  Sum_probs=197.1

Q ss_pred             eeeccCCCeEEEEEEEec---CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe-cCCeEEEEEee
Q 023270           25 RPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH-DDERIFLILEY  100 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~-~~~~~~~v~e~  100 (284)
                      +.||+|+||.||++.+..   ....+++|.+....  .....+.+.+|+.+++.++|+|++++++++. .++..++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998654   34569999875322  1223457778999999999999999999765 45568999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-------
Q 023270          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-------  172 (284)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-------  172 (284)
                      +.+++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......       
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999999764 35678888999999999999999999999999999999999999999999987533211       


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      .....++..|+|||.+.+..++.++||||||+++++|++ |.+||...+..+.......+. .......+++.+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHH
Confidence            112234668999999988889999999999999999999 567788777777666665543 233334678999999999


Q ss_pred             hcccCCCCCCCHHhhhcC
Q 023270          252 LLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~  269 (284)
                      ||..+|++||++.+++..
T Consensus       238 cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         238 CWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HcCCChhhCCCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-42  Score=264.87  Aligned_cols=271  Identities=25%  Similarity=0.418  Sum_probs=219.2

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      .+...+.-...+.|.-..+||+|.||.||+|+..++++.|++|++..+. ..........+|++++..++|+|++.++++
T Consensus         6 ~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEi   84 (376)
T KOG0669|consen    6 DSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEI   84 (376)
T ss_pred             hcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence            3444555566778999999999999999999999999999988875432 122233455689999999999999999998


Q ss_pred             Eec--------CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCE
Q 023270           88 FHD--------DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        88 ~~~--------~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~  158 (284)
                      |..        ...+|+|+.+|+. +|.-++.+. ..++..++..++.++++||.|+|+..|+|+|+|+.|++++.+|.+
T Consensus        85 c~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   85 CRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             HhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceE
Confidence            753        2368999999985 888888776 579999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccC-------CCCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 023270          159 KIGDFGWSVQSR-------SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK  230 (284)
Q Consensus       159 ~l~d~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~  230 (284)
                      +|.|||++....       +.......+.+|++||.+.+.. +++..|||+.||+|.+|+|+.+.+.+++....+..+..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            999999973221       1112234588999999988764 89999999999999999999999999888776665443


Q ss_pred             --cCCCCCCCCC-------------------------------CCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          231 --VDLSFPSAPS-------------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       231 --~~~~~~~~~~-------------------------------~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                        +......+|.                               -.++..+|+..+|..||.+|+.+.++|+|.||-+-+.
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence              2112111111                               1347789999999999999999999999999999887


Q ss_pred             CCC
Q 023270          278 PRG  280 (284)
Q Consensus       278 ~~~  280 (284)
                      |-+
T Consensus       324 pqa  326 (376)
T KOG0669|consen  324 PQA  326 (376)
T ss_pred             chh
Confidence            743

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.1e-39  Score=261.99  Aligned_cols=240  Identities=43%  Similarity=0.786  Sum_probs=206.5

Q ss_pred             CCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCchHHHH
Q 023270           31 KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL  110 (284)
Q Consensus        31 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  110 (284)
                      ++|.||++....+++.+++|++........  .+.+.+|++.++.++|++++++++.+......++++|++++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999998999999999866543321  568889999999999999999999999999999999999988999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCccccCCCcccCcccc
Q 023270          111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMV  188 (284)
Q Consensus       111 ~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~y~aPE~~  188 (284)
                      .....++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....  ......++..|+|||.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            8876689999999999999999999999999999999999999999999999999855443  23445578889999999


Q ss_pred             CCCCCCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHhh
Q 023270          189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLISRLLVKDSSKRLSLQKI  266 (284)
Q Consensus       189 ~~~~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~i  266 (284)
                      .+..++.++|+|++|++++++++|..||.. ...................... ++.++.+++.+|+..+|.+||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            888899999999999999999999999988 4444444444443333322222 88999999999999999999999999


Q ss_pred             hcCccc
Q 023270          267 MEHPWI  272 (284)
Q Consensus       267 l~~~~~  272 (284)
                      ++||||
T Consensus       239 ~~~~~~  244 (244)
T smart00220      239 LQHPFF  244 (244)
T ss_pred             hhCCCC
Confidence            999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.9e-39  Score=265.26  Aligned_cols=241  Identities=23%  Similarity=0.369  Sum_probs=191.6

Q ss_pred             eeeccCCCeEEEEEEEec--CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           25 RPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      +.||+|+||.||++....  ++..+++|.+......  .....+.+|+..++.++|+|++++++.+.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            468999999999997543  4567999988654322  223467889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-----
Q 023270          103 RGELYRELRKHR-----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (284)
Q Consensus       103 ~~~L~~~l~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----  172 (284)
                      +++|.+++....     .++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......     
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999987532     3567788899999999999999999999999999999999999999999987543221     


Q ss_pred             CccccCCCcccCccccCCC-------CCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC-CCCCC---CCC
Q 023270          173 RHTMCGTLDYLAPEMVENK-------EHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVD-LSFPS---APS  240 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~---~~~  240 (284)
                      .....++..|+|||++.+.       .++.++|+||||++++++++ |..||......+......... ...+.   ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            1223456789999988542       35789999999999999996 999998776665544333221 11111   124


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .++.+.+++++|+ .+|.+|||+++|+.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-41  Score=272.59  Aligned_cols=256  Identities=25%  Similarity=0.436  Sum_probs=210.7

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC--C----cccceeeEEe
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--P----NILRLYGWFH   89 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h--~----~i~~~~~~~~   89 (284)
                      +--++|.+++.+|+|.||.|..+.+..++..||+|++..-.  .  ..+..+-|++++.++.+  |    -++.+.++|.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--K--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--H--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            44678999999999999999999999999999999985432  2  23455568888888842  2    3677778899


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-------------
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-------------  154 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-------------  154 (284)
                      -.++.|+|+|.++ .|+.+++..+.  +++...++.+..|+++++++||+.+++|.||||+||++..             
T Consensus       162 yrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999999999984 59999998874  7899999999999999999999999999999999999943             


Q ss_pred             -------CCCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH---H
Q 023270          155 -------EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---T  224 (284)
Q Consensus       155 -------~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~---~  224 (284)
                             +..++++|||.++.........+.|--|.|||++.+-.++..+||||+||||+||+||...|...++.+   .
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM  320 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM  320 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence                   235999999999888877777788899999999999999999999999999999999999998877665   3


Q ss_pred             HHHHHhcC------------------CCCCCC-----------------------CCCCHHHHHHHHHhcccCCCCCCCH
Q 023270          225 FRRIMKVD------------------LSFPSA-----------------------PSISAEAKHLISRLLVKDSSKRLSL  263 (284)
Q Consensus       225 ~~~~~~~~------------------~~~~~~-----------------------~~~~~~l~~li~~~l~~~p~~Rps~  263 (284)
                      ++.++...                  +.++..                       +....++.+|++.||..||.+|+|+
T Consensus       321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl  400 (415)
T KOG0671|consen  321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL  400 (415)
T ss_pred             HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence            33332210                  000000                       0112358899999999999999999


Q ss_pred             HhhhcCccccccC
Q 023270          264 QKIMEHPWIIKNA  276 (284)
Q Consensus       264 ~~il~~~~~~~~~  276 (284)
                      .++|.||||....
T Consensus       401 ~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  401 REALSHPFFARLT  413 (415)
T ss_pred             HHHhcCHHhhcCC
Confidence            9999999998764

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=267.92  Aligned_cols=252  Identities=17%  Similarity=0.198  Sum_probs=192.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecC---CceEEEEehhhhhHHH--H------HHHHHHHHHHHHHHhCCCCcc
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEK--Y------KIQHQLRREMEIQSSLRHPNI   81 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~--~------~~~~~~~~~~~~~~~l~h~~i   81 (284)
                      ...+...+|++.+.||+|+||+||+|....+   +..+++|+........  .      ........+...+..+.|+++
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            3445667999999999999999999998777   6677777643221110  0      001112233445566789999


Q ss_pred             cceeeEEecCC----eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC
Q 023270           82 LRLYGWFHDDE----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR  157 (284)
Q Consensus        82 ~~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~  157 (284)
                      +++++.+....    ..+++++++. .++.+.+......+...++.++.|++.|+.|||+.|++|+||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence            99998765443    4577888875 477777766656788889999999999999999999999999999999999999


Q ss_pred             EEEeecccccccC----------CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh-HH---
Q 023270          158 LKIGDFGWSVQSR----------SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KD---  223 (284)
Q Consensus       158 ~~l~d~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~---  223 (284)
                      ++|+|||++....          .......|++.|+|||++.+..++.++||||||+++++|++|..||..... ..   
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            9999999974332          111224588999999999999999999999999999999999999987632 22   


Q ss_pred             -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          224 -----TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       224 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                           .+..+..+..   ..+..++++.++++.|+..+|++||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 AAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                 2222222222   22356899999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-38  Score=265.04  Aligned_cols=247  Identities=22%  Similarity=0.379  Sum_probs=202.1

Q ss_pred             cEeeeeeccCCCeEEEEEEEec---CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----
Q 023270           21 FEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----   92 (284)
                      |.+.+.||+|++|.||+|.+..   ++..|++|++........ ..+.+.+|++.++.++|+|++++++++...+     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS-DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            6788999999999999998654   467899999865433332 3456778999999999999999999876432     


Q ss_pred             -eEEEEEeecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccc
Q 023270           93 -RIFLILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                       ..+++++|+.+++|..++...      ..++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247889999999998877432      1478899999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 023270          166 SVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAP  239 (284)
Q Consensus       166 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
                      +......     .....+++.|++||.+.+..++.++||||||++++++++ |..||...+..+......... .....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCC
Confidence            7543221     112234567999999988889999999999999999998 899998887776666555443 233334


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ..+..+.+++.+||..+|.+|||+.+++..
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.2e-38  Score=262.12  Aligned_cols=241  Identities=22%  Similarity=0.357  Sum_probs=192.1

Q ss_pred             eeeccCCCeEEEEEEEecCC--ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           25 RPLGKGKFGRVYLVREVESK--HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      +.||+|+||.||++....++  ..+++|.+.....  ....+.+.+++..++.++|+|++++++.+......++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            46999999999999754433  3466777654322  2234678888999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-----CCC
Q 023270          103 RGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----SKR  173 (284)
Q Consensus       103 ~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-----~~~  173 (284)
                      +++|.+++.+.    ...+...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....     ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999999764    235677788999999999999999999999999999999999999999999874321     112


Q ss_pred             ccccCCCcccCccccCC-------CCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC----CCCCCCC
Q 023270          174 HTMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLS----FPSAPSI  241 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~  241 (284)
                      ....++..|+|||++..       ...+.++||||||+++++|++ +..||...+..+.+.........    ......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            23456788999998743       235789999999999999996 67889887777776665543221    2223357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+.+++..|+ .+|.+||+++++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-39  Score=298.17  Aligned_cols=250  Identities=30%  Similarity=0.515  Sum_probs=203.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-------   90 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-------   90 (284)
                      ..+|..++.||+||||.||+|+++-+|..||||++....  +......+.+|+..+.+++|||+++++..+.+       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            457899999999999999999999999999999997765  33445788899999999999999998754310       


Q ss_pred             --------------------------------------------------------------------------------
Q 023270           91 --------------------------------------------------------------------------------   90 (284)
Q Consensus        91 --------------------------------------------------------------------------------   90 (284)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEeecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 023270           91 ------------------------D--------ERIFLILEYAHRGELYRELRKHRRF-TEQQAATYIASLTNALAYCHE  137 (284)
Q Consensus        91 ------------------------~--------~~~~~v~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~~i~~~l~~lh~  137 (284)
                                              +        -.+||-||||+..++.+++..+... ....+++++++|++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        1278999999987777777766543 578899999999999999999


Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccccccC--------------C-------CCccccCCCcccCccccCCCC---C
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--------------S-------KRHTMCGTLDYLAPEMVENKE---H  193 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~--------------~-------~~~~~~~~~~y~aPE~~~~~~---~  193 (284)
                      .|++|+||||.||++++++.|||+|||+++...              .       ......||.-|.|||++.+..   +
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999985410              0       112345788899999997655   8


Q ss_pred             CchhhHhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          194 DYAVDNWTLGILCYEFLYGAPPFE-AESQKDTFRRIMKVDLSFP---SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       194 ~~~~Di~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.|.|+||||++++||+.   ||. .+..-..+..+.++.++.+   .. .--+.-..+|+.|++.||.+||||.|+|.+
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~-~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFD-PEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccccc-ccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            999999999999999984   354 3445566666776666555   22 223456789999999999999999999999


Q ss_pred             cccc
Q 023270          270 PWII  273 (284)
Q Consensus       270 ~~~~  273 (284)
                      .||.
T Consensus       872 ~llp  875 (1351)
T KOG1035|consen  872 ELLP  875 (1351)
T ss_pred             cCCC
Confidence            9997

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=269.88  Aligned_cols=261  Identities=33%  Similarity=0.588  Sum_probs=229.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~   92 (284)
                      -.++..+|..+.+||.|+||.|-++..+++.+.||||++.+.-+......+--..|-+++... +-|.+++++..|..-+
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            367889999999999999999999999999999999999776554433333334455555544 3578888999999899


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc---c
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---S  169 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~---~  169 (284)
                      .+|+||||+.||+|-..+++-+.+.+..+.-++..|+.||-+||++||+++||+.+|||++.+|++||.|||+...   .
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999843   2


Q ss_pred             CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                      ...+...+|+|.|+|||++..++|....|.||+|+++|+|+.|.+||.+.+.+++.+.+..-...++.  .+|.+..++.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK--slSkEAv~ic  581 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK--SLSKEAVAIC  581 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc--cccHHHHHHH
Confidence            34445678999999999999999999999999999999999999999999999999999987766665  7999999999


Q ss_pred             HHhcccCCCCCCCH-----HhhhcCccccccC
Q 023270          250 SRLLVKDSSKRLSL-----QKIMEHPWIIKNA  276 (284)
Q Consensus       250 ~~~l~~~p~~Rps~-----~~il~~~~~~~~~  276 (284)
                      ...|...|.+|.-+     .+|-+||||+.-+
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            99999999999843     6899999998753

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=283.62  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=227.2

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCce---EEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~---v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      .+++..+.-.|.++||.|.||.|+++..+..+++   ||||.++...  ++.....|..|+.+|-+.+||||+++-++..
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            4678889999999999999999999998877654   9999996654  3345688999999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ...-.-||+|||+.|+|..+|+.+ +.++..++.-+++.|+.|++||.+.|+||+||..+|||++.+=..|++|||+++.
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999999999876 5799999999999999999999999999999999999999999999999999965


Q ss_pred             cCCCCc----ccc--CCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          169 SRSKRH----TMC--GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       169 ~~~~~~----~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      ..+...    ...  -+.+|.|||.+....++.+|||||+|++|||.++ |..||...+..+.+..+.++ +..+.+.++
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g-yRLPpPmDC  859 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG-YRLPPPMDC  859 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-cCCCCCCCC
Confidence            432221    111  2468999999999999999999999999999875 99999999999999999887 467777799


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      |..+.+|+..||++|-.+||.++||+.+
T Consensus       860 P~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=266.43  Aligned_cols=256  Identities=31%  Similarity=0.563  Sum_probs=216.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH----HHHHHHHHHHHHHHHhCCCCcccceeeEEe-cCCe
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK----YKIQHQLRREMEIQSSLRHPNILRLYGWFH-DDER   93 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~-~~~~   93 (284)
                      .+|.++..||.|||+.||+|.+......||+|+-.....+.    ....+..-+|.++-+.++|+.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            46999999999999999999999999999999975444333    233466778999999999999999999996 4467


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecC---CCCEEEeecccccc
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDH---EGRLKIGDFGWSVQ  168 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~---~~~~~l~d~~~~~~  168 (284)
                      +|-|.|||+|.+|.-+++.++.+++++++.|+.||+.||.||.+..  |+|-||+|.|||+..   -|.+||.|||++..
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            8999999999999999999999999999999999999999999875  999999999999954   36899999999865


Q ss_pred             cCCCC----------ccccCCCcccCccccC----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHH---HHh
Q 023270          169 SRSKR----------HTMCGTLDYLAPEMVE----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRR---IMK  230 (284)
Q Consensus       169 ~~~~~----------~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~---~~~  230 (284)
                      +....          ....|+.+|+|||++-    .+.++.+.||||+|+++|..+.|+.||...... +++..   +..
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            54322          3356899999999884    344788999999999999999999999765443 33322   223


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ....++..+.++.+...||++||.+--++|....++-.||||.-
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            45567777899999999999999999999999999999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.1e-37  Score=279.46  Aligned_cols=255  Identities=19%  Similarity=0.279  Sum_probs=177.4

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecC----CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE-
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW-   87 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~-   87 (284)
                      ...+...+|.+.+.||+|+||.||+|.+..+    +..|++|++........    ....   .+....+.++..+... 
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e---~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE---RVRRACPNSCADFVYGF  198 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH---HHHhhchhhHHHHHHhh
Confidence            4567889999999999999999999999888    89999998754321111    1111   1111112222221111 


Q ss_pred             -----EecCCeEEEEEeecCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023270           88 -----FHDDERIFLILEYAHRGELYRELRKHRR--------------------FTEQQAATYIASLTNALAYCHENHVIH  142 (284)
Q Consensus        88 -----~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~~i~~~l~~lh~~gi~H  142 (284)
                           ...+...++|+||+++++|.+++.....                    .....+..++.|++.||.|||+.||+|
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH  278 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH  278 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence                 2456689999999999999998865321                    123446679999999999999999999


Q ss_pred             cCCCCCCeEecC-CCCEEEeecccccccCC----CCccccCCCcccCccccCCCC----------------------CCc
Q 023270          143 RDIKPENLLLDH-EGRLKIGDFGWSVQSRS----KRHTMCGTLDYLAPEMVENKE----------------------HDY  195 (284)
Q Consensus       143 ~dl~p~nil~~~-~~~~~l~d~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~----------------------~~~  195 (284)
                      +||||+|||++. ++.+||+|||++.....    ......+++.|+|||.+....                      ++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999986 57999999999854321    223456789999999653221                      334


Q ss_pred             hhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCC----------C---------CCCCCCCCHHHHHHHHHhccc
Q 023270          196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDL----------S---------FPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       196 ~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~----------~---------~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ++||||+||++++|+++..++..  .......... ...          .         +...+..+....+||.+||+.
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            56999999999999987665432  1111111111 000          0         000111233466899999999


Q ss_pred             CCCCCCCHHhhhcCccccccC
Q 023270          256 DSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ||++|||+.++|+||||++..
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCC
Confidence            999999999999999998764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-38  Score=269.71  Aligned_cols=268  Identities=30%  Similarity=0.545  Sum_probs=231.6

Q ss_pred             HHhhhhcccccccC--cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 023270            7 EREDNRKREWSLQD--FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (284)
Q Consensus         7 ~~~~~~~~~~~~~~--y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~   84 (284)
                      |+-..+-.+-++.+  |..++.||-|+||.|.++....+.+.||.|.+.+.+.-........+.|-.+|..-+++-+|++
T Consensus       615 ESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrL  694 (1034)
T KOG0608|consen  615 ESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRL  694 (1034)
T ss_pred             hhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEE
Confidence            34444444555544  8888999999999999999988999999999999888888888899999999999999999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecc
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                      +..|.+.+.+|+||+|.+||++-++|-+-+-+.++.++-++..+.-|++++|+.|++|+||||+|||+|.+|++||.|||
T Consensus       695 yySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  695 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             EEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecc
Confidence            99999999999999999999999999998999999999999999999999999999999999999999999999999999


Q ss_pred             ccccc---------CCCC------------------------------------ccccCCCcccCccccCCCCCCchhhH
Q 023270          165 WSVQS---------RSKR------------------------------------HTMCGTLDYLAPEMVENKEHDYAVDN  199 (284)
Q Consensus       165 ~~~~~---------~~~~------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di  199 (284)
                      +++-.         ++..                                    ...+|++.|+|||++....++..+|.
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            86211         0000                                    12468899999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHhhhcCccccc
Q 023270          200 WTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIK  274 (284)
Q Consensus       200 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~  274 (284)
                      ||.|++|++|+.|.+||...++.+...++.  ...+.++....++++..++|.++.+ ++..|.   -++++..||||+.
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence            999999999999999999888877655543  3456666777899999999998774 777887   5778999999985


Q ss_pred             c
Q 023270          275 N  275 (284)
Q Consensus       275 ~  275 (284)
                      -
T Consensus       934 I  934 (1034)
T KOG0608|consen  934 I  934 (1034)
T ss_pred             c
Confidence            4

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=274.18  Aligned_cols=257  Identities=23%  Similarity=0.383  Sum_probs=223.2

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCc---eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      .+..+.++||+|.||.|+++.++..+.   .||||.+.......  ....|.+|+..|.+|+|+|++++|+++.+ ...-
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            345667889999999999999876443   48999986655443  56889999999999999999999999987 6688


Q ss_pred             EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC
Q 023270           96 LILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  173 (284)
                      +|+|.++.|||.+.|...  ..|-...+-.++.||+.|+.||..++.+|+||..+|+++-....|||+|||+......+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999999999874  468888899999999999999999999999999999999999999999999986655444


Q ss_pred             ccc------cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          174 HTM------CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       174 ~~~------~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      ..+      ..+..|+|||.++...++.+||+|++|+++|||+| |..||.+.....+++.+- .....+.+..++.++.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY  345 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIY  345 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHH
Confidence            332      24567999999999999999999999999999997 999999999999888887 4456777778999999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      +++..||..+|.+|||+..|.+.-+.++.+.-.
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l~eaqp~~  378 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVLAEAQPAV  378 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHHHhcCCce
Confidence            999999999999999999998887777766543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=268.23  Aligned_cols=262  Identities=21%  Similarity=0.307  Sum_probs=191.9

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe----------------cCCceEEEEehhhhhHHHH-----------HHHHH
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV----------------ESKHPVALKIIFKEQIEKY-----------KIQHQ   65 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~v~iK~~~~~~~~~~-----------~~~~~   65 (284)
                      ...|+.++|++.++||+|+||+||++...                ..+..|+||.+........           ...+.
T Consensus       139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~  218 (507)
T PLN03224        139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET  218 (507)
T ss_pred             CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence            45688999999999999999999998642                2346799999854321110           01122


Q ss_pred             HHHHHHHHHhCCCCc-----ccceeeEEec--------CCeEEEEEeecCCCchHHHHHhc-------------------
Q 023270           66 LRREMEIQSSLRHPN-----ILRLYGWFHD--------DERIFLILEYAHRGELYRELRKH-------------------  113 (284)
Q Consensus        66 ~~~~~~~~~~l~h~~-----i~~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~-------------------  113 (284)
                      ...|+..+..++|.+     ++++++++..        .+..++|+||+++++|.+++...                   
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            334556666666554     3566776643        35689999999999999888642                   


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--c--cccCCCcccC
Q 023270          114 -----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--H--TMCGTLDYLA  184 (284)
Q Consensus       114 -----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~--~~~~~~~y~a  184 (284)
                           ..++...++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......  .  ...+++.|+|
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence                 123567788999999999999999999999999999999999999999999985432211  1  1234789999


Q ss_pred             ccccCCCCC----------------------CchhhHhhHHHHHHHHHhCCC-CCCCC-----------ChHHHHHHHHh
Q 023270          185 PEMVENKEH----------------------DYAVDNWTLGILCYEFLYGAP-PFEAE-----------SQKDTFRRIMK  230 (284)
Q Consensus       185 PE~~~~~~~----------------------~~~~Di~slG~il~~l~tg~~-p~~~~-----------~~~~~~~~~~~  230 (284)
                      ||.+.....                      ....|+||+|+++++|++|.. |+...           .....++....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998754321                      124699999999999999875 66432           11122233333


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHhhhcCccccc
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDS---SKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~il~~~~~~~  274 (284)
                      ....++..+..++..++|+.+||..+|   ++|+|++|+|+||||..
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            445555566789999999999999765   78999999999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=258.88  Aligned_cols=133  Identities=24%  Similarity=0.434  Sum_probs=115.4

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC--------CCcccceeeE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--------HPNILRLYGW   87 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~--------h~~i~~~~~~   87 (284)
                      ++..+|.+.++||.|-|++||+|-|..+.+.||+|+++....-+    +....||.+++++.        -.+|+++++.
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYt----EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYT----EAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHH----HHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            44579999999999999999999999999999999997766544    45668888888874        2479999999


Q ss_pred             Ee----cCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEec
Q 023270           88 FH----DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLD  153 (284)
Q Consensus        88 ~~----~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~  153 (284)
                      |.    .+.++|+|+|+.. ..|..+|...  +.++...++.|++|++.||.|||+. ||+|.||||+|||+.
T Consensus       151 FkhsGpNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ceecCCCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            85    4458999999994 6888888765  5799999999999999999999975 999999999999995

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=268.58  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=211.7

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecC--Cc--eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVES--KH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~--~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      .++.-..-...+.||.|-||.||.+....-  |.  -||||+.+.....  ...+.|..|..+++.++||||++++|++.
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            334444445567799999999999987543  22  3889988664322  23578899999999999999999999886


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                       +...++|||.++.|.|.++++.++ .|+...+..+..||..|+.|||+...+|+||..+|||+..+..|||+|||+++.
T Consensus       462 -e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  462 -EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             -ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence             456899999999999999999885 799999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCCc----cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          169 SRSKRH----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       169 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ......    ...-+..|+|||.++-..++.+||||.||++|||++. |..||.+-...+.+-.+..+ ...+.++.+|+
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~P~nCPp  619 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERLPCPPNCPP  619 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-CCCCCCCCCCh
Confidence            543321    2223567999999998999999999999999999875 99999998888887777766 47778889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .+..|+++||+.+|.+||.+.+|..
T Consensus       620 ~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  620 ALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999998877653

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=266.03  Aligned_cols=249  Identities=21%  Similarity=0.367  Sum_probs=217.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      +..-.+-...++||.|.||.||.+.++...-.||||.++-...    ...+|.+|..+|+.++|+|+++++++|..+--+
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3334456778899999999999999999888999999854332    246888999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 FLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      |||+|||..|.|.++++++.  .++.-.++.++.||..|+.||..++++|+||..+|+|+..+..||+.|||++..+.+.
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99999999999999998764  4677788899999999999999999999999999999999999999999999776554


Q ss_pred             Cccc----cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 RHTM----CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~~~~----~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      ....    .-+..|.|||.+....++.++|||+||++||++.| |-.||.+-+....+.-+.+ .+.+..+..+|+.+.+
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCCCCCHHHHH
Confidence            4332    23567999999999999999999999999999997 8899998888776665544 4677788899999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhc
Q 023270          248 LISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (284)
                      |+++||+++|.+||++.++-+
T Consensus       498 LMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHHH
Confidence            999999999999999998743

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-38  Score=251.77  Aligned_cols=262  Identities=31%  Similarity=0.610  Sum_probs=225.8

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEec
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD   90 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~   90 (284)
                      ..+.+.+++|+++++||.|+++.|.+++.+.+.+.||+|+++++.....+..+..+.|-.+..+- +||.++-++..|..
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            34567899999999999999999999999999999999999998877766667777777666654 68999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc--
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--  168 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~--  168 (284)
                      +..+++|.||.++|+|---++++.+++++.++-+-..|.-||.|||++||+++|+|.+||+++..|++||.|+|....  
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999999999988888888999999999999999999999999999999999999999999999999999743  


Q ss_pred             -cCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCC-------CChHHH-HHHHHhcCCCCCCCC
Q 023270          169 -SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA-------ESQKDT-FRRIMKVDLSFPSAP  239 (284)
Q Consensus       169 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~-------~~~~~~-~~~~~~~~~~~~~~~  239 (284)
                       .+..+...+|+|.|.|||++.+..+....|.|+||++|++|+.|+.||..       .+.++. .+-++......+.  
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--  480 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--  480 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--
Confidence             34455677899999999999999999999999999999999999999953       122333 3334444444443  


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC------CHHhhhcCcccccc
Q 023270          240 SISAEAKHLISRLLVKDSSKRL------SLQKIMEHPWIIKN  275 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp------s~~~il~~~~~~~~  275 (284)
                      .++-....+++..|++||++|.      -..++..|+||+.-
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence            5666788999999999999997      56899999999854

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=265.17  Aligned_cols=254  Identities=23%  Similarity=0.384  Sum_probs=217.1

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ....++--+...++++||+|.||.|.++... .+..||+|.+.......  ..+.|.+|+++|.+++||||+.++++|..
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            3445666677899999999999999999863 47899999997655433  35789999999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ++.+++++||++.|+|..++..+  +.+......+++.||+.|++||.+.+++|||+.++|+|++.++++||+|||++..
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence            99999999999999999999887  3446677788999999999999999999999999999999999999999999864


Q ss_pred             cCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHH--hCCCCCCCCChHHHHHHHHhcC------CCC
Q 023270          169 SRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL--YGAPPFEAESQKDTFRRIMKVD------LSF  235 (284)
Q Consensus       169 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--tg~~p~~~~~~~~~~~~~~~~~------~~~  235 (284)
                      .-...     ....-+.+|+|||.+..++++.+||+|+||+++||++  +...||...+++...+..-...      ...
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            33222     2234478899999999999999999999999999976  5889999999988887765432      122


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhh
Q 023270          236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIM  267 (284)
Q Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il  267 (284)
                      ..++.+|..+.+++-.||..+-++|||++++-
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            33457899999999999999999999999984

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.1e-38  Score=267.54  Aligned_cols=257  Identities=26%  Similarity=0.446  Sum_probs=217.9

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC------Ccccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH------PNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h------~~i~~~~~   86 (284)
                      .++.-..+|.|....|+|-||+|..|.+...|..||||++.......    +.=..|+++|++|..      -|+++++-
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            45667789999999999999999999999999999999996654433    455678999999963      48999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEee
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGD  162 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d  162 (284)
                      .|...+++|+|+|-... +|.+.++.-+   .|....+..++.|++-||..|...|++|.||+|+|||++.+ ..+||||
T Consensus       502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence            99999999999999874 9999998754   58889999999999999999999999999999999999887 5699999


Q ss_pred             cccccccCCCCc-cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 023270          163 FGWSVQSRSKRH-TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---  238 (284)
Q Consensus       163 ~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  238 (284)
                      ||.+.....+.. .+..+--|.|||++.+.+|+...|+||+||+||+|+||+..|.+.+.-..++-.+.....++..   
T Consensus       581 fGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  581 FGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             CccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            999876655443 3345566999999999999999999999999999999999999988877776665543333330   


Q ss_pred             ------------------------------------------------CCC-------CHHHHHHHHHhcccCCCCCCCH
Q 023270          239 ------------------------------------------------PSI-------SAEAKHLISRLLVKDSSKRLSL  263 (284)
Q Consensus       239 ------------------------------------------------~~~-------~~~l~~li~~~l~~~p~~Rps~  263 (284)
                                                                      +.+       -.++++|+..||..||.+|.|+
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                                                            011       2458899999999999999999


Q ss_pred             HhhhcCccccc
Q 023270          264 QKIMEHPWIIK  274 (284)
Q Consensus       264 ~~il~~~~~~~  274 (284)
                      .|+|.||||+.
T Consensus       741 nqAL~HpFi~~  751 (752)
T KOG0670|consen  741 NQALKHPFITE  751 (752)
T ss_pred             HHHhcCCcccC
Confidence            99999999985

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=248.66  Aligned_cols=265  Identities=26%  Similarity=0.401  Sum_probs=214.5

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHH-HHHhCCCCcccceeeEEe
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~-~~~~l~h~~i~~~~~~~~   89 (284)
                      ....++.-.+.+-+..||.|+||+|++..++.+|+.+|||.+.......  ..+.++.|.. .++.-+.|||+++++...
T Consensus        56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            3445566667778889999999999999999999999999997765522  3455556665 455557899999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeec
Q 023270           90 DDERIFLILEYAHRGELYRELR-----KHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                      .++-.++-||.++ .|+..+-+     +...+++..+-.+....+.||.||.+. .|+|+|+||+|||++..|.+|||||
T Consensus       134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence            9999999999997 47655432     234688998889999999999999965 8999999999999999999999999


Q ss_pred             ccccccCCC--CccccCCCcccCccccCCC--CCCchhhHhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCC
Q 023270          164 GWSVQSRSK--RHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDLSFPSA  238 (284)
Q Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~  238 (284)
                      |++....+.  .....|-..|+|||.+...  .++.+||+||||++|+|+.||..|+...+. .+.+.+...+..+....
T Consensus       213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence            997543322  2334567789999998643  489999999999999999999999987655 46666666665444333


Q ss_pred             C----CCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          239 P----SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       239 ~----~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +    .++..+..+|+-||.+|...||++.+++.+||++.-...
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence            2    368899999999999999999999999999999876443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=267.38  Aligned_cols=254  Identities=31%  Similarity=0.517  Sum_probs=214.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEe-----cCC
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH-----DDE   92 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~-----~~~   92 (284)
                      .-|.+...||.|.+|.||+++...+++..|+|+........    .++..|+.+++.. .|||++.+++++.     .++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            34889999999999999999999999999999986544332    4667788888877 5899999999984     557


Q ss_pred             eEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc--
Q 023270           93 RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--  168 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~--  168 (284)
                      .+++|||||.+||..+++++.  ..+.+..+..|++.++.|+.+||.+.++|+||+-.|||++.++.|||+|||.+.+  
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            999999999999999999875  4688999999999999999999999999999999999999999999999998743  


Q ss_pred             -cCCCCccccCCCcccCccccCC-----CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CCCC
Q 023270          169 -SRSKRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS-APSI  241 (284)
Q Consensus       169 -~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  241 (284)
                       .....+.-.|+|.|+|||++..     ..++..+|+||||++..+|..|.+|+-+..+...+..+...-..... +..=
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW  254 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW  254 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence             3455566789999999999853     34678999999999999999999999888886666555443211111 2345


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ++++.++|+.||..|.++||+..++|+|||+++++
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            67899999999999999999999999999999664

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.4e-36  Score=232.78  Aligned_cols=250  Identities=29%  Similarity=0.555  Sum_probs=199.9

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCC--e
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE--R   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~--~   93 (284)
                      ...+|++++++|.|.+|.||.+....++..++||++++-.      .+.+.+|+.++..+. |+||++++++..++.  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4567999999999999999999999999999999985432      467889999999997 999999999997764  5


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~  172 (284)
                      ..+++||.+..+...+-   +.++..++..++.+++.||.|+|+.||.|+|+||.|+|++.. ..++|+|||++......
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            78999999876555443   457889999999999999999999999999999999999876 56999999998655433


Q ss_pred             Cc--cccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhc-------------CCC-
Q 023270          173 RH--TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKV-------------DLS-  234 (284)
Q Consensus       173 ~~--~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~-~~~~~~~~~~~~~~~-------------~~~-  234 (284)
                      ..  -..-+-.|--||.+-..+ ++..-|+|||||++..|+..+.|| .+.+..+.+-++-+.             ... 
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            32  223455678999886654 899999999999999999988887 444333322222111             111 


Q ss_pred             ---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          235 ---------------------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       235 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                                           .....-.++++.+|+..+|..|-.+|+|+.+++.||||.-.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                                 11112357999999999999999999999999999999743

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=243.94  Aligned_cols=263  Identities=28%  Similarity=0.447  Sum_probs=212.5

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----   92 (284)
                      ..|-+-.+.||.|+||.||.+.+-.+|+.|++|++..-...- ..-+.+.+|++++...+|.|++..+++..-..     
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L-~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNL-ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHH-HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            455667789999999999999999999999999985533222 22356778999999999999999999875443     


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .+|+++|.+. .+|...|-+-+.++.+.+.-.+.||+.||+|||+.||.|+||||.|.+++.++.+||+|||++......
T Consensus       131 EiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            5788899885 588888888889999999999999999999999999999999999999999999999999998654432


Q ss_pred             Cc----cccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------
Q 023270          173 RH----TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-----------------  230 (284)
Q Consensus       173 ~~----~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----------------  230 (284)
                      ..    ....+..|.|||++.+.. ++.+.||||+||++.||+..+..|...++-+.+.-+..                 
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            22    234578899999998876 89999999999999999999988876655443332222                 


Q ss_pred             ------cCCCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCCCC
Q 023270          231 ------VDLSFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC  282 (284)
Q Consensus       231 ------~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  282 (284)
                            +....++.         ..-..+...++..++.+||.+|.+.++.+.|+|..++-.+.+.|
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~sC  356 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHSC  356 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeeee
Confidence                  11111211         12345678889999999999999999999999999987766665

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=263.87  Aligned_cols=239  Identities=31%  Similarity=0.486  Sum_probs=190.2

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC------eE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE------RI   94 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~------~~   94 (284)
                      +...+.||.|+||.||+++++.+|..||||.+.....-  ...+..-+|++++++++|+|||++.++-+...      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            45667899999999999999999999999999775532  23466778999999999999999999755433      56


Q ss_pred             EEEEeecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC--C--CEEEeeccccc
Q 023270           95 FLILEYAHRGELYRELRK---HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE--G--RLKIGDFGWSV  167 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~--~--~~~l~d~~~~~  167 (284)
                      .+|||||.+|+|...+.+   +..|++.+.+.++.++..|+.|||++||+|+||||.||++-.+  |  .-||+|||.++
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            899999999999999965   4579999999999999999999999999999999999999433  3  58999999985


Q ss_pred             ccC--CCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCC------
Q 023270          168 QSR--SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----DTFRRIMKVDLS------  234 (284)
Q Consensus       168 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~------  234 (284)
                      ...  .......||..|++||.+.. +.++...|+||||+++|++.||..||......    +...........      
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            543  44456679999999999984 77899999999999999999999999654322    233333222111      


Q ss_pred             -------------CCCCCCCCH----HHHHHHHHhcccCCCCCC
Q 023270          235 -------------FPSAPSISA----EAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       235 -------------~~~~~~~~~----~l~~li~~~l~~~p~~Rp  261 (284)
                                   ++.+-.+++    .+-..+..+|..+|++|.
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                         111112233    345667788899999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.9e-35  Score=282.91  Aligned_cols=239  Identities=20%  Similarity=0.289  Sum_probs=186.3

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ..|...+.||+|+||.||+|.+..++..||+|++......       ...+++.+++++||||+++++++.+++..++||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            4566778899999999999999899999999998543211       123577889999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH---ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh---~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  175 (284)
                      ||+++++|.+++..   +++..+..++.+++.|+.|||   +.+++|+|++|+||+++.++..++. ++....... ...
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-~~~  837 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-DTK  837 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-CCC
Confidence            99999999999964   789999999999999999999   6699999999999999988887765 444322111 122


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHh---------cCCCC--CCCC
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-----KDTFRRIMK---------VDLSF--PSAP  239 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~---------~~~~~--~~~~  239 (284)
                      ..+++.|+|||++.+..++.++||||||+++||++||+.||.....     .+..+....         .....  ....
T Consensus       838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            3567899999999999999999999999999999999999854211     111111100         00000  0000


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....++.+++.+||..+|++|||++++++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            122357789999999999999999999876

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=261.68  Aligned_cols=253  Identities=25%  Similarity=0.451  Sum_probs=214.4

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEec---C----CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccce
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVE---S----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRL   84 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~   84 (284)
                      .+++...+..+.+.||.|.||.|+++....   .    ...||||........  ...+.+..|+.+++.+. |+|++.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            566777777888899999999999987542   1    345899998665444  44678899999999985 9999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++.+...+..++|.||+..|+|.++++..+                .++..+++.++.||+.|+.||++...+||||..+
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998765                4899999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCCCcc----cc--CCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCC-
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSKRHT----MC--GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES-  220 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~~~~----~~--~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~-  220 (284)
                      ||++..+..+|++|||++.........    ..  -+..|+|||.+....++.+|||||+|+++||++| |..||.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999999643322111    11  3456999999999999999999999999999998 999998865 


Q ss_pred             hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ..+.++ .++.......+..+++++.++++.||+.+|++||++.++.+
T Consensus       528 ~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  528 TEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            556655 55555566666678999999999999999999999998875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=237.67  Aligned_cols=255  Identities=23%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-   92 (284)
                      ......+|.-++.+|.|.. .|..|-+.-.+.+|++|+...+... ....+...+|...+..++|+|+++++.++.-.. 
T Consensus        12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            4456678999999999999 7888888899999999998665332 233456678999999999999999999985433 


Q ss_pred             -----eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           93 -----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        93 -----~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                           ..|+|||+++ .+|...+.  -.++-+.+..++.|++-|++|||+.||+|+||||+||++..++.+|+.|||++.
T Consensus        90 l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   90 LEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence                 5899999997 58888776  346788899999999999999999999999999999999999999999999996


Q ss_pred             ccCCC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 023270          168 QSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--------  237 (284)
Q Consensus       168 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  237 (284)
                      ..+..  ...+..+-.|.|||+..+-.+.+..||||+||++.+|++|+..|.+.+.-+.+.++...-..+..        
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            65544  34455677899999999888999999999999999999999999886665554444332111110        


Q ss_pred             --------------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          238 --------------------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       238 --------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                                                      ++.-+..+++++.+||..||++|.|++++|.||||+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                            012245689999999999999999999999999997

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=4.4e-33  Score=221.85  Aligned_cols=209  Identities=42%  Similarity=0.734  Sum_probs=187.4

Q ss_pred             eccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCch
Q 023270           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (284)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L  106 (284)
                      ||.|.+|.||++.+..+++.+++|++.......  ..+.+.+|++.++.+.|++++++++++......++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999997655432  346788999999999999999999999999999999999998999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEeecccccccCCC---CccccCCCc
Q 023270          107 YRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRSK---RHTMCGTLD  181 (284)
Q Consensus       107 ~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~---~~~~~~~~~  181 (284)
                      .+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+......   .....+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9999876 57899999999999999999999999999999999999999 899999999998655443   344557788


Q ss_pred             ccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          182 YLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       182 y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      |.+||..... ..+.++|+|++|++++++                                 ..+.+++..|+..+|.+|
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R  205 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKR  205 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccC
Confidence            9999999877 788999999999999998                                 779999999999999999


Q ss_pred             CCHHhhhcCc
Q 023270          261 LSLQKIMEHP  270 (284)
Q Consensus       261 ps~~~il~~~  270 (284)
                      |+++++++++
T Consensus       206 ~~~~~l~~~~  215 (215)
T cd00180         206 PSAKEILEHL  215 (215)
T ss_pred             cCHHHHhhCC
Confidence            9999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=253.97  Aligned_cols=244  Identities=23%  Similarity=0.396  Sum_probs=208.6

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCc----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .+-.++||+|+||+||++.+...++    +|+||++......  +.-.++.+|+-.|.+++|+|++++++++.... .-+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            4556789999999999999877655    4788887554432  23468889999999999999999999987555 888


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcc
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  175 (284)
                      |++|++.|.|.++++.+ ..+..+..+.|..||++|+.|||+++++||||..+|||+...+++|+.|||++.........
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999999887 47899999999999999999999999999999999999999999999999998543322211


Q ss_pred             -----ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          176 -----MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       176 -----~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                           ....+.|+|-|.+....++.++||||+|+++||++| |..|+.+..-+++-.-+.++. +.+.++..+-++..++
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQPPICTIDVYMVM  933 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCCCCccHHHHHHH
Confidence                 123566899999999999999999999999999997 999999988887777666664 5888889999999999


Q ss_pred             HHhcccCCCCCCCHHhhhc
Q 023270          250 SRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~  268 (284)
                      .+||-.|+..||++.++.+
T Consensus       934 vkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHhccCcccCccHHHHHH
Confidence            9999999999999997754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=258.60  Aligned_cols=244  Identities=28%  Similarity=0.432  Sum_probs=192.1

Q ss_pred             cEeeeeeccCCCeE-EEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEEEE
Q 023270           21 FEIGRPLGKGKFGR-VYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        21 y~~~~~lg~g~~~~-v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      |.-.+++|.|..|+ ||++..  .++.||||++..+.      ...+.+|++.++.- +||||++++..-.+..+.||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            34455678999888 688875  67799999985543      34567899988887 4999999999888888999999


Q ss_pred             eecCCCchHHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CC--CEEEeeccccccc
Q 023270           99 EYAHRGELYRELRKH-R---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EG--RLKIGDFGWSVQS  169 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~--~~~l~d~~~~~~~  169 (284)
                      |.|. -+|.++++.. .   .......+.++.|+++|+++||+.+|+|+||+|.|||++.   ++  .++|+|||++...
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9997 5999999884 1   1222456788999999999999999999999999999976   33  6999999998554


Q ss_pred             CCC------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC-C
Q 023270          170 RSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPS-I  241 (284)
Q Consensus       170 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  241 (284)
                      ...      .....|+.+|.|||++....-+.+.|||||||++|+.++ |.+||...-..  ...++.+......... -
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~  739 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLP  739 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCc
Confidence            322      244568999999999998888889999999999999888 59999865443  2233333322222111 1


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ..+..+||++|++++|..||++.++|.||+|=..
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            1289999999999999999999999999999543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=244.53  Aligned_cols=202  Identities=31%  Similarity=0.546  Sum_probs=178.4

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHH-----HHHHHHHHHHhCC---CCcccceeeE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQSSLR---HPNILRLYGW   87 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~-----~~~~~~~~~~~l~---h~~i~~~~~~   87 (284)
                      -++.+|..++.+|.|+||.|++|.++.+...|+||.+.++..-...+.+     .+-.|+++|..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            3567899999999999999999999999999999999877664433322     3456899999997   9999999999


Q ss_pred             EecCCeEEEEEeec-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           88 FHDDERIFLILEYA-HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        88 ~~~~~~~~~v~e~~-~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      |++++++|++||.. ++.+|.++|+..+.+++.++..|+.|++.|+++||+.||+|+|||-+||.++.+|-+||+|||.+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            99999999999975 56799999999999999999999999999999999999999999999999999999999999987


Q ss_pred             cc-cCCCCccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCC
Q 023270          167 VQ-SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFE  217 (284)
Q Consensus       167 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~  217 (284)
                      .. ..++.....||.+|.|||++.+..| ...-|||++|+++|-++....||-
T Consensus       718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            44 4455667789999999999998885 678999999999998887777764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-32  Score=227.10  Aligned_cols=242  Identities=25%  Similarity=0.412  Sum_probs=183.9

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh--CCCCcccceeeEEecC---
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS--LRHPNILRLYGWFHDD---   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~--l~h~~i~~~~~~~~~~---   91 (284)
                      ..++-++.+.||.|.||.||++.+  .|+.||||+|....      .+...+|.++.+.  ++|+||+.+++.-..+   
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            456788999999999999999987  67789999995543      2345567666665  4899999999875433   


Q ss_pred             -CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCeEecCCCCEEEee
Q 023270           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--------HVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        92 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                       .++++|++|++.|||.++|.+ ..++.+..++++.-++.||++||..        .|.|+|||.+|||+..++...|.|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence             279999999999999999988 6789999999999999999999953        399999999999999999999999


Q ss_pred             cccccccC-------CCCccccCCCcccCccccCCCCC----C--chhhHhhHHHHHHHHHhC----------CCCCCC-
Q 023270          163 FGWSVQSR-------SKRHTMCGTLDYLAPEMVENKEH----D--YAVDNWTLGILCYEFLYG----------APPFEA-  218 (284)
Q Consensus       163 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~----~--~~~Di~slG~il~~l~tg----------~~p~~~-  218 (284)
                      +|++....       -+.+...||.+|+|||++.....    .  ..+||||||.++||+.-.          .+||-+ 
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            99984433       23355679999999999965432    1  368999999999998732          256533 


Q ss_pred             ---CChHHHHHH-HHhcCCCCCCCCC--CC---HHHHHHHHHhcccCCCCCCCHHhhh
Q 023270          219 ---ESQKDTFRR-IMKVDLSFPSAPS--IS---AEAKHLISRLLVKDSSKRLSLQKIM  267 (284)
Q Consensus       219 ---~~~~~~~~~-~~~~~~~~~~~~~--~~---~~l~~li~~~l~~~p~~Rps~~~il  267 (284)
                         ....+.+++ ..-....+..+..  -.   ..+-++++.||..||..|.|+--|-
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence               122233333 2222233322221  11   2466889999999999999886553

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=230.23  Aligned_cols=239  Identities=23%  Similarity=0.380  Sum_probs=182.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHH--hCCCCcccceeeEEecCC---
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS--SLRHPNILRLYGWFHDDE---   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~--~l~h~~i~~~~~~~~~~~---   92 (284)
                      +...++.+.||.|.||.||+|+.  .++.||||+|......      .+..|-++.+  .++|+||+++++.-..+.   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kq------s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQ------SFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHH------HHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            44567788999999999999986  4589999999665433      3334444333  568999999999765444   


Q ss_pred             -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCCeEecCCCCEEEee
Q 023270           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN---------HVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~---------gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                       .+.+|++|++.|+|.++|..+ .+++....+++.-+++||+|||+.         .|+|+|||.+|||+..|++..|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             899999999999999999885 579999999999999999999964         499999999999999999999999


Q ss_pred             ccccccc-----CCCCccccCCCcccCccccCCCC-CC-----chhhHhhHHHHHHHHHhCCCC------------CC--
Q 023270          163 FGWSVQS-----RSKRHTMCGTLDYLAPEMVENKE-HD-----YAVDNWTLGILCYEFLYGAPP------------FE--  217 (284)
Q Consensus       163 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Di~slG~il~~l~tg~~p------------~~--  217 (284)
                      ||++...     .+.....+||.+|+|||++.+.. +.     ...||||+|.++||+++....            |+  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9998433     23334467999999999997654 22     468999999999999975432            22  


Q ss_pred             ---CCChHHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHh
Q 023270          218 ---AESQKDTFRRIMKVDLSFPSAP-----SISAEAKHLISRLLVKDSSKRLSLQK  265 (284)
Q Consensus       218 ---~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~  265 (284)
                         .++.++...-....+.++..++     .-...+++.+..||+.||+.|.|+.=
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence               1233444444333333332221     22346889999999999999999863

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-31  Score=214.44  Aligned_cols=209  Identities=39%  Similarity=0.699  Sum_probs=181.0

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      |.+.+.||.|++++||++....+++.+++|.+......  ...+.+.+|++.++.++|+|++++++++......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999888999999999765433  2356888899999999999999999999998999999999


Q ss_pred             cCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----cc
Q 023270          101 AHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HT  175 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----~~  175 (284)
                      +++++|.+++..... ++...+..++.+++.++.+||+.|++|+|++|+||+++.++.++|+|||.+.......    ..
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            998899999988766 8999999999999999999999999999999999999999999999999875554332    44


Q ss_pred             ccCCCcccCcccc-CCCCCCchhhHhhHHHHHHHHHhCCCCCCC-CChH-HHHHHHHhc
Q 023270          176 MCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQK-DTFRRIMKV  231 (284)
Q Consensus       176 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~-~~~~~~~~~  231 (284)
                      ..+...|++||.+ ....++.++|+|+||++++++++|+.||.. .... ...+.+..+
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG  217 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence            4567889999998 666788899999999999999999999977 4444 555555444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.3e-33  Score=229.78  Aligned_cols=259  Identities=24%  Similarity=0.414  Sum_probs=204.2

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEec---CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCccccee
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLY   85 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~   85 (284)
                      ..+......+.|.++.+||.|.|++||++.+..   ....||+|.+...+..     ..+..|++.+..+. +.||+++.
T Consensus        27 l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~  101 (418)
T KOG1167|consen   27 LRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLN  101 (418)
T ss_pred             HHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcch
Confidence            344566777889999999999999999999887   7888999998665433     35778999999885 89999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeecc
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG  164 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~  164 (284)
                      +.+..+++..+|+||.+.....++...   ++..++..+++.++.||.++|.+||+|+||||+|++.+.. +.-.|+|||
T Consensus       102 ~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  102 GCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             hhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEech
Confidence            999999999999999998888887755   6789999999999999999999999999999999999764 789999999


Q ss_pred             cccc-c---------------CCC----------------C---------------ccccCCCcccCccccCCC-CCCch
Q 023270          165 WSVQ-S---------------RSK----------------R---------------HTMCGTLDYLAPEMVENK-EHDYA  196 (284)
Q Consensus       165 ~~~~-~---------------~~~----------------~---------------~~~~~~~~y~aPE~~~~~-~~~~~  196 (284)
                      ++.. .               ..+                .               -...||++|.|||++... .-+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            8630 0               000                0               013478999999998654 47889


Q ss_pred             hhHhhHHHHHHHHHhCCCCCCCCC-hHHHHHH---------------------------------HHhcCC---------
Q 023270          197 VDNWTLGILCYEFLYGAPPFEAES-QKDTFRR---------------------------------IMKVDL---------  233 (284)
Q Consensus       197 ~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~---------------------------------~~~~~~---------  233 (284)
                      .||||.|+++..++++..||-... +-..+.+                                 ......         
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            999999999999999999974321 1000000                                 000000         


Q ss_pred             -------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          234 -------SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       234 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                             .....+..+..+.+|+.+||..||.+|.|++++|.||||....
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence                   0011123466899999999999999999999999999998653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=245.10  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=218.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|..++++|.|++|.||+++++.+++..|+|+++....+.   ..-+.+|+-+++..+|+||+.+++.+.....+++.|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            57999999999999999999999999999999997655444   356778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---CCCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~~~~  175 (284)
                      |||++|+|++.-.-.+++++.++..+.+..+++++|||..|=+|+|||-.||++++.|.+|+.|||.+-..   ......
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            99999999997777789999999999999999999999999999999999999999999999999987332   233345


Q ss_pred             ccCCCcccCcccc---CCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CCCCCHHHHHHH
Q 023270          176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---APSISAEAKHLI  249 (284)
Q Consensus       176 ~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li  249 (284)
                      ..|++.|+|||+.   +.+.+...+|+|++|+...++-.-.+|.....+...+.-..+..+..+-   ...-++.+-+|+
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fv  251 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFV  251 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHH
Confidence            6799999999986   4667899999999999999998877776555555544444444333332   224567899999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      +.+|..+|++||+++.+|.|||+.+.-.
T Consensus       252 K~altknpKkRptaeklL~h~fvs~~l~  279 (829)
T KOG0576|consen  252 KGALTKNPKKRPTAEKLLQHPFVSQTLS  279 (829)
T ss_pred             HHHhcCCCccCCChhhheeceeeccchh
Confidence            9999999999999999999999987643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-32  Score=204.81  Aligned_cols=215  Identities=27%  Similarity=0.414  Sum_probs=175.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh-CCCCcccceeeEEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~-l~h~~i~~~~~~~~~~~   92 (284)
                      .++.-.+......||.|++|.|-+.++..+|...|+|.+...-...  ..+.+.+++.+..+ ..+|.++.+++.....+
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            4455556667788999999999999999999999999997655433  34566667766554 46899999999998999


Q ss_pred             eEEEEEeecCCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           93 RIFLILEYAHRGELYRE----LRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~----l~~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ..++.||.++. ||..+    ++.++.+++..+-+++.-+..|+.+||++ .++|+|+||+|||++.+|++|+||||.+.
T Consensus       119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999999974 77544    45567899999999999999999999987 79999999999999999999999999985


Q ss_pred             ccCCCC--ccccCCCcccCccccC----CCCCCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhc
Q 023270          168 QSRSKR--HTMCGTLDYLAPEMVE----NKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKV  231 (284)
Q Consensus       168 ~~~~~~--~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~  231 (284)
                      ...+.-  ....|-..|+|||.+.    ...|+.+|||||||+++.||.+++.||.. .++.+++.+....
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            443322  2245677899999875    33688999999999999999999999965 5677777776654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-31  Score=217.11  Aligned_cols=251  Identities=20%  Similarity=0.250  Sum_probs=208.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCC-----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      .+.-.+++....+-+|.||.||.+.+.+..     +.|.+|.+....  +.-....+..|.-++..+.|+|++++.++..
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            344456888888999999999999766543     346777764432  2234567778888889999999999999876


Q ss_pred             cC-CeEEEEEeecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEE
Q 023270           90 DD-ERIFLILEYAHRGELYRELRKH--------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI  160 (284)
Q Consensus        90 ~~-~~~~~v~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l  160 (284)
                      ++ ...++++.+.+-|+|..++..+        +.++..++..++.|++.|+.|||++|++|.||..+|.++++.-++||
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence            54 5778999999999999999733        35788899999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 023270          161 GDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLS  234 (284)
Q Consensus       161 ~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  234 (284)
                      +|=.++++.-...     .....+..|++||.+.+..++.++|+||||++||||+| |+.|+..-++.+...-++.+ .+
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-yR  516 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-YR  516 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-ce
Confidence            9988875433222     12234678999999999999999999999999999998 99999999998888777766 45


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ...+-++|+++..++-.||...|++||+++|+..
T Consensus       517 laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            5556689999999999999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=208.95  Aligned_cols=250  Identities=25%  Similarity=0.435  Sum_probs=194.3

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeE-EecCCeEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW-FHDDERIF   95 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~-~~~~~~~~   95 (284)
                      ...|.|.+.+|+|.||.+.++.+..+++.+++|.+..+....    ++|.+|...--.| .|.||+.-++. |..-+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~----~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ----ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH----HHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            356999999999999999999999999999999998766444    5666777655555 48999988776 45667889


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC--CCEEEeecccccccCCCC
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE--GRLKIGDFGWSVQSRSKR  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~--~~~~l~d~~~~~~~~~~~  173 (284)
                      +++||++.|+|.+-+..+ .+.+.....++.|+++||.|+|+.+++|+|||.+|||+-..  -.+||+|||.....+..-
T Consensus        99 F~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             EeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            999999999999877653 46788889999999999999999999999999999999543  379999999987776655


Q ss_pred             ccccCCCcccCccccCCC-----CCCchhhHhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCC-CCC-CCCCC
Q 023270          174 HTMCGTLDYLAPEMVENK-----EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLS-FPS-APSIS  242 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~-~~~-~~~~~  242 (284)
                      ........|.+||.....     ...+.+|+|.||++++.++||.+||.....    ..-+.+..++..+ .+. -..++
T Consensus       178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs  257 (378)
T KOG1345|consen  178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS  257 (378)
T ss_pred             hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence            444556678999976432     246899999999999999999999975322    1222333332211 111 12578


Q ss_pred             HHHHHHHHHhcccCCCCC---CCHHhhhcCccc
Q 023270          243 AEAKHLISRLLVKDSSKR---LSLQKIMEHPWI  272 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~R---ps~~~il~~~~~  272 (284)
                      +.+..+.++-|.+++++|   .++.......|.
T Consensus       258 ~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  258 EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             HHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            889999999999999999   566555554443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=6.4e-31  Score=247.96  Aligned_cols=194  Identities=18%  Similarity=0.214  Sum_probs=143.4

Q ss_pred             CcccceeeEE-------ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 023270           79 PNILRLYGWF-------HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (284)
Q Consensus        79 ~~i~~~~~~~-------~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~ni  150 (284)
                      .||+++++++       ...+.++.++|+++ ++|.+++... ..++...++.++.||+.||.|||++||+|+||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4677777766       22346777889875 6999999764 4689999999999999999999999999999999999


Q ss_pred             EecCCCCE-------------------EEeecccccccCCC-------------------CccccCCCcccCccccCCCC
Q 023270          151 LLDHEGRL-------------------KIGDFGWSVQSRSK-------------------RHTMCGTLDYLAPEMVENKE  192 (284)
Q Consensus       151 l~~~~~~~-------------------~l~d~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~  192 (284)
                      |++..+.+                   +++|||++......                   .....+++.|+|||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99665544                   55555554221100                   01124677899999999999


Q ss_pred             CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       193 ~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ++.++|||||||++|+|++|..|+....  .....+....... ......+....++.+||.++|.+||++.++++||||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~  268 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPP-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI  268 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcCh-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence            9999999999999999999988765322  1222222211111 111224567789999999999999999999999999


Q ss_pred             cccC
Q 023270          273 IKNA  276 (284)
Q Consensus       273 ~~~~  276 (284)
                      .+..
T Consensus       269 ~~~~  272 (793)
T PLN00181        269 NEPR  272 (793)
T ss_pred             hhhh
Confidence            8753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.3e-29  Score=197.34  Aligned_cols=162  Identities=20%  Similarity=0.214  Sum_probs=130.5

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCCCcc
Q 023270          104 GELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY  182 (284)
Q Consensus       104 ~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y  182 (284)
                      |+|.+++... ..+++..++.++.|++.||.|||+.|      ||+||+++.++.+++  ||.+.......  ..+++.|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--~~g~~~y   70 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--SRVDPYF   70 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc--CCCcccc
Confidence            5889999874 56999999999999999999999998      999999999999999  99875543322  2578999


Q ss_pred             cCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCC-----CCCCCCH--HHHHHHHHhcc
Q 023270          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDLSFP-----SAPSISA--EAKHLISRLLV  254 (284)
Q Consensus       183 ~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~--~l~~li~~~l~  254 (284)
                      +|||++.+..++.++||||||+++|+|++|..||..... ...............     ....++.  ++.+++.+||.
T Consensus        71 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~  150 (176)
T smart00750       71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCAS  150 (176)
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHh
Confidence            999999999999999999999999999999999976543 233333333221111     1112333  69999999999


Q ss_pred             cCCCCCCCHHhhhcCcccccc
Q 023270          255 KDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~  275 (284)
                      .+|.+||++.++++|+|+...
T Consensus       151 ~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      151 RLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             cccccccCHHHHHHHHHHHHH
Confidence            999999999999999998643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.9e-28  Score=221.05  Aligned_cols=256  Identities=28%  Similarity=0.418  Sum_probs=201.4

Q ss_pred             EeeeeeccCCCeEEEEEEEecCCceEEEEehhh---hhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFK---EQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .-...+|.|++|.++.+......+.+..|.+..   ...........+..|+-+-..++|++++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            567788999999888888777766666665532   12222222233667777788889999988877777666666669


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC-----
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-----  173 (284)
                      |||++ +|..++.....++..++-.++.|++.|+.|+|+.|+.|+|++++|++++.+|.+|++|||.+.......     
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99998 999999998889999999999999999999999999999999999999999999999999874433222     


Q ss_pred             --ccccCCCcccCccccCCCCCCc-hhhHhhHHHHHHHHHhCCCCCCCCChHHHHH--HHHhcC-----CCCCCCCCCCH
Q 023270          174 --HTMCGTLDYLAPEMVENKEHDY-AVDNWTLGILCYEFLYGAPPFEAESQKDTFR--RIMKVD-----LSFPSAPSISA  243 (284)
Q Consensus       174 --~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~tg~~p~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~  243 (284)
                        ....|+..|.|||.+.+..+++ ..||||.|+++..|.+|..||......+...  ......     ........++.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence              3456788999999999999876 6899999999999999999997655543321  111110     11111235788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +-+.+|.+||+++|.+|.|+++|++.+||+....+
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             hHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            89999999999999999999999999999987554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-26  Score=195.65  Aligned_cols=246  Identities=24%  Similarity=0.307  Sum_probs=192.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCC-ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC----CCcccceeeEE-ecCCe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR----HPNILRLYGWF-HDDER   93 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~----h~~i~~~~~~~-~~~~~   93 (284)
                      +|.+.+.||.|+||.||++.+..++ ..+|+|..........   ..+..|..++..+.    ..++..+++.+ ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999987775 5788888654321111   14556666666665    36899999988 57788


Q ss_pred             EEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-----CCEEEeecccc
Q 023270           94 IFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-----GRLKIGDFGWS  166 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-----~~~~l~d~~~~  166 (284)
                      .++||+.+ |.+|.++....  +.++...++.++.|++.+|.++|+.|++|+||||.|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 46999988655  479999999999999999999999999999999999999865     46999999998


Q ss_pred             c--cc----CC----C---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 023270          167 V--QS----RS----K---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL  233 (284)
Q Consensus       167 ~--~~----~~----~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  233 (284)
                      .  ..    ..    .   .....||..|+++....+...+++.|+||++.++.+++.|..||..........+..+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            6  21    11    0   1123389999999999999999999999999999999999999977664332333222211


Q ss_pred             CCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          234 SFP---SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       234 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...   .....+.++..+...+-..+...+|.+..+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111   223456788888888888999999999888665

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=7.2e-27  Score=180.76  Aligned_cols=249  Identities=21%  Similarity=0.295  Sum_probs=200.9

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC-CcccceeeEE
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWF   88 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h-~~i~~~~~~~   88 (284)
                      ...+..+....|.++++||+|+||.+|.+....+|..||||+-....-     ...+..|..+.+.+++ ..|..+..++
T Consensus         6 ~s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen    6 GSLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             cchhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhc
Confidence            445667889999999999999999999999999999999999533221     1355667777877765 6788888888


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC---CCEEEeecc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFG  164 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~---~~~~l~d~~  164 (284)
                      .+..+-.+||+... .||.++..-+ ..++.+.++-++.|++.-++|+|.++++|+||||+|+++.-+   ..+.|+|||
T Consensus        81 ~e~~ynvlVMdLLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   81 TEKDYNVLVMDLLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             cccccceeeeeccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence            88999999999994 6999988754 578999999999999999999999999999999999999755   579999999


Q ss_pred             cccccCCC----------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhc
Q 023270          165 WSVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---KDTFRRIMKV  231 (284)
Q Consensus       165 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~  231 (284)
                      ++......          .....||.+|.+-....+...+...|+-|+|.++.++--|..||.+...   ..-++++...
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek  239 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK  239 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence            98543322          2345688999999988888889999999999999999999999987533   3344444443


Q ss_pred             CCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023270          232 DLSFPS---APSISAEAKHLISRLLVKDSSKRLSLQ  264 (284)
Q Consensus       232 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~  264 (284)
                      ....+.   ...+|.++...+..|-..--++-|..-
T Consensus       240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            333222   346889999999999877777777654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-26  Score=185.08  Aligned_cols=245  Identities=23%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERI   94 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~   94 (284)
                      +....|+|.++||+|.||.+|.++...++.+||||.=...+     ...+++.|++..+.|. .++|..++.+..++.+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            56678999999999999999999999999999999853322     2457888888888885 68999999988999999


Q ss_pred             EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-----CEEEeecccccc
Q 023270           95 FLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----RLKIGDFGWSVQ  168 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-----~~~l~d~~~~~~  168 (284)
                      .+|+|... .||.++..-+ ..++.+.+..++.|++.-++++|++.++.+||||+|+|+...+     .+.++|||++..
T Consensus       100 iLVidLLG-PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLLG-PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhhC-cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            99999994 6999999877 4799999999999999999999999999999999999997654     599999999855


Q ss_pred             cCCCC----------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCCC
Q 023270          169 SRSKR----------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA---ESQKDTFRRIMKVDLSF  235 (284)
Q Consensus       169 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~---~~~~~~~~~~~~~~~~~  235 (284)
                      ...+.          ....||.+|++.....+..-+...|+-|||.++++++-|.+||.+   .+..+.++++-......
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            43322          235689999999999999999999999999999999999999976   45566666655443333


Q ss_pred             CC---CCCCCHHHHHHHHHhcccCCCCCCCHHhh
Q 023270          236 PS---APSISAEAKHLISRLLVKDSSKRLSLQKI  266 (284)
Q Consensus       236 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i  266 (284)
                      +.   ...+|.++..-++..-..+-.+-|.++-+
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence            22   23577788877777777777777766533

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.94  E-value=3.6e-27  Score=192.50  Aligned_cols=235  Identities=25%  Similarity=0.393  Sum_probs=160.2

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC----------CCcccceeeEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR----------HPNILRLYGWF   88 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~----------h~~i~~~~~~~   88 (284)
                      ..+.....||.|+++.||.+.+.++++.+++|++...........+.+++|......+.          |-.++..++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            35678889999999999999999999999999987665444445667777665554432          23444444543


Q ss_pred             ecC------------C-----eEEEEEeecCCCchHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 023270           89 HDD------------E-----RIFLILEYAHRGELYRELRK---HRR----FTEQQAATYIASLTNALAYCHENHVIHRD  144 (284)
Q Consensus        89 ~~~------------~-----~~~~v~e~~~~~~L~~~l~~---~~~----l~~~~~~~i~~~i~~~l~~lh~~gi~H~d  144 (284)
                      .-.            +     +.+++|+-+. ++|..++..   ...    +.....+.+..|++..+++||..|++|||
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence            211            1     3477888875 588777642   221    23344455668999999999999999999


Q ss_pred             CCCCCeEecCCCCEEEeecccccccCCCCccccCCCcccCccccCC--------CCCCchhhHhhHHHHHHHHHhCCCCC
Q 023270          145 IKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN--------KEHDYAVDNWTLGILCYEFLYGAPPF  216 (284)
Q Consensus       145 l~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~tg~~p~  216 (284)
                      |+|+|++++.+|.++|+||+.....+........+..|.|||....        ..++.+.|.|+||+++|.++++..||
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf  250 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF  250 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence            9999999999999999999987666655444445677999997643        24688999999999999999999999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 023270          217 EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  260 (284)
                      ...........      .+.....+|..++.||..+|++||.+|
T Consensus       251 ~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  251 GLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            86654322221      233344799999999999999999988

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=2.6e-24  Score=182.62  Aligned_cols=253  Identities=39%  Similarity=0.648  Sum_probs=208.7

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCC-cccceeeEEecCCeEEEEEe
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP-NILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~-~i~~~~~~~~~~~~~~~v~e   99 (284)
                      |.+.+.||.|+|+.||++.+.   ..+++|.+.............+.+++..+..+.|+ +++++.+.+...+..+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999987   78899998776655444567888999999999988 79999999987788899999


Q ss_pred             ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccCC----
Q 023270          100 YAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRS----  171 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~----  171 (284)
                      ++.++++.+.+....   .++......++.+++.++.++|+.|++|+|++|+||+++..+ .++++|||.+.....    
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777765   789999999999999999999999999999999999999998 799999998753322    


Q ss_pred             -----CCccccCCCcccCccccCC---CCCCchhhHhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCC-CCC-
Q 023270          172 -----KRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLS-FPS-  237 (284)
Q Consensus       172 -----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~-~~~-  237 (284)
                           ......++..|.+||...+   .......|+|++|++++++++|..||.....    ......+...... ... 
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 2345678999999999987   5788999999999999999999999877764    3444444433322 111 


Q ss_pred             -CCCC----CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          238 -APSI----SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       238 -~~~~----~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                       ....    ...+.+++..++..+|..|.+..+...+++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence             1111    15799999999999999999999999987766543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4.5e-25  Score=187.68  Aligned_cols=167  Identities=18%  Similarity=0.145  Sum_probs=127.6

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEec-CCceEEEEehhhhhH--HHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ......+|.+.+.||+|+||+||+|.+.. ++..+|||+......  ........+.+|+++++.++|+++++.+..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            45567889999999999999999998876 667789998653211  122335678999999999999999853322   


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI-KPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl-~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      .+..|+||||+++++|.. +.   ...   ...++.+++++|.+||+.|++|+|| ||+||+++.++.++|+|||++...
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            245899999999988863 21   111   1467889999999999999999999 999999999999999999998533


Q ss_pred             CCCC-----------ccccCCCcccCccccCC
Q 023270          170 RSKR-----------HTMCGTLDYLAPEMVEN  190 (284)
Q Consensus       170 ~~~~-----------~~~~~~~~y~aPE~~~~  190 (284)
                      ....           ....+++.|+|||.+..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            2211           12235667899998853

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-27  Score=215.74  Aligned_cols=237  Identities=24%  Similarity=0.344  Sum_probs=183.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhh--HHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +|..++.||.+.|=.|.++++.++  .|+||+|.+..  ..-....+.+ .+++ ...+++||++++.-.-..+...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            789999999999999999997543  39999986654  2222233333 3444 5567899999998887788888999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC----CCC
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR----SKR  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~----~~~  173 (284)
                      -+|.. -+|.+.+...+-+...+.+.|+.|++.|+..+|+.||+|||||.+|||++.-+++.|+||+..+..-    ++.
T Consensus       100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            99986 4999999999999999999999999999999999999999999999999999999999999763321    111


Q ss_pred             c------cccCCCcccCccccCCC-----------CCCchhhHhhHHHHHHHHHh-CCCCCCCCChH-------HHHHHH
Q 023270          174 H------TMCGTLDYLAPEMVENK-----------EHDYAVDNWTLGILCYEFLY-GAPPFEAESQK-------DTFRRI  228 (284)
Q Consensus       174 ~------~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~-------~~~~~~  228 (284)
                      .      ....-..|.|||.+-..           ..+++.||||+||+++||++ |.++|.-..--       ...++.
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence            0      11123459999988431           15789999999999999986 89998632111       111111


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +..        .-+..++++|..|++.||.+|.|+++.|+.
T Consensus       259 Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHh--------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111        123469999999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=5.6e-25  Score=174.61  Aligned_cols=176  Identities=12%  Similarity=0.159  Sum_probs=135.9

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHH------HHHHHHHHHhCCCCcccceeeEE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~------~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      .+--.+|++.+.+|.|+||.||++.+  ++..+++|++.............      +.+|++.+.++.|+++..+.+++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            45568899999999999999999655  46689999997655444433333      67899999999999999999886


Q ss_pred             ecC--------CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEE
Q 023270           89 HDD--------ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI  160 (284)
Q Consensus        89 ~~~--------~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l  160 (284)
                      ...        +..+++|||++|.+|.++..    ++.    ....+++.++..+|+.|++|||++|+||+++++| ++|
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            533        35799999999989977632    233    3456999999999999999999999999999999 999


Q ss_pred             eecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHH
Q 023270          161 GDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL  210 (284)
Q Consensus       161 ~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  210 (284)
                      +|||...........         ..+.....++.++|+|+||+++..+.
T Consensus       176 iDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence            999976443221111         01333444667999999999988764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.5e-25  Score=173.35  Aligned_cols=251  Identities=21%  Similarity=0.336  Sum_probs=208.4

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ..+...+.+.+..+..+|.....|..|+++.+++  .+++|++....... ..-+.|..|.-.++-..||||+++++.+.
T Consensus       181 lsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacn  257 (448)
T KOG0195|consen  181 LSRYTGIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACN  257 (448)
T ss_pred             cccccCcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhcc
Confidence            3456778888999999999999999999998654  46677776555443 33467788888888889999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCCCCEEEe--ec
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIG--DF  163 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~~~~~l~--d~  163 (284)
                      ++.++.++..|++.+||...+..+.  -.+..++.+++.+++.++.|||+..  |.---+....|+++++-+++|+  |-
T Consensus       258 sppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~  337 (448)
T KOG0195|consen  258 SPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT  337 (448)
T ss_pred             CCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence            9999999999999999999998764  3577889999999999999999874  4445688999999998776664  33


Q ss_pred             ccccccCCCCccccCCCcccCccccCCCCCC---chhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          164 GWSVQSRSKRHTMCGTLDYLAPEMVENKEHD---YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      .++.+..    .....|.|++||.+...+.+   .++|+|||++++|+|.|...||...++.+.-.++--..+....++.
T Consensus       338 kfsfqe~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippg  413 (448)
T KOG0195|consen  338 KFSFQEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPG  413 (448)
T ss_pred             eeeeecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCC
Confidence            3333222    22457899999998776644   5799999999999999999999999998888887777788888889


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhh
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIM  267 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il  267 (284)
                      ++..+..|++-|++.||-+||.+.+++
T Consensus       414 is~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  414 ISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999999999998775

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.7e-25  Score=193.03  Aligned_cols=240  Identities=35%  Similarity=0.627  Sum_probs=200.3

Q ss_pred             eeccCCCeEEEEEEEe---cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEEEeec
Q 023270           26 PLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILEYA  101 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v~e~~  101 (284)
                      .+|+|.+|.|+++...   ..++-|+.|+..+......... .-..+-.++..++ |+.++++...+..++..+++.++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            3789999999977543   3466688888765544332222 3345556677776 999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCCCc
Q 023270          102 HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD  181 (284)
Q Consensus       102 ~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  181 (284)
                      .++.|...+.....++......+...++-++.++|+.|++|+|+|++||+++.+|++++.|||.+......... +|+..
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-cgt~e  158 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-CGTYE  158 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-ccchh
Confidence            99999988888888888888899999999999999999999999999999999999999999998554333222 88999


Q ss_pred             ccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       182 y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      |+|||+.+  .....+|.||+|+++++++||..||..    ++...+++.....+.  .++..+++++.+++..+|.+|.
T Consensus       159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHh
Confidence            99999998  678899999999999999999999998    777777775544444  7899999999999999999998


Q ss_pred             C-----HHhhhcCcccccc
Q 023270          262 S-----LQKIMEHPWIIKN  275 (284)
Q Consensus       262 s-----~~~il~~~~~~~~  275 (284)
                      -     ..++++|+||+.-
T Consensus       231 g~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  231 GAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             ccCcchhHHHhccchheee
Confidence            4     5899999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=8.3e-24  Score=165.83  Aligned_cols=142  Identities=19%  Similarity=0.205  Sum_probs=111.6

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHH-----------------------HHHHHHHHHHHHHhCCCCc
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-----------------------IQHQLRREMEIQSSLRHPN   80 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~h~~   80 (284)
                      ...||+|++|.||+|.+. +|++||+|++.........                       .......|++.+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999986 8999999998654211100                       1123345889999998887


Q ss_pred             ccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCeEecCCCCEE
Q 023270           81 ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC-HENHVIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        81 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~l-h~~gi~H~dl~p~nil~~~~~~~~  159 (284)
                      +.....+...  ..++||||++++++.........++...+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            7544433222  2389999999877766555557889999999999999999999 799999999999999998 58899


Q ss_pred             Eeeccccccc
Q 023270          160 IGDFGWSVQS  169 (284)
Q Consensus       160 l~d~~~~~~~  169 (284)
                      |+|||++...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.8e-22  Score=157.65  Aligned_cols=143  Identities=17%  Similarity=0.183  Sum_probs=112.6

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH-----------------------HHHHHHHHHHHHHHHHhCCCC
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----------------------KYKIQHQLRREMEIQSSLRHP   79 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~l~h~   79 (284)
                      +.+.||+|++|.||+|.+. +|+.||||++......                       ..........|.+.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4578999999999999987 8999999998654211                       011123346788899999998


Q ss_pred             cccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCE
Q 023270           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        80 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~  158 (284)
                      ++.....+....  .++||||++++++.........++...+..++.+++.++.++|. .|++|+||+|+||+++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            876555544333  48999999887554443344567889999999999999999999 9999999999999998 8999


Q ss_pred             EEeeccccccc
Q 023270          159 KIGDFGWSVQS  169 (284)
Q Consensus       159 ~l~d~~~~~~~  169 (284)
                      +|+|||++...
T Consensus       157 ~liDFG~a~~~  167 (190)
T cd05145         157 YIIDVSQAVEL  167 (190)
T ss_pred             EEEEcccceec
Confidence            99999998544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=3.2e-23  Score=188.94  Aligned_cols=220  Identities=32%  Similarity=0.603  Sum_probs=176.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .-.+|..++.|..|++|.||.++++.+.+++|+|+ .+.....       +            ||+.+.+      ..++
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lil-------R------------nilt~a~------npfv  134 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLIL-------R------------NILTFAG------NPFV  134 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhh-------h------------ccccccC------Ccce
Confidence            34689999999999999999999999999999944 2222111       1            1222222      2233


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-----
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----  171 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-----  171 (284)
                      |      |+=...+++.++++.+.        +.+++|||..||+|+|++|+|.+++.=|++|+.|||++....-     
T Consensus       135 v------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  135 V------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             e------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence            3      45555666666666554        7789999999999999999999999999999999998622110     


Q ss_pred             -------------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 023270          172 -------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA  238 (284)
Q Consensus       172 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
                                   ....-+|+|.|.|||+...+.|....|.|++|+++|+++.|..||.+.+++++..........++-.
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence                         0122368999999999999999999999999999999999999999999999999988876666554


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCC---CHHhhhcCccccccC
Q 023270          239 -PSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKNA  276 (284)
Q Consensus       239 -~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~~  276 (284)
                       +..+++++++++++|..+|..|.   .+-++.+|+||+..+
T Consensus       281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence             36899999999999999999997   778899999999875

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.1e-23  Score=172.37  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=176.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCC-----------------------------------ceEEEEehhhh
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-----------------------------------HPVALKIIFKE   55 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----------------------------------~~v~iK~~~~~   55 (284)
                      ....++.+.+|.|..-||.|.-+.||.+....++                                   -+.|||.+..-
T Consensus       149 r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~  228 (598)
T KOG4158|consen  149 RIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF  228 (598)
T ss_pred             hhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc
Confidence            3345778889999999999999999988765421                                   12345544221


Q ss_pred             hH--HHHHHHHHHHHHHH--------------HHHh--------CCCCcccceeeEEe----------------------
Q 023270           56 QI--EKYKIQHQLRREME--------------IQSS--------LRHPNILRLYGWFH----------------------   89 (284)
Q Consensus        56 ~~--~~~~~~~~~~~~~~--------------~~~~--------l~h~~i~~~~~~~~----------------------   89 (284)
                      ..  .....++.+-+|+-              ..+.        -+||||+++...|.                      
T Consensus       229 ~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~  308 (598)
T KOG4158|consen  229 EHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWY  308 (598)
T ss_pred             ccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceec
Confidence            11  12222333333321              1111        24999999988764                      


Q ss_pred             -----cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC--CC--CEEE
Q 023270           90 -----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EG--RLKI  160 (284)
Q Consensus        90 -----~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~--~~--~~~l  160 (284)
                           .+..+|+||..++. +|..++-.+ ..+.....-++.|+++|+.|||++|+.|+|+|.+||++.-  |+  ++.+
T Consensus       309 p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv  386 (598)
T KOG4158|consen  309 PSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV  386 (598)
T ss_pred             ccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence                 23468999999874 999988664 4577778889999999999999999999999999999943  33  5889


Q ss_pred             eecccccccC---------CCCccccCCCcccCccccCCCCC------CchhhHhhHHHHHHHHHhCCCCCCCCChHHHH
Q 023270          161 GDFGWSVQSR---------SKRHTMCGTLDYLAPEMVENKEH------DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF  225 (284)
Q Consensus       161 ~d~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~------~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~  225 (284)
                      .|||.+.-..         +......|.-..+|||+.+..+-      -.++|.|+.|.+.||+++...||-......+-
T Consensus       387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~  466 (598)
T KOG4158|consen  387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD  466 (598)
T ss_pred             cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence            9999652221         11123345667899999864332      24899999999999999999999763332221


Q ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023270          226 RRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQ  264 (284)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  264 (284)
                      ..-.+...-+..++.+++.+++++..+|+.||++|+|..
T Consensus       467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            122222333455668999999999999999999999854

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.8e-22  Score=184.45  Aligned_cols=199  Identities=24%  Similarity=0.340  Sum_probs=165.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      +..++....|.|.+.||.|+||.||.|.+.. ++.||+|+=.....++.....+++..++ ..  --+.|..+.....-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccC
Confidence            4456777889999999999999999999877 9999999988888777665556555544 11  134456666666666


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-------CCCEEEeecc
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-------EGRLKIGDFG  164 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-------~~~~~l~d~~  164 (284)
                      +..++|+||.+.|+|.+++...+..++.....+..|++..+..||..||+||||||+|+|+..       ..-++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            778999999999999999998888999999999999999999999999999999999999953       2359999999


Q ss_pred             cccccC-----CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCC
Q 023270          165 WSVQSR-----SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP  214 (284)
Q Consensus       165 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~  214 (284)
                      .+.++.     ......+++-.+-.+|...|..++...|.|.++.+++.|+.|+.
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            884432     22334567888999999999999999999999999999998863

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=5.5e-21  Score=148.85  Aligned_cols=185  Identities=20%  Similarity=0.237  Sum_probs=137.9

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHH-HHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI-QHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~-~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +.+...|+.|+||+|+.+..  .+.+++.+.+.......... ...+++|+++++++. ++++++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45678999999999997764  77788888876555443221 235789999999995 4788888886    3469999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCeEecCCCCEEEeecccccccCCCCc---
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI-KPENLLLDHEGRLKIGDFGWSVQSRSKRH---  174 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl-~p~nil~~~~~~~~l~d~~~~~~~~~~~~---  174 (284)
                      ||+.|.+|......      . ...++.+++.++.++|++|++|+|| +|+||+++.++.++|+|||++........   
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99998888654321      1 2357789999999999999999999 79999999999999999999864433221   


Q ss_pred             -------------cccCCCcccCccccCCC-CCC-chhhHhhHHHHHHHHHhCCCCCCC
Q 023270          175 -------------TMCGTLDYLAPEMVENK-EHD-YAVDNWTLGILCYEFLYGAPPFEA  218 (284)
Q Consensus       175 -------------~~~~~~~y~aPE~~~~~-~~~-~~~Di~slG~il~~l~tg~~p~~~  218 (284)
                                   ....++.++.|+...-- ..+ ...+.++.|+.+|.++|+..+...
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                         11135556666654322 233 567888999999999998877643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-20  Score=163.03  Aligned_cols=195  Identities=25%  Similarity=0.392  Sum_probs=155.7

Q ss_pred             HhCCCCcccceeeEEecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCCeE
Q 023270           74 SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHV-IHRDIKPENLL  151 (284)
Q Consensus        74 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi-~H~dl~p~nil  151 (284)
                      +.+.|.|+.++++.+.++...++|.+||+.|+|.+.+... ..++......++++++.|+.|+|..-+ +||.+++.|.+
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl   81 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL   81 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence            5678999999999999999999999999999999999884 578999999999999999999998865 99999999999


Q ss_pred             ecCCCCEEEeecccccccCC-----CCccccCCCcccCccccCCCC-------CCchhhHhhHHHHHHHHHhCCCCCCCC
Q 023270          152 LDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKE-------HDYAVDNWTLGILCYEFLYGAPPFEAE  219 (284)
Q Consensus       152 ~~~~~~~~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~tg~~p~~~~  219 (284)
                      ++....+||+|||+......     .........-|.|||.+....       .+.+.|+||+|++++++++...||...
T Consensus        82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~  161 (484)
T KOG1023|consen   82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR  161 (484)
T ss_pred             eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence            99999999999998744432     111112234589999987642       467899999999999999999999652


Q ss_pred             ----ChHHHHHHHHhcCCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          220 ----SQKDTFRRIMKVDLSFPSA-----PSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       220 ----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                          ...++...+.++......+     ..+++++..++..||..+|.+||+++++-.
T Consensus       162 ~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  162 NLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence                3334555544422211111     134567999999999999999999998754

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=2.2e-20  Score=151.35  Aligned_cols=150  Identities=19%  Similarity=0.201  Sum_probs=116.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEE-EecCCceEEEEehhhhhHH---------------------HHHHHHHHHHHHHH
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIE---------------------KYKIQHQLRREMEI   72 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~~v~iK~~~~~~~~---------------------~~~~~~~~~~~~~~   72 (284)
                      -.+..-|++.+.||.|++|.||+|. +..+|..||+|++......                     .......+..|+..
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3344568999999999999999998 6678999999998653210                     00122346688899


Q ss_pred             HHhCCCCc--ccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCC
Q 023270           73 QSSLRHPN--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH-VIHRDIKPEN  149 (284)
Q Consensus        73 ~~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g-i~H~dl~p~n  149 (284)
                      +..+.+.+  +.++++.    ...++||||+++.++.........+....+..++.|++.++.+||..| ++|+||+|+|
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N  179 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN  179 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence            98887533  3333432    235899999998888766544455677778899999999999999999 9999999999


Q ss_pred             eEecCCCCEEEeeccccccc
Q 023270          150 LLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~  169 (284)
                      |+++ ++.++|+|||.+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9998 889999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=8e-19  Score=140.48  Aligned_cols=138  Identities=19%  Similarity=0.285  Sum_probs=114.9

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-----HHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++.||+|++|.||++..  .+..+++|+......     ........+.+|+..+..+.|+++..+..++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999986  677899998653221     22223356778999999999999888887777778889999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ||+++++|.+++.....    ....++.+++.++.++|..|++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998876432    7889999999999999999999999999999998 88999999998744

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.6e-19  Score=142.97  Aligned_cols=135  Identities=22%  Similarity=0.381  Sum_probs=105.4

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-----CCCcccceeeEEecCC---
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNILRLYGWFHDDE---   92 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-----~h~~i~~~~~~~~~~~---   92 (284)
                      +.-.+.||+|+++.||.  +..++.. +||++......   ..+.+.+|+.+++.+     .||||++++++++.+.   
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            34467899999999995  6566555 69988553222   235788999999999     5799999999998763   


Q ss_pred             eEE-EEEee--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCeEecCC----CCEEEeecc
Q 023270           93 RIF-LILEY--AHRGELYRELRKHRRFTEQQAATYIASLTNAL-AYCHENHVIHRDIKPENLLLDHE----GRLKIGDFG  164 (284)
Q Consensus        93 ~~~-~v~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l-~~lh~~gi~H~dl~p~nil~~~~----~~~~l~d~~  164 (284)
                      ..+ +|+||  +.+++|.+++++. .+++.  ..++.+++.++ .|||+++|+|+||||+||+++..    +.++|+|++
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            434 78999  4478999999764 45555  35677888777 99999999999999999999743    379999954

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=5.2e-20  Score=157.42  Aligned_cols=174  Identities=24%  Similarity=0.403  Sum_probs=136.2

Q ss_pred             eEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           93 RIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      ++|+.|++|...+|.+|+....   ..+....+.++.|++.++.|   +|.+|+|++|.||++..++.++|+|||+.+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5899999999999999997543   46788889999999999999   99999999999999999999999999997544


Q ss_pred             CCC---------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCCCCC
Q 023270          170 RSK---------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE-AESQKDTFRRIMKVDLSFPSAP  239 (284)
Q Consensus       170 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~  239 (284)
                      ...         .....|+..|++||.+.+..++.++|||+||+++++|++.   |. ..........+..+.+++....
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T~~er~~t~~d~r~g~ip~~~~~  483 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FSTQFERIATLTDIRDGIIPPEFLQ  483 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hccHHHHHHhhhhhhcCCCChHHhh
Confidence            332         2445689999999999999999999999999999999862   11 1122223333444433322322


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      +.| +-..|+.+++.+.|.+||++.+.--|+|.+
T Consensus       484 d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  484 DYP-EEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             cCc-HHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            333 346899999999999999888777777653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=2.8e-18  Score=136.06  Aligned_cols=133  Identities=16%  Similarity=0.247  Sum_probs=108.0

Q ss_pred             eeccCCCeEEEEEEEecCCceEEEEehhhhh-----HHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQ-----IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      .||+|++|.||++..  ++..+++|......     .+.......+.+|+++++.+.++++..+..++...+..+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            379999999999984  66889999864322     12222346778899999999988776666666667778999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      +++++|.+.+.....       .++.+++.+|.++|+.|++|+|++|+||+++ ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988755321       7889999999999999999999999999998 89999999998643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=2.8e-18  Score=135.97  Aligned_cols=138  Identities=22%  Similarity=0.323  Sum_probs=106.4

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH-------------------HHHHHHHHHHHHHHHhCCCCc-
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-------------------YKIQHQLRREMEIQSSLRHPN-   80 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~h~~-   80 (284)
                      |.+.+.||.|++|.||++... ++..|+||++.......                   .........|+..+..+.+.+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999874 78999999865422100                   011223567788888887764 


Q ss_pred             -ccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEE
Q 023270           81 -ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        81 -i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~  159 (284)
                       +..+++    ....++||||+++++|......      .....++.+++.++.++|..|++|+||+|+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             344433    2345899999999888765421      34567889999999999999999999999999999999999


Q ss_pred             Eeeccccccc
Q 023270          160 IGDFGWSVQS  169 (284)
Q Consensus       160 l~d~~~~~~~  169 (284)
                      |+|||.+...
T Consensus       166 liDfg~~~~~  175 (198)
T cd05144         166 IIDWPQMVST  175 (198)
T ss_pred             EEECCccccC
Confidence            9999987443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=1.2e-17  Score=151.28  Aligned_cols=138  Identities=17%  Similarity=0.233  Sum_probs=110.5

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhh-----hHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE-----QIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .|...+.||+|+||+||++.+...  .+++|+....     ........+.+.+|+++++.++|++++.+..+...++..
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            345688999999999999886443  3444432111     112223346788999999999999998888777777788


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ++||||+++++|.+++.        ....++.+++.++.+||+.|++|||++|+||++ .++.++|+|||++..
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999998875        346789999999999999999999999999999 678999999998744

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=8.8e-20  Score=165.10  Aligned_cols=257  Identities=30%  Similarity=0.489  Sum_probs=206.4

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCce-EEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERI   94 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~   94 (284)
                      ....|.+.+.||.|.++.+-.+....+... ++.|.+.... ........+..+..+-+.+. |.|++.+++...+.+..
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            377899999999999999998877555444 4555553332 22333456666777777776 99999999999999999


Q ss_pred             EEEEeecCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeEecCCC-CEEEeecccccccC
Q 023270           95 FLILEYAHRGELYREL-RKHR-RFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSR  170 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~~i~~~l~~lh-~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~  170 (284)
                      ++..++..++++.+.+ .... ..+...+...+.|+..++.|+| ..++.|+|++|+|.+++..+ ..++.|||++....
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999888 5554 6677888899999999999999 99999999999999999999 99999999985443


Q ss_pred             C-C-----CccccC-CCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHhc--CCCCCCCC
Q 023270          171 S-K-----RHTMCG-TLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRR-IMKV--DLSFPSAP  239 (284)
Q Consensus       171 ~-~-----~~~~~~-~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~--~~~~~~~~  239 (284)
                      . .     .....| ++.|.|||.+.+.. ..+..|+||.|+++..+++|..||........... ....  ......+.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            3 1     123456 89999999998854 46789999999999999999999977655543222 2221  22344556


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      .++....+++..++..+|..|.+.+++-.++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            78899999999999999999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=4e-17  Score=128.11  Aligned_cols=139  Identities=22%  Similarity=0.335  Sum_probs=96.7

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHH---------------------HHHHHHHHHhCCCCc-
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ---------------------LRREMEIQSSLRHPN-   80 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~---------------------~~~~~~~~~~l~h~~-   80 (284)
                      +.+.||+|++|+||+|.+. ++..|+||++.............                     ...+...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999876 78999999976533221111111                     134455555554332 


Q ss_pred             -ccceeeEEecCCeEEEEEeecCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCC
Q 023270           81 -ILRLYGWFHDDERIFLILEYAHRGELYR-ELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGR  157 (284)
Q Consensus        81 -i~~~~~~~~~~~~~~~v~e~~~~~~L~~-~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~  157 (284)
                       +.++++.    ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .|++|+||+|+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             3333332    24589999998843321 121111 11 6678899999999999999 9999999999999999 999


Q ss_pred             EEEeeccccccc
Q 023270          158 LKIGDFGWSVQS  169 (284)
Q Consensus       158 ~~l~d~~~~~~~  169 (284)
                      ++++|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999987433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=2.5e-16  Score=127.86  Aligned_cols=137  Identities=18%  Similarity=0.221  Sum_probs=103.1

Q ss_pred             eeec-cCCCeEEEEEEEecCCceEEEEehhhhhH----------HHHHHHHHHHHHHHHHHhCCCCcc--cceeeEEecC
Q 023270           25 RPLG-KGKFGRVYLVREVESKHPVALKIIFKEQI----------EKYKIQHQLRREMEIQSSLRHPNI--LRLYGWFHDD   91 (284)
Q Consensus        25 ~~lg-~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~~~~~~~~~~~~l~h~~i--~~~~~~~~~~   91 (284)
                      ..|| .||.|+||.+..  .+..+++|.+.....          .+......+.+|+.++..+.|+++  +.++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 899999998876  367899988743221          111233567889999999998775  5666654332


Q ss_pred             -C---eEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           92 -E---RIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        92 -~---~~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                       +   ..++|+|++++ .+|.+++.. ..++..    .+.+++.++.+||+.|++|+||+|.|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999986 688887765 345544    3578999999999999999999999999999999999999987


Q ss_pred             cc
Q 023270          167 VQ  168 (284)
Q Consensus       167 ~~  168 (284)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            43

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=4.7e-16  Score=117.34  Aligned_cols=131  Identities=24%  Similarity=0.289  Sum_probs=109.0

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC--CcccceeeEEecCCeEEEEEee
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h--~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      +++.||.|.++.||++...+  ..+++|.+.....     ...+.+|+..+..+.+  .++.+++.+...++..++++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            56789999999999999744  7899999865432     2456778888888876  5888888888877889999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeEecCCCCEEEeeccccc
Q 023270          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN---HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~---gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      +++.++..+       +......++.+++.++..+|..   +++|+|++|+||+++..+.++++||+.+.
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            988777654       4566678889999999999985   79999999999999998999999999764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.66  E-value=4.5e-15  Score=130.97  Aligned_cols=166  Identities=18%  Similarity=0.369  Sum_probs=130.9

Q ss_pred             EEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCC
Q 023270           37 LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRF  116 (284)
Q Consensus        37 ~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l  116 (284)
                      .+..+.++.++.|.+.....-   .....+.+.++.++.++||||+++++.++..+.+|+|+|.+.  .|..++++.   
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence            456677889999888865543   344567888999999999999999999999999999999984  677777664   


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeEecCCCCEEEeecccccccCCCC---ccccCCCcccCccccCCCC
Q 023270          117 TEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENKE  192 (284)
Q Consensus       117 ~~~~~~~i~~~i~~~l~~lh-~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~  192 (284)
                      +.......+.||+.||.+|| +.+++||||.-..|+++..|.++|++|.++.......   ........|..|+......
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            36677788899999999997 6789999999999999999999999999874443322   2222233466666543222


Q ss_pred             CCchhhHhhHHHHHHHHHhC
Q 023270          193 HDYAVDNWTLGILCYEFLYG  212 (284)
Q Consensus       193 ~~~~~Di~slG~il~~l~tg  212 (284)
                        -..|.|.||+++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              356999999999999988

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=1.6e-16  Score=138.42  Aligned_cols=258  Identities=21%  Similarity=0.255  Sum_probs=192.3

Q ss_pred             ccccccCcEeeeeecc--CCCeEEEEEEE--ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEE
Q 023270           14 REWSLQDFEIGRPLGK--GKFGRVYLVRE--VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWF   88 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~--g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~   88 (284)
                      ..+..+.+.+.+.+|.  |.+|.+|.+.-  ..++..+++|.-+............+ +++..-+.+ .|++.++.+..+
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~-~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKL-REFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccccccc-chhhcccccCccccccccCccc
Confidence            3455667889999999  99999998887  77888999998433222111111222 333333344 388999989999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCCeEecCC-CCEEEee
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTN----ALAYCHENHVIHRDIKPENLLLDHE-GRLKIGD  162 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~----~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d  162 (284)
                      ...+..|+-+|.|. .+|..+...- ..++...++..+.+...    |+.++|..+++|-|++|.||++..+ ...+++|
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence            99999999999997 5777766554 45889999999999999    9999999999999999999999999 8899999


Q ss_pred             cccccccCCCC--------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 023270          163 FGWSVQSRSKR--------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS  234 (284)
Q Consensus       163 ~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  234 (284)
                      |++........        ....+...|++||.. ++.++..+|+|++|.++.+..++..+....-. ..+.++....+.
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~ip  344 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGYIP  344 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC-CCccccccccCc
Confidence            99875554333        122466779999986 55678899999999999998877655432200 111111222223


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      .......+.++...+.+|++.+|..|++++.+++|+++...
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            33333566778889999999999999999999999998754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1e-15  Score=124.23  Aligned_cols=202  Identities=18%  Similarity=0.322  Sum_probs=147.3

Q ss_pred             HHHHHHHhCCCCcccceeeEEecCC-----eEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 023270           68 REMEIQSSLRHPNILRLYGWFHDDE-----RIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHEN  138 (284)
Q Consensus        68 ~~~~~~~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~  138 (284)
                      .....+-++-|.|+++++.|+.+..     ...+++||++.|++..+|++.    ..+......+|+.||++||.|||..
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            3344555567999999999986543     578899999999999999653    4688999999999999999999998


Q ss_pred             C--ccccCCCCCCeEecCCCCEEEeeccccccc-------CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHH
Q 023270          139 H--VIHRDIKPENLLLDHEGRLKIGDFGWSVQS-------RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEF  209 (284)
Q Consensus       139 g--i~H~dl~p~nil~~~~~~~~l~d~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  209 (284)
                      .  ++||++..+.|++..+|-+|++--......       ........+.++|.+||.=.....+-.+|||++|++..++
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            5  899999999999999999998643332110       1122334567899999987666777899999999999998


Q ss_pred             HhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          210 LYGAPPFEAESQ-KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       210 ~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ..+..--..... .+.-..+-...+..     -.+--+.++..|++..|..||++..++-||-.-+
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~l-----en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIGL-----ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheeec-----cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            866543222111 11111111111111     1233467899999999999999999999997654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=2.4e-16  Score=144.65  Aligned_cols=263  Identities=28%  Similarity=0.464  Sum_probs=209.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ...+..++.+.+.+..|.++.++.+.-..+++...+|+............+.++.+-.+.-...+|-++....-+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            45678889999999999999999988888887777776543322211112222222222222334555555555566778


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---  170 (284)
                      .++++++..+++|...+.+.+..+.+.+...+..+..+..+||...+.|++++|.|.+...+++.++.+++......   
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            99999999999999999998888888888889999999999999989999999999999999999999997320000   


Q ss_pred             -------------------------------CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC
Q 023270          171 -------------------------------SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE  219 (284)
Q Consensus       171 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~  219 (284)
                                                     .......+++.|.+||...+......+|.|++|+++++.++|.+||+..
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                           0011234688999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHhcCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHH---hhhcCccccccC
Q 023270          220 SQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKDSSKRLSLQ---KIMEHPWIIKNA  276 (284)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~---~il~~~~~~~~~  276 (284)
                      +.....+.+......++..+ ..+.+.++++...+..+|.+|..+.   ++-.|+||+..+
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            99999999998887777654 5788999999999999999999888   999999999864

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.59  E-value=3.1e-14  Score=110.93  Aligned_cols=143  Identities=13%  Similarity=0.166  Sum_probs=101.9

Q ss_pred             eeeeccCCCeEEEEEEEec------CCceEEEEehhhhh-----------------------HHHHHHHHHHHHHHHHHH
Q 023270           24 GRPLGKGKFGRVYLVREVE------SKHPVALKIIFKEQ-----------------------IEKYKIQHQLRREMEIQS   74 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~------~~~~v~iK~~~~~~-----------------------~~~~~~~~~~~~~~~~~~   74 (284)
                      ...||.|..+.||.|....      .+..+|+|++....                       ........+.++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999997543      35789999864211                       011122234458888888


Q ss_pred             hCCCC--cccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCeE
Q 023270           75 SLRHP--NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC-HENHVIHRDIKPENLL  151 (284)
Q Consensus        75 ~l~h~--~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~l-h~~gi~H~dl~p~nil  151 (284)
                      ++...  ++..++++    ..-++||||.++..+.........++......++.+++.++..+ |+.|++|||+++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            88654  44455543    45689999997643322222223456667778889999999998 8999999999999999


Q ss_pred             ecCCCCEEEeecccccccCC
Q 023270          152 LDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus       152 ~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +. ++.++++||+.+.....
T Consensus       158 ~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE-CCcEEEEECCCceeCCC
Confidence            96 57899999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.56  E-value=1.3e-14  Score=129.23  Aligned_cols=154  Identities=16%  Similarity=0.223  Sum_probs=96.7

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH-------------------------------
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-------------------------------   59 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-------------------------------   59 (284)
                      ....+-.+.+|+. +.||+|++|.|++|+...+|+.||||+..+.-...                               
T Consensus       112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v  190 (537)
T PRK04750        112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV  190 (537)
T ss_pred             CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence            3344455778888 89999999999999998779999999986431100                               


Q ss_pred             HHHHHHHHHHHHHHHhC----------CCCcccceeeEEec-CCeEEEEEeecCCCchHHHH--HhcCCCCHHHHHHHHH
Q 023270           60 YKIQHQLRREMEIQSSL----------RHPNILRLYGWFHD-DERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIA  126 (284)
Q Consensus        60 ~~~~~~~~~~~~~~~~l----------~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~  126 (284)
                      .+..+.+.+|+...+..          .+...+.+-.++.+ ....++||||++|+++.+..  ...+ .+....   +.
T Consensus       191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~l---a~  266 (537)
T PRK04750        191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLL---AE  266 (537)
T ss_pred             HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHH---HH
Confidence            01122333333333322          12222333333322 23567999999999997642  2222 222221   11


Q ss_pred             HHH-HHHHHHHhCCccccCCCCCCeEecCCC----CEEEeeccccccc
Q 023270          127 SLT-NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQS  169 (284)
Q Consensus       127 ~i~-~~l~~lh~~gi~H~dl~p~nil~~~~~----~~~l~d~~~~~~~  169 (284)
                      ..+ .-+..+...|++|+|+||.||+++.+|    .++++|||+....
T Consensus       267 ~~v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        267 RGVEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHHHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            111 113344569999999999999999988    9999999987433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=2.2e-13  Score=102.84  Aligned_cols=135  Identities=18%  Similarity=0.251  Sum_probs=107.3

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEeh-----hhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKII-----FKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~-----~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      ..+++|+.+.++.+..  -+.++++|.=     ..+..+..-......+|.+++..++--.+..+.=+..++....++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4678999999998854  3334667653     33444555556777889999999988888888888888889999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      |.+|..|.+.+...       ...++..+=..+..||..||+|||++++||++..++ +.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99998888888775       246667777778999999999999999999996555 999999997533

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=1e-13  Score=122.05  Aligned_cols=149  Identities=19%  Similarity=0.245  Sum_probs=97.6

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH-------------------------------HHHH
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-------------------------------KIQH   64 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-------------------------------~~~~   64 (284)
                      -.+..|. .+.||+|++|.||+|+. .+|+.||||+.........                               +...
T Consensus       115 ~~F~~fd-~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~  192 (437)
T TIGR01982       115 ELFAEFE-EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK  192 (437)
T ss_pred             HHHhhCC-CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence            3444555 36899999999999986 4789999999743211100                               0001


Q ss_pred             ------HHHHHHHHHHhC----CCCcccceeeEE-ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-H
Q 023270           65 ------QLRREMEIQSSL----RHPNILRLYGWF-HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTN-A  131 (284)
Q Consensus        65 ------~~~~~~~~~~~l----~h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~-~  131 (284)
                            .+.+|++.+..+    ++.+-+.+-.++ ...+..++||||++|++|.+..... ...+   ...++..++. .
T Consensus       193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~  269 (437)
T TIGR01982       193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSF  269 (437)
T ss_pred             HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHH
Confidence                  123333333333    232223333333 2234579999999999998876532 1222   2345555555 4


Q ss_pred             HHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270          132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus       132 l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..+|..|++|+|++|.||+++.++.++++|||++...
T Consensus       270 l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       270 LNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            67899999999999999999999999999999987544

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=2.8e-14  Score=124.54  Aligned_cols=254  Identities=21%  Similarity=0.253  Sum_probs=187.2

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEe-cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREV-ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~   91 (284)
                      .-....+|..+..||.|.|+.++.+... .++..|++|...............+ .|..+...+ -|.+.+.....+...
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccc
Confidence            4456778999999999999999987655 6788899999876655554433333 233333333 477888877778888


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~  170 (284)
                      +..|+--|||+++++...+.....+++...+++..|++.++.++|+..++|+|++|+||++..+ +.-+++|++..+...
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence            8888999999998888777665678899999999999999999999999999999999999886 788888988764322


Q ss_pred             CCCccccCCCccc--CccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          171 SKRHTMCGTLDYL--APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       171 ~~~~~~~~~~~y~--aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                      -........-++.  ++.......+..+.|+++||.-+.+..++...-+..+.   ...+..+.  .+..+....++..+
T Consensus       419 ~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~--~p~~~~~~~~~q~~  493 (524)
T KOG0601|consen  419 FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD--TPNLPGLKLQLQVL  493 (524)
T ss_pred             eecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc--ccCCCchHHhhhhh
Confidence            1111112223333  56666677788999999999999999988654332222   11222221  22233455788899


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      ..-++.+++..||++.++..|+-|-
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhcCCccccchhhhhhcccchhh
Confidence            9999999999999999998887553

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.47  E-value=1.9e-12  Score=97.55  Aligned_cols=145  Identities=19%  Similarity=0.182  Sum_probs=113.0

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEe-----hhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKI-----IFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~-----~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      .+..+.+|+.+.|+++.+  .|+.++||.     +..+..+..-..+..++|++.+.++.--.|.-..=++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567889999999998876  566666765     3445555556667888999999988877777777777788888999


Q ss_pred             EeecCC-CchHHHHHhcC-CCCHHH-HHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---CEEEeeccccccc
Q 023270           98 LEYAHR-GELYRELRKHR-RFTEQQ-AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQS  169 (284)
Q Consensus        98 ~e~~~~-~~L~~~l~~~~-~l~~~~-~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~~~l~d~~~~~~~  169 (284)
                      |||.++ .++.+++.... .-..+. ...++.+|=+.+..||.++++||||..+||++.+++   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999986 46777776542 223333 368889999999999999999999999999997765   3589999997544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=3.5e-13  Score=103.93  Aligned_cols=127  Identities=24%  Similarity=0.294  Sum_probs=92.3

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeEEEEEeecC
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      ++.++.|..+.||++..  .+..|++|........    ...+..|+..++.+.+.++ .+++...  ....++|||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence            46789999999999885  4778999997543211    1234567777777755444 3444433  334589999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCeEecCCCCEEEeeccccc
Q 023270          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV-----IHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi-----~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      +.++...    .    ......+.+++.++..||..++     +|||++|+||+++ ++.++++||+.+.
T Consensus        75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            8877643    0    1113456789999999999885     9999999999998 7789999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.37  E-value=2.4e-11  Score=102.58  Aligned_cols=234  Identities=15%  Similarity=0.212  Sum_probs=152.3

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh-CCCCcccceeeE------E-ecCCeE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGW------F-HDDERI   94 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~-l~h~~i~~~~~~------~-~~~~~~   94 (284)
                      ..+.||+|+.+.+|..-..   ..-+.|++.....-..   .   +....+.. -.||-+-.-+.+      . ..+...
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            3567999999999965432   2245677765543221   1   12222322 245433221111      1 122337


Q ss_pred             EEEEeecCCCchHHHH-------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           95 FLILEYAHRGELYREL-------RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l-------~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .++|+..++..--..+       .+.+..+++.+++..+.++.+...||.+|.+-||+.++|+|+++++.|.|+|-....
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence            8888887654322222       223457899999999999999999999999999999999999999999999866432


Q ss_pred             cc--CCCCccccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhC-CCCCCCC-------ChHH-HHH-----
Q 023270          168 QS--RSKRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYG-APPFEAE-------SQKD-TFR-----  226 (284)
Q Consensus       168 ~~--~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg-~~p~~~~-------~~~~-~~~-----  226 (284)
                      ..  +.......|.+.|++||.-+     +..-+..+|.|.||+++++++.| ++||.+-       ...+ .+.     
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            22  22334567888999999765     33456789999999999998875 9999752       2222 111     


Q ss_pred             ---HHHhcC---CCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHh
Q 023270          227 ---RIMKVD---LSFPSAPSISAEAKHLISRLLVK--DSSKRLSLQK  265 (284)
Q Consensus       227 ---~~~~~~---~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~~  265 (284)
                         +...+.   ...+....+++.++.+..+|+..  ++.-|||++.
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence               011111   11111235789999999999974  3568998875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.34  E-value=6.6e-11  Score=102.19  Aligned_cols=212  Identities=18%  Similarity=0.232  Sum_probs=154.6

Q ss_pred             CCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe----cCCeEEEEEeecCC-Cc
Q 023270           31 KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH----DDERIFLILEYAHR-GE  105 (284)
Q Consensus        31 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~----~~~~~~~v~e~~~~-~~  105 (284)
                      --.+.|++....+|..|++|+++-......   ...-.-++.++++.|.|++++.+++.    .+..+++|++|++. ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            456789999999999999999833222211   12234568889999999999999886    44579999999875 34


Q ss_pred             hHHHH---------------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270          106 LYREL---------------RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus       106 L~~~l---------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      |.++-               .++...++..+|.++.|+..||.++|+.|+.-.-|.|.+|+++.+-+++|+.+|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            54432               122346789999999999999999999999989999999999888899999998764333


Q ss_pred             CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCC-CCChHHH-HHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE-AESQKDT-FRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                      ...         .  +   .-.--.+.|.-.||.+++.|.||..--. .....+. ++.+..         ..+.+++++
T Consensus       445 ~d~---------~--~---~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~---------~yS~D~rn~  501 (655)
T KOG3741|consen  445 EDP---------T--E---PLESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT---------TYSTDLRNV  501 (655)
T ss_pred             CCC---------C--c---chhHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh---------hhhHHHHHH
Confidence            221         0  0   0112346799999999999999854321 1222222 222222         578999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~  269 (284)
                      |......++++ -++++++.+
T Consensus       502 v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  502 VEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHhcCccc-ccHHHHHHH
Confidence            99999999887 788888765

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=5.3e-13  Score=118.49  Aligned_cols=149  Identities=23%  Similarity=0.428  Sum_probs=116.1

Q ss_pred             HHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecccccccCCCCcc------------ccCCCcccCccccCCCCC
Q 023270          127 SLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------------MCGTLDYLAPEMVENKEH  193 (284)
Q Consensus       127 ~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~y~aPE~~~~~~~  193 (284)
                      +.+.|+.++|.. +++|++|.|++|.++.++.+||+.|+++....++...            ......|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            444899999976 8999999999999999999999999987554442211            112346999999999889


Q ss_pred             CchhhHhhHHHHHHHHH-hCCCCCCCCChHHHHHH--HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCc
Q 023270          194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRR--IMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  270 (284)
Q Consensus       194 ~~~~Di~slG~il~~l~-tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  270 (284)
                      +.++|+||+|++++.++ .|+..+........+..  .......+..+..+|.++++=+.+++..++.-||++..++..|
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP  266 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence            99999999999999998 67776655433322222  2222223333457999999999999999999999999999999


Q ss_pred             ccccc
Q 023270          271 WIIKN  275 (284)
Q Consensus       271 ~~~~~  275 (284)
                      ||++.
T Consensus       267 ff~D~  271 (700)
T KOG2137|consen  267 FFSDP  271 (700)
T ss_pred             ccCCc
Confidence            99986

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=3.7e-11  Score=96.68  Aligned_cols=139  Identities=17%  Similarity=0.262  Sum_probs=99.5

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc--ccceeeEEecC---CeEEEEEe
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGWFHDD---ERIFLILE   99 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~--i~~~~~~~~~~---~~~~~v~e   99 (284)
                      +.|+.|..+.+|++... +|..+++|........  .....+..|.+++..+.+.+  +.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            56899999999999874 3678999997553321  12346678888888887643  56677766553   36789999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE------------------------------------------  137 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~------------------------------------------  137 (284)
                      ++++.++.+.+.. ..++..+...++.+++.++..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9998877665432 234555556666666666666652                                          


Q ss_pred             --------------CCccccCCCCCCeEecC--CCCEEEeeccccc
Q 023270          138 --------------NHVIHRDIKPENLLLDH--EGRLKIGDFGWSV  167 (284)
Q Consensus       138 --------------~gi~H~dl~p~nil~~~--~~~~~l~d~~~~~  167 (284)
                                    ..++|||++|+||+++.  ++.+.++||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          24689999999999998  6778999999763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=1.1e-10  Score=90.63  Aligned_cols=129  Identities=22%  Similarity=0.342  Sum_probs=83.7

Q ss_pred             EEEEEEecCCceEEEEehhh-----------------------hhHHHHHHHHHHHHHHHHHHhCCCCc--ccceeeEEe
Q 023270           35 VYLVREVESKHPVALKIIFK-----------------------EQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGWFH   89 (284)
Q Consensus        35 v~~~~~~~~~~~v~iK~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~l~h~~--i~~~~~~~~   89 (284)
                      ||.|.. .++..+|+|+...                       ...+........++|.+.|..+...+  +.+++++. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            676665 4666888887431                       11233344578889999999998764  45555432 


Q ss_pred             cCCeEEEEEeecC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           90 DDERIFLILEYAH--RGELYRELRKHRRFTEQQAATYIASLTNALAY-CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        90 ~~~~~~~v~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~-lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                         .-++||||.+  |..+..+....  ++.+....++.+++..+.. +|..|++|||+++.||+++.+ .+.++|||.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa  153 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA  153 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence               3489999998  65665543332  1134556777888885444 689999999999999999877 9999999988


Q ss_pred             cccCC
Q 023270          167 VQSRS  171 (284)
Q Consensus       167 ~~~~~  171 (284)
                      .....
T Consensus       154 v~~~~  158 (188)
T PF01163_consen  154 VDSSH  158 (188)
T ss_dssp             EETTS
T ss_pred             eecCC
Confidence            66543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.23  E-value=9.4e-11  Score=93.97  Aligned_cols=142  Identities=20%  Similarity=0.262  Sum_probs=105.0

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhh-------------------hHHHHHHHHHHHHHHHHHHhCCCC--
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE-------------------QIEKYKIQHQLRREMEIQSSLRHP--   79 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~-------------------~~~~~~~~~~~~~~~~~~~~l~h~--   79 (284)
                      +.+..+||-|..|.||.+.+. .|.++++|.-...                   ..+-.-.....++|.+.|..+...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456788999999999999874 7889999962110                   011123356677889999888765  


Q ss_pred             cccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEE
Q 023270           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        80 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~  159 (284)
                      .+.++++    .+.-.+|||+.++..|...-     ++......++..|+..+...-..|++|||+++-||+++.+|.+.
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            6666666    34679999999986665432     13455556667777777776789999999999999999999999


Q ss_pred             EeecccccccCCC
Q 023270          160 IGDFGWSVQSRSK  172 (284)
Q Consensus       160 l~d~~~~~~~~~~  172 (284)
                      ++||-.+.....+
T Consensus       243 vIDwPQ~v~~~hp  255 (304)
T COG0478         243 VIDWPQAVPISHP  255 (304)
T ss_pred             EEeCcccccCCCC
Confidence            9999877554433

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=5.7e-10  Score=91.81  Aligned_cols=135  Identities=14%  Similarity=0.024  Sum_probs=93.7

Q ss_pred             CCeEEEEEEEecCCceEEEEehhhhhHHH--HH------HHHHHHHHHHHHHhCCCCccc--ceeeEEec-----CCeEE
Q 023270           31 KFGRVYLVREVESKHPVALKIIFKEQIEK--YK------IQHQLRREMEIQSSLRHPNIL--RLYGWFHD-----DERIF   95 (284)
Q Consensus        31 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~------~~~~~~~~~~~~~~l~h~~i~--~~~~~~~~-----~~~~~   95 (284)
                      ....|+++.  -+|+.|.||.........  ..      -...+.+|.+.+..+...+|.  .++.+++.     ....+
T Consensus        34 ~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            333455554  356789999764333211  00      001356777777777544443  34555543     23578


Q ss_pred             EEEeecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-------CCCEEEeeccc
Q 023270           96 LILEYAHRG-ELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-------EGRLKIGDFGW  165 (284)
Q Consensus        96 ~v~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-------~~~~~l~d~~~  165 (284)
                      +|+|++++. +|.+++..  ....+......++.+++..+..||..|++|||++++|||++.       +..+.|+||+-
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            999999875 78888754  234566778899999999999999999999999999999975       45799999997


Q ss_pred             cc
Q 023270          166 SV  167 (284)
Q Consensus       166 ~~  167 (284)
                      +.
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            63

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.10  E-value=2.3e-09  Score=84.30  Aligned_cols=144  Identities=17%  Similarity=0.152  Sum_probs=94.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHH------HHHHHHHHHHhCCC---Cccc
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH------QLRREMEIQSSLRH---PNIL   82 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~------~~~~~~~~~~~l~h---~~i~   82 (284)
                      ....|.-.+|.+.+++.......|.+..  .+++.+++|..............      ...+.+..+..+..   ....
T Consensus        24 l~~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~  101 (229)
T PF06176_consen   24 LGEKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA  101 (229)
T ss_pred             HHHHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence            3445677889999999999988888776  46789999998654432221111      11222332333322   2222


Q ss_pred             ceeeEEe-----cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC
Q 023270           83 RLYGWFH-----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR  157 (284)
Q Consensus        83 ~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~  157 (284)
                      .++-+.+     -....+++|||++|..|.+...    +++    .+...+.+++..+|+.|++|||.+|+|++++.+ .
T Consensus       102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             cceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c
Confidence            2222221     2235678999999988876532    222    244567788999999999999999999999754 4


Q ss_pred             EEEeecccc
Q 023270          158 LKIGDFGWS  166 (284)
Q Consensus       158 ~~l~d~~~~  166 (284)
                      ++++|++-.
T Consensus       173 i~iID~~~k  181 (229)
T PF06176_consen  173 IRIIDTQGK  181 (229)
T ss_pred             EEEEECccc
Confidence            999998754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=2.7e-09  Score=84.91  Aligned_cols=104  Identities=21%  Similarity=0.302  Sum_probs=81.1

Q ss_pred             HHHHHHHHHHHhCCCCc--ccceeeEEecC----CeEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 023270           64 HQLRREMEIQSSLRHPN--ILRLYGWFHDD----ERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCH  136 (284)
Q Consensus        64 ~~~~~~~~~~~~l~h~~--i~~~~~~~~~~----~~~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh  136 (284)
                      ....+|...+..+...+  ..+++++....    ...++|+|+.++ .+|.+++.....++......++.+++..+..||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34556666666664333  34555655442    245899999987 478988887555777888899999999999999


Q ss_pred             hCCccccCCCCCCeEecCCC---CEEEeeccccc
Q 023270          137 ENHVIHRDIKPENLLLDHEG---RLKIGDFGWSV  167 (284)
Q Consensus       137 ~~gi~H~dl~p~nil~~~~~---~~~l~d~~~~~  167 (284)
                      +.|++|+|++++|||+..++   .+.++||+-+.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            99999999999999999887   89999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=99.01  E-value=7.3e-09  Score=82.38  Aligned_cols=143  Identities=17%  Similarity=0.157  Sum_probs=97.2

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---------------------HHHHHHHHHHHHHHhCCCCcc-
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---------------------KIQHQLRREMEIQSSLRHPNI-   81 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~h~~i-   81 (284)
                      ...|+.|..+.||+|.. .++..+|+|++......-.                     ....+..+|++.|.++...++ 
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34688999999999876 5678999999754332211                     223455566666666654432 


Q ss_pred             -cceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEE
Q 023270           82 -LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        82 -~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~  159 (284)
                       .+.+.+.    .-.+||||.+......=....-++..+++..+..++++.+.-|-. .|++||||+.-|||+. ++.+.
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence             3334332    358999998653211111111233444678888899998888777 8999999999999998 89999


Q ss_pred             EeecccccccCCC
Q 023270          160 IGDFGWSVQSRSK  172 (284)
Q Consensus       160 l~d~~~~~~~~~~  172 (284)
                      ++|++.++....+
T Consensus       207 iID~~QaV~~~hp  219 (268)
T COG1718         207 IIDVSQAVTIDHP  219 (268)
T ss_pred             EEECccccccCCC
Confidence            9999998766543

>PRK09902 hypothetical protein; Provisional

Probab=99.00  E-value=6.8e-09  Score=81.35  Aligned_cols=136  Identities=13%  Similarity=0.131  Sum_probs=95.7

Q ss_pred             ccCCCeEEEEEEEecCCceEEEEehhhhhHHH---HHHHHHHHHHHHHHHhCCCCc--ccceeeEEe---cC--CeEEEE
Q 023270           28 GKGKFGRVYLVREVESKHPVALKIIFKEQIEK---YKIQHQLRREMEIQSSLRHPN--ILRLYGWFH---DD--ERIFLI   97 (284)
Q Consensus        28 g~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~~~~~~l~h~~--i~~~~~~~~---~~--~~~~~v   97 (284)
                      |.||-|.|+....  .|+.+.+|.-......+   +.-...+.+|+..+..+...+  +.++. ++.   .+  -.-++|
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5688899997764  33468888753111000   112356778888887775433  34444 332   11  246889


Q ss_pred             EeecCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC--EEEeecccc
Q 023270           98 LEYAHR-GELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWS  166 (284)
Q Consensus        98 ~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~--~~l~d~~~~  166 (284)
                      +|-.++ .+|.+++.+.  .+.+......++.+++.++..||+.|+.|+|+.+.||+++.+|.  +.++||.-+
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            997653 5788877653  34577888899999999999999999999999999999987777  999999854

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.70  E-value=3.2e-07  Score=73.94  Aligned_cols=132  Identities=18%  Similarity=0.198  Sum_probs=81.1

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc--ccceeeEEecCCeEEEEEeecC
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      ..||+|..+.||+.    .+..+++|...... .    ...+.+|.+.++.+..-+  +.+++++...++...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-D----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-C----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            56899999999973    24568899985422 1    234577888888876443  4667887777888899999998


Q ss_pred             CCc-hH--------------HHHHh-------c--CCCCHHHHHHHH-H----------HHHHH-HHHHH----hCCccc
Q 023270          103 RGE-LY--------------RELRK-------H--RRFTEQQAATYI-A----------SLTNA-LAYCH----ENHVIH  142 (284)
Q Consensus       103 ~~~-L~--------------~~l~~-------~--~~l~~~~~~~i~-~----------~i~~~-l~~lh----~~gi~H  142 (284)
                      |.+ +.              ..+..       .  ...+......-+ .          .+... ..+|.    ....+|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            853 11              11111       0  011111111100 0          01111 11111    124689


Q ss_pred             cCCCCCCeEecCCCCEEEeecccc
Q 023270          143 RDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       143 ~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      ||++|.||+++.++ +.++||+.+
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhc
Confidence            99999999999888 999999975

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.69  E-value=3.4e-07  Score=86.66  Aligned_cols=204  Identities=20%  Similarity=0.212  Sum_probs=145.8

Q ss_pred             HHHHHHHHHHHHhCCCCcccceeeEEecCCe----EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 023270           63 QHQLRREMEIQSSLRHPNILRLYGWFHDDER----IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN  138 (284)
Q Consensus        63 ~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~----~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~  138 (284)
                      ......|+..+....|+|+..++.|..+...    ..+..++|+..++...+..-+..+....+.+..+++.++.++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            3445567778888899999999988765543    345567899999999998888999999999999999999999999


Q ss_pred             CccccCCCCC---CeEecCCCCEEEe--ecccccccCCCCc--cccCCCcccCccccCCCCCCc--hhhHhhHHHHHHHH
Q 023270          139 HVIHRDIKPE---NLLLDHEGRLKIG--DFGWSVQSRSKRH--TMCGTLDYLAPEMVENKEHDY--AVDNWTLGILCYEF  209 (284)
Q Consensus       139 gi~H~dl~p~---nil~~~~~~~~l~--d~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~--~~Di~slG~il~~l  209 (284)
                      ...|.-+..+   +.-.+..+.+..+  ||+.+........  ....+..+.+||.......+.  ..|+|++|.....+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            7666655555   4444555666666  7877654443332  223355677888776666554  47999999999998


Q ss_pred             HhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          210 LYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       210 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ..+..+-..   .......+..        ....+..+.+..|+..++++|+++.+++.|+|.+-..+
T Consensus       386 ~~~~~i~~~---~~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  386 SQGEDISEK---SAVPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             hhcCccccc---ccchhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence            876443221   1111111111        12227889999999999999999999999999876543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.69  E-value=2.7e-07  Score=82.35  Aligned_cols=141  Identities=18%  Similarity=0.226  Sum_probs=88.3

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH-------------------------------HHHHHH------HH
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-------------------------------YKIQHQ------LR   67 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-------------------------------~~~~~~------~~   67 (284)
                      ..|+.++-|.|++|+.. +|+.||||+..+.-...                               .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999985 49999999843211100                               011112      22


Q ss_pred             HHHHHHHhC----CCCcccceeeEE-ecCCeEEEEEeecCCCchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023270           68 REMEIQSSL----RHPNILRLYGWF-HDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHENHV  140 (284)
Q Consensus        68 ~~~~~~~~l----~h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi  140 (284)
                      +|...+.++    ++..-+.+-.++ +-.+...++|||++|..+.+..  +. ...+.+.+...+.++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            222222222    122222222333 2234679999999998888774  44 3455444444333322  334445899


Q ss_pred             cccCCCCCCeEecCCCCEEEeeccccccc
Q 023270          141 IHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus       141 ~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +|+|.+|.||++..+|.+.+.|||.....
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecC
Confidence            99999999999999999999999986443

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=2.8e-06  Score=75.86  Aligned_cols=139  Identities=15%  Similarity=0.219  Sum_probs=84.4

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH----------------------------HHHHHHHHHHHHH----
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE----------------------------KYKIQHQLRREME----   71 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----------------------------~~~~~~~~~~~~~----   71 (284)
                      .+.|+..+.|.|++|+... |+.||||+=++.-..                            -.+..+.+..|+.    
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3679999999999999865 999999983211000                            0011122222222    


Q ss_pred             ------HHHhCCCCc------ccceeeEEecCCeEEEEEeecCCCchHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 023270           72 ------IQSSLRHPN------ILRLYGWFHDDERIFLILEYAHRGELYRE--LRKHRRFTEQQAATYIASLTNALAYCHE  137 (284)
Q Consensus        72 ------~~~~l~h~~------i~~~~~~~~~~~~~~~v~e~~~~~~L~~~--l~~~~~l~~~~~~~i~~~i~~~l~~lh~  137 (284)
                            ..+.+.|-+      |.+++..  -.....++|||++|..+.+.  +++.+ ++...+..-+.+...  ..+=.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~  319 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFK  319 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHh
Confidence                  222223333      2333322  23467999999999876544  44433 455544443333322  23345


Q ss_pred             CCccccCCCCCCeEecC----CCCEEEeecccccc
Q 023270          138 NHVIHRDIKPENLLLDH----EGRLKIGDFGWSVQ  168 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~----~~~~~l~d~~~~~~  168 (284)
                      .|++|+|=+|.||++++    ++.+.+.|+|+...
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            78999999999999984    56899999998643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.42  E-value=3.8e-06  Score=68.69  Aligned_cols=74  Identities=20%  Similarity=0.182  Sum_probs=48.9

Q ss_pred             eccCCC-eEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEEEeecCCC
Q 023270           27 LGKGKF-GRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        27 lg~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      |..|.. +.||++..  .+..+++|......      ...+.+|+++++.+. +-.+.+++.+...++..++|||+.+|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            334444 78898864  34688899975432      124456777776664 234556777776666789999999887


Q ss_pred             chHH
Q 023270          105 ELYR  108 (284)
Q Consensus       105 ~L~~  108 (284)
                      ++..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=1.2e-05  Score=64.85  Aligned_cols=78  Identities=26%  Similarity=0.300  Sum_probs=52.2

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCC--cccceeeEEe---cCCeEEEEE
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP--NILRLYGWFH---DDERIFLIL   98 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~--~i~~~~~~~~---~~~~~~~v~   98 (284)
                      ++.++.|..+.+|++....  ..+++|.....     .....+..|..+++.+...  .+.+++....   .....++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5678999999999998654  58999997554     1224555666666666433  3455665332   234579999


Q ss_pred             eecCCCchHH
Q 023270           99 EYAHRGELYR  108 (284)
Q Consensus        99 e~~~~~~L~~  108 (284)
                      +++++.++..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999877766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.39  E-value=1e-05  Score=63.17  Aligned_cols=95  Identities=24%  Similarity=0.300  Sum_probs=74.9

Q ss_pred             HHHHHHHhCCC-CcccceeeEEecCCeEEEEEeecCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 023270           68 REMEIQSSLRH-PNILRLYGWFHDDERIFLILEYAHRGELYRE---LRKHRRFTEQQAATYIASLTNALAYCHE---NHV  140 (284)
Q Consensus        68 ~~~~~~~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~~i~~~l~~lh~---~gi  140 (284)
                      .|.-+++.+.+ +++++++|+|.    .+++.|+.+.+++...   +.+--..++..+..++.++++.+.+++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            46677777776 69999999882    3778999876655421   1111234899999999999999999997   346


Q ss_pred             cccCCCCCCeEecCCCCEEEeecccc
Q 023270          141 IHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       141 ~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .-+|++|+|+-++.++.++++|....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhc
Confidence            67999999999999999999999875

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.28  E-value=1.2e-05  Score=60.93  Aligned_cols=131  Identities=19%  Similarity=0.203  Sum_probs=92.7

Q ss_pred             EeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccc-eeeEEecCCeEEEEEee
Q 023270           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR-LYGWFHDDERIFLILEY  100 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~-~~~~~~~~~~~~~v~e~  100 (284)
                      ++.+.|+.|+.|.||++..  .+..+++|+-..++     ....+..|.+++..+.-.++-+ ++.|.    ..++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence            4667899999999999986  45588888864432     2357788889888887666544 44433    23555999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCCeEecCCCCEEEeecccccccC
Q 023270          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK-PENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~-p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      .+|.+|.+.....   +.    ..+..+++...-|-..||-|+.|+ |...++..++.+.|+||..++...
T Consensus        94 i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          94 IDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             hcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            9988887765432   22    333456666677888899999986 566666677799999999886443

>PLN02876 acyl-CoA dehydrogenase

Probab=98.25  E-value=1.6e-05  Score=76.20  Aligned_cols=81  Identities=19%  Similarity=0.308  Sum_probs=55.7

Q ss_pred             eeeeeccCCCeEEEEEEEecCC--ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcc--cceeeEEecC---CeE
Q 023270           23 IGRPLGKGKFGRVYLVREVESK--HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNI--LRLYGWFHDD---ERI   94 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i--~~~~~~~~~~---~~~   94 (284)
                      .++.++.|.++.+|++.....+  ..+++|+........  ....+.+|+++++.+. |.++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            4677899999999998765433  468888864432111  1235778888998885 5554  6667766554   467


Q ss_pred             EEEEeecCCCc
Q 023270           95 FLILEYAHRGE  105 (284)
Q Consensus        95 ~~v~e~~~~~~  105 (284)
                      |+|||++++..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            99999998754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.25  E-value=1.1e-06  Score=72.83  Aligned_cols=138  Identities=18%  Similarity=0.260  Sum_probs=97.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-------------------HHHHHHHHHHHHHHHHHhCCC--
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-------------------EKYKIQHQLRREMEIQSSLRH--   78 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~h--   78 (284)
                      -+.+...||-|..+-||.+.+ ..|.+.++|.-.....                   |-.-..-...+|...|+.+..  
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            367888999999999999886 5677888885321111                   111222344567777777754  


Q ss_pred             CcccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCE
Q 023270           79 PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        79 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~  158 (284)
                      -.+.+.+++    +.-++|||+..+-+|...-.      ...+..+...+...+.-|..+|++|||+.--||++..++.+
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            344555553    35789999998877764321      22334566677777888899999999999999999999999


Q ss_pred             EEeecccccc
Q 023270          159 KIGDFGWSVQ  168 (284)
Q Consensus       159 ~l~d~~~~~~  168 (284)
                      +++||-....
T Consensus       242 ~vIDFPQmvS  251 (465)
T KOG2268|consen  242 VVIDFPQMVS  251 (465)
T ss_pred             EEeechHhhc
Confidence            9999986533

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.18  E-value=2.4e-05  Score=66.11  Aligned_cols=146  Identities=22%  Similarity=0.240  Sum_probs=101.1

Q ss_pred             EeeeeeccCCCeEEEEEEEecCCceEEEEehhhhh-----------------------HHHHHHHHHHHHHHHHHHhCCC
Q 023270           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-----------------------IEKYKIQHQLRREMEIQSSLRH   78 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~l~h   78 (284)
                      .+-..|+.|..+.||.|.. .+|..+|||++..+-                       ....-..-+...|++.+.++..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3445688999999999875 567779999864111                       1111223456678888888877


Q ss_pred             CcccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeEecCCCC
Q 023270           79 PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGR  157 (284)
Q Consensus        79 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh-~~gi~H~dl~p~nil~~~~~~  157 (284)
                      .+|...--+...  .-.+||+++....-..-....-.++...+..+..+++..+.-|- ..++||.||+--|+|+ .+|.
T Consensus       226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            666554433322  34789999865433333334446777888888888887776654 5699999999999999 7899


Q ss_pred             EEEeecccccccCC
Q 023270          158 LKIGDFGWSVQSRS  171 (284)
Q Consensus       158 ~~l~d~~~~~~~~~  171 (284)
                      +.++|.+.+.....
T Consensus       303 lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  303 LYIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEEccccccCCC
Confidence            99999988754433

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.10  E-value=2.7e-05  Score=63.30  Aligned_cols=29  Identities=31%  Similarity=0.422  Sum_probs=24.8

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .+++|||+++.||+++.++..-++||+.+
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            35899999999999987666679999975

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.08  E-value=6.8e-07  Score=79.78  Aligned_cols=241  Identities=17%  Similarity=0.133  Sum_probs=157.7

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc-ccceeeEEecCCeEEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~-i~~~~~~~~~~~~~~~v~   98 (284)
                      -|...+.++.++.+.+++.+...+.... .+.+...        ...+-+++++.+++||| .+..++-+..+....+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            3555666788888999888765554333 4444222        24456788999999999 455555555667889999


Q ss_pred             eecCCC-chH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--Cc
Q 023270           99 EYAHRG-ELY-RELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RH  174 (284)
Q Consensus        99 e~~~~~-~L~-~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~  174 (284)
                      ++++++ +.. ..-...-.+..-+...+.+.-+.+++++|+.--+|+|    ||+. .++..+..+++........  ..
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~~~~  388 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTMKPR  388 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCcccccc
Confidence            999877 222 1111112344455556667777889999988656776    6665 4478889999876443333  45


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC-----H-HHHHH
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS-----A-EAKHL  248 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~l~~l  248 (284)
                      ...+++.++|||+.....++.+.|.|+++.-..++.-|.+|-..+...     .......+..+.-.+     + .-+++
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~-----~~~~g~~p~s~~L~~~~aw~~~~~~~~  463 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV-----LPMIGNGPNSPMLTDKSAWSPVFHRDF  463 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc-----cCCCCCCCCccccchhhhcCcccccCC
Confidence            566889999999999999999999999998666666666554331000     000000000000000     1 11246


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      ...|+...|..|+....++-|.+|-.|+...
T Consensus       464 ~~~~~~g~P~~pkv~mgacfsKvfngCpl~i  494 (829)
T KOG0576|consen  464 PAPCLNGLPPTPKVHMGACFSKVFNGCPLRI  494 (829)
T ss_pred             cccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence            7789999999999999999999999997754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.06  E-value=6.4e-05  Score=61.00  Aligned_cols=75  Identities=20%  Similarity=0.250  Sum_probs=45.5

Q ss_pred             eeeeccCCCeEEEEEEEec-CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeEEEEEeec
Q 023270           24 GRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYA  101 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~~~v~e~~  101 (284)
                      ++.|..|-...+|++.... .++.|++|+.......    .-...+|+.+++.+...++ .+++....  +  .+++||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4677888888999887543 3568999987432111    1122356777777654444 33433322  2  4799999


Q ss_pred             CCCch
Q 023270          102 HRGEL  106 (284)
Q Consensus       102 ~~~~L  106 (284)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            87665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=0.00028  Score=59.38  Aligned_cols=136  Identities=19%  Similarity=0.174  Sum_probs=78.6

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc--ccceee------EEecCCeE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYG------WFHDDERI   94 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~--i~~~~~------~~~~~~~~   94 (284)
                      -.+.+..|....+|++..  ++..+++|++....      ...+..|++++..+.+.+  +.+++.      +...++..
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKVS------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCCCC------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            356777888889998864  34578999875411      123445666666554322  333333      12334567


Q ss_pred             EEEEeecCCCchHH----HH----------Hhc-CCC----------CHHHH----------HHHHHHHHHHHHHHHh--
Q 023270           95 FLILEYAHRGELYR----EL----------RKH-RRF----------TEQQA----------ATYIASLTNALAYCHE--  137 (284)
Q Consensus        95 ~~v~e~~~~~~L~~----~l----------~~~-~~l----------~~~~~----------~~i~~~i~~~l~~lh~--  137 (284)
                      ++|+++.+|.++..    ..          ... ..+          .+...          ......+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999998765421    11          000 000          00000          0011112333444443  


Q ss_pred             -----CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 -----NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 -----~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                           .+++|||++|.||+++.++.+.|+||+.+
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence                 47999999999999998887899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.90  E-value=0.00024  Score=55.56  Aligned_cols=128  Identities=20%  Similarity=0.262  Sum_probs=85.6

Q ss_pred             cCcEeeeeeccCCC-eEEEEEEEecCCceEEEEehhh---hhH-------H-H-------HHHHHHHHHHHHHHHhC---
Q 023270           19 QDFEIGRPLGKGKF-GRVYLVREVESKHPVALKIIFK---EQI-------E-K-------YKIQHQLRREMEIQSSL---   76 (284)
Q Consensus        19 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~v~iK~~~~---~~~-------~-~-------~~~~~~~~~~~~~~~~l---   76 (284)
                      .+++.++.||+|.- |.||++..  +|..||+|.+..   ...       . .       .....-+..|.+...++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 99999985  677999999321   000       0 0       01123445555555544   


Q ss_pred             CCCcc--cceeeEEecC------------------CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 023270           77 RHPNI--LRLYGWFHDD------------------ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH  136 (284)
Q Consensus        77 ~h~~i--~~~~~~~~~~------------------~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh  136 (284)
                      .+.++  ++.+++..-.                  -...||.||.+...         .++...    +.+|++-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            45566  8888886211                  13577888776543         223333    456666688899


Q ss_pred             hCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       137 ~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      +.||+-+|+++.|..   +  -+|+||+.+
T Consensus       182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---C--CEEEecccC
Confidence            999999999999986   3  378888753

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.90  E-value=0.00045  Score=54.31  Aligned_cols=131  Identities=21%  Similarity=0.333  Sum_probs=87.1

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-------------HHHHHHHHHHHHHHHHHhCC------CCcccce
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-------------EKYKIQHQLRREMEIQSSLR------HPNILRL   84 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~~~~~~~~~~~~~l~------h~~i~~~   84 (284)
                      ...||+|+.=.+|.--   .....+||+......             ......+..++|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4568899988888332   334567888866550             00011234445555444444      7899999


Q ss_pred             eeEEecCCeEEEEEeecC------CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC--
Q 023270           85 YGWFHDDERIFLILEYAH------RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG--  156 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~------~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~--  156 (284)
                      +|+.+.+.-..+|+|...      ..+|.++++.. .++. .....+.   +-..+|-+++|+..|++|.||++..++  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999999988899998642      23678877553 4555 4444443   445577889999999999999996543  


Q ss_pred             --CEEEee
Q 023270          157 --RLKIGD  162 (284)
Q Consensus       157 --~~~l~d  162 (284)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.89  E-value=6e-05  Score=62.09  Aligned_cols=132  Identities=15%  Similarity=0.171  Sum_probs=73.6

Q ss_pred             eeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeEEEEEeecCCC
Q 023270           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYAHRG  104 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~  104 (284)
                      .+..|-.+.+|++.  .++..+++|........-   .-...+|.++++.+...++ .+++...  +  -++|+||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence            46678888999886  456788899864321110   0123467777777754433 3344332  2  36899999876


Q ss_pred             chHH--------------HHH---hcC----CCCHHH-HHHHHHHH---------HHHHHHHHh--------CCccccCC
Q 023270          105 ELYR--------------ELR---KHR----RFTEQQ-AATYIASL---------TNALAYCHE--------NHVIHRDI  145 (284)
Q Consensus       105 ~L~~--------------~l~---~~~----~l~~~~-~~~i~~~i---------~~~l~~lh~--------~gi~H~dl  145 (284)
                      ++..              .+.   +..    +++... +..+..++         ...+..+..        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5431              111   111    112111 11111111         111222221        24899999


Q ss_pred             CCCCeEecCCCCEEEeeccccc
Q 023270          146 KPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       146 ~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .|.||+++.++ +.++||+.+.
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccC
Confidence            99999998877 7899999863

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.78  E-value=0.0011  Score=57.93  Aligned_cols=82  Identities=18%  Similarity=0.219  Sum_probs=50.9

Q ss_pred             EeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH--HH--HHHHHHHHHHHHHHHhCC---CCcccceeeEEecCCeE
Q 023270           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EK--YKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERI   94 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~--~~~~~~~~~~~~~~~~l~---h~~i~~~~~~~~~~~~~   94 (284)
                      .-.+.||.|..+.||++.+..+++.++||.-.....  ..  ....+....|.+.+..+.   ..++++++.+  +.+..
T Consensus        29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~  106 (401)
T PRK09550         29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA  106 (401)
T ss_pred             ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence            345789999999999999854445899998532100  00  011234445556565542   2455666665  44667


Q ss_pred             EEEEeecCCCc
Q 023270           95 FLILEYAHRGE  105 (284)
Q Consensus        95 ~~v~e~~~~~~  105 (284)
                      ++|||++++..
T Consensus       107 ~lVME~L~~~~  117 (401)
T PRK09550        107 VTVMEDLSDHK  117 (401)
T ss_pred             EEEEecCCCcc
Confidence            89999987643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.77  E-value=0.00011  Score=64.74  Aligned_cols=162  Identities=15%  Similarity=0.180  Sum_probs=105.0

Q ss_pred             HHHHHHHHHHhCCCCcccceeeEEecC-CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023270           65 QLRREMEIQSSLRHPNILRLYGWFHDD-ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR  143 (284)
Q Consensus        65 ~~~~~~~~~~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~  143 (284)
                      .+.-..++++.+.|++....+++-... ....+|+|+++ .||.+.+..+. +-.....                  +|+
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~------------------~~~   87 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL------------------AHG   87 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc------------------ccc
Confidence            455677889999999999988876533 35788999996 59999887654 2211111                  232


Q ss_pred             CCCCCCeEecCCCCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH
Q 023270          144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD  223 (284)
Q Consensus       144 dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~  223 (284)
                      -+ +-|++       +.+| .+....                    .....+++|||++|.++.++.-|...+......+
T Consensus        88 ~~-~~~~~-------~~td-~~~t~~--------------------~~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~  138 (725)
T KOG1093|consen   88 VL-HLNII-------YITD-HFLTKY--------------------PSPIGPKSDVWSLGFIILELYLGISLEAELTESE  138 (725)
T ss_pred             cc-eehhh-------hccc-cccccC--------------------CCCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHH
Confidence            11 11222       2222 111111                    0111259999999999999999987777666666


Q ss_pred             HHHHHHhcCCCCCCCC----------CCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          224 TFRRIMKVDLSFPSAP----------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~----------~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ....+.+-........          ..+.-+.++...|+...|..||...++.+++-|.+.
T Consensus       139 ~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  139 YLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            6655554321111110          235567788999999999999999999999888764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.75  E-value=0.00022  Score=60.18  Aligned_cols=76  Identities=22%  Similarity=0.235  Sum_probs=45.2

Q ss_pred             eeeeccCCCeEEEEEEEec------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeEEE
Q 023270           24 GRPLGKGKFGRVYLVREVE------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFL   96 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~~~   96 (284)
                      ++.+..|-...+|++....      .++.|++|+.......    .....+|.++++.+...++ .+++.++. +   ..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            4567778888899887543      2578999997543211    1234466666666654333 34455443 2   35


Q ss_pred             EEeecCCCchH
Q 023270           97 ILEYAHRGELY  107 (284)
Q Consensus        97 v~e~~~~~~L~  107 (284)
                      |+||++|.++.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            78888776553

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.66  E-value=0.0017  Score=55.27  Aligned_cols=29  Identities=28%  Similarity=0.413  Sum_probs=25.4

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .|++|||++|.||+++.+...-++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccc
Confidence            48999999999999986666689999976

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.56  E-value=0.0021  Score=54.49  Aligned_cols=143  Identities=17%  Similarity=0.177  Sum_probs=78.9

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc--ccceeeE------E
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGW------F   88 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~--i~~~~~~------~   88 (284)
                      .+....-.+.++.|....+|++..  ++..+++|.+..... .    ..+..+++++..+...+  +.+++..      .
T Consensus        20 ~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~-~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~   92 (307)
T TIGR00938        20 DLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK-A----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLS   92 (307)
T ss_pred             CCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCCC-H----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence            334455567788888889998864  344688898744211 1    12334445555543222  3333331      1


Q ss_pred             ecCCeEEEEEeecCCCchH----H-------HH---Hh-cCCC--------CHHH-----HH----------HHHHHHHH
Q 023270           89 HDDERIFLILEYAHRGELY----R-------EL---RK-HRRF--------TEQQ-----AA----------TYIASLTN  130 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~----~-------~l---~~-~~~l--------~~~~-----~~----------~i~~~i~~  130 (284)
                      ..++..+++++|++|.++.    .       .+   .. ...+        ....     ..          .....+..
T Consensus        93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~  172 (307)
T TIGR00938        93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK  172 (307)
T ss_pred             hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence            2345678999998874421    1       11   10 0000        0000     00          00111223


Q ss_pred             HHHHHH-------hCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          131 ALAYCH-------ENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       131 ~l~~lh-------~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .+.++.       ..+++|||+++.||+++.++...++||+.+
T Consensus       173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            444443       258999999999999998887789999975

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.33  E-value=0.0028  Score=54.30  Aligned_cols=76  Identities=17%  Similarity=0.193  Sum_probs=44.1

Q ss_pred             eeccCCCeEEEEEEEecCCceEEEEehhhhhH--HH--HHHHHHHHHHHHHHHhCC--CC-cccceeeEEecCCeEEEEE
Q 023270           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EK--YKIQHQLRREMEIQSSLR--HP-NILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~--~~~~~~~~~~~~~~~~l~--h~-~i~~~~~~~~~~~~~~~v~   98 (284)
                      .||.|....||++.+..+++.++||.-.....  +.  +-......-|...|+...  .| .+++++.  .+++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            57999999999999754446799997532111  00  111233334555555443  23 3333333  3556667899


Q ss_pred             eecCC
Q 023270           99 EYAHR  103 (284)
Q Consensus        99 e~~~~  103 (284)
                      |+.+.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            98854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.30  E-value=0.0029  Score=53.37  Aligned_cols=147  Identities=15%  Similarity=0.259  Sum_probs=83.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc--cceeeEEecCC--eE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI--LRLYGWFHDDE--RI   94 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i--~~~~~~~~~~~--~~   94 (284)
                      ....++..+..|....+|...+.  ++.++++ ... ............+|+..++.+..-.+  ...++++.++.  ..
T Consensus        25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p  100 (321)
T COG3173          25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP  100 (321)
T ss_pred             CCCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence            44556666667777777776654  7889999 321 11122234566678888887754333  33344444443  56


Q ss_pred             EEEEeecCCCchH------------------HHHHh---cC-----C------CCHHHHHHHHHHH--------------
Q 023270           95 FLILEYAHRGELY------------------RELRK---HR-----R------FTEQQAATYIASL--------------  128 (284)
Q Consensus        95 ~~v~e~~~~~~L~------------------~~l~~---~~-----~------l~~~~~~~i~~~i--------------  128 (284)
                      |.||+|.+|..+.                  +.|..   -+     .      ....++..+..+.              
T Consensus       101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            9999999873221                  11110   00     0      0111111111111              


Q ss_pred             HHHHHHHHhC--------CccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270          129 TNALAYCHEN--------HVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus       129 ~~~l~~lh~~--------gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      .....+++.+        .++|||+++.|+++++++-+=++||+.+...
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            1223344432        4799999999999999998999999987443

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.16  E-value=0.0064  Score=53.09  Aligned_cols=76  Identities=13%  Similarity=0.135  Sum_probs=47.1

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-----HHHHHHHHHHHHHHHHHhCC---CCcccceeeEEecCCeE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERI   94 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~~~~~~~~~~l~---h~~i~~~~~~~~~~~~~   94 (284)
                      ..+.||.|....||++.+  .+..++||.-.....     +.- .......|++.|+.+.   ..++.+++.++.  +..
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl-~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~  110 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPM-TKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA  110 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccC-CccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence            577889999999999886  345699998651111     000 1122223445554443   346677777665  446


Q ss_pred             EEEEeecCC
Q 023270           95 FLILEYAHR  103 (284)
Q Consensus        95 ~~v~e~~~~  103 (284)
                      +++||++++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            788999976

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.06  E-value=0.0068  Score=50.49  Aligned_cols=29  Identities=24%  Similarity=0.516  Sum_probs=24.0

Q ss_pred             CccccCCCCCCeEecCCCC-EEEeeccccc
Q 023270          139 HVIHRDIKPENLLLDHEGR-LKIGDFGWSV  167 (284)
Q Consensus       139 gi~H~dl~p~nil~~~~~~-~~l~d~~~~~  167 (284)
                      .++|||++|.||+++.++. .-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            4799999999999987554 5699999763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.05  E-value=0.0062  Score=51.90  Aligned_cols=108  Identities=18%  Similarity=0.235  Sum_probs=71.3

Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      +..+.|++|++.. +++.. ++   .-..+++..++.+.+..+.-+... ..-|+|++..||+++ .|+|.|+||.+++-
T Consensus       297 e~~y~yl~~kdhg-t~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDHG-TPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecCC-ceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            4457788999874 45442 22   235788889999988888777755 578999999999998 99999999998853


Q ss_pred             cCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHH
Q 023270          169 SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILC  206 (284)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  206 (284)
                      ..+...  .--...-.|-.+. +.-+..-+||-+.-.+
T Consensus       371 ~~~q~~--isy~rldhp~lF~-G~dd~QFeIYrlMr~l  405 (488)
T COG5072         371 SYSQGI--ISYNRLDHPDLFN-GVDDYQFEIYRLMRRL  405 (488)
T ss_pred             ccCCce--eeccccCchhhhc-CccceeeeHHHHHHHH
Confidence            222110  1111123444444 3446677777754443

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.03  E-value=0.023  Score=48.17  Aligned_cols=29  Identities=14%  Similarity=0.168  Sum_probs=26.7

Q ss_pred             CccccCCCCCCeEecCCCCEEEeeccccc
Q 023270          139 HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       139 gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      +++|||+.++||+++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.97  E-value=0.0059  Score=52.27  Aligned_cols=28  Identities=36%  Similarity=0.637  Sum_probs=24.8

Q ss_pred             ccccCCCCCCeEecC-CCCEEEeeccccc
Q 023270          140 VIHRDIKPENLLLDH-EGRLKIGDFGWSV  167 (284)
Q Consensus       140 i~H~dl~p~nil~~~-~~~~~l~d~~~~~  167 (284)
                      .+|+|+.+.||++++ ++.++++||+++.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            699999999999975 4789999999873

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.96  E-value=0.0074  Score=48.14  Aligned_cols=78  Identities=18%  Similarity=0.262  Sum_probs=52.7

Q ss_pred             EeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC---CCCcccceeeEEecCCeEEEEE
Q 023270           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l---~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +..+.+..|.--.-|.+.+  ...++.+|+-..+.      ...+..|+.-++.+   +.-.+.+++....+.++.|+|+
T Consensus        19 ~er~~v~gG~inea~~v~d--g~~~~FvK~n~~~~------~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl   90 (286)
T COG3001          19 KEREEVSGGDINEAWRLRD--GTDPFFVKCNQREQ------LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL   90 (286)
T ss_pred             hcccccCCccccceeEeec--CCcceEEEecchhh------HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence            3445566777777776654  55678899853332      23444555544444   4456778888888899999999


Q ss_pred             eecCCCchH
Q 023270           99 EYAHRGELY  107 (284)
Q Consensus        99 e~~~~~~L~  107 (284)
                      ||.+.+++.
T Consensus        91 e~L~~~~~d   99 (286)
T COG3001          91 EYLPTGPLD   99 (286)
T ss_pred             eeccCCCCC
Confidence            999876654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.95  E-value=0.00016  Score=71.24  Aligned_cols=262  Identities=11%  Similarity=-0.013  Sum_probs=155.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH--HHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ....|.+..+++.=-++-+..+.--..+.+.++  +.+++...-.++.-  ...+-...+..-.+...|+++.....=..
T Consensus      1222 skM~s~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ 1299 (2724)
T KOG1826|consen 1222 SKMFSAMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIP 1299 (2724)
T ss_pred             HHHHHHhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCC
Confidence            345667777777777766665543222222222  33444322222211  11122222223344456766655443222


Q ss_pred             --cCCeEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-C----ccccCCCCCCeEecCCCCE
Q 023270           90 --DDERIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHEN-H----VIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        90 --~~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~-g----i~H~dl~p~nil~~~~~~~  158 (284)
                        +....+.+++++.+|.+.+.|-++    +.++...+.....+.+....-+|.. +    .+|.++++-|.++..+-++
T Consensus      1300 ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v 1379 (2724)
T KOG1826|consen 1300 PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNV 1379 (2724)
T ss_pred             CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcc
Confidence              223568899999999999988554    3444444444444434444444432 2    5789999999999999999


Q ss_pred             EEeecccccccCCCC---ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 023270          159 KIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF  235 (284)
Q Consensus       159 ~l~d~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  235 (284)
                      +++++|+.+...+..   ....+++.|+.|++...-.++.++|+|..|+-++.+.-|..+|-.-... .+..+......+
T Consensus      1380 ~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~tf~ 1458 (2724)
T KOG1826|consen 1380 KLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNHTFF 1458 (2724)
T ss_pred             cccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHH-HHcCcccccccc
Confidence            999999986332221   3345677889999988888888899999999999888776555322221 112222222222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ..+...|.+.....-.+|...-..||.-...+.-+.|.-..
T Consensus      1459 sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1459 SIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGL 1499 (2724)
T ss_pred             cccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccccc
Confidence            22223355555555666666777889888888888876553

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.92  E-value=0.0058  Score=51.09  Aligned_cols=75  Identities=19%  Similarity=0.295  Sum_probs=44.7

Q ss_pred             EeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC---CCCcccceeeEEecCCeEEEEE
Q 023270           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l---~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      +-.+.++.|..+.+|++.  .+++.+.+|+-.....      ..+..|..-++.+   ..-.+.+++.+....+..++|+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhH------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            345668899999999877  6788899999753221      2344555555555   4556788888887777779999


Q ss_pred             eecCCC
Q 023270           99 EYAHRG  104 (284)
Q Consensus        99 e~~~~~  104 (284)
                      ||.+.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.85  E-value=0.01  Score=51.58  Aligned_cols=79  Identities=15%  Similarity=0.169  Sum_probs=46.6

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH--H-HHHHHHHHHHHHHHHhCC--CC-cccceeeEEecCCeEEE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--K-YKIQHQLRREMEIQSSLR--HP-NILRLYGWFHDDERIFL   96 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~-~~~~~~~~~~~~~~~~l~--h~-~i~~~~~~~~~~~~~~~   96 (284)
                      ..+.||.|.-.-||++.+..+++.++||--..-...  + +-..+...-|...|+...  .| ++++++.  .+++...+
T Consensus        33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~  110 (409)
T PRK12396         33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCC  110 (409)
T ss_pred             eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhH
Confidence            477899999999999997444567999864321110  0 111233444555555442  23 3444444  34556678


Q ss_pred             EEeecCC
Q 023270           97 ILEYAHR  103 (284)
Q Consensus        97 v~e~~~~  103 (284)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            8888753

>PLN02236 choline kinase

Probab=96.79  E-value=0.0074  Score=51.98  Aligned_cols=139  Identities=16%  Similarity=0.196  Sum_probs=76.5

Q ss_pred             cEeeeeeccCCCeEEEEEEEec----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccc-ceeeEEecCCeEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVE----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL-RLYGWFHDDERIF   95 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~-~~~~~~~~~~~~~   95 (284)
                      ..-++.+..|-...+|++....    .++.|++|+......   ...+ -.+|..+++.+...++- ++++.+..+    
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----  109 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----  109 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeec-hHHHHHHHHHHHHcCCCCceEEEECCc----
Confidence            4445566678888999987432    246799998754321   1111 14566666666544443 455555332    


Q ss_pred             EEEeecCCCchHHH----------H----H---hcC-C----C-CHHHHHHHHHH-----------------HHHHHHHH
Q 023270           96 LILEYAHRGELYRE----------L----R---KHR-R----F-TEQQAATYIAS-----------------LTNALAYC  135 (284)
Q Consensus        96 ~v~e~~~~~~L~~~----------l----~---~~~-~----l-~~~~~~~i~~~-----------------i~~~l~~l  135 (284)
                      .|.+|+++.++...          +    +   +.. +    . ..+.+..++.+                 +...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            47888776554311          1    0   000 0    0 11222222211                 11111111


Q ss_pred             ----H----hCCccccCCCCCCeEecC-CCCEEEeeccccc
Q 023270          136 ----H----ENHVIHRDIKPENLLLDH-EGRLKIGDFGWSV  167 (284)
Q Consensus       136 ----h----~~gi~H~dl~p~nil~~~-~~~~~l~d~~~~~  167 (284)
                          .    ...++|+|+++.||+++. ++.+.++||.++.
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                1    225899999999999976 4789999999863

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.48  E-value=0.066  Score=45.76  Aligned_cols=27  Identities=22%  Similarity=0.272  Sum_probs=22.9

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .+++|||+.+.||+++ + .+.++||+-+
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence            4689999999999995 4 5789999965

>PRK10593 hypothetical protein; Provisional

Probab=96.40  E-value=0.026  Score=47.56  Aligned_cols=106  Identities=10%  Similarity=0.045  Sum_probs=67.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC---CcccceeeEEec---CCe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH---PNILRLYGWFHD---DER   93 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h---~~i~~~~~~~~~---~~~   93 (284)
                      .-.-.+.||.|..+.||.....  +..+++|...... .    ...+..|...++.+..   -.+.++++++..   .+.
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~-~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARSFS-T----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC--CCCEEEEEecccc-c----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            3445667999999999988642  2357777753210 1    1356677777777753   356777776643   367


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE  137 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~  137 (284)
                      .++|||+.++.++.+.     ..+......+..++++++..||+
T Consensus        88 ~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         88 DVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             eEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence            8999999998776541     12233344555566666666665

>PTZ00384 choline kinase; Provisional

Probab=95.95  E-value=0.029  Score=49.02  Aligned_cols=29  Identities=21%  Similarity=0.150  Sum_probs=24.1

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ...+|.|+.+.||+.+ ++.+.++||.++.
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence            4579999999999875 4569999999873

>PTZ00296 choline kinase; Provisional

Probab=95.76  E-value=0.096  Score=46.69  Aligned_cols=28  Identities=25%  Similarity=0.456  Sum_probs=23.6

Q ss_pred             CccccCCCCCCeEecCCCCEEEeeccccc
Q 023270          139 HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       139 gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .++|+|+.+.||+.+.+ .++|+||.++.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            47999999999987644 49999999873

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.75  E-value=0.05  Score=43.35  Aligned_cols=115  Identities=21%  Similarity=0.236  Sum_probs=66.5

Q ss_pred             CCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecCCCchHHH
Q 023270           30 GKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRE  109 (284)
Q Consensus        30 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~  109 (284)
                      ++-++.-.++...  .+.++|++..-...-  ....++.+.+++.+++  +|+++..  ...-.+.++.|+|-.....  
T Consensus        73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i~--  142 (308)
T PF07387_consen   73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKIN--  142 (308)
T ss_pred             CCceEEEEecccc--chhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcccc--
Confidence            3444444443322  345566654332221  1234566677776554  3555542  1333678899998542111  


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCeEecCCCCEEEeeccc
Q 023270          110 LRKHRRFTEQQAATYIASLTNALAYCHEN--HVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus       110 l~~~~~l~~~~~~~i~~~i~~~l~~lh~~--gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                             .    ..++..=+.+|.-.|+.  +..|||..|+|||-+..|.+||.|=+.
T Consensus       143 -------~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  143 -------F----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             -------h----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence                   1    11112224556677843  689999999999999999999999664

The function of this family is unknown.

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.62  E-value=0.0083  Score=50.39  Aligned_cols=75  Identities=17%  Similarity=0.225  Sum_probs=54.1

Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC-HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~l-h~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      -.+||-|....-+..--..+-.|+.++......|+..++..| |+.-++|-|++--|+|+..+ .+.++|...+...
T Consensus       358 hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsvep  433 (531)
T KOG2269|consen  358 HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG-KVWVIDVSQSVEP  433 (531)
T ss_pred             ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC-ceEEEechhccCC
Confidence            467888875332222111223478888888889999888776 46689999999999999776 8889998766433

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.55  E-value=0.024  Score=46.95  Aligned_cols=44  Identities=30%  Similarity=0.444  Sum_probs=33.9

Q ss_pred             HHHHHHHHHHHHHhC--CccccCCCCCCeEecCCCCEEEeeccccc
Q 023270          124 YIASLTNALAYCHEN--HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       124 i~~~i~~~l~~lh~~--gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .+..+-.++.-++..  -++|+|+.|+|++.++.+.++|+||.++.
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            344444444444444  48999999999999999999999999874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.17  E-value=0.05  Score=46.05  Aligned_cols=28  Identities=25%  Similarity=0.440  Sum_probs=24.6

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .+++|||+++.||+++. +.+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            47899999999999987 67899999864

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.06  E-value=0.019  Score=44.61  Aligned_cols=27  Identities=26%  Similarity=0.517  Sum_probs=24.2

Q ss_pred             ccccCCCCCCeEecCCCCEEEeeccccc
Q 023270          140 VIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus       140 i~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .+|+|+.|.|++++.++ ++++||+++.
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCccc
Confidence            68999999999998777 8899999874

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	284
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-98
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-98
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-98
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-97
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-97
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-97
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-97
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-97
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-96
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-96
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-96
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-96
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-96
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-96
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-96
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-96
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-96
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-96
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-96
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-96
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-95
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-95
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-95
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-95
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-95
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-95
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-95
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-95
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-95
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-94
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-94
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-94
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-92
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-92
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-91
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-85
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-53
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-49
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-47
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-46
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-46
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-44
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-44
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-44
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-44
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-44
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-44
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-44
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-44
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-44
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-44
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-44
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-44
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-44
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-44
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-44
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-44
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-44
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-44
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-44
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-44
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-44
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-44
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-44
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-44
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-44
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-44
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-44
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-44
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-44
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-44
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-43
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-43
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-43
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-43
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-43
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-43
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-43
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-43
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-43
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-43
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-43
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-43
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-43
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-43
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-43
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-43
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-43
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-43
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-43
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-43
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-43
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-43
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-43
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-43
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-43
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-43
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-43
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-43
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-43
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-43
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-43
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-43
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-43
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-43
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-43
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-43
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-43
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-43
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-43
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-42
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-42
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-42
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-42
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-42
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-42
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-42
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-42
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-42
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-42
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-42
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-42
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-42
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-42
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-42
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-42
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-42
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-42
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-42
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-42
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-42
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-42
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-42
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-42
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-42
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-42
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-42
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-42
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-42
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-42
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-42
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-42
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-42
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-42
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-42
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-42
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-41
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-41
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-41
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-41
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-41
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-41
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-41
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-41
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-41
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-40
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-40
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-40
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-40
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-40
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-40
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-39
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-39
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-39
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-39
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-39
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-39
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-39
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-39
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-39
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-39
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-39
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-39
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-39
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-39
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-39
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-39
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-39
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-38
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-38
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-37
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-37
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-37
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-37
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-37
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-37
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-36
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-36
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-36
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-36
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-36
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-36
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-36
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-35
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-35
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-35
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-35
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-35
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-35
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-35
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-35
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-35
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-35
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-35
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-35
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-35
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-35
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-35
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-35
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-35
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-35
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-35
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-35
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-35
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-35
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-35
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-35
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-35
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-35
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-35
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-35
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-34
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-34
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-34
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-34
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-34
3soa_A	444	Full-Length Human Camkii Length = 444		2e-34
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-34
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-34
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-34
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-34
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-34
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-34
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-33
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-33
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-33
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-33
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-33
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-32
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-32
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-32
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-32
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-32
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-32
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-32
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-32
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-32
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-31
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-31
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-31
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-31
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-30
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-30
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-30
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-30
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-30
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-30
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-30
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-30
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-29
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-29
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-29
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-29
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-29
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-29
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-29
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-29
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-29
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-29
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-29
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-29
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-29
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-29
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-29
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-29
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-29
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-29
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-29
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-29
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-29
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-29
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-28
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-28
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-28
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-28
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-28
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-28
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-28
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-28
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-28
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-28
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-28
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-28
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-28
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-28
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-28
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-28
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-28
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-28
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-28
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-28
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-28
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-28
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-28
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-28
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-28
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-28
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-28
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-28
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-28
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-28
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-28
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-28
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-28
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-28
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-28
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-27
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-27
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-27
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-27
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-27
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-27
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-27
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-27
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-27
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-27
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-27
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-27
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-27
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-27
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-27
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-27
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-27
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-27
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-27
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-27
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-27
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-27
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-27
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-27
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-27
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-27
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-27
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-27
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-27
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-27
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-27
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-26
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-26
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-26
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-26
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-26
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-26
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-26
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-26
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-26
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-26
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-26
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-26
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-26
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-26
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-26
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-26
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-26
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-26
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-25
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-25
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-25
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-25
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-25
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-25
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-25
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-25
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-25
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-25
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-25
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-25
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-25
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-25
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-25
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-25
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-25
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-25
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-25
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-25
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-25
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-25
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-25
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-25
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-25
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-25
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-25
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-25
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-25
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-25
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-25
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-25
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-25
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-25
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-25
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-25
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-25
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-25
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-25
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-24
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-24
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-24
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-24
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-24
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-24
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-23
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-23
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-23
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-23
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-23
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-23
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-23
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-23
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-23
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-23
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-23
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-23
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-23
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-23
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-23
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-22
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-22
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-22
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-22
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-22
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-22
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-22
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-22
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-22
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-22
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-22
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-22
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-22
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-22
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-22
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-22
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-22
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-22
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-22
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-21
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-21
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-21
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-21
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-21
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-21
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-21
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-21
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-20
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-20
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-20
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-20
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-20
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-19
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-19
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-19
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-19
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-19
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-19
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-19
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-19
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-19
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-19
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-19
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-18
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-18
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-18
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-18
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-18
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-17
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-17
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-17
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-17
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-16
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-14
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-14
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-14
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-14
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-14
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-13
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-13
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-13
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-13
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-13
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		9e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-12
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-12
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-12
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-12
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-12
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-12
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-12
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-12
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-10
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-10

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  353 bits (907), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 164/274 (59%), Positives = 213/274 (77%), Gaps = 3/274 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA RGE+Y+EL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 241
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  352 bits (904), Expect = 9e-98,   Method: Compositional matrix adjust.
 Identities = 164/275 (59%), Positives = 212/275 (77%), Gaps = 3/275 (1%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ 
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARD 261
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           LISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 296

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  352 bits (904), Expect = 9e-98,   Method: Compositional matrix adjust.
 Identities = 164/275 (59%), Positives = 212/275 (77%), Gaps = 3/275 (1%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 134
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 194
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ 
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARD 252
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           LISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 253 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 287

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  350 bits (899), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 163/274 (59%), Positives = 211/274 (77%), Gaps = 3/274 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 241
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  350 bits (899), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 163/274 (59%), Positives = 211/274 (77%), Gaps = 3/274 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 273

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  350 bits (898), Expect = 6e-97,   Method: Compositional matrix adjust.
 Identities = 163/275 (59%), Positives = 211/275 (76%), Gaps = 3/275 (1%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEM 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ 
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARD 261
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           LISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 296

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  349 bits (896), Expect = 8e-97,   Method: Compositional matrix adjust.
 Identities = 164/266 (61%), Positives = 209/266 (78%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  RF EQ+ ATYI  L NAL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T+RRI +V+ +FP    ++  A+ LISR
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF--VTEGARDLISR 243
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  ++S+RL+L +++EHPWI  N++
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANSS 269

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  349 bits (896), Expect = 9e-97,   Method: Compositional matrix adjust.
 Identities = 163/273 (59%), Positives = 210/273 (76%), Gaps = 3/273 (1%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIE 180
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI 249
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LI
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLI 238
Query: 250 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  349 bits (896), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 164/266 (61%), Positives = 209/266 (78%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  RF EQ+ ATYI  L NAL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T+RRI +V+ +FP    ++  A+ LISR
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF--VTEGARDLISR 243
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  ++S+RL+L +++EHPWI  N++
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANSS 269

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  349 bits (895), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 162/274 (59%), Positives = 211/274 (77%), Gaps = 3/274 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI +FGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 180
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 238
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  348 bits (893), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 163/273 (59%), Positives = 209/273 (76%), Gaps = 3/273 (1%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE 180
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI 249
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LI
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLI 238
Query: 250 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  348 bits (893), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 163/273 (59%), Positives = 209/273 (76%), Gaps = 3/273 (1%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE 184
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI 249
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LI
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLI 242
Query: 250 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  348 bits (893), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 162/274 (59%), Positives = 210/274 (76%), Gaps = 3/274 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PE +
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 184 EGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 241
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 242 ISRLLKHNPSQRPXLREVLEHPWITANSSKPSNC 275

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  348 bits (892), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 162/274 (59%), Positives = 210/274 (76%), Gaps = 3/274 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 180
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 238
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 272

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  347 bits (891), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 162/274 (59%), Positives = 211/274 (77%), Gaps = 3/274 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA RGE+Y+EL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  + GTLDYL PEM+
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 241
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           ISRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  347 bits (891), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 163/271 (60%), Positives = 207/271 (76%), Gaps = 3/271 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISR
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           LL  + S+R  L++++EHPWI  N++    C
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  347 bits (890), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 163/272 (59%), Positives = 208/272 (76%), Gaps = 3/272 (1%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           +KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+E
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           IQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NA
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVEN 190
           L+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E 
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
           + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LIS
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLIS 238
Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  347 bits (890), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 162/269 (60%), Positives = 210/269 (78%), Gaps = 3/269 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           ISRLL  + S+R  L++++EHPWI  N++
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  346 bits (888), Expect = 7e-96,   Method: Compositional matrix adjust.
 Identities = 162/270 (60%), Positives = 207/270 (76%), Gaps = 3/270 (1%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISRL
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISRL 240
Query: 253 LVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           L  + S+R  L++++EHPWI  N++    C
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  346 bits (887), Expect = 9e-96,   Method: Compositional matrix adjust.
 Identities = 162/266 (60%), Positives = 207/266 (77%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISR
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISR 243
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  + S+R  L++++EHPWI  N++
Sbjct: 244 LLKHNPSQRPMLREVLEHPWITANSS 269

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  346 bits (887), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 161/269 (59%), Positives = 210/269 (78%), Gaps = 3/269 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI +FGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           ISRLL  + S+R  L++++EHPWI  N++
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  345 bits (886), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 162/270 (60%), Positives = 206/270 (76%), Gaps = 3/270 (1%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISRL
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISRL 240
Query: 253 LVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           L  + S+R  L++++EHPWI  N++    C
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  345 bits (885), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 162/266 (60%), Positives = 207/266 (77%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISR
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISR 238
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  + S+R  L++++EHPWI  N++
Sbjct: 239 LLKHNPSQRPMLREVLEHPWITANSS 264

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  345 bits (885), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 162/266 (60%), Positives = 205/266 (77%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE  SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + +DT++RI +V+ +FP    ++  A+ LISR
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  + S+R  L++++EHPWI  N++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  345 bits (885), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 161/270 (59%), Positives = 206/270 (76%), Gaps = 3/270 (1%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISRL
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISRL 243
Query: 253 LVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           L  + S+R  L++++EHPWI  N++    C
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSSKPSNC 273

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  345 bits (884), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 161/269 (59%), Positives = 209/269 (77%), Gaps = 3/269 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ L
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           ISRLL  + S+R  L++++EHPWI  N++
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  344 bits (883), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 162/266 (60%), Positives = 206/266 (77%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISR
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  + S+R  L++++EHPWI  N++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  343 bits (881), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 161/266 (60%), Positives = 206/266 (77%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISR
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  + S+R  L++++EHPWI  N++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  343 bits (879), Expect = 7e-95,   Method: Compositional matrix adjust.
 Identities = 161/266 (60%), Positives = 206/266 (77%), Gaps = 3/266 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISR
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL  + S+R  L++++EHPWI  N++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  342 bits (876), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 160/268 (59%), Positives = 206/268 (76%), Gaps = 3/268 (1%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
            +KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   GKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWS  +  S+R T+ GTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIE 180
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI 249
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LI
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLI 238
Query: 250 SRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           SRLL  + S+R  L++++EHPWI  N++
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSS 266

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  341 bits (874), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 160/265 (60%), Positives = 205/265 (77%), Gaps = 3/265 (1%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISRL
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISRL 243
Query: 253 LVKDSSKRLSLQKIMEHPWIIKNAN 277
           L  + S+R  L++++EHPWI  N++
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  339 bits (870), Expect = 9e-94,   Method: Compositional matrix adjust.
 Identities = 159/264 (60%), Positives = 204/264 (77%), Gaps = 3/264 (1%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W+L+DFEIGRPLGKGKFG VYL RE + K  +ALK++FK Q+EK  ++HQLRRE+EIQS
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+Y
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKEH 193
           CH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E + H
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           D  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISRLL
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISRLL 238
Query: 254 VKDSSKRLSLQKIMEHPWIIKNAN 277
             + S+R  L++++EHPWI  N++
Sbjct: 239 KHNPSQRPMLREVLEHPWITANSS 262

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  335 bits (859), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 159/265 (60%), Positives = 205/265 (77%), Gaps = 3/265 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR++++ DF+IGRPLGKGKFG VYL RE ++K  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 9   KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 68
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILR+Y +FHD +RI+L+LE+A RGELY+EL+KH RF EQ++AT++  L +AL
Sbjct: 69  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 128
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVENK 191
            YCHE  VIHRDIKPENLL+ ++G LKI DFGWSV + S +R  MCGTLDYL PEM+E K
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W  G+LCYEFL G PPF++ S  +T RRI+ VDL FP  P +S  +K LIS+
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLISK 246
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNA 276
           LL     +RL L+ +MEHPW+  N+
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWVKANS 271

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  332 bits (851), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 158/265 (59%), Positives = 204/265 (76%), Gaps = 3/265 (1%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR++++ DF+I RPLGKGKFG VYL RE ++K  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 8   KRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILR+Y +FHD +RI+L+LE+A RGELY+EL+KH RF EQ++AT++  L +AL
Sbjct: 68  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVENK 191
            YCHE  VIHRDIKPENLL+ ++G LKI DFGWSV + S +R  MCGTLDYL PEM+E K
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            HD  VD W  G+LCYEFL G PPF++ S  +T RRI+ VDL FP  P +S  +K LIS+
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLISK 245
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNA 276
           LL     +RL L+ +MEHPW+  N+
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKANS 270

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  310 bits (795), Expect = 4e-85,   Method: Compositional matrix adjust.
 Identities = 158/268 (58%), Positives = 198/268 (73%), Gaps = 3/268 (1%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D   R +++ DFEIGRPLGKGKFG VYL RE +S   VALK++FK QIEK  ++HQLRRE
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQ+ L HPNILRLY +F+D  RI+LILEYA RGELY+EL+K   F EQ+ AT +  L 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELA 133
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMV 188
           +AL YCH   VIHRDIKPENLLL  +G LKI DFGWSV + S +R TMCGTLDYL PEM+
Sbjct: 134 DALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMI 193
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
           E + H+  VD W +G+LCYE L G PPFE+ S  +T+RRI+KVDL FP+  S+   A+ L
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPA--SVPTGAQDL 251
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           IS+LL  + S+RL L ++  HPW+  N+
Sbjct: 252 ISKLLRHNPSERLPLAQVSAHPWVRANS 279

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  204 bits (520), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 104/263 (39%), Positives = 157/263 (59%), Gaps = 7/263 (2%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           ++SLQDF+I R LG G FGRV+L+R   +    A+K++ KE + + K       E  + S
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            + HP I+R++G F D ++IF+I++Y   GEL+  LRK +RF    A  Y A +  AL Y
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            H   +I+RD+KPEN+LLD  G +KI DFG++       + +CGT DY+APE+V  K ++
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
            ++D W+ GIL YE L G  PF   +   T+ +I+  +L FP  P  + + K L+SRL+ 
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLIT 239
Query: 255 KDSSKRL-----SLQKIMEHPWI 272
           +D S+RL       + +  HPW 
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPWF 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  192 bits (489), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 159/266 (59%), Gaps = 6/266 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++DF++G  LGKG F  VY    + +   VA+K+I K+ + K  +  +++ E++I   L+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCH 136
           HP+IL LY +F D   ++L+LE  H GE+ R L+   + F+E +A  ++  +   + Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEH 193
            + ++HRD+   NLLL     +KI DFG + Q +    K +T+CGT +Y++PE+     H
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
               D W+LG + Y  L G PPF+ ++ K+T  +++  D   PS  SI  EAK LI +LL
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI--EAKDLIHQLL 247
Query: 254 VKDSSKRLSLQKIMEHPWIIKNANPR 279
            ++ + RLSL  +++HP++ +N++ +
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNSSTK 273

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  184 bits (466), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 158/264 (59%), Gaps = 14/264 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEK-YKIQHQLRREMEIQSSL 76
           FE+ R LGKG +G+V+ VR+V   +     A+K++ K  I +  K     + E  I   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HP I+ L   F    +++LILEY   GEL+ +L +   F E  A  Y+A ++ AL + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
           +  +I+RD+KPEN++L+H+G +K+ DFG    S+   +  HT CGT++Y+APE++    H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           + AVD W+LG L Y+ L GAPPF  E++K T  +I+K  L+ P  P ++ EA+ L+ +LL
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQEARDLLKKLL 256
Query: 254 VKDSSKRLS-----LQKIMEHPWI 272
            ++++ RL        ++  HP+ 
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 157/264 (59%), Gaps = 14/264 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEK-YKIQHQLRREMEIQSSL 76
           FE+ R LGKG +G+V+ VR+V   +     A+K++ K  I +  K     + E  I   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HP I+ L   F    +++LILEY   GEL+ +L +   F E  A  Y+A ++ AL + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
           +  +I+RD+KPEN++L+H+G +K+ DFG    S+   +  H  CGT++Y+APE++    H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           + AVD W+LG L Y+ L GAPPF  E++K T  +I+K  L+ P  P ++ EA+ L+ +LL
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQEARDLLKKLL 256
Query: 254 VKDSSKRLS-----LQKIMEHPWI 272
            ++++ RL        ++  HP+ 
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  181 bits (459), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 153/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  R LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  IQ ++
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRIQQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  ++++LEYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 159/266 (59%), Gaps = 12/266 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ L
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL 239
Query: 253 LVKDSSKRLS-----LQKIMEHPWII 273
           L KD  +RL       +++MEH + +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 159/266 (59%), Gaps = 12/266 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 66  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ L
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL 242
Query: 253 LVKDSSKRLS-----LQKIMEHPWII 273
           L KD  +RL       +++MEH + +
Sbjct: 243 LKKDPKQRLGGGPSDAKEVMEHRFFL 268

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 159/266 (59%), Gaps = 12/266 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ L
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL 239
Query: 253 LVKDSSKRLS-----LQKIMEHPWII 273
           L KD  +RL       +++MEH + +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 159/266 (59%), Gaps = 12/266 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ L
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL 239
Query: 253 LVKDSSKRLS-----LQKIMEHPWII 273
           L KD  +RL       +++MEH + +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 159/266 (59%), Gaps = 12/266 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ L
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL 239
Query: 253 LVKDSSKRLS-----LQKIMEHPWII 273
           L KD  +RL       +++MEH + +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 159/266 (59%), Gaps = 12/266 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ L
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL 239
Query: 253 LVKDSSKRLS-----LQKIMEHPWII 273
           L KD  +RL       +++MEH + +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 159/266 (59%), Gaps = 12/266 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 68  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           +  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ L
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGL 244
Query: 253 LVKDSSKRLS-----LQKIMEHPWII 273
           L KD  +RL       +++MEH + +
Sbjct: 245 LKKDPKQRLGGGPSDAKEVMEHRFFL 270

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 153/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 153/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 153/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 84
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 85  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT +YLAPE++ +K ++ A
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKA 204
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 262
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 263 LTKRFGNLKDGVNDIKNHKWF 283

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  175 bits (444), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P + +L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  175 bits (444), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P + +L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  175 bits (444), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + +G G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG + + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 153/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  174 bits (442), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P + +L   F D+  +++++EYA  GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 155/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILN 69
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++LI+EYA  GE++  L  H R  E++A +    + +A+ YCH+
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S       K  T CG+  Y APE+ + K++D 
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ R LV
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRFLV 247
Query: 255 KDSSKRLSLQKIMEHPWI 272
            +  KR +L++IM+  WI
Sbjct: 248 LNPIKRGTLEQIMKDRWI 265

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 102/264 (38%), Positives = 148/264 (56%), Gaps = 13/264 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 75
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFR----RIMKVDLSFPSAPSISAEAKHLISR 251
           V D W+ G+  Y  L GA PFE   +   FR    RI+ V  + P    IS E +HLISR
Sbjct: 196 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 255
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKN 275
           + V D +KR+S+ +I  H W +KN
Sbjct: 256 IFVADPAKRISIPEIRNHEWFLKN 279

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  174 bits (441), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 119
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + +    T+CGT +YLAPE++ +K ++ A
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGYNKA 239
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 297
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF 318

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 102/264 (38%), Positives = 148/264 (56%), Gaps = 13/264 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIAANVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFR----RIMKVDLSFPSAPSISAEAKHLISR 251
           V D W+ G+  Y  L GA PFE   +   FR    RI+ V  + P    IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKN 275
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +++ DFG + + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + +G G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   G+++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 157/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ + L+
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKKFLI 249
Query: 255 KDSSKRLSLQKIMEHPWI 272
            + SKR +L++IM+  W+
Sbjct: 250 LNPSKRGTLEQIMKDRWM 267

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 152/261 (58%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + +G G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   G+++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 157/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ + L+
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKKFLI 249
Query: 255 KDSSKRLSLQKIMEHPWI 272
            + SKR +L++IM+  W+
Sbjct: 250 LNPSKRGTLEQIMKDRWM 267

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIXNHKWF 298

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 90/250 (36%), Positives = 154/250 (61%), Gaps = 13/250 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LVR+V   +S H  A+K++ K  +   K++ ++R +ME  I + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATL---KVRDRVRTKMERDILAD 86
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP +++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L   L + 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S   +    K ++ CGT++Y+APE+V  + 
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           H ++ D W+ G+L +E L G+ PF+ + +K+T   I+K  L  P    +S EA+ L+  L
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQF--LSTEAQSLLRAL 264
Query: 253 LVKDSSKRLS 262
             ++ + RL 
Sbjct: 265 FKRNPANRLG 274

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLPNGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/258 (34%), Positives = 153/258 (59%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILN 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++LI+EYA  GE++  L  H R  E++A +    + +A+ YCH+
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S       K    CG   Y APE+ + K++D 
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ R LV
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKRFLV 250
Query: 255 KDSSKRLSLQKIMEHPWI 272
            +  KR +L++IM+  WI
Sbjct: 251 LNPIKRGTLEQIMKDRWI 268

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 91
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 151
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 269
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF 290

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 119
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 297
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF 318

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 277
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 85
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 205
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 263
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 264 LTKRFGNLKNGVNDIKNHKWF 284

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/253 (36%), Positives = 148/253 (58%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP+A     +A+ L+ +LL
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAA--FFPKARDLVEKLL 272
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 273 VLDATKRLGCEEM 285

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  172 bits (435), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 157/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA++II K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ + L+
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKKFLI 249
Query: 255 KDSSKRLSLQKIMEHPWI 272
            + SKR +L++IM+  W+
Sbjct: 250 LNPSKRGTLEQIMKDRWM 267

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 93
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 213
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 271
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 272 LTKRFGNLKNGVNDIKNHKWF 292

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 119
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 297
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF 318

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L Y+   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 91
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 151
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 269
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF 290

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI  FG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFR----RIMKVDLSFPSAPSISAEAKHLISR 251
           V D W+ G+  Y  L GA PFE   +   FR    RI+ V  + P    IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKN 275
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAP ++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  171 bits (432), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 155/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K    CG   Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ + L+
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKKFLI 249
Query: 255 KDSSKRLSLQKIMEHPWI 272
            + SKR +L++IM+  W+
Sbjct: 250 LNPSKRGTLEQIMKDRWM 267

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  170 bits (431), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 146/264 (55%), Gaps = 13/264 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI  FG+S  S   S+     GT  Y+APE++  KE+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFR----RIMKVDLSFPSAPSISAEAKHLISR 251
           V D W+ G+  Y  L GA PFE   +   FR    RI+ V  + P    IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKN 275
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +K        +  I  H W 
Sbjct: 277 LTKAFGNLKNGVNDIKNHKWF 297

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  170 bits (430), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 147/253 (58%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R ++  GT  Y++PE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 270
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 271 VLDATKRLGCEEM 283

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  170 bits (430), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ ++   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++Y H   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFR----RIMKVDLSFPSAPSISAEAKHLISR 251
           V D W+ G+  Y  L GA PFE   +   FR    RI+ V  + P    IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKN 275
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 101/263 (38%), Positives = 157/263 (59%), Gaps = 13/263 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 206 -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG     ++  +   T CGT +YLAPE++E+ 
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           ++  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++  EAK L+S 
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSG 382
Query: 252 LLVKDSSKRLS-----LQKIMEH 269
           LL KD  +RL       ++IM+H
Sbjct: 383 LLKKDPKQRLGGGSEDAKEIMQH 405

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 101/263 (38%), Positives = 157/263 (59%), Gaps = 13/263 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 149 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 209 -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG     ++  +   T CGT +YLAPE++E+ 
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           ++  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++  EAK L+S 
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSG 385
Query: 252 LLVKDSSKRLS-----LQKIMEH 269
           LL KD  +RL       ++IM+H
Sbjct: 386 LLKKDPKQRLGGGSEDAKEIMQH 408

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 147/253 (58%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R ++  GT  Y++PE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 266
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 267 VLDATKRLGCEEM 279

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 267
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 268 VLDATKRLGCEEM 280

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 145/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F +I+K++  FP       +A+ L+ +LL
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLL 269
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 270 VLDATKRLGCEEM 282

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 156/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA++II K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K    CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ + L+
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKKFLI 249
Query: 255 KDSSKRLSLQKIMEHPWI 272
            + SKR +L++IM+  W+
Sbjct: 250 LNPSKRGTLEQIMKDRWM 267

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 269
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 270 VLDATKRLGCEEM 282

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 274
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 275 VLDATKRLGCEEM 287

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 270
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 271 VLDATKRLGCEEM 283

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 269
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 270 VLDATKRLGCEEM 282

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT + LAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 244
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 245 VLDATKRLGCEEM 257

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 267
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 268 VLDATKRLGCEEM 280

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 267
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 268 VLDATKRLGCEEM 280

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 156/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 64
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H    E++A      + +A+ YCH+
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + K++D 
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ + L+
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKKFLI 242
Query: 255 KDSSKRLSLQKIMEHPWI 272
            + SKR +L++IM+  W+
Sbjct: 243 LNPSKRGTLEQIMKDRWM 260

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 247
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 248 VLDATKRLGCEEM 260

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 269
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 270 VLDATKRLGCEEM 282

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 251
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 252 VLDATKRLGCEEM 264

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 245
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 246 VLDATKRLGCEEM 258

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 153/250 (61%), Gaps = 13/250 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LV+++   +++   A+K++ K  +   K++ ++R +ME  I   
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVE 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           H  + D W+ G+L +E L G  PF+ + +K+T   I+K  L  P    +S EA+ L+  L
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRML 260
Query: 253 LVKDSSKRLS 262
             ++ + RL 
Sbjct: 261 FKRNPANRLG 270

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   + GT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 145/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F +I+K++  FP       +A+ L+ +LL
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLL 269
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 270 VLDATKRLGCEEM 282

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 266
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 267 VLDATKRLGCEEM 279

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 246
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 247 VLDATKRLGCEEM 259

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 153/250 (61%), Gaps = 13/250 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LV+++   +++   A+K++ K  +   K++ ++R +ME  I   
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVE 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           H  + D W+ G+L +E L G  PF+ + +K+T   I+K  L  P    +S EA+ L+  L
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRML 260
Query: 253 LVKDSSKRLS 262
             ++ + RL 
Sbjct: 261 FKRNPANRLG 270

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 153/250 (61%), Gaps = 13/250 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LV+++   +++   A+K++ K  +   K++ ++R +ME  I   
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVE 83
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + 
Sbjct: 144 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           H  + D W+ G+L +E L G  PF+ + +K+T   I+K  L  P    +S EA+ L+  L
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRML 261
Query: 253 LVKDSSKRLS 262
             ++ + RL 
Sbjct: 262 FKRNPANRLG 271

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 156/263 (59%), Gaps = 13/263 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 67  -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG   +      TM   CGT +YLAPE++E+ 
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           ++  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++  EAK L+S 
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSG 243
Query: 252 LLVKDSSKRLS-----LQKIMEH 269
           LL KD  +RL       ++IM+H
Sbjct: 244 LLKKDPKQRLGGGSEDAKEIMQH 266

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   + GT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD 256
           VD W LG+L YE   G PPF A+     + +I+   + FPS    S++ K L+  LL  D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276
Query: 257 SSKRL-----SLQKIMEHPWI 272
            +KR       +  I  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 156/263 (59%), Gaps = 13/263 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 66  -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG   +      TM   CGT +YLAPE++E+ 
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           ++  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++  EAK L+S 
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSG 242
Query: 252 LLVKDSSKRLS-----LQKIMEH 269
           LL KD  +RL       ++IM+H
Sbjct: 243 LLKKDPKQRLGGGSEDAKEIMQH 265

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 156/263 (59%), Gaps = 13/263 (4%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 68  -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG   +      TM   CGT +YLAPE++E+ 
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           ++  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++  EAK L+S 
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSG 244
Query: 252 LLVKDSSKRLS-----LQKIMEH 269
           LL KD  +RL       ++IM+H
Sbjct: 245 LLKKDPKQRLGGGSEDAKEIMQH 267

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  G L + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R ++  GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 269
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 270 VLDATKRLGCEEM 282

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 156/261 (59%), Gaps = 17/261 (6%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQI-EKYKIQHQLRREMEI 72
            +++FE+ + LG G +G+V+LVR++   ++    A+K++ K  I +K K     R E ++
Sbjct: 52  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 73  QSSLRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
              +R  P ++ L+  F  + ++ LIL+Y + GEL+  L +  RFTE +   Y+  +  A
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKR-HTMCGTLDYLAPEM 187
           L + H+  +I+RDIK EN+LLD  G + + DFG S   V   ++R +  CGT++Y+AP++
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 188 VENKE--HDYAVDNWTLGILCYEFLYGAPPF----EAESQKDTFRRIMKVDLSFPSAPSI 241
           V   +  HD AVD W+LG+L YE L GA PF    E  SQ +  RRI+K +  +P    +
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 289
Query: 242 SAEAKHLISRLLVKDSSKRLS 262
           SA AK LI RLL+KD  KRL 
Sbjct: 290 SALAKDLIQRLLMKDPKKRLG 310

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 88/248 (35%), Positives = 146/248 (58%), Gaps = 6/248 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLR 77
            DF   + +GKG FG+V L R    +   A+K++ K+ I K K +  +  E  +   +++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP ++ L+  F   ++++ +L+Y + GEL+  L++ R F E +A  Y A + +AL Y H 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            ++++RD+KPEN+LLD +G + + DFG    +++  S   T CGT +YLAPE++  + +D
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W LG + YE LYG PPF + +  + +  I+   L     P+I+  A+HL+  LL 
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--KPNITNSARHLLEGLLQ 275
Query: 255 KDSSKRLS 262
           KD +KRL 
Sbjct: 276 KDRTKRLG 283

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 148/264 (56%), Gaps = 8/264 (3%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G +G V L ++  +    A+KII K  +        L  E+ +   L HPNI++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L++E    GEL+ E+   ++F+E  AA  +  + +   Y H+++++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + R   +KI DFG S   +   K     GT  Y+APE++  K++D   D 
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 188
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W+ G++ Y  L G PPF  ++ ++  +R+ K   SF  P    +S EAK L+  +L  + 
Sbjct: 189 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 248
Query: 258 SKRLSLQKIMEHPWIIKNANPRGT 281
           SKR+S ++ + HPWI+K  + + T
Sbjct: 249 SKRISAEEALNHPWIVKFCSQKHT 272

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 145/253 (57%), Gaps = 7/253 (2%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F    L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LL
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLL 267
Query: 254 VKDSSKRLSLQKI 266
           V D++KRL  +++
Sbjct: 268 VLDATKRLGCEEM 280

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  167 bits (422), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 148/267 (55%), Gaps = 8/267 (2%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDV 210
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W+ G++ Y  L G PPF   ++ D  +++ K   +F  P    +S  AK LI ++L    
Sbjct: 211 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 270
Query: 258 SKRLSLQKIMEHPWIIKNANPRGTCDI 284
           S R+S +  ++H WI      + + D+
Sbjct: 271 SMRISARDALDHEWIQTYTKEQISVDV 297

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 148/267 (55%), Gaps = 8/267 (2%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 175
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDV 234
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W+ G++ Y  L G PPF   ++ D  +++ K   +F  P    +S  AK LI ++L    
Sbjct: 235 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 294
Query: 258 SKRLSLQKIMEHPWIIKNANPRGTCDI 284
           S R+S +  ++H WI      + + D+
Sbjct: 295 SMRISARDALDHEWIQTYTKEQISVDV 321

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 148/267 (55%), Gaps = 8/267 (2%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 174
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDV 233
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W+ G++ Y  L G PPF   ++ D  +++ K   +F  P    +S  AK LI ++L    
Sbjct: 234 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 293
Query: 258 SKRLSLQKIMEHPWIIKNANPRGTCDI 284
           S R+S +  ++H WI      + + D+
Sbjct: 294 SMRISARDALDHEWIQTYTKEQISVDV 320

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 89/257 (34%), Positives = 145/257 (56%), Gaps = 8/257 (3%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G +G V L ++  +    A+KII K  +        L  E+ +   L HPNI++L
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L++E    GEL+ E+   ++F+E  AA  +  + +   Y H+++++HRD
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + R   +KI DFG S   +   K     GT  Y+APE++  K++D   D 
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 205
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W+ G++ Y  L G PPF  ++ ++  +R+ K   SF  P    +S EAK L+  +L  + 
Sbjct: 206 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 265
Query: 258 SKRLSLQKIMEHPWIIK 274
           SKR+S ++ + HPWI+K
Sbjct: 266 SKRISAEEALNHPWIVK 282

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  166 bits (420), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 149/264 (56%), Gaps = 7/264 (2%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           N      + +FE  R LGKG FG+V L R  E+    A+K++ K+ I +         E 
Sbjct: 15  NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 71  EIQSSLR-HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
            I S  R HP + +L+  F   +R+F ++E+ + G+L   ++K RRF E +A  Y A + 
Sbjct: 75  RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPE 186
           +AL + H+  +I+RD+K +N+LLDHEG  K+ DFG     + +     T CGT DY+APE
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           +++   +  AVD W +G+L YE L G  PFEAE++ D F  I+  ++ +P+   +  +A 
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LHEDAT 252
Query: 247 HLISRLLVKDSSKRL-SLQKIMEH 269
            ++   + K+ + RL SL +  EH
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEH 276

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 144/255 (56%), Gaps = 8/255 (3%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 157
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDV 216
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W+ G++ Y  L G PPF   ++ D  +++ K   +F  P    +S  AK LI ++L    
Sbjct: 217 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 276
Query: 258 SKRLSLQKIMEHPWI 272
           S R+S +  ++H WI
Sbjct: 277 SMRISARDALDHEWI 291

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 150/257 (58%), Gaps = 6/257 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIXKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L+ EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K    CG   Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P   S   E  +L+ + L+
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCE--NLLKKFLI 249
Query: 255 KDSSKRLSLQKIMEHPW 271
            + SKR +L++I +  W
Sbjct: 250 LNPSKRGTLEQIXKDRW 266

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 145/264 (54%), Gaps = 13/264 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++  + +G G FG   L+R+  +K  VA+K I +       I   ++RE+    SLRHPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSLRHPN 77
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +I+EYA  GELY  +    RF+E +A  +   L + ++YCH   +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  +E+D  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 197 V-DNWTLGILCYEFLYGAPPFE-AESQKD---TFRRIMKVDLSFPSAPSISAEAKHLISR 251
           + D W+ G+  Y  L GA PFE  E  +D   T +RI+ V  S P    IS E  HLISR
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKN 275
           + V D + R+S+ +I  H W +KN
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKN 281

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 146/267 (54%), Gaps = 8/267 (2%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRD 151
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCDV 210
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W+ G++ Y  L G PPF   ++ D  +++ K   +F  P    +S  AK LI + L    
Sbjct: 211 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVP 270
Query: 258 SKRLSLQKIMEHPWIIKNANPRGTCDI 284
           S R+S +  ++H WI      + + D+
Sbjct: 271 SXRISARDALDHEWIQTYTKEQISVDV 297

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 157/258 (60%), Gaps = 6/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R V +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQ-KLFREVRIMKILN 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            +++HRD+K ENLLLD +  +KI DFG+S      +K  T CG+  Y APE+ + K++D 
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++L+ +LLV
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKKLLV 250
Query: 255 KDSSKRLSLQKIMEHPWI 272
            +  KR SL++IM+  W+
Sbjct: 251 LNPIKRGSLEQIMKDRWM 268

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 147/255 (57%), Gaps = 9/255 (3%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G +G V L R+  +    A+KII K  +       +L  E+ +   L HPNI++L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKL 101
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L++E    GEL+ E+    +F E  AA  I  + + + Y H+++++HRD
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 145 IKPENLLLDH---EGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+    +  +KI DFG S   +++ K     GT  Y+APE++  K++D   D 
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDV 220
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDS 257
           W++G++ +  L G PPF  ++ ++  R++ K   +F  P   ++S  AK LI ++L  DS
Sbjct: 221 WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280
Query: 258 SKRLSLQKIMEHPWI 272
            +R+S Q+ +EHPWI
Sbjct: 281 QRRISAQQALEHPWI 295

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 148/265 (55%), Gaps = 5/265 (1%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +++ +  GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            +P+++  +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEH 193
            N VIHRD+K  NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            + VD W+LG + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI R+L
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR--HINPVASALIRRML 277
Query: 254 VKDSSKRLSLQKIMEHPWIIKNANP 278
             D + R S+ +++   +      P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 147/265 (55%), Gaps = 5/265 (1%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +++ +  GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            +P+++  +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEH 193
            N VIHRD+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            + VD W+LG + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI R+L
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR--HINPVASALIRRML 277
Query: 254 VKDSSKRLSLQKIMEHPWIIKNANP 278
             D + R S+ +++   +      P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 143/258 (55%), Gaps = 5/258 (1%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL +P+++ 
Sbjct: 31  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H N VIHR
Sbjct: 91  FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 150
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W
Sbjct: 151 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIW 210
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR 260
           +LG + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI R+L  D + R
Sbjct: 211 SLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR--HINPVASALIRRMLHADPTLR 268
Query: 261 LSLQKIMEHPWIIKNANP 278
            S+ +++   +      P
Sbjct: 269 PSVAELLTDEFFTSGYAP 286

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  160 bits (405), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 143/258 (55%), Gaps = 5/258 (1%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL +P+++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H N VIHR
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIW 226
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR 260
           +LG + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI R+L  D + R
Sbjct: 227 SLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR--HINPVASALIRRMLHADPTLR 284
Query: 261 LSLQKIMEHPWIIKNANP 278
            S+ +++   +      P
Sbjct: 285 PSVAELLTDEFFTSGYAP 302

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  160 bits (404), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 88/253 (34%), Positives = 139/253 (54%), Gaps = 9/253 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I KE +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDSSK 259
           +G++ Y  L G PPF  E+    F +I+K +  F  P    IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 260 RLSLQKIMEHPWI 272
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/253 (34%), Positives = 139/253 (54%), Gaps = 9/253 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I KE +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDSSK 259
           +G++ Y  L G PPF  E+    F +I+K +  F  P    IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 260 RLSLQKIMEHPWI 272
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/253 (34%), Positives = 139/253 (54%), Gaps = 9/253 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I KE +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDSSK 259
           +G++ Y  L G PPF  E+    F +I+K +  F  P    IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 260 RLSLQKIMEHPWI 272
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/252 (34%), Positives = 142/252 (56%), Gaps = 6/252 (2%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG+V L    +++  VALK I ++ ++K  +  ++ RE+     LRHP+I++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
                  I +++EYA  GEL+  + + +R TE +   +   +  A+ YCH + ++HRD+K
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 147 PENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-VDNWTLG 203
           PENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +    VD W+ G
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
           I+ Y  L G  PF+ E   + F+++       P    +S  A+ LI R++V D  +R+++
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF--LSPGAQSLIRRMIVADPMQRITI 253
Query: 264 QKIMEHPWIIKN 275
           Q+I   PW   N
Sbjct: 254 QEIRRDPWFNVN 265

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/244 (33%), Positives = 138/244 (56%), Gaps = 5/244 (2%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H + VD W++G
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
            + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI ++L  D + R ++
Sbjct: 209 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPTI 266
Query: 264 QKIM 267
            +++
Sbjct: 267 NELL 270

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/244 (33%), Positives = 138/244 (56%), Gaps = 5/244 (2%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H + VD W++G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
            + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI ++L  D + R ++
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPTI 262
Query: 264 QKIM 267
            +++
Sbjct: 263 NELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 81/244 (33%), Positives = 138/244 (56%), Gaps = 5/244 (2%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H + VD W++G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
            + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI ++L  D + R ++
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPTI 262
Query: 264 QKIM 267
            +++
Sbjct: 263 NELL 266

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 87/253 (34%), Positives = 139/253 (54%), Gaps = 9/253 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I K+ +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDSSK 259
           +G++ Y  L G PPF  E+    F +I+K +  F  P    IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 260 RLSLQKIMEHPWI 272
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 90/262 (34%), Positives = 146/262 (55%), Gaps = 9/262 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   ++  ++   A+K+I K    K K    + RE+E+   L HPNI++L+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H+++++HRD+K
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 147 PENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PEN+LL+ + +   +KI DFG S   Q  +K     GT  Y+APE++    +D   D W+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWS 207
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRI--MKVDLSFPSAPSISAEAKHLISRLLVKDSSK 259
            G++ Y  L G PPF  +++ D  +R+   K     P   +IS +AK LI ++L    S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 260 RLSLQKIMEHPWIIKNANPRGT 281
           R++  + +EHPWI K ++   T
Sbjct: 268 RITATQCLEHPWIQKYSSETPT 289

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 98/275 (35%), Positives = 150/275 (54%), Gaps = 13/275 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D   R+     FE+   LG+G    VY  ++  ++ P ALK++ K+ ++K KI   +R E
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDK-KI---VRTE 98
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + +   L HPNI++L   F     I L+LE    GEL+  + +   ++E+ AA  +  + 
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 130 NALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            A+AY HEN ++HRD+KPENLL      +  LKI DFG S  V+ +    T+CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDTFRRIMKVDLSF--PSAPSI 241
           PE++    +   VD W++GI+ Y  L G  PF  E   +  FRRI+  +  F  P    +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           S  AK L+ +L+V D  KRL+  + ++HPW+   A
Sbjct: 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 145/257 (56%), Gaps = 6/257 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+ G++ Y  L    PF+ ES    F+ I     + P    +S  A  LI R+L+
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF--LSPGAAGLIKRMLI 249
Query: 255 KDSSKRLSLQKIMEHPW 271
            +   R+S+ +IM+  W
Sbjct: 250 VNPLNRISIHEIMQDDW 266

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 145/257 (56%), Gaps = 6/257 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+ G++ Y  L    PF+ ES    F+ I     + P    +S  A  LI R+L+
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF--LSPGAAGLIKRMLI 248
Query: 255 KDSSKRLSLQKIMEHPW 271
            +   R+S+ +IM+  W
Sbjct: 249 VNPLNRISIHEIMQDDW 265

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 145/257 (56%), Gaps = 6/257 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+ G++ Y  L    PF+ ES    F+ I     + P    +S  A  LI R+L+
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF--LSPGAAGLIKRMLI 243
Query: 255 KDSSKRLSLQKIMEHPW 271
            +   R+S+ +IM+  W
Sbjct: 244 VNPLNRISIHEIMQDDW 260

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 145/257 (56%), Gaps = 6/257 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
             VD W+ G++ Y  L    PF+ ES    F+ I     + P    +S  A  LI R+L+
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF--LSPGAAGLIKRMLI 239
Query: 255 KDSSKRLSLQKIMEHPW 271
            +   R+S+ +IM+  W
Sbjct: 240 VNPLNRISIHEIMQDDW 256

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 137/244 (56%), Gaps = 5/244 (2%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W++G
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
            + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI ++L  D + R ++
Sbjct: 227 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPTI 284
Query: 264 QKIM 267
            +++
Sbjct: 285 NELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 137/244 (56%), Gaps = 5/244 (2%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W++G
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
            + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI ++L  D + R ++
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPTI 286
Query: 264 QKIM 267
            +++
Sbjct: 287 NELL 290

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 89/258 (34%), Positives = 145/258 (56%), Gaps = 9/258 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   ++  ++   A+K+I K    K K    + RE+E+   L HPNI++L+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H+++++HRD+K
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 147 PENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PEN+LL+ + +   +KI DFG S   Q  +K     GT  Y+APE++    +D   D W+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWS 207
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRI--MKVDLSFPSAPSISAEAKHLISRLLVKDSSK 259
            G++ Y  L G PPF  +++ D  +R+   K     P   +IS +AK LI ++L    S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 260 RLSLQKIMEHPWIIKNAN 277
           R++  + +EHPWI K ++
Sbjct: 268 RITATQCLEHPWIQKYSS 285

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 89/258 (34%), Positives = 145/258 (56%), Gaps = 9/258 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   ++  ++   A+K+I K    K K    + RE+E+   L HPNI++L+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H+++++HRD+K
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 147 PENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PEN+LL+ + +   +KI DFG S   Q  +K     GT  Y+APE++    +D   D W+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWS 207
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRI--MKVDLSFPSAPSISAEAKHLISRLLVKDSSK 259
            G++ Y  L G PPF  +++ D  +R+   K     P   +IS +AK LI ++L    S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 260 RLSLQKIMEHPWIIKNAN 277
           R++  + +EHPWI K ++
Sbjct: 268 RITATQCLEHPWIQKYSS 285

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 139/255 (54%), Gaps = 5/255 (1%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W++G
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSL 263
            + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI ++L  D + R ++
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPTI 260
Query: 264 QKIMEHPWIIKNANP 278
            +++   +      P
Sbjct: 261 NELLNDEFFTSGYIP 275

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 155/291 (53%), Gaps = 21/291 (7%)
Query: 12  RKREWSLQD--FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---------- 59
           RK+E  + +  F++ R LG G +G V L +E       A+K+I K Q +K          
Sbjct: 28  RKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
            K   ++  E+ +  SL HPNI++L+  F D +  +L+ E+   GEL+ ++    +F E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL---KIGDFGWS--VQSRSKRH 174
            AA  +  + + + Y H+++++HRDIKPEN+LL+++  L   KI DFG S       K  
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-- 232
              GT  Y+APE+++ K+++   D W+ G++ Y  L G PPF  ++ +D  +++ K    
Sbjct: 207 DRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 283
             F    +IS EAK LI  +L  D +KR + ++ +   WI K AN     D
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSD 316

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 140/273 (51%), Gaps = 10/273 (3%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           K +  L  ++I   LG G FG V+ V E  + +  A K +          +  +R+E++ 
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQT 207
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNA 131
            S LRHP ++ L+  F DD  + +I E+   GEL+ ++  +H + +E +A  Y+  +   
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 132 LAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSKRHT--MCGTLDYLAPEM 187
           L + HEN+ +H D+KPEN++        LK+ DFG +     K+      GT ++ APE+
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEA 245
            E K   Y  D W++G+L Y  L G  PF  E+  +T R +   D +   +    IS + 
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           K  I +LL+ D + R+++ + +EHPW+     P
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 140/273 (51%), Gaps = 10/273 (3%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           K +  L  ++I   LG G FG V+ V E  + +  A K +          +  +R+E++ 
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQT 101
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNA 131
            S LRHP ++ L+  F DD  + +I E+   GEL+ ++  +H + +E +A  Y+  +   
Sbjct: 102 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 161
Query: 132 LAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSKRHT--MCGTLDYLAPEM 187
           L + HEN+ +H D+KPEN++        LK+ DFG +     K+      GT ++ APE+
Sbjct: 162 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 221
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEA 245
            E K   Y  D W++G+L Y  L G  PF  E+  +T R +   D +   +    IS + 
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 281
Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           K  I +LL+ D + R+++ + +EHPW+     P
Sbjct: 282 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 314

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 138/259 (53%), Gaps = 9/259 (3%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE    LG G F  V L  E  +    A+K I K+ ++    +  +  E+ +   ++H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGK--ESSIENEIAVLRKIKHEN 81
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ L   +     ++L+++    GEL+  + +   +TE+ A+T I  + +A+ Y H   +
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 141 IHRDIKPENLLL---DHEGRLKIGDFGWS-VQSRSK-RHTMCGTLDYLAPEMVENKEHDY 195
           +HRD+KPENLL    D E ++ I DFG S ++ +     T CGT  Y+APE++  K +  
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLL 253
           AVD W++G++ Y  L G PPF  E+    F +I+K +  F  P    IS  AK  I  L+
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 254 VKDSSKRLSLQKIMEHPWI 272
            KD +KR + ++   HPWI
Sbjct: 262 EKDPNKRYTCEQAARHPWI 280

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  151 bits (381), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 135/256 (52%), Gaps = 9/256 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V+LV++  +    ALK I K    +      L  E+ +   ++H NI+ L  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +      +L+++    GEL+  + +   +TE+ A+  I  + +A+ Y HEN ++HRD+K
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 147 PENLLL---DHEGRLKIGDFGWS-VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           PENLL    +   ++ I DFG S ++      T CGT  Y+APE++  K +  AVD W++
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193
Query: 203 GILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDSSKR 260
           G++ Y  L G PPF  E++   F +I +    F  P    IS  AK  I  LL KD ++R
Sbjct: 194 GVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNER 253
Query: 261 LSLQKIMEHPWIIKNA 276
            + +K + HPWI  N 
Sbjct: 254 YTCEKALSHPWIDGNT 269

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           M ++  ++  N      L DF     LGKG FG+V L     ++   A+KI+ K+ + + 
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 61  KIQHQLRREMEIQSSLRHPNIL-RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
                   E  + + L  P  L +L+  F   +R++ ++EY + G+L   +++  +F E 
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP 120
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--- 176
           QA  Y A ++  L + H+  +I+RD+K +N++LD EG +KI DFG       K H M   
Sbjct: 121 QAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEHMMDGV 175
Query: 177 -----CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV 231
                CGT DY+APE++  + +  +VD W  G+L YE L G PPF+ E + + F+ IM+ 
Sbjct: 176 TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 235
Query: 232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           ++S+P   S+S EA  +   L+ K  +KRL 
Sbjct: 236 NVSYPK--SLSKEAVSICKGLMTKHPAKRLG 264

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 82/254 (32%), Positives = 134/254 (52%), Gaps = 5/254 (1%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +G  LG G FG+V +     + H VA+KI+ +++I    +  +++RE++     RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++LY         F+++EY   GEL+  + KH R  E +A      + +A+ YCH + V
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-V 197
           +HRD+KPEN+LLD     KI DFG S  +       T CG+ +Y APE++  + +    V
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           D W+ G++ Y  L G  PF+ E     F++I       P    ++     L+  +L  D 
Sbjct: 193 DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--YLNRSVATLLMHMLQVDP 250
Query: 258 SKRLSLQKIMEHPW 271
            KR +++ I EH W
Sbjct: 251 LKRATIKDIREHEW 264

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  147 bits (371), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 150/273 (54%), Gaps = 19/273 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSS 75
           Q + +   +G+G +G V +  +  ++   A K I   F E ++++K      +E+EI  S
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK------QEIEIMKS 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           L HPNI+RLY  F D+  I+L++E    GEL+  +   R F E  AA  +  + +A+AYC
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVEN 190
           H+ +V HRD+KPEN L      +  LK+ DFG + + +  +   T  GT  Y++P+++E 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHL 248
             +    D W+ G++ Y  L G PPF A +  +   +I +   +FP     ++S +A+ L
Sbjct: 183 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIK--NANPR 279
           I RLL K   +R++  + +EH W  K  +++PR
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  147 bits (370), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 147/273 (53%), Gaps = 13/273 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           +E+G  LG G+F  V   R+  +    A K I K ++   +    + ++ RE+ I   +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + + + Y H 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 138 NHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN++L  +     R+K+ DFG +  +++ ++   + GT +++APE+V  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  E++++T   I  V+  F      + S  AK  I
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI--IKNANPRG 280
            RLLVKD  +R+++ + +EH WI  I+  N RG
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 145/266 (54%), Gaps = 9/266 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V    ++ +    A KII  +++   +   +L RE  I   L+HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA-RDHQKLEREARICRLLKHP 63
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++ +CH N 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEH 193
           ++HRD+KPENLLL  + +   +K+ DFG +++ +  +       GT  YL+PE++    +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISR 251
              VD W  G++ Y  L G PPF  E Q   +++I      FPS    +++ EAK LI++
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 243
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           +L  + +KR++  + ++HPWI + + 
Sbjct: 244 MLTINPAKRITASEALKHPWICQRST 269

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 149/275 (54%), Gaps = 21/275 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A++++ KE +   +    ++ E  + + +
Sbjct: 50  GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G     ++      T CGT +Y+APE++  ++
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------FRRIMKVDLSFPSAPSISA 243
           + ++VD W LG+L +E + G  PF+     D          F+ I++  +  P   S+S 
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSV 287
Query: 244 EAKHLISRLLVKDSSKRL------SLQKIMEHPWI 272
           +A  ++   L KD  +RL          I  HP+ 
Sbjct: 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  147 bits (370), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 150/273 (54%), Gaps = 19/273 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSS 75
           Q + +   +G+G +G V +  +  ++   A K I   F E ++++K      +E+EI  S
Sbjct: 26  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK------QEIEIMKS 79
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           L HPNI+RLY  F D+  I+L++E    GEL+  +   R F E  AA  +  + +A+AYC
Sbjct: 80  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 139
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVEN 190
           H+ +V HRD+KPEN L      +  LK+ DFG + + +  +   T  GT  Y++P+++E 
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 199
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHL 248
             +    D W+ G++ Y  L G PPF A +  +   +I +   +FP     ++S +A+ L
Sbjct: 200 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIK--NANPR 279
           I RLL K   +R++  + +EH W  K  +++PR
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  147 bits (370), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 145/266 (54%), Gaps = 9/266 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V    ++ +    A KII  +++   +   +L RE  I   L+HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA-RDHQKLEREARICRLLKHP 63
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++ +CH N 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEH 193
           ++HRD+KPENLLL  + +   +K+ DFG +++ +  +       GT  YL+PE++    +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISR 251
              VD W  G++ Y  L G PPF  E Q   +++I      FPS    +++ EAK LI++
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 243
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           +L  + +KR++  + ++HPWI + + 
Sbjct: 244 MLTINPAKRITASEALKHPWICQRST 269

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG GKF  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 146/258 (56%), Gaps = 7/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSL 76
           ++DFE+ + LGKG FG+V+L    ++    A+K + K+ +     ++  +  +  +  + 
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
              +++RD+K +N+LLD +G +KI DFG    ++   +K +  CGT DY+APE++  +++
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           +++VD W+ G+L YE L G  PF  + +++ F  I   +  +P    +  EAK L+ +L 
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLF 254
Query: 254 VKDSSKRLSLQ-KIMEHP 270
           V++  KRL ++  I +HP
Sbjct: 255 VREPEKRLGVRGDIRQHP 272

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 136/252 (53%), Gaps = 5/252 (1%)
Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           +G  LG G FG+V + +   + H VA+KI+ +++I    +  ++RRE++     RHP+I+
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           +LY        IF+++EY   GEL+  + K+ R  E+++      + + + YCH + V+H
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH 139
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-VDN 199
           RD+KPEN+LLD     KI DFG S  +         CG+ +Y APE++  + +    VD 
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDI 199
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSK 259
           W+ G++ Y  L G  PF+ +     F++I   D  F +   ++     L+  +L  D  K
Sbjct: 200 WSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVISLLKHMLQVDPMK 257
Query: 260 RLSLQKIMEHPW 271
           R +++ I EH W
Sbjct: 258 RATIKDIREHEW 269

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 148/275 (53%), Gaps = 21/275 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +
Sbjct: 18  GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 77
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 78  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  ++
Sbjct: 138 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 197
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------FRRIMKVDLSFPSAPSISA 243
           + ++VD W LG+L +E + G  PF+     D          F+ I++  +  P   S+S 
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SMSV 255
Query: 244 EAKHLISRLLVKDSSKRL------SLQKIMEHPWI 272
           +A  ++   L KD  +RL          I  HP+ 
Sbjct: 256 KAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF 290

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           +E+G  LG G+F  V   R+  +    A K I K ++   +    + ++ RE+ I   +R
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + + + Y H 
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 138 NHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN++L  +     R+K+ DFG +  +++ ++   + GT +++APE+V  +
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  E++++T   I  V+  F      + S  AK  I
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 267
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI--IKNANPRG 280
            RLLVKD  +R+ + + +EH WI  I+  N RG
Sbjct: 268 RRLLVKDPKRRMXIAQSLEHSWIKAIRRRNVRG 300

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 148/275 (53%), Gaps = 21/275 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +
Sbjct: 7   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  ++
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 186
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------FRRIMKVDLSFPSAPSISA 243
           + ++VD W LG+L +E + G  PF+     D          F+ I++  +  P   S+S 
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSV 244
Query: 244 EAKHLISRLLVKDSSKRL------SLQKIMEHPWI 272
           +A  ++   L KD  +RL          I  HP+ 
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 141/260 (54%), Gaps = 9/260 (3%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +++   LGKG F  V    +V +    A KII  +++   +   +L RE  I   L+HPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA-RDHQKLEREARICRLLKHPN 82
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+RL+    ++   +LI +    GEL+ ++     ++E  A+  I  +  A+ +CH+  V
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 141 IHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEHD 194
           +HRD+KPENLLL  +     +K+ DFG +++   ++       GT  YL+PE++    + 
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRL 252
             VD W  G++ Y  L G PPF  E Q   +++I      FPS    +++ EAK LI+++
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 262
Query: 253 LVKDSSKRLSLQKIMEHPWI 272
           L  + SKR++  + ++HPWI
Sbjct: 263 LTINPSKRITAAEALKHPWI 282

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 133/254 (52%), Gaps = 5/254 (1%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +G  LG G FG+V +     + H VA+KI+ +++I    +  +++RE++     RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++LY         F+++EY   GEL+  + KH R  E +A      + +A+ YCH + V
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-V 197
           +HRD+KPEN+LLD     KI DFG S  +         CG+ +Y APE++  + +    V
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEV 192
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           D W+ G++ Y  L G  PF+ E     F++I       P    ++     L+  +L  D 
Sbjct: 193 DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--YLNRSVATLLMHMLQVDP 250
Query: 258 SKRLSLQKIMEHPW 271
            KR +++ I EH W
Sbjct: 251 LKRATIKDIREHEW 264

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 148/275 (53%), Gaps = 21/275 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +
Sbjct: 3   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  ++
Sbjct: 123 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 182
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------FRRIMKVDLSFPSAPSISA 243
           + ++VD W LG+L +E + G  PF+     D          F+ I++  +  P   S+S 
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSV 240
Query: 244 EAKHLISRLLVKDSSKRL------SLQKIMEHPWI 272
           +A  ++   L KD  +RL          I  HP+ 
Sbjct: 241 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 275

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 146/286 (51%), Gaps = 15/286 (5%)
Query: 1   MDTKTAEREDNRKREWSLQ-------DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF 53
           M + T  ++  R  E+ +        ++++   LGKG F  V       +    A KII 
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 54  KEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH 113
            +++     Q +L RE  I   L+HPNI+RL+    ++   +L+ +    GEL+ ++   
Sbjct: 64  TKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 114 RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSR 170
             ++E  A+  I  +  ++AYCH N ++HR++KPENLLL  + +   +K+ DFG +++  
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 171 SKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRI 228
                H   GT  YL+PE+++   +   VD W  G++ Y  L G PPF  E Q   + +I
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 229 MKVDLSFPSA--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                 +PS    +++ EAK LI  +L  +  KR++  + ++ PWI
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 137/260 (52%), Gaps = 8/260 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 65
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
           ++HR++KPENLLL  + +   +K+ DFG +++       H   GT  YL+PE+++   + 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRL 252
             VD W  G++ Y  L G PPF  E Q   + +I      +PS    +++ EAK LI  +
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 253 LVKDSSKRLSLQKIMEHPWI 272
           L  +  KR++  + ++ PWI
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 139/266 (52%), Gaps = 8/266 (3%)
Query: 3   TKTAEREDNR--KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEK 59
           T T  + DN   +    L DF     LGKG FG+V L     +    A+KI+ K+  I+ 
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             ++  +  +  +    + P + +L+  F   +R++ ++EY + G+L   +++  RF E 
Sbjct: 62  DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTM 176
            A  Y A +   L +     +I+RD+K +N++LD EG +KI DFG    ++         
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF 181
Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
           CGT DY+APE++  + +  +VD W  G+L YE L G  PFE E + + F+ IM+ ++++P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 241
Query: 237 SAPSISAEAKHLISRLLVKDSSKRLS 262
              S+S EA  +   L+ K   KRL 
Sbjct: 242 K--SMSKEAVAICKGLMTKHPGKRLG 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 137/260 (52%), Gaps = 8/260 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+HP
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N 
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
           ++HR++KPENLLL  + +   +K+ DFG +++       H   GT  YL+PE+++   + 
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRL 252
             VD W  G++ Y  L G PPF  E Q   + +I      +PS    +++ EAK LI  +
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 244
Query: 253 LVKDSSKRLSLQKIMEHPWI 272
           L  +  KR++  + ++ PWI
Sbjct: 245 LTVNPKKRITADQALKVPWI 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 137/260 (52%), Gaps = 8/260 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 65
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
           ++HR++KPENLLL  + +   +K+ DFG +++       H   GT  YL+PE+++   + 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRL 252
             VD W  G++ Y  L G PPF  E Q   + +I      +PS    +++ EAK LI  +
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 253 LVKDSSKRLSLQKIMEHPWI 272
           L  +  KR++  + ++ PWI
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT  ++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  144 bits (363), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 146/271 (53%), Gaps = 12/271 (4%)
Query: 14  REWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           R+  ++D +E+G  LG G+F  V   R+  +    A K I K ++   +    + ++ RE
Sbjct: 6   RQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   +RHPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + 
Sbjct: 66  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +     R+K+ DFG +  +++ ++   + GT +++
Sbjct: 126 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSI 241
           APE+V  +      D W++G++ Y  L GA PF  E++++T   I  V+  F      + 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 245
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           S  AK  I RLLVKD  +R+ + + +EH WI
Sbjct: 246 SELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  143 bits (361), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 147/266 (55%), Gaps = 9/266 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   +GKG F  V    ++ + H  A KII  +++   +   +L RE  I   L+H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSA-RDHQKLEREARICRLLKHS 63
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  A+ +CH+  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEH 193
           V+HRD+KPENLLL  + +   +K+ DFG +++ +  +       GT  YL+PE++  + +
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISR 251
              VD W  G++ Y  L G PPF  E Q   +++I      FPS    +++ EAK+LI++
Sbjct: 184 GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQ 243
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           +L  + +KR++  + ++HPW+ + + 
Sbjct: 244 MLTINPAKRITAHEALKHPWVCQRST 269

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 145/258 (56%), Gaps = 7/258 (2%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSL 76
           ++DF + + LGKG FG+V+L    ++    A+K + K+ +     ++  +  +  +  + 
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
              +++RD+K +N+LLD +G +KI DFG    ++   +K +  CGT DY+APE++  +++
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKY 195
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           +++VD W+ G+L YE L G  PF  + +++ F  I   +  +P    +  EAK L+ +L 
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLF 253
Query: 254 VKDSSKRLSLQ-KIMEHP 270
           V++  KRL ++  I +HP
Sbjct: 254 VREPEKRLGVRGDIRQHP 271

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/260 (33%), Positives = 139/260 (53%), Gaps = 12/260 (4%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 195 --YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSISAEAKHL 248
             Y    D W++G+  YE L G  PF A+S   T+ +IM  K  L+FP    IS EAK+L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 249 ISRLLVKDSSKRLSLQKIME 268
           I   L  D   RL    + E
Sbjct: 313 ICAFLT-DREVRLGRNGVEE 331

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 137/260 (52%), Gaps = 7/260 (2%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQ 65
           +   NR R   L DF     LGKG FG+V L     +    A+KI+ K+  I+   ++  
Sbjct: 330 DNNGNRDR-MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           +  +  +    + P + +L+  F   +R++ ++EY + G+L   +++  RF E  A  Y 
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDY 182
           A +   L +     +I+RD+K +N++LD EG +KI DFG    ++         CGT DY
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDY 508
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           +APE++  + +  +VD W  G+L YE L G  PFE E + + F+ IM+ ++++P   S+S
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMS 566
Query: 243 AEAKHLISRLLVKDSSKRLS 262
            EA  +   L+ K   KRL 
Sbjct: 567 KEAVAICKGLMTKHPGKRLG 586

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/260 (33%), Positives = 139/260 (53%), Gaps = 12/260 (4%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 195 --YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSISAEAKHL 248
             Y    D W++G+  YE L G  PF A+S   T+ +IM  K  L+FP    IS EAK+L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 249 ISRLLVKDSSKRLSLQKIME 268
           I   L  D   RL    + E
Sbjct: 313 ICAFLT-DREVRLGRNGVEE 331

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/260 (33%), Positives = 139/260 (53%), Gaps = 12/260 (4%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 195 --YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSISAEAKHL 248
             Y    D W++G+  YE L G  PF A+S   T+ +IM  K  L+FP    IS EAK+L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 249 ISRLLVKDSSKRLSLQKIME 268
           I   L  D   RL    + E
Sbjct: 308 ICAFLT-DREVRLGRNGVEE 326

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 142/262 (54%), Gaps = 9/262 (3%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +++++   LGKG F  V    +V +    A  II  +++     Q +L RE  I   L+H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKH 69
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +LI +    GEL+ ++     ++E  A+  I  +  A+ +CH+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 139 HVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
            V+HR++KPENLLL  +     +K+ DFG +++   ++       GT  YL+PE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLIS 250
           +   VD W  G++ Y  L G PPF  E Q   +++I      FPS    +++ EAK LI+
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
           ++L  + SKR++  + ++HPWI
Sbjct: 250 KMLTINPSKRITAAEALKHPWI 271

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 148/280 (52%), Gaps = 26/280 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILR 83
           +PLG+G F         +S    A+KII K      +++   ++E+  ++    HPNI++
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  FHD    FL++E  + GEL+  ++K + F+E +A+  +  L +A+++ H+  V+HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 144 DIKPENLLLDHEG---RLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           D+KPENLL   E     +KI DFG++           T C TL Y APE++    +D + 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 198 DNWTLGILCYEFLYGAPPFEA-------ESQKDTFRRIMKVDLSFPSAP--SISAEAKHL 248
           D W+LG++ Y  L G  PF++        S  +  ++I K D SF      ++S EAK L
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIK----NANPRGTCDI 284
           I  LL  D +KRL +  +  + W+      ++NP  T DI
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDI 290

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LI E    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI 249
                 D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 144/261 (55%), Gaps = 11/261 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FEI R +GKG FG+V +V++ ++K   A+K + K++  +      + +E++I   L HP 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++ L+  F D+E +F++++    G+L   L+++  F E+    +I  L  AL Y     +
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKE---HDY 195
           IHRD+KP+N+LLD  G + I DF  +  +   ++  TM GT  Y+APEM  +++   + +
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 196 AVDNWTLGILCYEFLYGAPPF---EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           AVD W+LG+  YE L G  P+    + S K+         +++PSA   S E   L+ +L
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKL 254
Query: 253 LVKDSSKRLS-LQKIMEHPWI 272
           L  +  +R S L  +   P++
Sbjct: 255 LEPNPDQRFSQLSDVQNFPYM 275

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 146/274 (53%), Gaps = 15/274 (5%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           R  +   +D+++ + +G+G FG V LVR   S+   A+K++ K ++ K         E +
Sbjct: 68  RGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERD 127
Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           I +    P +++L+  F DD+ +++++EY   G+L   L  +    E+ A  Y A +  A
Sbjct: 128 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLA 186
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEM 187
           L   H   +IHRD+KP+N+LLD  G LK+ DFG  ++        C    GT DY++PE+
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246
Query: 188 VENKEHD--YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSI 241
           ++++  D  Y    D W++G+  +E L G  PF A+S   T+ +IM  K  L FP    I
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEI 306
Query: 242 SAEAKHLISRLLVKDSSKRL---SLQKIMEHPWI 272
           S  AK+LI   L  D   RL    +++I +HP+ 
Sbjct: 307 SKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFF 339

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 144/271 (53%), Gaps = 12/271 (4%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + HPNI+ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSI 241
           APE+V  +      D W++G++ Y  L GA PF  +++++T   I  V   F        
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           S  AK  I +LLVK++ KRL++Q+ + HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 148/269 (55%), Gaps = 15/269 (5%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPV---ALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           D+++   LGKG F    +VR    K P    A KII  +++   +   +L RE  I   L
Sbjct: 32  DYQLFEELGKGAFS---VVRRCVKKTPTQEYAAKIINTKKLSA-RDHQKLEREARICRLL 87
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++ + H
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 137 ENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVEN 190
           ++ ++HRD+KPENLLL  + +   +K+ DFG +++ + ++       GT  YL+PE++  
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
             +   VD W  G++ Y  L G PPF  E Q   +++I      FPS    +++ EAK+L
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           I+++L  + +KR++  + ++HPW+ + + 
Sbjct: 268 INQMLTINPAKRITADQALKHPWVCQRST 296

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSF-PSA-PSISA 243
            V    ++ AVD W+LG++ +  L G PPF E  +Q     +I     +F P     +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 136/253 (53%), Gaps = 10/253 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG+V+   E  +   +A KII   +    K + +++ E+ + + L H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKII---KTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 87  WFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F     I L++EY   GEL+ R + +    TE     ++  +   + + H+ +++H D+
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 146 KPENLLLDHEG--RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           KPEN+L  +    ++KI DFG +   + R K     GT ++LAPE+V      +  D W+
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKV--DLSFPSAPSISAEAKHLISRLLVKDSSK 259
           +G++ Y  L G  PF  ++  +T   I+    DL       IS EAK  IS+LL+K+ S 
Sbjct: 274 VGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSW 333
Query: 260 RLSLQKIMEHPWI 272
           R+S  + ++HPW+
Sbjct: 334 RISASEALKHPWL 346

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSF-PSA-PSISA 243
            V    ++ AVD W+LG++ +  L G PPF E  +Q     +I     +F P     +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 70  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSF-PSA-PSISA 243
            V    ++ AVD W+LG++ +  L G PPF E  +Q     +I     +F P     +S 
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 248
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 249 KALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  138 bits (347), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSF-PSA-PSISA 243
            V    ++ AVD W+LG++ +  L G PPF E  +Q     +I     +F P     +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 77  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSF-PSA-PSISA 243
            V    ++ AVD W+LG++ +  L G PPF E  +Q     +I     +F P     +S 
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 255
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 256 KALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA++II K +      +       +  E+EI  
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 210 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 328
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSF-PSA-PSISA 243
            V    ++ AVD W+LG++ +  L G PPF E  +Q     +I     +F P     +S 
Sbjct: 329 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 388
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 389 KALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA++II K +      +       +  E+EI  
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 196 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSF-PSA-PSISA 243
            V    ++ AVD W+LG++ +  L G PPF E  +Q     +I     +F P     +S 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSI 241
           APE+V  +      D W++G++ Y  L GA PF  +++++T   I  V   F        
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           S  AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSI 241
           APE+V  +      D W++G++ Y  L GA PF  +++++T   I  V   F        
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           S  AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSI 241
           APE+V  +      D W++G++ Y  L GA PF  +++++T   I  V   F        
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           S  AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSI 241
           APE+V  +      D W++G++ Y  L GA PF  +++++T   I  V   F        
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           S  AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSI 241
           APE+V  +      D W++G++ Y  L GA PF  +++++T   I  V   F        
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           S  AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 133/250 (53%), Gaps = 13/250 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E ++  +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F DD  ++L+++Y   G+L   L K   R  E+ A  Y+A +  A+   H+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMVENKE- 192
            H +HRDIKP+N+L+D  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 193 ----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPS-APSISAEA 245
               +    D W+LG+  YE LYG  PF AES  +T+ +IM  K    FP+    +S  A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 246 KHLISRLLVK 255
           K LI RL+  
Sbjct: 314 KDLIRRLICS 323

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 142/258 (55%), Gaps = 12/258 (4%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V L RE  S   VA+K++    + K + +  L  E+ I    +H N++ +Y 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   E +++++E+   G L  ++    R  E+Q AT   ++  ALAY H   VIHRDIK
Sbjct: 110 SYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR  + GT  ++APE++    +   VD W+LG
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPSISAEAKHLISRLLVKDSSKR 260
           I+  E + G PP+ ++S     +R+   D   P   ++  +S   +  + R+LV+D  +R
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286
Query: 261 LSLQKIMEHPWIIKNANP 278
            + Q++++HP++++   P
Sbjct: 287 ATAQELLDHPFLLQTGLP 304

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 132/250 (52%), Gaps = 13/250 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   ++   A+KI+ K ++ K       R E ++  +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   +  E  A  YI  +  A+   H+
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMVENKEH 193
            H +HRDIKP+N+LLD  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 194 DYA-----VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPS-APSISAEA 245
                    D W+LG+  YE LYG  PF AES  +T+ +IM  +    FPS    +S EA
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 329
Query: 246 KHLISRLLVK 255
           K LI RL+  
Sbjct: 330 KDLIQRLICS 339

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 132/250 (52%), Gaps = 13/250 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   ++   A+KI+ K ++ K       R E ++  +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   +  E  A  YI  +  A+   H+
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KRHTMCGTLDYLAPEMVENKEH 193
            H +HRDIKP+N+LLD  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 194 DYA-----VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPS-APSISAEA 245
                    D W+LG+  YE LYG  PF AES  +T+ +IM  +    FPS    +S EA
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 313
Query: 246 KHLISRLLVK 255
           K LI RL+  
Sbjct: 314 KDLIQRLICS 323

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 26/269 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +E+   +G G +          +    A+KII K + +  +         EI+  LR   
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---------EIEILLRYGQ 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L   + D + ++++ E    GEL  ++ + + F+E++A+  + ++T  + Y H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 138 NHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKRH---TMCGTLDYLAPEMVEN 190
             V+HRD+KP N+L +D  G    ++I DFG++ Q R++     T C T +++APE++E 
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM------KVDLSFPSAPSISAE 244
           + +D A D W+LG+L Y  L G  PF A    DT   I+      K  LS     S+S  
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 245 AKHLISRLLVKDSSKRLSLQKIMEHPWII 273
           AK L+S++L  D  +RL+   ++ HPWI+
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  131 bits (329), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 145/290 (50%), Gaps = 39/290 (13%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLY 85
           LG+G + +V     +++    A+KII K+       + ++ RE+E +     + NIL L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHS---RSRVFREVETLYQCQGNKNILELI 77
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +F DD R +L+ E    G +   ++K + F E++A+  +  +  AL + H   + HRD+
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 146 KPENLLLDHEGR---LKIGDF--GWSVQ--------SRSKRHTMCGTLDYLAPEMVE--- 189
           KPEN+L +   +   +KI DF  G  ++        +  +  T CG+ +Y+APE+VE   
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 190 --NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRRIMKVD 232
                +D   D W+LG++ Y  L G PPF      D                F  I +  
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 233 LSFPSA--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 280
             FP      IS+EAK LIS+LLV+D+ +RLS  ++++HPW+   A  +G
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKG 307

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 133/260 (51%), Gaps = 12/260 (4%)
Query: 21  FEIGRPLGKGKFGRVY-LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++I   LG G FG V+  V +   +  VA  I     ++KY +++    E+ I + L HP
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN----EISIMNQLHHP 108
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            ++ L+  F D   + LILE+   GEL+ R   +  + +E +   Y+      L + HE+
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 139 HVIHRDIKPENLLLDHE--GRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
            ++H DIKPEN++ + +    +KI DFG + +            T ++ APE+V+ +   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRL 252
           +  D W +G+L Y  L G  PF  E   +T + + + D  F   +  S+S EAK  I  L
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288
Query: 253 LVKDSSKRLSLQKIMEHPWI 272
           L K+  KRL++   +EHPW+
Sbjct: 289 LQKEPRKRLTVHDALEHPWL 308

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 26/269 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +E+   +G G +          +    A+KII K + +  +         EI+  LR   
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE---------EIEILLRYGQ 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L   + D + ++++ E    GEL  ++ + + F+E++A+  + ++T  + Y H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 138 NHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVEN 190
             V+HRD+KP N+L +D  G    ++I DFG++ Q R++     T C T +++APE++E 
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLER 194
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM------KVDLSFPSAPSISAE 244
           + +D A D W+LG+L Y  L G  PF A    DT   I+      K  LS     S+S  
Sbjct: 195 QGYDAACDIWSLGVLLYTXLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 245 AKHLISRLLVKDSSKRLSLQKIMEHPWII 273
           AK L+S+ L  D  +RL+   ++ HPWI+
Sbjct: 254 AKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 123/211 (58%), Gaps = 14/211 (6%)
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+ L   + D + ++L+ E    GEL  ++ + + F+E++A+  + ++   + Y H
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 137 ENHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKRH---TMCGTLDYLAPEMVE 189
              V+HRD+KP N+L +D  G    L+I DFG++ Q R++     T C T +++APE+++
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM------KVDLSFPSAPSISA 243
            + +D   D W+LGIL Y  L G  PF A    DT   I+      K  LS  +  ++S 
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSGKFTLSGGNWNTVSE 257
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
            AK L+S++L  D  +RL+ +++++HPW+ +
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 123/211 (58%), Gaps = 14/211 (6%)
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+ L   + D + ++L+ E    GEL  ++ + + F+E++A+  + ++   + Y H
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 137 ENHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKRH---TMCGTLDYLAPEMVE 189
              V+HRD+KP N+L +D  G    L+I DFG++ Q R++     T C T +++APE+++
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM------KVDLSFPSAPSISA 243
            + +D   D W+LGIL Y  L G  PF A    DT   I+      K  LS  +  ++S 
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSGKFTLSGGNWNTVSE 257
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
            AK L+S++L  D  +RL+ +++++HPW+ +
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 138/264 (52%), Gaps = 20/264 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKI-------IFKEQIEKYKIQHQLRREMEIQSSLR-H 78
           +G+G    V       + H  A+KI       +  EQ+E+  ++   RRE  I   +  H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE--VREATRRETHILRQVAGH 159
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P+I+ L   +     +FL+ +   +GEL+  L +    +E++  + + SL  A+++ H N
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE------N 190
           +++HRD+KPEN+LLD   ++++ DFG+S  ++   K   +CGT  YLAPE+++      +
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHL 248
             +   VD W  G++ +  L G+PPF    Q    R IM+    F  P     S+  K L
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDL 339
Query: 249 ISRLLVKDSSKRLSLQKIMEHPWI 272
           ISRLL  D   RL+ ++ ++HP+ 
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFF 363

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 15/259 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +  E  +   VA+K   K  + K + +  L  E+ I     H N++ +Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q AT   S+  AL+Y H   VIHRDIK
Sbjct: 110 SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR  + GT  ++APE++    +   VD W+LG
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLG 228
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP----SISAEAKHLISRLLVKDSSK 259
           I+  E + G PP+  E      RRI     S P        +S+  +  +  +LV++ S+
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDLMLVREPSQ 285
Query: 260 RLSLQKIMEHPWIIKNANP 278
           R + Q+++ HP+ +K A P
Sbjct: 286 RATAQELLGHPF-LKLAGP 303

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 132/266 (49%), Gaps = 21/266 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   R LG G FG V+LV E  S     +K I K++ +      Q+  E+E+  SL HPN
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPN 81
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNALAYCH 136
           I++++  F D   +++++E    GEL   +     + +  +E   A  +  + NALAY H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 137 ENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENK 191
             HV+H+D+KPEN+L         +KI DFG +   +S  H+    GT  Y+APE V  +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKR 200
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAES-----QKDTFRRIMKVDLSFPSAPSISAEAK 246
           +  +  D W+ G++ Y  L G  PF   S     QK T++         P  P    +A 
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP----QAV 256
Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWI 272
            L+ ++L KD  +R S  +++ H W 
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 141/269 (52%), Gaps = 21/269 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-----HQLRREMEIQSS 75
           +E+   +GKG F  V      E+    A+KI+    + K+          L+RE  I   
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIV---DVAKFTSSPGLSTEDLKREASICHM 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           L+HP+I+ L   +  D  ++++ E+    +L  E+ K       ++E  A+ Y+  +  A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAP 185
           L YCH+N++IHRD+KPEN+LL   ++   +K+GDFG ++Q   S        GT  ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-PSAPS-ISA 243
           E+V+ + +   VD W  G++ +  L G  PF    ++  F  I+K      P   S IS 
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISE 261
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            AK L+ R+L+ D ++R+++ + + HPW+
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/291 (31%), Positives = 143/291 (49%), Gaps = 40/291 (13%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLY 85
           LG+G   RV     + +    A+KII K+      I+ ++ RE+E+    + H N+L L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +F +++R +L+ E    G +   + K R F E +A+  +  + +AL + H   + HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 146 KPENLLLDHEGR---LKIGDFG----------WSVQSRSKRHTMCGTLDYLAPEMVENKE 192
           KPEN+L +H  +   +KI DFG           S  S  +  T CG+ +Y+APE+VE   
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 193 -----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRRIMKVD 232
                +D   D W+LG++ Y  L G PPF      D                F  I +  
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 233 LSFPSA--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 281
             FP      IS  AK LIS+LLV+D+ +RLS  ++++HPW ++   P  T
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW-VQGCAPENT 307

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 110/205 (53%), Gaps = 10/205 (4%)
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   +   H+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHD- 194
            +++HRD+KPEN+LLD +  +K+ DFG+S Q     K  ++CGT  YLAPE++E   +D 
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDN 202
Query: 195 ---YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKH 247
              Y   VD W+ G++ Y  L G+PPF    Q    R IM  +  F  P     S   K 
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
           L+SR LV    KR + ++ + HP+ 
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 137/254 (53%), Gaps = 9/254 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG+  LV+  E      +K I   ++   K + + RRE+ + ++++HPNI++   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRE 90
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENHVIHRD 144
            F ++  ++++++Y   G+L++ +   +   F E Q   +   +  AL + H+  ++HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 145 IKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC-GTLDYLAPEMVENKEHDYAVDNWT 201
           IK +N+ L  +G +++GDFG +  + S  +    C GT  YL+PE+ ENK ++   D W 
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKDSSKR 260
           LG + YE       FEA S K+   +I  +  SFP      S + + L+S+L  ++   R
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKI--ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDR 268
Query: 261 LSLQKIMEHPWIIK 274
            S+  I+E  +I K
Sbjct: 269 PSVNSILEKGFIAK 282

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 8/256 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 85  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      + I   +     +   +S   K  + RLLV+D ++R +
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 263
Query: 263 LQKIMEHPWIIKNANP 278
             ++++HP++ K   P
Sbjct: 264 AAELLKHPFLAKAGPP 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 8/256 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 94  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      + I   +     +   +S   K  + RLLV+D ++R +
Sbjct: 213 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 272
Query: 263 LQKIMEHPWIIKNANP 278
             ++++HP++ K   P
Sbjct: 273 AAELLKHPFLAKAGPP 288

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 8/256 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 96  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      + I   +     +   +S   K  + RLLV+D ++R +
Sbjct: 215 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 274
Query: 263 LQKIMEHPWIIKNANP 278
             ++++HP++ K   P
Sbjct: 275 AAELLKHPFLAKAGPP 290

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 8/256 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 89  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      + I   +     +   +S   K  + RLLV+D ++R +
Sbjct: 208 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 267
Query: 263 LQKIMEHPWIIKNANP 278
             ++++HP++ K   P
Sbjct: 268 AAELLKHPFLAKAGPP 283

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 8/256 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 139 SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      + I   +     +   +S   K  + RLLV+D ++R +
Sbjct: 258 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 317
Query: 263 LQKIMEHPWIIKNANP 278
             ++++HP++ K   P
Sbjct: 318 AAELLKHPFLAKAGPP 333

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 10/205 (4%)
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   +   H+
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHD- 194
            +++HRD+KPEN+LLD +  +K+ DFG+S Q     K   +CGT  YLAPE++E   +D 
Sbjct: 130 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 189
Query: 195 ---YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKH 247
              Y   VD W+ G++ Y  L G+PPF    Q    R IM  +  F  P     S   K 
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 249
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
           L+SR LV    KR + ++ + HP+ 
Sbjct: 250 LVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 8/256 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 216 SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS 262
           I+  E + G PP+  E      + I   +     +   +S   K  + RLLV+D ++R +
Sbjct: 335 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 394
Query: 263 LQKIMEHPWIIKNANP 278
             ++++HP++ K   P
Sbjct: 395 AAELLKHPFLAKAGPP 410

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 144/278 (51%), Gaps = 20/278 (7%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRRE 69
           R+ + +DF EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV------E 84
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASL 128
           ++I +S  HPNI++L   F+ +  +++++E+   G +    L   R  TE Q        
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 144
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAP 185
            +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S ++     +R +  GT  ++AP
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 186 EMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           E+V     +++ +DY  D W+LGI   E     PP    +      +I K +    + PS
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 241 -ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 144/278 (51%), Gaps = 20/278 (7%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRRE 69
           R+ + +DF EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV------E 84
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASL 128
           ++I +S  HPNI++L   F+ +  +++++E+   G +    L   R  TE Q        
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 144
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAP 185
            +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S ++     +R +  GT  ++AP
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 186 EMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           E+V     +++ +DY  D W+LGI   E     PP    +      +I K +    + PS
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 241 -ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--------------------- 56
           L  + +   +GKG +G V L          A+K++ K++                     
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 57  --IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK 112
             I+      Q+ +E+ I   L HPN+++L     D  ++ ++++ E  ++G +  E+  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPT 130
Query: 113 HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---S 169
            +  +E QA  Y   L   + Y H   +IHRDIKP NLL+  +G +KI DFG S +   S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 170 RSKRHTMCGTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFEAESQKDTFR 226
            +      GT  ++APE +      +   A+D W +G+  Y F++G  PF  E       
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 227 RIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
           +I    L FP  P I+ + K LI+R+L K+   R+ + +I  HPW+ +
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 10/205 (4%)
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   +   H+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHD- 194
            +++HRD+KPEN+LLD +  +K+ DFG+S Q     K   +CGT  YLAPE++E   +D 
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 195 ---YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKH 247
              Y   VD W+ G++ Y  L G+PPF    Q    R IM  +  F  P     S   K 
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
           L+SR LV    KR + ++ + HP+ 
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 143/278 (51%), Gaps = 20/278 (7%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRRE 69
           R+ + +DF EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV------E 84
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASL 128
           ++I +S  HPNI++L   F+ +  +++++E+   G +    L   R  TE Q        
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 144
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAP 185
            +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S ++     +R    GT  ++AP
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 186 EMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           E+V     +++ +DY  D W+LGI   E     PP    +      +I K +    + PS
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 241 -ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I + L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINAMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  124 bits (310), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 144/291 (49%), Gaps = 40/291 (13%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLY 85
           LG+G   RV     + +    A+KII K+      I+ ++ RE+E+    + H N+L L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +F +++R +L+ E    G +   + K R F E +A+  +  + +AL + H   + HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 146 KPENLLLDHEGR---LKIGDF--GWSVQ--------SRSKRHTMCGTLDYLAPEMVENKE 192
           KPEN+L +H  +   +KI DF  G  ++        S  +  T CG+ +Y+APE+VE   
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 193 -----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRRIMKVD 232
                +D   D W+LG++ Y  L G PPF      D                F  I +  
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 233 LSFPSA--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 281
             FP      IS  AK LIS+LLV+D+ +RLS  ++++HPW ++   P  T
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW-VQGCAPENT 307

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 61
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 238
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 239 ------LLHKILVENPSARITIPDIKKDRW 262

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 276 ANP 278
             P
Sbjct: 292 TKP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 276 ANP 278
             P
Sbjct: 293 TKP 295

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 127/255 (49%), Gaps = 13/255 (5%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +L +F I + +G+G+F  VY    +    PVALK +    +   K +    +E+++   L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNAL 132
            HPN+++ Y  F +D  + ++LE A  G+L R +    ++ R   E+    Y   L +AL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVE 189
            + H   V+HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--DTFRRIMKVDLSFPSAPS--ISAEA 245
              +++  D W+LG L YE      PF  +        ++I + D  +P  PS   S E 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEEL 267
Query: 246 KHLISRLLVKDSSKR 260
           + L++  +  D  KR
Sbjct: 268 RQLVNMCINPDPEKR 282

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 276 ANP 278
             P
Sbjct: 292 TKP 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 276 ANP 278
             P
Sbjct: 294 TKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 276 ANP 278
             P
Sbjct: 293 TKP 295

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 276 ANP 278
             P
Sbjct: 292 TKP 294

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 17/270 (6%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 244
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 364
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---RRIMKVDLSFPSAPSISAEAKH 247
             +D + D ++LG + ++ L G  PF     KD     R  + + +  P   S S E + 
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRS 422
Query: 248 LISRLLVKDSSKRLSL-----QKIMEHPWI 272
           L+  LL +D ++RL       Q++ E P+ 
Sbjct: 423 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 276 ANP 278
             P
Sbjct: 294 TKP 296

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 276 ANP 278
             P
Sbjct: 291 TKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 63
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 115
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 116 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 174
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 234
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 235 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294
Query: 276 ANP 278
             P
Sbjct: 295 TKP 297

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 276 ANP 278
             P
Sbjct: 293 TKP 295

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G  G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 276 ANP 278
             P
Sbjct: 291 TKP 293

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 17/270 (6%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 245
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---RRIMKVDLSFPSAPSISAEAKH 247
             +D + D ++LG + ++ L G  PF     KD     R  + + +  P   S S E + 
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRS 423
Query: 248 LISRLLVKDSSKRLSL-----QKIMEHPWI 272
           L+  LL +D ++RL       Q++ E P+ 
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 145/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 276 ANP 278
             P
Sbjct: 291 TKP 293

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 17/270 (6%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 245
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---RRIMKVDLSFPSAPSISAEAKH 247
             +D + D ++LG + ++ L G  PF     KD     R  + + +  P   S S E + 
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRS 423
Query: 248 LISRLLVKDSSKRLSL-----QKIMEHPWI 272
           L+  LL +D ++RL       Q++ E P+ 
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 140/267 (52%), Gaps = 18/267 (6%)
Query: 20  DFEIGRP-LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           D+++ +  LG G  G+V       +    ALK+++     + ++ H      +       
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH----WQASGGPHI 84
Query: 79  PNILRLYGWFHDDERIFLI-LEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYC 135
             IL +Y   H  +R  LI +E    GEL+  +  R  + FTE++AA  +  +  A+ + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
           H +++ HRD+KPENLL    + +  LK+ DFG++ + +++   T C T  Y+APE++  +
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPE 204
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----RRIMKVDLSFPSA--PSISAEA 245
           ++D + D W+LG++ Y  L G PPF + + +       RRI      FP+     +S +A
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWI 272
           K LI  LL  D ++RL++ + M HPWI
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 17/270 (6%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 245
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---RRIMKVDLSFPSAPSISAEAKH 247
             +D + D ++LG + ++ L G  PF     KD     R  + + +  P   S S E + 
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRS 423
Query: 248 LISRLLVKDSSKRLSL-----QKIMEHPWI 272
           L+  LL +D ++RL       Q++ E P+ 
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/296 (29%), Positives = 144/296 (48%), Gaps = 51/296 (17%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 142/303 (46%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+          + F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ--------DLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 276 ANP 278
             P
Sbjct: 291 TKP 293

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 140/267 (52%), Gaps = 18/267 (6%)
Query: 20  DFEIGRP-LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           D+++ +  LG G  G+V       +    ALK+++     + ++ H      +       
Sbjct: 10  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH----WQASGGPHI 65
Query: 79  PNILRLYGWFHDDERIFLI-LEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYC 135
             IL +Y   H  +R  LI +E    GEL+  +  R  + FTE++AA  +  +  A+ + 
Sbjct: 66  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 125
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
           H +++ HRD+KPENLL    + +  LK+ DFG++ + +++   T C T  Y+APE++  +
Sbjct: 126 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPE 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----RRIMKVDLSFPSA--PSISAEA 245
           ++D + D W+LG++ Y  L G PPF + + +       RRI      FP+     +S +A
Sbjct: 186 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 245
Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWI 272
           K LI  LL  D ++RL++ + M HPWI
Sbjct: 246 KQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  121 bits (303), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 141/295 (47%), Gaps = 35/295 (11%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            HPNI++L    H + +++L+ E+ H+  + + +             +Y+  L   LA+C
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVEN- 190
           H + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y APE++   
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------D 232
           K +  AVD W+LG +  E +     F  +S+ D   RI +                    
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 233 LSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
            SFP           P +  + + L+S++L  D +KR+S +  + HP+      P
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 144/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 276 ANP 278
             P
Sbjct: 294 TKP 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 131/261 (50%), Gaps = 19/261 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKDS 257
            W+LGI+  E + G PP+  E+       I          P  +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  120 bits (301), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 144/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 276 ANP 278
             P
Sbjct: 292 TKP 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 144/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 276 ANP 278
             P
Sbjct: 291 TKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 67
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 119
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 178
Query: 185 PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE ++  K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 238
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 239 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 298
Query: 277 NP 278
            P
Sbjct: 299 KP 300

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE ++  K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 277 NP 278
            P
Sbjct: 292 KP 293

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 67
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 119
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 178
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 238
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 239 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 298
Query: 277 NP 278
            P
Sbjct: 299 KP 300

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 277 NP 278
            P
Sbjct: 291 KP 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 64
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 116
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 175
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 235
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 236 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295
Query: 277 NP 278
            P
Sbjct: 296 KP 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 113
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 172
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 277 NP 278
            P
Sbjct: 293 KP 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 277 NP 278
            P
Sbjct: 291 KP 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 277 NP 278
            P
Sbjct: 292 KP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 277 NP 278
            P
Sbjct: 291 KP 292

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 240
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 241 ------LLHKILVENPSARITIPDIKKDRW 264

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 137/281 (48%), Gaps = 19/281 (6%)
Query: 12  RKREWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           R +E  LQ  DFEI + +G+G F  V +V+  ++    A+KI+ K  + K       R E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASL 128
            ++  +     I +L+  F D+  ++L++EY   G+L   L K   R   + A  Y+A +
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KRHTMCGTLDYLA 184
             A+   H    +HRDIKP+N+LLD  G +++ DFG  ++ R+    +     GT DYL+
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 185 PEMVENKEHDYA-------VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSF 235
           PE+++               D W LG+  YE  YG  PF A+S  +T+ +I+  K  LS 
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 236 PSAP-SISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWII 273
           P     +  EA+  I RLL    ++  R        HP+  
Sbjct: 292 PLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 138/269 (51%), Gaps = 21/269 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-----HQLRREMEIQSS 75
           +E+   +GKG F  V      E+    A+KI+    + K+          L+RE  I   
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV---DVAKFTSSPGLSTEDLKREASICHM 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           L+HP+I+ L   +  D  ++++ E+    +L  E+ K       ++E  A+ Y+  +  A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAP 185
           L YCH+N++IHRD+KP  +LL   ++   +K+G FG ++Q   S        GT  ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-PSAPS-ISA 243
           E+V+ + +   VD W  G++ +  L G  PF    ++  F  I+K      P   S IS 
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISE 261
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            AK L+ R+L+ D ++R+++ + + HPW+
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 143/301 (47%), Gaps = 51/301 (16%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASLT 129
           PNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQLL 112
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAP 185
             LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y AP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 171
Query: 186 EMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------- 231
           E++   K +  AVD W+LG +  E +     F  +S+ D   RI +              
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 232 -----DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
                  SFP           P +  + + L+S++L  D +KR+S +  + HP+      
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
Query: 278 P 278
           P
Sbjct: 292 P 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 138/269 (51%), Gaps = 21/269 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-----HQLRREMEIQSS 75
           +E+   +GKG F  V      E+    A+KI+    + K+          L+RE  I   
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV---DVAKFTSSPGLSTEDLKREASICHM 84
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           L+HP+I+ L   +  D  ++++ E+    +L  E+ K       ++E  A+ Y+  +  A
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAP 185
           L YCH+N++IHRD+KP  +LL   ++   +K+G FG ++Q   S        GT  ++AP
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 204
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-PSAPS-ISA 243
           E+V+ + +   VD W  G++ +  L G  PF    ++  F  I+K      P   S IS 
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISE 263
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            AK L+ R+L+ D ++R+++ + + HPW+
Sbjct: 264 SAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 140/294 (47%), Gaps = 35/294 (11%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HPNI++L    H + +++L+ E+ H+  + + +             +Y+  L   LA+CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVEN-K 191
            + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y APE++   K
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 178
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------DL 233
            +  AVD W+LG +  E +     F  +S+ D   RI +                     
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 234 SFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           SFP           P +  + + L+S++L  D +KR+S +  + HP+      P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 130/265 (49%), Gaps = 14/265 (5%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK--------VDLSFPSAPS--ISAEAKH 247
           D W++G+   E   G  P      K+  R  M         V+   P  PS   S E + 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 244
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
            +++ L+K+ ++R  L+++M H +I
Sbjct: 245 FVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 144/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              L++CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 277 NP 278
            P
Sbjct: 292 KP 293

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 134/265 (50%), Gaps = 19/265 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E+EI ++  
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV------EIEILATCD 66
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HP I++L G ++ D ++++++E+   G +    L   R  TE Q       +  AL + H
Sbjct: 67  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 126
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV----- 188
              +IHRD+K  N+L+  EG +++ DFG S   +++  KR +  GT  ++APE+V     
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKH 247
           ++  +DY  D W+LGI   E     PP    +      +I K D      PS  S E + 
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 246
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
            +   L K+   R S  +++EHP++
Sbjct: 247 FLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 130/259 (50%), Gaps = 8/259 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 83
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 84  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 143
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 144 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 203
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK--VDLSFPSAPS--ISAEAKHLISRLL 253
           D W++G+   E   G  P  + S       ++   V+   P  PS   S E +  +++ L
Sbjct: 204 DIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 263
Query: 254 VKDSSKRLSLQKIMEHPWI 272
           +K+ ++R  L+++M H +I
Sbjct: 264 IKNPAERADLKQLMVHAFI 282

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 134/265 (50%), Gaps = 19/265 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E+EI ++  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV------EIEILATCD 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HP I++L G ++ D ++++++E+   G +    L   R  TE Q       +  AL + H
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV----- 188
              +IHRD+K  N+L+  EG +++ DFG S   +++  KR +  GT  ++APE+V     
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKH 247
           ++  +DY  D W+LGI   E     PP    +      +I K D      PS  S E + 
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
            +   L K+   R S  +++EHP++
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 131/261 (50%), Gaps = 19/261 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HR+IK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKDS 257
            W+LGI+  E + G PP+  E+       I          P  +SA  +  ++R L  D 
Sbjct: 200 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 259
Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            KR S +++++H + +K A P
Sbjct: 260 EKRGSAKELIQHQF-LKIAKP 279

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRRIMKVDLSFPSAPSI 241
            H   VD W+ GI+    L G  P++  S          +K T+    K   S P A   
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLA--- 239
Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L+ ++LV++ S R+++  I +  W
Sbjct: 240 ------LLHKILVENPSARITIPDIKKDRW 263

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 19/261 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR  M GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKDS 257
            W+LGI+  E + G PP+  E+       I          P  +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 258
Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 19/261 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR  M GT  ++APE+V  K +   VD
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKDS 257
            W+LGI+  E + G PP+  E+       I          P  +SA  +  ++R L  D 
Sbjct: 200 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 259
Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            KR S +++++H + +K A P
Sbjct: 260 EKRGSAKELIQHQF-LKIAKP 279

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 144/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+  +     +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 276 ANP 278
             P
Sbjct: 294 TKP 296

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 131/260 (50%), Gaps = 16/260 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F++   LG+G +G VY     E+   VA+K     Q+       ++ +E+ I      P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQQCDSPH 85
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENH 139
           +++ YG +  +  +++++EY   G +   +R +++  TE + AT + S    L Y H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            IHRDIK  N+LL+ EG  K+ DFG + Q     +KR+ + GT  ++APE+++   ++  
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---PSI-SAEAKHLISRL 252
            D W+LGI   E   G PP+   +     R I  +  + P     P + S      + + 
Sbjct: 206 ADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262
Query: 253 LVKDSSKRLSLQKIMEHPWI 272
           LVK   +R +  ++++HP++
Sbjct: 263 LVKSPEQRATATQLLQHPFV 282

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 47/287 (16%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASLTNALAYCHENHVI 141
             H  +R+ L+ E+     L ++L+K     E       A +++  L N +AYCH+  V+
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K++   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTT 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---PSISAEAKH------ 247
           +D W++G +  E + GAP F   S+ D   RI ++ L  P++   P+++   K+      
Sbjct: 182 IDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRI-LGTPNSKNWPNVTELPKYDPNFTV 240
Query: 248 -------------------LISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                              L+S++L  D ++R++ ++ +EH +  +N
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 143/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VAL  I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 277 NP 278
            P
Sbjct: 292 KP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 143/302 (47%), Gaps = 51/302 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VAL  I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------ 231
           PE++   K +  AVD W+LG +  E +     F  +S+ D   RI +             
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 232 ------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                   SFP           P +  + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 277 NP 278
            P
Sbjct: 291 KP 292

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 19/261 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR  M GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHLISRLLVKDS 257
            W+LGI+  E + G PP+  E+       I          P  +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 143/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+    F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKD---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 276 ANP 278
             P
Sbjct: 293 TKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 143/303 (47%), Gaps = 51/303 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+    F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKD---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
           APE++   K +  AVD W+LG +  E +     F  +S+ D   RI +            
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 232 -------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                    SFP           P +  + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 276 ANP 278
             P
Sbjct: 294 TKP 296

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/253 (33%), Positives = 123/253 (48%), Gaps = 17/253 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG +G VY  R++ ++  +A+K I  E+  +Y     L  E+ +   L+H NI++  G
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRY--SQPLHEEIALHKHLKHKNIVQYLG 86
Query: 87  WFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHR 143
            F ++  I + +E    G L   LR      +  EQ    Y   +   L Y H+N ++HR
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 144 DIKPENLLLD-HEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDY--AV 197
           DIK +N+L++ + G LKI DFG S           T  GTL Y+APE+++     Y  A 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 198 DNWTLGILCYEFLYGAPPFE--AESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLV 254
           D W+LG    E   G PPF    E Q   F+  M KV    P   S+SAEAK  I +   
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE--SMSAEAKAFILKCFE 264
Query: 255 KDSSKRLSLQKIM 267
            D  KR     ++
Sbjct: 265 PDPDKRACANDLL 277

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/253 (33%), Positives = 123/253 (48%), Gaps = 17/253 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG +G VY  R++ ++  +A+K I  E+  +Y     L  E+ +   L+H NI++  G
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRY--SQPLHEEIALHKHLKHKNIVQYLG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHR 143
            F ++  I + +E    G L   LR      +  EQ    Y   +   L Y H+N ++HR
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 144 DIKPENLLLD-HEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDY--AV 197
           DIK +N+L++ + G LKI DFG S           T  GTL Y+APE+++     Y  A 
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 192
Query: 198 DNWTLGILCYEFLYGAPPFE--AESQKDTFRRIM-KVDLSFPSAPSISAEAKHLISRLLV 254
           D W+LG    E   G PPF    E Q   F+  M KV    P   S+SAEAK  I +   
Sbjct: 193 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE--SMSAEAKAFILKCFE 250
Query: 255 KDSSKRLSLQKIM 267
            D  KR     ++
Sbjct: 251 PDPDKRACANDLL 263

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 4/204 (1%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   LG G    VYL  +      VA+K IF    EK +   +  RE+   S L H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ +     +D+  +L++EY     L   +  H   +   A  +   + + + + H+  +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           +HRDIKP+N+L+D    LKI DFG     S  S ++ + + GT+ Y +PE  + +  D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 197 VDNWTLGILCYEFLYGAPPFEAES 220
            D +++GI+ YE L G PPF  E+
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 127/255 (49%), Gaps = 11/255 (4%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S      + + YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G     LR    F E Q AT +  +   L Y H    IHRDIK
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 207
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLISRLLVKDSSKRL 261
           I   E   G PP    S     R +  +  + P       +   K  I   L KD S R 
Sbjct: 208 ITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRP 264
Query: 262 SLQKIMEHPWIIKNA 276
           + +++++H +I+KN+
Sbjct: 265 TAKELLKHKFIVKNS 279

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 145/287 (50%), Gaps = 47/287 (16%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASLTNALAYCHENHVI 141
             H  +R+ L+ E+     L ++L+K     E       A +++  L N +AYCH+  V+
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K++   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTT 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---PSISAEAKH------ 247
           +D W++G +  E + G P F   S+ D   RI ++ L  P++   P+++   K+      
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI-LGTPNSKNWPNVTELPKYDPNFTV 240
Query: 248 -------------------LISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                              L+S++L  D ++R++ ++ +EH +  +N
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 145/287 (50%), Gaps = 47/287 (16%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASLTNALAYCHENHVI 141
             H  +R+ L+ E+     L ++L+K     E       A +++  L N +AYCH+  V+
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K++   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTT 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---PSISAEAKH------ 247
           +D W++G +  E + G P F   S+ D   RI ++ L  P++   P+++   K+      
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI-LGTPNSKNWPNVTELPKYDPNFTV 240
Query: 248 -------------------LISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                              L+S++L  D ++R++ ++ +EH +  +N
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 106
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 183 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 243 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 67
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 68  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 127
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 128 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 188 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 247
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 248 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 290

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 60
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 181 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 241 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 68
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 69  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 128
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 129 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 189 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 248
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 249 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 291

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 76
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 77  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 136
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 137 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 196
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 197 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 256
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 257 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 299

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 61  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 112
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 113 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 172
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 173 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 233 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 292
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 293 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 335

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 61
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 62  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 121
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 122 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 182 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 241
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 242 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 284

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 66
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 67  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 126
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 127 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 186
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 187 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 246
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 247 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 289

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 150/283 (53%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 183 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 243 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 130/261 (49%), Gaps = 11/261 (4%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LG+G+FG V+   E  SK     K +  +  +    Q  +++E+ I +  RH
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARH 60
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
            NIL L+  F   E + +I E+    +++  +        E++  +Y+  +  AL + H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 138 NHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSKRH--TMCGTLDYLAPEMVENKEH 193
           +++ H DI+PEN++        +KI +FG + Q +   +   +    +Y APE+ ++   
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISR 251
             A D W+LG L Y  L G  PF AE+ +     IM  + +F   +   IS EA   + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 252 LLVKDSSKRLSLQKIMEHPWI 272
           LLVK+   R++  + ++HPW+
Sbjct: 241 LLVKERKSRMTASEALQHPWL 261

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 130/259 (50%), Gaps = 19/259 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 93  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 152 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 211
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSI----SAEAKHLISRLLVKDS 257
           I   E   G PP             MKV    P  + P++    S   K  +   L K+ 
Sbjct: 212 ITAIELARGEPPHSE-------LHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 264
Query: 258 SKRLSLQKIMEHPWIIKNA 276
           S R + +++++H +I++NA
Sbjct: 265 SFRPTAKELLKHKFILRNA 283

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 149/283 (52%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 60
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHTM--CGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S       C T
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R+ + + 
Sbjct: 181 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 241 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 130/259 (50%), Gaps = 19/259 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 191
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSI----SAEAKHLISRLLVKDS 257
           I   E   G PP             MKV    P  + P++    S   K  +   L K+ 
Sbjct: 192 ITAIELARGEPPHSE-------LHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 258 SKRLSLQKIMEHPWIIKNA 276
           S R + +++++H +I++NA
Sbjct: 245 SFRPTAKELLKHKFILRNA 263

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  114 bits (284), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 142/288 (49%), Gaps = 41/288 (14%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  ++ + +  VALK I +   E   I     RE+ +   L HPNI+ L  
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
             H +  + L+ E+  + +L + L +++    + Q   Y+  L   +A+CH++ ++HRD+
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 146 KPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNW 200
           KP+NLL++ +G LK+ DFG    + +  RS  H +  TL Y AP+ ++ +K++  +VD W
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIW 204
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---------------------- 238
           ++G +  E + G P F   +  D   +I  + L  P+                       
Sbjct: 205 SIGCIFAEMITGKPLFPGVTDDDQLPKIFSI-LGTPNPREWPQVQELPLWKQRTFQVFEK 263
Query: 239 -------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
                  P    E   L+S +L  D +KR+S +  M HP+  K+ +P+
Sbjct: 264 KPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY-FKDLDPQ 310

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 142/288 (49%), Gaps = 41/288 (14%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  ++ + +  VALK I +   E   I     RE+ +   L HPNI+ L  
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
             H +  + L+ E+  + +L + L +++    + Q   Y+  L   +A+CH++ ++HRD+
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 146 KPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNW 200
           KP+NLL++ +G LK+ DFG    + +  RS  H +  TL Y AP+ ++ +K++  +VD W
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIW 204
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---------------------- 238
           ++G +  E + G P F   +  D   +I  + L  P+                       
Sbjct: 205 SIGCIFAEMITGKPLFPGVTDDDQLPKIFSI-LGTPNPREWPQVQELPLWKQRTFQVFEK 263
Query: 239 -------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
                  P    E   L+S +L  D +KR+S +  M HP+  K+ +P+
Sbjct: 264 KPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY-FKDLDPQ 310

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 19/276 (6%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREM 70
           + RE    ++ +G  LGKG FG V+    +  +  VA+K+I + ++  +  +   +   +
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 71  EIQ------SSLRHPNILRLYGWFHDDERIFLILEYAHRGE-LYRELRKHRRFTEQQAAT 123
           E+       +   HP ++RL  WF   E   L+LE     + L+  + +     E  +  
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLD 181
           +   +  A+ +CH   V+HRDIK EN+L+D   G  K+ DFG       + +T   GT  
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV 203
Query: 182 YLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           Y  PE +   + H      W+LGIL Y+ + G  PFE + +      I++ +L FP+   
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPA--H 255
Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           +S +   LI R L    S R SL++I+  PW+   A
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 188
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 189 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 240
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 241 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 273

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 189
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 241
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 242 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 274

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 190
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 242
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 243 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 190
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 242
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 243 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 237
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 189
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 241
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 242 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 274

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 190
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 242
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 243 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 205
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 257
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 258 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 217
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 269
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 204
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI  
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRW 256
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 257 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 289

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 143/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 26  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 86  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I++  
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ 259
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 260 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 12/252 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
              D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSADLDAV 253
Query: 249 ISRLLVKDSSKR 260
           + + L K+   R
Sbjct: 254 VLKALAKNPENR 265

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 143/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 34  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 94  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 153
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I++  
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ 267
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 268 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 317

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 128/257 (49%), Gaps = 8/257 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 67
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 68  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 127
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-RHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   +  +   GT  Y++PE ++   +    
Sbjct: 128 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQS 187
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS--ISAEAKHLISRLLVK 255
           D W++G+   E   G  P    +  +    I  V+   P  PS   S E +  +++ L+K
Sbjct: 188 DIWSMGLSLVEMAVGRYPRPPMAIFELLDYI--VNEPPPKLPSAVFSLEFQDFVNKCLIK 245
Query: 256 DSSKRLSLQKIMEHPWI 272
           + ++R  L+++M H +I
Sbjct: 246 NPAERADLKQLMVHAFI 262

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S E +HLI  
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSXECQHLIRW 237
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 19/259 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 88  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+   GT  ++APE+++   +D   D W+LG
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLG 206
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSI----SAEAKHLISRLLVKDS 257
           I   E   G PP             MKV    P  + P++    S   K  +   L K+ 
Sbjct: 207 ITAIELARGEPPHSE-------LHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 258 SKRLSLQKIMEHPWIIKNA 276
           S R + +++++H +I++NA
Sbjct: 260 SFRPTAKELLKHKFILRNA 278

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 19/259 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+   GT  ++APE+++   +D   D W+LG
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLG 191
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSI----SAEAKHLISRLLVKDS 257
           I   E   G PP             MKV    P  + P++    S   K  +   L K+ 
Sbjct: 192 ITAIELARGEPPHSE-------LHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 258 SKRLSLQKIMEHPWIIKNA 276
           S R + +++++H +I++NA
Sbjct: 245 SFRPTAKELLKHKFILRNA 263

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 205
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S E +HLI  
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSXECQHLIRW 257
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 258 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 204
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S E +HLI  
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSXECQHLIRW 256
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 257 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 289

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 212
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S E +HLI  
Sbjct: 213 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSXECQHLIRW 264
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 265 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 297

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 39  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 98
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 99  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 158
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 159 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 218
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I++  
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ 272
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 273 VFFRQ--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 322

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I+   + F     +S+E +HLI  
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ--RVSSECQHLIRW 237
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L    S R + ++I  HPW+     P+ T +I
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 12/252 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
              D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 253
Query: 249 ISRLLVKDSSKR 260
           + + L K+   R
Sbjct: 254 VLKALAKNPENR 265

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I+   
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQ 253
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 254 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 34  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 94  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 153
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I++  
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ 267
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 268 VFFRQ--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 317

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I+   
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQ 253
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 254 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 55/301 (18%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNILRL 84
           +G+G +G V +  E +++   A+KI+ K +I +   K   +++ E+ +   L HPNI RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 85  YGWFHDDERIFLILEYAHRGELYREL---------------------------------- 110
           Y  + D++ I L++E  H G L  +L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 111 ----RKHRRFT--EQQAATYIASLTNALAYCHENHVIHRDIKPENLLL--DHEGRLKIGD 162
               R+   F   E+  +  +  + +AL Y H   + HRDIKPEN L   +    +K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 163 FGWSVQSRSKRH-------TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGA 213
           FG S +     +       T  GT  ++APE++      Y    D W+ G+L +  L GA
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 214 PPFEAESQKDTFRRIMKVDLSF--PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            PF   +  DT  +++   L F  P+   +S  A+ L+S LL ++  +R    + ++HPW
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333
Query: 272 I 272
           I
Sbjct: 334 I 334

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 118/252 (46%), Gaps = 12/252 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+L+     +K+ DFG       S  S  +   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
              D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 253
Query: 249 ISRLLVKDSSKR 260
           + + L K+   R
Sbjct: 254 VLKALAKNPENR 265

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 12/252 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
              D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 253
Query: 249 ISRLLVKDSSKR 260
           + + L K+   R
Sbjct: 254 VLKALAKNPENR 265

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 79  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 138
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I+   
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQ 252
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 253 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 79  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 138
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I+   
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQ 252
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 253 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 139/272 (51%), Gaps = 20/272 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +D+E+   +G G +GR   +R + + K  V  ++ +    E  K    L  E+ +   L+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELK 63
Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIAS-LTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K    R++ +++    + + LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +       S   T  GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SIS 242
           +PE +    ++   D W+LG L YE     PPF A SQK+   +I   +  F   P   S
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--EGKFRRIPYRYS 241
Query: 243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
            E   +I+R+L      R S+++I+E+P I++
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 79  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 138
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I+   
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQ 252
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 253 VFFRQ--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I+   
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQ 253
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 254 VFFRQ--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 17/292 (5%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +      I+   
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQ 253
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + F     +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 254 VFFRQ--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 12/252 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
              D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 253
Query: 249 ISRLLVKDSSKR 260
           + + L K+   R
Sbjct: 254 VLKALAKNPENR 265

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 12/252 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
              D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   +
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 270
Query: 249 ISRLLVKDSSKR 260
           + + L K+   R
Sbjct: 271 VLKALAKNPENR 282

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 128/263 (48%), Gaps = 19/263 (7%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKE---QIEKYKIQHQLRREMEIQSSLRHPN 80
            + LG+GKF  V       +    A K + K    Q  + +I H++   +E+  S   P 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV-LELAKSC--PR 90
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYR----ELRKHRRFTEQQAATYIASLTNALAYCH 136
           ++ L+  + +   I LILEYA  GE++     EL +    +E      I  +   + Y H
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVYYLH 148
Query: 137 ENHVIHRDIKPENLLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
           +N+++H D+KP+N+LL      G +KI DFG S  +    +   + GT +YLAPE++   
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRI--MKVDLSFPSAPSISAEAKHLI 249
               A D W +GI+ Y  L    PF  E  ++T+  I  + VD S  +  S+S  A   I
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFI 268
Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
             LLVK+  KR + +  + H W+
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 17/273 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 205
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
            H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S E +HLI  
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--RVSXECQHLIRW 257
Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            L      R + ++I  HPW+     P+ T +I
Sbjct: 258 CLALRPXDRPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 127/257 (49%), Gaps = 19/257 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG VY   +  +K  VA+KII  +  E       +++E+ + S    P I R +G
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G    +L K     E   AT +  +   L Y H    IHRDIK
Sbjct: 85  SYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+   GT  ++APE+++   +D+  D W+LG
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLG 203
Query: 204 ILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSI----SAEAKHLISRLLVKDS 257
           I   E   G PP       ++    M+V    P  S P++    S   K  +   L KD 
Sbjct: 204 ITAIELAKGEPP-------NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDP 256
Query: 258 SKRLSLQKIMEHPWIIK 274
             R + +++++H +I +
Sbjct: 257 RFRPTAKELLKHKFITR 273

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 137/282 (48%), Gaps = 33/282 (11%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G G +G+VY  R V++    A+K++     E+ +I+ ++     ++    H N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM---LKKYSHHRN 82
Query: 81  ILRLYGWFHD------DERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNAL 132
           I   YG F        D++++L++E+   G +   ++  K     E+  A     +   L
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVE 189
           ++ H++ VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  ++APE++ 
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 190 NKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
             E     +D+  D W+LGI   E   GAPP             M+     P  P+   +
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPAPRLK 255
Query: 245 AK-------HLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
           +K         I   LVK+ S+R + +++M+HP+I    N R
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 138/272 (50%), Gaps = 20/272 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +D+E+   +G G +GR   +R + + K  V  ++ +    E  K    L  E+ +   L+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELK 63
Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIAS-LTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K    R++ +++    + + LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +       S      GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SIS 242
           +PE +    ++   D W+LG L YE     PPF A SQK+   +I   +  F   P   S
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--EGKFRRIPYRYS 241
Query: 243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
            E   +I+R+L      R S+++I+E+P I++
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 143/283 (50%), Gaps = 27/283 (9%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK +        +   + RRE+E
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVE 106
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + ++ E    GEL+  +  R  + FTE++A+  
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
             S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 167 XKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +           T  R  + + 
Sbjct: 227 PYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEF 286
Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             P    +S E K LI  LL  + ++R ++ +   HPWI ++ 
Sbjct: 287 PNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQST 329

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 21/270 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ------IEKYKIQHQLRREMEI 72
           Q +    PLG G FG V+   + E    V +K I KE+      IE  K+  ++  E+ I
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL-GKVTLEIAI 82
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNA 131
            S + H NI+++   F +     L++E    G +L+  + +H R  E  A+     L +A
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPE-MV 188
           + Y     +IHRDIK EN+++  +  +K+ DFG +      +  +T CGT++Y APE ++
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
            N      ++ W+LG+  Y  ++   PF E E           V+ +      +S E   
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEAAIHPPYLVSKELMS 253
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           L+S LL     +R +L+K++  PW+ +  N
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 139/275 (50%), Gaps = 26/275 (9%)
Query: 19  QDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +D+E+   +G G +GR   +R + + K  V  ++ +    E  K    L  E+ +   L+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELK 63
Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIAS-LTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K    R++ +++    + + LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------MCGTL 180
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +   R   H         GT 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA---RILNHDEDFAKEFVGTP 180
Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP- 239
            Y++PE +    ++   D W+LG L YE     PPF A SQK+   +I +    F   P 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPY 238
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
             S E   +I+R+L      R S+++I+E+P I++
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 6/264 (2%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHR 143
            G +  +   +L++EY   G     L  H++   E + A         LAY H +++IHR
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNW 200
           D+K  N+LL   G +K+GDFG S    +  +   GT  ++APE++   +  ++D  VD W
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR 260
           +LGI C E     PP    +       I + +     +   S   ++ +   L K    R
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 261 LSLQKIMEHPWIIKNANPRGTCDI 284
            + + +++H ++++   P    D+
Sbjct: 259 PTSEVLLKHRFVLRERPPTVIMDL 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 6/264 (2%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRHPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHR 143
            G +  +   +L++EY   G     L  H++   E + A         LAY H +++IHR
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNW 200
           D+K  N+LL   G +K+GDFG S    +  +   GT  ++APE++   +  ++D  VD W
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKR 260
           +LGI C E     PP    +       I + +     +   S   ++ +   L K    R
Sbjct: 238 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 261 LSLQKIMEHPWIIKNANPRGTCDI 284
            + + +++H ++++   P    D+
Sbjct: 298 PTSEVLLKHRFVLRERPPTVIMDL 321

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 7/213 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V  V+   S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 74
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L++ +R  E+       ++   LAY  E H
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 134
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y+APE ++   +    
Sbjct: 135 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQS 194
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRR 227
           D W++G+   E   G    PP +A+  +  F R
Sbjct: 195 DIWSMGLSLVELAVGRYPIPPPDAKELEAIFGR 227

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 46/297 (15%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 126
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 186
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 187 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 246
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRRIMKVDLS-------------------- 234
           D W++G+   E   G    PP +A+  +  F   ++ D +                    
Sbjct: 247 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 306
Query: 235 -----------------FPSAPS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                             P  PS   S E +  +++ L+K+ ++R  L+++M H +I
Sbjct: 307 RPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 363

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 46/297 (15%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRRIMKVDLS-------------------- 234
           D W++G+   E   G    PP +A+  +  F   ++ D +                    
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 235 -----------------FPSAPS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                             P  PS   S E +  +++ L+K+ ++R  L+++M H +I
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 46/297 (15%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRRIMKVDLS-------------------- 234
           D W++G+   E   G    PP +A+  +  F   ++ D +                    
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 235 -----------------FPSAPS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                             P  PS   S E +  +++ L+K+ ++R  L+++M H +I
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 46/297 (15%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRRIMKVDLS-------------------- 234
           D W++G+   E   G    PP +A+  +  F   ++ D +                    
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 235 -----------------FPSAPS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                             P  PS   S E +  +++ L+K+ ++R  L+++M H +I
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 46/297 (15%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRRIMKVDLS-------------------- 234
           D W++G+   E   G    PP +A+  +  F   ++ D +                    
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 235 -----------------FPSAPS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                             P  PS   S E +  +++ L+K+ ++R  L+++M H +I
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 46/297 (15%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 91
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRRIMKVDLS-------------------- 234
           D W++G+   E   G    PP +A+  +  F   ++ D +                    
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 235 -----------------FPSAPS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                             P  PS   S E +  +++ L+K+ ++R  L+++M H +I
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 11/261 (4%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 85  YGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
              +   + + L+L   + G+L   +       F E +A  Y A +   L   H   +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENKEHDYAVDNW 200
           RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+V+N+ + ++ D W
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS--ISAEAKHLISRLLVKDSS 258
            LG L YE + G  PF+   +K     + ++    P   S   S +A+ L S+LL KD +
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429
Query: 259 KRL-----SLQKIMEHPWIIK 274
           +RL     S +++ EHP   K
Sbjct: 430 ERLGCRGGSAREVKEHPLFKK 450

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 11/261 (4%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 85  YGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
              +   + + L+L   + G+L   +       F E +A  Y A +   L   H   +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENKEHDYAVDNW 200
           RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+V+N+ + ++ D W
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS--ISAEAKHLISRLLVKDSS 258
            LG L YE + G  PF+   +K     + ++    P   S   S +A+ L S+LL KD +
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429
Query: 259 KRL-----SLQKIMEHPWIIK 274
           +RL     S +++ EHP   K
Sbjct: 430 ERLGCRGGSAREVKEHPLFKK 450

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 135/261 (51%), Gaps = 17/261 (6%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSISA 243
           +  +E+D++VD + LG+  YE +    PF A  +    K+  +R+++  +++P     S 
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 244 EAKHLISRLLVKDSSKRLSLQ 264
            +K     LL KD  KRL  +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFR 439

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 135/261 (51%), Gaps = 17/261 (6%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSISA 243
           +  +E+D++VD + LG+  YE +    PF A  +    K+  +R+++  +++P     S 
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 244 EAKHLISRLLVKDSSKRLSLQ 264
            +K     LL KD  KRL  +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFR 439

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 135/261 (51%), Gaps = 17/261 (6%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSISA 243
           +  +E+D++VD + LG+  YE +    PF A  +    K+  +R+++  +++P     S 
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 244 EAKHLISRLLVKDSSKRLSLQ 264
            +K     LL KD  KRL  +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFR 439

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 135/261 (51%), Gaps = 17/261 (6%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSISA 243
           +  +E+D++VD + LG+  YE +    PF A  +    K+  +R+++  +++P     S 
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 244 EAKHLISRLLVKDSSKRLSLQ 264
            +K     LL KD  KRL  +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFR 439

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 142/313 (45%), Gaps = 62/313 (19%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           D KT E     +RE +  + ++   +G G FG V+  + VES   VA+K + +++  ++K
Sbjct: 31  DGKTGE-----QREIAYTNCKV---IGNGSFGVVFQAKLVESDE-VAIKKVLQDK--RFK 79
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRR 115
                 RE++I   ++HPN++ L  +F+      D+  + L+LEY     +YR  R + +
Sbjct: 80  -----NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAK 133
Query: 116 FTEQQAAT----YIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWS---V 167
             +         Y+  L  +LAY H   + HRDIKP+NLLLD   G LK+ DFG +   +
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
Query: 168 QSRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR 226
                   +C    Y APE++     +   +D W+ G +  E + G P F  ES  D   
Sbjct: 194 AGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252
Query: 227 RIMKVDLSFPSA----------------------------PSISAEAKHLISRLLVKDSS 258
            I+KV L  PS                             P    +A  LISRLL    S
Sbjct: 253 EIIKV-LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311
Query: 259 KRLSLQKIMEHPW 271
            RL+  + + HP+
Sbjct: 312 ARLTAIEALCHPF 324

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + + +  K     
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 + +FP            P    EA  L SRLL    + RL+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 263 LQKIMEH 269
             +   H
Sbjct: 297 PLEACAH 303

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 54/310 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 43  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 94
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 95  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 212 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
Query: 263 LQKIMEHPWI 272
             +   H + 
Sbjct: 331 PLEACAHSFF 340

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 138/307 (44%), Gaps = 54/307 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 10  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 61
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 62  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 118
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 119 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 179 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 237
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 238 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 297
Query: 263 LQKIMEH 269
             +   H
Sbjct: 298 PLEACAH 304

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 35/299 (11%)
Query: 9   EDNRKREWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ED+    WS+   D+E+   +G G    V        K  VA+K I  E+ +      +L
Sbjct: 3   EDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDEL 60
Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR--------KHRRFTE 118
            +E++  S   HPNI+  Y  F   + ++L+++    G +   ++        K     E
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRS 171
              AT +  +   L Y H+N  IHRD+K  N+LL  +G ++I DFG S         +R+
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 172 K-RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
           K R T  GT  ++APE++E  + +D+  D W+ GI   E   GA P+            +
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 230 KVDLSFPSAPSISAEAKH-----------LISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           + D   P +     + K            +IS  L KD  KR +  +++ H +  K  N
Sbjct: 241 QND---PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 21  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 72
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 73  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 129
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 130 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 190 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 249 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 308
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 309 PLEACAHSF 317

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 28  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 79
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 80  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 136
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 137 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 197 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 255
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 256 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 315
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 316 PLEACAHSF 324

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 17  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 68
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 69  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 125
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 126 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 186 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 244
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 245 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 304
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 305 PLEACAHSF 313

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 297 PLEACAHSF 305

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 138/307 (44%), Gaps = 54/307 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 263 LQKIMEH 269
             +   H
Sbjct: 297 PLEACAH 303

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 21  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 72
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 73  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 129
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 130 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 190 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 249 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 308
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 309 PLEACAHSF 317

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 13  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 64
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 65  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 121
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 122 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 182 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 240
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 241 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 300
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 301 PLEACAHSF 309

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 14  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 65
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 66  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 122
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 123 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 183 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 241
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 242 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 301
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 302 PLEACAHSF 310

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + + +  K     
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 178 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 + +FP            P    EA  L SRLL    + RL+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 263 LQKIMEH 269
             +   H
Sbjct: 297 PLEACAH 303

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 54/310 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 47  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 98
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 99  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 155
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 156 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 216 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 274
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 275 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 334
Query: 263 LQKIMEHPWI 272
             +   H + 
Sbjct: 335 PLEACAHSFF 344

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 54/310 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 88  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 139
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 140 --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 196
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 197 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 257 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 315
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 316 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 375
Query: 263 LQKIMEHPWI 272
             +   H + 
Sbjct: 376 PLEACAHSFF 385

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 54/310 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 37  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 88
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 89  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 145
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 146 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 206 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 264
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 265 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 324
Query: 263 LQKIMEHPWI 272
             +   H + 
Sbjct: 325 PLEACAHSFF 334

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 54/310 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 45  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 96
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 97  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 153
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 154 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 214 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 272
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 273 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 332
Query: 263 LQKIMEHPWI 272
             +   H + 
Sbjct: 333 PLEACAHSFF 342

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 54/310 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 43  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 94
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 95  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 212 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
Query: 263 LQKIMEHPWI 272
             +   H + 
Sbjct: 331 PLEACAHSFF 340

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 22  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 73
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 74  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 130
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 131 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 191 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 249
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 250 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 309
Query: 263 LQKIMEHPW 271
             +   H +
Sbjct: 310 PLEACAHSF 318

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 138/307 (44%), Gaps = 54/307 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 178 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 263 LQKIMEH 269
             +   H
Sbjct: 297 PLEACAH 303

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 135/307 (43%), Gaps = 54/307 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + + +  K     
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 178 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 263 LQKIMEH 269
             +   H
Sbjct: 297 PLEACAH 303

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 137/307 (44%), Gaps = 54/307 (17%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D   + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D    I+
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 230 KV-----------------DLSFPSA----------PSISAEAKHLISRLLVKDSSKRLS 262
           KV                 +  FP            P    EA  L SRLL    + RL+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 263 LQKIMEH 269
             +   H
Sbjct: 297 PLEACAH 303

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +G VY   +  +   VA+K I  E  E+  +     RE+ +   L+H NI+ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
             H + R+ LI EYA   +L + + K+   + +   +++  L N + +CH    +HRD+K
Sbjct: 101 VIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 147 PENLLL-----DHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEH-DYA 196
           P+NLLL          LKIGDFG    + +  R   H +  TL Y  PE++    H   +
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----DLSFPSAPSIS--------- 242
           VD W++  +  E L   P F  +S+ D   +I +V     D ++P   ++          
Sbjct: 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF 278
Query: 243 --------------AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                          E   L++ +L  D  KR+S +  +EHP+   N
Sbjct: 279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 139/281 (49%), Gaps = 44/281 (15%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHTMCGTLD 181
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++  ++        
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK-------- 174
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA------ESQKDTFRRIMKVDLSF 235
                      +D + D W+LG++ Y  L G PPF +           T  R+ + +   
Sbjct: 175 -----------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223
Query: 236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           P    +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 135/272 (49%), Gaps = 19/272 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEIQSSLRHP 79
           + +G  LG+G +G+V  V + E+    A+KI+ K+++ +    +  +++E+++   LRH 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 80  NILRLYGWFHDDER--IFLILEYAHRG--ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           N+++L    +++E+  +++++EY   G  E+   +   +RF   QA  Y   L + L Y 
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPEMVEN 190
           H   ++H+DIKP NLLL   G LKI   G +       +     T  G+  +  PE+   
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAK 246
            +    + VD W+ G+  Y    G  PFE ++    F  I K   + P    P +S    
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS---- 241
Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
            L+  +L  + +KR S+++I +H W  K   P
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 138/300 (46%), Gaps = 47/300 (15%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  ++  +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNAL 132
           H NI+RL+   H D+++ L+ E+  +     +L+K+          +   +++  L   L
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMV 188
            +CH  +V+HRD+KP+NLL++  G LK+ DFG    + +  R     +  TL Y  P+++
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 173
Query: 189 EN-KEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIMKVDLSFPS--------- 237
              K +  ++D W+ G +  E    A P F      D  +RI ++ L  P+         
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRL-LGTPTEEQWPSMTK 232
Query: 238 -------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                               P ++A  + L+  LL  +  +R+S ++ ++HP+      P
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 126/253 (49%), Gaps = 17/253 (6%)
Query: 41  VESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIF 95
           V    PVA+K + K++I  + ++ +  R  ME+    + S     ++RL  WF   +   
Sbjct: 73  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 132
Query: 96  LILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD- 153
           LILE      +L+  + +     E+ A ++   +  A+ +CH   V+HRDIK EN+L+D 
Sbjct: 133 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 192
Query: 154 HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLY 211
           + G LK+ DFG     +   +T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + 
Sbjct: 193 NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252
Query: 212 GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           G  PFE + +      I++  + F     +S+E +HLI   L    S R + ++I  HPW
Sbjct: 253 GDIPFEHDEE------IIRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304
Query: 272 IIKNANPRGTCDI 284
           +     P+ T +I
Sbjct: 305 MQDVLLPQETAEI 317

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           +IG+ +G+G +G V+  R  ++   VA+K  F E  +   I+    RE+ +   L+HPN+
Sbjct: 7   KIGK-IGEGSYGVVFKCRNRDTGQIVAIK-KFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           + L   F    R+ L+ EY     L+   R  R   E    +       A+ +CH+++ I
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAV 197
           HRD+KPEN+L+     +K+ DFG++               T  Y +PE +V + ++   V
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------DLSFPSA 238
           D W +G +  E L G P +  +S  D    I K                     +  P  
Sbjct: 185 DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244
Query: 239 ----------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                     P+IS  A  L+   L  D ++RL+ ++++ HP+ 
Sbjct: 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 48/286 (16%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  VY  +   + + VALK I  E  E         RE+ +   L+H NI+ L+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI--REVSLLKDLKHANIVTLHD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVI 141
             H ++ + L+ EY     L ++L+++               ++  L   LAYCH   V+
Sbjct: 68  IIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++  G LK+ DFG     S+ +++  + +  TL Y  P+ ++ + ++   
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQ 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS------------------- 237
           +D W +G + YE   G P F   + ++    I ++ L  P+                   
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI-LGTPTEETWPGILSNEEFKTYNYP 240
Query: 238 ----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII 273
                     AP + ++   L+++LL  +   R+S +  M+HP+ +
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 135/302 (44%), Gaps = 40/302 (13%)
Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           R++  K  W ++  +   +P+G G +G V    +  +   VA+K +++   +      + 
Sbjct: 13  RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRA 71
Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRKHRRFTEQQ 120
            RE+ +   +RH N++ L   F  DE +      +L++ +   G    +L KH +  E +
Sbjct: 72  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDR 129
Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL 180
               +  +   L Y H   +IHRD+KP NL ++ +  LKI DFG + Q+ S+      T 
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR 189
Query: 181 DYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA- 238
            Y APE++ N   +   VD W++G +  E + G   F+     D  + IMKV  + P+  
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 239 ----------------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
                                        + S  A +L+ ++LV D+ +R++  + + HP
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 271 WI 272
           + 
Sbjct: 310 YF 311

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 127/289 (43%), Gaps = 35/289 (12%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           WS+   D+E+   +G G    V        K  VA+K I  E+ +      +L +E++  
Sbjct: 5   WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAM 62
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR--------KHRRFTEQQAATYI 125
           S   HPNI+  Y  F   + ++L+++    G +   ++        K     E   AT +
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRSK-RHTMC 177
             +   L Y H+N  IHRD+K  N+LL  +G ++I DFG S         +R+K R T  
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 178 GTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
           GT  ++APE++E  + +D+  D W+ GI   E   GA P+            ++ D   P
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND---P 239
Query: 237 SAPSISAEAKH-----------LISRLLVKDSSKRLSLQKIMEHPWIIK 274
            +     + K            +IS  L KD  KR +  +++ H +  K
Sbjct: 240 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 5/217 (2%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S++ +E    +G+G +G V   R  ++   VA+K  F E  +   ++    RE+++   L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK-FLESDDDKMVKKIAMREIKLLKQL 81
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           RH N++ L       +R +L+ E+     L            Q    Y+  + N + +CH
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPE-MVENKE 192
            +++IHRDIKPEN+L+   G +K+ DFG++    +          T  Y APE +V + +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
           +  AVD W +G L  E   G P F  +S  D    IM
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 138/300 (46%), Gaps = 47/300 (15%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  ++  +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNAL 132
           H NI+RL+   H D+++ L+ E+  +     +L+K+          +   +++  L   L
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMV 188
            +CH  +V+HRD+KP+NLL++  G LK+ +FG    + +  R     +  TL Y  P+++
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 173
Query: 189 EN-KEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPS--------- 237
              K +  ++D W+ G +  E    G P F      D  +RI ++ L  P+         
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEEQWPSMTK 232
Query: 238 -------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                               P ++A  + L+  LL  +  +R+S ++ ++HP+      P
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 15/233 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G +  VY      +   VALK +  +  E         RE+ +   L+H NI+RLY 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYD 70
Query: 87  WFHDDERIFLILEYAHRG-ELY---RELRKHRRFTEQQAATYIA-SLTNALAYCHENHVI 141
             H + ++ L+ E+     + Y   R +    R  E     Y    L   LA+CHEN ++
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAV 197
           HRD+KP+NLL++  G+LK+GDFG +       +T      TL Y AP+ ++ ++ +  ++
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---PSISAEAKH 247
           D W+ G +  E + G P F   + ++  + I  + +  P+    PS++   K+
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI-MGTPNESLWPSVTKLPKY 242

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 123/263 (46%), Gaps = 22/263 (8%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++ E+   +G+G FG V        K     K +  +QIE    +     E+   S + H
Sbjct: 9   KEIEVEEVVGRGAFGVV-------CKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH 61
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYC 135
           PNI++LYG   +   + L++EYA  G LY  L        +T   A ++    +  +AY 
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 136 HENH---VIHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK 191
           H      +IHRD+KP NLLL   G  LKI DFG +   ++      G+  ++APE+ E  
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGS 179
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--DLSFPSAPSISAEAKHLI 249
            +    D ++ GI+ +E +    PF+ E     FR +  V      P   ++    + L+
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 238
Query: 250 SRLLVKDSSKRLSLQ---KIMEH 269
           +R   KD S+R S++   KIM H
Sbjct: 239 TRCWSKDPSQRPSMEEIVKIMTH 261

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 29/274 (10%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR-EMEIQSSL 76
           + D E    +G G  G+V+ +R  ++ H +A+K     Q+ +   + + +R  M++   L
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK-----QMRRSGNKEENKRILMDLDVVL 78
Query: 77  RH---PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNA 131
           +    P I++ +G F  +  +F+ +E    G    +L+K  +    E+       ++  A
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 132 LAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEM 187
           L Y  E H VIHRD+KP N+LLD  G++K+ DFG S   V  ++K  +  G   Y+APE 
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-AGCAAYMAPER 195
Query: 188 VE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----DLSFPSA 238
           ++       ++D   D W+LGI   E   G  P+  ++ K  F  + KV        P  
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLPGH 253
Query: 239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
              S + +  +   L KD  KR    K++EH +I
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 123/263 (46%), Gaps = 22/263 (8%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++ E+   +G+G FG V        K     K +  +QIE    +     E+   S + H
Sbjct: 8   KEIEVEEVVGRGAFGVV-------CKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH 60
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYC 135
           PNI++LYG   +   + L++EYA  G LY  L        +T   A ++    +  +AY 
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 136 HENH---VIHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK 191
           H      +IHRD+KP NLLL   G  LKI DFG +   ++      G+  ++APE+ E  
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--DLSFPSAPSISAEAKHLI 249
            +    D ++ GI+ +E +    PF+ E     FR +  V      P   ++    + L+
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237
Query: 250 SRLLVKDSSKRLSLQ---KIMEH 269
           +R   KD S+R S++   KIM H
Sbjct: 238 TRCWSKDPSQRPSMEEIVKIMTH 260

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 117/259 (45%), Gaps = 29/259 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LG+G F  V LV  +   H  ALK I+  EQ ++ + Q    RE ++     HPNILRL 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ----READMHRLFNHPNILRLV 92
Query: 86  GWFHDD----ERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHE 137
            +   +       +L+L +  RG L+ E+     K    TE Q    +  +   L   H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS----RSKRHTMC--------GTLDYLAP 185
               HRD+KP N+LL  EG+  + D G   Q+       R  +          T+ Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 186 EMVENKEH---DYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSAPSI 241
           E+   + H   D   D W+LG + Y  ++G  P++   QK D+    ++  LS P +P  
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272
Query: 242 SAEAKHLISRLLVKDSSKR 260
           S+    L++ ++  D  +R
Sbjct: 273 SSALWQLLNSMMTVDPHQR 291

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 121/259 (46%), Gaps = 11/259 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DY 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           +APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+ 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 237
Query: 242 SAEAKHLISRLLVKDSSKR 260
                 L+++    D S+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 17/268 (6%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEK 59
           M + T + E  R+R       E+GR +G+G+FG V+    +  ++P +A+ I   +    
Sbjct: 3   MGSSTRDYEIQRER------IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS 56
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             ++ +  +E        HP+I++L G   ++  +++I+E    GEL R   + R+++  
Sbjct: 57  DSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLD 114
Query: 120 QAAT--YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT 175
            A+   Y   L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +    
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174
Query: 176 MCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVD 232
             G L   ++APE +  +    A D W  G+  +E L +G  PF+     D   RI   +
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKR 260
              P  P+       L+++    D S+R
Sbjct: 235 -RLPMPPNCPPTLYSLMTKCWAYDPSRR 261

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 17/268 (6%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEK 59
           M + T + E  R+R       E+GR +G+G+FG V+    +  ++P +A+ I   +    
Sbjct: 26  MGSSTRDYEIQRER------IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS 79
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             ++ +  +E        HP+I++L G   ++  +++I+E    GEL R   + R+++  
Sbjct: 80  DSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLD 137
Query: 120 QAAT--YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT 175
            A+   Y   L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +    
Sbjct: 138 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 197
Query: 176 MCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVD 232
             G L   ++APE +  +    A D W  G+  +E L +G  PF+     D   RI   +
Sbjct: 198 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 257
Query: 233 LSFPSAPSISAEAKHLISRLLVKDSSKR 260
              P  P+       L+++    D S+R
Sbjct: 258 -RLPMPPNCPPTLYSLMTKCWAYDPSRR 284

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 112/228 (49%), Gaps = 24/228 (10%)
Query: 12  RKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIF-------KEQIEKYKI 62
           + R  +L D EI   + +GKG FG V+  R V+ K  VA+K +         E IEK++ 
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ- 68
Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQA 121
             + +RE+ I S+L HPNI++LYG  H+  R  +++E+   G+LY R L K         
Sbjct: 69  --EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 122 ATYIASLTNALAYCHENH--VIHRDIKPENLL---LDHEGRL--KIGDFGWSVQSRSKRH 174
              +  +   + Y    +  ++HRD++  N+    LD    +  K+ DFG S QS     
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184
Query: 175 TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGAPPFEAES 220
            + G   ++APE +  +E  Y    D ++  ++ Y  L G  PF+  S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 112/228 (49%), Gaps = 24/228 (10%)
Query: 12  RKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIF-------KEQIEKYKI 62
           + R  +L D EI   + +GKG FG V+  R V+ K  VA+K +         E IEK++ 
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ- 68
Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQA 121
             + +RE+ I S+L HPNI++LYG  H+  R  +++E+   G+LY R L K         
Sbjct: 69  --EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 122 ATYIASLTNALAYCHENH--VIHRDIKPENLL---LDHEGRL--KIGDFGWSVQSRSKRH 174
              +  +   + Y    +  ++HRD++  N+    LD    +  K+ DFG S QS     
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVS 184
Query: 175 TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGAPPFEAES 220
            + G   ++APE +  +E  Y    D ++  ++ Y  L G  PF+  S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 121/259 (46%), Gaps = 11/259 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DY 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           +APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+ 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 237
Query: 242 SAEAKHLISRLLVKDSSKR 260
                 L+++    D S+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+   LG G FG V      ++   VA+K   +E   K + +  L  E++I   L HPN
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPN 73
Query: 81  ILRL------YGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNA 131
           ++              ++   L +EY   G+L + L +        E    T ++ +++A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 132 LAYCHENHVIHRDIKPENLLLD-HEGRL--KIGDFGWSVQSRSKRHTMC----GTLDYLA 184
           L Y HEN +IHRD+KPEN++L     RL  KI D G++      +  +C    GTL YLA
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTEFVGTLQYLA 191
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           PE++E K++   VD W+ G L +E + G  PF
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+   LG G FG V      ++   VA+K   +E   K + +  L  E++I   L HPN
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPN 74
Query: 81  ILRL------YGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNA 131
           ++              ++   L +EY   G+L + L +        E    T ++ +++A
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 132 LAYCHENHVIHRDIKPENLLLD-HEGRL--KIGDFGWSVQSRSKRHTMC----GTLDYLA 184
           L Y HEN +IHRD+KPEN++L     RL  KI D G++      +  +C    GTL YLA
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTEFVGTLQYLA 192
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           PE++E K++   VD W+ G L +E + G  PF
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 11/258 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRRE 69
            R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIAS 127
                   HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y   
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQ 499
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DYL 183
           L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   ++
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+  
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCP 618
Query: 243 AEAKHLISRLLVKDSSKR 260
                L+++    D S+R
Sbjct: 619 PTLYSLMTKCWAYDPSRR 636

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 11/258 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRRE 69
            R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIAS 127
                   HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y   
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQ 499
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DYL 183
           L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   ++
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+  
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCP 618
Query: 243 AEAKHLISRLLVKDSSKR 260
                L+++    D S+R
Sbjct: 619 PTLYSLMTKCWAYDPSRR 636

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 11/259 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DY 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           +APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+ 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 237
Query: 242 SAEAKHLISRLLVKDSSKR 260
                 L+++    D S+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 11/259 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DY 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           +APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+ 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 237
Query: 242 SAEAKHLISRLLVKDSSKR 260
                 L+++    D S+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 11/259 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 120
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DY 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 121 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 180
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           +APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+ 
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 239
Query: 242 SAEAKHLISRLLVKDSSKR 260
                 L+++    D S+R
Sbjct: 240 PPTLYSLMTKCWAYDPSRR 258

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 118/248 (47%), Gaps = 11/248 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E        HP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIASLTNALAYCHE 137
           +I++L G   ++  +++I+E    GEL R   + R+++   A+   Y   L+ ALAY   
Sbjct: 69  HIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DYLAPEMVENKEH 193
              +HRDI   N+L+     +K+GDFG S  ++  +      G L   ++APE +  +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
             A D W  G+  +E L +G  PF+     D   RI   +   P  P+       L+++ 
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMTKC 245
Query: 253 LVKDSSKR 260
              D S+R
Sbjct: 246 WAYDPSRR 253

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 11/259 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 121
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DY 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 122 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 181
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
           +APE +  +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+ 
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 240
Query: 242 SAEAKHLISRLLVKDSSKR 260
                 L+++    D S+R
Sbjct: 241 PPTLYSLMTKCWAYDPSRR 259

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 24/228 (10%)
Query: 12  RKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIF-------KEQIEKYKI 62
           + R  +L D EI   + +GKG FG V+  R V+ K  VA+K +         E IEK++ 
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ- 68
Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQA 121
             + +RE+ I S+L HPNI++LYG  H+  R  +++E+   G+LY R L K         
Sbjct: 69  --EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 122 ATYIASLTNALAYCHENH--VIHRDIKPENLL---LDHEGRL--KIGDFGWSVQSRSKRH 174
              +  +   + Y    +  ++HRD++  N+    LD    +  K+ DF  S QS     
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVS 184
Query: 175 TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGAPPFEAES 220
            + G   ++APE +  +E  Y    D ++  ++ Y  L G  PF+  S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 143/302 (47%), Gaps = 53/302 (17%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+    + +   V +KI+  + ++K KI    +RE++I 
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKNKI----KREIKIL 85
Query: 74  SSLRH-PNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            +LR  PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  
Sbjct: 86  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILK 142
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE- 186
           AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE 
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV-------------- 231
           +V+ + +DY++D W+LG +    ++   P F      D   RI KV              
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 232 ---DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHP 270
              D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 271 WI 272
           + 
Sbjct: 323 YF 324

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 134/312 (42%), Gaps = 48/312 (15%)
Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + Q  +  RP+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 16  RQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY 75
Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   L+H N++ L   F       D   ++L+      G     + K +  +
Sbjct: 76  ----RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALS 129
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     +  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 130 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV 189
Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
            T  Y APE++ N  H +  VD W++G +  E L G   F      D  +RIM+V +  P
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV-VGTP 248
Query: 237 SA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQKI 266
           S      IS+E                           A  L+ R+LV DS +R+S  + 
Sbjct: 249 SPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 308
Query: 267 MEHPWIIKNANP 278
           + H +  +  +P
Sbjct: 309 LAHAYFSQYHDP 320

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK--IIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           G  LGKG FG+   V   E+   + +K  I F E+      Q    +E+++   L HPN+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-----QRTFLKEVKVMRCLEHPNV 69
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHV 140
           L+  G  + D+R+  I EY   G L   ++    ++   Q  ++   + + +AY H  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS-----------------VQSRSKRHTMCGTLDYL 183
           IHRD+   N L+     + + DFG +                    R KR+T+ G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL 210
           APEM+  + +D  VD ++ GI+  E +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 134/312 (42%), Gaps = 48/312 (15%)
Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + Q  +  RP+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 16  RQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY 75
Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   L+H N++ L   F       D   ++L+      G     + K +  +
Sbjct: 76  ----RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALS 129
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     +  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 130 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV 189
Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
            T  Y APE++ N  H +  VD W++G +  E L G   F      D  +RIM+V +  P
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV-VGTP 248
Query: 237 SA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQKI 266
           S      IS+E                           A  L+ R+LV DS +R+S  + 
Sbjct: 249 SPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 308
Query: 267 MEHPWIIKNANP 278
           + H +  +  +P
Sbjct: 309 LAHAYFSQYHDP 320

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 8/212 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRHPNILRL 84
           LG+G+F  VY  R+  +   VA+K I      + K  I     RE+++   L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
              F     I L+ ++                T      Y+      L Y H++ ++HRD
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137
Query: 145 IKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDN 199
           +KP NLLLD  G LK+ DFG    +   +R+  H +  T  Y APE++   + +   VD 
Sbjct: 138 LKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGARMYGVGVDM 196
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRRIMKV 231
           W +G +  E L   P    +S  D   RI + 
Sbjct: 197 WAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 134/312 (42%), Gaps = 48/312 (15%)
Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + Q  +  RP+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 8   RQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY 67
Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   L+H N++ L   F       D   ++L+      G     + K +  +
Sbjct: 68  ----RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALS 121
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     +  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 122 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV 181
Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
            T  Y APE++ N  H +  VD W++G +  E L G   F      D  +RIM+V +  P
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV-VGTP 240
Query: 237 SA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQKI 266
           S      IS+E                           A  L+ R+LV DS +R+S  + 
Sbjct: 241 SPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 300
Query: 267 MEHPWIIKNANP 278
           + H +  +  +P
Sbjct: 301 LAHAYFSQYHDP 312

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 135/304 (44%), Gaps = 44/304 (14%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRV---------YLVREVESKHPVALKIIFKEQIEKYKI 62
           ++++  + D+ I R L +GKF ++         Y +++ E       +   K   +K  I
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 63  QHQ---LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG------ELYRELRKH 113
           + +    + E++I + +++   L   G   + + +++I EY          E +  L K+
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 114 RR--FTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
                  Q     I S+ N+ +Y H E ++ HRD+KP N+L+D  GR+K+ DFG S    
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 171 SKRHTMC-GTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFEAE-SQKDTF 225
            K+     GT +++ PE   N E  Y    VD W+LGI  Y   Y   PF  + S  + F
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSN-ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 226 RRIMKVDLSFP-----------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
             I   ++ +P                 S   +S E    +   L K+ ++R++ +  ++
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 269 HPWI 272
           H W+
Sbjct: 323 HEWL 326

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D  I   +G G FG V+  R       VA+KI+ ++     ++ ++  RE+ I   LRHP
Sbjct: 38  DLNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHP 94
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCH 136
           NI+   G       + ++ EY  RG LYR L K     +  E++  +    +   + Y H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 137 ENH--VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENK 191
             +  ++HRD+K  NLL+D +  +K+ DFG S    S         GT +++APE++ ++
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 192 EHDYAVDNWTLGILCYEF 209
             +   D ++ G++ +E 
Sbjct: 215 PSNEKSDVYSFGVILWEL 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D  I   +G G FG V+  R       VA+KI+ ++     ++   LR E+ I   LRHP
Sbjct: 38  DLNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCH 136
           NI+   G       + ++ EY  RG LYR L K     +  E++  +    +   + Y H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 137 ENH--VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENK 191
             +  ++HR++K  NLL+D +  +K+ DFG S    S      +  GT +++APE++ ++
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 192 EHDYAVDNWTLGILCYEF 209
             +   D ++ G++ +E 
Sbjct: 215 PSNEKSDVYSFGVILWEL 232

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 138/314 (43%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-I 62
           T  R++  K  W + + ++   P+G G +G V    +V+S     LKI  K+    ++ I
Sbjct: 36  TFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKS----GLKIAVKKLSRPFQSI 91
Query: 63  QHQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHR 114
            H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K +
Sbjct: 92  IHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQ 149
Query: 115 RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH 174
           + T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +  
Sbjct: 150 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 209
Query: 175 TMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL 233
               T  Y APE++ N  H +  VD W++G +  E L G   F      +  ++IM++  
Sbjct: 210 GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTG 269
Query: 234 SFPSA-----PSISAE------------------------AKHLISRLLVKDSSKRLSLQ 264
           + P++     PS  A                         A  L+ ++LV D+ KR++  
Sbjct: 270 TPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITAS 329
Query: 265 KIMEHPWIIKNANP 278
           + + HP+  +  +P
Sbjct: 330 EALAHPYFSQYHDP 343

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 118/264 (44%), Gaps = 56/264 (21%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E S + + +G+ LG G FG V  V ++ES    ALK + ++   +YK      RE++I  
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD--PRYK-----NRELDIMK 55
Query: 75  SLRHPNILRLYGWFH-------------DDER-------------------------IFL 96
            L H NI++L  +F+             DD                           + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 97  ILEYA----HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL 152
           I+EY     H+  L   +R  R       + YI  L  A+ + H   + HRDIKP+NLL+
Sbjct: 116 IMEYVPDTLHK-VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 153 DH-EGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCY 207
           +  +  LK+ DFG +   + S      +C    Y APE M+   E+  ++D W++G +  
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-YRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 208 EFLYGAPPFEAESQKDTFRRIMKV 231
           E + G P F  E+  D   RI+++
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQI 257

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EXSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 117/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    ++T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 24/288 (8%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           +D+K      N+  E    D E    LG+G +G V  +R V S   +A+K I        
Sbjct: 33  LDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TV 88
Query: 61  KIQHQLRREMEIQSSLRH---PNILRLYGWFHDDERIFLILEYAHRG--ELYRE-LRKHR 114
             Q Q R  M++  S+R    P  +  YG    +  +++ +E       + Y++ + K +
Sbjct: 89  NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ 148
Query: 115 RFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSR 170
              E        S+  AL + H    VIHRD+KP N+L++  G++K+ DFG S   V S 
Sbjct: 149 TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV 208
Query: 171 SKRHTMCGTLDYLAPEMV--ENKEHDYAV--DNWTLGILCYEFLYGAPPFEAESQKDTFR 226
           +K     G   Y+APE +  E  +  Y+V  D W+LGI   E      P+  +S    F+
Sbjct: 209 AKTID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQ 265
Query: 227 RIMK-VDLSFPSAPS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           ++ + V+   P  P+   SAE     S+ L K+S +R +  ++M+HP+
Sbjct: 266 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 313

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 18/242 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154
Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K++   F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +T   +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILG 273
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE--AKHL 248
             +   +D W+LG +  E L G P    E + D    ++++ L  PS   + A   AK+ 
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPSQKLLDASKRAKNF 332
Query: 249 IS 250
           +S
Sbjct: 333 VS 334

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 69  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 129 D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 305 PYPGIPVEELFK 316

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 18/242 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154
Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K++   F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +T   +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILG 273
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE--AKHL 248
             +   +D W+LG +  E L G P    E + D    ++++ L  PS   + A   AK+ 
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPSQKLLDASKRAKNF 332
Query: 249 IS 250
           +S
Sbjct: 333 VS 334

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/341 (24%), Positives = 147/341 (43%), Gaps = 76/341 (22%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           R+R   L ++E G  +G+G +G VY  +  + K      +   +QIE   I     RE+ 
Sbjct: 15  RERVEDLFEYE-GCKVGRGTYGHVYKAKRKDGKDDKDYAL---KQIEGTGISMSACREIA 70
Query: 72  IQSSLRHPNILRLYGWF--HDDERIFLILEYAHRGELYRELRKHR---------RFTEQQ 120
           +   L+HPN++ L   F  H D +++L+ +YA   +L+  ++ HR         +     
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWS------VQSR 170
             + +  + + + Y H N V+HRD+KP N+L+  E    GR+KI D G++      ++  
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 171 SKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK------- 222
           +    +  T  Y APE++    H   A+D W +G +  E L   P F    +        
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249
Query: 223 --DTFRRIMKVDLSFPS---------APSIS----------------------------A 243
             D   RI  V + FP+          P  S                            +
Sbjct: 250 HHDQLDRIFNV-MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 244 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           +A HL+ +LL  D  KR++ ++ M+ P+ +++  P  T D+
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP--TSDV 347

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G  +G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 147
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S     T     + GT  Y+APE +
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 208 RG-EITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G  +G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 147
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S     T     + GT  Y+APE +
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 208 RG-EITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 47/304 (15%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L+ +E+ + LGKG +G V+   +  +   VA+K IF         Q   R  M +     
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 78  HPNILRLYGWFH--DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNALAY 134
           H NI+ L       +D  ++L+ +Y    +L+  +R +    E     Y+   L   + Y
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKY 124
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLD---------- 181
            H   ++HRD+KP N+LL+ E  +K+ DFG S   V  R   + +  +++          
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 182 -----------YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
                      Y APE ++ + ++   +D W+LG +  E L G P F   S  +   RI+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 230 KVDLSFPSAPSI----SAEAKHLISRLL----VKDSSKRLSLQKIMEHPW--IIKNANPR 279
            V + FPS   +    S  AK +I  L     ++ S+KR    K     W  ++   NP+
Sbjct: 245 GV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK-----WKNLLLKINPK 298
Query: 280 GTCD 283
             C+
Sbjct: 299 ADCN 302

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  --DLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 15  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 74
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 75  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 132
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 133 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 190
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 191 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 250
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 251 PYPGIPVEELFK 262

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 12  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 71
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 72  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 129
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 130 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 187
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 188 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 247
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 248 PYPGIPVEELFK 259

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 10  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 69
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 70  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 127
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 128 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLTARNVLVTENNVMKI 185
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 186 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 245
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 246 PYPGIPVEELFK 257

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K   K       I 
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 236
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 237 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 297 QALAHAYFAQYHDP 310

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     ++I
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMRI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 27  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 83
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 141
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 201
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 260
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 261 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 320
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 321 QALAHAYFAQYHDP 334

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 32/258 (12%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           M    A   D R R+  +  F++ R  G+G FG V L +E  +   VA+K +    I+  
Sbjct: 6   MSLNAAAAADERSRK-EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDP 60
Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFH-----DDERIFL--ILEYAHRGELYRELRKH 113
           + +++  + M+  + L HPNI++L  +F+     D   I+L  ++EY     L+R  R +
Sbjct: 61  RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNY 119
Query: 114 RRFTEQQAA-------TYIASLTNALAYCH--ENHVIHRDIKPENLLLDH-EGRLKIGDF 163
            R   +Q A        ++  L  ++   H    +V HRDIKP N+L++  +G LK+ DF
Sbjct: 120 YR---RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 164 GWSVQ---SRSKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
           G + +   S      +C    Y APE++  N+ +  AVD W++G +  E + G P F  +
Sbjct: 177 GSAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235
Query: 220 SQKDTFRRIMKVDLSFPS 237
           +       I++V L  PS
Sbjct: 236 NSAGQLHEIVRV-LGCPS 252

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 130/275 (47%), Gaps = 18/275 (6%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +++ +D +    +G+G +G V  +    S   +A+K I     EK + Q  +  ++ ++S
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYRELRK--HRRFTEQQAATYIASLTN 130
           S   P I++ YG    +   ++ +E       + Y+ +         E+       +   
Sbjct: 78  S-DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 131 ALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPE 186
           AL +  EN  +IHRDIKP N+LLD  G +K+ DFG S   V S +K     G   Y+APE
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 195
Query: 187 MVE----NKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVD---LSFPSA 238
            ++     + +D   D W+LGI  YE   G  P+    S  D   +++K D   LS    
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII 273
              S    + ++  L KD SKR   +++++HP+I+
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 27  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 83
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 141
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 260
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 261 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 320
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 321 QALAHAYFAQYHDP 334

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 26  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 82
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 140
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 259
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 260 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 319
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 320 QALAHAYFAQYHDP 333

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 114/236 (48%), Gaps = 13/236 (5%)
Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M+   A +++  +  W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA 230
Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFT 117
           +         E  + + LRH N+++L G   +++  ++++ EY  +G L   LR   R  
Sbjct: 231 Q-----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 285
Query: 118 EQQAATYIASL--TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                    SL    A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345
Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               + + APE +  K+     D W+ GIL +E + +G  P+     KD   R+ K
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K   K       I 
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 236
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 237 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 297 QALAHAYFAQYHDP 310

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  E+
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEE 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 246
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 247 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 306
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 307 QALAHAYFAQYHDP 320

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 113/236 (47%), Gaps = 13/236 (5%)
Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M    A +++  +  W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA 58
Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFT 117
           +         E  + + LRH N+++L G   +++  ++++ EY  +G L   LR   R  
Sbjct: 59  Q-----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113
Query: 118 EQQAATYIASL--TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                    SL    A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               + + APE +  K+     D W+ GIL +E + +G  P+     KD   R+ K
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 115/252 (45%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+ YA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 17  TFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 73
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 131
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 132 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 191
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 250
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 251 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 310
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 311 QALAHAYFAQYHDP 324

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 62/298 (20%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQ 73
           DFE    LG+G FG+V   R        A+K          KI+H       +  E+ + 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVMLL 56
Query: 74  SSLRHPNILRLYG-WFH------------DDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           +SL H  ++R Y  W                  +F+ +EY   G LY  +  H     QQ
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQ 114
Query: 121 AATY---IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------- 168
              Y      +  AL+Y H   +IHRD+KP N+ +D    +KIGDFG +           
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 169 --------SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAE 219
                   S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y   PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 220 SQK-DTFRRIMKVDLSFP---SAPSISAEAKHLISRLLVK-DSSKRLSLQKIMEHPWI 272
            ++ +  +++  V + FP       +  E K  I RLL+  D +KR   + ++   W+
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKK--IIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 115/252 (45%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+ YA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K   K       I 
Sbjct: 3   TFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K  +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 236
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 237 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 297 QALAHAYFAQYHDP 310

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 38  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 274
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 275 AALYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 125/268 (46%), Gaps = 20/268 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 6   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E +    IA  T   
Sbjct: 62  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 120
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 121 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 180
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   ++  + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 181 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 240
Query: 244 EA----KHLISRLLVKDSSKRLSLQKIM 267
                 K L++  L K   +R S  +I+
Sbjct: 241 NCPKRMKRLMAECLKKKRDERPSFPRIL 268

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 19  QDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG+V+L     +   + K  VA+K +    +   K     +RE E+ 
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELL 71
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFT 117
           ++L+H +I++ YG   D + + ++ EY   G+L + LR H                    
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RS 171
             Q     + + + + Y    H +HRD+   N L+     +KIGDFG S  V S    R 
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
             HTM   + ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I +
Sbjct: 192 GGHTML-PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 14/266 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +    VD  +   P +   
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK---AVDEGYRLPPPMDCP 264
Query: 245 AK--HLISRLLVKDSSKRLSLQKIME 268
           A    L+     KD + R   ++I+ 
Sbjct: 265 AALYQLMLDCWQKDRNNRPKFEQIVS 290

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 14/266 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +    VD  +   P +   
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK---AVDEGYRLPPPMDCP 247
Query: 245 AK--HLISRLLVKDSSKRLSLQKIME 268
           A    L+     KD + R   ++I+ 
Sbjct: 248 AALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 87
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVD--LSFPSAP 239
                          D W+LG + Y   YG  PF+   +Q      I+  +  + FP  P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 266 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G  +G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 30  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 141
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S           + GT  Y+APE +
Sbjct: 142 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 202 RG-EITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/307 (22%), Positives = 142/307 (46%), Gaps = 35/307 (11%)
Query: 1   MDTKTAEREDNRKREWSLQD--------FEIGRPLGKGKFGRVYLVREVESKHPVALKII 52
           MD+     +D+ K   S  +        + I + +G G   +V+ V   E K   A+K +
Sbjct: 30  MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 88
Query: 53  FKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYAHRGELYREL 110
             E+ +   +    R E+   + L+     I+RLY +   D+ I++++E  +  +L   L
Sbjct: 89  NLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWL 146
Query: 111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +K +     +  +Y  ++  A+   H++ ++H D+KP N L+  +G LK+ DFG + Q +
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 171 SK-----RHTMCGTLDYLAPEMVENKEHD-----------YAVDNWTLGILCYEFLYGAP 214
                  + +  GT++Y+ PE +++                  D W+LG + Y   YG  
Sbjct: 206 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 215 PFEA-ESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           PF+   +Q      I+  +  + FP  P    + + ++   L +D  +R+S+ +++ HP+
Sbjct: 266 PFQQIINQISKLHAIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 272 IIKNANP 278
           +    +P
Sbjct: 324 VQIQTHP 330

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 10  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 67
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 68  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 127 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVD--LSFPSAP 239
                          D W+LG + Y   YG  PF +  +Q      I+  +  + FP  P
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 245
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 246 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 282

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 87
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVD--LSFPSAP 239
                          D W+LG + Y   YG  PF+   +Q      I+  +  + FP  P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 266 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 110/256 (42%), Gaps = 16/256 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEIQSSLRHPNILRLY 85
           +G G FG+VY  R       VA+K    +  E   +    +R+E ++ + L+HPNI+ L 
Sbjct: 15  IGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH---VIH 142
           G    +  + L++E+A  G L R L   +R        +   +   + Y H+     +IH
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 143 RDIKPENLLL-------DHEGR-LKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEH 193
           RD+K  N+L+       D   + LKI DFG + +  R+ + +  G   ++APE++     
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMF 191
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
               D W+ G+L +E L G  PF           +    L+ P   +       L+    
Sbjct: 192 SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCW 251
Query: 254 VKDSSKRLSLQKIMEH 269
             D   R S   I++ 
Sbjct: 252 NPDPHSRPSFTNILDQ 267

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 14  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 71
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 72  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 131 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVD--LSFPSAP 239
                          D W+LG + Y   YG  PF +  +Q      I+  +  + FP  P
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 249
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 250 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 286

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 68
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 128 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVD--LSFPSAP 239
                          D W+LG + Y   YG  PF+   +Q      I+  +  + FP  P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 247 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 11/221 (4%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K +W L  +D  +G  +G+G FG V+  R       VA+K   +E +    ++ +  +E 
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPP-DLKAKFLQEA 163
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
            I     HPNI+RL G     + I++++E    G+    LR    R   +     +    
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLA 184
             + Y      IHRD+   N L+  +  LKI DFG S +     +   G L      + A
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 185 PEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
           PE +    +    D W+ GIL +E F  GA P+   S + T
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/307 (22%), Positives = 142/307 (46%), Gaps = 35/307 (11%)
Query: 1   MDTKTAEREDNRKREWSLQD--------FEIGRPLGKGKFGRVYLVREVESKHPVALKII 52
           MD+     +D+ K   S  +        + I + +G G   +V+ V   E K   A+K +
Sbjct: 30  MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 88
Query: 53  FKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYAHRGELYREL 110
             E+ +   +    R E+   + L+     I+RLY +   D+ I++++E  +  +L   L
Sbjct: 89  NLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWL 146
Query: 111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +K +     +  +Y  ++  A+   H++ ++H D+KP N L+  +G LK+ DFG + Q +
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 171 SK-----RHTMCGTLDYLAPEMVENKEHD-----------YAVDNWTLGILCYEFLYGAP 214
                  + +  GT++Y+ PE +++                  D W+LG + Y   YG  
Sbjct: 206 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 215 PFEA-ESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           PF+   +Q      I+  +  + FP  P    + + ++   L +D  +R+S+ +++ HP+
Sbjct: 266 PFQQIINQISKLHAIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 272 IIKNANP 278
           +    +P
Sbjct: 324 VQIQTHP 330

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG +        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNI 81
           R LG+G FG+V+L  E  +  P   KI+   +  K      +    RE E+ ++L+H +I
Sbjct: 19  RELGEGAFGKVFLA-ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH-------------RRFTEQQAATYIASL 128
           ++ YG   + + + ++ EY   G+L + LR H                T+ Q       +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RSKRHTMCGTLDY 182
              + Y    H +HRD+   N L+     +KIGDFG S  V S    R   HTM   + +
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRW 196
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           + PE +  ++     D W+LG++ +E F YG  P+   S  +    I +
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG          +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 20/268 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 73
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E +    IA  T   
Sbjct: 74  LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    + G++ ++APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   ++  + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252
Query: 244 EA----KHLISRLLVKDSSKRLSLQKIM 267
                 K L++  L K   +R S  +I+
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 20/268 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 73
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E +    IA  T   
Sbjct: 74  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    + G++ ++APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   ++  + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252
Query: 244 EA----KHLISRLLVKDSSKRLSLQKIM 267
                 K L++  L K   +R S  +I+
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 13/221 (5%)
Query: 16  WSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   +         E  + 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQ-----AFLAEASVM 53
Query: 74  SSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFTEQQAATYIASL--TN 130
           + LRH N+++L G   +++  ++++ EY  +G L   LR   R           SL    
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
           A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  
Sbjct: 114 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 173
Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           K+     D W+ GIL +E + +G  P+     KD   R+ K
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 138/306 (45%), Gaps = 49/306 (16%)
Query: 19  QDFEIG------RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           Q F++G      + +G+G +G V    +   K  VA+K I   + + Y  Q  LR E++I
Sbjct: 37  QPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTY-CQRTLR-EIQI 94
Query: 73  QSSLRHPNILRLYGWFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
               RH N++ +         +  R   I++     +LY+ L K ++ +      ++  +
Sbjct: 95  LLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK-LLKSQQLSNDHICYFLYQI 153
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDY 182
              L Y H  +V+HRD+KP NLL++    LKI DFG + +      HT        T  Y
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 183 LAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------DL- 233
            APE M+ +K +  ++D W++G +  E L   P F  +   D    I+ +       DL 
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 273
Query: 234 ------------SFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                       S PS          P   ++A  L+ R+L  + +KR+++++ + HP++
Sbjct: 274 CIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333
Query: 273 IKNANP 278
            +  +P
Sbjct: 334 EQYYDP 339

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 18/242 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154
Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K++   F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +    +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILG 273
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE--AKHL 248
             +   +D W+LG +  E L G P    E + D    ++++ L  P    + A   AK+ 
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPXQKLLDASKRAKNF 332
Query: 249 IS 250
           +S
Sbjct: 333 VS 334

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 11/221 (4%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K +W L  +D  +G  +G+G FG V+  R       VA+K   +E +    ++ +  +E 
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPP-DLKAKFLQEA 163
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLT 129
            I     HPNI+RL G     + I++++E    G+    LR +  R   +     +    
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLA 184
             + Y      IHRD+   N L+  +  LKI DFG S +         G L      + A
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTA 283
Query: 185 PEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
           PE +    +    D W+ GIL +E F  GA P+   S + T
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + K       I 
Sbjct: 19  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKP---FQSII 75
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 133
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 252
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 253 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 312
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 313 QALAHAYFAQYHDP 326

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 35/234 (14%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQH 64
           ED    ++  +  +  R LGKG FG V + R    +  +   VA+K          K+QH
Sbjct: 3   EDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQH 52
Query: 65  Q-------LRREMEIQSSLRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR- 114
                     RE+EI  SL+H NI++  G  +   R  + LI+E+   G L   L+KH+ 
Sbjct: 53  STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE 112
Query: 115 RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKR 173
           R    +   Y + +   + Y      IHRD+   N+L+++E R+KIGDFG + V  + K 
Sbjct: 113 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172
Query: 174 HTMC-----GTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
                      + + APE +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 173 XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 246
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 247 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 306
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 307 QALAHAYFAQYHDP 320

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 98
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ E    G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 22/273 (8%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E    D E    LG+G +G V  +R V S   +A+K I          Q Q R  M++  
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDI 58
Query: 75  SLRH---PNILRLYGWFHDDERIFLILEYAHRG--ELYRE-LRKHRRFTEQQAATYIASL 128
           S+R    P  +  YG    +  +++ +E       + Y++ + K +   E        S+
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 129 TNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL + H    VIHRD+KP N+L++  G++K+ DFG S  +     +    G   Y+AP
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 186 EMV--ENKEHDYAV--DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDLSFPSAPS 240
           E +  E  +  Y+V  D W+LGI   E      P+  +S    F+++ + V+   P  P+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPA 236
Query: 241 --ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
              SAE     S+ L K+S +R +  ++M+HP+
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 71
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 72  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 131
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 132 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 227

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 66
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 67  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 126
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 127 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 242
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 243 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 302
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 303 QALAHAYFAQYHDP 316

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 67
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I  + RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLAFRHENIIGIND 90
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCGINLKARNYLLS 268
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 73
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 74  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 133
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 134 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 70
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 67
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 65
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 66  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 126 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 221

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 72
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 73  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 132
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 133 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 228

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 74
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 75  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 134
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 135 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 36/288 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           +G G +G VY  R+  S H VALK +     E+      +R    ++   +  HPN++RL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 85  Y---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
                    D  I + L + H  +    Y +         +     +      L + H N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            ++HRD+KPEN+L+   G +K+ DFG +     +     +  TL Y APE++    +   
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYATP 191
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSFPSA------- 238
           VD W++G +  E     P F   S+ D   +I  +           D+S P         
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP 251
Query: 239 -------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN-ANP 278
                  P +      L+  +L  +  KR+S  + ++H ++ K+  NP
Sbjct: 252 RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG    +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 85
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 241

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKR 173
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG +     +    K 
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
                 + ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 36/288 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           +G G +G VY  R+  S H VALK +     E+      +R    ++   +  HPN++RL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 85  Y---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
                    D  I + L + H  +    Y +         +     +      L + H N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            ++HRD+KPEN+L+   G +K+ DFG +     +     +  TL Y APE++    +   
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATP 191
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSFPSA------- 238
           VD W++G +  E     P F   S+ D   +I  +           D+S P         
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP 251
Query: 239 -------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN-ANP 278
                  P +      L+  +L  +  KR+S  + ++H ++ K+  NP
Sbjct: 252 RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 85
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 241

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 36/288 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           +G G +G VY  R+  S H VALK +     E+      +R    ++   +  HPN++RL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 85  Y---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
                    D  I + L + H  +    Y +         +     +      L + H N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            ++HRD+KPEN+L+   G +K+ DFG +     +     +  TL Y APE++    +   
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYATP 191
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSFPSA------- 238
           VD W++G +  E     P F   S+ D   +I  +           D+S P         
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP 251
Query: 239 -------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN-ANP 278
                  P +      L+  +L  +  KR+S  + ++H ++ K+  NP
Sbjct: 252 RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 4   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 60
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 118
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 237
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 238 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 297
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 298 QALAHAYFAQYHDP 311

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/307 (22%), Positives = 141/307 (45%), Gaps = 35/307 (11%)
Query: 1   MDTKTAEREDNRKREWSLQD--------FEIGRPLGKGKFGRVYLVREVESKHPVALKII 52
           MD+     +D+ K   S  +        + I + +G G   +V+ V   E K   A+K +
Sbjct: 30  MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 88
Query: 53  FKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYAHRGELYREL 110
             E+ +   +    R E+   + L+     I+RLY +   D+ I++++E  +  +L   L
Sbjct: 89  NLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWL 146
Query: 111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +K +     +  +Y  ++  A+   H++ ++H D+KP N L+  +G LK+ DFG + Q +
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 171 SK-----RHTMCGTLDYLAPEMVENKEHD-----------YAVDNWTLGILCYEFLYGAP 214
                  + +  G ++Y+ PE +++                  D W+LG + Y   YG  
Sbjct: 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 215 PFEA-ESQKDTFRRIMKVD--LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           PF+   +Q      I+  +  + FP  P    + + ++   L +D  +R+S+ +++ HP+
Sbjct: 266 PFQQIINQISKLHAIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 272 IIKNANP 278
           +    +P
Sbjct: 324 VQIQTHP 330

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 4   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 60
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 118
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 237
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 238 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 297
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 298 QALAHAYFAQYHDP 311

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 236
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 297 QALAHAYFAQYHDP 310

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 132/307 (42%), Gaps = 51/307 (16%)
Query: 8   REDNRKREWSLQDFEIGRP-LGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           ++D  K  W L    +    +G G +G V    +  S   VA+K +   F+ +I      
Sbjct: 12  KQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FA 67
Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRK--HRR 115
            +  RE+ +   ++H N++ L   F     +      +L++ +     +  +L+K    +
Sbjct: 68  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLK 122
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
           F+E++    +  +   L Y H   V+HRD+KP NL ++ +  LKI DFG +  + ++   
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-- 232
              T  Y APE++ +  H +  VD W++G +  E L G   F+ +   D   +I+KV   
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242
Query: 233 ------------------LSFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQK 265
                              S P           P  S +A  L+ ++L  D  KRL+  +
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302
Query: 266 IMEHPWI 272
            + HP+ 
Sbjct: 303 ALTHPFF 309

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 242
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 243 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 302
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 303 QALAHAYFAQYHDP 316

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 245
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 246 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 305
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 306 QALAHAYFAQYHDP 319

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 19  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 75
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 133
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 252
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 253 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 312
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 313 QALAHAYFAQYHDP 326

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 242
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 243 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 302
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 303 QALAHAYFAQYHDP 316

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 18  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 74
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 132
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 192
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 251
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 252 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 311
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 312 QALAHAYFAQYHDP 325

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 247
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 308 QALAHAYFAQYHDP 321

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 19  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 75
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 133
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 252
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 253 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 312
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 313 QALAHAYFAQYHDP 326

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 26  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 82
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 140
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 259
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 260 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 319
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 320 QALAHAYFAQYHDP 333

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 27  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 83
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 141
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 260
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 261 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 320
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 321 QALAHAYFAQYHDP 334

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 5   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 61
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 62  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 119
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 120 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 179
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 238
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 239 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 298
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 299 QALAHAYFAQYHDP 312

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 242
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 243 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 302
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 303 QALAHAYFAQYHDP 316

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 247
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 308 QALAHAYFAQYHDP 321

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 246
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 247 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 306
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 307 QALAHAYFAQYHDP 320

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 245
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 246 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 305
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 306 QALAHAYFAQYHDP 319

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DF  +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 247
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 308 QALAHAYFAQYHDP 321

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 246
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 247 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 306
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 307 QALAHAYFAQYHDP 320

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 247
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 308 QALAHAYFAQYHDP 321

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 30  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 86
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 144
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 204
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 263
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 264 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 323
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 324 QALAHAYFAQYHDP 337

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 245
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 246 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 305
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 306 QALAHAYFAQYHDP 319

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 6   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 62
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 120
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 121 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 180
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 239
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 240 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 299
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 300 QALAHAYFAQYHDP 313

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 30  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 86
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 144
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 204
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 263
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 264 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 323
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 324 QALAHAYFAQYHDP 337

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 18  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 74
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 132
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 192
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 251
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 252 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 311
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 312 QALAHAYFAQYHDP 325

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 67
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I  + RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLAFRHENIIGIND 90
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 268
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 245
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 246 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 305
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 306 QALAHAYFAQYHDP 319

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 116/266 (43%), Gaps = 14/266 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ E    G L   LRKH  +FT  Q    +  + + 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +    VD  +   P +   
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK---AVDEGYRLPPPMDCP 247
Query: 245 AK--HLISRLLVKDSSKRLSLQKIME 268
           A    L+     KD + R   ++I+ 
Sbjct: 248 AALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 131/307 (42%), Gaps = 51/307 (16%)
Query: 8   REDNRKREWSLQDFEIGRP-LGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           ++D  K  W L    +    +G G +G V    +  S   VA+K +   F+ +I      
Sbjct: 30  KQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FA 85
Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRK--HRR 115
            +  RE+ +   ++H N++ L   F     +      +L++ +     +  +L+K     
Sbjct: 86  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGME 140
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
           F+E++    +  +   L Y H   V+HRD+KP NL ++ +  LKI DFG +  + ++   
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 200
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-- 232
              T  Y APE++ +  H +  VD W++G +  E L G   F+ +   D   +I+KV   
Sbjct: 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 260
Query: 233 ------------------LSFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQK 265
                              S P           P  S +A  L+ ++L  D  KRL+  +
Sbjct: 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320
Query: 266 IMEHPWI 272
            + HP+ 
Sbjct: 321 ALTHPFF 327

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 14/265 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ E    G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E +  ++   A D W+ GI+ +E + YG  P+   S +D    I  VD  +   P +   
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYRLPPPMDCP 276
Query: 245 AK--HLISRLLVKDSSKRLSLQKIM 267
           A    L+     KD + R   ++I+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 129/306 (42%), Gaps = 53/306 (17%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++EI   +G G +G V   R   +   VA+K I     +      +  RE++I    +H 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 80  NILRL---------YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           NI+ +         YG F   + ++++L+     +L++ +   +  T +    ++  L  
Sbjct: 114 NIIAIKDILRPTVPYGEF---KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-----MCGTLDYL 183
            L Y H   VIHRD+KP NLL++    LKIGDFG +  + +    H         T  Y 
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           APE M+   E+  A+D W++G +  E L     F  ++     + IM V L  PS   I 
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV-LGTPSPAVIQ 288
Query: 243 A------------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           A                              +A  L+ R+L  + S R+S    + HP++
Sbjct: 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348
Query: 273 IKNANP 278
            K  +P
Sbjct: 349 AKYHDP 354

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 62/298 (20%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQ 73
           DFE    LG+G FG+V   R        A+K          KI+H       +  E+ + 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVMLL 56
Query: 74  SSLRHPNILRLYG-WFH------------DDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           +SL H  ++R Y  W                  +F+ +EY     LY  +  H     QQ
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI--HSENLNQQ 114
Query: 121 AATY---IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------- 168
              Y      +  AL+Y H   +IHRD+KP N+ +D    +KIGDFG +           
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 169 --------SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAE 219
                   S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y   PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 220 SQK-DTFRRIMKVDLSFP---SAPSISAEAKHLISRLLVK-DSSKRLSLQKIMEHPWI 272
            ++ +  +++  V + FP       +  E K  I RLL+  D +KR   + ++   W+
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKK--IIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G   G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 27  GNKXGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAA------NGIN 138
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S           + GT  Y APE +
Sbjct: 139 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 199 RG-EITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+    +G G FG+V+     ++KH +  K    +++ KY    +  RE++  + L H 
Sbjct: 12  DFKEIELIGSGGFGQVF-----KAKHRIDGKTYVIKRV-KYN-NEKAEREVKALAKLDHV 64
Query: 80  NILRLYGWF----HDDER------------IFLILEYAHRGEL--YRELRKHRRFTEQQA 121
           NI+   G +    +D E             +F+ +E+  +G L  + E R+  +  +  A
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCGT 179
                 +T  + Y H   +I+RD+KP N+ L    ++KIGDFG   S+++  KR    GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGT 184
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLY 211
           L Y++PE + ++++   VD + LG++  E L+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 23/268 (8%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V    L    + +  VA+K +     E+ +   +   E  I     HPNI+R
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIR 79
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           L G   +   + ++ E+   G L   LR    +FT  Q    +  + + + Y  E   +H
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD------YLAPEMVENKEHD 194
           RD+   N+L++     K+ DFG S  ++  S   T   +L       + APE +  ++  
Sbjct: 140 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFT 199
Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            A D W+ GI+ +E + +G  P+   S +D    I + D   P  P        L+    
Sbjct: 200 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-DYRLPPPPDCPTSLHQLMLDCW 258
Query: 254 VKDSSKR-------LSLQKIMEHPWIIK 274
            KD + R        +L K++ +P  +K
Sbjct: 259 QKDRNARPRFPQVVSALDKMIRNPASLK 286

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 39/291 (13%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-----SSLRHPNI 81
           +G G +G VY  R+  S H VALK +             +    E+       +  HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 82  LRLY---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYC 135
           +RL         D  I + L + H  +    Y +         +     +      L + 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-MCGTLDYLAPEMVENKEH 193
           H N ++HRD+KPEN+L+   G +K+ DFG + + S     T +  TL Y APE++    +
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY 196
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSFPSA---- 238
              VD W++G +  E     P F   S+ D   +I  +           D+S P      
Sbjct: 197 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPP 256
Query: 239 ----------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN-ANP 278
                     P +      L+  +L  +  KR+S  + ++H ++ K+  NP
Sbjct: 257 RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 20  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 75
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 76  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 133
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    
Sbjct: 134 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D    ++   
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 253
Query: 233 LSFPSAPSISAEAKHLISRLLVK 255
              P    + +     + RL+ +
Sbjct: 254 YLSPDLSKVRSNCPKAMKRLMAE 276

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 116/248 (46%), Gaps = 23/248 (9%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-LRREMEIQSSLRHPNILRLY 85
           +G G FG VY   + +    VA+KI+  + ++    Q Q  R E+ +    RH NIL   
Sbjct: 44  IGSGSFGTVY---KGKWHGDVAVKIL--KVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM 98
Query: 86  GWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           G+   D  + ++ ++     LY+ L  +  +F   Q           + Y H  ++IHRD
Sbjct: 99  GYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRD 157
Query: 145 IKPENLLLDHEG-RLKIGDFG-------WSVQSRSKRHTMCGTLDYLAPEMV---ENKEH 193
           +K  N+ L HEG  +KIGDFG       WS   + ++ T  G++ ++APE++   +N   
Sbjct: 158 MKSNNIFL-HEGLTVKIGDFGLATVKSRWSGSQQVEQPT--GSVLWMAPEVIRMQDNNPF 214
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            +  D ++ GI+ YE + G  P+   + +D    ++    + P    +       + R L
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKR-L 273
Query: 254 VKDSSKRL 261
           V D  K++
Sbjct: 274 VADCVKKV 281

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 68
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 69  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 128
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHR++   N+L+++E R+KIGDFG + V  + K +          + + APE
Sbjct: 129 EYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 224

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 121/263 (46%), Gaps = 17/263 (6%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 19  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 74
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 75  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 132
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    
Sbjct: 133 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D    ++   
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 252
Query: 233 LSFPSAPSISAEAKHLISRLLVK 255
              P    + +     + RL+ +
Sbjct: 253 YLSPDLSKVRSNCPKAMKRLMAE 275

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 23/268 (8%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V    L    + +  VA+K +     E+ +   +   E  I     HPNI+R
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIR 81
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           L G   +   + ++ E+   G L   LR    +FT  Q    +  + + + Y  E   +H
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD------YLAPEMVENKEHD 194
           RD+   N+L++     K+ DFG S  ++  S   T   +L       + APE +  ++  
Sbjct: 142 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFT 201
Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            A D W+ GI+ +E + +G  P+   S +D    I + D   P  P        L+    
Sbjct: 202 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-DYRLPPPPDCPTSLHQLMLDCW 260
Query: 254 VKDSSKR-------LSLQKIMEHPWIIK 274
            KD + R        +L K++ +P  +K
Sbjct: 261 QKDRNARPRFPQVVSALDKMIRNPASLK 288

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 53/308 (17%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF++   LG+G +G V       +   VA+K I  E  +K     +  RE++I    +H 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHE 69
Query: 80  NILRLYGW-----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           NI+ ++       F +   +++I E   + +L+R +   +  ++     +I     A+  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAVKV 127
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------------VQSRSKRHTMCGTLD 181
            H ++VIHRD+KP NLL++    LK+ DFG +                +S       T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 182 YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------D 232
           Y APE M+ + ++  A+D W+ G +  E     P F     +     I  +        D
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 233 L----------------SFPSA------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
           L                 +P+A      P ++ +   L+ R+LV D +KR++ ++ +EHP
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 271 WIIKNANP 278
           ++    +P
Sbjct: 308 YLQTYHDP 315

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 74
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 191
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 82
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 83  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 199
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 256

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 206
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 206
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 13/221 (5%)
Query: 16  WSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   +         E  + 
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQ-----AFLAEASVM 59
Query: 74  SSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFTEQQAATYIASL--TN 130
           + LRH N+++L G   +++  ++++ EY  +G L   LR   R           SL    
Sbjct: 60  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 119
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
           A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  
Sbjct: 120 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 179
Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                  D W+ GIL +E + +G  P+     KD   R+ K
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 129/306 (42%), Gaps = 53/306 (17%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++EI   +G G +G V   R   +   VA+K I     +      +  RE++I    +H 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 80  NILRL---------YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           NI+ +         YG F   + ++++L+     +L++ +   +  T +    ++  L  
Sbjct: 115 NIIAIKDILRPTVPYGEF---KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-----MCGTLDYL 183
            L Y H   VIHRD+KP NLL++    LKIGDFG +  + +    H         T  Y 
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           APE M+   E+  A+D W++G +  E L     F  ++     + IM V L  PS   I 
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV-LGTPSPAVIQ 289
Query: 243 A------------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           A                              +A  L+ R+L  + S R+S    + HP++
Sbjct: 290 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349
Query: 273 IKNANP 278
            K  +P
Sbjct: 350 AKYHDP 355

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 53/308 (17%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF++   LG+G +G V       +   VA+K I  E  +K     +  RE++I    +H 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHE 69
Query: 80  NILRLYGW-----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           NI+ ++       F +   +++I E   + +L+R +   +  ++     +I     A+  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAVKV 127
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------------VQSRSKRHTMCGTLD 181
            H ++VIHRD+KP NLL++    LK+ DFG +                +S       T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 182 YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------D 232
           Y APE M+ + ++  A+D W+ G +  E     P F     +     I  +        D
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 233 L----------------SFPSA------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
           L                 +P+A      P ++ +   L+ R+LV D +KR++ ++ +EHP
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 271 WIIKNANP 278
           ++    +P
Sbjct: 308 YLQTYHDP 315

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 78
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 79  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 195
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 124/291 (42%), Gaps = 38/291 (13%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75  SLRHPNILRLYGWF---HDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
              L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y APE
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSF 235
           ++    +   VD W++G +  E     P F   S  D   +I+ V           D++ 
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 236 PS--------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           P                  I    K L+ + L  + +KR+S    + HP+ 
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 53/308 (17%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF++   LG+G +G V       +   VA+K I  E  +K     +  RE++I    +H 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHE 69
Query: 80  NILRLYGW-----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           NI+ ++       F +   +++I E   + +L+R +   +  ++     +I     A+  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAVKV 127
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------------VQSRSKRHTMCGTLD 181
            H ++VIHRD+KP NLL++    LK+ DFG +                +S       T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 182 YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------D 232
           Y APE M+ + ++  A+D W+ G +  E     P F     +     I  +        D
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 233 L----------------SFPSA------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
           L                 +P+A      P ++ +   L+ R+LV D +KR++ ++ +EHP
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 271 WIIKNANP 278
           ++    +P
Sbjct: 308 YLQTYHDP 315

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 81
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 82  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 198
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 255

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 38/290 (13%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75  SLRHPNILRLYGWF---HDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
              L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y APE
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSF 235
           ++    +   VD W++G +  E     P F   S  D   +I+ V           D++ 
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 236 PS--------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           P                  I    K L+ + L  + +KR+S    + HP+
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 38/290 (13%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75  SLRHPNILRLYGWF---HDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
              L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y APE
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-----------DLSF 235
           ++    +   VD W++G +  E     P F   S  D   +I+ V           D++ 
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 236 PS--------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           P                  I    K L+ + L  + +KR+S    + HP+
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 51/300 (17%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+    +G G FG+V+     ++KH +  K     ++ KY    +  RE++  + L H 
Sbjct: 13  DFKEIELIGSGGFGQVF-----KAKHRIDGKTYVIRRV-KYN-NEKAEREVKALAKLDHV 65
Query: 80  NILRLYGWF------------------HDDER-----------IFLILEYAHRGELYR-- 108
           NI+   G +                  +D E            +F+ +E+  +G L +  
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 109 ELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--S 166
           E R+  +  +  A      +T  + Y H   +IHRD+KP N+ L    ++KIGDFG   S
Sbjct: 126 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 167 VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTF 225
           +++  KR    GTL Y++PE + ++++   VD + LG++  E L+     FE        
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 245
Query: 226 RRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA---NPRGTC 282
           R  +  D+          + K L+ +LL K    R +  +I+    + K +   N R TC
Sbjct: 246 RDGIISDI-------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC 298

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D+G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 11/236 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKY 60
           D   A RE  ++ + S    +I + +G G+FG V   R +V  K  + + I   +     
Sbjct: 14  DPNQAVREFAKEIDASC--IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQ 119
           K +     E  I     HPNI+ L G     + + +I EY   G L   LRK+  RFT  
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI 131
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHT 175
           Q    +  + + + Y  +   +HRD+   N+L++     K+ DFG S        +   T
Sbjct: 132 QLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 191
Query: 176 MCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
             G +   + APE +  ++   A D W+ GI+ +E + YG  P+   S +D  + I
Sbjct: 192 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 130
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 247
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 122/298 (40%), Gaps = 62/298 (20%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQ 73
           DFE    LG+G FG+V   R        A+K          KI+H       +  E+ + 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVXLL 56
Query: 74  SSLRHPNILRLYG-WFH------------DDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           +SL H  ++R Y  W                  +F+  EY     LY  +  H     QQ
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI--HSENLNQQ 114
Query: 121 AATY---IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------- 168
              Y      +  AL+Y H   +IHR++KP N+ +D    +KIGDFG +           
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 169 --------SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAE 219
                   S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y   PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTG 231
Query: 220 SQK-DTFRRIMKVDLSFPSAPSISAEA----KHLISRLLVKDSSKRLSLQKIMEHPWI 272
            ++ +  +++  V + FP  P          K +I  L+  D +KR   + ++   W+
Sbjct: 232 XERVNILKKLRSVSIEFP--PDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 116/263 (44%), Gaps = 10/263 (3%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E      +I R +G G+FG V   R ++  K  VA+ I   +     K +     E  I
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPN++ L G     + + +++E+   G L   LRKH  +FT  Q    +  +   
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGT---LDYLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S          +T  G    + + AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E ++ ++   A D W+ GI+ +E + YG  P+   S +D  + I +     P+     A 
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEE-GYRLPAPMDCPAG 276
Query: 245 AKHLISRLLVKDSSKRLSLQKIM 267
              L+     K+ ++R   ++I+
Sbjct: 277 LHQLMLDCWQKERAERPKFEQIV 299

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 270
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 93
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 271
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 272 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 324

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 96
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 155
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 216 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 274
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 275 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 327

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 266
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 266
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 90
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 268
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 321

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 9/217 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +I + +G G+FG V   R +V  K  + + I   +     K +     E  I     HP
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + +I EY   G L   LRK+  RFT  Q    +  + + + Y  + 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLD--YLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S        +   T  G +   + APE +  ++
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
              A D W+ GI+ +E + YG  P+   S +D  + I
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 9/217 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +I + +G G+FG V   R +V  K  + + I   +     K +     E  I     HP
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + +I EY   G L   LRK+  RFT  Q    +  + + + Y  + 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLD--YLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S        +   T  G +   + APE +  ++
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
              A D W+ GI+ +E + YG  P+   S +D  + I
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 12  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           E ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 266
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 108
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 286
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 287 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 339

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 118/263 (44%), Gaps = 17/263 (6%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 12  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 67
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 68  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 125
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    
Sbjct: 126 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D    ++   
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 245
Query: 233 LSFPSAPSISAEAKHLISRLLVK 255
              P    + +     + RL+ +
Sbjct: 246 YLSPDLSKVRSNCPKAMKRLMAE 268

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 118/263 (44%), Gaps = 17/263 (6%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 20  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 75
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 76  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 133
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    
Sbjct: 134 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD 232
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D    ++   
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 253
Query: 233 LSFPSAPSISAEAKHLISRLLVK 255
              P    + +     + RL+ +
Sbjct: 254 YLSPDLSKVRSNCPKAMKRLMAE 276

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y    +  RE++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY--XQRTLREIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 270
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 12  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           E ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 70
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+ H  R    +   Y + +   +
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGM 130
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNXIINLKARNYLLS 266
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 93
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 271
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 272 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 324

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 94
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 153
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 272
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 273 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 325

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 85
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 144
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 263
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 264 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 316

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 270
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 86
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 264
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 265 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 317

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 4   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 59
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 60  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 118
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 119 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   +   + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 179 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 238
Query: 244 EAKHLISRLLVKDSSKR 260
                + RL+ +   K+
Sbjct: 239 NCPKAMKRLMAECLKKK 255

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 18  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           E ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNXIINLKARNYLLS 266
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 63  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 122 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   +   + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 244 EAKHLISRLLVKDSSKR 260
                + RL+ +   K+
Sbjct: 242 NCPKAMKRLMAECLKKK 258

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 24/244 (9%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
            E++I S L +H NI+ L G       + +I EY   G+L   LR+  R  E   A  IA
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 127 SLT--------------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
           + T                +A+    + IHRD+   N+LL +    KIGDFG +    + 
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 173 RHTMCGT-----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
            + +        + ++APE + +  +    D W+ GIL +E F  G  P+        F 
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 227 RIMK 230
           +++K
Sbjct: 278 KLVK 281

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 58  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   +   + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 244 EAKHLISRLLVKDSSKR 260
                + RL+ +   K+
Sbjct: 237 NCPKAMKRLMAECLKKK 253

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 8   KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           E ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 8   KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           E ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 63  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 122 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   +   + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 244 EAKHLISRLLVKDSSKR 260
                + RL+ +   K+
Sbjct: 242 NCPKAMKRLMAECLKKK 258

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 270
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 129/292 (44%), Gaps = 43/292 (14%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 86
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------------------DLSF 235
           ++D W++G +  E L   P F  +   D    I+ +                     LS 
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSL 265
Query: 236 PSA---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           P           P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 266 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 317

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 8   KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-WSVQSRSKRHTMCG-----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG      ++  H +          + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           E ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 15  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRI 228
            G+L +E F  G  P+E  S  +    I
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 108
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   ++ +    +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 286
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 287 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 339

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 24/244 (9%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
            E++I S L +H NI+ L G       + +I EY   G+L   LR+  R  E   A  IA
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 127 SLT--------------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
           + T                +A+    + IHRD+   N+LL +    KIGDFG +    + 
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 173 RHTMCGT-----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
            + +        + ++APE + +  +    D W+ GIL +E F  G  P+        F 
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 227 RIMK 230
           +++K
Sbjct: 278 KLVK 281

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 18  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-WSVQSRSKRHTMCG-----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG      ++  H +          + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           E ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 78
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKCQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 270
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 113/269 (42%), Gaps = 25/269 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH--QLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L R          ++  K    +    H   L++E+EI  +L H NI+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 83  RLYGWFHDD--ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           +  G   +D    I LI+E+   G L   L K++ +   +Q   Y   +   + Y     
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD----YLAPEMVENKEH 193
            +HRD+   N+L++ E ++KIGDFG +  +++  +  T+    D    + APE +   + 
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKF 206
Query: 194 DYAVDNWTLGILCYE--------------FLYGAPPFEAESQKDTFRRIMKVDLSFPSAP 239
             A D W+ G+  +E              FL    P   +         +K     P  P
Sbjct: 207 YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPP 266
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIME 268
           +   E   L+ +      S R S Q ++E
Sbjct: 267 NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 8   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 62
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 63  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 183 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 218

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGEL--YRELRK--------------HRRFTE 118
           + +H NI+ L G    D  +++I+EYA +G L  Y + R+                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 206
Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 58
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 58  LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   +   + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 244 EAKHLISRLLVKDSSKR 260
                + RL+ +   K+
Sbjct: 237 NCPKAMKRLMAECLKKK 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 63
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 64  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 15  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 69
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 70  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 129
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 130 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 190 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 225

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI  FG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 63
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 64  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 113/269 (42%), Gaps = 25/269 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH--QLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L R          ++  K    +    H   L++E+EI  +L H NI+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 83  RLYGWFHDD--ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           +  G   +D    I LI+E+   G L   L K++ +   +Q   Y   +   + Y     
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD----YLAPEMVENKEH 193
            +HRD+   N+L++ E ++KIGDFG +  +++  +  T+    D    + APE +   + 
Sbjct: 135 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKF 194
Query: 194 DYAVDNWTLGILCYE--------------FLYGAPPFEAESQKDTFRRIMKVDLSFPSAP 239
             A D W+ G+  +E              FL    P   +         +K     P  P
Sbjct: 195 YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPP 254
Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIME 268
           +   E   L+ +      S R S Q ++E
Sbjct: 255 NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 18  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRI 228
            G+L +E F  G  P+E  S  +    I
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 15  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRI 228
            G+L +E F  G  P+E  S  +    I
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 13  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRI 228
            G+L +E F  G  P+E  S  +    I
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 35  IGSGQFGLVHLGYWL-NKDKVAIKTIKEGSMS----EDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRI 228
            G+L +E F  G  P+E  S  +    I
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V+ +++ ++    A+K   K ++E ++++     E+   + L  P I+ LYG
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 131
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 147 PENLLLDHEG-RLKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G R  + DFG ++        +S      + GT  ++APE+V  K  D  V
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 251
Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+   +    L G  P+
Sbjct: 252 DIWSSCCMMLHMLNGCHPW 270

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 11/216 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 78
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S        T   G+   + +  PE++   + 
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
               D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA++ I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
           ++D W++G +  E L   P F  +   D    I+ + L  PS                  
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNYLLS 270
Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 27  LGKGKFGRVY--LVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           +G G+FG VY  +++    K   PVA+K +     EK ++      E  I     H NI+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHNII 109
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVI 141
           RL G     + + +I EY   G L + LR K   F+  Q    +  +   + Y    + +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLAPEMVENKEHDY 195
           HRD+   N+L++     K+ DFG S          +T  G    + + APE +  ++   
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 196 AVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           A D W+ GI+ +E + YG  P+   S  +  + I
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 16  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRRI 228
            G+L +E F  G  P+E  S  +    I
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 25/267 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K        QH+   ++E++I  +L H +I+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 83  RLYGWFHDD--ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D     + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHD 194
           IHRD+   N+LLD++  +KIGDFG +       +    R      + + APE ++  +  
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFY 215
Query: 195 YAVDNWTLGILCYEFLY-----GAPPFE-------AESQKDTFR--RIMKVDLSFPSAPS 240
           YA D W+ G+  YE L       +PP +       A+ Q    R   +++     P    
Sbjct: 216 YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 275
Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIM 267
             AE  HL+      ++S R + + ++
Sbjct: 276 CPAEVYHLMKNCWETEASFRPTFENLI 302

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 16/257 (6%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 58  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 176
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           ++   +   + +  D +  GI+ YE + G  P+   + +D    ++      P    + +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 244 EAKHLISRLLVKDSSKR 260
                + RL+ +   K+
Sbjct: 237 NCPKAMKRLMAECLKKK 253

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 98/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E Y  Q +L   ME 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEA 99
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 273

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I+++ + 
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG 240
Query: 235 FPSA---PSISAE---------------------------AKHLISRLLVKDSSKRLSLQ 264
            P A     IS+E                           A  L+ ++LV DS KR++  
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 265 KIMEHPWIIKNANP 278
           + + H +  +  +P
Sbjct: 301 QALAHAYFAQYHDP 314

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG V+ +++ ++    A+K   K ++E ++++     E+   + L  P I+ LYG
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 117
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 147 PENLLLDHEG-RLKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G R  + DFG ++        +S      + GT  ++APE+V  K  D  V
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+   +    L G  P+
Sbjct: 238 DIWSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG V+ +++ ++    A+K   K ++E ++++     E+   + L  P I+ LYG
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 133
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 147 PENLLLDHEG-RLKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G R  + DFG ++        +S      + GT  ++APE+V  K  D  V
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 253
Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+   +    L G  P+
Sbjct: 254 DIWSSCCMMLHMLNGCHPW 272

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 13/217 (5%)
Query: 23  IGRPLGKGKFGRVYLVR-EVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I R +G G+FG V   R ++  K   PVA+K +     EK +       E  I     HP
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 83
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + ++ EY   G L   L+K+  +FT  Q    +  ++  + Y  + 
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S        +   T  G +   + APE +  ++
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
              A D W+ GI+ +E + YG  P+   + +D  + +
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV 240

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 116/262 (44%), Gaps = 15/262 (5%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D EIGR    G F  VY   + E+   VA   +   ++ K + Q + + E E    L+HP
Sbjct: 31  DIEIGR----GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEXLKGLQHP 85
Query: 80  NILRLYGWFHDDER----IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           NI+R Y  +    +    I L+ E    G L   L++ +    +   ++   +   L + 
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 136 HENH--VIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRSK-RHTMCGTLDYLAPEMVENK 191
           H     +IHRD+K +N+ +    G +KIGD G +   R+     + GT ++ APE  E K
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK 205
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            +D +VD +  G    E      P+ E ++    +RR+               E K +I 
Sbjct: 206 -YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
             + ++  +R S++ ++ H + 
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFF 286

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 126/283 (44%), Gaps = 41/283 (14%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V+ + + ++    A+K   K ++E ++ +     E+   + L  P I+ LYG
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAE-----ELMACAGLTSPRIVPLYG 152
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 147 PENLLLDHEGR-LKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G    + DFG +V        +S      + GT  ++APE+V  +  D  V
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV 272
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF---------PSAPSISAEA--- 245
           D W+   +    L G  P+        FR  + + ++          PS   ++A+A   
Sbjct: 273 DVWSSCCMMLHMLNGCHPW-----TQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQE 327
Query: 246 ---KHLISRLLVKDSSKRL--SLQKI--MEHPWIIKNANPRGT 281
              K  I R+   +   ++  +LQ++  ++ PW  +   PRG 
Sbjct: 328 GLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRGN 370

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 25/267 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K        QH+   ++E++I  +L H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQHY 138
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHD 194
           IHR++   N+LLD++  +KIGDFG +            R      + + APE ++  +  
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 195 YAVDNWTLGILCYEFLY-----GAPPFE-------AESQKDTFR--RIMKVDLSFPSAPS 240
           YA D W+ G+  YE L       +PP +       A+ Q    R   +++     P    
Sbjct: 199 YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 258
Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIM 267
              E  HL+      ++S R + + ++
Sbjct: 259 CPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 98/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S L H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 259

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 98/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S L H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 273

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 25/267 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K        QH+   ++E++I  +L H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHY 138
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHD 194
           IHR++   N+LLD++  +KIGDFG +            R      + + APE ++  +  
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 195 YAVDNWTLGILCYEFLY-----GAPPFE-------AESQKDTFR--RIMKVDLSFPSAPS 240
           YA D W+ G+  YE L       +PP +       A+ Q    R   +++     P    
Sbjct: 199 YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 258
Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIM 267
              E  HL+      ++S R + + ++
Sbjct: 259 CPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 11/210 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G+FG V L +  + ++ VA+K+I +  +     + +  +E +    L HP +++ 
Sbjct: 14  KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKF 68
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTE-QQAATYIASLTNALAYCHENHVIHR 143
           YG    +  I+++ EY   G L   LR H +  E  Q       +   +A+   +  IHR
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRH-TMCGT---LDYLAPEMVENKEHDYAVDN 199
           D+   N L+D +  +K+ DFG +      ++ +  GT   + + APE+    ++    D 
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 200 WTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
           W  GIL +E F  G  P++  +  +   ++
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           + +  PNI++L     D   +   LI EY +  + ++ L  +   T+     YI  L  A
Sbjct: 81  NLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKA 137
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD-------------- 232
           V+ +++DY++D W+LG +    ++   P F      D   +I KV               
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 233 ------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                             L F +A +   +S EA   + +LL  D  +RL+  + M HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 272 I 272
Sbjct: 318 F 318

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 134/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+    + +   VA      + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVA-----VKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+L+DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 29/230 (12%)
Query: 27  LGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           LG+G FG+V+L         + K  VA+K + KE  E  +     +RE E+ + L+H +I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESAR--QDFQREAELLTMLQHQHI 105
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIA 126
           +R +G   +   + ++ EY   G+L R LR H                     Q     +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----LD 181
            +   + Y    H +HRD+   N L+     +KIGDFG S    S  +   G      + 
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 8   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 63
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 29/230 (12%)
Query: 27  LGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           LG+G FG+V+L         + K  VA+K + KE  E  +     +RE E+ + L+H +I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESAR--QDFQREAELLTMLQHQHI 82
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIA 126
           +R +G   +   + ++ EY   G+L R LR H                     Q     +
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----LD 181
            +   + Y    H +HRD+   N L+     +KIGDFG S    S  +   G      + 
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I +
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 252

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 22/232 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRH 78
           +EI   +GKG FG+V    +   +  VA+KII  ++  + + +I+ +L   M    +   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASL 128
             I+ L   F     + L+ E      LY  LR            R+F +Q     +   
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           T  L+      +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE
Sbjct: 175 TPELS------IIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 228
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA 238
           ++    +D A+D W+LG +  E   G P F   ++ D   +I++V L  P A
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIPPA 279

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 22/232 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRH 78
           +EI   +GKG FG+V    +   +  VA+KII  ++  + + +I+ +L   M    +   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASL 128
             I+ L   F     + L+ E      LY  LR            R+F +Q     +   
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           T  L+      +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE
Sbjct: 175 TPELS------IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 228
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA 238
           ++    +D A+D W+LG +  E   G P F   ++ D   +I++V L  P A
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIPPA 279

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY+    +    VA+K + ++ +E      +  +E  +
Sbjct: 26  KWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 81
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---YIAS-L 128
              ++HPN+++L G    +   +++ EY   G L   LR+  R  E+  A    Y+A+ +
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR--EEVTAVVLLYMATQI 139
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLA 184
           ++A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + A
Sbjct: 140 SSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 199
Query: 185 PEMVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           PE +         D W  G+L +E   YG  P+
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 22/232 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRH 78
           +EI   +GKG FG+V    +   +  VA+KII  ++  + + +I+ +L   M    +   
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASL 128
             I+ L   F     + L+ E      LY  LR            R+F +Q     +   
Sbjct: 97  YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 155
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           T  L+      +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE
Sbjct: 156 TPELS------IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 209
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA 238
           ++    +D A+D W+LG +  E   G P F   ++ D   +I++V L  P A
Sbjct: 210 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIPPA 260

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 29/230 (12%)
Query: 27  LGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           LG+G FG+V+L         + K  VA+K + KE  E  +     +RE E+ + L+H +I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESAR--QDFQREAELLTMLQHQHI 76
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIA 126
           +R +G   +   + ++ EY   G+L R LR H                     Q     +
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----LD 181
            +   + Y    H +HRD+   N L+     +KIGDFG S    S  +   G      + 
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I +
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 246

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G+FG VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 6   WEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 61
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE 
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPES 181
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 126/297 (42%), Gaps = 25/297 (8%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRV---YLVREVESKHPVALKIIFKEQIE 58
           D   A RE    +E  +   +I + +G G+FG V   +L    + +  VA+K +     E
Sbjct: 18  DPNEAVRE--FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 75
Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFT 117
           K +       E  I     HPN++ L G       + +I E+   G L   LR++  +FT
Sbjct: 76  KQR--RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT 175
             Q    +  +   + Y  + + +HRD+   N+L++     K+ DFG S  ++  +   T
Sbjct: 134 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193
Query: 176 MCGTLD------YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
               L       + APE ++ ++   A D W+ GI+ +E + YG  P+   + +D    I
Sbjct: 194 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253
Query: 229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL-------SLQKIMEHPWIIKNANP 278
            + D   P      +    L+     KD + R        +L K++ +P  +K   P
Sbjct: 254 EQ-DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAP 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 13/226 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR---EVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           RE       I + +G G  G V   R     +   PVA+K +     E+ +       E 
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEA 101
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
            I     HPNI+RL G         ++ EY   G L   LR H  +FT  Q    +  + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGT---LDYL 183
             + Y  +   +HRD+   N+L+D     K+ DFG S          +T  G    + + 
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           APE +  +    A D W+ G++ +E L YG  P+   + +D    +
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 259

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 17  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 76
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 136
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 137 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 196
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 197 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 250

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 63
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 81
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 82  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 135
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 136 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNK 255
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 256 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 315
Query: 269 HPWI 272
           HP+ 
Sbjct: 316 HPYF 319

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGC 205
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 259

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 10  DNRKREWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
           D    +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  
Sbjct: 4   DPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFL 59
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIA 126
           +E  +   ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 127 S-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LD 181
           + +++A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + 
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           + APE +   +     D W  G+L +E   YG  P+
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 9   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 64
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE 
Sbjct: 125 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPES 184
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 81  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 134
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNK 254
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 255 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 269 HPWI 272
           HP+ 
Sbjct: 315 HPYF 318

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 42  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 101
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 161
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 162 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 221
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 275

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 82
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 83  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 136
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 137 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 196
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 197 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNK 256
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 257 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 316
Query: 269 HPWI 272
           HP+ 
Sbjct: 317 HPYF 320

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 32  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 91
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 151
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 152 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 211
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 265

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 81  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 134
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNK 254
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 255 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 269 HPWI 272
           HP+ 
Sbjct: 315 HPYF 318

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 81
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 82  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 135
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 136 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNK 255
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 256 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 315
Query: 269 HPWI 272
           HP+ 
Sbjct: 316 HPYF 319

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI++L     D   +   LI EY +  + ++ L  +   T+     YI  L  A
Sbjct: 81  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKA 137
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD-------------- 232
           V+ +++DY++D W+LG +    ++   P F      D   +I KV               
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 233 ------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                             L F +A +   +S EA   + +LL  D  +RL+  + M HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 272 I 272
Sbjct: 318 F 318

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 101
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 102 NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 155
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 156 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 215
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 216 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNK 275
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 276 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 335
Query: 269 HPWI 272
           HP+ 
Sbjct: 336 HPYF 339

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 81  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 134
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNK 254
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 255 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 269 HPWI 272
           HP+ 
Sbjct: 315 HPYF 318

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 60
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 81  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 134
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVD----------- 232
           E +V+ +++DY++D W+LG +    ++   P F      D   +I KV            
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNK 254
Query: 233 ---------------------LSFPSAPS---ISAEAKHLISRLLVKDSSKRLSLQKIME 268
                                L F +A +   +S EA   + +LL  D  +RL+  + M 
Sbjct: 255 YRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 269 HPWI 272
           HP+ 
Sbjct: 315 HPYF 318

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 13/226 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR---EVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           RE       I + +G G  G V   R     +   PVA+K +     E+ +       E 
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEA 101
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
            I     HPNI+RL G         ++ EY   G L   LR H  +FT  Q    +  + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLD--YL 183
             + Y  +   +HRD+   N+L+D     K+ DFG S        +   T  G +   + 
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT 221
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           APE +  +    A D W+ G++ +E L YG  P+   + +D    +
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++     S   VA+K +   +     +Q  L  E  +  +L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTL---KPGTMSVQAFLE-EANLMKTLQHDKLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
               +E I++I EY  +G L   L+     +    +   + A +   +AY    + IHRD
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 135
Query: 145 IKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL YE + YG  P+   +  D    +
Sbjct: 196 SFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 8   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 63
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 98/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 52  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 111
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L +
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 171
Query: 131 -------ALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 172 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 231
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 285

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 125
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G  G + + R +     VA+K I  E       + QL RE     S  HPN++R + 
Sbjct: 32  LGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRE-----SDEHPNVIRYFC 85
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASLTNALAYCHENHVIHRD 144
              D +  ++ +E        +E  + + F     +  T +   T+ LA+ H  +++HRD
Sbjct: 86  TEKDRQFQYIAIELC--AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 145 IKPENLLL---DHEGRLK--IGDFGWSVQ------SRSKRHTMCGTLDYLAPEMV--ENK 191
           +KP N+L+   +  G++K  I DFG   +      S S+R  + GT  ++APEM+  + K
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 192 EH-DYAVDNWTLGILCYEFLY-GAPPF--EAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           E+  Y VD ++ G + Y  +  G+ PF    + Q +       +D   P        A+ 
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE-DVIARE 262
Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
           LI +++  D  KR S + +++HP+ 
Sbjct: 263 LIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 43  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 102
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 162
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 163 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 222
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 223 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 276

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 66
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR-- 67
           ++ K E+  ++  +G+ LG+G+FG+V        K       +  + +++     +LR  
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 68  -REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----------- 115
             E  +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+           
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 116 -------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
                         T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 163 FGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           FG S       S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 217 EA 218
Sbjct: 254 PG 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F+++E    G+L   LR+ R    Q ++  +  L  
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 21  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 76
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 77  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 136
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE 
Sbjct: 137 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 196
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K   E    +++   +RE+EI  +L H +I+
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQHY 133
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHD 194
           IHR +   N+LLD++  +KIGDFG +       +    R      + + APE ++  +  
Sbjct: 134 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 193
Query: 195 YAVDNWTLGILCYEFL 210
           YA D W+ G+  YE L
Sbjct: 194 YASDVWSFGVTLYELL 209

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR-- 67
           ++ K E+  ++  +G+ LG+G+FG+V        K       +  + +++     +LR  
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 68  -REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----------- 115
             E  +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+           
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 116 -------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
                         T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 163 FGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           FG S       S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 217 EA 218
Sbjct: 254 PG 255

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K   E    +++   +RE+EI  +L H +I+
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQHY 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHD 194
           IHR +   N+LLD++  +KIGDFG +       +    R      + + APE ++  +  
Sbjct: 133 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 192
Query: 195 YAVDNWTLGILCYEFL 210
           YA D W+ G+  YE L
Sbjct: 193 YASDVWSFGVTLYELL 208

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F+++E    G+L   LR+ R    Q ++  +  L  
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 273

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 86  -------GWFHDDERIFLILEYAHR---GELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQK 222
              E DY   +D W  G +  E    +P  +  +++
Sbjct: 202 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 236

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 86  -------GWFHDDERIFLILEYAHR---GELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQK 222
              E DY   +D W  G +  E    +P  +  +++
Sbjct: 202 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 236

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 86  -------GWFHDDERIFLILEYAHR---GELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 140
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 200
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQK 222
              E DY   +D W  G +  E    +P  +  +++
Sbjct: 201 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 135/309 (43%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------ 238
           PE++    +   VD W++G++  E + G   F      D + ++++  L  PS       
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPSPEFMKKL 252
Query: 239 -PSI----------------------------------SAEAKHLISRLLVKDSSKRLSL 263
            P++                                  +++A+ L+S++LV D+SKR+S+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR-- 67
           ++ K E+  ++  +G+ LG+G+FG+V        K       +  + +++     +LR  
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 68  -REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----------- 115
             E  +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+           
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 116 -------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
                         T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 163 FGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           FG S       S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 217 EA 218
Sbjct: 254 PG 255

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 86  -------GWFHDDERIFLILEYAHR---GELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQK 222
              E DY   +D W  G +  E    +P  +  +++
Sbjct: 202 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 236

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 6   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 61
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S        T   G    + + APE 
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPES 181
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 17/253 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG VY    V + H      VA+K   K+     K   +   E  I 
Sbjct: 8   EDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 63
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
            +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +  A+
Sbjct: 64  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 122
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT----LDYLAPEMV 188
           AY    + +HRDI   N+L+     +K+GDFG S     + +         + +++PE +
Sbjct: 123 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 182
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
             +    A D W   +  +E L +G  PF     KD    + K D   P           
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYT 241
Query: 248 LISRLLVKDSSKR 260
           L++R    D S R
Sbjct: 242 LMTRCWDYDPSDR 254

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 32/288 (11%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 72
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
               F +++K      S     AE   ++      D  KR + ++I++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 61
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 122 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 182 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 241
Query: 232 DL 233
            L
Sbjct: 242 GL 243

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++LR+    T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQ--TLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 17/253 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG VY    V + H      VA+K   K+     K   +   E  I 
Sbjct: 24  EDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 79
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
            +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +  A+
Sbjct: 80  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 138
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT----LDYLAPEMV 188
           AY    + +HRDI   N+L+     +K+GDFG S     + +         + +++PE +
Sbjct: 139 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 198
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
             +    A D W   +  +E L +G  PF     KD    + K D   P           
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYT 257
Query: 248 LISRLLVKDSSKR 260
           L++R    D S R
Sbjct: 258 LMTRCWDYDPSDR 270

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 32/288 (11%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 31  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 88
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 89  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 148
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 149 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 208
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 209 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 268
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
               F +++K      S     AE   ++      D  KR + ++I++
Sbjct: 269 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 70
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 250
Query: 232 DL 233
            L
Sbjct: 251 GL 252

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 17/253 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG VY    V + H      VA+K   K+     K   +   E  I 
Sbjct: 12  EDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 67
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
            +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +  A+
Sbjct: 68  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT----LDYLAPEMV 188
           AY    + +HRDI   N+L+     +K+GDFG S     + +         + +++PE +
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
             +    A D W   +  +E L +G  PF     KD    + K D   P           
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYT 245
Query: 248 LISRLLVKDSSKR 260
           L++R    D S R
Sbjct: 246 LMTRCWDYDPSDR 258

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 32/288 (11%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 38  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 95
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 96  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 216 RHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 275
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
               F +++K      S     AE   ++      D  KR + ++I++
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 32/288 (11%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 38  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 95
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 96  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 216 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 275
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
               F +++K      S     AE   ++      D  KR + ++I++
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 135/309 (43%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------ 238
           PE++    +   VD W++G++  E + G   F      D + ++++  L  PS       
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPSPEFMKKL 252
Query: 239 -PSI----------------------------------SAEAKHLISRLLVKDSSKRLSL 263
            P++                                  +++A+ L+S++LV D+SKR+S+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG+VY  R  +    VA+K + +E+ +  ++Q Q   E+E+ S   H N+LRL G
Sbjct: 46  LGRGGFGKVYKGRLADGTL-VAVKRLKEERXQGGELQFQ--TEVEMISMAVHRNLLRLRG 102
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY-----IA-SLTNALAYCHEN-- 138
           +        L+  Y   G +   LR+  R   Q    +     IA      LAY H++  
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRE--RPESQPPLDWPKRQRIALGSARGLAYLHDHCD 160
Query: 139 -HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC---GTLDYLAPEMVENKEH 193
             +IHRD+K  N+LLD E    +GDFG + +      H      GT+ ++APE +   + 
Sbjct: 161 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKS 220
Query: 194 DYAVDNWTLGILCYEFLYGAPPFE 217
               D +  G++  E + G   F+
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAFD 244

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 32/288 (11%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 33  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 90
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 91  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 150
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 151 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 210
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 211 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 270
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
               F +++K      S     AE   ++      D  KR + ++I++
Sbjct: 271 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V+ + + ++    A+K   K ++E ++ +     E+   + L  P I+ LYG
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAE-----ELMACAGLTSPRIVPLYG 133
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 147 PENLLLDHEGR-LKIGDFGWSVQSRS--------KRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G    + DFG +V  +             + GT  ++APE+V  +  D  V
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV 253
Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+   +    L G  P+
Sbjct: 254 DVWSSCCMMLHMLNGCHPW 272

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 12/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++ + LG G+FG V++     S   VA+K +   +     +Q  L  E  +  +L+H
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTL---KPGTMSVQAFLE-EANLMKTLQH 66
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCH 136
             ++RLY     +E I++I E+  +G L   L+     +    +   + A +   +AY  
Sbjct: 67  DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKE 192
             + IHRD++  N+L+      KI DFG +        + R      + + APE +    
Sbjct: 127 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
                + W+ GIL YE + YG  P+   +  D    +
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 26/246 (10%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR------------ 114
            E++I S L +H NI+ L G       + +I EY   G+L   LR+ R            
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 115 ----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
               + + +    + + +   +A+    + IHRD+   N+LL +    KIGDFG +    
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 171 SKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
           +  + +        + ++APE + +  +    D W+ GIL +E F  G  P+        
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 277
Query: 225 FRRIMK 230
           F +++K
Sbjct: 278 FYKLVK 283

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKS 195
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 196 DVWSFGVLMWEAFSYGQKPY 215

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 15/245 (6%)
Query: 27  LGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG G FG VY    V E E+ K PVA+KI+ +    K  ++     E  I +S+ HP+++
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPHLV 103
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           RL G       I L+ +    G L   + +H+     Q    +   +   + Y  E  ++
Sbjct: 104 RLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 162
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENKEHDYA 196
           HRD+   N+L+     +KI DFG +  ++   K +   G    + ++A E +  ++  + 
Sbjct: 163 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 222
Query: 197 VDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
            D W+ G+  +E + +G  P++    ++    + K +   P  P  + +   ++ +  + 
Sbjct: 223 SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQPPICTIDVYMVMVKCWMI 281
Query: 256 DSSKR 260
           D+  R
Sbjct: 282 DADSR 286

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 269
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHR++   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 20/240 (8%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 30  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 89
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRF 116
            E++I S L +H NI+ L G       + +I EY   G+L   LR+           R  
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
             +    + + +   +A+    + IHRD+   N+LL +    KIGDFG +    +  + +
Sbjct: 150 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 177 CGT-----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                   + ++APE + +  +    D W+ GIL +E F  G  P+        F +++K
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 71  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 130 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 189
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 190 DVWSFGVLMWEAFSYGQKPY 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 23/285 (8%)
Query: 14  REWSLQDFEIGRPLGKGKFGRV---YLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           +E  +   +I + +G G+FG V   +L    + +  VA+K +     EK +       E 
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEA 59
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLT 129
            I     HPN++ L G       + +I E+   G L   LR++  +FT  Q    +  + 
Sbjct: 60  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 119
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD------ 181
             + Y  + + +HR +   N+L++     K+ DFG S  ++  +   T    L       
Sbjct: 120 AGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 179
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           + APE ++ ++   A D W+ GI+ +E + YG  P+   + +D    I + D   P    
Sbjct: 180 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMD 238
Query: 241 ISAEAKHLISRLLVKDSSKRL-------SLQKIMEHPWIIKNANP 278
             +    L+     KD + R        +L K++ +P  +K   P
Sbjct: 239 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAP 283

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 18/271 (6%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E    D E    LG+G +G V   R V S    A+K I        + Q +L  +++I  
Sbjct: 30  EVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDISX 87
Query: 75  -SLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYRE-LRKHRRFTEQQAATYIASLTN 130
            ++  P  +  YG    +  +++  E       + Y++ + K +   E        S+  
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 147
Query: 131 ALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           AL + H    VIHRD+KP N+L++  G++K  DFG S  +     +    G   Y APE 
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPER 207
Query: 188 V--ENKEHDYAV--DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-VDLSFPSAPS-- 240
           +  E  +  Y+V  D W+LGI   E      P+  +S    F+++ + V+   P  P+  
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADK 265
Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            SAE     S+ L K+S +R +  ++ +HP+
Sbjct: 266 FSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 112/250 (44%), Gaps = 38/250 (15%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L DFE  + LG+G FG V+  +        A+K I     E  +   ++ RE++  + L 
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61
Query: 78  HPNILRLY-GWFHDDE---------RIFLILEYA-HRGELYRELRKHRRFTEQQAATY-- 124
           HP I+R +  W   +          +++L ++    R E  ++    R   E++  +   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 125 --IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQ 168
                +  A+ + H   ++HRD+KP N+    +  +K+GDFG               +  
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 169 SRSKRHT-MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRR 227
               RHT   GT  Y++PE +    + + VD ++LG++ +E LY   PF   +Q +  R 
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF--STQMERVRT 236
Query: 228 IMKV-DLSFP 236
           +  V +L FP
Sbjct: 237 LTDVRNLKFP 246

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 211
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 212 DVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 211
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 212 DVWSFGVLMWEAFSYGQKPY 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 20/240 (8%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRF 116
            E++I S L +H NI+ L G       + +I EY   G+L   LR+           R  
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
             +    + + +   +A+    + IHRD+   N+LL +    KIGDFG +    +  + +
Sbjct: 158 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 177 CGT-----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                   + ++APE + +  +    D W+ GIL +E F  G  P+        F +++K
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 277

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 115/251 (45%), Gaps = 15/251 (5%)
Query: 27  LGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG G FG VY    V E E+ K PVA+KI+ +    K  ++     E  I +S+ HP+++
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPHLV 80
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           RL G       I L+ +    G L   + +H+     Q    +   +   + Y  E  ++
Sbjct: 81  RLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 139
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENKEHDYA 196
           HRD+   N+L+     +KI DFG +  ++   K +   G    + ++A E +  ++  + 
Sbjct: 140 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 199
Query: 197 VDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
            D W+ G+  +E + +G  P++    ++    + K +   P  P  + +   ++ +  + 
Sbjct: 200 SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQPPICTIDVYMVMVKCWMI 258
Query: 256 DSSKRLSLQKI 266
           D+  R   +++
Sbjct: 259 DADSRPKFKEL 269

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 73  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 192 DVWSFGVLMWEAFSYGQKPY 211

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 195
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 196 DVWSFGVLMWEAFSYGQKPY 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 83  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 201
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 202 DVWSFGVLMWEAFSYGQKPY 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 134/309 (43%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------ 238
           PE++    +   VD W++G +  E + G   F      D + ++++  L  PS       
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPSPEFMKKL 252
Query: 239 -PSI----------------------------------SAEAKHLISRLLVKDSSKRLSL 263
            P++                                  +++A+ L+S++LV D+SKR+S+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 91  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 150 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 209
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 210 DVWSFGVLMWEAFSYGQKPY 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/314 (21%), Positives = 136/314 (43%), Gaps = 62/314 (19%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA----KRAYRELVLLK 76
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
            + H NI+ L   F       + + ++L++E      L + +  H     ++ +  +  +
Sbjct: 77  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--HMELDHERMSYLLYQM 133
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAP 185
              + + H   +IHRD+KP N+++  +  LKI DFG + ++ S    M     T  Y AP
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTASTNFMMTPYVVTRYYRAP 192
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------- 238
           E++    +   VD W++G +  E + G+  F+     D + ++++  L  PSA       
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE-QLGTPSAEFMAALQ 251
Query: 239 PSI----------------------------------SAEAKHLISRLLVKDSSKRLSLQ 264
           P++                                  +++A+ L+S++LV D  KR+S+ 
Sbjct: 252 PTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 311
Query: 265 KIMEHPWIIKNANP 278
           + + HP+I    +P
Sbjct: 312 EALRHPYITVWYDP 325

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 308
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHR++   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 141/314 (44%), Gaps = 54/314 (17%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 ---IIKNANPRGTC 282
              ++K+    G+ 
Sbjct: 324 FYTVVKDQARMGSS 337

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 134/309 (43%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------ 238
           PE++    +   VD W++G +  E + G   F      D + ++++  L  PS       
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPSPEFMKKL 252
Query: 239 -PSI----------------------------------SAEAKHLISRLLVKDSSKRLSL 263
            P++                                  +++A+ L+S++LV D+SKR+S+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 67
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 128 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 188 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 247
Query: 232 DL 233
            L
Sbjct: 248 GL 249

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 27  LGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R+ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
           G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HRD+
Sbjct: 437 G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAVDN 199
              N+LL  +   KI DFG S   R+  +           + + APE +   +     D 
Sbjct: 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 555
Query: 200 WTLGILCYE-FLYGAPPF 216
           W+ G+L +E F YG  P+
Sbjct: 556 WSFGVLMWEAFSYGQKPY 573

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 31  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 85
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 142
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 272 I 272
Sbjct: 323 F 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 37  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 91
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 92  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 148
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 149 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 208
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 209 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 268
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 269 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328
Query: 272 I 272
Sbjct: 329 F 329

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 134/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+    + +      + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 63
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 243
Query: 232 DL 233
            L
Sbjct: 244 GL 245

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 8   EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 65
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 186 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 243

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 69
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 249
Query: 232 DL 233
            L
Sbjct: 250 GL 251

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 30  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 84
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 141
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 272 I 272
Sbjct: 322 F 322

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 27  LGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R+ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
           G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HRD+
Sbjct: 438 G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAVDN 199
              N+LL  +   KI DFG S   R+  +           + + APE +   +     D 
Sbjct: 497 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 556
Query: 200 WTLGILCYE-FLYGAPPF 216
           W+ G+L +E F YG  P+
Sbjct: 557 WSFGVLMWEAFSYGQKPY 574

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 31  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 85
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 142
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 272 I 272
Sbjct: 323 F 323

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 134/309 (43%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------ 238
           PE++    +   VD W++G +  E + G   F      D + ++++  L  PS       
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPSPEFMKKL 252
Query: 239 -PSI----------------------------------SAEAKHLISRLLVKDSSKRLSL 263
            P++                                  +++A+ L+S++LV D+SKR+S+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------------- 231
           V+ + +DY++D W+LG +    ++   P F      D   RI KV               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 232 --DLSFPSAPS----------ISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 271
             D  F               + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 272 I 272
Sbjct: 324 F 324

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 70
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 250
Query: 232 DL 233
            L
Sbjct: 251 GL 252

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 69
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 249
Query: 232 DL 233
            L
Sbjct: 250 GL 251

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 76
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256
Query: 232 DL 233
            L
Sbjct: 257 GL 258

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 98
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 159 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 219 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 278
Query: 232 DL 233
            L
Sbjct: 279 GL 280

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 134/309 (43%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------ 238
           PE++    +   VD W++G +  E + G   F      D + ++++  L  PS       
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPSPEFMKKL 252
Query: 239 -PSI----------------------------------SAEAKHLISRLLVKDSSKRLSL 263
            P++                                  +++A+ L+S++LV D+SKR+S+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG+VY  R  +    VA+K + +E+ +  ++Q Q   E+E+ S   H N+LRL G
Sbjct: 38  LGRGGFGKVYKGRLADGXL-VAVKRLKEERTQGGELQFQ--TEVEMISMAVHRNLLRLRG 94
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY-----IA-SLTNALAYCHEN-- 138
           +        L+  Y   G +   LR+  R   Q    +     IA      LAY H++  
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRE--RPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 139 -HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC---GTLDYLAPEMVENKEH 193
             +IHRD+K  N+LLD E    +GDFG + +      H      G + ++APE +   + 
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKS 212
Query: 194 DYAVDNWTLGILCYEFLYGAPPFE 217
               D +  G++  E + G   F+
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFD 236

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 61/312 (19%)
Query: 17  SLQDFEIG------RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++  F++G      +PLG G  G V+   + +    VA+K I     +   ++H LR E+
Sbjct: 3   NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALR-EI 59
Query: 71  EIQSSLRHPNILRLY--------------GWFHDDERIFLILEYAHRGELYRELRKHRRF 116
           +I   L H NI++++              G   +   ++++ EY         + +    
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPL 117
Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS----VQSRS 171
            E+ A  ++  L   L Y H  +V+HRD+KP NL ++ E   LKIGDFG +         
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 172 KRHTMCGTLD--YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRI 228
           K H   G +   Y +P  ++    +  A+D W  G +  E L G   F    + +  + I
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 229 MKV----------------------DLSFPS------APSISAEAKHLISRLLVKDSSKR 260
           ++                       D++ P        P IS EA   + ++L      R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 261 LSLQKIMEHPWI 272
           L+ ++ + HP++
Sbjct: 298 LTAEEALSHPYM 309

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G +G VYL  +  ++  VA+K +   F++ I+  +I     RE+ I + L+   I+R
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI----LREITILNRLKSDYIIR 89
Query: 84  LYGWFHDDE-----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           LY     D+      ++++LE A   +L +  +     TE+   T + +L     + HE+
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLD---------------- 181
            +IHRD+KP N LL+ +  +K+ DFG +    S++ T +   L+                
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 182 --------YLAPEMVENKE-HDYAVDNWTLGILCYEFL 210
                   Y APE++  +E +  ++D W+ G +  E L
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/308 (21%), Positives = 134/308 (43%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 80
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 135
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +    +    T  Y A
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E + G   F      D + ++++              
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 255
Query: 231 ----------------------VDLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSLQ 264
                                  D+ FP+        +++A+ L+S++LV D+SKR+S+ 
Sbjct: 256 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 315
Query: 265 KIMEHPWI 272
           + ++HP+I
Sbjct: 316 EALQHPYI 323

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 37/295 (12%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYK 61
           E E + K E+  ++ E G+ LG G FG+V     Y + +      VA+K++ KE+ +  +
Sbjct: 33  EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSE 91
Query: 62  IQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQ 119
            +  L  E+++ + L  H NI+ L G       I+LI EY   G+L   LR  R +F+E 
Sbjct: 92  -REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 120 QA----------------------ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR 157
           +                         +   +   + +      +HRD+   N+L+ H   
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 158 LKIGDFGWS--VQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLY 211
           +KI DFG +  + S S    R      + ++APE +    +    D W+ GIL +E F  
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 212 GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKI 266
           G  P+        F ++++           + E   ++      DS KR S   +
Sbjct: 271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 134/309 (43%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------ 238
           PE++    +   VD W++G +  E + G   F      D + ++++  L  PS       
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPSPEFMKKL 252
Query: 239 -PSI----------------------------------SAEAKHLISRLLVKDSSKRLSL 263
            P++                                  +++A+ L+S++LV D+SKR+S+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 25  RPLGKGKFGRVY---LVREVESKHPVALK----IIFKEQIEKYKIQHQLRREMEIQSSLR 77
           R +GKG FG VY    + + +++   A+K    I   +Q+E +       RE  +   L 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL------REGLLMRGLN 80
Query: 78  HPNILRLYGWFHDDERI-FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYC 135
           HPN+L L G     E +  ++L Y   G+L + +R   R  T +   ++   +   + Y 
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----------WSVQSRSKRHTMCGTLDYLAP 185
            E   +HRD+   N +LD    +K+ DFG          +SVQ    RH     + + A 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH--RHARL-PVKWTAL 197
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLY-GAPPF 216
           E ++        D W+ G+L +E L  GAPP+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/308 (21%), Positives = 133/308 (43%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD--YLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +        +   Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E + G   F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 ----------------------VDLSFPSAPSISA----EAKHLISRLLVKDSSKRLSLQ 264
                                  D+ FP+    +A    +A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVD 313
Query: 265 KIMEHPWI 272
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/314 (21%), Positives = 134/314 (42%), Gaps = 62/314 (19%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA----KRAYRELVLLK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
            + H NI+ L   F       + + ++L++E      L + +  H     ++ +  +  +
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--HMELDHERMSYLLYQM 135
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAP 185
              + + H   +IHRD+KP N+++  +  LKI DFG + ++      M     T  Y AP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTACTNFMMTPYVVTRYYRAP 194
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------- 238
           E++    +   VD W++G +  E + G   F+     D + ++++  L  PSA       
Sbjct: 195 EVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIE-QLGTPSAEFMAALQ 253
Query: 239 PSI----------------------------------SAEAKHLISRLLVKDSSKRLSLQ 264
           P++                                  +++A+ L+S++LV D  KR+S+ 
Sbjct: 254 PTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 313
Query: 265 KIMEHPWIIKNANP 278
           + + HP+I    +P
Sbjct: 314 EALRHPYITVWYDP 327

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 43/217 (19%)
Query: 96  LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH- 154
           L+ EY +  + +++L  ++  T+     Y+  L  AL YCH   ++HRD+KP N+++DH 
Sbjct: 112 LVFEYINNTD-FKQL--YQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 155 EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLY 211
           + +L++ D+G +       + +    +  +  PE +V+ + +DY++D W+LG +    ++
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 212 GAPP-FEAESQKDTFRRIMKV---------------DL-----------------SFPSA 238
              P F  +   D   RI KV               DL                 +F  +
Sbjct: 229 RREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHS 288
Query: 239 PS---ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            +   +S EA  L+ +LL  D  +RL+ ++ MEHP+ 
Sbjct: 289 ENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/308 (21%), Positives = 133/308 (43%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 79
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 134
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E + G   F      D + ++++              
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 231 ----------------------VDLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSLQ 264
                                  D+ FP+        +++A+ L+S++LV D+SKR+S+ 
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 265 KIMEHPWI 272
           + ++HP+I
Sbjct: 315 EALQHPYI 322

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 43/217 (19%)
Query: 96  LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH- 154
           L+ EY +  + +++L  ++  T+     Y+  L  AL YCH   ++HRD+KP N+++DH 
Sbjct: 117 LVFEYINNTD-FKQL--YQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 155 EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLY 211
           + +L++ D+G +       + +    +  +  PE +V+ + +DY++D W+LG +    ++
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 212 GAPP-FEAESQKDTFRRIMKV---------------DL-----------------SFPSA 238
              P F  +   D   RI KV               DL                 +F  +
Sbjct: 234 RREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHS 293
Query: 239 PS---ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            +   +S EA  L+ +LL  D  +RL+ ++ MEHP+ 
Sbjct: 294 ENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/308 (21%), Positives = 133/308 (43%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E + G   F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 ----------------------VDLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSLQ 264
                                  D+ FP+        +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 265 KIMEHPWI 272
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 122/293 (41%), Gaps = 27/293 (9%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+      +G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 116 -----FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-----W 165
                 T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG     +
Sbjct: 136 LYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIY 195
Query: 166 SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                 ++      L ++APE + ++ +    D W+ G+L +E F  GA P+      + 
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255
Query: 225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 256 FXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 308

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   + R  + +  VA+K++ K+  EK   + ++ RE +I   L +P I+RL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTE-EMMREAQIMHQLDNPYIVRL 75
Query: 85  YGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            G     E + L++E A  G L++ L  K         A  +  ++  + Y  E + +HR
Sbjct: 76  IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 144 DIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           D+   N+LL +    KI DFG S          + R      L + APE +  ++     
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194
Query: 198 DNWTLGILCYEFL-YGAPPFE 217
           D W+ G+  +E L YG  P++
Sbjct: 195 DVWSYGVTMWEALSYGQKPYK 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/240 (22%), Positives = 104/240 (43%), Gaps = 25/240 (10%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           +E SL        LG+ +FG+VY   L      +   A+ I   +   +  ++ + R E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT------- 123
            +++ L+HPN++ L G    D+ + +I  Y   G+L+  L      ++  +         
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 124 ---------YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKR 173
                     +A +   + Y   +HV+H+D+   N+L+  +  +KI D G   +   +  
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 174 HTMCGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
           + + G     + ++APE +   +     D W+ G++ +E F YG  P+   S +D    I
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 105/243 (43%), Gaps = 25/243 (10%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            + +E SL        LG+ +FG+VY   L      +   A+ I   +   +  ++ + R
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---- 123
            E  +++ L+HPN++ L G    D+ + +I  Y   G+L+  L      ++  +      
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 124 ------------YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-R 170
                        +A +   + Y   +HV+H+D+   N+L+  +  +KI D G   +   
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 171 SKRHTMCGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTF 225
           +  + + G     + ++APE +   +     D W+ G++ +E F YG  P+   S +D  
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 226 RRI 228
             I
Sbjct: 241 EMI 243

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 63
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N  +  +  +KIGDFG +    ++   R 
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 243
Query: 232 DL 233
            L
Sbjct: 244 GL 245

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 106/242 (43%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 76
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R            S
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256
Query: 232 DL 233
            L
Sbjct: 257 GL 258

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 106/242 (43%), Gaps = 25/242 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 66
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R            S
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKV 231
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +M+ 
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 246
Query: 232 DL 233
            L
Sbjct: 247 GL 248

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 122/293 (41%), Gaps = 27/293 (9%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+      +G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 116 -----FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-----W 165
                 T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG     +
Sbjct: 136 LYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIY 195
Query: 166 SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                 ++      L ++APE + ++ +    D W+ G+L +E F  GA P+      + 
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255
Query: 225 FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 256 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 308

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 13/155 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSL 76
           ++EI   +G+G +G VYL  +  +   VA+K +   F++ I+  +I     RE+ I + L
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRI----LREITILNRL 84
Query: 77  RHPNILRLYGWFHDDE-----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +   I+RL+     ++      ++++LE A   +L +  +     TEQ   T + +L   
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
             + HE+ +IHRD+KP N LL+ +  +KI DFG +
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 23/236 (9%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+     E
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNE 69
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE----------Q 119
             +       +++RL G     +   +++E    G+L   LR  R   E          Q
Sbjct: 70  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 129
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTM 176
           +     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R   
Sbjct: 130 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 177 CGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
            G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 190 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 123/295 (41%), Gaps = 29/295 (9%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 20  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHR 77
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 78  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKP 137
Query: 116 -------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
                   T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +  
Sbjct: 138 EDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 169 -----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQK 222
                   ++      L ++APE + ++ +    D W+ G+L +E F  GA P+      
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 196 RDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/296 (21%), Positives = 122/296 (41%), Gaps = 30/296 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+      +G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 19  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 76
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 77  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 136
Query: 116 --------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
                    T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG + 
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 168 Q-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQ 221
                    ++      L ++APE + ++ +    D W+ G+L +E F  GA P+     
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 222 KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
            + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 134
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG +            R      + + APE + +      
Sbjct: 135 RDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQ 194
Query: 197 VDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
            D W+ G++ YE F Y     ++ S    F R+M  +   P+
Sbjct: 195 SDVWSFGVVLYELFTYCD---KSCSPSAEFLRMMGCERDVPA 233

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 20  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 77
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 78  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKE 137
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 138 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 197
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 198 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 257
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 258 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 314

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           W L D      LG+G    V+  R  ++    A+K+     I   +      RE E+   
Sbjct: 11  WLLSDI-----LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKK 63
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTN 130
           L H NI++L+    +       LI+E+   G LY  L +        E +    +  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 131 ALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            + +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +  ++ GT +YL 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 185 PEMVE--------NKEHDYAVDNWTLGILCYEFLYGAPPF 216
           P+M E         K++   VD W++G+  Y    G+ PF
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 7/232 (3%)
Query: 35  VYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI 94
           VY   +   +  VALK+  +        + + +RE      L+ P+++ ++ +   D ++
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 95  FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH 154
           ++     +  +L   LR+       +A   +  + +AL   H     HRD+KPEN+L+  
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 155 EGRLKIGDFGWSVQSRSKRHT----MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
           +    + DFG +  +  ++ T      GTL Y APE        Y  D + L  + YE L
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECL 229
Query: 211 YGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRLLVKDSSKR 260
            G+PP++ +        I +  +  PS   P I      +I+R   K+   R
Sbjct: 230 TGSPPYQGDQLSVXGAHINQA-IPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 167 VQ-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                     ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 167 VQ-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                     ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 55  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 112
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 113 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 172
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 232
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 233 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           W L D      LG+G    V+  R  ++    A+K+     I   +      RE E+   
Sbjct: 11  WLLSDI-----LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKK 63
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTN 130
           L H NI++L+    +       LI+E+   G LY  L +        E +    +  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 131 ALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            + +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +   + GT +YL 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLH 183
Query: 185 PEMVE--------NKEHDYAVDNWTLGILCYEFLYGAPPF 216
           P+M E         K++   VD W++G+  Y    G+ PF
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HR++   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 69
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HR++   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 130 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 189
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIM 229
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +M
Sbjct: 190 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 247

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 167 VQ-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                     ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/308 (22%), Positives = 138/308 (44%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLG-----ILCYEFLY----------------GAP-PFEAESQK 222
           PE++    +   VD W++G     ++C++ L+                G P P   +  +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQ 253
Query: 223 DTFRRIMK--------------VDLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSLQ 264
            T R  ++               D+ FP+        +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 265 KIMEHPWI 272
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 31/297 (10%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             + F R +K      +    + E    +      + S+R +  +++EH   +  AN
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 102/253 (40%), Gaps = 33/253 (13%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 23  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 82
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH------------- 113
            E++I S L +H NI+ L G       + +I EY   G+L   LR+              
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 114 ----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
                     R    +    + + +   +A+    + IHRD+   N+LL +    KIGDF
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 164 GWSVQSRSKRHTMCGT-----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFE 217
           G +    +  + +        + ++APE + +  +    D W+ GIL +E F  G  P+ 
Sbjct: 203 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 262
Query: 218 AESQKDTFRRIMK 230
                  F +++K
Sbjct: 263 GILVNSKFYKLVK 275

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   + R  + +  VA+K++ K+  EK   + ++ RE +I   L +P I+RL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTE-EMMREAQIMHQLDNPYIVRL 401
Query: 85  YGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            G     E + L++E A  G L++ L  K         A  +  ++  + Y  E + +HR
Sbjct: 402 IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 144 DIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           ++   N+LL +    KI DFG S          + R      L + APE +  ++     
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 198 DNWTLGILCYEFL-YGAPPFE 217
           D W+ G+  +E L YG  P++
Sbjct: 521 DVWSYGVTMWEALSYGQKPYK 541

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 133/296 (44%), Gaps = 48/296 (16%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 66
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 67  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGW-----SV 167
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG      S 
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 168 QS--RSKRHTMCGTLDYLAPEMVENKEH-------DYAVDNWTLGILCYEFLY-GAPPF- 216
           QS  R+  +   GT  + APE++E   +         ++D +++G + Y  L  G  PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 217 -EAESQKDTFRRIMKVD-LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
            +   + +  R I  +D +      S+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 138
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG +            R      + + APE + +      
Sbjct: 139 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 198
Query: 197 VDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
            D W+ G++ YE F Y     ++ S    F R+M  +   P+
Sbjct: 199 SDVWSFGVVLYELFTYCD---KSCSPSAEFLRMMGCERDVPA 237

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 150
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG +            R      + + APE + +      
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 210
Query: 197 VDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
            D W+ G++ YE F Y     ++ S    F R+M  +   P+
Sbjct: 211 SDVWSFGVVLYELFTYCD---KSCSPSAEFLRMMGCERDVPA 249

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 119/288 (41%), Gaps = 39/288 (13%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R L +G F  VY  ++V S    ALK +   + EK +   Q    M+  S   HPNI++ 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG--HPNIVQF 91
Query: 85  -----YGWFHDD--ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
                 G    D  +  FL+L    +G+L   L+K          T +            
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 138 NH-----VIHRDIKPENLLLDHEGRLKIGDFG------------WSVQSRS---KRHTMC 177
            H     +IHRD+K ENLLL ++G +K+ DFG            WS Q R+   +  T  
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
            T  Y  PE+++   N       D W LG + Y   +   PFE  ++     RI+    S
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRIVNGKYS 267
Query: 235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKI---MEHPWIIKNANPR 279
            P   +       LI  +L  +  +RLS+ ++   ++     +N NP+
Sbjct: 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/309 (21%), Positives = 137/309 (44%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 72
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 127
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 185 PEMVENKEHDYAVDNWTLG-----ILCYEFLYGA------------------PPFEAESQ 221
           PE++    +   VD W++G     ++C++ L+                    P F  + Q
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 222 KD--------------TFRRIMKVDLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSL 263
                           +F ++   D+ FP+        +++A+ L+S++LV D+SKR+S+
Sbjct: 248 PTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 306
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 307 DEALQHPYI 315

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/309 (21%), Positives = 137/309 (44%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 83
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 138
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 185 PEMVENKEHDYAVDNWTLG-----ILCYEFLYGA------------------PPFEAESQ 221
           PE++    +   VD W++G     ++C++ L+                    P F  + Q
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 258
Query: 222 KD--------------TFRRIMKVDLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSL 263
                           +F ++   D+ FP+        +++A+ L+S++LV D+SKR+S+
Sbjct: 259 PTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 317
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 318 DEALQHPYI 326

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 77  NPHVCRLLG-ICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 254
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 255 KCWMIDADSRPKFRELI 271

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG +            R      + + APE + +      
Sbjct: 138 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 197
Query: 197 VDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
            D W+ G++ YE F Y     ++ S    F R+M  +   P+
Sbjct: 198 SDVWSFGVVLYELFTYCD---KSCSPSAEFLRMMGSERDVPA 236

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/309 (21%), Positives = 137/309 (44%), Gaps = 64/309 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLG-----ILCYEFLYGA------------------PPFEAESQ 221
           PE++    +   VD W++G     ++C++ L+                    P F  + Q
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 222 KD--------------TFRRIMKVDLSFPSAPS----ISAEAKHLISRLLVKDSSKRLSL 263
                           +F ++   D+ FP+        +++A+ L+S++LV D+SKR+S+
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 264 QKIMEHPWI 272
            + ++HP+I
Sbjct: 313 DEALQHPYI 321

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 253
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 254 KCWMIDADSRPKFRELI 270

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I++++EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 257 EERPTFE 263

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 77  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 254
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 255 KCWMIDADSRPKFRELI 271

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 80  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 257
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 258 KCWMIDADSRPKFRELI 274

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 255
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 256 KCWMIDADSRPKFRELI 272

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 105/250 (42%), Gaps = 31/250 (12%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVY-LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  + +EI   LG+G FGRV   V        VALKII  + +EKYK   +L   +  +
Sbjct: 29  DWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKII--KNVEKYKEAARLEINVLEK 86
Query: 74  SSLRHPN----ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE---QQAATYIA 126
            + + P+     ++++ WF  D    + + +   G    +  K   +      Q      
Sbjct: 87  INEKDPDNKNLCVQMFDWF--DYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAF 144
Query: 127 SLTNALAYCHENHVIHRDIKPENLLL---DHE----------------GRLKIGDFGWSV 167
            L  A+ + H+N + H D+KPEN+L    D+E                  +++ DFG + 
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRR 227
                  T+  T  Y APE++         D W++G + +E+  G   F+    ++    
Sbjct: 205 FDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 228 IMKVDLSFPS 237
           + ++    PS
Sbjct: 265 MERILGPIPS 274

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 79  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 256
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 257 KCWMIDADSRPKFRELI 273

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 22/272 (8%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           + +R   +  Q F+    LG G +G V+ VR  E     A+K   +        + + R+
Sbjct: 47  DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK---RSMSPFRGPKDRARK 103
Query: 69  EMEIQS---SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQ 120
             E+ S     +HP  +RL   + +   ++L  E          L++H         E Q
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGP-----SLQQHCEAWGASLPEAQ 158
Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCG 178
              Y+     ALA+ H   ++H D+KP N+ L   GR K+GDFG  V+  +        G
Sbjct: 159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG 218
Query: 179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA 238
              Y+APE+++   +  A D ++LG+   E    A   E     + ++++ +  L     
Sbjct: 219 DPRYMAPELLQGS-YGTAADVFSLGLTILEV---ACNMELPHGGEGWQQLRQGYLPPEFT 274
Query: 239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
             +S+E + ++  +L  D   R + + ++  P
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLALP 306

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 15/225 (6%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W +  +  ++ + LG G+FG V++     +KH    K+  K              E 
Sbjct: 7   KDAWEIPRESLKLEKKLGAGQFGEVWMA--TYNKH---TKVAVKTMKPGSMSVEAFLAEA 61
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASL 128
            +  +L+H  +++L+      E I++I E+  +G L   L+      +   +   + A +
Sbjct: 62  NVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 120
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLA 184
              +A+  + + IHRD++  N+L+      KI DFG +        + R      + + A
Sbjct: 121 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 180
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           PE +         D W+ GIL  E + YG  P+   S  +  R +
Sbjct: 181 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I++++EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 257 EERPTFE 263

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           E +  +F+    +G G FG+VY  ++R+      VALK   +   E  +   +   E+E 
Sbjct: 35  EEATNNFDHKFLIGHGVFGKVYKGVLRD---GAKVALK---RRTPESSQGIEEFETEIET 88
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT-----EQQAATYIAS 127
            S  RHP+++ L G+  +   + LI +Y   G L R L      T     EQ+    I +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDY 182
               L Y H   +IHRD+K  N+LLD     KI DFG S +      T     + GTL Y
Sbjct: 149 -ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL 210
           + PE           D ++ G++ +E L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           E +  +F+    +G G FG+VY  ++R+      VALK   +   E  +   +   E+E 
Sbjct: 35  EEATNNFDHKFLIGHGVFGKVYKGVLRD---GAKVALK---RRTPESSQGIEEFETEIET 88
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT-----EQQAATYIAS 127
            S  RHP+++ L G+  +   + LI +Y   G L R L      T     EQ+    I +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDY 182
               L Y H   +IHRD+K  N+LLD     KI DFG S +      T     + GTL Y
Sbjct: 149 -ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL 210
           + PE           D ++ G++ +E L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+   + E  R +G+G FGRV+  R       E    VA+K++ +E      +Q   +RE
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 100
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT-------EQQAA 122
             + +   +PNI++L G     + + L+ EY   G+L   LR     T       +    
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 123 TYIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW 165
             ++S                 +   +AY  E   +HRD+   N L+     +KI DFG 
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 166 SVQSRSKRHTMCGTLD-----YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAE 219
           S    S  +      D     ++ PE +    +    D W  G++ +E F YG  P+   
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 220 SQKDTF 225
           + ++  
Sbjct: 281 AHEEVI 286

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 130/292 (44%), Gaps = 44/292 (15%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 84
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 85  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGWSVQ---- 168
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG   +    
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 169 ---SRSKRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLY-GAPPF--EAE 219
               R   +   GT  + APE++E    +    ++D +++G + Y  L  G  PF  +  
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 220 SQKDTFRRIMKVD-LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
            + +  R I  +D +      S+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 260 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 77
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 78  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 132
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 192
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 253 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 312
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 313 DALQHPYI 320

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 314 DALQHPYI 321

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 130/292 (44%), Gaps = 44/292 (15%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 84
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 85  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGWSVQ---- 168
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG   +    
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 169 ---SRSKRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLY-GAPPF--EAE 219
               R   +   GT  + APE++E    +    ++D +++G + Y  L  G  PF  +  
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 220 SQKDTFRRIMKVD-LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
            + +  R I  +D +      S+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 260 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 314 DALQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 116
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 171
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 352 DALQHPYI 359

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/257 (19%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 253
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 254 KCWMIDADSRPKFRELI 270

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 79
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 134
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 315 DALQHPYI 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 79
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 134
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 315 DALQHPYI 322

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 80  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 257
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 258 KCWMIDADSRPKFRELI 274

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 314 DALQHPYI 321

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 255
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 256 KCWMIDADSRPKFRELI 272

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 116/257 (45%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMR 255
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 256 KCWMIDADSRPKFRELI 272

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 314 DALQHPYI 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 71
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 126
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 307 DALQHPYI 314

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 72
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 127
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 308 DALQHPYI 315

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 17/221 (7%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W +  +  ++ + LG G+FG V++     +KH    K+  K              E 
Sbjct: 174 KDAWEIPRESLKLEKKLGAGQFGEVWMA--TYNKH---TKVAVKTMKPGSMSVEAFLAEA 228
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASL 128
            +  +L+H  +++L+      E I++I E+  +G L   L+      +   +   + A +
Sbjct: 229 NVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 287
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
              +A+  + + IHRD++  N+L+      KI DFG +      R      + + APE +
Sbjct: 288 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA------RVGAKFPIKWTAPEAI 341
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
                    D W+ GIL  E + YG  P+   S  +  R +
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 71
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 126
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 307 DALQHPYI 314

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 116
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 171
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 352 DALQHPYI 359

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 72
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 127
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 308 DALQHPYI 315

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 15/225 (6%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W +  +  ++ + LG G+FG V++     +KH    K+  K              E 
Sbjct: 180 KDAWEIPRESLKLEKKLGAGQFGEVWMA--TYNKH---TKVAVKTMKPGSMSVEAFLAEA 234
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASL 128
            +  +L+H  +++L+      E I++I E+  +G L   L+      +   +   + A +
Sbjct: 235 NVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLA 184
              +A+  + + IHRD++  N+L+      KI DFG +        + R      + + A
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           PE +         D W+ GIL  E + YG  P+   S  +  R +
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 314 DALQHPYI 321

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 70  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 247
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 248 KCWMIDADSRPKFRELI 264

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 62/308 (20%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK-------------- 230
           PE++    +   VD W++G +  E +     F      D + ++++              
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 -------------VDLSFPSA------PSIS-------AEAKHLISRLLVKDSSKRLSLQ 264
                          L+FP        P+ S       ++A+ L+S++LV D +KR+S+ 
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 265 KIMEHPWI 272
             ++HP+I
Sbjct: 314 DALQHPYI 321

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 129/296 (43%), Gaps = 48/296 (16%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 66
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 67  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGWS------ 166
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG        
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 167 -VQSRSKRHTMCGTLDYLAPEMVENKEH-------DYAVDNWTLGILCYEFLY-GAPPF- 216
               R   +   GT  + APE++E   +         ++D +++G + Y  L  G  PF 
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 217 -EAESQKDTFRRIMKVD-LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
            +   + +  R I  +D +      S+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I++++EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 257 EERPTFE 263

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 255
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 256 KCWMIDADSRPKFRELI 272

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 71
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 72  -VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 128
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 189 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 247
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 248 EERPTFE 254

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 101 NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 160 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 220 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 278
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 279 KCWMIDADSRPKFRELI 295

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 256
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 257 KCWMIDADSRPKFRELI 273

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 257 EERPTFE 263

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMR 253
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 254 KCWMIDADSRPKFRELI 270

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 73  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 132 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 192 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 250
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 251 KCWMIDADSRPKFRELI 267

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMR 256
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 257 KCWMIDADSRPKFRELI 273

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 256
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 257 KCWMIDADSRPKFRELI 273

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 69
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 70  -VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 126
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 187 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 245
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 246 EERPTFE 252

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 83  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 260
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 261 KCWMIDADSRPKFRELI 277

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 82  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 141 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 201 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 259
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 260 KCWMIDADSRPKFRELI 276

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 253
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 254 KCWMIDADSRPKFRELI 270

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 86  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 145 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 205 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMR 263
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 264 KCWMIDADSRPKFRELI 280

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 257 EERPTFE 263

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 23  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 78  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 197 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 225

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 22  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 77  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 196 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 20/230 (8%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-R 77
            D +    +G+G FG+V   R  +    +   I   ++            E+E+   L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQA 121
           HPNI+ L G       ++L +EYA  G L   LRK R                  + QQ 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD 181
             + A +   + Y  +   IHRD+   N+L+      KI DFG S           G L 
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 182 --YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
             ++A E +    +    D W+ G+L +E +  G  P+   +  + + ++
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 244

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 30  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 85  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 204 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 232

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 29  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 84  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 203 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 231

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 76  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 20/230 (8%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-R 77
            D +    +G+G FG+V   R  +    +   I   ++            E+E+   L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQA 121
           HPNI+ L G       ++L +EYA  G L   LRK R                  + QQ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD 181
             + A +   + Y  +   IHRD+   N+L+      KI DFG S           G L 
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 182 --YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRI 228
             ++A E +    +    D W+ G+L +E +  G  P+   +  + + ++
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 27  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 82  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 76  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----KIQHQLRREMEIQSSL 76
           F + R +G G FGRV L + +++K   A+K++    I+KY    KI+  + ++++     
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAY 134
            +  + + +G F   + + LI E      LY  + +  +  F  +    Y   +  AL Y
Sbjct: 95  NNNIV-KYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 135 CHENHVIHRDIKPENLLLDH--------------EGR-----------LKIGDFGWSVQS 169
             +  + H D+KPEN+LLD               +G+           +K+ DFG +   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
                ++  T  Y APE++ N   D + D W+ G +  E   G+  F
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 21  FEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +E+   +  G  G +YL   R V  + PV LK +      + +      R+    + + H
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQF--LAEVVH 138
Query: 79  PNILRLYGWF-----HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           P+I++++ +      H D   ++++EY     L R   K ++    +A  Y+  +  AL+
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS--KGQKLPVAEAIAYLLEILPALS 196
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEH 193
           Y H   +++ D+KPEN++L  E +LK+ D G +V   +    + GT  + APE+V     
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEE-QLKLIDLG-AVSRINSFGYLYGTPGFQAPEIVRTGP- 253
Query: 194 DYAVDNWTLG 203
             A D +T+G
Sbjct: 254 TVATDIYTVG 263

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/257 (19%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMR 255
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 256 KCWMIDADSRPKFRELI 272

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 253
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 254 KCWMIDADSRPKFRELI 270

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/257 (20%), Positives = 115/257 (44%), Gaps = 11/257 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  E    K   ++  E  + +S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 83  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            + +  D W+ G+  +E + +G+ P++     +    I++     P  P  + +   ++ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 260
Query: 251 RLLVKDSSKRLSLQKIM 267
           +  + D+  R   ++++
Sbjct: 261 KCWMIDADSRPKFRELI 277

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 26  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 81  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 200 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 228

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 100/247 (40%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD+   N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 257 EERPTFE 263

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 27  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 82  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/254 (22%), Positives = 103/254 (40%), Gaps = 21/254 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSP----EAFLQEAQVMKKLRHEKLVQLYA 247
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 248 -VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 304
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG          + R      + + APE           D
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 423
Query: 258 SKRLS---LQKIME 268
            +R +   LQ  +E
Sbjct: 424 EERPTFEYLQAFLE 437

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 76  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 18/247 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   +RH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKIRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
            W+ GIL  E    G  P+     ++   ++ +     P  P        L+ +   KD 
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 258 SKRLSLQ 264
            +R + +
Sbjct: 257 EERPTFE 263

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 31  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 86  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRRI 228
           + GIL  E + +G  P+   +  +  + +
Sbjct: 205 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 233
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	284
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-162
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-161
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-153
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-139
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-139
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-128
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-102
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-99
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-99
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-91
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-91
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-91
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-90
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-90
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-90
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-89
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-89
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-89
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-89
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-89
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-89
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-89
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-88
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-88
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-88
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-88
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-88
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-87
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-87
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-87
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-87
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-87
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-87
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-87
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-87
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-87
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-87
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-86
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-86
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-86
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-86
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-86
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-86
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-86
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-86
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-86
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-86
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-86
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-86
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-86
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-85
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-85
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-85
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-85
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-85
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-84
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-84
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-84
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-84
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-84
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-84
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-84
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-84
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-83
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-82
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-82
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-82
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-82
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-82
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-81
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-81
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-81
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-80
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-79
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-79
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-79
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-79
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-79
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-78
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-77
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-75
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-74
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-74
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-73
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-72
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-71
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-70
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-67
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-66
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-65
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-64
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-61
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-60
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-59
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-57
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-57
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-56
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-55
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-55
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-54
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-54
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-54
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-53
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-53
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-52
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-51
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-51
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-48
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-47
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-47
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-47
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-47
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-46
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-46
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-46
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-46
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-45
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-45
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-45
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-42
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-42
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-41
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-41
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-40
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-39
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-38
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-37
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-37
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-36
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-36
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-33
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-33
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-32
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-32
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-32
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-30
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-30
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-30
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-30
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-30
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-29
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-28
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-27
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-25
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-24
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-24
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-24
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-22
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-21
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-20
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	7e-04

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  449 bits (1158), Expect = e-162
 Identities = 162/273 (59%), Positives = 209/273 (76%), Gaps = 3/273 (1%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S +R  +CGTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE 180

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI 249
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LI
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLI 238

Query: 250 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 282
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  448 bits (1156), Expect = e-161
 Identities = 160/271 (59%), Positives = 207/271 (76%), Gaps = 3/271 (1%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
            +  KR++++ DF+IGRPLGKGKFG VYL RE ++K  +ALK++FK Q+EK  ++HQLRR
Sbjct: 4   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILR+Y +FHD +RI+L+LE+A RGELY+EL+KH RF EQ++AT++  L
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEM 187
            +AL YCHE  VIHRDIKPENLL+ ++G LKI DFGWSV + S +R TMCGTLDYL PEM
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEM 183

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +E K HD  VD W  G+LCYEFL G PPF++ S  +T RRI+ VDL FP  P +S  +K 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKD 241

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           LIS+LL     +RL L+ +MEHPW+  N+  
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  428 bits (1104), Expect = e-153
 Identities = 92/271 (33%), Positives = 159/271 (58%), Gaps = 6/271 (2%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
                ++DF++G  LGKG F  VY    + +   VA+K+I K+ + K  +  +++ E++I
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
              L+HP+IL LY +F D   ++L+LE  H GE+ R L+   + F+E +A  ++  +   
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMV 188
           + Y H + ++HRD+   NLLL     +KI DFG + Q +    K +T+CGT +Y++PE+ 
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
               H    D W+LG + Y  L G PPF+ ++ K+T  +++  D   PS   +S EAK L
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS--FLSIEAKDL 242

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
           I +LL ++ + RLSL  +++HP++ +N++ +
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  395 bits (1016), Expect = e-139
 Identities = 85/279 (30%), Positives = 146/279 (52%), Gaps = 5/279 (1%)

Query: 4   KTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
              E  +      S + +  GR LGKG F + + + + ++K   A KI+ K  + K   +
Sbjct: 26  PAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR 85

Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT 123
            ++  E+ I  SL H +++  +G+F D++ +F++LE   R  L    ++ +  TE +A  
Sbjct: 86  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 145

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTL 180
           Y+  +     Y H N VIHRD+K  NL L+ +  +KIGDFG + +      ++  +CGT 
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 205

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS 240
           +Y+APE++  K H + VD W++G + Y  L G PPFE    K+T+ RI K + S P    
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KH 263

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
           I+  A  LI ++L  D + R ++ +++   +      P 
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  392 bits (1009), Expect = e-139
 Identities = 84/270 (31%), Positives = 144/270 (53%), Gaps = 5/270 (1%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
               S + +  GR LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
             SL H +++  +G+F D++ +F++LE   R  L    ++ +  TE +A  Y+  +    
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVE 189
            Y H N VIHRD+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++ 
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI 249
            K H + VD W++G + Y  L G PPFE    K+T+ RI K + S P    I+  A  LI
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLI 246

Query: 250 SRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
            ++L  D + R ++ +++   +      P 
Sbjct: 247 QKMLQTDPTARPTINELLNDEFFTSGYIPA 276

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  367 bits (943), Expect = e-128
 Identities = 71/318 (22%), Positives = 130/318 (40%), Gaps = 46/318 (14%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
                  +  ++++  + D+ I R L +GKF ++ L  +       ALK   K  +EK +
Sbjct: 14  SNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKR 71

Query: 62  --------------IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY 107
                              + E++I + +++   L   G   + + +++I EY     + 
Sbjct: 72  DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL 131

Query: 108 RELRKH--------RRFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGRL 158
           +                  Q     I S+ N+ +Y H E ++ HRD+KP N+L+D  GR+
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191

Query: 159 KIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPP 215
           K+ DFG S      K     GT +++ PE   N+   +   VD W+LGI  Y   Y   P
Sbjct: 192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

Query: 216 FEAE-SQKDTFRRIMKVDLSFP-----------------SAPSISAEAKHLISRLLVKDS 257
           F  + S  + F  I   ++ +P                 S   +S E    +   L K+ 
Sbjct: 252 FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311

Query: 258 SKRLSLQKIMEHPWIIKN 275
           ++R++ +  ++H W+   
Sbjct: 312 AERITSEDALKHEWLADT 329

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  300 bits (771), Expect = e-102
 Identities = 92/271 (33%), Positives = 150/271 (55%), Gaps = 13/271 (4%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           + R+   +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE +
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           + S L HP  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +A
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPE 186
           L Y H   +IHRD+KPEN+LL+ +  ++I DFG +        +++ ++  GT  Y++PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           ++  K    + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKAR 260

Query: 247 HLISRLLVKDSSKRL------SLQKIMEHPW 271
            L+ +LLV D++KRL          +  HP+
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  294 bits (755), Expect = 2e-99
 Identities = 92/270 (34%), Positives = 149/270 (55%), Gaps = 7/270 (2%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           + E   +    L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K     
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             E  I  ++  P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
            +     Y H   +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT + LAPE
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPE 208

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           ++ +K ++ AVD W LG+L YE   G PPF A+     + +I+   + FP     S++ K
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLK 266

Query: 247 HLISRLLVKDSSKRLSLQK-----IMEHPW 271
            L+  LL  D +KR    K     I  H W
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  291 bits (748), Expect = 7e-99
 Identities = 105/261 (40%), Positives = 157/261 (60%), Gaps = 7/261 (2%)

Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +SLQDF+I R LG G FGRV+L+R   +    A+K++ KE + + K       E  + S 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I+R++G F D ++IF+I++Y   GEL+  LRK +RF    A  Y A +  AL Y 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           H   +I+RD+KPEN+LLD  G +KI DFG++       +T+CGT DY+APE+V  K ++ 
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 182

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
           ++D W+ GIL YE L G  PF   +   T+ +I+  +L FP  P  + + K L+SRL+ +
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLITR 240

Query: 256 DSSKRL-----SLQKIMEHPW 271
           D S+RL       + +  HPW
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPW 261

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  286 bits (733), Expect = 9e-97
 Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 27/284 (9%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + +   + LG+G F  V LV  +   H  ALK I   + +    + + +RE ++     H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNH 85

Query: 79  PNILRLYGWFHDDE----RIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTN 130
           PNILRL  +   +       +L+L +  RG L+ E+     K    TE Q    +  +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------------RHTMCG 178
            L   H     HRD+KP N+LL  EG+  + D G   Q+                     
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 179 TLDYLAPEMVENKEH---DYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLS 234
           T+ Y APE+   + H   D   D W+LG + Y  ++G  P++   QK D+    ++  LS
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265

Query: 235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
            P +P  S+    L++ ++  D  +R  +  ++     ++   P
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  279 bits (716), Expect = 4e-94
 Identities = 62/279 (22%), Positives = 132/279 (47%), Gaps = 23/279 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+ 
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQ 85

Query: 79  PN--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            +  I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMCGTLDYLAPEMVENK 191
           ++ ++H D+KP N L+  +G LK+ DFG + Q     +   + +  GT++Y+ PE +++ 
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 192 -----------EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAP 239
                      +     D W+LG + Y   YG  PF +  +Q      I+  +       
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263

Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  272 bits (697), Expect = 1e-91
 Identities = 89/266 (33%), Positives = 146/266 (54%), Gaps = 9/266 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LGKG FG V   ++  ++   A+K+I K   +  K    + RE+E+   L H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDH 80

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++L+    D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H++
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 139 HVIHRDIKPENLLLDHEG---RLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +++HRD+KPEN+LL+ +     +KI DFG S   Q  +K     GT  Y+APE V    +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
           D   D W+ G++ Y  L G PPF  +++ D  +R+     +F      +IS +AK LI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           +L    S R++  + +EHPWI K ++
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSS 285

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  271 bits (696), Expect = 1e-91
 Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 11/266 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           Q + +   +G+G +G V +  +  ++   A K I K  +E      + ++E+EI  SL H
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDH 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RLY  F D+  I+L++E    GEL+  +   R F E  AA  +  + +A+AYCH+ 
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +V HRD+KPEN L      +  LK+ DFG +   +      T  GT  Y++P+ V    +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLY 184

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
               D W+ G++ Y  L G PPF A +  +   +I +   +FP     ++S +A+ LI R
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           LL K   +R++  + +EH W  K  +
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLS 270

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  272 bits (697), Expect = 3e-91
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 9/274 (3%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           + +     + F     LG G F  V+LV++  +    ALK I K    +      L  E+
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEI 57

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            +   ++H NI+ L   +      +L+++    GEL+  + +   +TE+ A+  I  + +
Sbjct: 58  AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117

Query: 131 ALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR-HTMCGTLDYLAPE 186
           A+ Y HEN ++HRD+KPENLL    +   ++ I DFG S   ++    T CGT  Y+APE
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPE 177

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAE 244
           ++  K +  AVD W++G++ Y  L G PPF  E++   F +I +    F S     IS  
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237

Query: 245 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           AK  I  LL KD ++R + +K + HPWI  N   
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  272 bits (698), Expect = 4e-91
 Identities = 62/279 (22%), Positives = 132/279 (47%), Gaps = 23/279 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+ 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQ 66

Query: 79  PN--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            +  I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMCGTLDYLAPEMVENK 191
           ++ ++H D+KP N L+  +G LK+ DFG + Q     +   + +  GT++Y+ PE +++ 
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 192 -----------EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAP 239
                      +     D W+LG + Y   YG  PF +  +Q      I+  +       
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

Query: 240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  274 bits (702), Expect = 5e-91
 Identities = 80/270 (29%), Positives = 144/270 (53%), Gaps = 11/270 (4%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           +   + +   FEI R +GKG FG+V +V++ ++K   A+K + K++  +      + +E+
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           +I   L HP ++ L+  F D+E +F++++    G+L   L+++  F E+    +I  L  
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           AL Y     +IHRD+KP+N+LLD  G + I DF  +  +   ++  TM GT  Y+APEM 
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186

Query: 189 ENKE---HDYAVDNWTLGILCYEFLYGAPPFE---AESQKDTFRRIMKVDLSFPSAPSIS 242
            +++   + +AVD W+LG+  YE L G  P+    + S K+         +++P   + S
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWS 244

Query: 243 AEAKHLISRLLVKDSSKRL-SLQKIMEHPW 271
            E   L+ +LL  +  +R   L  +   P+
Sbjct: 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  269 bits (689), Expect = 2e-90
 Identities = 81/265 (30%), Positives = 135/265 (50%), Gaps = 8/265 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 64

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 139 HVIHRDIKPENLLLDHEG---RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEH 193
            ++HR++KPENLLL  +     +K+ DFG +  V      H   GT  YL+PE+++   +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
              VD W  G++ Y  L G PPF  E Q   + +I      +PS    +++ EAK LI  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNA 276
           +L  +  KR++  + ++ PWI    
Sbjct: 245 MLTVNPKKRITADQALKVPWICNRE 269

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  268 bits (687), Expect = 3e-90
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 9/265 (3%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  ++         +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 HD-YAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKVDLSFPSAPSISAEAKHLIS 250
                VD W+ GI+    L G  P++  S     +    +          I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKN 275
           ++LV++ S R+++  I +  W  K 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKP 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  267 bits (686), Expect = 4e-90
 Identities = 82/271 (30%), Positives = 136/271 (50%), Gaps = 5/271 (1%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
                  +  + +G  LG G FG+V +     + H VA+KI+ +++I    +  +++RE+
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           +     RHP+I++LY         F+++EY   GEL+  + KH R  E +A      + +
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMV 188
           A+ YCH + V+HRD+KPEN+LLD     KI DFG S          T CG+ +Y APE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182

Query: 189 ENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
             + +    VD W+ G++ Y  L G  PF+ E     F++I       P    ++     
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP--EYLNRSVAT 240

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           L+  +L  D  KR +++ I EH W  ++   
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  273 bits (701), Expect = 1e-89
 Identities = 90/273 (32%), Positives = 147/273 (53%), Gaps = 8/273 (2%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             ++  R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++LY +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
            ++HRD+KPENLLL     +  ++I DFG S   ++  K     GT  Y+APE V +  +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-VLHGTY 204

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
           D   D W+ G++ Y  L G PPF   ++ D  +++ K   +F       +S  AK LI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           +L    S R+S +  ++H WI      + + D+
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  269 bits (690), Expect = 1e-89
 Identities = 80/265 (30%), Positives = 135/265 (50%), Gaps = 8/265 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 87

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 139 HVIHRDIKPENLLLDHEG---RLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
            ++HR++KPENLLL  +     +K+ DFG ++        H   GT  YL+PE+++   +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
              VD W  G++ Y  L G PPF  E Q   + +I      +PS    +++ EAK LI  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNA 276
           +L  +  KR++  + ++ PWI    
Sbjct: 268 MLTVNPKKRITADQALKVPWICNRE 292

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  266 bits (683), Expect = 2e-89
 Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 13/264 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             F   R LG G FG V+LV E  S     +K I K++ +      Q+  E+E+  SL H
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDH 79

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAY 134
           PNI++++  F D   +++++E    GEL         + +  +E   A  +  + NALAY
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
            H  HV+H+D+KPEN+L         +KI DFG +   +S        GT  Y+APE V 
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VF 198

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP-SISAEAKHL 248
            ++  +  D W+ G++ Y  L G  PF   S ++  ++    + ++      ++ +A  L
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWI 272
           + ++L KD  +R S  +++ H W 
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWF 282

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  273 bits (700), Expect = 2e-89
 Identities = 89/270 (32%), Positives = 147/270 (54%), Gaps = 9/270 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LGKG FG V   ++  ++   A+K+I K   +  K    + RE+E+   L H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDH 80

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++L+    D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H++
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEH 193
           +++HRD+KPEN+LL   + +  +KI DFG S   +  +K     GT  Y+APE V    +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
           D   D W+ G++ Y  L G PPF  +++ D  +R+     +F      +IS +AK LI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGT 281
           +L    S R++  + +EHPWI K ++   T
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPT 289

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  266 bits (682), Expect = 6e-89
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 9/265 (3%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  ++         +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 HD-YAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKVDLSFPSAPSISAEAKHLIS 250
                VD W+ GI+    L G  P++  S     +    +          I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKN 275
           ++LV++ S R+++  I +  W  K 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKP 268

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  267 bits (685), Expect = 7e-89
 Identities = 98/267 (36%), Positives = 142/267 (53%), Gaps = 13/267 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++  + +G G FG   L+R+  +K  VA+K I +       I   ++RE+    SLRHPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPN 77

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +I+EYA  GELY  +    RF+E +A  +   L + ++YCH   +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137

Query: 141 IHRDIKPENLLLDH--EGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHD-Y 195
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  +E+D  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFR----RIMKVDLSFPSAPSISAEAKHLISR 251
             D W+ G+  Y  L GA PFE   +   +R    RI+ V  S P    IS E  HLISR
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANP 278
           + V D + R+S+ +I  H W +KN   
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKNLPA 284

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  265 bits (679), Expect = 9e-89
 Identities = 80/291 (27%), Positives = 137/291 (47%), Gaps = 17/291 (5%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK- 61
           T+ A    +       +++E    LG+G    V       +    A+KII       +  
Sbjct: 1   TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 62  -----IQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR 115
                ++    +E++I   +  HPNI++L   +  +   FL+ +   +GEL+  L +   
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKR 173
            +E++    + +L   +   H+ +++HRD+KPEN+LLD +  +K+ DFG+S Q     K 
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180

Query: 174 HTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRR 227
             +CGT  YLAPE++E      +  +   VD W+ G++ Y  L G+PPF    Q    R 
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240

Query: 228 IMKVDLSFPSAP--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           IM  +  F S      S   K L+SR LV    KR + ++ + HP+  +  
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  264 bits (676), Expect = 2e-88
 Identities = 82/263 (31%), Positives = 141/263 (53%), Gaps = 11/263 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLR 77
           +E+G  LG G+F  V   R+  +    A K I K ++    +   + ++ RE+ I   +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + + + Y H 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 138 NHVIHRDIKPENLLLDHE----GRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN++L  +     R+K+ DFG +   ++ ++   + GT +++APE+V  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLI 249
                 D W++G++ Y  L GA PF  E++++T   I  V+  F      + S  AK  I
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246

Query: 250 SRLLVKDSSKRLSLQKIMEHPWI 272
            RLLVKD  +R+++ + +EH WI
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWI 269

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  266 bits (681), Expect = 2e-88
 Identities = 78/315 (24%), Positives = 137/315 (43%), Gaps = 55/315 (17%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSL 76
           + + +   +G+G +G V +  E +++   A+KI+ K +I +   K   +++ E+ +   L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK------------------------ 112
            HPNI RLY  + D++ I L++E  H G L  +L                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 113 ----------------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL--DH 154
                                E+  +  +  + +AL Y H   + HRDIKPEN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 155 EGRLKIGDFGWSVQSRSKR-------HTMCGTLDYLAPEMVENKEHDY--AVDNWTLGIL 205
              +K+ DFG S +             T  GT  ++APE++      Y    D W+ G+L
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 206 CYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISRLLVKDSSKRLSL 263
            +  L GA PF   +  DT  +++   L F +     +S  A+ L+S LL ++  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 264 QKIMEHPWIIKNANP 278
            + ++HPWI + ++ 
Sbjct: 326 MRALQHPWISQFSDK 340

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  269 bits (689), Expect = 2e-88
 Identities = 82/266 (30%), Positives = 142/266 (53%), Gaps = 9/266 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +++++   LGKG F  V    +V +    A  II  +++     Q +L RE  I   L+H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKH 69

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +LI +    GEL+ ++     ++E  A+  I  +  A+ +CH+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENKE 192
            V+HR++KPENLLL        +K+ DFG +++   ++       GT  YL+PE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLIS 250
           +   VD W  G++ Y  L G PPF  E Q   +++I      FPS    +++ EAK LI+
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKNA 276
           ++L  + SKR++  + ++HPWI   +
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRS 275

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  264 bits (678), Expect = 3e-88
 Identities = 79/271 (29%), Positives = 136/271 (50%), Gaps = 11/271 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK---EQIEKYKIQHQLRREMEIQSS 75
             ++IG  LG G+F  V   RE  +    A K I K       +   + ++ RE+ I   
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + + + Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 136 HENHVIHRDIKPENLLL----DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
           H   + H D+KPEN++L         +K+ DFG +   +   +   + GT +++APE+V 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKH 247
            +      D W++G++ Y  L GA PF  +++++T   I  V   F        S  AK 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
            I +LLVK++ KRL++Q+ + HPWI    N 
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  267 bits (685), Expect = 3e-88
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 15/273 (5%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           R      +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           I +    P +++L+  F DD  +++++EY   G+L   +       E+ A  Y A +  A
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLA 180

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGTLDYLAPEM 187
           L   H    IHRD+KP+N+LLD  G LK+ DFG  ++   +      T  GT DY++PE+
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 188 VENK----EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPSAPSI 241
           ++++     +    D W++G+  YE L G  PF A+S   T+ +IM  K  L+FP    I
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300

Query: 242 SAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 271
           S EAK+LI   L  D   RL    +++I  H +
Sbjct: 301 SKEAKNLICAFL-TDREVRLGRNGVEEIKRHLF 332

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  268 bits (688), Expect = 1e-87
 Identities = 90/266 (33%), Positives = 151/266 (56%), Gaps = 9/266 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + ++  + LG G +G V L R+  +    A+KII K  +       +L  E+ +   L H
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS-KLLEEVAVLKLLDH 95

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++LY +F D    +L++E    GEL+ E+    +F E  AA  I  + + + Y H++
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +++HRD+KPENLLL   + +  +KI DFG S   +++ K     GT  Y+APE V  K++
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
           D   D W++G++ +  L G PPF  ++ ++  R++ K   +F S    ++S  AK LI +
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNAN 277
           +L  DS +R+S Q+ +EHPWI +  +
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCS 300

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  263 bits (675), Expect = 1e-87
 Identities = 96/274 (35%), Positives = 159/274 (58%), Gaps = 14/274 (5%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQI-EKYKIQHQ 65
           +    +   + FE+ R LGKG +G+V+ VR+V   +     A+K++ K  I    K    
Sbjct: 8   NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
            + E  I   ++HP I+ L   F    +++LILEY   GEL+ +L +   F E  A  Y+
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDY 182
           A ++ AL + H+  +I+RD+KPEN++L+H+G +K+ DFG     +   +  HT CGT++Y
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           +APE++    H+ AVD W+LG L Y+ L GAPPF  E++K T  +I+K  L+ P  P ++
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLT 245

Query: 243 AEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
            EA+ L+ +LL ++++ RL        ++  HP+
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  264 bits (677), Expect = 1e-87
 Identities = 80/271 (29%), Positives = 136/271 (50%), Gaps = 11/271 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK---EQIEKYKIQHQLRREMEIQSS 75
             ++IG  LG G+F  V   RE  +    A K I K       +   + ++ RE+ I   
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HPNI+ L+  + +   + LILE    GEL+  L +    +E++A ++I  + + + Y 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 136 HENHVIHRDIKPENLLL----DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
           H   + H D+KPEN++L         +K+ DFG +   +   +   + GT +++APE+V 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKH 247
            +      D W++G++ Y  L GA PF  +++++T   I  V   F        S  AK 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
            I +LLVK++ KRL++Q+ + HPWI      
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  262 bits (671), Expect = 2e-87
 Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 40/289 (13%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             DFE    LG+G FG+V   R        A+K I   + +       +  E+ + +SL 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLN 60

Query: 78  HPNILRLYGWFHDDER-------------IFLILEYAHRGELYRELRKHRRFT-EQQAAT 123
           H  ++R Y  + +                +F+ +EY   G LY  +          +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----------------- 166
               +  AL+Y H   +IHRD+KP N+ +D    +KIGDFG +                 
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 167 VQSRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF 225
             S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y  P      + +  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238

Query: 226 RRIMKVDLSFPSA--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           +++  V + FP     +     K +I  L+  D +KR   + ++   W+
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  263 bits (673), Expect = 2e-87
 Identities = 90/271 (33%), Positives = 153/271 (56%), Gaps = 6/271 (2%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
               +  + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q  L RE+
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREV 65

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            I   L HPNI++L+     ++ ++LI+EYA  GE++  L  H R  E++A +    + +
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           A+ YCH+  ++HRD+K ENLLLD +  +KI DFG+S       K    CG   Y APE+ 
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185

Query: 189 ENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           + K++D   VD W+LG++ Y  + G+ PF+ ++ K+   R+++     P    +S + ++
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMSTDCEN 243

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           L+ R LV +  KR +L++IM+  WI      
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  262 bits (672), Expect = 3e-87
 Identities = 82/271 (30%), Positives = 138/271 (50%), Gaps = 11/271 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSS 75
             ++ G  LG G+F  V   RE  +    A K I K +     +   +  + RE+ I   
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           ++HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 136 HENHVIHRDIKPENLLLDHE----GRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
           H   + H D+KPEN++L        R+KI DFG +      ++   + GT +++APE+V 
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKH 247
            +      D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
            I RLLVKD  KR+++Q  ++HPWI      
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  263 bits (675), Expect = 5e-87
 Identities = 60/278 (21%), Positives = 129/278 (46%), Gaps = 23/278 (8%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+  
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQH 114

Query: 80  N--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           +  I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPEMVENK- 191
           + ++H D+KP N L+  +G LK+ DFG +       +   + +  G ++Y+ PE +++  
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 192 ----------EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPS 240
                     +     D W+LG + Y   YG  PF +  +Q      I+  +        
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
              + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  267 bits (684), Expect = 6e-87
 Identities = 88/277 (31%), Positives = 143/277 (51%), Gaps = 18/277 (6%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI----------QHQLRR 68
           + +   R LG G +G V L +E       A+K+I K Q +K +             ++  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+ +  SL HPNI++L+  F D +  +L+ E+   GEL+ ++    +F E  AA  +  +
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 129 TNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYL 183
            + + Y H+++++HRDIKPEN+LL   +    +KI DFG S       K     GT  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SI 241
           APE V  K+++   D W+ G++ Y  L G PPF  ++ +D  +++ K    F      +I
Sbjct: 216 APE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           S EAK LI  +L  D +KR + ++ +   WI K AN 
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  261 bits (668), Expect = 8e-87
 Identities = 88/277 (31%), Positives = 141/277 (50%), Gaps = 17/277 (6%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQ 73
            ++ + + LG G  G V L  E ++   VA+KII K +       +      +  E+EI 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
             L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ 
Sbjct: 70  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 134 YCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           Y HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 189 ENKE---HDYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFRRIMKVDLSFPSAP--SIS 242
            +     ++ AVD W+LG++ +  L G PPF     Q     +I     +F       +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
            +A  L+ +LLV D   R + ++ + HPW+      R
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  260 bits (668), Expect = 9e-87
 Identities = 87/272 (31%), Positives = 150/272 (55%), Gaps = 14/272 (5%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV---ALKIIFKEQIEKYKIQHQLR 67
               +     FE+ + LG+G FG+V+LV+++         A+K++ K  ++         
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 75

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E +I   + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A 
Sbjct: 76  -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
           L  AL + H   +I+RD+KPEN+LLD EG +K+ DFG S   +    K ++ CGT++Y+A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           PE+V  + H  + D W+ G+L +E L G  PF+ + +K+T   I+K  L  P    +S E
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPE 252

Query: 245 AKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
           A+ L+  L  ++ + RL      +++I  H +
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  260 bits (667), Expect = 1e-86
 Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 11/267 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LG+G+FG V+   E  SK     K +  +  ++      +++E+ I +  RH
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHE 137
            NIL L+  F   E + +I E+    +++ R         E++  +Y+  +  AL + H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 138 NHVIHRDIKPENLLLDHE--GRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +++ H DI+PEN++        +KI +FG +   +       +    +Y APE+ ++   
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISR 251
             A D W+LG L Y  L G  PF AE+ +     IM  + +F       IS EA   + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANP 278
           LLVK+   R++  + ++HPW+ +    
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER 267

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  259 bits (663), Expect = 2e-86
 Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 32/297 (10%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH---- 64
             +      L  + +   +GKG +G V L          A+K++ K+++ +         
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 65  -------------------QLRREMEIQSSLRHPNILRLYGWFHD--DERIFLILEYAHR 103
                              Q+ +E+ I   L HPN+++L     D  ++ ++++ E  ++
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
           G +  E+   +  +E QA  Y   L   + Y H   +IHRDIKP NLL+  +G +KI DF
Sbjct: 123 GPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 164 GWSVQSRSKR---HTMCGTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFE 217
           G S + +          GT  ++APE +      +   A+D W +G+  Y F++G  PF 
Sbjct: 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 218 AESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
            E       +I    L FP  P I+ + K LI+R+L K+   R+ + +I  HPW+ +
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  259 bits (664), Expect = 3e-86
 Identities = 77/284 (27%), Positives = 129/284 (45%), Gaps = 19/284 (6%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQH 64
                 + RE    ++ +G  LGKG FG V+    +  +  VA+K+I + ++  +  +  
Sbjct: 18  TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD 77

Query: 65  QLRREMEIQ------SSLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFT 117
            +   +E+       +   HP ++RL  WF   E   L+LE      +L+  + +     
Sbjct: 78  SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS-VQSRSKRHT 175
           E  +  +   +  A+ +CH   V+HRDIK EN+L+D   G  K+ DFG   +        
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197

Query: 176 MCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS 234
             GT  Y  PE +   ++       W+LGIL Y+ + G  PFE +      + I++ +L 
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELH 251

Query: 235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           FP    +S +   LI R L    S R SL++I+  PW+   A  
Sbjct: 252 FP--AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  261 bits (669), Expect = 3e-86
 Identities = 90/278 (32%), Positives = 152/278 (54%), Gaps = 10/278 (3%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
            ++      +        DF   + +GKG FG+V L R    +   A+K++ K+ I K K
Sbjct: 21  PSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK 80

Query: 62  IQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
            +  +  E  +   +++HP ++ L+  F   ++++ +L+Y + GEL+  L++ R F E +
Sbjct: 81  EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
           A  Y A + +AL Y H  ++++RD+KPEN+LLD +G + + DFG     ++  S   T C
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC 200

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
           GT +YLAPE++  + +D  VD W LG + YE LYG PPF + +  + +  I+   L    
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK- 259

Query: 238 APSISAEAKHLISRLLVKDSSKRL----SLQKIMEHPW 271
            P+I+  A+HL+  LL KD +KRL       +I  H +
Sbjct: 260 -PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  260 bits (666), Expect = 3e-86
 Identities = 73/267 (27%), Positives = 138/267 (51%), Gaps = 9/267 (3%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S++ +   + +G+G FG+  LV+  E      +K I   ++   K + + RRE+ + +++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANM 80

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAY 134
           +HPNI++    F ++  ++++++Y   G+L++ +   +   F E Q   +   +  AL +
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENK 191
            H+  ++HRDIK +N+ L  +G +++GDFG +     +        GT  YL+PE+ ENK
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-ISAEAKHLIS 250
            ++   D W LG + YE       FEA S K+   +I+     FP      S + + L+S
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FPPVSLHYSYDLRSLVS 258

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           +L  ++   R S+  I+E  +I K   
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAKRIE 285

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  260 bits (666), Expect = 3e-86
 Identities = 78/270 (28%), Positives = 144/270 (53%), Gaps = 7/270 (2%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           +   + + +  ++DF + + LGKG FG+V+L    ++    A+K + K+ +         
Sbjct: 5   KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64

Query: 67  RREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
             E  +   +  HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDY 182
           A +   L + H   +++RD+K +N+LLD +G +KI DFG     +   +K +T CGT DY
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           +APE++  ++++++VD W+ G+L YE L G  PF  + +++ F  I   +  +P    + 
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLE 242

Query: 243 AEAKHLISRLLVKDSSKRL-SLQKIMEHPW 271
            EAK L+ +L V++  KRL     I +HP 
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  260 bits (666), Expect = 4e-86
 Identities = 78/286 (27%), Positives = 143/286 (50%), Gaps = 20/286 (6%)

Query: 4   KTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
            +  ++ +R        +E+   +G G +          +    A+KII K + +     
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----- 61

Query: 64  HQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
                E+EI     +HPNI+ L   + D + ++++ E    GEL  ++ + + F+E++A+
Sbjct: 62  --PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWSVQSRSKRH---T 175
             + ++T  + Y H   V+HRD+KP N+L      +   ++I DFG++ Q R++     T
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF---EAESQKDTFRRIMKVD 232
            C T +++APE++E + +D A D W+LG+L Y  L G  PF     ++ ++   RI    
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239

Query: 233 LSFPSAP--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
            S       S+S  AK L+S++L  D  +RL+   ++ HPWI+   
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  262 bits (671), Expect = 6e-86
 Identities = 87/277 (31%), Positives = 140/277 (50%), Gaps = 17/277 (6%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQ 73
            ++ + + LG G  G V L  E ++   VA++II K +       +      +  E+EI 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
             L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ 
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 134 YCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           Y HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 189 ENKEH---DYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFRRIMKVDLSFPSAP--SIS 242
            +      + AVD W+LG++ +  L G PPF     Q     +I     +F       +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373

Query: 243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
            +A  L+ +LLV D   R + ++ + HPW+      R
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  259 bits (664), Expect = 7e-86
 Identities = 95/275 (34%), Positives = 146/275 (53%), Gaps = 13/275 (4%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D   R+     FE+   LG+G    VY  ++  ++ P ALK++     +K   +  +R E
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL-----KKTVDKKIVRTE 98

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + +   L HPNI++L   F     I L+LE    GEL+  + +   ++E+ AA  +  + 
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158

Query: 130 NALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            A+AY HEN ++HRD+KPENLL      +  LKI DFG S  V+ +    T+CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDTFRRIMKVDLSFPSAP--SI 241
           PE++    +   VD W++GI+ Y  L G  PF  E   +  FRRI+  +  F S     +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           S  AK L+ +L+V D  KRL+  + ++HPW+   A
Sbjct: 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  260 bits (665), Expect = 8e-86
 Identities = 79/272 (29%), Positives = 134/272 (49%), Gaps = 16/272 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQ 73
           Q ++    +G+G    V       + H  A+KI+          +  +++   RRE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 74  SSLR-HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
             +  HP+I+ L   +     +FL+ +   +GEL+  L +    +E++  + + SL  A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPE---- 186
           ++ H N+++HRD+KPEN+LLD   ++++ DFG+S       K   +CGT  YLAPE    
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273

Query: 187 --MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SIS 242
                +  +   VD W  G++ +  L G+PPF    Q    R IM+    F S      S
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333

Query: 243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
           +  K LISRLL  D   RL+ ++ ++HP+  +
Sbjct: 334 STVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  260 bits (665), Expect = 8e-86
 Identities = 53/297 (17%), Positives = 89/297 (29%), Gaps = 41/297 (13%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++  PL  G    V+LVR+VE     ALK+             +L       + L  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 79  PNILRLYGWFH--------------------------DDERIFLILEYAH------RGEL 106
            +                                         L++  A          L
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                              A L    A      ++H    P+NL +  +GRL +GD    
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 167 VQSRSKRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAES---- 220
            +  ++       + Y   E +        +A++ W LG+  Y       PF   +    
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 221 ---QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
              ++ + R      L+F S   +    K LI R L  D  +RL   + ME P  ++
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  258 bits (661), Expect = 8e-86
 Identities = 80/293 (27%), Positives = 135/293 (46%), Gaps = 17/293 (5%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
            D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  +
Sbjct: 25  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 84

Query: 61  KI---QHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYA-HRGELYRELRKHR 114
                  ++  E+ +   +      ++RL  WF   +   LILE      +L+  + +  
Sbjct: 85  GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG 144

Query: 115 RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS-VQSRSK 172
              E+ A ++   +  A+ +CH   V+HRDIK EN+L+D   G LK+ DFG   +   + 
Sbjct: 145 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204

Query: 173 RHTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV 231
                GT  Y  PE +    +   +   W+LGIL Y+ + G  PFE +        I++ 
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRG 258

Query: 232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
            + F     +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 259 QVFFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  259 bits (663), Expect = 9e-86
 Identities = 99/263 (37%), Positives = 151/263 (57%), Gaps = 10/263 (3%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I           E  +  + 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEH 193
              V++RDIK ENL+LD +G +KI DFG     +   +   T CGT +YLAPE++E+ ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ LL
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLL 240

Query: 254 VKDSSKRL-----SLQKIMEHPW 271
            KD  +RL       +++MEH +
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRF 263

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  256 bits (656), Expect = 1e-85
 Identities = 64/280 (22%), Positives = 119/280 (42%), Gaps = 35/280 (12%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             DF+    +G G FG+V+  +         +K +            +  RE++  + L 
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62

Query: 78  HPNILRLYGWFHDDE----------------RIFLILEYAHRGELYRELRKHR--RFTEQ 119
           H NI+   G +   +                 +F+ +E+  +G L + + K R  +  + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC 177
            A      +T  + Y H   +I+RD+KP N+ L    ++KIGDFG    +++  KR    
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRRIMKVDLSFP 236
           GTL Y++PE + ++++   VD + LG++  E L+     FE       F  +    +S  
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIIS-- 237

Query: 237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                  + K L+ +LL K    R +  +I+    + K +
Sbjct: 238 --DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  257 bits (659), Expect = 2e-85
 Identities = 71/270 (26%), Positives = 129/270 (47%), Gaps = 17/270 (6%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI-----QHQLRREMEI 72
            Q +    PLG G FG V+   + E    V +K I KE++ +          ++  E+ I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNA 131
            S + H NI+++   F +     L++E    G +L+  + +H R  E  A+     L +A
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE 189
           + Y     +IHRDIK EN+++  +  +K+ DFG +  ++     +T CGT++Y APE++ 
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202

Query: 190 NKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
              +    ++ W+LG+  Y  ++   PF            ++  +  P    +S E   L
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIHPP--YLVSKELMSL 254

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           +S LL     +R +L+K++  PW+ +  N 
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  262 bits (670), Expect = 3e-85
 Identities = 80/274 (29%), Positives = 139/274 (50%), Gaps = 5/274 (1%)

Query: 8   REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            +        +  + +G  LG G FG+V + +   + H VA+KI+ +++I    +  ++R
Sbjct: 5   EKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR 64

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
           RE++     RHP+I++LY        IF+++EY   GEL+  + K+ R  E+++      
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ 124

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAP 185
           + + + YCH + V+HRD+KPEN+LLD     KI DFG S          T CG+ +Y AP
Sbjct: 125 ILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184

Query: 186 EMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           E++  + +    VD W+ G++ Y  L G  PF+ +     F++I       P    ++  
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPS 242

Query: 245 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
              L+  +L  D  KR +++ I EH W  ++   
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK 276

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  259 bits (663), Expect = 4e-85
 Identities = 79/283 (27%), Positives = 131/283 (46%), Gaps = 10/283 (3%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           +  K   +    K+      ++I   LG G FG V+   E  +      K I        
Sbjct: 33  IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD- 91

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQ 119
             ++ ++ E+ I + L HP ++ L+  F D   + LILE+   GEL+ R   +  + +E 
Sbjct: 92  --KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA 149

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSV--QSRSKRHT 175
           +   Y+      L + HE+ ++H DIKPEN++ +      +KI DFG +           
Sbjct: 150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF 235
              T ++ APE+V+ +   +  D W +G+L Y  L G  PF  E   +T + + + D  F
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269

Query: 236 PSA--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
                 S+S EAK  I  LL K+  KRL++   +EHPW+  + 
Sbjct: 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  256 bits (655), Expect = 9e-85
 Identities = 86/269 (31%), Positives = 137/269 (50%), Gaps = 22/269 (8%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNIL 82
            +PLG+G F         +S    A+KII K            ++E+        HPNI+
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN------TQKEITALKLCEGHPNIV 69

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           +L+  FHD    FL++E  + GEL+  ++K + F+E +A+  +  L +A+++ H+  V+H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129

Query: 143 RDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRH---TMCGTLDYLAPEMVENKEHDYA 196
           RD+KPENLL   E     +KI DFG++           T C TL Y APE++    +D +
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDT-------FRRIMKVDLSFPSAP--SISAEAKH 247
            D W+LG++ Y  L G  PF++  +  T        ++I K D SF      ++S EAK 
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           LI  LL  D +KRL +  +  + W+   +
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  256 bits (657), Expect = 1e-84
 Identities = 90/275 (32%), Positives = 147/275 (53%), Gaps = 12/275 (4%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
               N      + +FE  R LGKG FG+V L R  E+    A+K++ K+ I +       
Sbjct: 11  GIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT 70

Query: 67  RREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
             E  I   +  HP + +L+  F   +R+F ++E+ + G+L   ++K RRF E +A  Y 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDY 182
           A + +AL + H+  +I+RD+K +N+LLDHEG  K+ DFG     + +     T CGT DY
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS 242
           +APE+++   +  AVD W +G+L YE L G  PFEAE++ D F  I+  ++ +P    + 
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLH 248

Query: 243 AEAKHLISRLLVKDSSKRL------SLQKIMEHPW 271
            +A  ++   + K+ + RL          I+ HP+
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  257 bits (658), Expect = 1e-84
 Identities = 78/279 (27%), Positives = 141/279 (50%), Gaps = 12/279 (4%)

Query: 7   EREDNRKREWSLQDFEIGRP--LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
            R    K+      + + +   LG G+FG+V+   E  +   +A KII    ++    + 
Sbjct: 75  HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KE 131

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAAT 123
           +++ E+ + + L H N+++LY  F     I L++EY   GEL+ R + +    TE     
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSV--QSRSKRHTMCGT 179
           ++  +   + + H+ +++H D+KPEN+L  +    ++KI DFG +   + R K     GT
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA- 238
            ++LAPE+V      +  D W++G++ Y  L G  PF  ++  +T   I+          
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311

Query: 239 -PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
              IS EAK  IS+LL+K+ S R+S  + ++HPW+  + 
Sbjct: 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  256 bits (655), Expect = 1e-84
 Identities = 88/261 (33%), Positives = 144/261 (55%), Gaps = 6/261 (2%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + I   LG+G FG+V L    +++  VALK I ++ ++K  +  ++ RE+     LRHP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++LY        I +++EYA  GEL+  + + +R TE +   +   +  A+ YCH + +
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHD-YAV 197
           +HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +    V
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDS 257
           D W+ GI+ Y  L G  PF+ E   + F+++       P    +S  A+ LI R++V D 
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIRRMIVADP 247

Query: 258 SKRLSLQKIMEHPWIIKNANP 278
            +R+++Q+I   PW   N   
Sbjct: 248 MQRITIQEIRRDPWFNVNLPD 268

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  255 bits (654), Expect = 3e-84
 Identities = 84/279 (30%), Positives = 140/279 (50%), Gaps = 11/279 (3%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           +T +    +  +    L DF     LGKG FG+V L     +    A+KI+ K+ + +  
Sbjct: 3   NTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD 62

Query: 62  IQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
                  E  +     + P + +L+  F   +R++ ++EY + G+L   +++  RF E  
Sbjct: 63  DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 122

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
           A  Y A +   L +     +I+RD+K +N++LD EG +KI DFG     +       T C
Sbjct: 123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC 182

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
           GT DY+APE++  + +  +VD W  G+L YE L G  PFE E + + F+ IM+ ++++P 
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP- 241

Query: 238 APSISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
             S+S EA  +   L+ K   KRL       + I EH +
Sbjct: 242 -KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  254 bits (651), Expect = 4e-84
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 11/265 (4%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNIL 82
            + LG+GKF  V       +    A K + K +  +   + ++  E+ +    +  P ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVI 92

Query: 83  RLYGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHENHV 140
            L+  + +   I LILEYA  GE++           +E      I  +   + Y H+N++
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152

Query: 141 IHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           +H D+KP+N+LL      G +KI DFG S       +   + GT +YLAPE++       
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISRLL 253
           A D W +GI+ Y  L    PF  E  ++T+  I +V++ +      S+S  A   I  LL
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLL 272

Query: 254 VKDSSKRLSLQKIMEHPWIIKNANP 278
           VK+  KR + +  + H W+ +    
Sbjct: 273 VKNPEKRPTAEICLSHSWLQQWDFE 297

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  253 bits (648), Expect = 5e-84
 Identities = 73/270 (27%), Positives = 131/270 (48%), Gaps = 15/270 (5%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSLRHP 79
           + +G  LG+G +G+V  V + E+    A+KI+ K+++ +    +  +++E+++   LRH 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 80  NILRLYGWFHDDER--IFLILEYAHRG--ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           N+++L    +++E+  +++++EY   G  E+   +   +RF   QA  Y   L + L Y 
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVEN 190
           H   ++H+DIKP NLLL   G LKI   G +             T  G+  +  PE+   
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185

Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
            +    + VD W+ G+  Y    G  PFE ++    F  I K   + P           L
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDCGPPLSDL 243

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           +  +L  + +KR S+++I +H W  K   P
Sbjct: 244 LKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  261 bits (669), Expect = 6e-84
 Identities = 81/271 (29%), Positives = 136/271 (50%), Gaps = 10/271 (3%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   LG G FG V+ V E  + +  A K +          +  +R+E++  S LRHP 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPT 215

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           ++ L+  F DD  + +I E+   GEL+ +   +H + +E +A  Y+  +   L + HEN+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 140 VIHRDIKPENLLLDH--EGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            +H D+KPEN++        LK+ DFG +     +       GT ++ APE+ E K   Y
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRLL 253
             D W++G+L Y  L G  PF  E+  +T R +   D +   +    IS + K  I +LL
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395

Query: 254 VKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
           + D + R+++ + +EHPW+     P     I
Sbjct: 396 LADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  255 bits (653), Expect = 7e-84
 Identities = 43/297 (14%), Positives = 82/297 (27%), Gaps = 51/297 (17%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-- 77
               G  LG+          + E+     + + +  +        Q++ E+     LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 78  -----------------------HPNILRLYGWFHDDE--RIFLILEYAHR------GEL 106
                                     ++R+     D      F +              L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                 H+             +   LA  H   ++H  ++P +++LD  G + +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 167 VQSRSKRHTMCGTLDYLAPEMV-----------ENKEHDYAVDNWTLGILCYEFLYGAPP 215
           V+    R     +  +  PE+                  ++ D W LG++ Y       P
Sbjct: 254 VRD-GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 216 FEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
              ++       I      F S  +I    + L+   L      RL   + ME P  
Sbjct: 313 ITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  253 bits (648), Expect = 2e-83
 Identities = 75/271 (27%), Positives = 134/271 (49%), Gaps = 15/271 (5%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRH 78
           +E+   +GKG F  V      E+    A+KI+   +           L+RE  I   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNALAY 134
           P+I+ L   +  D  ++++ E+    +L  E+         ++E  A+ Y+  +  AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV 188
           CH+N++IHRD+KP  +LL   ++   +K+G FG ++Q   S        GT  ++APE+V
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAK 246
           + + +   VD W  G++ +  L G  PF    ++  F  I+K            IS  AK
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAK 264

Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
            L+ R+L+ D ++R+++ + + HPW+ +   
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  249 bits (637), Expect = 1e-82
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 18/275 (6%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +D+E+   +G G +GR   +R       +  K +    + +   +  L  E+ +   L+
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELK 63

Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K  +      E+     +  LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +       S   T  GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI-S 242
           +PE +    ++   D W+LG L YE     PPF A SQK+   +I +    F   P   S
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRYS 241

Query: 243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
            E   +I+R+L      R S+++I+E+P I+++ +
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  253 bits (649), Expect = 2e-82
 Identities = 87/276 (31%), Positives = 141/276 (51%), Gaps = 17/276 (6%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           ++     +DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E +
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTN 130
           +  +     I  L+  F DD  ++L+++Y   G+L   L K   R  E+ A  Y+A +  
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPE 186
           A+   H+ H +HRDIKP+N+L+D  G +++ DFG           +     GT DY++PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 187 MVENKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLSFPS-A 238
           +++  E     +    D W+LG+  YE LYG  PF AES  +T+ +IM  K    FP+  
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306

Query: 239 PSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 271
             +S  AK LI RL+      RL    ++   +HP+
Sbjct: 307 TDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPF 341

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  254 bits (650), Expect = 2e-82
 Identities = 97/273 (35%), Positives = 151/273 (55%), Gaps = 11/273 (4%)

Query: 8   REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
                K   ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I          
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 196

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +  + RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A 
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256

Query: 128 LTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           + +AL Y H    V++RD+K ENL+LD +G +KI DFG     ++  +   T CGT +YL
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           APE++E+ ++  AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++  
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGP 374

Query: 244 EAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
           EAK L+S LL KD  +RL       ++IM+H +
Sbjct: 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  251 bits (643), Expect = 6e-82
 Identities = 82/281 (29%), Positives = 130/281 (46%), Gaps = 19/281 (6%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              ++      DFEI + +G+G F  V +V+  ++    A+KI+ K  + K       R 
Sbjct: 51  VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIAS 127
           E ++  +     I +L+  F D+  ++L++EY   G+L   L K   R   + A  Y+A 
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYL 183
           +  A+   H    +HRDIKP+N+LLD  G +++ DFG           +     GT DYL
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230

Query: 184 APEMVENKE-------HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM--KVDLS 234
           +PE+++          +    D W LG+  YE  YG  PF A+S  +T+ +I+  K  LS
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290

Query: 235 FPSAPS-ISAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 271
            P     +  EA+  I RLL      RL          HP+
Sbjct: 291 LPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPF 330

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  249 bits (637), Expect = 9e-82
 Identities = 81/278 (29%), Positives = 150/278 (53%), Gaps = 21/278 (7%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
                LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  +
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 73  -QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
            + +  HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ A
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV 188
           L Y HE  +I+RD+K +N+LLD EG +K+ D+G     ++      T CGT +Y+APE++
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPF---------EAESQKDTFRRIMKVDLSFPSAP 239
             +++ ++VD W LG+L +E + G  PF         +  ++   F+ I++  +  P   
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--R 240

Query: 240 SISAEAKHLISRLLVKDSSKRL------SLQKIMEHPW 271
           S+S +A  ++   L KD  +RL          I  HP+
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  247 bits (632), Expect = 2e-81
 Identities = 87/295 (29%), Positives = 141/295 (47%), Gaps = 40/295 (13%)

Query: 19  QDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             +++    LG+G   RV     + +    A+KII K+      I+ ++ RE+E+    +
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQ 68

Query: 78  -HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            H N+L L  +F +++R +L+ E    G +   + K R F E +A+  +  + +AL + H
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 137 ENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR----------HTMCGTLDYL 183
              + HRD+KPEN+L +H  +   +KI DF      +              T CG+ +Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 184 APEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAE---------------SQKD 223
           APE+VE        +D   D W+LG++ Y  L G PPF                   Q  
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 224 TFRRIMKVDLSFPSAP--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
            F  I +    FP      IS  AK LIS+LLV+D+ +RLS  ++++HPW+   A
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  248 bits (635), Expect = 2e-81
 Identities = 100/285 (35%), Positives = 161/285 (56%), Gaps = 22/285 (7%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV---ALKIIFKEQI-EKYKI 62
                   +  +++FE+ + LG G +G+V+LVR++         A+K++ K  I +K K 
Sbjct: 42  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 101

Query: 63  QHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
               R E ++ +   + P ++ L+  F  + ++ LIL+Y + GEL+  L +  RFTE + 
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 161

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKR-HTMC 177
             Y+  +  AL + H+  +I+RDIK EN+LLD  G + + DFG S   V   ++R +  C
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221

Query: 178 GTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRRIMKV 231
           GT++Y+AP++V   +  HD AVD W+LG+L YE L GA PF  + +K++     RRI+K 
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281

Query: 232 DLSFPSAPSISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
           +  +P    +SA AK LI RLL+KD  KRL        +I EH +
Sbjct: 282 EPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  247 bits (632), Expect = 2e-81
 Identities = 59/306 (19%), Positives = 113/306 (36%), Gaps = 48/306 (15%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             + +   LG+G    V+  R  ++    A+K+       +        RE E+   L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66

Query: 79  PNILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALA 133
            NI++L+    +       LI+E+   G LY  L +        E +    +  +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 134 YCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +  ++ GT +YL P+M
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 188 VE--------NKEHDYAVDNWTLGILCYEFLYGAPPFEA----ESQKDTFRRIMKVDLSF 235
            E         K++   VD W++G+  Y    G+ PF         K+   +I+    S 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 236 PSA-----------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
             +                         +      +++ +L  D  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 273 IKNANP 278
           I +   
Sbjct: 307 ILHRGN 312

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  248 bits (634), Expect = 1e-80
 Identities = 80/289 (27%), Positives = 151/289 (52%), Gaps = 21/289 (7%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           +               LQDF++ R +G+G + +V LVR  ++    A++++ KE +   +
Sbjct: 35  EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE 94

Query: 62  IQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
               ++ E  + + +  HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ 
Sbjct: 95  DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
           A  Y A ++ AL Y HE  +I+RD+K +N+LLD EG +K+ D+G     ++      T C
Sbjct: 155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 214

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF---------EAESQKDTFRRI 228
           GT +Y+APE++  +++ ++VD W LG+L +E + G  PF         +  ++   F+ I
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

Query: 229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRL------SLQKIMEHPW 271
           ++  +  P   S+S +A  ++   L KD  +RL          I  HP+
Sbjct: 275 LEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  242 bits (620), Expect = 1e-79
 Identities = 60/266 (22%), Positives = 108/266 (40%), Gaps = 10/266 (3%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           +R   +  Q F+    LG G +G V+ VR  E     A+K              +L    
Sbjct: 49  SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
             +   +HP  +RL   + +   ++L  E      L +          E Q   Y+    
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTL 167

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEM 187
            ALA+ H   ++H D+KP N+ L   GR K+GDFG  V+  +        G   Y+APE+
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           ++   +  A D ++LG+   E       P   E  +   +  +  + +      +S+E +
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT----AGLSSELR 282

Query: 247 HLISRLLVKDSSKRLSLQKIMEHPWI 272
            ++  +L  D   R + + ++  P +
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVL 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  241 bits (618), Expect = 2e-79
 Identities = 73/270 (27%), Positives = 131/270 (48%), Gaps = 13/270 (4%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +L +F I + +G+G+F  VY    +    PVALK +    +   K +    +E+++   L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNAL 132
            HPN+++ Y  F +D  + ++LE A  G+L R ++  ++      E+    Y   L +AL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVE 189
            + H   V+HRDIKP N+ +   G +K+GD G         +  H++ GT  Y++PE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAE--SQKDTFRRIMKVDLSFPSAPS--ISAEA 245
              +++  D W+LG L YE      PF  +  +     ++I + D  +P  PS   S E 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEEL 267

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
           + L++  +  D  KR  +  + +    +  
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  244 bits (625), Expect = 3e-79
 Identities = 79/278 (28%), Positives = 146/278 (52%), Gaps = 27/278 (9%)

Query: 18  LQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
           + D+++  + LG G  G+V  +    ++   ALK++            + RRE+E+   +
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRA 111

Query: 76  LRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLT 129
            + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  + S+ 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLA 184
            A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T  Y+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRRIMKVDLSFPSAP- 239
           PE++  +++D + D W+LG++ Y  L G PPF +            RI      FP+   
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291

Query: 240 -SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
             +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  242 bits (619), Expect = 3e-79
 Identities = 78/276 (28%), Positives = 145/276 (52%), Gaps = 26/276 (9%)

Query: 19  QDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSL 76
            D+++ +  LG G  G+V       +    ALK+++           + R+E++    + 
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQAS 79

Query: 77  RHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTN 130
             P+I+ +   + +       + +I+E    GEL+  +  R  + FTE++AA  +  +  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQ-SRSKRHTMCGTLDYLAPE 186
           A+ + H +++ HRD+KPENLL   + +   LK+ DFG++ + +++   T C T  Y+APE
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE 199

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRRIMKVDLSFPSAP--S 240
           ++  +++D + D W+LG++ Y  L G PPF + + +       RRI      FP+     
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           +S +AK LI  LL  D ++RL++ + M HPWI ++ 
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  252 bits (644), Expect = 4e-79
 Identities = 78/274 (28%), Positives = 138/274 (50%), Gaps = 15/274 (5%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQL--R 67
                 ++ DF + R +G+G FG VY  R+ ++    A+K + K++I+  +     L  R
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
             + + S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A 
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-HTMCGTLDYLAPE 186
           +   L + H   V++RD+KP N+LLD  G ++I D G +     K+ H   GT  Y+APE
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 360

Query: 187 MVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---FRRIMKVDLSFPSAPSIS 242
           +++    +D + D ++LG + ++ L G  PF     KD     R  + + +  P   S S
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFS 418

Query: 243 AEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
            E + L+  LL +D ++RL       Q++ E P+
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  248 bits (634), Expect = 7e-78
 Identities = 84/280 (30%), Positives = 140/280 (50%), Gaps = 11/280 (3%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
            +T +    +  +    L DF     LGKG FG+V L     +    A+KI+ K+ + + 
Sbjct: 323 ANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 382

Query: 61  KIQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
                   E  +     + P + +L+  F   +R++ ++EY + G+L   +++  RF E 
Sbjct: 383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 442

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTM 176
            A  Y A +   L +     +I+RD+K +N++LD EG +KI DFG     +       T 
Sbjct: 443 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF 502

Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP 236
           CGT DY+APE++  + +  +VD W  G+L YE L G  PFE E + + F+ IM+ ++++P
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562

Query: 237 SAPSISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
              S+S EA  +   L+ K   KRL       + I EH +
Sbjct: 563 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  241 bits (618), Expect = 9e-77
 Identities = 75/276 (27%), Positives = 134/276 (48%), Gaps = 18/276 (6%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
             +      F   R LG+G FG V+  +   +    A K + K++++K K       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIAS 127
           I + +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A 
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLA 184
           + + L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++A
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRRIMKVDLSFPSAPS 240
           PE++  +E+D++VD + LG+  YE +    PF A  +K       +R+++  +++P    
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DK 415

Query: 241 ISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
            S  +K     LL KD  KRL     S   +  HP 
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  234 bits (598), Expect = 3e-75
 Identities = 59/303 (19%), Positives = 113/303 (37%), Gaps = 48/303 (15%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             + +   LG+G    V+  R  ++    A+K+       +        RE E+   L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66

Query: 79  PNILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALA 133
            NI++L+    +       LI+E+   G LY  L +        E +    +  +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 134 YCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +  ++ GT +YL P+M
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 188 VE--------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK--------- 230
            E         K++   VD W++G+  Y    G+ PF         + +M          
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 231 ------------VDLSFPS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                       +D S         +  +      +++ +L  D  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 273 IKN 275
           I +
Sbjct: 307 ILH 309

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  236 bits (605), Expect = 2e-74
 Identities = 78/273 (28%), Positives = 133/273 (48%), Gaps = 15/273 (5%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
            ++  +   F   R LGKG FG V   +   +    A K + K++I+K K +     E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLT 129
           I   +    ++ L   +   + + L+L   + G+L   +    +  F E +A  Y A + 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEM 187
             L   H   +++RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRRIMKVDLSFPSAPSISA 243
           V+N+ + ++ D W LG L YE + G  PF+   +K       R + +V   +      S 
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSP 414

Query: 244 EAKHLISRLLVKDSSKRL-----SLQKIMEHPW 271
           +A+ L S+LL KD ++RL     S +++ EHP 
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  229 bits (585), Expect = 4e-74
 Identities = 72/289 (24%), Positives = 114/289 (39%), Gaps = 38/289 (13%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HP 79
             + R L +G F  VY  ++V S    ALK +   + EK +    + +E+     L  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGHP 86

Query: 80  NILRLYGWFHDDER-------IFLILEYAHRGELYREL---RKHRRFTEQQAATYIASLT 129
           NI++        +         FL+L    +G+L   L         +            
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 130 NALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFG------------WSVQSRSKRH- 174
            A+ + H     +IHRD+K ENLLL ++G +K+ DFG            WS Q R+    
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 175 --TMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM 229
             T   T  Y  PE+++   N       D W LG + Y   +   PFE  ++     RI+
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIV 262

Query: 230 KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
               S P   +       LI  +L  +  +RLS+ +++     I  A  
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  226 bits (578), Expect = 2e-73
 Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 44/283 (15%)

Query: 11  NRKREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
             K+   + D+++  + LG G  G+V  +    ++   ALK++              RRE
Sbjct: 9   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARRE 60

Query: 70  MEI-QSSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAA 122
           +E+   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSRSKRHTMCGT 179
             + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG               
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------- 165

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRRIMKVDLSF 235
               A E    +++D + D W+LG++ Y  L G PPF +            RI      F
Sbjct: 166 ---FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221

Query: 236 PSAP--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 276
           P+     +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  223 bits (569), Expect = 3e-72
 Identities = 60/292 (20%), Positives = 121/292 (41%), Gaps = 37/292 (12%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L DFE  + LG+G FG V+  +        A+K I     E  +   ++ RE++  + L 
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61

Query: 78  HPNILRLYGWFHDDER------------IFLILEYAHRGELYREL--RKHRRFTEQQAAT 123
           HP I+R +  + +               +++ ++   +  L   +  R      E+    
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 124 YIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---------------V 167
           +I   +  A+ + H   ++HRD+KP N+    +  +K+GDFG                 +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRR 227
            + ++     GT  Y++PE +    + + VD ++LG++ +E LY   PF  + ++     
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238

Query: 228 IMKVDLSFPSAPS-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
            ++ +L FP   +        ++  +L     +R     I+E+        P
Sbjct: 239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  224 bits (573), Expect = 4e-71
 Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 30/293 (10%)

Query: 2   DTKTAEREDNRKREWSLQ----DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI 57
            + + E++D  +    +      F     LG G  G +   R +     VA+K I  E  
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF 61

Query: 58  EKYKIQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRR 115
                     RE+++ + S  HPN++R +    D +  ++ +E      L   + +K   
Sbjct: 62  SF------ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----RLKIGDFGWSVQ-- 168
               +  T +   T+ LA+ H  +++HRD+KP N+L+         +  I DFG   +  
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 169 ----SRSKRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFL-YGAPPFEAES 220
               S S+R  + GT  ++APEM+     +   Y VD ++ G + Y  +  G+ PF    
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 221 QKDTFRRIMKVDLSFPSA-PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           Q+     +    L            A+ LI +++  D  KR S + +++HP+ 
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  229 bits (584), Expect = 1e-70
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 21/282 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +E+   LG G FG V      ++   VA+K   +E   K   + +   E++I   L HP
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHP 72

Query: 80  NILRLY------GWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTN 130
           N++              ++   L +EY   G+L + L +        E    T ++ +++
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
           AL Y HEN +IHRD+KPEN++L         KI D G++  +          GTL YLAP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
           E++E K++   VD W+ G L +E + G  PF    Q   +   ++   +           
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWI--IKNANP--RGTCD 283
               S +L    +    +       W+  +   +   RGT  
Sbjct: 253 AVKFSSVL-PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  209 bits (534), Expect = 6e-67
 Identities = 59/285 (20%), Positives = 105/285 (36%), Gaps = 31/285 (10%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             +F     +G G+FG V+   +       A+K   K        Q+ LR         +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALA 133
           H +++R +  + +D+ + +  EY + G L   + ++ R    F E +    +  +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 134 YCHENHVIHRDIKPENLLLDHEGRL-------------------KIGDFGWSVQSRSKRH 174
           Y H   ++H DIKP N+ +                         KIGD G  V   S   
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG-HVTRISSPQ 188

Query: 175 TMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL 233
              G   +LA E++ EN  H    D + L +         P        D +  I +   
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGR- 244

Query: 234 SFPSAPS-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
             P  P  +S E   L+  ++  D  +R S   +++H  ++  + 
Sbjct: 245 -LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  211 bits (539), Expect = 4e-66
 Identities = 64/295 (21%), Positives = 117/295 (39%), Gaps = 51/295 (17%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLR 77
                 + LG G  G V   +      PVA+K +  +  +          E+++   S  
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDI------ALMEIKLLTESDD 67

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-------YRELRKHRRFTEQQAATYIASLTN 130
           HPN++R Y     D  +++ LE      L              +   E    + +  + +
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEG-------------RLKIGDFGWSVQ-------SR 170
            +A+ H   +IHRD+KP+N+L+                 R+ I DFG   +        R
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 171 SKRHTMCGTLDYLAPEMVENKEH-------DYAVDNWTLGILCYEFL-YGAPPFEAESQK 222
           +  +   GT  + APE++E   +         ++D +++G + Y  L  G  PF  +  +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 223 DTFRRIMKVDLSFPSAPS-----ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           ++   I++   S           + AEA  LIS+++  D  KR +  K++ HP  
Sbjct: 247 ES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  207 bits (529), Expect = 6e-65
 Identities = 46/293 (15%), Positives = 85/293 (29%), Gaps = 48/293 (16%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
              G  LG+          + E+     + + +  +        Q++ E+     LR   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 78  ----------------------HPNILRLYGWFHDD--ERIFLILEYAHR------GELY 107
                                    ++R+     D      F +              L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 108 RELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
                H+             +   LA  H   ++H  ++P +++LD  G + +  F   V
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 168 QSRSKRHTMCGTL----DYLAPEMVENKEHD-----YAVDNWTLGILCYEFLYGAPPFEA 218
           +  +   +  G      +  A  M+   +H      +A D WTLG+  Y       P   
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 219 ESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           ++       I      F S  +I    + L+   L      RL   + ME P 
Sbjct: 320 DAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  203 bits (518), Expect = 5e-64
 Identities = 57/275 (20%), Positives = 109/275 (39%), Gaps = 18/275 (6%)

Query: 8   REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
           +  + +    +        +G+G FG V+ +++ ++    A+K +        +++    
Sbjct: 47  KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRV 98

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E+   + L  P I+ LYG   +   + + +E    G L + +++     E +A  Y+  
Sbjct: 99  EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ 158

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQ--------SRSKRHTMCG 178
               L Y H   ++H D+K +N+LL  +G R  + DFG ++         S      + G
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA 238
           T  ++APE+V  K  D  VD W+   +    L G  P+    +     +I          
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278

Query: 239 P-SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           P S +      I   L K+   R S  ++      
Sbjct: 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  197 bits (503), Expect = 2e-61
 Identities = 48/294 (16%), Positives = 95/294 (32%), Gaps = 45/294 (15%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQ 63
           +   + +   +   +   LG+G F +VY        + ++K    LK+       ++ I 
Sbjct: 55  KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI- 113

Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-----FTE 118
               + ME          ++ Y          L+ E    G L   +  ++        +
Sbjct: 114 --GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLL-----------DHEGRLKIGDFGWSV 167
               ++   +   +   H+  +IH DIKP+N +L           D    L + D G S+
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 168 QSR-----SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ- 221
             +     +     C T  +   EM+ NK  +Y +D + +    Y  L+G          
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 222 ----KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
               +  FRR+  +D+                  +L       L    ++    
Sbjct: 292 ECKPEGLFRRLPHLDMW-----------NEFFHVMLNIPDCHHLPSLDLLRQKL 334

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  193 bits (493), Expect = 1e-60
 Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 19/270 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F     +GKG FG V+   +  ++  VA+KII  E+ E  +I+  +++E+ + S    
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDS 79

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P + + YG +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H  
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDY 195
             IHRDIK  N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP------SISAEAKHLI 249
             D W+LGI   E   G PP             MKV    P         + S   K  +
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNPPTLEGNYSKPLKEFV 251

Query: 250 SRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
              L K+ S R + +++++H +I++NA   
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFILRNAKKT 281

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  189 bits (483), Expect = 3e-59
 Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 15/277 (5%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
              D  + ++   +      LGKG +G VY  R++ ++  +A+K I +      +    L
Sbjct: 10  CESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PL 66

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---RFTEQQAAT 123
             E+ +   L+H NI++  G F ++  I + +E    G L   LR      +  EQ    
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQ---SRSKRHTMCGT 179
           Y   +   L Y H+N ++HRDIK +N+L++ + G LKI DFG S +         T  GT
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186

Query: 180 LDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFE--AESQKDTFRRIMKVDLSF 235
           L Y+APE+++     +  A D W+LG    E   G PPF    E Q   F ++    +  
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHP 245

Query: 236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
               S+SAEAK  I +    D  KR     ++   ++
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  185 bits (472), Expect = 1e-57
 Identities = 63/259 (24%), Positives = 117/259 (45%), Gaps = 11/259 (4%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
               +G+G F  VY   + E+   VA   +   ++ K + Q + + E E+   L+HPNI+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQHPNIV 88

Query: 83  RLYGWFHD----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           R Y  +       + I L+ E    G L   L++ +    +   ++   +   L + H  
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 139 H--VIHRDIKPENLLLDHE-GRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHD 194
              +IHRD+K +N+ +    G +KIGD G +     S    + GT +++APEM E K +D
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YD 207

Query: 195 YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
            +VD +  G+   E      P+ E ++    +RR+               E K +I   +
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267

Query: 254 VKDSSKRLSLQKIMEHPWI 272
            ++  +R S++ ++ H + 
Sbjct: 268 RQNKDERYSIKDLLNHAFF 286

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  187 bits (476), Expect = 2e-57
 Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 46/318 (14%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
              +    +  +  E    DFE    LG G  G V+ V    S   +A K+I  E     
Sbjct: 15  KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA- 73

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
            I++Q+ RE+++      P I+  YG F+ D  I + +E+   G L + L+K  R  EQ 
Sbjct: 74  -IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 132

Query: 121 AATYIASLTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCG 178
                 ++   L Y  E H ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  G
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 192

Query: 179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA 238
           T  Y++PE ++   +    D W++G+   E   G  P      K+             + 
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 239 PSI------------------------------------------SAEAKHLISRLLVKD 256
                                                        S E +  +++ L+K+
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312

Query: 257 SSKRLSLQKIMEHPWIIK 274
            ++R  L+++M H +I +
Sbjct: 313 PAERADLKQLMVHAFIKR 330

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  181 bits (461), Expect = 6e-56
 Identities = 78/265 (29%), Positives = 133/265 (50%), Gaps = 11/265 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
           + +     +G+G  G VY   +V +   VA++ +  ++Q +K  I      E+ +    +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENK 75

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           +PNI+     +   + +++++EY   G L  ++       E Q A        AL + H 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHD 194
           N VIHRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K + 
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLL 253
             VD W+LGI+  E + G PP+  E+       I         +   +SA  +  ++R L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254

Query: 254 VKDSSKRLSLQKIMEHPWIIKNANP 278
             D  KR S +++++H + +K A P
Sbjct: 255 EMDVEKRGSAKELLQHQF-LKIAKP 278

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  179 bits (457), Expect = 5e-55
 Identities = 77/268 (28%), Positives = 141/268 (52%), Gaps = 14/268 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
              +    +G+G  G V L RE  S   VA+K++  ++Q  +  +      E+ I    +
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF----NEVVIMRDYQ 100

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N++ +Y  +   E +++++E+   G L  ++    R  E+Q AT   ++  ALAY H 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHD 194
             VIHRDIK +++LL  +GR+K+ DFG+  Q      KR ++ GT  ++APE++    + 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD---LSFPSAPSISAEAKHLISR 251
             VD W+LGI+  E + G PP+ ++S     +R+       L       +S   +  + R
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSH--KVSPVLRDFLER 277

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPR 279
           +LV+D  +R + Q++++HP++++   P 
Sbjct: 278 MLVRDPQERATAQELLDHPFLLQTGLPE 305

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  179 bits (455), Expect = 7e-55
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 19/284 (6%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
             ++ +  + D E    +G G  G+V+ +R  ++ H +A+K + +   ++     ++  +
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMD 73

Query: 70  MEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           +++   S   P I++ +G F  +  +F+ +E         + R      E+       ++
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133

Query: 129 TNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             AL Y  E H VIHRD+KP N+LLD  G++K+ DFG S   V  ++K     G   Y+A
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSAGCAAYMA 192

Query: 185 PEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL----SF 235
           PE ++       ++D   D W+LGI   E   G  P+  ++ K  F  + KV        
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLL 250

Query: 236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
           P     S + +  +   L KD  KR    K++EH +I +     
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  177 bits (452), Expect = 1e-54
 Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 30/298 (10%)

Query: 9   EDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ED+    WS+   D+E+   +G G    V        K  VA+K I  E+ +   +  +L
Sbjct: 3   EDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMD-EL 60

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY--------RELRKHRRFTE 118
            +E++  S   HPNI+  Y  F   + ++L+++    G +         +   K     E
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------SR 170
              AT +  +   L Y H+N  IHRD+K  N+LL  +G ++I DFG S            
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

Query: 171 SKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES--------Q 221
             R T  GT  ++APE M + + +D+  D W+ GI   E   GA P+             
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240

Query: 222 KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
           ++    +                 + +IS  L KD  KR +  +++ H +  + A  +
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF-FQKAKNK 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  175 bits (447), Expect = 6e-54
 Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 20/280 (7%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ- 73
           E    D E    LG+G +G V  +R V S   +A+K I      +   Q +L  +++I  
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISM 60

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYREL-RKHRRFTEQQAATYIASLTN 130
            ++  P  +  YG    +  +++ +E       + Y+++  K +   E        S+  
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 131 ALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPE- 186
           AL + H    VIHRD+KP N+L++  G++K+ DFG S        +    G   Y+APE 
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180

Query: 187 ---MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK--VDLSFPSAPSI 241
               +  K +    D W+LGI   E      P+++     T  + +K  V+   P  P+ 
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW---GTPFQQLKQVVEEPSPQLPAD 237

Query: 242 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
             SAE     S+ L K+S +R +  ++M+HP+   + +  
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  176 bits (448), Expect = 1e-53
 Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 20/285 (7%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           +    +  +++ +D +    +G+G +G V  +    S   +A+K I     EK   Q QL
Sbjct: 10  KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQL 67

Query: 67  RREMEIQ-SSLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYRELRK--HRRFTEQQA 121
             ++++   S   P I++ YG    +   ++ +E       + Y+ +         E+  
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127

Query: 122 ATYIASLTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
                +   AL +  EN  +IHRDIKP N+LLD  G +K+ DFG S   V S +K     
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA- 186

Query: 178 GTLDYLAPE----MVENKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVD 232
           G   Y+APE        + +D   D W+LGI  YE   G  P+    S  D   +++K D
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246

Query: 233 ---LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 274
              LS       S    + ++  L KD SKR   +++++HP+I+ 
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  174 bits (442), Expect = 5e-53
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 32/280 (11%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + +EI   LG G FG+VY  +  E+    A K+I  +  E+ +       E+EI ++  H
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YIVEIEILATCDH 75

Query: 79  PNILRLYGWFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           P I++L G ++ D ++++++E+   G    +  EL +    TE Q       +  AL + 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFL 133

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV---- 188
           H   +IHRD+K  N+L+  EG +++ DFG S +   +  KR +  GT  ++APE+V    
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 189 -ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS------- 240
            ++  +DY  D W+LGI   E     PP    +        M+V L    +         
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSDPPTLLTPS 246

Query: 241 -ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
             S E +  +   L K+   R S  +++EHP+ + +    
Sbjct: 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPF-VSSITSN 285

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  174 bits (442), Expect = 6e-53
 Identities = 72/274 (26%), Positives = 135/274 (49%), Gaps = 31/274 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLRHP 79
           F++   LG+G +G VY     E+   VA+K +  +  +++      + +E+ I      P
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQCDSP 84

Query: 80  NILRLYGWFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           ++++ YG +  +  +++++EY   G   ++ R   +++  TE + AT + S    L Y H
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH 142

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEH 193
               IHRDIK  N+LL+ EG  K+ DFG + Q   + +KR+T+ GT  ++APE+++   +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS--------ISAEA 245
           +   D W+LGI   E   G PP+            M+     P+ P          S   
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIH-------PMRAIFMIPTNPPPTFRKPELWSDNF 255

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
              + + LVK   +R +  ++++HP+ +++A   
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQHPF-VRSAKGV 288

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  172 bits (437), Expect = 5e-52
 Identities = 58/332 (17%), Positives = 117/332 (35%), Gaps = 84/332 (25%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L DFE  + +G+G FG V+  +        A+K I     E  +   ++ RE++  + L 
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 62

Query: 78  HPNILRLYGWFHDDER-------------------------------------------- 93
           HP I+R +  + +                                               
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 94  -IFLILEYAHRGELY-----------RELRKHRR---FTEQQAATYIAS-LTNALAYCHE 137
            +  +   + +  LY           ++    R      E     +I   +  A+ + H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG---------------WSVQSRSKRHTMCGTLDY 182
             ++HRD+KP N+    +  +K+GDFG                 + + +      GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKVDLSFPSAPS- 240
           ++PE +    + + VD ++LG++ +E LY    F  + ++      +    L FP   + 
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN--LKFPLLFTQ 297

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
              +   ++  +L    ++R     I+E+   
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  170 bits (433), Expect = 3e-51
 Identities = 68/267 (25%), Positives = 123/267 (46%), Gaps = 13/267 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F   R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHE 137
           PN ++  G +  +   +L++EY   G     L  H++   E + A         LAY H 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHD 194
           +++IHRD+K  N+LL   G +K+GDFG +    +  ++  GT  ++APE++   +  ++D
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-MAPANSFVGTPYWMAPEVILAMDEGQYD 231

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPSISAEAKHLISR 251
             VD W+LGI C E     PP       +    +  +  +      +   S   ++ +  
Sbjct: 232 GKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANP 278
            L K    R + + +++H + +    P
Sbjct: 289 CLQKIPQDRPTSEVLLKHRF-VLRERP 314

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  169 bits (430), Expect = 5e-51
 Identities = 82/304 (26%), Positives = 146/304 (48%), Gaps = 33/304 (10%)

Query: 1   MDTKTAEREDNRKREWSLQD----FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ 56
           M + +  R  +     +L+D    FE+   +G G +G+VY  R V++    A+K++    
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61

Query: 57  IEKYKIQHQLRREMEIQSSL-RHPNILRLYGWF------HDDERIFLILEYAHRG---EL 106
            E+ +I+    +E+ +      H NI   YG F        D++++L++E+   G   +L
Sbjct: 62  DEEEEIK----QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117

Query: 107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            +  +      E+  A     +   L++ H++ VIHRDIK +N+LL     +K+ DFG S
Sbjct: 118 IKNTKG-NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 167 VQ---SRSKRHTMCGTLDYLAPEMVENKEH-----DYAVDNWTLGILCYEFLYGAPPFEA 218
            Q   +  +R+T  GT  ++APE++   E+     D+  D W+LGI   E   GAPP   
Sbjct: 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-- 234

Query: 219 ESQKDTFRRIMKVDLSFP---SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 275
                  R +  +  +      +   S + +  I   LVK+ S+R + +++M+HP+I   
Sbjct: 235 -CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293

Query: 276 ANPR 279
            N R
Sbjct: 294 PNER 297

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  160 bits (407), Expect = 1e-47
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 44/292 (15%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII----FKEQIEKYKIQHQLRREMEIQ 73
           ++ +E    +G+G +G V+  R  ++   VA+K          I+K  +     RE+ + 
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRML 56

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
             L+HPN++ L   F    R+ L+ EY     +  EL +++R   E    +       A+
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEM-V 188
            +CH+++ IHRD+KPEN+L+     +K+ DFG++               T  Y +PE+ V
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------------- 231
            + ++   VD W +G +  E L G P +  +S  D    I K                  
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235

Query: 232 --DLSFPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
              +  P            P+IS  A  L+   L  D ++RL+ ++++ HP+
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  160 bits (408), Expect = 1e-47
 Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 38/290 (13%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S++ +E    +G+G +G V   R  ++   VA+K    E  +   ++    RE+++   L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQL 81

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYC 135
           RH N++ L       +R +L+ E+     +  +L         Q    Y+  + N + +C
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEM-VEN 190
           H +++IHRDIKPEN+L+   G +K+ DFG     +         +  T  Y APE+ V +
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGD 199

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------- 231
            ++  AVD W +G L  E   G P F  +S  D    IM                     
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259

Query: 232 DLSFPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            +  P            P +S     L  + L  D  KR    +++ H +
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  162 bits (411), Expect = 1e-47
 Identities = 55/322 (17%), Positives = 105/322 (32%), Gaps = 62/322 (19%)

Query: 20  DFEIGRPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +E+   +GKG      V L R   +   V ++ I  E      +   L+ E+ +     
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFN 84

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYC 135
           HPNI+     F  D  ++++  +   G     +  H      E   A  +  +  AL Y 
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMC-------GTLDYLAP 185
           H    +HR +K  ++L+  +G++ +     ++       ++  +          L +L+P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 186 EMVENKEH--DYAVDNWTLGILCYEFLYGAPPF--------------------------- 216
           E+++      D   D +++GI   E   G  PF                           
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264

Query: 217 -----------------EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSK 259
                                   T R       S P   + S    H + + L ++   
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324

Query: 260 RLSLQKIMEHPWIIKNANPRGT 281
           R S   ++ H +  K    R +
Sbjct: 325 RPSASTLLNHSF-FKQIKRRAS 345

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  158 bits (402), Expect = 7e-47
 Identities = 71/288 (24%), Positives = 132/288 (45%), Gaps = 38/288 (13%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +     LG+G +  VY  +   + + VALK I  E  E         RE+ +   L+
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI--REVSLLKDLK 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCH 136
           H NI+ L+   H ++ + L+ EY  + +L + L              ++  L   LAYCH
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENK 191
              V+HRD+KP+NLL++  G LK+ DFG     S+ +++  + +  TL Y  P+ ++ + 
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------------D 232
           ++   +D W +G + YE   G P F   + ++    I ++                    
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 233 LSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            ++P          AP + ++   L+++LL  +   R+S +  M+HP+
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  157 bits (399), Expect = 1e-46
 Identities = 79/287 (27%), Positives = 138/287 (48%), Gaps = 37/287 (12%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +     +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELK 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCH 136
           H NI++LY   H  +R+ L+ E+  + +L + L           A +++  L N +AYCH
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENK 191
           +  V+HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSK 176

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------DL 233
           ++   +D W++G +  E + G P F   S+ D   RI ++                  D 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 234 SFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
           +F              +      L+S++L  D ++R++ ++ +EH +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  157 bits (400), Expect = 1e-46
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 41/293 (13%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+  +     LG+G +G VY   +  +   VA+K I  E  E+  +     RE+ +   L
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKEL 90

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +H NI+ L    H + R+ LI EYA   +L + + K+   + +   +++  L N + +CH
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149

Query: 137 ENHVIHRDIKPENLLLD-----HEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE- 186
               +HRD+KP+NLLL          LKIGDFG    + +  R   H +  TL Y  PE 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEI 208

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------------- 231
           ++ ++ +  +VD W++  +  E L   P F  +S+ D   +I +V               
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268

Query: 232 ---DLSFPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                SFP              +  E   L++ +L  D  KR+S +  +EHP+
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  155 bits (395), Expect = 5e-46
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 37/288 (12%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  +   +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCH 136
           H NI+RL+   H D+++ L+ E+  + +L +           +   +++  L   L +CH
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENK 191
             +V+HRD+KP+NLL++  G LK+ +FG    + +  R     +  TL Y  P+ +   K
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 177

Query: 192 EHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKV-------------DL---- 233
            +  ++D W+ G +  E    G P F      D  +RI ++              L    
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 234 SFPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
            +P            P ++A  + L+  LL  +  +R+S ++ ++HP+
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  155 bits (395), Expect = 7e-46
 Identities = 77/289 (26%), Positives = 140/289 (48%), Gaps = 38/289 (13%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            ++ ++    +G+G +G VY  ++ + +  VALK I  +  E   I     RE+ +   L
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDA-EDEGIPSTAIREISLLKEL 76

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYC 135
            HPNI+ L    H +  + L+ E+  + +L + L +++    + Q   Y+  L   +A+C
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVEN 190
           H++ ++HRD+KP+NLL++ +G LK+ DFG    + +  RS  H +  TL Y AP+ ++ +
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGS 194

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------------------- 231
           K++  +VD W++G +  E + G P F   +  D   +I  +                   
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254

Query: 232 DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
             +F            P    E   L+S +L  D +KR+S +  M HP+
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  155 bits (394), Expect = 1e-45
 Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 45/297 (15%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S   F+    LG G +  VY      +   VALK +  +  E         RE+ +   L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST--AIREISLMKEL 60

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRG-----ELYRELRKHRRFTEQQAATYIASLTNA 131
           +H NI+RLY   H + ++ L+ E+         +        R         +   L   
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE- 186
           LA+CHEN ++HRD+KP+NLL++  G+LK+GDFG    + +   +    +  TL Y AP+ 
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDV 179

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------------- 231
           ++ ++ +  ++D W+ G +  E + G P F   + ++  + I  +               
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 232 ---DLSFP--------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
              + +                +   +       +  LL  +   RLS ++ + HPW
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  155 bits (394), Expect = 2e-45
 Identities = 71/298 (23%), Positives = 118/298 (39%), Gaps = 54/298 (18%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-------IQHQLRRE 69
             + +E    LG+G+F  VY  R+  +   VA+K I      + K       +     RE
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-----RE 62

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATY 124
           +++   L HPNI+ L   F     I L+ ++     +  +L           T      Y
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAY 117

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTL 180
           +      L Y H++ ++HRD+KP NLLLD  G LK+ DFG    +   +R+  H +  T 
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TR 176

Query: 181 DYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------- 231
            Y APE +   + +   VD W +G +  E L   P    +S  D   RI +         
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236

Query: 232 -----DL----SFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                 L    +F S           +   +   LI  L + +   R++  + ++  +
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  153 bits (389), Expect = 3e-45
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 11/249 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   LG G    VYL  +      VA+K IF    EK +   +  RE+   S L H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ +     +D+  +L++EY     L   +  H   +   A  +   + + + + H+  +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           +HRDIKP+N+L+D    LKI DFG     S  S ++ + + GT+ Y +PE  + +  D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-----ISAEAKHLISR 251
            D +++GI+ YE L G PPF  E+       I  +  S P+  +     I     ++I R
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDVRKDIPQSLSNVILR 250

Query: 252 LLVKDSSKR 260
              KD + R
Sbjct: 251 ATEKDKANR 259

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  153 bits (390), Expect = 3e-45
 Identities = 58/246 (23%), Positives = 112/246 (45%), Gaps = 7/246 (2%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + + R +G+G  G VY   +   +  VALK++ +        + +++RE      L+ P+
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++ ++ +   D ++++ +   +  +L   LR+       +A   +  + +AL   H    
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+KPEN+L+  +    + DFG     + +  ++     GTL Y+APE        Y 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRLLV 254
            D + L  + YE L G+PP++ +        I +  +  PS   P I      +I+R + 
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMA 274

Query: 255 KDSSKR 260
           K+   R
Sbjct: 275 KNPEDR 280

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  152 bits (385), Expect = 2e-44
 Identities = 61/265 (23%), Positives = 116/265 (43%), Gaps = 13/265 (4%)

Query: 15  EW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +      D  I   +G G FG V+  R       VA+KI+ ++     ++  +  RE+ I
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVN-EFLREVAI 87

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLT 129
              LRHPNI+   G       + ++ EY  RG LYR L K     +  E++  +    + 
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147

Query: 130 NALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             + Y H  +  ++HR++K  NLL+D +  +K+ DFG S     +     +  GT +++A
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           PE++ ++  +   D ++ G++ +E      P+   +       +           +++ +
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267

Query: 245 AKHLISRLLVKDSSKRLSLQKIMEH 269
              +I      +  KR S   IM+ 
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDL 292

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  149 bits (378), Expect = 2e-43
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 23/263 (8%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            ++ E+   +G+G FG V   +       VA+K I  E   K         E+   S + 
Sbjct: 7   YKEIEVEEVVGRGAFGVVC--KAKWRAKDVAIKQIESESERK-----AFIVELRQLSRVN 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAY 134
           HPNI++LYG   +   + L++EYA  G LY  L        +T   A ++    +  +AY
Sbjct: 60  HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 135 CHE---NHVIHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
            H      +IHRD+KP NLLL   G  LKI DFG +   ++      G+  ++APE+ E 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEG 177

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD----LSFPSAPSISAEAK 246
             +    D ++ GI+ +E +    PF+ E     FR +  V            ++    +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNGTRPPLIK--NLPKPIE 234

Query: 247 HLISRLLVKDSSKRLSLQKIMEH 269
            L++R   KD S+R S+++I++ 
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKI 257

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (374), Expect = 3e-43
 Identities = 65/285 (22%), Positives = 119/285 (41%), Gaps = 28/285 (9%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII----FKEQIEKYK 61
           +E   +R    +  + E  + +GKG FG V+  R V+ K  VA+K +     + + E  +
Sbjct: 6   SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
              + +RE+ I S+L HPNI++LYG  H      +++E+   G+LY  L       +   
Sbjct: 66  KFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSV 123

Query: 122 ATYIAS-LTNALAYCHENH--VIHRDIKPENLLLDHEGR-----LKIGDFGWSVQSRSKR 173
              +   +   + Y    +  ++HRD++  N+ L           K+ DFG    S+   
Sbjct: 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL---SQQSV 180

Query: 174 HTM---CGTLDYLAPEM--VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRI 228
           H++    G   ++APE    E + +    D ++  ++ Y  L G  PF+  S        
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240

Query: 229 MKVD----LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
           M  +     + P         +++I      D  KR     I++ 
Sbjct: 241 MIREEGLRPTIPE--DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  146 bits (371), Expect = 2e-42
 Identities = 60/289 (20%), Positives = 117/289 (40%), Gaps = 25/289 (8%)

Query: 1   MDTKTAEREDNRKREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
              + A +     +EW    +  EIG  +GKG+FG+VY          VA+++I  E+  
Sbjct: 13  SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVY---HGRWHGEVAIRLIDIERDN 69

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE 118
           + +++   +RE+      RH N++   G       + +I        LY  +R  +   +
Sbjct: 70  EDQLK-AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128

Query: 119 QQAATYIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSK 172
                 IA  +   + Y H   ++H+D+K +N+  D  G++ I DFG       +Q+  +
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187

Query: 173 RHTM---CGTLDYLAPEMV---------ENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              +    G L +LAPE++         +        D + LG + YE      PF+ + 
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247

Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
            +    ++        S   +  E   ++      +  +R +  K+M+ 
Sbjct: 248 AEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  146 bits (370), Expect = 3e-42
 Identities = 70/253 (27%), Positives = 120/253 (47%), Gaps = 14/253 (5%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRE-LRKHRRFTEQQAATYIASLTNALAYC 135
           I+ +Y     +       ++++EY   G   R+ +      T ++A   IA    AL + 
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG--WSVQSRSKRHT----MCGTLDYLAPEMVE 189
           H+N +IHRD+KP N+++     +K+ DFG   ++       T    + GT  YL+PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKH 247
               D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252

Query: 248 LISRLLVKDSSKR 260
           ++ + L K+   R
Sbjct: 253 VVLKALAKNPENR 265

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  145 bits (369), Expect = 4e-42
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
             R +   D   G  LGKG FG+   V   E+   + +K + +   E  +      +E++
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVK 59

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQA---ATYIAS 127
           +   L HPN+L+  G  + D+R+  I EY   G L   ++    ++   Q    A  IAS
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----------------VQSR 170
               +AY H  ++IHRD+   N L+     + + DFG +                    R
Sbjct: 120 ---GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
            KR+T+ G   ++APEM+  + +D  VD ++ GI+  E +       
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  144 bits (365), Expect = 6e-42
 Identities = 63/265 (23%), Positives = 110/265 (41%), Gaps = 16/265 (6%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE-QIEKYKIQHQLRREMEIQSSL 76
             +  +   +G G FG+VY  R       VA+K    +   +  +    +R+E ++ + L
Sbjct: 6   FAELTLEEIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+ L G    +  + L++E+A  G L R L   +R        +   +   + Y H
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLH 122

Query: 137 ENH---VIHRDIKPENLLLDHEGR--------LKIGDFGWS-VQSRSKRHTMCGTLDYLA 184
           +     +IHRD+K  N+L+  +          LKI DFG +    R+ + +  G   ++A
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMA 182

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE 244
           PE++         D W+ G+L +E L G  PF           +    L+ P   +    
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242

Query: 245 AKHLISRLLVKDSSKRLSLQKIMEH 269
              L+      D   R S   I++ 
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILDQ 267

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  147 bits (373), Expect = 1e-41
 Identities = 83/293 (28%), Positives = 128/293 (43%), Gaps = 51/293 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +   + +G G FG VY  +  +S   VA+K + +++  K        RE++I   L H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 108

Query: 81  ILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS----LTN 130
           I+RL  +F+      D+  + L+L+Y     +YR  R + R  +     Y+      L  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 131 ALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG---WSVQSRSKRHTMCGTLDYLAPE 186
           +LAY H   + HRDIKP+NLLLD +   LK+ DFG     V+       +C +  Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYYRAPE 226

Query: 187 -MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------- 231
            +    ++  ++D W+ G +  E L G P F  +S  D    I+KV              
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286

Query: 232 ---DLSFPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
              +  FP            P    EA  L SRLL    + RL+  +   H +
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  142 bits (361), Expect = 2e-41
 Identities = 48/272 (17%), Positives = 94/272 (34%), Gaps = 22/272 (8%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           N+      +       L +   G ++  +     + + +K++        K +     E 
Sbjct: 2   NKHSGIDFKQLNFLTKLNENHSGELW--KGRWQGNDIVVKVLKVRDWSTRKSR-DFNEEC 58

Query: 71  EIQSSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRR--FTEQQA---AT 123
                  HPN+L + G           LI  +   G LY  L +       + QA   A 
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 124 YIASLTNALAYCH--ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTL 180
            +A     +A+ H  E  +    +   ++++D +   +I          S +        
Sbjct: 119 DMAR---GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV---KFSFQSPGRMYAP 172

Query: 181 DYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS 237
            ++APE ++ K  D    + D W+  +L +E +    PF   S  +   ++    L    
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232

Query: 238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
            P IS     L+   + +D +KR     I+  
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  142 bits (360), Expect = 9e-41
 Identities = 68/294 (23%), Positives = 118/294 (40%), Gaps = 40/294 (13%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQS 74
           +   +E    +G G +G VY  R+  S H VALK +           +     RE+ +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 75  SLR---HPNILRLYGWFHDDE-----RIFLILEYAHRGEL--YRELRKHRRFTEQQAATY 124
            L    HPN++RL             ++ L+ E+  + +L  Y +         +     
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-MCGTLDY 182
           +      L + H N ++HRD+KPEN+L+   G +K+ DFG + + S     T +  TL Y
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----------- 231
            APE++    +   VD W++G +  E     P F   S+ D   +I  +           
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245

Query: 232 -----DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                  +FP           P +      L+  +L  +  KR+S  + ++H +
Sbjct: 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  144 bits (364), Expect = 1e-40
 Identities = 84/293 (28%), Positives = 129/293 (44%), Gaps = 52/293 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +   + +G G FG V+  + VES   VA+K + +++  K        RE++I   ++HPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------RELQIMRIVKHPN 93

Query: 81  ILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS----LTN 130
           ++ L  +F+      D+  + L+LEY     +YR  R + +  +      I      L  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 131 ALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG---WSVQSRSKRHTMCGTLDYLAPE 186
           +LAY H   + HRDIKP+NLLLD   G LK+ DFG     +        +C +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPE 211

Query: 187 -MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------------- 231
            +     +   +D W+ G +  E + G P F  ES  D    I+KV              
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271

Query: 232 ---DLSFPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
              +  FP            P    +A  LISRLL    S RL+  + + HP+
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  138 bits (349), Expect = 9e-39
 Identities = 69/302 (22%), Positives = 121/302 (40%), Gaps = 49/302 (16%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            +  +E    +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLL 73

Query: 77  RHPNILRLYGWFHDDER--------IFLILEYAHRGELYREL-RKHRRFTEQQAATYIAS 127
           +H N++ L                 I+L+ ++    +L   L     +FT  +    +  
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCG---TL 180
           L N L Y H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 181 DYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------- 231
            Y  PE++   +++   +D W  G +  E    +P  +  +++     I ++        
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252

Query: 232 -----------DLSFP-----------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
                       L               A      A  LI +LLV D ++R+     + H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312

Query: 270 PW 271
            +
Sbjct: 313 DF 314

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  143 bits (361), Expect = 9e-39
 Identities = 52/246 (21%), Positives = 98/246 (39%), Gaps = 21/246 (8%)

Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +E+   +  G  G +YL      +  PV LK +      +   Q     E +  + + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA--QAMAMAERQFLAEVVHP 139

Query: 80  NILRLY-----GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +I++++        H D   ++++EY   G+  +  +  ++    +A  Y+  +  AL+Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKG-QKLPVAEAIAYLLEILPALSY 197

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            H   +++ D+KPEN++L  E +LK+ D G +V   +    + GT  + APE+V      
Sbjct: 198 LHSIGLVYNDLKPENIMLT-EEQLKLIDLG-AVSRINSFGYLYGTPGFQAPEIVRTGPTV 255

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
            A D +T+G          P                                 L+ R + 
Sbjct: 256 -ATDIYTVGRTLAALTLDLPTRNGRYVDGLPED--------DPVLKTYDSYGRLLRRAID 306

Query: 255 KDSSKR 260
            D  +R
Sbjct: 307 PDPRQR 312

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  137 bits (347), Expect = 1e-38
 Identities = 71/301 (23%), Positives = 128/301 (42%), Gaps = 42/301 (13%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV-ESKHPVALKIIFKEQIEKYKIQHQLR 67
           +D   R  + Q +E    +G+G +G+V+  R++      VALK +  +   +  +     
Sbjct: 3   KDGLCR--ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTI 59

Query: 68  REMEIQSSLR---HPNILRLYGWFHDDE-----RIFLILEYAHRGEL--YRELRKHRRFT 117
           RE+ +   L    HPN++RL+            ++ L+ E+  + +L  Y +        
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT- 175
            +     +  L   L + H + V+HRD+KP+N+L+   G++K+ DFG + + S     T 
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV---- 231
           +  TL Y APE++    +   VD W++G +  E     P F   S  D   +I+ V    
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 232 ------------DLSFPS---------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
                         +F S            I    K L+ + L  + +KR+S    + HP
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 271 W 271
           +
Sbjct: 299 Y 299

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  135 bits (341), Expect = 8e-38
 Identities = 75/306 (24%), Positives = 135/306 (44%), Gaps = 53/306 (17%)

Query: 10  DNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++   EW  QD +++ R LG+GK+  V+    + +   V +KI+   + +K K      R
Sbjct: 26  ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------R 79

Query: 69  EMEIQSSLR-HPNILRLYGWFHDDE--RIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           E++I  +LR  PNI+ L     D       L+ E+ +  +  +  +     T+     Y+
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYM 136

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS-VQSRSKRHTM-CGTLDY 182
             +  AL YCH   ++HRD+KP N+++DHE R L++ D+G +      + + +   +  +
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196

Query: 183 LAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKV--------- 231
             PE +V+ + +DY++D W+LG +    ++   P F      D   RI KV         
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256

Query: 232 ------------DLSFPS--------------APSISAEAKHLISRLLVKDSSKRLSLQK 265
                       +                      +S EA   + +LL  D   RL+ ++
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316

Query: 266 IMEHPW 271
            MEHP+
Sbjct: 317 AMEHPY 322

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  133 bits (337), Expect = 1e-37
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 16/218 (7%)

Query: 11  NRKREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           +   +W        +G+ +G G FG VY   + +    VA+K++        ++Q   + 
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKN 69

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS- 127
           E+ +    RH NIL   G+     ++ ++ ++     LY  L       E +    IA  
Sbjct: 70  EVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDY 182
               + Y H   +IHRD+K  N+ L  +  +KIGDFG +          +   + G++ +
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188

Query: 183 LAPEMVENKEH---DYAVDNWTLGILCYEFLYGAPPFE 217
           +APE++  ++     +  D +  GI+ YE + G  P+ 
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  132 bits (334), Expect = 3e-37
 Identities = 30/245 (12%), Positives = 63/245 (25%), Gaps = 31/245 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +    G     + +   +      VAL  +  + +    +  +        S +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           + R+    H      ++ E+   G L          +   A   + SL  A    H   V
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
                 P  + +  +G + +                      +          +   D  
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-----------------TMPDA-------NPQDDIR 186

Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS-----ISAEAKHLISRLLVK 255
            +G   Y  L    P      +       +     P  P+     I  +   + +R +  
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQG 246

Query: 256 DSSKR 260
           D   R
Sbjct: 247 DGGIR 251

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  133 bits (337), Expect = 1e-36
 Identities = 80/341 (23%), Positives = 133/341 (39%), Gaps = 77/341 (22%)

Query: 1   MDTKTAEREDNRKREWSLQDFEI-GRPLGKGKFGRVYLVR--EVESKHPVALKIIFKEQI 57
           MD     +  +  RE     FE  G  +G+G +G VY  +  + +     ALK     QI
Sbjct: 3   MDYDFKVKLSSE-RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QI 56

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGWF--HDDERIFLILEYA--------HRGELY 107
           E   I     RE+ +   L+HPN++ L   F  H D +++L+ +YA              
Sbjct: 57  EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRAS 116

Query: 108 RELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDF 163
           +  +K  +       + +  + + + Y H N V+HRD+KP N+L+  E    GR+KI D 
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 164 G----WSVQSRSKRHTMCG--TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           G    ++   +          T  Y APE ++  + +  A+D W +G +  E L   P F
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

Query: 217 EAES---------QKDTFRRIMKVDLSFPS------------------------------ 237
                          D   RI  V + FP+                              
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNV-MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295

Query: 238 -------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 271
                       ++A HL+ +LL  D  KR++ ++ M+ P+
Sbjct: 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  132 bits (334), Expect = 1e-36
 Identities = 75/305 (24%), Positives = 129/305 (42%), Gaps = 60/305 (19%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSS 75
           +  F++ R  G+G FG V L +E  +   VA+K + ++   +       R  + M+  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAV 75

Query: 76  LRHPNILRLYGWFH-------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS- 127
           L HPNI++L  +F+        D  + +++EY     L+R  R + R         I   
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134

Query: 128 ---LTNALAYCHEN--HVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRSKRHTM----C 177
              L  ++   H    +V HRDIKP N+L++   G LK+ DFG S +  S         C
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSEPNVAYIC 193

Query: 178 GTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----- 231
            +  Y APE +  N+ +  AVD W++G +  E + G P F  ++       I++V     
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252

Query: 232 ------------DLSFPS-------------APSISAEAKHLISRLLVKDSSKRLSLQKI 266
                       D+   +             +   + EA  L+S LL     +R+   + 
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312

Query: 267 MEHPW 271
           + HP+
Sbjct: 313 LCHPY 317

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  128 bits (324), Expect = 1e-35
 Identities = 67/297 (22%), Positives = 114/297 (38%), Gaps = 56/297 (18%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSL 76
           +D  +   +GKG++G V+          VA+KI      + +       RE E+     L
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGE--NVAVKIFSSRDEKSWF------RETELYNTVML 59

Query: 77  RHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           RH NIL          H   +++LI  Y   G LY  L+             + S+ + L
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118

Query: 133 AYCHENH--------VIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRSKRHTMC 177
           A+ H           + HRD+K +N+L+   G+  I D G +V       Q     +   
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 178 GTLDYLAPEMVENK------EHDYAVDNWTLGILCYEFLYGA----------PPFEAESQ 221
           GT  Y+APE+++        +    VD W  G++ +E               PPF     
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 222 KDTFRRIMKVDLSF----PSAPS--ISAEAKHLISRLLVK----DSSKRLSLQKIME 268
            D     M+  +      P+ P+   S      +++L+ +    + S RL+  +I +
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  126 bits (319), Expect = 1e-34
 Identities = 58/298 (19%), Positives = 111/298 (37%), Gaps = 56/298 (18%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SS 75
            +  ++ + +GKG++G V++ +       VA+K+ F  +   +       RE EI     
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGE--KVAVKVFFTTEEASWF------RETEIYQTVL 87

Query: 76  LRHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +RH NIL              +++LI +Y   G LY  L+       +       S  + 
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSG 146

Query: 132 LAYCHE--------NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-------HTM 176
           L + H           + HRD+K +N+L+   G   I D G +V+  S         +T 
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206

Query: 177 CGTLDYLAPEM------VENKEHDYAVDNWTLGILCYEFLYG----------APPFEAES 220
            GT  Y+ PE+        + +     D ++ G++ +E                P+    
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266

Query: 221 QKDTFRRIMKVD-------LSFPS---APSISAEAKHLISRLLVKDSSKRLSLQKIME 268
             D     M+          SFP+   +     +   L++     + + RL+  ++ +
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  125 bits (316), Expect = 8e-34
 Identities = 76/326 (23%), Positives = 136/326 (41%), Gaps = 85/326 (26%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +G+ LG G FG V  V ++ES    ALK + ++   +YK      RE++I   L H N
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKN-----RELDIMKVLDHVN 61

Query: 81  ILRLYGWFH--------------------------------------DDERIFLILEYAH 102
           I++L  +F+                                       ++ + +I+EY  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120

Query: 103 RGE-LYRELRKHRR----FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-G 156
             + L++ L+   R          + YI  L  A+ + H   + HRDIKP+NLL++ +  
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 157 RLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYG 212
            LK+ DFG S +             +  Y APE M+   E+  ++D W++G +  E + G
Sbjct: 180 TLKLCDFG-SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 213 APPFEAESQKDTFRRIMKV-----------------DLSFPSAPSIS----------AEA 245
            P F  E+  D   RI+++                 ++ FP+  +            + A
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPW 271
             L+ ++L  +   R++  + M HP+
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPF 324

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  124 bits (313), Expect = 1e-33
 Identities = 64/298 (21%), Positives = 118/298 (39%), Gaps = 56/298 (18%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SS 75
            +   +   +GKG+FG V+  +       VA+KI    +   +       RE EI     
Sbjct: 41  ARTIVLQESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSW------FREAEIYQTVM 92

Query: 76  LRHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           LRH NIL              +++L+ +Y   G L+  L ++   T +       S  + 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASG 151

Query: 132 LAYCHENH--------VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM------- 176
           LA+ H           + HRD+K +N+L+   G   I D G +V+  S   T+       
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211

Query: 177 CGTLDYLAPEMVEN------KEHDYAVDNWTLGILCYEFLYG----------APPFEAES 220
            GT  Y+APE++++       E     D + +G++ +E                P+    
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271

Query: 221 QKDTFRRIMKVDLSF----PSAPS--ISAEAKHLISRLLV----KDSSKRLSLQKIME 268
             D     M+  +      P+ P+   S EA  ++++++      + + RL+  +I +
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  122 bits (307), Expect = 5e-33
 Identities = 63/297 (21%), Positives = 113/297 (38%), Gaps = 58/297 (19%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLR 77
             ++     +G+FG V+  + +     VA+KI   +       +   + E E+     ++
Sbjct: 25  PLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQD------KQSWQNEYEVYSLPGMK 76

Query: 78  HPNILRLYGW----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           H NIL+  G        D  ++LI  +  +G L   L+ +   +  +      ++   LA
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLA 135

Query: 134 YCHEN----------HVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCG 178
           Y HE+           + HRDIK +N+LL +     I DFG ++     +S    H   G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 179 TLDYLAPEMVE---NKEHDY--AVDNWTLGILCYEFLYG-----------APPFEAESQK 222
           T  Y+APE++E   N + D    +D + +G++ +E                 PFE E  +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255

Query: 223 DTFRRIM-------KVDLSFPSAPSISAEAKHLISRLLVK----DSSKRLSLQKIME 268
                 M       K                 ++   + +    D+  RLS   + E
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQ-KHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  121 bits (306), Expect = 1e-32
 Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 56/298 (18%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEIQ 73
           + +     +G G +G V    +  S   VA+K +   F+ +I         R  RE+ + 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI------FAKRAYRELLLL 77

Query: 74  SSLRHPNILRLYGWFHDDER------IFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
             ++H N++ L   F            +L++ +    +L + +    +F+E++    +  
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQ 134

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLA 184
           +   L Y H   V+HRD+KP NL ++ +  LKI DFG    +R     M G   T  Y A
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL---ARHADAEMTGYVVTRWYRA 191

Query: 185 PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------DLSF- 235
           PE ++    ++  VD W++G +  E L G   F+ +   D   +I+KV        +   
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251

Query: 236 --PSA-------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
              +A                   P  S +A  L+ ++L  D  KRL+  + + HP+ 
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  121 bits (304), Expect = 2e-32
 Identities = 68/314 (21%), Positives = 111/314 (35%), Gaps = 69/314 (21%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           E SL   + ++   +G+G++G VY  +    + PVA+K+           +     E  I
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVY--KGSLDERPVAVKVFSFAN------RQNFINEKNI 58

Query: 73  Q--SSLRHPNILRLYG-----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
                + H NI R                 L++EY   G L + L  H       +    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLA 117

Query: 126 ASLTNALAYCHENH---------VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--- 173
            S+T  LAY H            + HRD+   N+L+ ++G   I DFG S++    R   
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 174 --------HTMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYEFLYG------ 212
                    +  GT+ Y+APE++E        +     VD + LG++ +E          
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 213 -------APPFEAESQKDTFRRIM-------KVDLSFPSAPSISAEAKHLISRLLVK--- 255
                     F+ E         M       K    FP A   ++ A   +   +     
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

Query: 256 -DSSKRLSLQKIME 268
            D+  RL+ Q   E
Sbjct: 298 QDAEARLTAQXAEE 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  121 bits (305), Expect = 3e-32
 Identities = 74/322 (22%), Positives = 135/322 (41%), Gaps = 61/322 (18%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIG------RPLGKGKFGRVYLVREVESKHPVALKII-- 52
           M +    R    ++E +   +E+       +P+G G +G V    +  +   VA+K +  
Sbjct: 1   MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60

Query: 53  -FKEQIEKYKIQHQLR--REMEIQSSLRHPNILRLYGWFHDDER------IFLILEYAHR 103
            F+ ++         R  RE+ +   +RH N++ L   F  DE        +L++ +   
Sbjct: 61  PFQSEL------FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114

Query: 104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
            +L + ++ H +  E +    +  +   L Y H   +IHRD+KP NL ++ +  LKI DF
Sbjct: 115 -DLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 172

Query: 164 GWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
           G    +R     M G   T  Y APE ++    +   VD W++G +  E + G   F+  
Sbjct: 173 GL---ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229

Query: 220 SQKDTFRRIMKV-------DLSF---PSA-------------------PSISAEAKHLIS 250
              D  + IMKV        +       A                    + S  A +L+ 
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289

Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
           ++LV D+ +R++  + + HP+ 
Sbjct: 290 KMLVLDAEQRVTAGEALAHPYF 311

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  119 bits (301), Expect = 8e-32
 Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 61/304 (20%)

Query: 19  QDFEIG------RPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR-- 67
             +E+        P+G G +G V    + ++   VA+K +   F+  I      H  R  
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII------HAKRTY 76

Query: 68  REMEIQSSLRHPNILRLY------GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           RE+ +   ++H N++ L           +   ++L+       +L   ++  ++ T+   
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK-CQKLTDDHV 134

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG--- 178
              I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG    +R     M G   
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTADEMTGYVA 191

Query: 179 TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV------ 231
           T  Y APE M+    ++  VD W++G +  E L G   F      D  + I+++      
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251

Query: 232 -DLSF---PSA-------------------PSISAEAKHLISRLLVKDSSKRLSLQKIME 268
             L      SA                      +  A  L+ ++LV DS KR++  + + 
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311

Query: 269 HPWI 272
           H + 
Sbjct: 312 HAYF 315

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  118 bits (297), Expect = 1e-30
 Identities = 63/309 (20%), Positives = 127/309 (41%), Gaps = 64/309 (20%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEI 72
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q       H  R  RE+ +
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT------HAKRAYRELVL 114

Query: 73  QSSLRHPNILRLY------GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
              + H NI+ L           + + ++L++E      L + ++       ++ +  + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLY 171

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYL 183
            +   + + H   +IHRD+KP N+++  +  LKI DFG + ++      M     T  Y 
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYR 230

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM-------------- 229
           APE++    +   VD W++G +  E +     F      D + +++              
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 230 ---------------KVDLS--FPSAPS---------ISAEAKHLISRLLVKDSSKRLSL 263
                           +     FP +            +++A+ L+S++LV D +KR+S+
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 264 QKIMEHPWI 272
              ++HP+I
Sbjct: 351 DDALQHPYI 359

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  116 bits (292), Expect = 2e-30
 Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 51/300 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY------KIQHQLR--REMEI 72
           + + R +  G +G V    + E   PVA+K +F    +              R  RE+ +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 73  QSSLRHPNILRLYGWFHDDER-----IFLILEYAHRGELYRELRKHRR-FTEQQAATYIA 126
            +   HPNIL L   F   E      ++L+ E     +L + +   R   + Q    ++ 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYL 183
            +   L   HE  V+HRD+ P N+LL     + I DF  + +  +             Y 
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-REDTADANKTHYVTHRWYR 200

Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-------DLSF 235
           APE +++ K     VD W+ G +  E       F   +  +   +I++V       D+  
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260

Query: 236 ---PSA--------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
              PSA                    P+    A  LI+++L  +  +R+S ++ + HP+ 
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  115 bits (289), Expect = 2e-30
 Identities = 68/312 (21%), Positives = 121/312 (38%), Gaps = 63/312 (20%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLR--REMEIQSSLR 77
           +   +PLG G  G V+   + +    VA+K I+  +              RE++I   L 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ------SVKHALREIKIIRRLD 66

Query: 78  HPNILRLY--------------GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT 123
           H NI++++              G   +   ++++ EY    +L   L +     E+ A  
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARL 124

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFG---WSVQSRSKRHTMCG- 178
           ++  L   L Y H  +V+HRD+KP NL ++ E   LKIGDFG         S +  +   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 179 --TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF 235
             T  Y +P  ++    +  A+D W  G +  E L G   F    + +  + I++  +  
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES-IPV 243

Query: 236 PSA-----------------------------PSISAEAKHLISRLLVKDSSKRLSLQKI 266
                                           P IS EA   + ++L      RL+ ++ 
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 267 MEHPWIIKNANP 278
           + HP++   + P
Sbjct: 304 LSHPYMSIYSFP 315

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  115 bits (291), Expect = 2e-30
 Identities = 70/305 (22%), Positives = 132/305 (43%), Gaps = 59/305 (19%)

Query: 19  QDFEIGR------PLGKGKFGRVYLVREVESKHPVALKII--FKEQIEKYKIQHQLR--R 68
           Q F++G        +G+G +G V    +  +K  VA+K I  F+ Q       +  R  R
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT------YCQRTLR 74

Query: 69  EMEIQSSLRHPNILRLYGWFH-----DDERIFLILEYAHRGELYRELRKHRRFTEQQAAT 123
           E++I    RH NI+ +            + ++++ +     +LY+ L+  +  +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY 132

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL 183
           ++  +   L Y H  +V+HRD+KP NLLL+    LKI DFG +  +           +Y+
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 184 ------APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV----- 231
                 APE M+ +K +  ++D W++G +  E L   P F  +   D    I+ +     
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

Query: 232 --DLSF---PSA-------------------PSISAEAKHLISRLLVKDSSKRLSLQKIM 267
             DL+      A                   P+  ++A  L+ ++L  +  KR+ +++ +
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

Query: 268 EHPWI 272
            HP++
Sbjct: 313 AHPYL 317

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  114 bits (288), Expect = 6e-30
 Identities = 71/308 (23%), Positives = 126/308 (40%), Gaps = 61/308 (19%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII--FKEQIEKYKIQHQLR--REMEIQ 73
             DF++   LG+G +G V       +   VA+K I  F + +        LR  RE++I 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL------FALRTLREIKIL 63

Query: 74  SSLRHPNILRLY-----GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
              +H NI+ ++       F +   +++I E     +L+R +   +  ++     +I   
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQT 121

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD------- 181
             A+   H ++VIHRD+KP NLL++    LK+ DFG +                      
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 182 ------YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--- 231
                 Y APE M+ + ++  A+D W+ G +  E     P F     +     I  +   
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 232 -----DLSF---PSA-------------------PSISAEAKHLISRLLVKDSSKRLSLQ 264
                DL     P A                   P ++ +   L+ R+LV D +KR++ +
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301

Query: 265 KIMEHPWI 272
           + +EHP++
Sbjct: 302 EALEHPYL 309

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  115 bits (290), Expect = 1e-29
 Identities = 72/366 (19%), Positives = 135/366 (36%), Gaps = 99/366 (27%)

Query: 3   TKTAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           +K          +W + D +EI   +G G +G V    +   K  VA+K I +   +   
Sbjct: 36  SKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID 95

Query: 62  IQHQLRREMEIQSSLRHPNILRLY-----GWFHDDERIFLILEYAHRGELYRELRKHRRF 116
            +  LR E+ I + L H +++++            + ++++LE A   +  +  R     
Sbjct: 96  CKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYL 153

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG------------ 164
           TE    T + +L   + Y H   ++HRD+KP N L++ +  +K+ DFG            
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213

Query: 165 ---------------WSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWTLG-I 204
                              +++ +  + G   T  Y APE ++  + +  A+D W++G I
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273

Query: 205 L----------CYEFLYGAPPF--------------------EAESQKDTFRRIMKV--- 231
                              P F                         +D    I  +   
Sbjct: 274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333

Query: 232 ----DL-------------SFPSA---------PSISAEAKHLISRLLVKDSSKRLSLQK 265
               D+              FP           P+ SA+A HL+ R+LV + +KR+++ +
Sbjct: 334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE 393

Query: 266 IMEHPW 271
            + HP+
Sbjct: 394 CLAHPF 399

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  113 bits (286), Expect = 2e-29
 Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 9/223 (4%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             + +D  +G  +G+G FG V+  R       VA+K   +E +        L+ E  I  
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQ-EARILK 167

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALA 133
              HPNI+RL G     + I++++E    G+    LR        +     +      + 
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL-----APEMV 188
           Y      IHRD+   N L+  +  LKI DFG S +     +   G L  +     APE +
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287

Query: 189 ENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               +    D W+ GIL +E F  GA P+   S + T   + K
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  114 bits (287), Expect = 3e-29
 Identities = 50/239 (20%), Positives = 98/239 (41%), Gaps = 13/239 (5%)

Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
            +  T         +W +   D  +   LG G++G VY     +    VA+K + ++ +E
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 259

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--F 116
                 +  +E  +   ++HPN+++L G    +   ++I E+   G L   LR+  R   
Sbjct: 260 ----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSK 172
           +          +++A+ Y  + + IHR++   N L+     +K+ DFG S      + + 
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                  + + APE +   +     D W  G+L +E   YG  P+        +  + K
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  111 bits (280), Expect = 1e-28
 Identities = 67/332 (20%), Positives = 133/332 (40%), Gaps = 70/332 (21%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGR------PLGKGKFGRVYLVREVESKHPVALKII-- 52
           M +++    +    E     F + +      P+G G  G V    +   +  VA+K +  
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60

Query: 53  -FKEQIEKYKIQHQLR--REMEIQSSLRHPNILRLYGWFHDDER------IFLILEYAHR 103
            F+ Q       H  R  RE+ +   + H NI+ L   F   +       +++++E    
Sbjct: 61  PFQNQT------HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD- 113

Query: 104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
             L + ++       ++ +  +  +   + + H   +IHRD+KP N+++  +  LKI DF
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171

Query: 164 GWSVQSRSKRHTMCG---TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
           G + ++      M     T  Y APE++    +   VD W++G +  E + G   F    
Sbjct: 172 GLA-RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230

Query: 221 QKDTFRRIM-----------------------------KVDLS--FPSA---------PS 240
             D + +++                                    FP             
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290

Query: 241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
            +++A+ L+S++LV D+SKR+S+ + ++HP+I
Sbjct: 291 KASQARDLLSKMLVIDASKRISVDEALQHPYI 322

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  110 bits (277), Expect = 2e-28
 Identities = 49/222 (22%), Positives = 101/222 (45%), Gaps = 14/222 (6%)

Query: 20  DFEIGRPLGKGKFGRVY----LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +F+  + LG G FG VY    +    + K PVA+K + +    K     ++  E  + +S
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAY 134
           + +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y
Sbjct: 74  VDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGT---LDYLAPEMVE 189
             +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 190 NKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           ++ + +  D W+ G+  +E   +G+ P++     +    + K
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  110 bits (278), Expect = 4e-28
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 15/221 (6%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154

Query: 79  ----PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K+  + F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +T   +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILG 273

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV 231
             +   +D W+LG +  E L G P    E + D    ++++
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  108 bits (272), Expect = 1e-27
 Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 15/243 (6%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQI 57
           ++ +  +   +     S         +G+G FG VY   L+     K   A+K +    I
Sbjct: 71  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR-I 128

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR- 115
                  Q   E  I     HPN+L L G     +    ++L Y   G+L   +R     
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 188

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKR 173
            T +    +   +   + +      +HRD+   N +LD +  +K+ DFG +  +  +   
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248

Query: 174 HTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRR 227
                T   L     A E ++ ++     D W+ G+L +E    GAPP+   +  D    
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308

Query: 228 IMK 230
           +++
Sbjct: 309 LLQ 311

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  109 bits (275), Expect = 3e-27
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 12/238 (5%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIE 58
           +  T      R  E   +  E+GR +G+G+FG V+    +        VA+K       +
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFT 117
             + +    +E        HP+I++L G    +  +++I+E    GEL   L+  +    
Sbjct: 433 SVREK--FLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLD 489

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT 175
                 Y   L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +    
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549

Query: 176 MCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
             G L   ++APE +  +    A D W  G+  +E  ++G  PF+     D   RI  
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  107 bits (268), Expect = 3e-27
 Identities = 51/222 (22%), Positives = 102/222 (45%), Gaps = 14/222 (6%)

Query: 20  DFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +F+  + LG G FG VY    + E E  K PVA+K + +    K     ++  E  + +S
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAY 134
           + +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y
Sbjct: 74  VDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGT---LDYLAPEMVE 189
             +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 190 NKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           ++ + +  D W+ G+  +E   +G+ P++     +    + K
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  105 bits (265), Expect = 4e-27
 Identities = 51/243 (20%), Positives = 98/243 (40%), Gaps = 15/243 (6%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQI 57
           ++ +  +   +     S         +G+G FG VY   L+     K   A+K +     
Sbjct: 7   LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRIT 65

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR- 115
           +  ++  Q   E  I     HPN+L L G     +    ++L Y   G+L   +R     
Sbjct: 66  DIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 124

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSR--- 170
            T +    +   +   + Y      +HRD+   N +LD +  +K+ DFG +  +  +   
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184

Query: 171 SKRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRR 227
           S  +     L   ++A E ++ ++     D W+ G+L +E    GAPP+   +  D    
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244

Query: 228 IMK 230
           +++
Sbjct: 245 LLQ 247

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  107 bits (268), Expect = 5e-27
 Identities = 64/318 (20%), Positives = 115/318 (36%), Gaps = 67/318 (21%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII-----FKEQIEK-YKIQHQLRR-EMEIQ 73
           + + R LG G F  V+L +++ +   VA+KI+     + E  E   K+  ++   +   +
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 74  SSLRHPNILRLYGWF----HDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIAS 127
            S+   +IL+L   F     +   + ++ E      L   ++K  HR             
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 128 LTNALAYCH-ENHVIHRDIKPENLLLDHEGR------LKIGDFGWSVQSRSKRHTMCGTL 180
           L   L Y H    +IH DIKPEN+L++          +KI D G +            T 
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------RIMKVDLS 234
           +Y +PE++         D W+   L +E + G   FE +      +      +I+++   
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259

Query: 235 FPSA------------------------------PSISAEAKH----------LISRLLV 254
            PS                                 ++ + K            +S +L 
Sbjct: 260 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319

Query: 255 KDSSKRLSLQKIMEHPWI 272
            D  KR     ++ HPW+
Sbjct: 320 LDPRKRADAGGLVNHPWL 337

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  105 bits (265), Expect = 7e-27
 Identities = 57/256 (22%), Positives = 94/256 (36%), Gaps = 45/256 (17%)

Query: 11  NRKREWSLQDFEI-------GRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKY 60
           + + +  L+D  I       GR LGKG+FG V    L +E  S   VA+K++ K  I   
Sbjct: 8   SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIAS 66

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYG------WFHDDERIFLILEYAHRGELYRELRKHR 114
               +  RE        HP++ +L G               +IL +   G+L+  L   R
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126

Query: 115 ------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
                     Q    ++  +   + Y    + IHRD+   N +L  +  + + DFG S  
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-- 184

Query: 169 SRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
               R    G  DY             LA E + +  +    D W  G+  +E    G  
Sbjct: 185 ----RKIYSG--DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238

Query: 215 PFEAESQKDTFRRIMK 230
           P+      + +  ++ 
Sbjct: 239 PYAGIENAEIYNYLIG 254

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  105 bits (263), Expect = 7e-27
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 26/235 (11%)

Query: 12  RKREWSLQDFEI---GRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           R +E  L    +    + LG G FG V     +  +    VA+KI+ K +     ++ +L
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDEL 65

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             E  +   L +P I+R+ G   + E   L++E A  G L + L+++R   ++     + 
Sbjct: 66  LAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 124

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY---- 182
            ++  + Y  E++ +HRD+   N+LL  +   KI DFG S      +        Y    
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS------KALRADENYYKAQT 178

Query: 183 --------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
                    APE +   +     D W+ G+L +E F YG  P+      +    +
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  104 bits (262), Expect = 1e-26
 Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 14/239 (5%)

Query: 5   TAEREDNRKREWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEK 59
           +A     +     +   D  +   LG G FG V              VA+K +  + + +
Sbjct: 2   SAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTE 118
            +      RE+    SL H N++RLYG       + ++ E A  G L   LRKH+  F  
Sbjct: 62  PEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL 120

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTM 176
              + Y   +   + Y      IHRD+   NLLL     +KIGDFG    +      + M
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180

Query: 177 CGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                    + APE ++ +   +A D W  G+  +E F YG  P+   +      +I K
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  106 bits (267), Expect = 1e-26
 Identities = 48/225 (21%), Positives = 87/225 (38%), Gaps = 13/225 (5%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             E   +   +   LG+G FG V++         VA+K +               +E ++
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL----KPGTMSPEAFLQEAQV 232

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              LRH  +++LY     +E I+++ EY  +G L   L+          Q     A + +
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY----LAPE 186
            +AY    + +HRD++  N+L+      K+ DFG +       +T      +     APE
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

Query: 187 MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                      D W+ GIL  E    G  P+     ++   ++ +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  107 bits (268), Expect = 2e-26
 Identities = 48/225 (21%), Positives = 87/225 (38%), Gaps = 13/225 (5%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             E   +   +   LG+G FG V++         VA+K +               +E ++
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL----KPGTMSPEAFLQEAQV 315

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              LRH  +++LY    + E I+++ EY  +G L   L+          Q     A + +
Sbjct: 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY----LAPE 186
            +AY    + +HRD++  N+L+      K+ DFG +       +T      +     APE
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434

Query: 187 MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                      D W+ GIL  E    G  P+     ++   ++ +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  104 bits (261), Expect = 2e-26
 Identities = 50/258 (19%), Positives = 97/258 (37%), Gaps = 35/258 (13%)

Query: 1   MDTKTAEREDNRKREWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKE 55
           +  + +E   N+  +  +      +G+ LG+G+FG V    L +E  +   VA+K + K 
Sbjct: 14  LVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KL 72

Query: 56  QIEKYKIQHQLRREMEIQSSLRHPNILRLYG-----WFHDDERIFLILEYAHRGELYREL 110
                +   +   E        HPN++RL G           +  +IL +   G+L+  L
Sbjct: 73  DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132

Query: 111 RKHR------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG 164
              R          Q    ++  +   + Y    + +HRD+   N +L  +  + + DFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192

Query: 165 WS--VQS----RSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYG 212
            S  + S    R  R         +     A E + ++ +    D W  G+  +E    G
Sbjct: 193 LSKKIYSGDYYRQGRIAK------MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246

Query: 213 APPFEAESQKDTFRRIMK 230
             P+      + +  ++ 
Sbjct: 247 MTPYPGVQNHEMYDYLLH 264

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (258), Expect = 3e-26
 Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 27/232 (11%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             E   ++  + + LG G+FG V L +  + ++ VA+K+I KE       + +  +E + 
Sbjct: 2   HMELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMI-KEG---SMSEDEFFQEAQT 56

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNA 131
              L HP +++ YG    +  I+++ EY   G L   LR H +     Q       +   
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL-------- 183
           +A+   +  IHRD+   N L+D +  +K+ DFG    +R           Y+        
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG---MTRYVLDD-----QYVSSVGTKFP 168

Query: 184 ----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               APE+    ++    D W  GIL +E F  G  P++  +  +   ++ +
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  104 bits (261), Expect = 3e-26
 Identities = 59/246 (23%), Positives = 91/246 (36%), Gaps = 27/246 (10%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIE 58
           +   A R     RE       I + +G G  G V    L    +   PVA+K +     E
Sbjct: 34  EPGRAGRSF--TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFT 117
           + +       E  I     HPNI+RL G         ++ EY   G L   LR H  +FT
Sbjct: 92  RQRRD--FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
             Q    +  +   + Y  +   +HRD+   N+L+D     K+ DFG S      R    
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS------RVLED 203

Query: 178 GTLDYL------------APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                             APE +  +    A D W+ G++ +E   YG  P+   + +D 
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263

Query: 225 FRRIMK 230
              + +
Sbjct: 264 ISSVEE 269

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  103 bits (260), Expect = 3e-26
 Identities = 55/245 (22%), Positives = 99/245 (40%), Gaps = 39/245 (15%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E + +   + R LG+G FG VY      V + E +  VA+K + +    + +I+     E
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNE 78

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
             +       +++RL G     +   +I+E   RG+L   LR  R            SL+
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 130 NAL----------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
             +          AY + N  +HRD+   N ++  +  +KIGDFG +      R      
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYET- 191

Query: 180 LDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTF 225
            DY             ++PE +++       D W+ G++ +E       P++  S +   
Sbjct: 192 -DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250

Query: 226 RRIMK 230
           R +M+
Sbjct: 251 RFVME 255

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  103 bits (258), Expect = 4e-26
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 17/230 (7%)

Query: 14  REWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
            E         R +GKG FG VY    + + +++   A+K +    I + +      RE 
Sbjct: 18  HERV--VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SR-ITEMQQVEAFLREG 73

Query: 71  EIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASL 128
            +   L HPN+L L G     +    ++L Y   G+L + +R  +R  T +   ++   +
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSR---SKRHTMCGTL--D 181
              + Y  E   +HRD+   N +LD    +K+ DFG +  +  R   S +      L   
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           + A E ++        D W+ G+L +E    GAPP+      D    + +
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  104 bits (262), Expect = 4e-26
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 17/223 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +EI   +GKG FG+V    +   +  VA+KII  +  + +   +Q + E+ +   +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAF--LNQAQIEVRLLELMNKHD 111

Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNAL 132
                 I+ L   F     + L+ E      LY  LR       +      +   +  AL
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 133 AYCHEN--HVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
            +       +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE++
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL 230

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV 231
               +D A+D W+LG +  E   G P F   ++ D   +I++V
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  102 bits (256), Expect = 5e-26
 Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 29/232 (12%)

Query: 15  EWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W +   +    + +G G+FG V+L     +K  VA+K I +E       +     E E+
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI-REG---AMSEEDFIEEAEV 56

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
              L HP +++LYG   +   I L+ E+   G L   LR  R  F  +        +   
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSK---RHTMCGT 179
           +AY  E  VIHRD+   N L+     +K+ DFG +           + +K   +      
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---- 172

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               +PE+     +    D W+ G+L +E F  G  P+E  S  +    I  
Sbjct: 173 ----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (260), Expect = 8e-26
 Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 15/240 (6%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIE 58
           D      E    +E    +  I + +G G+FG V    L    + +  VA+K +     E
Sbjct: 30  DPTQTVHEF--AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFT 117
           K +       E  I     HPNI+RL G     + + ++ EY   G L   LRKH  +FT
Sbjct: 88  KQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKR 173
             Q    +  + + + Y  +   +HRD+   N+L++     K+ DFG          +  
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205

Query: 174 HTMCGTLDYL--APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
            T  G +     +PE +  ++   A D W+ GI+ +E   YG  P+   S +D  + + +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  101 bits (255), Expect = 9e-26
 Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 13/225 (5%)

Query: 15  EWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W +   D  +   LG G++G VY     +    VA+K + KE         +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED---TMEVEEFLKEAAV 62

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+  R   +          +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDY--LAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S  +   +              APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

Query: 187 MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
            +   +     D W  G+L +E   YG  P+        +  + K
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (256), Expect = 1e-25
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 17/218 (7%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              +  +  +    LGKG FG V L         +   VA+K +     ++   Q   +R
Sbjct: 17  PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQR 73

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYI 125
           E++I  +L    I++  G  +    + + L++EY   G L   L++HR R    +   Y 
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDY- 182
           + +   + Y      +HRD+   N+L++ E  +KI DFG +  +      + +       
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 183 ---LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
               APE + +       D W+ G++ YE F Y     
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  101 bits (253), Expect = 2e-25
 Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 27/243 (11%)

Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M    A +++  +  W+L  ++ ++ + +GKG+FG V         + VA+K I K    
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI-KNDAT 57

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR-- 115
                     E  + + LRH N+++L G    +   ++++ EY  +G L   LR   R  
Sbjct: 58  A----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                   +   +  A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173

Query: 176 -------MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRR 227
                          APE +  K+     D W+ GIL +E + +G  P+     KD   R
Sbjct: 174 GKLPVKWT-------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226

Query: 228 IMK 230
           + K
Sbjct: 227 VEK 229

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  101 bits (253), Expect = 2e-25
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 29/234 (12%)

Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
              W +  +D    + LG G+FG V   +    ++ VA+K+I KE       + +   E 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEG---SMSEDEFIEEA 70

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLT 129
           ++  +L H  +++LYG       IF+I EY   G L   LR+ R RF  QQ       + 
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL------ 183
            A+ Y      +HRD+   N L++ +G +K+ DFG    SR          +Y       
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG---LSRYVLDD-----EYTSSVGSK 182

Query: 184 ------APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                  PE++   +     D W  G+L +E +  G  P+E  +  +T   I +
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (253), Expect = 2e-25
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 30/239 (12%)

Query: 11  NRKREWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           +  R++ +Q    E+GR +G+G+FG V+    +        VA+K       +  + +  
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-- 62

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATY 124
             +E        HP+I++L G    +  +++I+E    GEL   L+  +          Y
Sbjct: 63  FLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY-- 182
              L+ ALAY      +HRDI   N+L+     +K+GDFG    SR    +      Y  
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDS-----TYYK 173

Query: 183 ----------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                     +APE +  +    A D W  G+  +E  ++G  PF+     D   RI  
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (253), Expect = 2e-25
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 29/229 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
             ++  +  +  + LGKG FG V +      +  +   VA+K + +   E++       R
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH--LRDFER 60

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYI 125
           E+EI  SL+H NI++  G  +      + LI+EY   G L   L+KH+ R    +   Y 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY--- 182
           + +   + Y      IHRD+   N+L+++E R+KIGDFG +      +        +   
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KVLPQDKEFFKVK 174

Query: 183 ---------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQ 221
                     APE +   +   A D W+ G++ YE F Y        ++
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  101 bits (253), Expect = 2e-25
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 28/229 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              +  +  +  R LG+G FG+V L         +   VA+K +  E    +     L++
Sbjct: 15  PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKK 72

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYI 125
           E+EI  +L H NI++  G         I LI+E+   G L   L K++ +   +Q   Y 
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY--- 182
             +   + Y      +HRD+   N+L++ E ++KIGDFG +      +        Y   
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT------KAIETDKEYYTVK 186

Query: 183 ---------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQ 221
                     APE +   +   A D W+ G+  +E   Y        + 
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  101 bits (253), Expect = 3e-25
 Identities = 52/229 (22%), Positives = 102/229 (44%), Gaps = 14/229 (6%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRR 68
            R +   +    + LG G FG V+    + E ES K PV +K+I +++  + +    +  
Sbjct: 7   ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGR-QSFQAVTD 64

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIAS 127
            M    SL H +I+RL G       + L+ +Y   G L   +R+HR     Q    +   
Sbjct: 65  HMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGT---LDY 182
           +   + Y  E+ ++HR++   N+LL    ++++ DFG +  +    K+         + +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
           +A E +   ++ +  D W+ G+  +E   +GA P+      +    + K
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  100 bits (251), Expect = 4e-25
 Identities = 64/254 (25%), Positives = 104/254 (40%), Gaps = 42/254 (16%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQH 64
               +    +D  + R LG+G FG+V+L     +   + K  VA+K + K+     +   
Sbjct: 6   GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD- 63

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
             +RE E+ ++L+H +I++ YG   D + + ++ EY   G+L + LR H           
Sbjct: 64  -FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122

Query: 125 IASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-- 166
                  L                 Y    H +HRD+   N L+     +KIGDFG S  
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182

Query: 167 VQS----RSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
           V S    R   HTM      L      PE +  ++     D W+ G++ +E F YG  P+
Sbjct: 183 VYSTDYYRVGGHTM------LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

Query: 217 EAESQKDTFRRIMK 230
              S  +    I +
Sbjct: 237 FQLSNTEVIECITQ 250

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (252), Expect = 5e-25
 Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 26/246 (10%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQI 57
           D   A  +     E         + +G G+FG VY         + + PVA+K +     
Sbjct: 29  DPNQAVLKF--TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT 86

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RF 116
           EK ++      E  I     H NI+RL G     + + +I EY   G L + LR+    F
Sbjct: 87  EKQRVD--FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF 144

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
           +  Q    +  +   + Y    + +HRD+   N+L++     K+ DFG S          
Sbjct: 145 SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA- 203

Query: 177 CGTLDY-----------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                Y            APE +  ++   A D W+ GI+ +E   YG  P+   S  + 
Sbjct: 204 ----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259

Query: 225 FRRIMK 230
            + I  
Sbjct: 260 MKAIND 265

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  102 bits (255), Expect = 5e-25
 Identities = 70/349 (20%), Positives = 131/349 (37%), Gaps = 102/349 (29%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEI 72
             ++ I   +G+G +G VYL  +  ++  VA+K +   F++ I         R  RE+ I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI------DCKRILREITI 78

Query: 73  QSSLRHPNILRLYGWF-----HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            + L+   I+RLY           + ++++LE A   +L +  +     TE+   T + +
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYN 137

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQSRSKR 173
           L     + HE+ +IHRD+KP N LL+ +  +K+ DFG                ++   + 
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 174 HTMCGTLD-----------YLAPE-MVENKEHDYAVDNWTLG-ILCYEFLYGAPPFEAES 220
                 L            Y APE ++  + +  ++D W+ G I   E L        + 
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNMLQSHINDP 256

Query: 221 QK----------------------------DTFRRIMKV-------DLSF---PSA---- 238
                                         D    I  +       DL     P      
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316

Query: 239 ---------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                          PSIS +  +L+  +L  + +KR+++ + ++HP++
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (251), Expect = 6e-25
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 29/241 (12%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQ 56
                +  ED    ++  +  +  + LGKG FG V +      +  +   VA+K + +  
Sbjct: 23  QGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHS 81

Query: 57  IEKYKIQHQLRREMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR 114
            E++       RE+EI  SL+H NI++  G  +      + LI+EY   G L   L+KH+
Sbjct: 82  TEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK 139

Query: 115 -RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR 173
            R    +   Y + +   + Y      IHRD+   N+L+++E R+KIGDFG +      +
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------K 193

Query: 174 HTMCGTLDY------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                   Y             APE +   +   A D W+ G++ YE F Y        +
Sbjct: 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253

Query: 221 Q 221
           +
Sbjct: 254 E 254

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  102 bits (255), Expect = 8e-25
 Identities = 59/236 (25%), Positives = 109/236 (46%), Gaps = 13/236 (5%)

Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M+   A +++  +  W+L  ++ ++ + +GKG+FG V         + VA+K I K    
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI-KNDAT 229

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR-- 115
                     E  + + LRH N+++L G    +   ++++ EY  +G L   LR   R  
Sbjct: 230 ----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 285

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                   +   +  A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
               + + APE +  K+     D W+ GIL +E + +G  P+     KD   R+ K
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  100 bits (252), Expect = 8e-25
 Identities = 62/322 (19%), Positives = 117/322 (36%), Gaps = 75/322 (23%)

Query: 21  FEIGRPLGKGKFGRVYLVRE-VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +EI   LG+G FG+V    +    K  VALKII    + KY  +   R E+ +   ++  
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKY--REAARLEINVLKKIKEK 76

Query: 80  ------NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNA 131
                   + +  WF+    + +  E   +   +  L+++  + +           L +A
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 132 LAYCHENHVIHRDIKPENLLLDHEG-------------------RLKIGDFGWSVQSRSK 172
           L + HEN + H D+KPEN+L  +                      +++ DFG +      
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV- 231
             T+  T  Y  PE++         D W++G + +E+  G   F+    ++    + K+ 
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255

Query: 232 --------------------DLSFPSAPSISAEAKH---------------------LIS 250
                                L +    S     K                      L+ 
Sbjct: 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315

Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
           R+L  D ++R++L + + HP+ 
Sbjct: 316 RMLEFDPAQRITLAEALLHPFF 337

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 48/238 (20%), Positives = 80/238 (33%), Gaps = 40/238 (16%)

Query: 20  DFEIGRPLGKGKFGRVYL-------VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           D      LG+G F +++              +  V LK++ K                 +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY---SESFFEAASM 65

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
            S L H +++  YG     +   L+ E+   G L   L+K++              L  A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRL--------KIGDFGWS--VQSRSKRHTMCGTLD 181
           + +  EN +IH ++  +N+LL  E           K+ D G S  V  +          D
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----------D 175

Query: 182 YL-------APE-MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
            L        PE +   K  + A D W+ G   +E    G  P  A   +   +    
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.7 bits (249), Expect = 1e-24
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 28/228 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              +  +  +  R LG+G FG+V L         +   VA+K +  +   +++     ++
Sbjct: 25  PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG--WKQ 82

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           E++I  +L H +I++  G         + L++EY   G L   L +H      Q   +  
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQ 141

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY---- 182
            +   +AY H  H IHRD+   N+LLD++  +KIGDFG +      +    G   Y    
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA------KAVPEGHEYYRVRE 195

Query: 183 --------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQ 221
                    APE ++  +  YA D W+ G+  YE   +        ++
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  100 bits (250), Expect = 1e-24
 Identities = 59/322 (18%), Positives = 115/322 (35%), Gaps = 75/322 (23%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH-PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +EI   LG+G FG+V    + ++    VA+KI+  + +++Y      R E+++   L   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRY--CEAARSEIQVLEHLNTT 71

Query: 80  ------NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNA 131
                   +++  WF     I ++ E       Y  ++++    F           +  +
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 132 LAYCHENHVIHRDIKPENLLLDHEG-------------------RLKIGDFGWSVQSRSK 172
           + + H N + H D+KPEN+L                         +K+ DFG +      
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV- 231
             T+  T  Y APE++         D W++G +  E+  G   F     K+    + ++ 
Sbjct: 191 HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250

Query: 232 --------------------DLSFPSAPSIS---------------------AEAKHLIS 250
                                L +    S                            LI 
Sbjct: 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310

Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
           ++L  D +KR++L++ ++HP+ 
Sbjct: 311 KMLEYDPAKRITLREALKHPFF 332

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 98.4 bits (246), Expect = 2e-24
 Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 30/235 (12%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           ++ +   D  + R LG+G FG VY          K  VA+K   K+     K +     E
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FMSE 63

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASL 128
             I  +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +
Sbjct: 64  AVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY------ 182
             A+AY    + +HRDI   N+L+     +K+GDFG    SR          DY      
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG---LSRYIEDE-----DYYKASVT 174

Query: 183 ------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                 ++PE +  +    A D W   +  +E   +G  PF     KD    + K
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 99.3 bits (248), Expect = 2e-24
 Identities = 64/255 (25%), Positives = 106/255 (41%), Gaps = 51/255 (20%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLR 67
                 +D  +   LG+G FG+V+L     +   + K  VA+K + KE  E  +     +
Sbjct: 35  VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD--FQ 91

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA------ 121
           RE E+ + L+H +I+R +G   +   + ++ EY   G+L R LR H    +  A      
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151

Query: 122 ------------ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS 169
                       A+ +A+    + Y    H +HRD+   N L+     +KIGDFG    S
Sbjct: 152 PGPLGLGQLLAVASQVAA---GMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG---MS 205

Query: 170 RSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
           R    T     DY             + PE +  ++     D W+ G++ +E F YG  P
Sbjct: 206 RDIYST-----DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

Query: 216 FEAESQKDTFRRIMK 230
           +   S  +    I +
Sbjct: 261 WYQLSNTEAIDCITQ 275

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  100 bits (250), Expect = 2e-24
 Identities = 77/340 (22%), Positives = 128/340 (37%), Gaps = 88/340 (25%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEI 72
           L+ +E+ + LGKG +G V+   +  +   VA+K I   F+            R  RE+ I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST------DAQRTFREIMI 61

Query: 73  QSSLR-HPNILRLYGWFH--DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
            + L  H NI+ L       +D  ++L+ +Y    +L+  +R             +  L 
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR-ANILEPVHKQYVVYQLI 119

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQSRSKRHT 175
             + Y H   ++HRD+KP N+LL+ E  +K+ DFG                +        
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 176 MCGTLDYL----------APE-MVENKEHDYAVDNWTLG-ILCYEFLYGAPPFEAESQKD 223
                  L          APE ++ + ++   +D W+LG IL  E L G P F   S  +
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMN 238

Query: 224 TFRRIMKV-------DL-------------SFPSAPSI---------------------- 241
              RI+ V       D+             S      I                      
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 242 ---SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
              + EA  L+ +LL  + +KR+S    ++HP++    NP
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 99.7 bits (249), Expect = 2e-24
 Identities = 67/328 (20%), Positives = 121/328 (36%), Gaps = 81/328 (24%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           F + R +G G FGRV L + +++K   A+K++    I+KY      + E +I   +++  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKY--TRSAKIEADILKKIQNDD 92

Query: 79  ---PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALA 133
               NI++ +G F   + + LI E      LY  + ++    F  +    Y   +  AL 
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 134 YCHENHVIHRDIKPENLLLDHEG-------------------------RLKIGDFGWSVQ 168
           Y  +  + H D+KPEN+LLD                             +K+ DFG +  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211

Query: 169 SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRI 228
                 ++  T  Y APE++ N   D + D W+ G +  E   G+  F      +    +
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271

Query: 229 MKV--------------------------DLSFPSAPSISAEAKH--------------- 247
             +                           L++P   S     KH               
Sbjct: 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331

Query: 248 ---LISRLLVKDSSKRLSLQKIMEHPWI 272
               +  +L  D + R S  ++++H ++
Sbjct: 332 FCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 97.7 bits (244), Expect = 5e-24
 Identities = 58/254 (22%), Positives = 104/254 (40%), Gaps = 45/254 (17%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQL 66
           + +E SL        LG+ +FG+VY          E    VA+K + K++ E   ++ + 
Sbjct: 2   KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEG-PLREEF 59

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           R E  +++ L+HPN++ L G    D+ + +I  Y   G+L+  L      ++  +     
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 127 SLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---- 166
           ++ +AL                 Y   +HV+H+D+   N+L+  +  +KI D G      
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 167 ------VQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                 +   S    R          APE +   +     D W+ G++ +E F YG  P+
Sbjct: 180 AADYYKLLGNSLLPIRWM--------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

Query: 217 EAESQKDTFRRIMK 230
              S +D    I  
Sbjct: 232 CGYSNQDVVEMIRN 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 98.6 bits (246), Expect = 6e-24
 Identities = 66/242 (27%), Positives = 93/242 (38%), Gaps = 29/242 (11%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            +E   ++  + R LG G FG VY      +    S   VA+K + +   E+ ++     
Sbjct: 65  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FL 122

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-------- 119
            E  I S   H NI+R  G        F++LE    G+L   LR+ R    Q        
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 120 --QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRH 174
               A  IA       Y  ENH IHRDI   N LL   G     KIGDFG +       +
Sbjct: 183 LLHVARDIAC---GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239

Query: 175 TMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
              G    L      PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299

Query: 229 MK 230
             
Sbjct: 300 TS 301

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.8 bits (244), Expect = 6e-24
 Identities = 65/242 (26%), Positives = 93/242 (38%), Gaps = 29/242 (11%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            +E   ++  + R LG G FG VY      +    S   VA+K + +   E+ ++     
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FL 81

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-------- 119
            E  I S   H NI+R  G        F+++E    G+L   LR+ R    Q        
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 120 --QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRH 174
               A  IA       Y  ENH IHRDI   N LL   G     KIGDFG +       +
Sbjct: 142 LLHVARDIAC---GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198

Query: 175 TMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
              G    L      PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

Query: 229 MK 230
             
Sbjct: 259 TS 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 95.8 bits (239), Expect = 2e-23
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 28/234 (11%)

Query: 14  REWSLQ--DFEIGR-PLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++  L+  +  I    LG G FG V   + R  + +  VA+K++ +   +      ++ R
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMR 59

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIAS 127
           E +I   L +P I+RL G     E + L++E A  G L++ L   R        A  +  
Sbjct: 60  EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY----- 182
           ++  + Y  E + +HRD+   N+LL +    KI DFG S      +        Y     
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS------KALGADDSYYTARSA 172

Query: 183 -------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRI 228
                   APE +  ++     D W+ G+  +E   YG  P++     +    I
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 51/241 (21%), Positives = 95/241 (39%), Gaps = 23/241 (9%)

Query: 3   TKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
             +  ++   K  W +  +  ++ + LG G+FG V++         VA+K +        
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTM----KPGS 224

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTE 118
                   E  +  +L+H  +++L+      E I++I E+  +G L   L+         
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL 283

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG 178
            +   + A +   +A+  + + IHRD++  N+L+      KI DFG +       +T   
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343

Query: 179 --------TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIM 229
                   T    APE +         D W+ GIL  E   YG  P+   S  +  R + 
Sbjct: 344 GAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

Query: 230 K 230
           +
Sbjct: 400 R 400

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.9 bits (241), Expect = 8e-23
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 21/246 (8%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRP--------LGKGKFGRVY--LVREVESKHPVALK 50
           MDT   E   +   E   +   + R         LG G FG V   + R  + +  VA+K
Sbjct: 310 MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK 369

Query: 51  IIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL 110
           ++ +   +      ++ RE +I   L +P I+RL G     E + L++E A  G L++ L
Sbjct: 370 VLKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL 426

Query: 111 RKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--V 167
              R        A  +  ++  + Y  E + +HR++   N+LL +    KI DFG S  +
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486

Query: 168 QSRSKRHTMCGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQK 222
            +    +T        L + APE +  ++     D W+ G+  +E   YG  P++     
Sbjct: 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546

Query: 223 DTFRRI 228
           +    I
Sbjct: 547 EVMAFI 552

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 93.8 bits (234), Expect = 9e-23
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 31/233 (13%)

Query: 15  EWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           EW +  +  ++   LG G+FG V++         VA+K +     +          E  +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSL----KQGSMSPDAFLAEANL 61

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              L+H  ++RLY      E I++I EY   G L   L+       T  +     A +  
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL------- 183
            +A+  E + IHRD++  N+L+      KI DFG    +R          +Y        
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL---ARLIEDN-----EYTAREGAKF 172

Query: 184 -----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRRIMK 230
                APE +         D W+ GIL  E   +G  P+   +  +  + + +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 62/233 (26%), Positives = 95/233 (40%), Gaps = 54/233 (23%)

Query: 22  EIGRPLGKGKFGRVYL-----VREVESKHPVALKII-----FKEQIEKYKIQHQLRREME 71
           + G+ LG G FG+V       + + ++   VA+K++       E+         L  E++
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-------LMSELK 101

Query: 72  IQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT- 129
           I S L +H NI+ L G       + +I EY   G+L   LR+  R  E   A  IA+ T 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 130 -------------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
                          +A+    + IHRD+   N+LL +    KIGDFG +      R  M
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RDIM 215

Query: 177 CGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
                              +APE + +  +    D W+ GIL +E F  G  P
Sbjct: 216 ND--SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 59/264 (22%), Positives = 98/264 (37%), Gaps = 53/264 (20%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQH 64
                E+   + E  R +G+G FGRV+      +   E    VA+K++ KE+     +Q 
Sbjct: 38  KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASA-DMQA 95

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
             +RE  + +   +PNI++L G     + + L+ EY   G+L   LR     T    +  
Sbjct: 96  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155

Query: 125 IASLTNAL------------------------AYCHENHVIHRDIKPENLLLDHEGRLKI 160
             S    +                        AY  E   +HRD+   N L+     +KI
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 215

Query: 161 GDFGWSVQSRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCY 207
            DFG    SR+         DY             + PE +    +    D W  G++ +
Sbjct: 216 ADFGL---SRNIYSA-----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267

Query: 208 E-FLYGAPPFEAESQKDTFRRIMK 230
           E F YG  P+   + ++    +  
Sbjct: 268 EIFSYGLQPYYGMAHEEVIYYVRD 291

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 92.3 bits (230), Expect = 6e-22
 Identities = 57/259 (22%), Positives = 102/259 (39%), Gaps = 53/259 (20%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+  ++  +G+ LG+G+FG+V       ++       VA+K++ KE          L  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASP-SELRDLLSE 76

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
             +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+       +  +  +
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 130 NAL------------------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW 165
           ++L                         Y  E  ++HRD+   N+L+    ++KI DFG 
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196

Query: 166 SVQSRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLY 211
           S      R       D              +A E + +  +    D W+ G+L +E    
Sbjct: 197 S------RDVYEE--DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248

Query: 212 GAPPFEAESQKDTFRRIMK 230
           G  P+     +  F  +  
Sbjct: 249 GGNPYPGIPPERLFNLLKT 267

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 92.0 bits (229), Expect = 8e-22
 Identities = 59/255 (23%), Positives = 97/255 (38%), Gaps = 32/255 (12%)

Query: 3   TKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIE 58
               +   +      L   D +    +G+G FG+V    +++   +   A+K + KE   
Sbjct: 7   HHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYAS 65

Query: 59  KYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT 117
           K         E+E+   L  HPNI+ L G       ++L +EYA  G L   LRK R   
Sbjct: 66  K-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 118 EQQAATYIASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIG 161
              A     S  + L                 Y  +   IHRD+   N+L+      KI 
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184

Query: 162 DFGWSVQSRSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
           DFG    SR +   +  T+  L     A E +    +    D W+ G+L +E    G  P
Sbjct: 185 DFGL---SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

Query: 216 FEAESQKDTFRRIMK 230
           +   +  + + ++ +
Sbjct: 242 YCGMTCAELYEKLPQ 256

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 91.5 bits (228), Expect = 1e-21
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 28/185 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ---HQLRREMEIQSSL 76
           +F     LG+G FG+VY  R +     VA+K     ++++ + Q    Q + E+E+ S  
Sbjct: 31  NFSNKNILGRGGFGKVYKGR-LADGTLVAVK-----RLKEERTQGGELQFQTEVEMISMA 84

Query: 77  RHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRF-------TEQQAATYIASL 128
            H N+LRL G+     ER+ L+  Y   G +   LR+             Q+ A   A  
Sbjct: 85  VHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR- 142

Query: 129 TNALAYCHEN---HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRH---TMCGTLD 181
              LAY H++    +IHRD+K  N+LLD E    +GDFG + +      H    + GT+ 
Sbjct: 143 --GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200

Query: 182 YLAPE 186
           ++APE
Sbjct: 201 HIAPE 205

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.8 bits (226), Expect = 2e-21
 Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 48/239 (20%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+       G+ LG G FG+V       + + ++   VA+K++ K        +  L  E
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPS-AHLTEREALMSE 76

Query: 70  MEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           +++ S L  H NI+ L G         +I EY   G+L   LR+ R        +     
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 129 TNAL------------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
            + L                  A+    + IHRD+   N+LL H    KI DFG    +R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL---AR 193

Query: 171 SKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
             ++                     +APE + N  + +  D W+ GI  +E F  G+ P
Sbjct: 194 DIKND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 58/259 (22%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVY-------LVREVESKHPVALKII-----FKEQIEKYKI 62
           E+      +G+PLG+G FG+V           + +    VA+K++      K+  +    
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---- 86

Query: 63  QHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
              L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    + +
Sbjct: 87  ---LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143

Query: 122 ATYIASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW 165
                     +                 Y      IHRD+   N+L+     +KI DFG 
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203

Query: 166 SVQSRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLY 211
              +R   +      DY             +APE + ++ + +  D W+ G+L +E F  
Sbjct: 204 ---ARDINNI-----DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255

Query: 212 GAPPFEAESQKDTFRRIMK 230
           G  P+     ++ F+ + +
Sbjct: 256 GGSPYPGIPVEELFKLLKE 274

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 90.0 bits (224), Expect = 3e-21
 Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 43/232 (18%)

Query: 20  DFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             ++G+PLG+G FG+V       + +  +   VA+K++ KE          L  E++I  
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATH-SEHRALMSELKILI 85

Query: 75  SL-RHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            +  H N++ L G        + +I+E+   G L   LR  R               + L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 133 ----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----R 170
                            +      IHRD+   N+LL  +  +KI DFG +  +       
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 171 SKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
            K          L     APE + ++ +    D W+ G+L +E F  GA P+
Sbjct: 206 RKGDAR------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.1 bits (224), Expect = 6e-21
 Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 44/260 (16%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVY-------LVREVESKHPVALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V           + +    VA+K++ K+   +
Sbjct: 69  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATE 127

Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE 118
            K    L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 128 -KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186

Query: 119 QQAATYIASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
           + +          +                 Y      IHRD+   N+L+     +KI D
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 246

Query: 163 FGWS--VQS----RSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FL 210
           FG +  + +    +   +        L     APE + ++ + +  D W+ G+L +E F 
Sbjct: 247 FGLARDINNIDYYKKTTNGR------LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

Query: 211 YGAPPFEAESQKDTFRRIMK 230
            G  P+     ++ F+ + +
Sbjct: 301 LGGSPYPGIPVEELFKLLKE 320

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 89.2 bits (222), Expect = 8e-21
 Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 19/180 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            +F+    +G G FG+VY    +     VALK    E  +  +   +   E+E  S  RH
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRH 94

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA------L 132
           P+++ L G+  +   + LI +Y   G L R L  +       + ++   L         L
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGL 152

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------MCGTLDYLAPE 186
            Y H   +IHRD+K  N+LLD     KI DFG S +      T        GTL Y+ PE
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK-GTLGYIDPE 211

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 88.4 bits (220), Expect = 1e-20
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 27/177 (15%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE--MEIQ--SSLRHPNIL 82
           +G+G FG VY  +   +   VA+K +            +L+++   EI+  +  +H N++
Sbjct: 39  MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDIT---TEELKQQFDQEIKVMAKCQHENLV 93

Query: 83  RLYGW-FHDDERIFLILEYAHRGELYRELRKHRRF------TEQQAATYIASLTNALAYC 135
            L G+    D+   L+  Y   G L   L               + A   A   N + + 
Sbjct: 94  ELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA---NGINFL 149

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT----MCGTLDYLAPE 186
           HENH IHRDIK  N+LLD     KI DFG +   +  ++       + GT  Y+APE
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV-GTTAYMAPE 205

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 57/237 (24%), Positives = 87/237 (36%), Gaps = 53/237 (22%)

Query: 22  EIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           E G+ LG G FG+V       + +      VA+K++ KE+ +    +  L  E+++ + L
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADS-SEREALMSELKMMTQL 105

Query: 77  -RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL--- 132
             H NI+ L G       I+LI EY   G+L   LR  R    +    Y           
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 133 --------------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
                                +      +HRD+   N+L+ H   +KI DFG +      
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219

Query: 173 RHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
           R  M                   +APE +    +    D W+ GIL +E F  G  P
Sbjct: 220 RDIMSD--SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 87.4 bits (217), Expect = 7e-20
 Identities = 58/252 (23%), Positives = 102/252 (40%), Gaps = 58/252 (23%)

Query: 22  EIGRPLGKGKFGRVY-------LVREVESKHPVALKII-----FKEQIEKYKIQHQLRRE 69
            +G+PLG+G FG+V           +      VA+K++      K+  +       L  E
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-------LISE 124

Query: 70  MEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           ME+   + +H NI+ L G    D  +++I+EYA +G L   L+  R    + +     + 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 129 TNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
              L                 Y      IHRD+   N+L+  +  +KI DFG +      
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------ 238

Query: 173 RHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEA 218
           R       DY             +APE + ++ + +  D W+ G+L +E F  G  P+  
Sbjct: 239 RDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 219 ESQKDTFRRIMK 230
              ++ F+ + +
Sbjct: 297 VPVEELFKLLKE 308

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 52/269 (19%), Positives = 92/269 (34%), Gaps = 67/269 (24%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           + + R LG G F  V+L  +++ K  VA+K++  +  E Y        E+ +  S+R   
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHY--TETALDEIRLLKSVRNSD 94

Query: 78  --HPN---ILRLYGWFH----DDERIFLILEYA-HRGELYRELRKHRRFTEQQAATYIAS 127
              PN   +++L   F     +   I ++ E   H    +     ++          I  
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154

Query: 128 LTNALAYCH-ENHVIHRDIKPENLLL---------------------------------- 152
           +   L Y H +  +IH DIKPEN+LL                                  
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 153 ---------------DHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
                            + ++KI D G +            T  Y + E++    ++   
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFR 226
           D W+   + +E   G   FE  S ++  R
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTR 303

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 80.5 bits (199), Expect = 7e-18
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 28/236 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLRH- 78
           + +GR +G G FG +YL  ++ +   VA+K+      E  K +H QL  E +I   ++  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQGG 64

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I  +     + +   +++E    G    +L     R+F+ +        + + + Y H
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 137 ENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRH-------TMCGTLDYL 183
             + IHRD+KP+N L+        + I DFG + +   +R+ +H        + GT  Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPP---FEAESQKDTFRRIMKVDLSFP 236
           +       E     D  +LG +   F  G+ P    +A +++  + RI +  +S P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 54/236 (22%), Positives = 102/236 (43%), Gaps = 28/236 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLR-H 78
           F +GR +G G FG +YL   +++   VA+K+      E  K +H QL  E +I   L+  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYESKIYRILQGG 62

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I  +  +  + +   L+++    G    +L     R+ + +        + N + + H
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 137 ENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRH-------TMCGTLDYL 183
               +HRDIKP+N L+       ++ I DFG + +   + + +H        + GT  Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPP---FEAESQKDTFRRIMKVDLSFP 236
           +       E     D  +LG +   FL G+ P    +A ++K  + +I +  ++  
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 2e-17
 Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 30/238 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLRH- 78
           +++GR +G+G FG ++    + +   VA+K       E  +    QLR E      L   
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLAGC 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I  +Y +  +     L+++    G    +L     R+F+ +  A     +   +   H
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 137 ENHVIHRDIKPENLLL-----DHEGRLKIGDFGWSVQ---SRSKRH-------TMCGTLD 181
           E  +++RDIKP+N L+      +   + + DFG         +K+H        + GT  
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP---FEAESQKDTFRRIMKVDLSFP 236
           Y++      +E     D   LG +   FL G+ P    +A + K  + RI +   S P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 78.2 bits (193), Expect = 7e-17
 Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 30/238 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLRH- 78
           F +G+ +G G FG + L + + +   VA+K+      E  K +  QL  E      L   
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL------EPMKSRAPQLHLEYRFYKQLGSG 64

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I ++Y +    +   ++LE    G    +L     R F+ +        L + + Y H
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 137 ENHVIHRDIKPENLLLDHEGRLK-----IGDFGWSVQ---SRSKRH-------TMCGTLD 181
             ++I+RD+KPEN L+   G        I DF  + +     +K+H       ++ GT  
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP---FEAESQKDTFRRIMKVDLSFP 236
           Y++      KE     D   LG +   FL G+ P    +A++ K+ +++I     + P
Sbjct: 183 YMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.1 bits (172), Expect = 5e-14
 Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 26/165 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-------- 72
           + +G+ +G G FG +YL          A  ++   ++E  +    L  E++         
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV---KVEYQENG-PLFSELKFYQRVAKKD 94

Query: 73  -------QSSLRHPNILRLYGW----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
                  +  L +  I   YG     F      F+++E     +L +   ++  F +   
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTV 153

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFG 164
                 + + L Y HEN  +H DIK  NLLL   +  ++ + D+G
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG 198

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.0 bits (165), Expect = 3e-13
 Identities = 44/261 (16%), Positives = 81/261 (31%), Gaps = 60/261 (22%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-----FKEQIEKYKIQHQLRREME 71
             +  +    +G+G FG V+         PVA+KII             K   ++  E+ 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 72  IQSSL---------RHPNILRLYGWFH------------------------------DDE 92
           I   L         R    + L                                    D+
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 93  RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH-VIHRDIKPENLL 151
           ++F++LE+   G    ++R  +  +   A + +  LT +LA    +    HRD+   N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 152 LDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY 211
           L      K+         +S     CG         V   ++  +       ++  +   
Sbjct: 195 LKKTSLKKLHYTL---NGKSSTIPSCGL-------QVSIIDYTLSRLERDGIVVFCDVSM 244

Query: 212 GAPPFEAES--QKDTFRRIMK 230
               F  +   Q D +R + K
Sbjct: 245 DEDLFTGDGDYQFDIYRLMKK 265

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.5 bits (165), Expect = 4e-13
 Identities = 28/164 (17%), Positives = 64/164 (39%), Gaps = 21/164 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH--------PVALKI------IFKEQI--EKYKIQH 64
           +++     +   G +Y      +            +LK+      +F EQ   ++     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 65  QLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAA 122
           Q+ +  ++ S      I    G+  H D+  FL+L    R  +   ++      +E+   
Sbjct: 104 QVNKWKKLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLL--DHEGRLKIGDFG 164
                L +AL + HEN  +H ++  EN+ +  + + ++ +  +G
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.9 bits (161), Expect = 1e-12
 Identities = 36/198 (18%), Positives = 75/198 (37%), Gaps = 43/198 (21%)

Query: 21  FEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +++G P+G+G FG +YL        V S  P  +K+   +          L  E++    
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFYQR 89

Query: 76  LRHPNILRLYGWFHDDE-----RIFLILEYAHRGELYREL--------------RKHRRF 116
              P  ++ +      +     + +    +   G+ YR +                 +RF
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQ---SRS 171
           + +        + + L Y HE+  +H DIK  NLLL+  +  ++ + D+G + +      
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 172 KRH-------TMCGTLDY 182
            +           GT+++
Sbjct: 210 HKAYAADPKRCHDGTIEF 227

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 4e-09
 Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 9/108 (8%)

Query: 20  DFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             ++G+PLG+G FG+V       + +  +   VA+K++ KE     + +  L  E++I  
Sbjct: 23  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHR-ALMSELKILI 80

Query: 75  SL-RHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
            +  H N++ L G        + +I+E+   G L   LR  R      
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 17/188 (9%)

Query: 36  YLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRHPNILRLYGWFHDDER 93
           YL  +     P   K     Q + Y   I   L+R ++  +S +          F +++ 
Sbjct: 117 YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS----SGFVEEKS 172

Query: 94  IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD 153
           +  + E     +LY++       T +    Y   +   + +      IHRD+   N+LL 
Sbjct: 173 LSDVEEEEAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 227

Query: 154 HEGRLKIGDFGWS---VQSRSKRHTMCGTLDY--LAPEMVENKEHDYAVDNWTLGILCYE 208
            +  +KI DFG +    +           L    +APE + ++ +    D W+ G+L +E
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287

Query: 209 -FLYGAPP 215
            F  GA P
Sbjct: 288 IFSLGASP 295

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 5e-07
 Identities = 43/265 (16%), Positives = 79/265 (29%), Gaps = 71/265 (26%)

Query: 37  LVREVESKHPVALKII------FKEQIEKYKIQHQLRREMEIQSSLRH--PNILR-LY-- 85
           L REV + +P  L II           + +K  +  +    I+SSL    P   R ++  
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377

Query: 86  -GWFHDDERI----FLIL----EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
              F     I      ++      +    +  +L K     E+Q      S+        
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK-YSLVEKQPKESTISI-------- 428

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
               I+ ++K +   L++E  L               H            +V++      
Sbjct: 429 --PSIYLELKVK---LENEYAL---------------HRS----------IVDHYNIPKT 458

Query: 197 VDNWTLGILC-----YEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
            D+  L         Y  + +     E   +   FR +  +D  F     +  + +H  +
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF-LDFRF-----LEQKIRHDST 512

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKN 275
                 S      Q     P+I  N
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDN 537

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 39.5 bits (92), Expect = 7e-04
 Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 20/159 (12%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKI------IFKEQIEKYKIQHQLRREMEIQSSL 76
           IG+ +G+GK   V+     +      +K        FK+  EK          + I+S+ 
Sbjct: 94  IGKLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 152

Query: 77  R-HPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
                + +L G      +  E   +++E     EL        R   +     +  +   
Sbjct: 153 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKEL-------YRVRVENPDEVLDMILEE 205

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +A  +   ++H D+   N+L+  E  + I DF  SV+  
Sbjct: 206 VAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 243

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	284
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.93
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.86
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.85
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.6
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.98
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.97
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.9
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.67
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.53
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.45
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.43
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.84
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.69
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	95.91
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.89
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	95.83
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.49

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-65  Score=425.81  Aligned_cols=261  Identities=35%  Similarity=0.634  Sum_probs=238.9

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ....+..+|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+++++.++||||+++++++.+++
T Consensus        26 ~~~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           26 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             -CCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            34566788999999999999999999999999999999998766555555678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC--
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~--  170 (284)
                      .+|+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++....  
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999996532  


Q ss_pred             ---CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          171 ---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                         ......+||+.|+|||++.+..++.++||||+||++|+|+||.+||.+.+..++..++......++  +.+++++++
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~d  263 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP--EKFFPKARD  263 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--TTCCHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--cccCHHHHH
Confidence               223456799999999999999999999999999999999999999999999999999998876554  479999999


Q ss_pred             HHHHhcccCCCCCCCHHh------hhcCcccccc
Q 023270          248 LISRLLVKDSSKRLSLQK------IMEHPWIIKN  275 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~------il~~~~~~~~  275 (284)
                      ||++||..||++|||++|      |++||||++-
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            999999999999999998      5899999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-64  Score=414.63  Aligned_cols=256  Identities=34%  Similarity=0.637  Sum_probs=218.0

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .+.+|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+++++.++||||+++++++.+++.+|+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46899999999999999999999999999999999976655555556788999999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--CCc
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRH  174 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~~~  174 (284)
                      ||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||++||+|+||||+|||++.++++||+|||++.....  ...
T Consensus        91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            99999 579999999999999999999999999999999999999999999999999999999999999865432  234


Q ss_pred             cccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          175 TMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ...||+.|+|||++.+..+ +.++||||+||++|+|+||..||.+.+..++...+..+...++  ..+|+++++||.+||
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L  247 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP--KFLSPGAAGLIKRML  247 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--TTSCHHHHHHHHHHS
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHc
Confidence            5679999999999998876 5899999999999999999999999999999998888765554  479999999999999


Q ss_pred             ccCCCCCCCHHhhhcCcccccc
Q 023270          254 VKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +.||++|||++|+++||||+..
T Consensus       248 ~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          248 IVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHTT
T ss_pred             cCChhHCcCHHHHHcCcccccC
Confidence            9999999999999999999854

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5e-64  Score=425.51  Aligned_cols=261  Identities=28%  Similarity=0.523  Sum_probs=229.7

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ...++++|++++.||+|+||+||+|.+..+++.||||++........ ..+.+.+|+++++.++||||+++++++.+++.
T Consensus        19 ~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           19 YFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             BCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            45678899999999999999999999999999999999976554432 35788999999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           94 IFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +|+|||||++|+|.+++...+  .+++..++.++.||+.||.|||++||+|+||||+|||++.+|++||+|||++.....
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            999999999999999997653  578999999999999999999999999999999999999999999999999965543


Q ss_pred             C---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          172 K---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       172 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+++.++..+... +.+..+|+++++|
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~l  256 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHH
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHH
Confidence            2   23456999999999999999999999999999999999999999999999999998887643 3455799999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      |.+||..||++|||++|+|+||||++..
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            9999999999999999999999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.8e-63  Score=420.31  Aligned_cols=256  Identities=28%  Similarity=0.504  Sum_probs=230.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.++||+|+||+||+|.+..+|+.||||++.......   .+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56999999999999999999999999999999996544322   356789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~  175 (284)
                      |||++|+|.+++.. +.+++..++.++.||+.||.|||++||+|+||||+|||++.+|++||+|||++.....   ....
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999998876 5699999999999999999999999999999999999999999999999999865432   3345


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..... ....+..+|+++++||.+||.
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            6799999999999999999999999999999999999999999999888888776532 333445789999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .||++|||++|+|+||||++...|
T Consensus       310 ~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          310 RDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             CChhHCcCHHHHhcCHhhcCCCCC
Confidence            999999999999999999987543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-62  Score=405.43  Aligned_cols=255  Identities=24%  Similarity=0.448  Sum_probs=219.6

Q ss_pred             cCc-EeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec----CCe
Q 023270           19 QDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----DER   93 (284)
Q Consensus        19 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~----~~~   93 (284)
                      .+| ++.++||+|+||+||+|.+..++..||+|++........ ..+.+.+|++++++++||||+++++++..    ++.
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            355 788899999999999999999999999999976554432 35678999999999999999999999864    356


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecC-CCCEEEeecccccccC
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDH-EGRLKIGDFGWSVQSR  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~  170 (284)
                      +|+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++. +|.+||+|||++....
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            8999999999999999999999999999999999999999999998  999999999999974 7999999999996543


Q ss_pred             C-CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          171 S-KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                      . ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...+. ..+...+..+......+...++++++|
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  262 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence            3 3345679999999999865 699999999999999999999999976554 445555555444334445688999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |.+||..||++|||++++|+||||++.
T Consensus       263 i~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          263 IEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHccCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.7e-62  Score=420.75  Aligned_cols=256  Identities=28%  Similarity=0.504  Sum_probs=230.2

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.++||+|+||+||+|.+..+|+.||||++.......   .+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            56999999999999999999999999999999986543322   356789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~  175 (284)
                      |||++|+|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++....   .....
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            99999999998875 569999999999999999999999999999999999999999999999999986543   23345


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  254 (284)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..... .......+++++++||.+||.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            6799999999999999999999999999999999999999999999988888776532 334456799999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .||++|||++|+|+||||++...|
T Consensus       387 ~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          387 RDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             CChhHCcCHHHHhcCHHhcCCCCC
Confidence            999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-63  Score=413.09  Aligned_cols=259  Identities=34%  Similarity=0.647  Sum_probs=225.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      .+...++|++++.||+|+||+||+|++.   .+++.||+|++........ ....+.+|++++++++||||+++++++.+
T Consensus        19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4556789999999999999999999874   3577899999865433221 12356789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ++.+|+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++....
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999986432


Q ss_pred             ---CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          171 ---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                         .......||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+++..+......++  ..+|+++++
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~  255 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQS  255 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC--CcCCHHHHH
Confidence               233456799999999999999999999999999999999999999999999999999988765544  479999999


Q ss_pred             HHHHhcccCCCCCCC-----HHhhhcCcccccc
Q 023270          248 LISRLLVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       248 li~~~l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      ||++||+.||++|||     ++|+++||||+.-
T Consensus       256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            999999999999998     4799999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.4e-62  Score=410.81  Aligned_cols=257  Identities=24%  Similarity=0.400  Sum_probs=228.6

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ....|++.++||+|+||+||+|.+..+++.||||++.....        ..+|+.+++.++||||+++++++.+++.+|+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45679999999999999999999999999999999965432        2468999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccCCC---
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~---  172 (284)
                      |||||++|+|.+++++.+.+++..++.++.||+.||.|||++||+|+||||+|||++.+| .+||+|||++......   
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999989999999999999999999999999999999999999999987 6999999998643321   


Q ss_pred             -----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCCCCCHHHH
Q 023270          173 -----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-PSAPSISAEAK  246 (284)
Q Consensus       173 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~  246 (284)
                           .....||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+..++...+....... ..++.+++++.
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                 122469999999999999999999999999999999999999999888877777777654332 24567999999


Q ss_pred             HHHHHhcccCCCCCCCHHhh-------------hcCccccccCCCCCC
Q 023270          247 HLISRLLVKDSSKRLSLQKI-------------MEHPWIIKNANPRGT  281 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~i-------------l~~~~~~~~~~~~~~  281 (284)
                      +||.+||..||.+|||++|+             |+|||+++-.+|++.
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~n  335 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN  335 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC-
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCCC
Confidence            99999999999999999997             679999999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-58  Score=399.06  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=223.3

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec------CC
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD------DE   92 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~------~~   92 (284)
                      .+|++++.||+|+||+||+|.+..+|+.||||++....... ...+.+.+|+++++.++||||+++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            57999999999999999999999999999999996544333 334677899999999999999999998753      36


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC--
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~--  170 (284)
                      .+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++....  
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999996 6899999988999999999999999999999999999999999999999999999999999985432  


Q ss_pred             -----CCCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-------
Q 023270          171 -----SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS-------  237 (284)
Q Consensus       171 -----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------  237 (284)
                           .......||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+.+..+.+..+......++.       
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                 2234567999999999988754 699999999999999999999999999998888877654222211       


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          238 ----------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       238 ----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                            .+.+++++.+||++||..||.+|||++|+|+||||++..+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                  1346899999999999999999999999999999998654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-59  Score=391.86  Aligned_cols=255  Identities=22%  Similarity=0.395  Sum_probs=202.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----   92 (284)
                      +.+|++++.||+|+||+||+|.+..+++.||||++.....  ....+.+.+|++++++++||||+++++++.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            4579999999999999999999999999999999865432  223467889999999999999999999986543     


Q ss_pred             -------eEEEEEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           93 -------RIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        93 -------~~~~v~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                             .+|+|||||++++|.+++.....   .+...++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   47999999999999999987653   45667889999999999999999999999999999999999999999


Q ss_pred             cccccccCCC---------------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHH
Q 023270          163 FGWSVQSRSK---------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFR  226 (284)
Q Consensus       163 ~~~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~  226 (284)
                      ||++......               .....||+.|+|||++.+..++.++|||||||++|+|++   ||...... ..+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            9998543221               123469999999999999999999999999999999996   77643322 2233


Q ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          227 RIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ....... ++..+..++.+.+||.+||+.||.+|||++|+|+||||++.+-|
T Consensus       239 ~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          239 DVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            3332221 11222356678899999999999999999999999999987554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-58  Score=385.36  Aligned_cols=256  Identities=23%  Similarity=0.447  Sum_probs=222.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      ...+..++|.+.+.||+|+||+||+|.+.     .++..||||++....   ....+.+.+|++++++++||||++++++
T Consensus         7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~   83 (299)
T 4asz_A            7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGV   83 (299)
T ss_dssp             CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence            45677889999999999999999999864     357789999986543   2335689999999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKH-------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~  154 (284)
                      +.+++.+++|||||++|+|.+++...             ..+++..++.++.|++.||.|||+++|+||||||+|||++.
T Consensus        84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~  163 (299)
T 4asz_A           84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  163 (299)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence            99999999999999999999999764             36899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 023270          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRI  228 (284)
Q Consensus       155 ~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  228 (284)
                      ++++||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||+| |..||...+..++...+
T Consensus       164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998543222     122357899999999999999999999999999999998 89999999999998888


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ..+.. .+.+..+|+++.+|+.+||+.||++|||++++  ++|+++
T Consensus       244 ~~~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          244 TQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             HHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             HcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            87653 44556799999999999999999999999999  456654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-57  Score=378.56  Aligned_cols=256  Identities=22%  Similarity=0.410  Sum_probs=212.4

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      +....+++...++++.++||+|+||+||+|++.   ..||||++....... ...+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~  101 (307)
T 3omv_A           26 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYM  101 (307)
T ss_dssp             ---CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            344457889999999999999999999999864   359999986543333 3457899999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .+ +.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++.
T Consensus       102 ~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             CS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             EC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence            54 5689999999999999999765 579999999999999999999999999999999999999999999999999985


Q ss_pred             ccCC-----CCccccCCCcccCccccCC---CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---
Q 023270          168 QSRS-----KRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---  236 (284)
Q Consensus       168 ~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---  236 (284)
                      ....     ......||+.|+|||++.+   ..++.++||||||+++|+|+||..||...+...............+   
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~  260 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS  260 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence            4321     2234579999999999864   4589999999999999999999999998776665555554433222   


Q ss_pred             -CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          237 -SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                       .++.+|+++.+|+.+||+.||++|||+.+++++
T Consensus       261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             234689999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.6e-57  Score=381.76  Aligned_cols=253  Identities=23%  Similarity=0.415  Sum_probs=217.9

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      ...+...+|.+.++||+|+||+||+|...     .++..||||++....   ....+.+.+|++++++++||||++++++
T Consensus        35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            34567789999999999999999999864     367889999996543   2335789999999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL  152 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~  152 (284)
                      +.+++.+++|||||++|+|.+++...               .++++.+++.++.|++.||.|||+.+|+||||||+|||+
T Consensus       112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV  191 (329)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence            99999999999999999999999754               358999999999999999999999999999999999999


Q ss_pred             cCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 023270          153 DHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR  226 (284)
Q Consensus       153 ~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~  226 (284)
                      +.++++||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||+| |+.||...+..+.+.
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999998543221     233568999999999999999999999999999999999 899999999998888


Q ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          227 RIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+..+. ..+.+..+|+++.+|+.+||+.||++|||+++|+++
T Consensus       272 ~i~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            887764 445556899999999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.7e-57  Score=406.66  Aligned_cols=261  Identities=28%  Similarity=0.501  Sum_probs=227.8

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHH---HHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ...+++++|++++.||.|+||+||+|++..+|+.||+|++.+.......   .....+.++.+++.++||||+++++++.
T Consensus       183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            4578899999999999999999999999999999999999765543322   2233344567788889999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +++.+|+|||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+|+||||+|||++.+|++||+|||++...
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999654


Q ss_pred             C-CCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 R-SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAE---SQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      . ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.   +..++..........+  +..+|++
T Consensus       343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~--p~~~S~~  420 (689)
T 3v5w_A          343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--PDSFSPE  420 (689)
T ss_dssp             SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC--CTTSCHH
T ss_pred             CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC--CccCCHH
Confidence            3 34456789999999999965 57999999999999999999999999753   3445556666655444  4479999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHhhhcCcccccc
Q 023270          245 AKHLISRLLVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      +++||.+||..||.+|++     +++|++||||+.-
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            999999999999999998     7999999999863

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.1e-57  Score=379.23  Aligned_cols=256  Identities=22%  Similarity=0.385  Sum_probs=222.6

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      ....++...++++.++||+|+||+||+|...     .+++.||||++......  ...+.+.+|+.++++++||||++++
T Consensus        18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~   95 (308)
T 4gt4_A           18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLL   95 (308)
T ss_dssp             -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            3456788899999999999999999999853     46678999998654322  2346789999999999999999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      +++.+++.+++|||||++|+|.++|...                ..+++..++.++.||+.||.|||+++++||||||+|
T Consensus        96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N  175 (308)
T 4gt4_A           96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN  175 (308)
T ss_dssp             EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence            9999999999999999999999999653                358999999999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCC-----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      ||++.++++||+|||++.....     ......||+.|+|||++.+..++.++||||||+++|||+| |..||.+.+..+
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999854322     2234568999999999999999999999999999999998 899999999988


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....+..+. ..+.++.+|+++.+|+.+||+.||++|||+.+|+++
T Consensus       256 ~~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          256 VVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            888777654 445566899999999999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.4e-56  Score=380.77  Aligned_cols=250  Identities=22%  Similarity=0.428  Sum_probs=207.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCe
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDER   93 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~   93 (284)
                      -++|++.+.||+|+||+||+|.+.   .+++.||+|++.....     ...+.+|+++++.+ +||||+++++++.++++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            467999999999999999999875   3577899999865432     23567899999988 69999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~  172 (284)
                      +|+||||+++++|.+++.   .+++.+++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus        95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            999999999999999884   58999999999999999999999999999999999999877 89999999998533211


Q ss_pred             -------------------------------CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCC-C
Q 023270          173 -------------------------------RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEA-E  219 (284)
Q Consensus       173 -------------------------------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~-~  219 (284)
                                                     .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.. .
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                           1234689999999999876 489999999999999999999999954 3


Q ss_pred             ChHHHHHHHHhc----------------------------------------------------CCCCCCCCCCCHHHHH
Q 023270          220 SQKDTFRRIMKV----------------------------------------------------DLSFPSAPSISAEAKH  247 (284)
Q Consensus       220 ~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~l~~  247 (284)
                      +..+.+..+...                                                    ......+..+|+++.+
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            443433332210                                                    0011223468899999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||++||..||++|||++|+|+||||++-
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.8e-56  Score=402.25  Aligned_cols=259  Identities=32%  Similarity=0.637  Sum_probs=233.0

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .+.+|++.+.||+|+||+||+|.+..+|+.||+|++.......   .+.+.+|+++++.++||||+++++++.+++.+|+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            4578999999999999999999999999999999986644332   4678899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC--CCEEEeecccccccCCC-
Q 023270           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE--GRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~--~~~~l~d~~~~~~~~~~-  172 (284)
                      |||||++|+|.+++.. .+.+++..+..++.||+.||.|||++||+|+||||+|||++.+  +.+||+|||++...... 
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999999999999864 4679999999999999999999999999999999999999864  89999999999654432 


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLI  249 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  249 (284)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.  ...+++++++||
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli  391 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  391 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence             23457999999999999999999999999999999999999999999999999998887655443  357899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ++||..||.+|||++|+|+||||+....|
T Consensus       392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          392 RKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            99999999999999999999999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.3e-56  Score=377.83  Aligned_cols=259  Identities=23%  Similarity=0.417  Sum_probs=220.5

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCC-----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC-Ccccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h-~~i~~~~~   86 (284)
                      .+++...+|++.+.||+|+||+||+|.+...+     +.||||.+.......  ..+.+.+|++++.++.| |||+++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~--~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH--HHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            46788899999999999999999999987643     569999986544332  34678899999999975 89999999


Q ss_pred             EEecC-CeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           87 WFHDD-ERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        87 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      ++.++ +.+++|||||++|+|.++|...                ..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            98654 5789999999999999999763                248999999999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      ||++.++++||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||+| |..||.+.+..+
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999654322     123457899999999999999999999999999999998 999998876555


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC--cccc
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH--PWII  273 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~--~~~~  273 (284)
                      .+.+.......++.++.+++++.+++.+||+.||++|||+++|++|  .+++
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            5555444445566667899999999999999999999999999998  4444

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-54  Score=367.90  Aligned_cols=262  Identities=34%  Similarity=0.654  Sum_probs=235.4

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ..+....+|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+++++.++||||+++++++..++
T Consensus         9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A            9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            34567889999999999999999999999999999999997654433 33567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC--
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~--  170 (284)
                      ..++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....  
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999999999988899999999999999999999999999999999999999999999999999985433  


Q ss_pred             CCCccccCCCcccCccccCCCCCC-chhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          171 SKRHTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                      .......|++.|+|||++.+..++ .++||||||+++++|++|..||.+.+..+....+..+....+.  .+++++.+|+
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li  245 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLL  245 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHH
Confidence            233455789999999999888765 8999999999999999999999999999999998887665544  6899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ++||..||.+|||++++++||||+...+
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            9999999999999999999999987643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-54  Score=365.18  Aligned_cols=259  Identities=41%  Similarity=0.737  Sum_probs=238.2

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++.+++|++.+.||.|+||+||+|.+..+++.||+|++...........+.+.+|..+++.++||||+++++++.+.+.+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            46789999999999999999999999999999999999776554444456778899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCc
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH  174 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  174 (284)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.+|.++|+|||++........
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~  161 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  161 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999977666666


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......++  +.+++++.++|++||.
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~lL~  239 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLIT  239 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTC
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhc
Confidence            77899999999999999999999999999999999999999999999999988888765544  4789999999999999


Q ss_pred             cCCCCCC-----CHHhhhcCcccccc
Q 023270          255 KDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       255 ~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      .||.+||     +++++++||||++.
T Consensus       240 ~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          240 RDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             cCHHHcCCCcCCCHHHHhcCccccCC
Confidence            9999999     99999999999853

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.2e-54  Score=365.96  Aligned_cols=259  Identities=38%  Similarity=0.645  Sum_probs=234.9

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++.+++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.+
T Consensus         1 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CCChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence            36789999999999999999999999999999999999776544444456788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---C
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---S  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~  171 (284)
                      ++||||+++++|..++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.+|.++|+|||++....   .
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999986432   2


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......++  ..+++++.+||.+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~  238 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHH
Confidence            33455689999999999999999999999999999999999999999999888888887765544  3789999999999


Q ss_pred             hcccCCCCCC-----CHHhhhcCcccccc
Q 023270          252 LLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      ||..||.+||     +++++++||||+.-
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999999     99999999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-54  Score=359.28  Aligned_cols=269  Identities=60%  Similarity=1.103  Sum_probs=241.2

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ..+|.+.+|++.+.||.|+||+||+|.+..++..|++|++.............+.+|+.+++.++|+||+++++++.+++
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            45789999999999999999999999999999999999997766555555678889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-  171 (284)
                      ..++||||+++++|.+.+.....++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... 
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999998754432 


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+  ..+++++.+|+.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~  240 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR  240 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--TTSCHHHHHHHHH
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC--CcCCHHHHHHHHH
Confidence            23445689999999999999999999999999999999999999999999888888877654443  4789999999999


Q ss_pred             hcccCCCCCCCHHhhhcCccccccCCCCCCCC
Q 023270          252 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD  283 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~  283 (284)
                      ||..||.+|||++++++||||+........|.
T Consensus       241 ~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~  272 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQ  272 (279)
T ss_dssp             HCCSSGGGSCCHHHHHHCHHHHHHCSSCCCC-
T ss_pred             HhccChhhCCCHHHHhhCccccCCccCccccc
Confidence            99999999999999999999999998888885

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-53  Score=366.36  Aligned_cols=261  Identities=34%  Similarity=0.639  Sum_probs=240.3

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .....+.+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++
T Consensus        35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            44577899999999999999999999999999999999997765544445567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .+|+||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++|+||+|+||+++.+|.++|+|||++......
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999777666


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHh
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL  252 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (284)
                      .....|++.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+..+...++  ..+++++.++|.+|
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~l  272 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKDLLRNL  272 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTCCHHHHHHHHHH
T ss_pred             cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHH
Confidence            6667899999999999999999999999999999999999999999999999999888765544  47899999999999


Q ss_pred             cccCCCCCCC-----HHhhhcCcccccc
Q 023270          253 LVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       253 l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      |..||.+||+     ++++++||||+..
T Consensus       273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          273 LQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            9999999998     9999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.4e-54  Score=369.08  Aligned_cols=263  Identities=35%  Similarity=0.629  Sum_probs=230.5

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEe
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH   89 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~   89 (284)
                      .....+.+.+|++++.||+|+||+||+|.+..+++.||+|++.............+.+|..++..+ +||||+++++++.
T Consensus        15 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             --------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CCcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            344568889999999999999999999999999999999999876555555567788899999988 6999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      .++.+|+||||+++++|..++...+.+++..++.++.||+.||.|||++|++|+||||+|||++.+|.++|+|||++...
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999998643


Q ss_pred             C---CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          170 R---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       170 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      .   .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+......++.  .+++++.
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~  252 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLHEDAT  252 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHH
Confidence            2   2334456899999999999888999999999999999999999999999999999999987665554  6899999


Q ss_pred             HHHHHhcccCCCCCCCH------HhhhcCcccccc
Q 023270          247 HLISRLLVKDSSKRLSL------QKIMEHPWIIKN  275 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~------~~il~~~~~~~~  275 (284)
                      +||++||..||.+||++      +++++||||++.
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            99999999999999999      899999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-53  Score=364.08  Aligned_cols=262  Identities=30%  Similarity=0.579  Sum_probs=231.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEec
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD   90 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~   90 (284)
                      ....+...+|++.+.||+|+||.||+|.+..+++.||+|++.............+..|..++..+ +||||+++++++..
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   89 (345)
T ss_dssp             ------CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ccCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            44578899999999999999999999999999999999999776544333445677788888766 89999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc-
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~-  169 (284)
                      ++.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.+|.++|+|||++... 
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            9999999999999999999998889999999999999999999999999999999999999999999999999998643 


Q ss_pred             --CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          170 --RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       170 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                        ........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+......++  ..+++++.+
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~  247 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEAKD  247 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC--cccCHHHHH
Confidence              2233456789999999999999999999999999999999999999999999999888887765544  468999999


Q ss_pred             HHHHhcccCCCCCCCHH-hhhcCcccccc
Q 023270          248 LISRLLVKDSSKRLSLQ-KIMEHPWIIKN  275 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~-~il~~~~~~~~  275 (284)
                      ||.+||..||.+||++. ++++||||+..
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            99999999999999998 99999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.3e-53  Score=362.80  Aligned_cols=262  Identities=32%  Similarity=0.565  Sum_probs=231.9

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEe
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH   89 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~   89 (284)
                      .....+.+.+|++.+.||.|+||.||+|.+..+++.||+|++...........+.+..|..++..+ +|++|+++++++.
T Consensus        12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            345578899999999999999999999999999999999999776554444456777888999887 7999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      ..+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++...
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998643


Q ss_pred             ---CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          170 ---RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       170 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                         ........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+......++  ..+++++.
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~  249 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAV  249 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHH
Confidence               2233456789999999999999999999999999999999999999999999999999888765554  47999999


Q ss_pred             HHHHHhcccCCCCCCC-----HHhhhcCccccc
Q 023270          247 HLISRLLVKDSSKRLS-----LQKIMEHPWIIK  274 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps-----~~~il~~~~~~~  274 (284)
                      +||.+||..||.+||+     ++++++||||+.
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            9999999999999995     699999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.1e-53  Score=367.37  Aligned_cols=262  Identities=31%  Similarity=0.612  Sum_probs=226.2

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEec
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD   90 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~   90 (284)
                      ....+.+++|++++.||+|+||+||+|++..+++.||+|++...........+.+..|..++..+ +||||+++++++..
T Consensus        45 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           45 ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             ----CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            34567889999999999999999999999999999999999876655555556677888888776 89999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc-
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~-  169 (284)
                      ++.+++||||+++++|...+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++... 
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999999999999889999999999999999999999999999999999999999999999999998642 


Q ss_pred             --CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCCCC
Q 023270          170 --RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE---------SQKDTFRRIMKVDLSFPSA  238 (284)
Q Consensus       170 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~---------~~~~~~~~~~~~~~~~~~~  238 (284)
                        ........|++.|+|||++.+..++.++|+||||+++|+|++|..||...         ........+......++  
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--  282 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--  282 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC--
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC--
Confidence              23344567899999999999999999999999999999999999999642         23345555666554444  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCH------HhhhcCcccccc
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSL------QKIMEHPWIIKN  275 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~------~~il~~~~~~~~  275 (284)
                      ..+++++.+||++||..||.+||++      +++++||||++.
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            4799999999999999999999995      799999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-52  Score=358.86  Aligned_cols=260  Identities=31%  Similarity=0.611  Sum_probs=229.2

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~   92 (284)
                      ..+.+++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|..++..+ +||||+++++++..++
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            356789999999999999999999999999999999999876554445567788899999887 8999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc---
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---  169 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~---  169 (284)
                      .+|+||||+++++|..++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++...   
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998642   


Q ss_pred             CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCC---------CChHHHHHHHHhcCCCCCCCCC
Q 023270          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA---------ESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      ........|++.|+|||++.+..++.++|+||||+++|+|++|..||..         .........+.......  +..
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--p~~  241 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--PRS  241 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC--CTT
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC--CCC
Confidence            2233456789999999999999999999999999999999999999975         23344555555554444  347


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HhhhcCcccccc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSL------QKIMEHPWIIKN  275 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~------~~il~~~~~~~~  275 (284)
                      +++++.+||.+||..||.+||++      +++++||||++.
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            89999999999999999999996      899999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-52  Score=351.85  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=227.4

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .-...+|++.+.||+|+||+||+|.+..+++.||+|++.......   .+.+.+|+.+++.++||||+++++++..++..
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            345678999999999999999999999999999999986544332   35678899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---  171 (284)
                      ++||||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999999998774 689999999999999999999999999999999999999999999999998754332   


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCCCCCCHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-DLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~  250 (284)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+........... ......+..+++.+.+|+.
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            223456899999999999999999999999999999999999999988887766665543 3344445578999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +||..||++|||++++++||||+...
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHccCChhHCcCHHHHhhChhhcccC
Confidence            99999999999999999999999764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.1e-53  Score=362.52  Aligned_cols=258  Identities=31%  Similarity=0.575  Sum_probs=229.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---HHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ..+|++.+.||.|+||+||+|.+..++..||+|++........   ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4569999999999999999999999999999999865433211   1235688999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC----CEEEeecccccccC
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSR  170 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~  170 (284)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++    .++|+|||++....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999998888999999999999999999999999999999999999998877    79999999986543


Q ss_pred             C--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHH
Q 023270          171 S--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAK  246 (284)
Q Consensus       171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  246 (284)
                      .  ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++.  ++.+++++.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  250 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK  250 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence            3  234556899999999999989999999999999999999999999999999999888877655442  247899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +||.+||..||.+|||++++|+||||+..
T Consensus       251 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          251 DFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            99999999999999999999999999853

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.2e-52  Score=348.70  Aligned_cols=266  Identities=60%  Similarity=1.076  Sum_probs=237.3

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ....+..++|++.+.||+|+||.||++.+..++..|++|++...........+.+.+|+.+++.++|+||+++++++..+
T Consensus         7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (284)
T 2vgo_A            7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR   86 (284)
T ss_dssp             ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence            34678899999999999999999999999999999999999766544444456788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +..++|+||+++++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999998854433


Q ss_pred             -CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          172 -KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                       ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......  ++.+++++.+++.
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~  244 (284)
T 2vgo_A          167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF--PPFLSDGSKDLIS  244 (284)
T ss_dssp             SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--CTTSCHHHHHHHH
T ss_pred             cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC--CCcCCHHHHHHHH
Confidence             2344568999999999999999999999999999999999999999998888888777765443  3478999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      +||..||.+|||++++++||||++...+.
T Consensus       245 ~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             HHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence            99999999999999999999999876544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-52  Score=368.15  Aligned_cols=257  Identities=32%  Similarity=0.598  Sum_probs=230.5

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            467999999999999999999999999999999987655433 2356788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec---CCCCEEEeecccccccCCCC-
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRSKR-  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~-  173 (284)
                      |||+++++|.+.+...+.+++..+..++.||+.||.|||+.|++|+||||+||+++   .++.+||+|||++....... 
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999999989999999999999999999999999999999999999998   46789999999986544322 


Q ss_pred             --ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCCHHHHHHH
Q 023270          174 --HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI  249 (284)
Q Consensus       174 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li  249 (284)
                        ....|++.|+|||++.+..++.++||||+|+++|+|++|..||...+..+....+..+...++.+  +.+++++.+||
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence              34568999999999999899999999999999999999999999999999999988876655543  47899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCcccccc
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      .+||..||.+|||++++|+||||++.
T Consensus       249 ~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          249 NKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-53  Score=363.51  Aligned_cols=259  Identities=34%  Similarity=0.635  Sum_probs=226.1

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ....+.+|.+.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            34677899999999999999999999999999999999976654444444678899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--  171 (284)
                      .++||||+ +++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....  
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999999 579999998888999999999999999999999999999999999999999999999999999854432  


Q ss_pred             CCccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      ......|++.|+|||++.+..+ ++++||||||+++++|++|..||...........+....  ...++.+++++.+|++
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC--CCCCTTSCHHHHHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CCCcccCCHHHHHHHH
Confidence            2345568999999999988775 789999999999999999999998766554444333332  2334468999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCcccccc
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +||..||.+|||++++++||||+..
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999865

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-52  Score=366.33  Aligned_cols=265  Identities=32%  Similarity=0.552  Sum_probs=234.9

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      .....+....+|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|..+++.++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            44567788999999999999999999999999999999999997654444333455778999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +++.+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+||+++.+|.+||+|||++...
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            99999999999999999998876 46899999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----CccccCCCcccCccccCCCC----CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCCC
Q 023270          170 RSK----RHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPSAP  239 (284)
Q Consensus       170 ~~~----~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~  239 (284)
                      ...    .....|++.|+|||++.+..    ++.++|+||||+++|+|++|..||...+..+...++....  ..++...
T Consensus       219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  298 (410)
T 3v8s_A          219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN  298 (410)
T ss_dssp             CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred             ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence            332    23567999999999997665    7889999999999999999999999999999888887643  4455556


Q ss_pred             CCCHHHHHHHHHhcccCCCC--CCCHHhhhcCcccccc
Q 023270          240 SISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  275 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  275 (284)
                      .+++++++||.+||..+|.+  ||++++|++||||++.
T Consensus       299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            79999999999999999988  9999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.8e-52  Score=353.44  Aligned_cols=266  Identities=36%  Similarity=0.674  Sum_probs=223.2

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHH-HHHHHHHHHHHHHHHHhCCCCcccc
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSLRHPNILR   83 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~~~~~~~~~~~l~h~~i~~   83 (284)
                      ........+...+|++.+.||+|+||.||+|.+.   .+++.||+|++...... .......+.+|+.+++.++|+||++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~   85 (327)
T 3a62_A            6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD   85 (327)
T ss_dssp             -------CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCC
T ss_pred             ccCCCCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccc
Confidence            3344567788999999999999999999999985   68899999998764332 2233456778999999999999999


Q ss_pred             eeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeec
Q 023270           84 LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        84 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                      +++++..++..++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+||
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           86 LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             EEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             eeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeC
Confidence            99999999999999999999999999998888999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC---CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          164 GWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       164 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      |++....   .......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.......+  +.
T Consensus       166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p--~~  243 (327)
T 3a62_A          166 GLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PY  243 (327)
T ss_dssp             SCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC--TT
T ss_pred             CcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CC
Confidence            9985432   223345689999999999999999999999999999999999999999999998888887655443  47


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHhhhcCcccccc
Q 023270          241 ISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      +++++.++|.+||..||.+||     +++++++||||++.
T Consensus       244 ~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            899999999999999999999     89999999999853

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-52  Score=356.57  Aligned_cols=257  Identities=28%  Similarity=0.525  Sum_probs=229.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++.+.||+|+||+||+|.+..++..|++|.+......    ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            57899999999999999999999999999999998654322    35678999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC--CCCEEEeecccccccCCC--
Q 023270           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~--  172 (284)
                      |||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.  ++.++|+|||++......  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            99999999999997754 7999999999999999999999999999999999999987  789999999998654332  


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLIS  250 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~  250 (284)
                      .....+++.|+|||++.+..++.++||||||+++++|++|..||...+..+....+......++.  .+.+++++.+|+.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence            23456899999999999888999999999999999999999999999999999888887655443  2468999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +||..||.+|||++++|+||||++...+
T Consensus       240 ~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  267 (321)
T 1tki_A          240 RLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             TTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHcCCChhHCcCHHHHhcChhhccCccc
Confidence            9999999999999999999999987544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.8e-52  Score=358.19  Aligned_cols=262  Identities=31%  Similarity=0.581  Sum_probs=231.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ....+.+.+|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+++++.++||||+++++++...
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            35678899999999999999999999999999999999999776655545567888999999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-  170 (284)
                      +..++||||+++++|..++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++.... 
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999999999999998899999999999999999999999999999999999999999999999999986543 


Q ss_pred             -CCCccccCCCcccCccccCC---CCCCchhhHhhHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          171 -SKRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEA---ESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       171 -~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                       .......|++.|+|||++.+   ..++.++||||||+++|+|++|..||..   ....+............  +..+++
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--p~~~s~  245 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY--PSAWSQ  245 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC--CTTSCH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC--CCcCCH
Confidence             33345678999999999864   4589999999999999999999999974   34455555555554433  347899


Q ss_pred             HHHHHHHHhcccCCCCCCC-HHhhhcCcccccc
Q 023270          244 EAKHLISRLLVKDSSKRLS-LQKIMEHPWIIKN  275 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps-~~~il~~~~~~~~  275 (284)
                      ++.+||.+||..||.+||+ ++++++||||++.
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            9999999999999999998 9999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-52  Score=350.62  Aligned_cols=261  Identities=30%  Similarity=0.573  Sum_probs=222.6

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH-----------------------HHHHHHHHHH
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-----------------------YKIQHQLRRE   69 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-----------------------~~~~~~~~~~   69 (284)
                      ...+.+++|++.+.||+|+||.||+|.+..+++.||+|++.......                       ....+.+.+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            34467899999999999999999999999999999999986543211                       1223568899


Q ss_pred             HHHHHhCCCCcccceeeEEec--CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023270           70 MEIQSSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKP  147 (284)
Q Consensus        70 ~~~~~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p  147 (284)
                      +++++.++|+||+++++++..  ++..++||||+++++|.+++. ...+++..++.++.|++.||.|||+.|++|+||+|
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            999999999999999999986  568999999999999987543 45799999999999999999999999999999999


Q ss_pred             CCeEecCCCCEEEeecccccccCCC---CccccCCCcccCccccCCCC---CCchhhHhhHHHHHHHHHhCCCCCCCCCh
Q 023270          148 ENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQ  221 (284)
Q Consensus       148 ~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~  221 (284)
                      +||+++.++.++|+|||++......   .....+++.|+|||.+.+..   .+.++||||||+++++|++|..||.....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            9999999999999999998654332   23456899999999997765   37889999999999999999999999888


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          222 KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ......+.......+..+.+++++.++|.+||..||++|||++++++||||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            88888887777777777789999999999999999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.3e-52  Score=358.16  Aligned_cols=261  Identities=37%  Similarity=0.618  Sum_probs=219.6

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ........+|++++.||+|+||+||++.+..+++.||+|++.......    +.+.+|+..++.++|+||+++++++..+
T Consensus        13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            345567789999999999999999999999999999999986543222    4577899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC--EEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~--~~l~d~~~~~~~  169 (284)
                      +..++||||+++++|.+++...+.++...++.++.|++.||.|||++|++|+||+|+||+++.++.  +||+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999999999988889999999999999999999999999999999999999987765  999999998532


Q ss_pred             --CCCCccccCCCcccCccccCCCCCCch-hhHhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCCCCCC
Q 023270          170 --RSKRHTMCGTLDYLAPEMVENKEHDYA-VDNWTLGILCYEFLYGAPPFEAESQ----KDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       170 --~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~  242 (284)
                        ........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.....    ......+.......+....++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence              223345568999999999988887655 8999999999999999999987443    556666666666666666789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +++.+||.+||..||.+|||++++++||||++..
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            9999999999999999999999999999997653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.2e-52  Score=357.70  Aligned_cols=257  Identities=31%  Similarity=0.603  Sum_probs=230.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999999999999999997654433 2346788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---CEEEeecccccccCCC--
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~~~--  172 (284)
                      |||+++++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++   .+||+|||++......  
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999999998888899999999999999999999999999999999999998654   5999999998654432  


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCCHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLIS  250 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  250 (284)
                      .....|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..+...++..  +.+++++.+||.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            234568999999999999899999999999999999999999999999999888888876655443  468999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCcccccc
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +||..||.+|||++++|+||||++.
T Consensus       267 ~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          267 SMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHcCCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-52  Score=368.85  Aligned_cols=262  Identities=30%  Similarity=0.588  Sum_probs=236.6

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ....+...+|.+.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..+
T Consensus         9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A            9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            45677889999999999999999999999999999999999776554444456888999999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +..++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999865432


Q ss_pred             --CCccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          172 --KRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                        ......|++.|+|||++.+..+ +.++||||||+++++|++|..||...+.......+..+....  +..+++++.+|
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~L  246 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT--PQYLNPSVISL  246 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC--CTTCCHHHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC--CccCCHHHHHH
Confidence              2344568999999999988775 689999999999999999999999999888888888775443  34689999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +++||..||.+|||++++++||||++.
T Consensus       247 i~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            999999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8e-52  Score=346.66  Aligned_cols=257  Identities=25%  Similarity=0.494  Sum_probs=216.4

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +++|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+++.++|+||+++++++.+++..++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            478999999999999999999999999999999986544322 2345677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CC
Q 023270           98 LEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~  173 (284)
                      |||+++ ++.+.+. ..+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            999986 5555554 467899999999999999999999999999999999999999999999999999865432   22


Q ss_pred             ccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCC----------------
Q 023270          174 HTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTFRRIMKVDLSF----------------  235 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p-~~~~~~~~~~~~~~~~~~~~----------------  235 (284)
                      ....+++.|+|||++.+.. ++.++||||||+++++|++|..| |...+..+....+.......                
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            3456789999999997766 79999999999999999987766 66667666666655421111                


Q ss_pred             -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          236 -----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       236 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                 ...+.+++++++|+.+||..||++|||++++|+||||++-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                       11135789999999999999999999999999999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-52  Score=353.89  Aligned_cols=260  Identities=32%  Similarity=0.576  Sum_probs=229.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---HHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ...+|++.+.||.|+||.||+|.+..++..||+|++........   ...+.+.+|+.+++.++||||+++++++..++.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34579999999999999999999999999999999865432210   123568899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC----CEEEeeccccccc
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQS  169 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~----~~~l~d~~~~~~~  169 (284)
                      .++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++    .++|+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999999999998888899999999999999999999999999999999999998887    8999999998554


Q ss_pred             C--CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHH
Q 023270          170 R--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEA  245 (284)
Q Consensus       170 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l  245 (284)
                      .  .......+++.|+|||++.+..++.++||||||+++++|++|..||.+.+..+....+......++.  .+.+++++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  248 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence            3  2334456899999999999899999999999999999999999999999988888887776544432  24688999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .+||.+||..||.+|||++++|+||||+...
T Consensus       249 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999998653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.8e-51  Score=341.84  Aligned_cols=260  Identities=30%  Similarity=0.601  Sum_probs=232.5

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      .++|++.+.||+|+||.||+|.+..++..|++|++....... ...+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            578999999999999999999999999999999997655433 2346788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC---EEEeecccccccCCCC-
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR-  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~~~-  173 (284)
                      +||+++++|.+.+.....++...++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|+|||.+....... 
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999988888999999999999999999999999999999999999987655   9999999985544322 


Q ss_pred             -ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCCHHHHHHHH
Q 023270          174 -HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLIS  250 (284)
Q Consensus       174 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  250 (284)
                       ....+++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+.......+..  ..+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence             34568999999999999999999999999999999999999999999998888888776554443  478999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +||..||.+|||++++|+||||++....
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          244 SMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             HHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             HHcccChhhCCCHHHHhcCccccCChhH
Confidence            9999999999999999999999987543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.4e-52  Score=368.54  Aligned_cols=261  Identities=37%  Similarity=0.629  Sum_probs=225.5

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...+..++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++..++
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~  221 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD  221 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence            34567889999999999999999999999999999999997765545455567788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccC-
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-  170 (284)
                      .+++||||+++++|.+++...+.+++..++.++.|++.||.|||+ .||+|+||+|+|||++.++.++|+|||++.... 
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999999999988899999999999999999999998 999999999999999999999999999985422 


Q ss_pred             --CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          171 --SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                        .......|++.|+|||++.+..++.++||||||+++++|++|..||...+.......+......++  ..+++++.+|
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~l  379 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEAKSL  379 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHHHHH
Confidence              223445689999999999999999999999999999999999999999999988888887765544  3789999999


Q ss_pred             HHHhcccCCCCCC-----CHHhhhcCcccccc
Q 023270          249 ISRLLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       249 i~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      |.+||..||.+||     +++++++||||+..
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            9999999999999     99999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-51  Score=344.33  Aligned_cols=264  Identities=31%  Similarity=0.607  Sum_probs=236.3

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      .....++|.+.+.||+|+||.||++.+..+++.|++|++...........+.+.+|+.+++.++|+||+++++++..++.
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence            34567899999999999999999999999999999999876554444456788899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---  170 (284)
                      .++|+||+++++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....   
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999985533   


Q ss_pred             CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      .......+++.|+|||.+.+..++.++||||||+++++|++|..||......+............  +..+++++.+++.
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~  247 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI--PKHINPVAASLIQ  247 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--CTTSCHHHHHHHH
T ss_pred             cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC--ccccCHHHHHHHH
Confidence            22334568899999999999889999999999999999999999999998888887777665433  3478999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      +||..||.+|||++++++||||++...|-
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHcccChhhCcCHHHHhhChheecCCcCC
Confidence            99999999999999999999999886653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.2e-52  Score=357.23  Aligned_cols=261  Identities=34%  Similarity=0.634  Sum_probs=225.5

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHH-HHhCCCCcccceeeEEecC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~-~~~l~h~~i~~~~~~~~~~   91 (284)
                      ...++..+|++++.||+|+||.||+|++..++..||+|++.............+..|..+ ++.++|+||+++++++...
T Consensus        32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            346788999999999999999999999999999999999977665444444555666665 5678999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc--
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS--  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~--  169 (284)
                      +.+|+||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++|+||||+||+++.+|+++|+|||++...  
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999999999998888999999999999999999999999999999999999999999999999998642  


Q ss_pred             -CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          170 -RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       170 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                       ........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+......++  +.+++++.+|
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~l  269 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHL  269 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC--SSSCHHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC--CCCCHHHHHH
Confidence             2233456789999999999999999999999999999999999999999999999998888755444  4799999999


Q ss_pred             HHHhcccCCCCCCCH----HhhhcCcccccc
Q 023270          249 ISRLLVKDSSKRLSL----QKIMEHPWIIKN  275 (284)
Q Consensus       249 i~~~l~~~p~~Rps~----~~il~~~~~~~~  275 (284)
                      |.+||..||.+||++    +++++||||+..
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999987    699999999753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-51  Score=348.96  Aligned_cols=265  Identities=28%  Similarity=0.488  Sum_probs=218.6

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      -.....+...++|++++.||+|+||+||+|.+. +++.||+|++...... ......+.+|+++++.++||||+++++++
T Consensus        11 ~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   88 (311)
T 3niz_A           11 RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVI   88 (311)
T ss_dssp             ----CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            344566777899999999999999999999984 5899999998654322 23346778999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ..++..++||||+++ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence            999999999999985 888777665 469999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC---CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------
Q 023270          168 QSRS---KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS------  237 (284)
Q Consensus       168 ~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------  237 (284)
                      ....   ......+++.|+|||++.+ ..++.++||||||+++++|++|..||...+..+....+.........      
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            5432   2234467999999999876 45899999999999999999999999887777666665442111110      


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          238 ----------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       238 ----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                            .+.+++++.+||++||..||.+|||++++|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                  134678999999999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-51  Score=342.06  Aligned_cols=262  Identities=31%  Similarity=0.588  Sum_probs=226.2

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...+...+|++.+.||+|++|.||++.+..+++.|++|++...........+.+.+|+..++.++|+||+++++++..++
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            45678899999999999999999999999999999999997665444444567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..++|+||+++++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999998554332


Q ss_pred             --CccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                        .....+++.|+|||.+.+... +.++||||||+++++|++|..||...+.......+.......  +..++.++.+++
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  242 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI--PEYLNRSVATLL  242 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC--chhcCHHHHHHH
Confidence              234457899999999987765 689999999999999999999999988888888777665433  346899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .+||..||.+|||++++++||||++..
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHccCChhhCCCHHHHHhChhhccCc
Confidence            999999999999999999999998763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-52  Score=366.24  Aligned_cols=266  Identities=31%  Similarity=0.556  Sum_probs=231.9

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      .....++...+|++.+.||+|+||+||++.+..+++.||+|++.............+.+|..++..++|+||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            44556778899999999999999999999999999999999997655444333445788999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      +++.+|+||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++..
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            99999999999999999999987 46899999999999999999999999999999999999999999999999999854


Q ss_pred             cCCC----CccccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCC
Q 023270          169 SRSK----RHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFPS  237 (284)
Q Consensus       169 ~~~~----~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~  237 (284)
                      ....    .....|++.|+|||++.     ...++.++||||||+++|+|++|..||...+..+....+....  ..++.
T Consensus       225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  304 (437)
T 4aw2_A          225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT  304 (437)
T ss_dssp             CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred             cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence            4322    12357899999999986     4568999999999999999999999999999998888886532  22222


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCC--CCCHHhhhcCcccccc
Q 023270          238 -APSISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  275 (284)
Q Consensus       238 -~~~~~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  275 (284)
                       ...+++++++||++||..+|++  ||+++++++||||++.
T Consensus       305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence             2458999999999999888888  9999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.8e-52  Score=344.22  Aligned_cols=261  Identities=34%  Similarity=0.704  Sum_probs=204.3

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .-.+.+|++.+.||+|+||.||+|.+..+++.|++|++...........+.+.+|+.+++.++|+||+++++++..++..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            44678999999999999999999999999999999999765544444456788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--
Q 023270           95 FLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--  171 (284)
                      ++|+||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....  
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999999876 6799999999999999999999999999999999999999999999999999855432  


Q ss_pred             -CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          172 -KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                       ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+..........  ..+..++.++.+++.
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~  244 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY--EMPSFLSIEAKDLIH  244 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC--CCCTTSCHHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc--CCccccCHHHHHHHH
Confidence             22345678999999999988899999999999999999999999988776655554443332  334468999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      +||..||.+|||++++++||||++...
T Consensus       245 ~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          245 QLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHcccCHhhCCCHHHHhcCccccCCCC
Confidence            999999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.7e-52  Score=352.36  Aligned_cols=257  Identities=30%  Similarity=0.561  Sum_probs=220.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.+|++++.||+|+||+||+|.+..+++.||+|++......  ...+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            57999999999999999999999999999999998544322  2235778999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-----CC
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----SK  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-----~~  172 (284)
                      |||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....     ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999985432     12


Q ss_pred             CccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      .....|++.|+|||++.+..+ +.++||||||+++++|++|..||...+.. ..................+++++.+|+.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            234568999999999987775 77999999999999999999999876554 3334444444444444578999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +||..||.+|||++++++||||++..
T Consensus       244 ~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          244 KILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHccCChhhCcCHHHHhhChhhcccc
Confidence            99999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-51  Score=357.37  Aligned_cols=270  Identities=19%  Similarity=0.297  Sum_probs=224.1

Q ss_pred             HHhhhhcccccccCcEeeeeeccC--CCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 023270            7 EREDNRKREWSLQDFEIGRPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (284)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~   84 (284)
                      ...+....-....+|++++.||.|  +||+||+|.+..+++.||+|++....... ...+.+.+|+.+++.++|+||+++
T Consensus        13 ~~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~   91 (389)
T 3gni_B           13 YFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPY   91 (389)
T ss_dssp             CCC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcE
Confidence            344555666788899999999999  99999999999999999999997654333 456788899999999999999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                      ++++..++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~d  171 (389)
T 3gni_B           92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSG  171 (389)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             eEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcc
Confidence            99999999999999999999999999876  6799999999999999999999999999999999999999999999999


Q ss_pred             cccccccC----------CCCccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 023270          163 FGWSVQSR----------SKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK  230 (284)
Q Consensus       163 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~  230 (284)
                      ||.+....          .......+++.|+|||++.+  ..++.++||||||+++++|++|..||.+.+..........
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            99863221          11223467888999999987  5789999999999999999999999987665554443332


Q ss_pred             cCCC--------------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhh
Q 023270          231 VDLS--------------------------------------------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKI  266 (284)
Q Consensus       231 ~~~~--------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i  266 (284)
                      +...                                            .+....+++++.+||++||..||.+|||++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            2111                                            11233578899999999999999999999999


Q ss_pred             hcCccccccCC
Q 023270          267 MEHPWIIKNAN  277 (284)
Q Consensus       267 l~~~~~~~~~~  277 (284)
                      |+||||++...
T Consensus       332 l~hp~f~~~~~  342 (389)
T 3gni_B          332 LNHSFFKQIKR  342 (389)
T ss_dssp             TTSGGGGGC--
T ss_pred             hcCHHHHHHhh
Confidence            99999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5e-51  Score=348.33  Aligned_cols=262  Identities=32%  Similarity=0.613  Sum_probs=234.9

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .....+|.+.+.||+|+||.||++.+..+++.|++|++...........+.+.+|+.+++.++|+||+++++++.+++..
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            34567899999999999999999999999999999998765544444567888999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---C
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---S  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~  171 (284)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....   .
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999985543   2


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      ......+++.|+|||++.+..++.++||||||+++++|++|..||......+....+.......  +..+++++.+|+.+
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~  274 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI--PKHINPVAASLIQK  274 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CTTSCHHHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC--CccCCHHHHHHHHH
Confidence            2334568899999999999899999999999999999999999999988888887777765443  34789999999999


Q ss_pred             hcccCCCCCCCHHhhhcCccccccCCC
Q 023270          252 LLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ||..||.+|||++++++||||+....|
T Consensus       275 ~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          275 MLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HccCChhHCcCHHHHhcCccccCCCcc
Confidence            999999999999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=346.18  Aligned_cols=259  Identities=27%  Similarity=0.468  Sum_probs=219.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +++|++++.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|+++++.++|+||+++++++..++..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            57899999999999999999999999999999998654433 33456778999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---Cc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~~  174 (284)
                      |||+++++|.+++.....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999998888888999999999999999999999999999999999999999999999999998654322   23


Q ss_pred             cccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------------
Q 023270          175 TMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-------------------  234 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------------  234 (284)
                      ...+++.|+|||++.+ ..++.++||||||+++++|++|..||...+..+....+......                   
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            4467899999999876 56899999999999999999999999998887766554432111                   


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          235 FPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       235 ~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .+.          .+.+++++.+|+.+||..||.+|||++++|+||||++..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            010          1357889999999999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=359.08  Aligned_cols=264  Identities=31%  Similarity=0.523  Sum_probs=229.6

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ....++..++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|..++..++|+||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            34556788999999999999999999999999999999999976554444445567889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      ++.+|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++++||+|||++...
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            99999999999999999999875 47999999999999999999999999999999999999999999999999998554


Q ss_pred             CCC----CccccCCCcccCccccC-------CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCC
Q 023270          170 RSK----RHTMCGTLDYLAPEMVE-------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD--LSFP  236 (284)
Q Consensus       170 ~~~----~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~  236 (284)
                      ...    .....|++.|+|||++.       +..++.++|+||||+++|+|++|..||...+..+...++....  ...+
T Consensus       213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  292 (412)
T 2vd5_A          213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP  292 (412)
T ss_dssp             CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence            322    22357899999999987       3568999999999999999999999999999988888877532  2222


Q ss_pred             -CCCCCCHHHHHHHHHhcccCCCCC---CCHHhhhcCcccccc
Q 023270          237 -SAPSISAEAKHLISRLLVKDSSKR---LSLQKIMEHPWIIKN  275 (284)
Q Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~R---ps~~~il~~~~~~~~  275 (284)
                       ....+++++++||++||. +|.+|   |+++++++||||+.-
T Consensus       293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence             234789999999999999 99998   599999999999764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-52  Score=347.96  Aligned_cols=245  Identities=22%  Similarity=0.339  Sum_probs=193.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC----e
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----R   93 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~----~   93 (284)
                      .++|.+.++||+|+||+||+|++  +|+.||||++.......    .....|+..+..++||||+++++++.+++    .
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            36799999999999999999986  68899999996654222    22345667777889999999999997654    6


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCeEecCCCCEEEeeccc
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--------HVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      +++||||+++|+|.+++.. .+++++.+..++.|++.||.|||++        ||+||||||+|||++.++++||+|||+
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            8999999999999999976 4689999999999999999999987        999999999999999999999999999


Q ss_pred             ccccCCC-------CccccCCCcccCccccCCC------CCCchhhHhhHHHHHHHHHhCCCCCCCC-------------
Q 023270          166 SVQSRSK-------RHTMCGTLDYLAPEMVENK------EHDYAVDNWTLGILCYEFLYGAPPFEAE-------------  219 (284)
Q Consensus       166 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~-------------  219 (284)
                      +......       .....||+.|+|||++.+.      .++.++||||||+++|||+||..||...             
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            8543221       1234689999999998764      3577999999999999999997765321             


Q ss_pred             --ChHHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          220 --SQKDTFRRIMKVDLSFPSAP-----SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       220 --~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                        ...............+..+.     ..++.+.+|+.+||..||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              22334444444333333222     133578899999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4e-51  Score=339.78  Aligned_cols=257  Identities=33%  Similarity=0.617  Sum_probs=228.6

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ..++|++.+.||+|+||+||++.+..++..+++|++.......   .+.+.+|+++++.++|+||+++++++..++..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            3567999999999999999999999999999999986644332   3567899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe---cCCCCEEEeecccccccC--C
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSR--S  171 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~--~  171 (284)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++....  .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999999999988889999999999999999999999999999999999999   778899999999985433  2


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCCHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI  249 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li  249 (284)
                      ......+++.|+|||.+.+. ++.++||||||+++++|++|..||...+..+....+.......+..  ..+++++.+++
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI  242 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred             chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence            33445689999999998654 8999999999999999999999999999999888888876554432  26899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .+||..||.+|||+.++|+||||++...
T Consensus       243 ~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            9999999999999999999999987543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.5e-51  Score=342.10  Aligned_cols=255  Identities=29%  Similarity=0.522  Sum_probs=214.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.+|++.+.||.|+||+||+|.+ .+++.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999998 678999999986543222 1235677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CC
Q 023270           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~  173 (284)
                      ||++++ +|.+++... +.++...++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.....   ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999985 999888765 6799999999999999999999999999999999999999999999999999854332   22


Q ss_pred             ccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 023270          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-----------------  235 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----------------  235 (284)
                      ....+++.|+|||++.+. .++.++||||||+++++|++|..||...+..+....+.......                 
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            334678999999998764 58999999999999999999999999988877776665421100                 


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          236 ----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       236 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                                .....+++++.+|+.+||..||++|||++++|+||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                      0113478999999999999999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4e-51  Score=350.97  Aligned_cols=257  Identities=29%  Similarity=0.550  Sum_probs=220.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH--HHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      -.+|++.+.||+|+||+||+|.+..+++.||+|++........  ...+.+.+|+.+++.++||||+++++++..++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4679999999999999999999999999999999865433211  12457889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC---EEEeecccccc
Q 023270           96 LILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQ  168 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~---~~l~d~~~~~~  168 (284)
                      +||||+++++|.+.+...    ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.   ++|+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998887543    25899999999999999999999999999999999999987654   99999999865


Q ss_pred             cCCC---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCH
Q 023270          169 SRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISA  243 (284)
Q Consensus       169 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  243 (284)
                      ....   .....|++.|+|||++.+..++.++||||||+++|+|++|..||... .......+.........  ...+++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCH
Confidence            4432   23456899999999999999999999999999999999999999875 44556666655443332  246899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ++.+||.+||..||.+|||++++|+||||++.
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            99999999999999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.6e-51  Score=348.37  Aligned_cols=263  Identities=29%  Similarity=0.471  Sum_probs=215.5

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ......+.+|++.+.||+|+||+||+|.+..+++.||+|++....... ...+.+.+|+.+++.++|+||+++++++..+
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            345677889999999999999999999999999999999996544322 3345677899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec-----CCCCEEEeecccc
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-----HEGRLKIGDFGWS  166 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~-----~~~~~~l~d~~~~  166 (284)
                      +..++||||++ ++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++     .++.++|+|||++
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99999999998 59999999988999999999999999999999999999999999999995     4456999999998


Q ss_pred             cccC---CCCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----
Q 023270          167 VQSR---SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----  238 (284)
Q Consensus       167 ~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----  238 (284)
                      ....   .......+++.|+|||++.+.. ++.++||||||+++++|++|..||...+..+.+..+..........    
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            5433   2223445789999999998754 8999999999999999999999999998888777766532111110    


Q ss_pred             ------------------------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          239 ------------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       239 ------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                              ..+++++.+||.+||..||.+|||++++|+||||++..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                                    01678999999999999999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-50  Score=347.90  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=227.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .+|++.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+++++.++|+||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999986554444445578889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcccc
Q 023270           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC  177 (284)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  177 (284)
                      ||++ ++|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-~~~~~  211 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANSFV  211 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCCCC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-CCccc
Confidence            9997 588877754 46799999999999999999999999999999999999999999999999999865433 33457


Q ss_pred             CCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       178 ~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      |++.|+|||++.   +..++.++||||||+++++|++|..||...+.......+.............++.+.+|+.+||.
T Consensus       212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  291 (348)
T 1u5q_A          212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  291 (348)
T ss_dssp             SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            899999999984   56789999999999999999999999999888887777777665555556789999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .||.+|||++++++||||++...+
T Consensus       292 ~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          292 KIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             SSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             cChhhCcCHHHHhhChhhhccCCc
Confidence            999999999999999999876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.7e-51  Score=347.92  Aligned_cols=270  Identities=26%  Similarity=0.427  Sum_probs=223.8

Q ss_pred             hHHHhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 023270            5 TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (284)
Q Consensus         5 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~   84 (284)
                      +++..........+.+|++.+.||.|+||.||+|.+..+++.|++|++....... ...+.+.+|+.+++.++|+||+++
T Consensus        11 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~   89 (331)
T 4aaa_A           11 GVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNL   89 (331)
T ss_dssp             --------CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhccccchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeE
Confidence            3445556677889999999999999999999999999999999999986544332 334667889999999999999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecc
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                      ++++..++..++||||+++++|..++.....++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A           90 LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCC
Confidence            99999999999999999998888888877889999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---CCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------
Q 023270          165 WSVQSRS---KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS------  234 (284)
Q Consensus       165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------  234 (284)
                      ++.....   ......+++.|+|||.+.+. .++.++||||||+++++|++|..||...+..+....+......      
T Consensus       170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            9854322   22345688999999999775 6899999999999999999999999998887766655432110      


Q ss_pred             -------------CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          235 -------------FPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       235 -------------~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                                   .+.          .+.+++++.+|+.+||..||.+|||++++|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                         000          13578999999999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.9e-51  Score=348.22  Aligned_cols=258  Identities=36%  Similarity=0.603  Sum_probs=212.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      ....+|++.+.||+|+||+||+|.+..+++.||+|++....     ..+.+.+|+.+++.++|+||+++++++..++..+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            33466999999999999999999999999999999986543     2356778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeecccccccCCC
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~  172 (284)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.++|+|||++......
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            99999999999999998888999999999999999999999999999999999999975   889999999998654332


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCC--CCCCCHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKVDLSFPS--APSISAEAKH  247 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~l~~  247 (284)
                        .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.........  .+.++.++.+
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  284 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD  284 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence              234568999999999999999999999999999999999999997766554 55555554433322  3578999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ||.+||..||++|||++++|+||||++....
T Consensus       285 li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          285 LVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             HHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            9999999999999999999999999987554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-50  Score=338.24  Aligned_cols=262  Identities=29%  Similarity=0.528  Sum_probs=221.8

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ...-.-..++|++.+.||.|+||+||+|.+..++..+++|++.......  ..+.+.+|+++++.++|+||+++++++..
T Consensus        14 ~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   91 (285)
T 3is5_A           14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFED   91 (285)
T ss_dssp             CEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence            3333445578999999999999999999999999999999986654221  23578899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe---cCCCCEEEeec
Q 023270           91 DERIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDF  163 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~---~~~~~~~l~d~  163 (284)
                      .+..++||||+++++|.+.+...    ..+++..++.++.|++.||.|||+.|++|+||+|+||++   +.++.++|+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            99999999999999999988543    679999999999999999999999999999999999999   45678999999


Q ss_pred             ccccccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-CC
Q 023270          164 GWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA-PS  240 (284)
Q Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (284)
                      |++.....  ......+++.|+|||.+. ..++.++||||||+++++|++|..||...+..+............... ..
T Consensus       172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (285)
T 3is5_A          172 GLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP  250 (285)
T ss_dssp             CCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred             ecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence            99854332  234456899999999985 568899999999999999999999999998888877766654443332 35


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +++++.+|+.+||..||++|||++++|+||||++.
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            79999999999999999999999999999999873

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5e-51  Score=345.77  Aligned_cols=259  Identities=27%  Similarity=0.477  Sum_probs=206.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      +.++|++++.||+|+||+||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            357899999999999999999999999999999998654321  123467789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           97 ILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ||||++ ++|.+++...      ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999998 5999988764      358999999999999999999999999999999999999999999999999986543


Q ss_pred             C---CCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 023270          171 S---KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-----------  235 (284)
Q Consensus       171 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----------  235 (284)
                      .   ......+++.|+|||++.+. .++.++||||||+++++|++|..||.+.+..+....+.......           
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            2   22345679999999999764 58999999999999999999999999998888777665421100           


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          236 ---------------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       236 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                           .....+++++.+||.+||..||.+|||++++|+||||++...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                 0112578899999999999999999999999999999987543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-50  Score=373.35  Aligned_cols=261  Identities=32%  Similarity=0.566  Sum_probs=233.5

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~   91 (284)
                      ...+.+.+|++++.||.|+||.||+|.+..+++.||||++...........+.+..|..++..+ +|++|+++++++...
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            4567889999999999999999999999999999999999776554444456777888888877 699999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc--
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS--  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~--  169 (284)
                      +.+|+||||+++++|..++...+.+++..++.++.||+.||.|||+.||+|+||||+|||++.++++||+|||++...  
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999999999999889999999999999999999999999999999999999999999999999998642  


Q ss_pred             -CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          170 -RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       170 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                       ........|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..++...+......++.  .+++++.+|
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~l  572 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAI  572 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT--TSCHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHH
Confidence             22334567899999999999999999999999999999999999999999999999999987665554  799999999


Q ss_pred             HHHhcccCCCCCCCH-----HhhhcCcccccc
Q 023270          249 ISRLLVKDSSKRLSL-----QKIMEHPWIIKN  275 (284)
Q Consensus       249 i~~~l~~~p~~Rps~-----~~il~~~~~~~~  275 (284)
                      |++||..||.+||++     ++|++||||+..
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999998     999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.4e-51  Score=346.10  Aligned_cols=258  Identities=31%  Similarity=0.562  Sum_probs=228.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---HHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++........   ...+.+.+|+.+++.++|+||+++++++..++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4579999999999999999999999999999999865432210   1135678999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC----CEEEeecccccccC
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSR  170 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~  170 (284)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++    .++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999888    79999999985543


Q ss_pred             C--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHH
Q 023270          171 S--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAK  246 (284)
Q Consensus       171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  246 (284)
                      .  ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.......+.  ...+++++.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK  250 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence            3  223456899999999999999999999999999999999999999999998888887776544332  146889999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +||.+||..||.+|||++++++||||+..
T Consensus       251 ~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.5e-50  Score=336.79  Aligned_cols=265  Identities=30%  Similarity=0.509  Sum_probs=230.0

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhh------HHHHHHHHHHHHHHHHHHhCC-CCcccceee
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ------IEKYKIQHQLRREMEIQSSLR-HPNILRLYG   86 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~   86 (284)
                      ..-...+|++.+.||.|++|.||+|.+..+++.|++|++....      .......+.+.+|+.+++++. |+||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            3445789999999999999999999999999999999986432      122334567889999999995 999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      ++..++..++|+||+++++|.+++.....++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence            99999999999999999999999998888999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC--CCccccCCCcccCccccC------CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 023270          167 VQSRS--KRHTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA  238 (284)
Q Consensus       167 ~~~~~--~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
                      .....  ......+++.|+|||++.      ...++.++||||||+++++|++|..||...+.......+.........+
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence            55432  233456889999999884      4568899999999999999999999999998888888887766554433


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          239 --PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       239 --~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                        ..+++++.+++.+||..||.+|||++++++||||++....
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence              3689999999999999999999999999999999987543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-50  Score=350.33  Aligned_cols=257  Identities=30%  Similarity=0.550  Sum_probs=227.0

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++.......   ...+.+|+.+++.++|+||+++++++.+++..++
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            3468999999999999999999999999999999986543222   3567899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC--CCCEEEeecccccccCCC-
Q 023270           97 ILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~-  172 (284)
                      ||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.  ++.++|+|||++...... 
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999999987654 7999999999999999999999999999999999999974  467999999998654332 


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSISAEAKHLI  249 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li  249 (284)
                       .....+++.|+|||++.+..++.++||||||+++++|++|..||...+..+....+......+.  ....+++++.+||
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  285 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI  285 (387)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence             2344689999999999999999999999999999999999999999998888888877654433  2346899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .+||..||.+|||++++|+||||+...
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          286 KNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHcCCChhHCcCHHHHhhCccccCCc
Confidence            999999999999999999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-50  Score=340.55  Aligned_cols=257  Identities=34%  Similarity=0.590  Sum_probs=227.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++.+.||+|+||+||++.+..+++.|++|++......   ..+.+.+|+.+++.++|+||+++++++..++..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            346899999999999999999999999999999998654322   23567899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe---cCCCCEEEeecccccccCCC-
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      |+||+++++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            99999999999999888889999999999999999999999999999999999999   77889999999998554332 


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLIS  250 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~  250 (284)
                      .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+..+...++.  .+.+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  243 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC  243 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence            23345899999999999999999999999999999999999999999998888888877554433  3578999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +||..||.+|||++++++||||++..
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHcCCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999999998763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.9e-50  Score=336.03  Aligned_cols=258  Identities=23%  Similarity=0.432  Sum_probs=220.1

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec----C
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----D   91 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~----~   91 (284)
                      .....|++.+.||+|+||+||+|.+..++..|++|++....... ...+.+.+|+.+++.++|+||+++++++..    .
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34455999999999999999999999999999999987655443 335778899999999999999999998864    4


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEec-CCCCEEEeecccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLD-HEGRLKIGDFGWSVQ  168 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~-~~~~~~l~d~~~~~~  168 (284)
                      ...++||||+++++|.+++...+.++...++.++.|++.||.|||+.|  ++|+||+|+||+++ .++.++|+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            578999999999999999998889999999999999999999999999  99999999999997 789999999999855


Q ss_pred             cCCC-CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          169 SRSK-RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       169 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      .... .....+++.|+|||++.+ .++.++||||||+++++|++|..||...... ...................++++.
T Consensus       182 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  260 (290)
T 1t4h_A          182 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence            4433 234568999999998864 5899999999999999999999999885544 444444444333334456789999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +++.+||..||.+|||++++++||||++.
T Consensus       261 ~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-50  Score=344.85  Aligned_cols=254  Identities=34%  Similarity=0.612  Sum_probs=202.8

Q ss_pred             ccCcEee---eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCe
Q 023270           18 LQDFEIG---RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDER   93 (284)
Q Consensus        18 ~~~y~~~---~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~   93 (284)
                      .++|++.   +.||+|+||+||+|.+..+++.||+|++....      ...+.+|+..++.+. ||||+++++++.+++.
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            3567775   78999999999999999999999999986542      235668899999997 9999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---CEEEeecccccccC
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSR  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~  170 (284)
                      .++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++   .++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999999999999999999999999999999999999999999999999999998766   89999999985433


Q ss_pred             C---CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCCCCCCC--
Q 023270          171 S---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-------QKDTFRRIMKVDLSFPSA--  238 (284)
Q Consensus       171 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~--  238 (284)
                      .   ......+++.|+|||++.+..++.++||||||+++++|++|..||...+       ..+....+..+...+...  
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (325)
T 3kn6_A          161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW  240 (325)
T ss_dssp             C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred             CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc
Confidence            2   2234557899999999999999999999999999999999999997643       345666666655443322  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ..+++++.+||.+||..||.+|||++++++||||++...
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            358999999999999999999999999999999998643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.5e-50  Score=363.22  Aligned_cols=262  Identities=34%  Similarity=0.590  Sum_probs=228.4

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH----------HHHHHHHHHHHHHHhCCCCccccee
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----------KIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~----------~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      ....+|++++.||+|+||+||+|.+..++..||+|++........          ...+.+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            346789999999999999999999999999999999876543321          2346788999999999999999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---CEEEee
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGD  162 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~~~l~d  162 (284)
                      +++.+++..++||||+++++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++   .++|+|
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999999999999999999999888999999999999999999999999999999999999998876   699999


Q ss_pred             cccccccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--C
Q 023270          163 FGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--A  238 (284)
Q Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~  238 (284)
                      ||++.....  ......|++.|+|||++. ..++.++||||+|+++|+|++|..||.+.+..+....+..+...++.  +
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW  271 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence            999865433  234456899999999986 46899999999999999999999999999999999998887655443  2


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ..+++++.+||++||.+||.+|||++++|+||||++....
T Consensus       272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            4789999999999999999999999999999999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-50  Score=347.40  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=219.9

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-----CCcccceeeEEe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-----HPNILRLYGWFH   89 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-----h~~i~~~~~~~~   89 (284)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++.....    ..+....|+.+++.+.     |+||+++++++.
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH----HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh----hhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            3445789999999999999999999999999999999864321    2345667888888886     999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-------------
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-------------  154 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-------------  154 (284)
                      ..+..++|||++ +++|.+++....  .++...++.++.||+.||.|||+.|++|+||||+||+++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 789999998764  5899999999999999999999999999999999999975             


Q ss_pred             ------------CCCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH
Q 023270          155 ------------EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK  222 (284)
Q Consensus       155 ------------~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~  222 (284)
                                  ++.++|+|||++...........+++.|+|||++.+..++.++||||||+++++|++|..||...+..
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  265 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM  265 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence                        78999999999977666666778899999999999999999999999999999999999999998887


Q ss_pred             HHHHHHHhcCCCCCC--------------------------C------------------CCCCHHHHHHHHHhcccCCC
Q 023270          223 DTFRRIMKVDLSFPS--------------------------A------------------PSISAEAKHLISRLLVKDSS  258 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~--------------------------~------------------~~~~~~l~~li~~~l~~~p~  258 (284)
                      +....+.......+.                          .                  ...++.+.+||.+||+.||.
T Consensus       266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  345 (360)
T 3llt_A          266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT  345 (360)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence            777666553322211                          0                  01237788999999999999


Q ss_pred             CCCCHHhhhcCcccc
Q 023270          259 KRLSLQKIMEHPWII  273 (284)
Q Consensus       259 ~Rps~~~il~~~~~~  273 (284)
                      +|||++++|+||||+
T Consensus       346 ~Rpta~elL~hp~f~  360 (360)
T 3llt_A          346 LRPSPAELLKHKFLE  360 (360)
T ss_dssp             GSCCHHHHTTSGGGC
T ss_pred             hCCCHHHHhcCcccC
Confidence            999999999999996

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.9e-50  Score=346.53  Aligned_cols=257  Identities=31%  Similarity=0.557  Sum_probs=226.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhh-----HHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-----IEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~   91 (284)
                      ..+|++.+.||.|++|.||+|.+..+|+.||||++....     .......+.+.+|+.+++.+ +|+||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            357999999999999999999998899999999985432     12234456788999999998 799999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +..++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999998854432


Q ss_pred             --CCccccCCCcccCccccC------CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCC
Q 023270          172 --KRHTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSI  241 (284)
Q Consensus       172 --~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  241 (284)
                        ......|++.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+..+...+..  +..+
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence              334456899999999885      335788999999999999999999999998888888887776554433  2468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ++++.+++.+||..||.+|||++++|+||||++
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            899999999999999999999999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.7e-50  Score=340.94  Aligned_cols=255  Identities=30%  Similarity=0.548  Sum_probs=224.1

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|...+.||+|+||.||+|.+..+++.||||++......   ..+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            388889999999999999999989999999998654322   23567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCccc
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTM  176 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~~  176 (284)
                      |+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   .....
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            9999999998865 5689999999999999999999999999999999999999999999999998754332   22345


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-FPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .|++.|+|||++.+..++.++||||||+++++|++|..||...+.......+...... ......+++++.+++.+||..
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            6899999999999999999999999999999999999999998888877777665332 223346889999999999999


Q ss_pred             CCCCCCCHHhhhcCccccccCCC
Q 023270          256 DSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       256 ~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ||++|||++++++||||++...|
T Consensus       282 dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          282 DPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             STTTSCCHHHHHTSGGGGGCCCG
T ss_pred             ChhhCcCHHHHhcChhhccCCCc
Confidence            99999999999999999987544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-50  Score=347.58  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=217.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----   92 (284)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+.+|+.+++.++|+||+++++++..++     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            57899999999999999999999999999999998554322 234567889999999999999999999997653     


Q ss_pred             -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                       .+|+|||++ +++|.+++.. ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 6799998877 5789999999999999999999999999999999999999999999999999977666


Q ss_pred             CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 023270          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF---------------  235 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------------  235 (284)
                      ......+++.|+|||++.+ ..++.++||||+|+++++|++|..||.+.+..+.+..+.......               
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence            6666778999999999877 678999999999999999999999999988877776655421111               


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          236 --------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       236 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                    ...+..++++.+|+.+||..||.+|||++++|+||||++..++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                          0123578999999999999999999999999999999986543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.8e-50  Score=361.17  Aligned_cols=260  Identities=33%  Similarity=0.600  Sum_probs=228.8

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++..++.+++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            4578999999999999999999999999999999986544322 124577899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec---CCCCEEEeecccccccCC--
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRS--  171 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~--  171 (284)
                      |+||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||++.....  
T Consensus        99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            999999999999998888999999999999999999999999999999999999995   456799999999854432  


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLI  249 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  249 (284)
                      ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..+...+..  +..+++++.+||
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  257 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI  257 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHH
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHH
Confidence            2234568999999999875 5899999999999999999999999999999999988887655443  346899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .+||..||.+|||++++|+||||++....
T Consensus       258 ~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          258 RKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             HHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             HHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence            99999999999999999999999986543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-50  Score=363.12  Aligned_cols=260  Identities=30%  Similarity=0.487  Sum_probs=228.6

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...+..++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++.+++
T Consensus       178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  257 (576)
T 2acx_A          178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD  257 (576)
T ss_dssp             TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence            44578899999999999999999999999999999999997765544444567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 RIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      .+|+||||+++++|.+++...+  .+++..++.++.||+.||.|||++||+|+||+|+||+++.+|.+||+|||++....
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999999998754  49999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES----QKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ..  .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....    ...+...+......+  +..++++
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~--p~~~s~~  415 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY--SERFSPQ  415 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC--CTTSCHH
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC--CccCCHH
Confidence            22  234578999999999999889999999999999999999999998753    344555554443333  3579999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHhhhcCccccc
Q 023270          245 AKHLISRLLVKDSSKRL-----SLQKIMEHPWIIK  274 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~  274 (284)
                      +.+||.+||..||.+||     +++++++||||++
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            99999999999999999     8999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.6e-51  Score=348.36  Aligned_cols=261  Identities=30%  Similarity=0.532  Sum_probs=223.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH--HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      .++|++.+.||+|+||+||+|.+..++..||+|++......  .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46799999999999999999999999999999998765432  2334578889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 023270           96 LILEYAHRGELYRELRKH----------------------------------------RRFTEQQAATYIASLTNALAYC  135 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~----------------------------------------~~l~~~~~~~i~~~i~~~l~~l  135 (284)
                      +||||+++++|.+++...                                        ..+++..++.++.|++.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999988521                                        1236778889999999999999


Q ss_pred             HhCCccccCCCCCCeEecCCC--CEEEeecccccccCC-------CCccccCCCcccCccccCC--CCCCchhhHhhHHH
Q 023270          136 HENHVIHRDIKPENLLLDHEG--RLKIGDFGWSVQSRS-------KRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGI  204 (284)
Q Consensus       136 h~~gi~H~dl~p~nil~~~~~--~~~l~d~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~  204 (284)
                      |+.|++|+||+|+||+++.++  .++|+|||++.....       ......+++.|+|||.+.+  ..++.++||||||+
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998777  899999999854321       1234568999999999865  66899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          205 LCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       205 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ++++|++|..||...+..+..............+.  .+++++.+||.+||..||.+|||++++|+||||++..+.
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            99999999999999999998888888765554432  479999999999999999999999999999999987654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=339.75  Aligned_cols=262  Identities=25%  Similarity=0.415  Sum_probs=210.5

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH--HHHHHHHHHHHHHH---HhCCCCcccceeeEEe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK--YKIQHQLRREMEIQ---SSLRHPNILRLYGWFH   89 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~~~~~~---~~l~h~~i~~~~~~~~   89 (284)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++.......  ......+.+|+..+   +.++|+||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            355689999999999999999999999999999999986432110  00011233444444   4456999999999987


Q ss_pred             cCC-----eEEEEEeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           90 DDE-----RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        90 ~~~-----~~~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                      ...     ..++|+|+++ ++|.+++.....  +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            655     5899999997 599999988654  89999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 023270          163 FGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---  237 (284)
Q Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---  237 (284)
                      ||++.....  ......+++.|+|||++.+..++.++||||||+++++|++|..||...+..+....+.......+.   
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999854432  233456899999999999999999999999999999999999999999988888777653211110   


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          238 ----------------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       238 ----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                            .+.+++++.+||.+||..||.+|||++++|+||||++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence                                  1357899999999999999999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-51  Score=366.39  Aligned_cols=262  Identities=33%  Similarity=0.600  Sum_probs=232.0

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .....+|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34557899999999999999999999999999999998654433223346788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe---cCCCCEEEeecccccccCC
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~  171 (284)
                      ++|+||+.+++|.+.+...+.+++..++.++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999999999998899999999999999999999999999999999999999   5678999999999854432


Q ss_pred             C--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHH
Q 023270          172 K--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKH  247 (284)
Q Consensus       172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  247 (284)
                      .  .....|++.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+....+..+...+..  +..+++++++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            2  234568999999999866 6899999999999999999999999999999999998887655543  3468999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ||++||..||.+|||++++|+||||++...
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            999999999999999999999999987643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-50  Score=348.69  Aligned_cols=266  Identities=28%  Similarity=0.432  Sum_probs=227.7

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ......++...+|++.+.||+|+||+||++.+..++..||+|++.....  ....+.+.+|+.+++.++|+||+++++++
T Consensus        23 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  100 (360)
T 3eqc_A           23 QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAF  100 (360)
T ss_dssp             HHHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             hhhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence            3455678888999999999999999999999999999999999865432  23356788999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ..++..++||||+++++|.+++...+.++...+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||++.
T Consensus       101 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            99999999999999999999999988899999999999999999999986 99999999999999999999999999874


Q ss_pred             ccC-CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHH---------------------
Q 023270          168 QSR-SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------------  225 (284)
Q Consensus       168 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~---------------------  225 (284)
                      ... .......+++.|+|||++.+..++.++||||||+++++|++|..||...+..+..                     
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            332 2233456899999999999999999999999999999999999999876654432                     


Q ss_pred             ---------------------HHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          226 ---------------------RRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       226 ---------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                           ...............++.++.+||.+||..||.+|||++++|+||||++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                 222222223333345789999999999999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.4e-50  Score=358.99  Aligned_cols=260  Identities=28%  Similarity=0.458  Sum_probs=230.0

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...+...+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++...+
T Consensus       179 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             TSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            35678899999999999999999999999999999999997766554444567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           93 RIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      .+|+||||+++++|..++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.+|.+||+|||++..
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence            999999999999999999764    3699999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCCCCC
Q 023270          169 SRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       169 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      ....   .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...    ...+....+......++  +.+
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~  416 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKF  416 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTS
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--ccc
Confidence            4322   23347899999999999999999999999999999999999999875    34566666666554443  479


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHhhhcCccccc
Q 023270          242 SAEAKHLISRLLVKDSSKRLS-----LQKIMEHPWIIK  274 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps-----~~~il~~~~~~~  274 (284)
                      ++++.+||++||..||.+||+     ++++++||||++
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            999999999999999999996     589999999997

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-50  Score=335.23  Aligned_cols=260  Identities=30%  Similarity=0.553  Sum_probs=222.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++.+.||+|+||.||+|.+..+++.|++|++......  ...+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            46899999999999999999999999999999998654432  2346788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-----CC
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----SK  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-----~~  172 (284)
                      +||+++++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....     ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            9999999999999887789999999999999999999999999999999999999999999999999985432     12


Q ss_pred             CccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      .....+++.|+|||.+.+..+ +.++||||||+++++|++|..||...... ..................+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            234568899999999987775 77999999999999999999999876553 2333344333333334568999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      +||..||.+|||++++++||||++.....
T Consensus       244 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          244 KILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             HHCCCCchhCCCHHHHhcCccccChhhcc
Confidence            99999999999999999999999875543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-50  Score=361.38  Aligned_cols=256  Identities=35%  Similarity=0.640  Sum_probs=222.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++++.||+|+||+||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++..++..++|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            346999999999999999999999999999999987544322 1245678999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC---CCEEEeecccccccCC--C
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRS--K  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~--~  172 (284)
                      |||+++++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++..   +.++|+|||++.....  .
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            9999999999999888899999999999999999999999999999999999999764   4599999999855432  2


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCCHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLIS  250 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  250 (284)
                      .....|++.|+|||++. ..++.++||||+|+++|+|++|..||.+.+..+....+..+...+..+  ..+++++.+||.
T Consensus       195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  273 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK  273 (494)
T ss_dssp             BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence            33456899999999986 468999999999999999999999999999999999988876655443  478999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCcccccc
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +||..||.+|||++++|+||||++.
T Consensus       274 ~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          274 QMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHCCCChhhCccHHHHhcCcccccC
Confidence            9999999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.1e-50  Score=336.41  Aligned_cols=263  Identities=25%  Similarity=0.363  Sum_probs=213.5

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      .++..++|++.+.||+|+||+||+|.+..+++.||+|++....... ...+.+.++...++.++|+||+++++++..++.
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            4678899999999999999999999999999999999986653333 234455566666888999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           94 IFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      .++||||+++ +|.+++..    ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999999974 88777654    46799999999999999999999998 999999999999999999999999999854


Q ss_pred             cCC--CCccccCCCcccCcccc----CCCCCCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCCC
Q 023270          169 SRS--KRHTMCGTLDYLAPEMV----ENKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       169 ~~~--~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      ...  ......+++.|+|||.+    .+..++.++||||||+++++|++|..||.. ......................+
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            432  22334688999999996    556689999999999999999999999986 45555555555555555555678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ++++.+++.+||..||.+|||++++++||||+.....
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~  276 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK  276 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence            9999999999999999999999999999999876443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=340.50  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=208.0

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ..++|++.++||+|+||+||+|.+..+++.||||++...........+.+.+.....+..+|+||+++++++.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            33679999999999999999999999999999999865443343334444444444555599999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--C
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--R  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~  173 (284)
                      |||+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......  .
T Consensus       135 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          135 QTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             EEECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             EEeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence            999995 5888887665 46999999999999999999999999999999999999999999999999998554332  2


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ....|++.|+|||++.+ .++.++||||||+++++|++|..++...   .....+............+++++.+++.+||
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  289 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGLSSELRSVLVMML  289 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence            33458999999999876 6899999999999999999997665543   2333344333333334568999999999999


Q ss_pred             ccCCCCCCCHHhhhcCccccc
Q 023270          254 VKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       254 ~~~p~~Rps~~~il~~~~~~~  274 (284)
                      .+||.+|||++++|+||||++
T Consensus       290 ~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          290 EPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCChhhCcCHHHHHhCccccC
Confidence            999999999999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-50  Score=349.75  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=209.9

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCC-
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE-   92 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~-   92 (284)
                      ....++|++++.||.|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+. |+||+++++++..++ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            455789999999999999999999999999999999985433222 23456778999999997 999999999997544 


Q ss_pred             -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                       .+|+||||++ ++|..++.. ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence             7899999997 589988876 5789999999999999999999999999999999999999999999999999854321


Q ss_pred             ------------------------CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 023270          172 ------------------------KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR  226 (284)
Q Consensus       172 ------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~  226 (284)
                                              ......+++.|+|||++.+ ..++.++|||||||++++|++|.+||.+.+..+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                                    1123468899999999986 568999999999999999999999999988887777


Q ss_pred             HHHhcCCCCC---------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          227 RIMKVDLSFP---------------------------------------------SAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       227 ~~~~~~~~~~---------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      .+......+.                                             ....+++++.+|+++||..||.+||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            7654211110                                             1125788999999999999999999


Q ss_pred             CHHhhhcCcccccc
Q 023270          262 SLQKIMEHPWIIKN  275 (284)
Q Consensus       262 s~~~il~~~~~~~~  275 (284)
                      |++++|+||||+.-
T Consensus       322 t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          322 SANDALKHPFVSIF  335 (388)
T ss_dssp             CHHHHTTSTTTTTT
T ss_pred             CHHHHhCCHHHHHh
Confidence            99999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=344.82  Aligned_cols=258  Identities=27%  Similarity=0.486  Sum_probs=215.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +++|++++.||+|+||+||+|.+..+++.||+|++......  .....+.+|+.+++.++|+||+++++++..++..++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            47899999999999999999999999999999998654321  1122445789999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---C
Q 023270           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---~  173 (284)
                      |||++ ++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            99998 5888888775 46899999999999999999999999999999999999999999999999998544322   2


Q ss_pred             ccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------------
Q 023270          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---------------  237 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------  237 (284)
                      ....+++.|+|||++.+ ..++.++||||||+++++|++|..||.+.+..+....+.........               
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            33457899999999876 56899999999999999999999999999888877776553211110               


Q ss_pred             -------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          238 -------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       238 -------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                   .+.+++++.+||.+||..||.+|||++++|+||||++..++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                         12478899999999999999999999999999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-50  Score=342.76  Aligned_cols=262  Identities=23%  Similarity=0.452  Sum_probs=220.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC--CcccceeeEEec
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHD   90 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h--~~i~~~~~~~~~   90 (284)
                      ...+..++|++.+.||+|+||.||++.+ .+++.||+|++....... ...+.+.+|+.+++.++|  +||+++++++..
T Consensus         3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            3 CISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             CEESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             eeeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            3456788999999999999999999988 568899999986544333 345678899999999986  999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ++..++|||+ .+++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus        81 ~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           81 DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             CCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            9999999995 5679999999988999999999999999999999999999999999999996 6889999999985543


Q ss_pred             CCC-----ccccCCCcccCccccCC-----------CCCCchhhHhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCC
Q 023270          171 SKR-----HTMCGTLDYLAPEMVEN-----------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDL  233 (284)
Q Consensus       171 ~~~-----~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~  233 (284)
                      ...     ....|++.|+|||++.+           ..++.++||||||+++++|++|..||..... ............
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            222     24468999999999864           6688999999999999999999999987543 345555555555


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ....+...++++.+|+.+||..||.+|||++++|+||||+....|
T Consensus       239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            555666788999999999999999999999999999999876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-50  Score=336.27  Aligned_cols=258  Identities=32%  Similarity=0.596  Sum_probs=224.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---HHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      ++|++.+.||+|+||.||++.+..+++.|++|++........   ...+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999865432211   12357889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC----CEEEeecccccccCC
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSRS  171 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~~  171 (284)
                      +|+||+++++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||+++.++    .++|+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999998877    899999999855432


Q ss_pred             --CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHH
Q 023270          172 --KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKH  247 (284)
Q Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  247 (284)
                        ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.........  .+.+++.+.+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD  244 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence              223445889999999999999999999999999999999999999999988888877765443332  2467899999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ++.+||..||.+|||++++++||||++..
T Consensus       245 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            99999999999999999999999998753

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-50  Score=342.91  Aligned_cols=266  Identities=26%  Similarity=0.402  Sum_probs=217.0

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH--HHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK--YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .....+|++.+.||+|+||.||++.+..+++.||+|++.......  ....+.+.+|+.+++.++|+||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            445789999999999999999999999999999999996543322  122346778999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ..++|+||+++ +|...+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            99999999985 888888765 4689999999999999999999999999999999999999999999999999865432


Q ss_pred             ---CCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----------
Q 023270          172 ---KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS----------  237 (284)
Q Consensus       172 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------  237 (284)
                         ......+++.|+|||++.+. .++.++||||||+++++|++|.+||.+.+..+.+..+.........          
T Consensus       165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence               22345689999999998764 4899999999999999999999999999888887776653111100          


Q ss_pred             ----------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCCC
Q 023270          238 ----------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  281 (284)
Q Consensus       238 ----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (284)
                                      ...+++++.+||.+||..||.+|||++++|+||||++.+.|...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~  304 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG  304 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCc
Confidence                            13467899999999999999999999999999999987655433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-50  Score=345.76  Aligned_cols=252  Identities=31%  Similarity=0.563  Sum_probs=218.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~   95 (284)
                      ...+|++.+.||.|+||.||+|.+..+++.||+|++......       ..+|++++.++ +||||+++++++.+++..|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            356799999999999999999999999999999998654322       23566667666 7999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC----CCEEEeecccccccCC
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWSVQSRS  171 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~----~~~~l~d~~~~~~~~~  171 (284)
                      +||||+++++|.+.+...+.+++..+..++.||+.||.|||+.|++|+||+|+||++..+    +.++|+|||++.....
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999999999988899999999999999999999999999999999999998543    3599999999864332


Q ss_pred             ---CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCCCCC--CCCCCH
Q 023270          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA---ESQKDTFRRIMKVDLSFPS--APSISA  243 (284)
Q Consensus       172 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~  243 (284)
                         ......+++.|+|||++.+..++.++||||||+++|+|++|..||..   .+..+....+..+....+.  ++.+++
T Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  252 (342)
T 2qr7_A          173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD  252 (342)
T ss_dssp             TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred             CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence               23345689999999999888889999999999999999999999975   4566777777776655443  357899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ++.+||++||..||++|||++++++||||++.
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            99999999999999999999999999999763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.2e-50  Score=334.53  Aligned_cols=266  Identities=26%  Similarity=0.411  Sum_probs=226.8

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ..++...+|++.+.||+|+||.||++.+..++..||+|++...........+.+.+|+..++.++||||+++++++..++
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD   84 (294)
T ss_dssp             CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred             hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence            34566789999999999999999999999999999999986544444455678899999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..++||||+++++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999998544322


Q ss_pred             ----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCCCCCHHH
Q 023270          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---SAPSISAEA  245 (284)
Q Consensus       173 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l  245 (284)
                          .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+......+.........   ..+.+|+.+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence                2234589999999999999999999999999999999999999999888877766665433221   235689999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .+++.+||..||.+||+..+.+.++|..-..+.
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            999999999999999977777777665544333

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.9e-50  Score=346.13  Aligned_cols=252  Identities=29%  Similarity=0.578  Sum_probs=217.5

Q ss_pred             cEe--eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           21 FEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        21 y~~--~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      |.+  .+.||+|+||.||+|.+..++..||+|++......   ..+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus        89 ~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             EEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            444  67899999999999999999999999998764432   2457889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe--cCCCCEEEeecccccccCC--CC
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL--DHEGRLKIGDFGWSVQSRS--KR  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~--~~~~~~~l~d~~~~~~~~~--~~  173 (284)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++.....  ..
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            999999999888664 468999999999999999999999999999999999999  5667899999999865432  22


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHH
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLISR  251 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  251 (284)
                      ....|++.|+|||++.+..++.++||||||+++++|++|..||...+..+.+..+.......+.  ...+++++.+||.+
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  325 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK  325 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence            3446899999999999888999999999999999999999999999999888888876544332  24689999999999


Q ss_pred             hcccCCCCCCCHHhhhcCcccccc
Q 023270          252 LLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||..||.+|||++++|+||||++.
T Consensus       326 ~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          326 LLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.4e-51  Score=344.21  Aligned_cols=264  Identities=26%  Similarity=0.427  Sum_probs=226.7

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      .......++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A            5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            34556678999999999999999999999999999999999776555555567888999999999999999999998755


Q ss_pred             C----eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           92 E----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        92 ~----~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      +    ..++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            4    349999999999999999988899999999999999999999999999999999999999999999999999985


Q ss_pred             ccCCC------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CC
Q 023270          168 QSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--AP  239 (284)
Q Consensus       168 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~  239 (284)
                      .....      .....|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+............+.  ..
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            43221      12345799999999999999999999999999999999999999999888877777665433322  24


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      .+++++.+++.+||..||.+||++.+++.|+|++..
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            589999999999999999999999999999999854

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.5e-50  Score=339.58  Aligned_cols=256  Identities=34%  Similarity=0.613  Sum_probs=213.1

Q ss_pred             ccCcEee-eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEE
Q 023270           18 LQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        18 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~   95 (284)
                      ..+|++. +.||+|+||+||+|.+..+++.||+|++......   ..+.+.+|++++.++ +|+||+++++++..++..+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4679995 7899999999999999999999999998654322   235677899999884 7999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC---EEEeecccccccCC-
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRS-  171 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~-  171 (284)
                      +||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|+|||++..... 
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998888999999999999999999999999999999999999988776   99999998743321 


Q ss_pred             ---------CCccccCCCcccCccccCC-----CCCCchhhHhhHHHHHHHHHhCCCCCCCCC---------------hH
Q 023270          172 ---------KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAES---------------QK  222 (284)
Q Consensus       172 ---------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~---------------~~  222 (284)
                               ......+++.|+|||++.+     ..++.++||||||+++++|++|..||....               ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence                     1123458899999999865     457899999999999999999999997754               23


Q ss_pred             HHHHHHHhcCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          223 DTFRRIMKVDLSFPSA--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .....+......++..  ..+++++.+|+.+||..||.+|||++++|+||||++..
T Consensus       248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            4455555554444321  36889999999999999999999999999999999764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.5e-50  Score=342.47  Aligned_cols=265  Identities=25%  Similarity=0.418  Sum_probs=220.4

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec---
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD---   90 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~---   90 (284)
                      ..-.+.+|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+++.++|+||+++++++..   
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            3346789999999999999999999999999999999986543222 123456689999999999999999999876   


Q ss_pred             -----CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecc
Q 023270           91 -----DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        91 -----~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                           ++..++||||+++ +|...+... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence                 4578999999985 777766654 679999999999999999999999999999999999999999999999999


Q ss_pred             cccccC-------CCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 023270          165 WSVQSR-------SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP  236 (284)
Q Consensus       165 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  236 (284)
                      ++....       .......+++.|+|||++.+. .++.++||||||+++++|++|..||.+.+.......+.......+
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            985432       122334578999999998764 579999999999999999999999999988877777655322221


Q ss_pred             C--CCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCC
Q 023270          237 S--APS----------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  280 (284)
Q Consensus       237 ~--~~~----------------------------~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (284)
                      .  .+.                            .++++.+||.+||..||.+|||++++|+||||+..+.|..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence            1  111                            2678999999999999999999999999999998877654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2e-49  Score=334.68  Aligned_cols=262  Identities=24%  Similarity=0.424  Sum_probs=221.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ....++...+|++.+.||+|+||+||+|.+  ++..||+|++....... ...+.+.+|+.++++++|+||+++++++..
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            345678889999999999999999999976  67889999986654333 335678899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCCCCEEEeeccc
Q 023270           91 DERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      ++..++||||+++++|.+++...+.   +++..++.++.|++.||.|||+.|  ++|+||+|+||+++.++.++|+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            9999999999999999999987643   899999999999999999999999  99999999999999999999999999


Q ss_pred             ccccCCC---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          166 SVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       166 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      +......   .....|++.|+|||++.+..++.++||||||+++++|++|..||...+..+..............+..++
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN  265 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred             CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence            8543322   2345689999999999999999999999999999999999999999999888888766666666677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhc--Ccccccc
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIME--HPWIIKN  275 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~--~~~~~~~  275 (284)
                      +++.+|+.+||..||.+|||++++++  .++++..
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            99999999999999999999999998  4666544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-49  Score=345.40  Aligned_cols=261  Identities=23%  Similarity=0.455  Sum_probs=219.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC--CCcccceeeEEecC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--HPNILRLYGWFHDD   91 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~--h~~i~~~~~~~~~~   91 (284)
                      ..+...+|++.+.||.|+||+||++.+.. +..||||++....... ...+.+.+|+.+++.+.  |+||+++++++..+
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccH-HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            44556779999999999999999999864 8899999986544332 34567889999999996  59999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +.+++||| +.+++|.+++.....++...++.++.||+.||.|||+.||+|+||+|+|||++ ++.+||+|||++.....
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             CEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99999999 45789999999988999999999999999999999999999999999999994 68999999999865432


Q ss_pred             C-----CccccCCCcccCccccCC-----------CCCCchhhHhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCC
Q 023270          172 K-----RHTMCGTLDYLAPEMVEN-----------KEHDYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFRRIMKVDLS  234 (284)
Q Consensus       172 ~-----~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~  234 (284)
                      .     .....|++.|+|||++.+           ..++.++||||||+++|+|++|..||.... ....+..+......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            2     234568999999999865           368899999999999999999999998754 34556666666555


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ...+...++++.+||.+||..||.+|||++++|+||||+....|
T Consensus       287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            55566678999999999999999999999999999999876544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5e-50  Score=345.85  Aligned_cols=258  Identities=24%  Similarity=0.426  Sum_probs=202.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------   91 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~------   91 (284)
                      ..+|++++.||.|+||.||+|.+..+++.||||++...... ....+.+.+|+.+++.++|+||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            47899999999999999999999999999999998654322 23346778999999999999999999998654      


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ...++|+|++ +++|.+++.. +.++...++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 5799988876 6799999999999999999999999999999999999999999999999999876655


Q ss_pred             CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 023270          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF---------------  235 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------------  235 (284)
                      ......+++.|+|||++.+ ..++.++||||||+++++|++|..||.+.+..+.+..+......+               
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  264 (367)
T 2fst_X          185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  264 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred             cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence            5556678999999999877 668999999999999999999999999988877766655421110               


Q ss_pred             --------CC------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          236 --------PS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       236 --------~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                              +.      .+..++++.+||++||..||.+|||++++|+||||++..+|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                    00      12468899999999999999999999999999999986543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.8e-50  Score=354.42  Aligned_cols=256  Identities=22%  Similarity=0.374  Sum_probs=211.9

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----   91 (284)
                      ..++|++++.||.|+||+||+|.+..+++.||||++....... ...+.+.+|+.+++.++|+||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh-HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            4688999999999999999999999999999999997543222 3456788999999999999999999998654     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       ...|+||||+++ .|...+..  .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             467999999986 56666643  48999999999999999999999999999999999999999999999999986544


Q ss_pred             CC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 023270          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP------------  236 (284)
Q Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------------  236 (284)
                      ..  .....+++.|+|||++.+..++.++||||||+++++|++|..||.+.+..+.+..+........            
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            32  3445789999999999999999999999999999999999999999888777776654211110            


Q ss_pred             -------CCCC---------------------CCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          237 -------SAPS---------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       237 -------~~~~---------------------~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                             ....                     .++++.+||++||..||++|||++++|+||||+...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                   0000                     156799999999999999999999999999998643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.3e-50  Score=336.91  Aligned_cols=267  Identities=27%  Similarity=0.427  Sum_probs=200.8

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      +...++.+...+|++.+.||.|+||.||++.+..+++.|++|++......  ...+.+.+|+..++.++|+||+++++++
T Consensus         5 s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A            5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             --------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred             ccccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            34567788899999999999999999999999999999999998654322  2346778899999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEE
Q 023270           89 HDDERIFLILEYAHRGELYRELRK--------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI  160 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l  160 (284)
                      ..++..++||||+++++|.+++..        ...++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence            999999999999999999999874        356899999999999999999999999999999999999999999999


Q ss_pred             eecccccccCC--------CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 023270          161 GDFGWSVQSRS--------KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV  231 (284)
Q Consensus       161 ~d~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  231 (284)
                      +|||++.....        ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||...............
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            99998743321        1123458899999999875 56899999999999999999999999887776665555443


Q ss_pred             CCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          232 DLSF--------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       232 ~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ....        .....+++++.+++.+||..||.+|||++++++||||++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            3221        112467899999999999999999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=336.03  Aligned_cols=262  Identities=28%  Similarity=0.471  Sum_probs=221.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEec
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD   90 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~   90 (284)
                      .......++|++.+.||.|+||.||+|.+..+++.|++|++......    .+.+.+|+..++.+ +|+||+++++++..
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            34445667899999999999999999999999999999998654322    24677889999988 79999999999876


Q ss_pred             ------CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           91 ------DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        91 ------~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                            .+..++||||+++++|.+++...  ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                  56899999999999999999875  5789999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC---CCccccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 023270          163 FGWSVQSRS---KRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS  234 (284)
Q Consensus       163 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  234 (284)
                      ||++.....   ......+++.|+|||++.     +..++.++||||||+++++|++|..||...+.......+......
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            999854432   223446889999999987     566889999999999999999999999988888777777666555


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          235 FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      ......+++++.++|.+||..||.+|||++++++||||++.+.
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            5555678999999999999999999999999999999998653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.6e-49  Score=346.57  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=217.4

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC------CCCcccceeeEEe
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL------RHPNILRLYGWFH   89 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l------~h~~i~~~~~~~~   89 (284)
                      ....+|++.+.||.|+||+||+|.+..+++.||||++......    .+.+.+|+++++.+      +|+||+++++++.
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch----HHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            4456799999999999999999999999999999999654322    23455666666655      5779999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC--EEEeeccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGW  165 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~--~~l~d~~~  165 (284)
                      ..+..++|||+++ ++|.+++....  .+++..++.++.||+.||.|||+.|++|+||||+|||++.++.  ++|+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999997 58999888764  5899999999999999999999999999999999999999987  99999999


Q ss_pred             ccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 023270          166 SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---------  236 (284)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  236 (284)
                      +...........+++.|+|||++.+..++.++||||||+++++|++|.+||.+.+..+.+..+.......+         
T Consensus       249 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~  328 (429)
T 3kvw_A          249 SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR  328 (429)
T ss_dssp             CEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred             ceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence            97776666677899999999999999999999999999999999999999999888877766554211100         


Q ss_pred             ------------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          237 ------------------------------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       237 ------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                                                                      .....++++.+||++||.+||++|||++|+|+
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence                                                            00123788999999999999999999999999


Q ss_pred             CccccccC
Q 023270          269 HPWIIKNA  276 (284)
Q Consensus       269 ~~~~~~~~  276 (284)
                      ||||++..
T Consensus       409 Hpw~~~~~  416 (429)
T 3kvw_A          409 HPWLRRRL  416 (429)
T ss_dssp             STTTC---
T ss_pred             ChhhccCC
Confidence            99999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-49  Score=331.54  Aligned_cols=259  Identities=27%  Similarity=0.525  Sum_probs=220.8

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH-HHHHHHHHHHHHHHHhCCCCcccceeeEEe--cCCe
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPNILRLYGWFH--DDER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~--~~~~   93 (284)
                      ..++|++.+.||+|+||.||++.+..++..|++|++....... ......+.+|+.+++.++|+||+++++++.  +.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999999999999999997654332 234567889999999999999999999984  4568


Q ss_pred             EEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           94 IFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      .++||||++++ |.+++...  ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999999865 77777653  5689999999999999999999999999999999999999999999999999854322


Q ss_pred             -----CCccccCCCcccCccccCCCC--CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          172 -----KRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       172 -----~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                           ......+++.|+|||++.+..  .+.++||||||+++++|++|..||...+..+....+.......  +..++++
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~  239 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI--PGDCGPP  239 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--CSSSCHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC--CCccCHH
Confidence                 223445889999999997654  3789999999999999999999999999888888877765443  3478999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +.+++.+||..||.+|||++++++||||++...+
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            9999999999999999999999999999886543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.3e-49  Score=332.12  Aligned_cols=262  Identities=28%  Similarity=0.471  Sum_probs=221.8

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ...-...+|++.+.||.|+||.||+|.+..++..|++|++.....   ...+.+.+|+.+++.++||||+++++++..++
T Consensus        13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            334456789999999999999999999999999999999865432   22457788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-
Q 023270           93 RIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-  170 (284)
                      ..++|+||+++++|.+++.. ...++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... 
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999998876 4679999999999999999999999999999999999999999999999999863221 


Q ss_pred             --CCCccccCCCcccCcccc-----CCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCCCCC
Q 023270          171 --SKRHTMCGTLDYLAPEMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-PSAPSIS  242 (284)
Q Consensus       171 --~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  242 (284)
                        .......+++.|+|||++     .+..++.++||||||+++++|++|..||...+............... ..+..++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence              122344688999999998     46678999999999999999999999999988888777776654332 2334678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .++.+++.+||..||.+|||++++++||||++...
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            99999999999999999999999999999998643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-49  Score=330.59  Aligned_cols=260  Identities=29%  Similarity=0.496  Sum_probs=225.4

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe--cCCeE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH--DDERI   94 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~--~~~~~   94 (284)
                      ...+|++.+.||+|+||.||++.+..+++.|++|++....... ...+.+.+|+.+++.++|+||+++++++.  .++..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            5679999999999999999999999999999999987654333 33567889999999999999999999874  45789


Q ss_pred             EEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCCeEecCCCCEEEeeccc
Q 023270           95 FLILEYAHRGELYRELRKHR----RFTEQQAATYIASLTNALAYCHENH-----VIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~lh~~g-----i~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      ++||||+++++|.+++....    .+++..++.++.|++.||.|||+.|     ++|+||+|+||+++.++.++|+|||.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            99999999999999997643    4899999999999999999999999     99999999999999999999999999


Q ss_pred             ccccCCCC---ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          166 SVQSRSKR---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       166 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      +.......   ....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+..+... ..+..++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~  241 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYS  241 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTSC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCcccC
Confidence            85543322   2345789999999999988999999999999999999999999999888887777776542 3344789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +++.+++.+||..||.+|||++++++|+|+.....+
T Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            999999999999999999999999999999988655

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-50  Score=343.13  Aligned_cols=251  Identities=27%  Similarity=0.490  Sum_probs=216.1

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH-----HHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-----KIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++........     .....+.+|+.+++.++|+||+++++++..+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            34689999999999999999999999999999999865432111     1223566799999999999999999999999


Q ss_pred             CeEEEEEeecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      +..++|||++..+ +|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999999998666 999999998899999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--CccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          171 SK--RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      ..  .....|++.|+|||++.+..+ +.++||||||+++++|++|..||.....      ....  ....+..+++++.+
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~~~~~l~~  253 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA--AIHPPYLVSKELMS  253 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT--CCCCSSCCCHHHHH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh--ccCCCcccCHHHHH
Confidence            32  234568999999999988876 8899999999999999999999976322      1111  22333468999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |+.+||.+||.+|||++++++||||++.
T Consensus       254 li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHccCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-49  Score=341.77  Aligned_cols=255  Identities=25%  Similarity=0.435  Sum_probs=215.7

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE----
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI----   94 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~----   94 (284)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|++....... ...+.+.+|+.+++.++|+||+++++++...+..    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch-hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            68999999999999999999999999999999986543322 3456788999999999999999999999877654    


Q ss_pred             --EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           95 --FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        95 --~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                        ++|+||++ ++|.+.+.  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  197 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  197 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence              99999997 58887763  35899999999999999999999999999999999999999999999999999776666


Q ss_pred             CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 023270          173 RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF----------------  235 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------------  235 (284)
                      .....+++.|+|||++.+ ..++.++||||||+++++|++|..||.+.+..+.+..+.......                
T Consensus       198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  277 (371)
T 4exu_A          198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  277 (371)
T ss_dssp             --CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred             cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence            666778999999999887 678999999999999999999999999988877776665421111                


Q ss_pred             -------CC------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          236 -------PS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       236 -------~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                             ..      .+.+++++.+||.+||..||.+|||++++|+||||+...+
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                   00      1357899999999999999999999999999999986543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-51  Score=357.08  Aligned_cols=251  Identities=15%  Similarity=0.239  Sum_probs=207.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHH---HHHHhCCCCccccee-------eE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM---EIQSSLRHPNILRLY-------GW   87 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~---~~~~~l~h~~i~~~~-------~~   87 (284)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            57899999999999999999999999999999998644333333456788888   556666899999998       66


Q ss_pred             EecCC-----------------eEEEEEeecCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcccc
Q 023270           88 FHDDE-----------------RIFLILEYAHRGELYRELRKHRRFTE-------QQAATYIASLTNALAYCHENHVIHR  143 (284)
Q Consensus        88 ~~~~~-----------------~~~~v~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~~i~~~l~~lh~~gi~H~  143 (284)
                      +..++                 ..|+||||++ |+|.+++...+.++.       ..++.++.||+.||.|||++|++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            65553                 3899999994 799999987655555       7888899999999999999999999


Q ss_pred             CCCCCCeEecCCCCEEEeecccccccCCCCccccCCCcccCccccCCC-----------CCCchhhHhhHHHHHHHHHhC
Q 023270          144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK-----------EHDYAVDNWTLGILCYEFLYG  212 (284)
Q Consensus       144 dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~il~~l~tg  212 (284)
                      ||||+|||++.++.+||+|||++...........| +.|+|||++.+.           .++.++||||||+++++|++|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg  309 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA  309 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence            99999999999999999999999776665556667 999999999887           799999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          213 APPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ..||...+.......+..      ..+.+++++.+|+.+||..||.+|||+.++++||||++..
T Consensus       310 ~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          310 DLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             SCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             CCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            999987655443332222      2247899999999999999999999999999999998754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-50  Score=343.87  Aligned_cols=263  Identities=27%  Similarity=0.505  Sum_probs=227.2

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHH--------------HHHHHHHHHHHHHhCC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--------------IQHQLRREMEIQSSLR   77 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~   77 (284)
                      ....+...+|++.+.||+|+||.||+|.+  +++.||+|++.........              ..+.+.+|+.+++.++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            34556678999999999999999999998  8999999999765433211              0157889999999999


Q ss_pred             CCcccceeeEEecCCeEEEEEeecCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 023270           78 HPNILRLYGWFHDDERIFLILEYAHRGELYRE------LRK--HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPE  148 (284)
Q Consensus        78 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~  148 (284)
                      |+||+++++++..++..++||||+++++|.++      +..  ...++...++.++.|++.||.|||+ .|++|+||+|+
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            99999999999999999999999999999998      665  5679999999999999999999999 99999999999


Q ss_pred             CeEecCCCCEEEeecccccccC-CCCccccCCCcccCccccCCC-CCCc-hhhHhhHHHHHHHHHhCCCCCCCCCh-HHH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENK-EHDY-AVDNWTLGILCYEFLYGAPPFEAESQ-KDT  224 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~il~~l~tg~~p~~~~~~-~~~  224 (284)
                      ||+++.++.++|+|||.+.... .......+++.|+|||.+.+. .++. ++||||||+++++|++|..||...+. .+.
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             hEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9999999999999999986533 233455688999999999887 5665 99999999999999999999998777 777


Q ss_pred             HHHHHhcCCCCCCC-----------------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          225 FRRIMKVDLSFPSA-----------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       225 ~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ...+.......+..                 ..+++++.+|+.+||..||.+|||++++++||||++..
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            77777665554431                 56899999999999999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-49  Score=330.90  Aligned_cols=260  Identities=33%  Similarity=0.590  Sum_probs=226.8

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ....++|++.+.||.|++|.||+|.+..+++.|++|++....... ...+.+.+|+.+++.++|+||+++++++...+..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            344578999999999999999999999999999999986544322 2235678899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC---CCEEEeecccccccCC
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRS  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~  171 (284)
                      ++|+|++++++|.+.+.....++...++.++.|++.||.+||+.|++|+||+|+||+++.+   +.++|+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999999999888889999999999999999999999999999999999999764   4799999999865433


Q ss_pred             CC--ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHH
Q 023270          172 KR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKH  247 (284)
Q Consensus       172 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  247 (284)
                      ..  ....+++.|+|||.+.+. ++.++||||||+++++|++|..||...+..+....+..+......  ...+++++.+
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          177 NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            22  233478889999998754 899999999999999999999999999988888888776554433  2468999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ++.+||..||.+|||++++++||||++..
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999999764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-49  Score=350.14  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=198.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-----CC
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-----DE   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-----~~   92 (284)
                      ..+|++.+.||.|+||+||+|.+..+++.||||++...... ....+.+.+|+.+++.++|+||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            47899999999999999999999999999999998654322 2335678899999999999999999999843     35


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .+|+|||+++ ++|..++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7999999986 699999998888999999999999999999999999999999999999999999999999998544311


Q ss_pred             ------------------------------CccccCCCcccCcccc-CCCCCCchhhHhhHHHHHHHHHh----------
Q 023270          173 ------------------------------RHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLY----------  211 (284)
Q Consensus       173 ------------------------------~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t----------  211 (284)
                                                    .....|++.|+|||++ .+..++.++|||||||++|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence                                          1234578999999976 45669999999999999999998          


Q ss_pred             -CCCCCCCCCh--------------------HHHHHHHHhc-----------------------CCC------CCCCCCC
Q 023270          212 -GAPPFEAESQ--------------------KDTFRRIMKV-----------------------DLS------FPSAPSI  241 (284)
Q Consensus       212 -g~~p~~~~~~--------------------~~~~~~~~~~-----------------------~~~------~~~~~~~  241 (284)
                       |.++|.+.+.                    .+.+..+...                       ...      ....+..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6777765431                    1111111110                       000      0012356


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ++++.+||++||..||++|||++++|+||||++..
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            89999999999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-48  Score=344.00  Aligned_cols=260  Identities=27%  Similarity=0.457  Sum_probs=211.1

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----   91 (284)
                      ...+|++.+.||.|+||+||+|.+..+++.||||++...... ....+.+.+|+.+++.++|+||+++++++...     
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            457899999999999999999999999999999998654322 23456788999999999999999999998766     


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      +..|+|||+++ ++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            57999999997 59999999888899999999999999999999999999999999999999999999999999854432


Q ss_pred             C-------------------------CccccCCCcccCcccc-CCCCCCchhhHhhHHHHHHHHHhC-----------CC
Q 023270          172 K-------------------------RHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYG-----------AP  214 (284)
Q Consensus       172 ~-------------------------~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~tg-----------~~  214 (284)
                      .                         .....+++.|+|||++ ....++.++|||||||++++|++|           .+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            1                         2445689999999986 556699999999999999999984           44


Q ss_pred             CCCCCCh-----------------HHHHHHHHh-----------------------c-CCCCCC-----CCCCCHHHHHH
Q 023270          215 PFEAESQ-----------------KDTFRRIMK-----------------------V-DLSFPS-----APSISAEAKHL  248 (284)
Q Consensus       215 p~~~~~~-----------------~~~~~~~~~-----------------------~-~~~~~~-----~~~~~~~l~~l  248 (284)
                      +|.+.+.                 .+.+..+..                       . ....+.     .+.+++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence            4444321                 111111111                       1 001110     13589999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      |++||..||.+|||++++|+||||++...+
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            999999999999999999999999986443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=330.82  Aligned_cols=258  Identities=27%  Similarity=0.477  Sum_probs=218.0

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ......+|++.+.||.|+||.||++.+..+++.|++|.+.....     .+.+.+|+.+++.++|+||+++++++..++.
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            44566789999999999999999999999999999999865432     2467789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++|+||+++++|.+++.. ...++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999999999974 567999999999999999999999999999999999999999999999999998544322


Q ss_pred             ---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 023270          173 ---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-SFPSAPSISAEAKHL  248 (284)
Q Consensus       173 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  248 (284)
                         .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+............. ....+..+++++.++
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence               2345678999999999999999999999999999999999999998887766655544322 222334578999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      +.+||..||.+|||++++++||||++.+
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            9999999999999999999999999764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.1e-49  Score=339.58  Aligned_cols=255  Identities=24%  Similarity=0.419  Sum_probs=216.1

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----Ce
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----ER   93 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----~~   93 (284)
                      .+|++++.||+|+||.||+|.+..++..||+|++.....  ....+.+.+|+++++.++|+||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            589999999999999999999999999999999864332  22346788999999999999999999998655     37


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  172 (284)
                      .++|+|+++ ++|.+++.. ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            899999997 599998876 46899999999999999999999999999999999999999999999999998544322 


Q ss_pred             -----CccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 023270          173 -----RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP----------  236 (284)
Q Consensus       173 -----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  236 (284)
                           .....+++.|+|||++.+. .++.++||||||+++++|++|..||.+.+..+.+..+........          
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                 2334689999999986544 489999999999999999999999998877766666543211110          


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          237 -------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       237 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                         ..+.+++++.+||.+||..||.+|||++++|+||||++..+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                               01357899999999999999999999999999999998643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.6e-49  Score=336.65  Aligned_cols=258  Identities=28%  Similarity=0.498  Sum_probs=222.1

Q ss_pred             ccCcEee-eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEE
Q 023270           18 LQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIF   95 (284)
Q Consensus        18 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~   95 (284)
                      -++|.+. +.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.++..+. |+||+++++++..++..+
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            3458887 88999999999999999999999999986543222 12356778999999885 699999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeecccccccC
Q 023270           96 LILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWSVQSR  170 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~  170 (284)
                      +||||+++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.++|+|||++....
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999988553  67999999999999999999999999999999999999987   7899999999986543


Q ss_pred             CC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHH
Q 023270          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAK  246 (284)
Q Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  246 (284)
                      ..  .....+++.|+|||++.+..++.++||||||+++++|++|..||...+..+....+.........  ...+++.+.
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  265 (327)
T 3lm5_A          186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT  265 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence            32  23456899999999999999999999999999999999999999999998888877765444333  347899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          247 HLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ++|.+||..||.+|||++++|+||||++..
T Consensus       266 ~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          266 DFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             HHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            999999999999999999999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.9e-49  Score=343.38  Aligned_cols=255  Identities=31%  Similarity=0.589  Sum_probs=209.3

Q ss_pred             cccccCcEee-eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHH-HhCCCCcccceeeEEec--
Q 023270           15 EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHD--   90 (284)
Q Consensus        15 ~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~-~~l~h~~i~~~~~~~~~--   90 (284)
                      ...+.+|.+. +.||.|+||+||++.+..+++.||||++...        ..+.+|+.++ +..+|+||+++++++..  
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3456788887 7899999999999999999999999998532        2344566665 55689999999998865  


Q ss_pred             --CCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeec
Q 023270           91 --DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDF  163 (284)
Q Consensus        91 --~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~  163 (284)
                        .+.+++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|++|+||||+||+++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              567999999999999999998753  5999999999999999999999999999999999999988   789999999


Q ss_pred             ccccccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCCCC
Q 023270          164 GWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRRIMKVDLSFPS  237 (284)
Q Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~  237 (284)
                      |++.....  ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+...    ....+..+...++.
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            99865432  2234567999999999999999999999999999999999999997654322    33444444443332


Q ss_pred             --CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          238 --APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       238 --~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                        +..+++++.+||++||..||.+|||++++++||||.+...
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence              3578999999999999999999999999999999987643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-49  Score=348.94  Aligned_cols=258  Identities=32%  Similarity=0.581  Sum_probs=209.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH-----HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++......     .......+.+|+.+++.++||||+++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            46899999999999999999999999999999998764322     1222345788999999999999999999875 45


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---CEEEeeccccccc
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQS  169 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~~~l~d~~~~~~~  169 (284)
                      ..++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++   .+||+|||++...
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5899999999999999998888999999999999999999999999999999999999997654   5999999998654


Q ss_pred             CCC--CccccCCCcccCccccCC---CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCC--CCCC
Q 023270          170 RSK--RHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRRIMKVDLSFPS--APSI  241 (284)
Q Consensus       170 ~~~--~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~--~~~~  241 (284)
                      ...  .....|++.|+|||++.+   ..++.++||||||+++++|++|..||....... ....+..+......  ...+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  372 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  372 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence            432  234568999999999864   567889999999999999999999997654433 33333333322221  2468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ++++.+|+.+||..||.+|||++++|+||||++..
T Consensus       373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            99999999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1e-48  Score=329.42  Aligned_cols=256  Identities=30%  Similarity=0.482  Sum_probs=225.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++.+.||+|+||.||++.+..+++.|++|++.......  ..+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            356999999999999999999999999999999986543222  246788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~  174 (284)
                      |||+++++|.+++.. +.++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....   ...
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            999999999998865 5789999999999999999999999999999999999999999999999999854432   223


Q ss_pred             cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 023270          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ...+++.|+|||.+.+..++.++||||||+++++|++|..||...........+.... .......++.++.+++.+||.
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHCC
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHHHHcC
Confidence            4568899999999999999999999999999999999999999888877776665543 333445789999999999999


Q ss_pred             cCCCCCCCHHhhhcCccccccCC
Q 023270          255 KDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .||.+|||++++++||||++...
T Consensus       257 ~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          257 KEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             SSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             CChhhCcCHHHHhhChhhhcCCC
Confidence            99999999999999999987643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.9e-49  Score=328.50  Aligned_cols=253  Identities=21%  Similarity=0.336  Sum_probs=211.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ..+|++.+.||+|+||+||+|.+..+++.|++|++........ ....+.+|+..+..+ +||||+++++++.+++..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4689999999999999999999999999999999865433222 235677888888888 89999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-----------------
Q 023270           97 ILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-----------------  155 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-----------------  155 (284)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999999775    568999999999999999999999999999999999999854                 


Q ss_pred             --CCEEEeecccccccCCCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 023270          156 --GRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD  232 (284)
Q Consensus       156 --~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  232 (284)
                        ..++|+|||.+...... ....+++.|+|||.+.+. .++.++||||||+++++|++|.+++.....   ...+....
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~  244 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGR  244 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTC
T ss_pred             CceEEEEcccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCC
Confidence              47999999998665443 334589999999999766 567899999999999999999887654432   33333332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          233 LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      . ...+..+++++.+++.+||..||.+|||++++++||||++..
T Consensus       245 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          245 L-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             C-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             C-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            2 333457899999999999999999999999999999999763

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.7e-49  Score=334.62  Aligned_cols=260  Identities=22%  Similarity=0.410  Sum_probs=219.5

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEE-ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCC------ccccee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVRE-VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP------NILRLY   85 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~------~i~~~~   85 (284)
                      ...+...+|++.+.||.|+||+||+|.+ ..++..||+|++....    ...+.+.+|+++++.++|+      ++++++
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            3455668999999999999999999998 5678899999986432    2235667788887777654      599999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---------
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---------  154 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---------  154 (284)
                      +++...+..++||||+ +++|.+++...+  .++...++.++.|++.||.|||++|++|+||+|+||+++.         
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 679999998765  6899999999999999999999999999999999999987         


Q ss_pred             ----------CCCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHH
Q 023270          155 ----------EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (284)
Q Consensus       155 ----------~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~  224 (284)
                                ++.++|+|||++...........+++.|+|||++.+..++.++||||||+++++|++|..||...+..+.
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                      6689999999997766666667889999999999999999999999999999999999999998887766


Q ss_pred             HHHHHhcCCCCC------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCC
Q 023270          225 FRRIMKVDLSFP------------------------------------------SAPSISAEAKHLISRLLVKDSSKRLS  262 (284)
Q Consensus       225 ~~~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps  262 (284)
                      ...+.......+                                          ..+..++++.+|+.+||..||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            554433211110                                          11123577999999999999999999


Q ss_pred             HHhhhcCccccccCC
Q 023270          263 LQKIMEHPWIIKNAN  277 (284)
Q Consensus       263 ~~~il~~~~~~~~~~  277 (284)
                      ++++++||||++...
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999998643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-49  Score=339.01  Aligned_cols=252  Identities=20%  Similarity=0.366  Sum_probs=205.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----   92 (284)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++......  ...+.+.+|+.+++.++||||+++++++.+.+     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            46899999999999999999999999999999998643322  23467889999999999999999999885543     


Q ss_pred             ----------------------------------------------------eEEEEEeecCCCchHHHHHhcC---CCC
Q 023270           93 ----------------------------------------------------RIFLILEYAHRGELYRELRKHR---RFT  117 (284)
Q Consensus        93 ----------------------------------------------------~~~~v~e~~~~~~L~~~l~~~~---~l~  117 (284)
                                                                          ..++||||+++++|.+++....   ..+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                3899999999999999998764   356


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---------------CccccCCCcc
Q 023270          118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---------------RHTMCGTLDY  182 (284)
Q Consensus       118 ~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---------------~~~~~~~~~y  182 (284)
                      ...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......               .....+++.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6678999999999999999999999999999999999999999999998544322               1234589999


Q ss_pred             cCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 023270          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS  262 (284)
Q Consensus       183 ~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  262 (284)
                      +|||++.+..++.++||||||+++++|++|..|+.  ............. ........++++.+++.+||..||++|||
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps  319 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPE  319 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--HHHHHHHHHHTTC-CCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--HHHHHHHHhhccC-CCcccccCChhHHHHHHHHccCCCCcCCC
Confidence            99999999999999999999999999999865432  1122222222221 11111245678999999999999999999


Q ss_pred             HHhhhcCccccc
Q 023270          263 LQKIMEHPWIIK  274 (284)
Q Consensus       263 ~~~il~~~~~~~  274 (284)
                      ++++|+||||++
T Consensus       320 ~~~~l~~~~f~~  331 (332)
T 3qd2_B          320 ATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHSTTCCC
T ss_pred             HHHHhhchhhhc
Confidence            999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-48  Score=337.77  Aligned_cols=256  Identities=23%  Similarity=0.392  Sum_probs=209.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----   92 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~----   92 (284)
                      ...+|++.+.||.|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++|+||+++++++...+    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            467999999999999999999999999999999998654322 233467789999999999999999999987654    


Q ss_pred             --eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 --RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                        ..++||||+++ +|.+.+.  ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              78999999975 7888775  458999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 023270          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP------------  236 (284)
Q Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------------  236 (284)
                      ..  .....+++.|+|||++.+..++.++||||||+++++|++|..||.+.+..+.+..+........            
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            32  2345689999999999999999999999999999999999999999888877777655321110            


Q ss_pred             -------CC--------------C-------CCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          237 -------SA--------------P-------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       237 -------~~--------------~-------~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                             ..              +       ..++++.+||++||..||.+|||++++|+||||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                   00              0       0156799999999999999999999999999998643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-49  Score=341.54  Aligned_cols=253  Identities=29%  Similarity=0.490  Sum_probs=210.9

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec----
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~----   90 (284)
                      +....+|++.+.||+|+||+||+|.+..+++.||+|++....       ....+|+++++.++|+||+++++++..    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            355679999999999999999999999999999999985432       123478999999999999999999843    


Q ss_pred             ----------------------------------CCeEEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 023270           91 ----------------------------------DERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNAL  132 (284)
Q Consensus        91 ----------------------------------~~~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l  132 (284)
                                                        +...++||||+++ +|.+.+.    ....+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              3358999999984 7766664    356799999999999999999


Q ss_pred             HHHHhCCccccCCCCCCeEec-CCCCEEEeeccccccc--CCCCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHH
Q 023270          133 AYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYE  208 (284)
Q Consensus       133 ~~lh~~gi~H~dl~p~nil~~-~~~~~~l~d~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~  208 (284)
                      .|||+.|++|+||+|+||+++ .++.++|+|||++...  ........+++.|+|||++.+.. ++.++||||+|+++++
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            999999999999999999997 6889999999998643  23334556889999999987754 8999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCC-----------------CC----------CCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          209 FLYGAPPFEAESQKDTFRRIMKVDLS-----------------FP----------SAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       209 l~tg~~p~~~~~~~~~~~~~~~~~~~-----------------~~----------~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      |++|..||.+.+..+.+..+......                 ++          .+..+++++.+||++||..||.+||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999999888877776542111                 00          1235789999999999999999999


Q ss_pred             CHHhhhcCcccccc
Q 023270          262 SLQKIMEHPWIIKN  275 (284)
Q Consensus       262 s~~~il~~~~~~~~  275 (284)
                      |++++|+||||++.
T Consensus       315 t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          315 NPYEAMAHPFFDHL  328 (383)
T ss_dssp             CHHHHHTSGGGHHH
T ss_pred             CHHHHhcCHHHHHH
Confidence            99999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=335.45  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=214.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER----   93 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~----   93 (284)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+.+|+.+++.++|+||+++++++...+.    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            47899999999999999999999999999999998654322 2345678899999999999999999999977654    


Q ss_pred             --EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           94 --IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 --~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                        .++||||++ ++|.+++..  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              599999997 588877643  589999999999999999999999999999999999999999999999999876655


Q ss_pred             CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 023270          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-----------------  233 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----------------  233 (284)
                      ......+++.|+|||++.+ ..++.++||||||+++++|++|..||.+.+..+.+..+.....                 
T Consensus       179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence            5556678999999999877 6789999999999999999999999998887766665543110                 


Q ss_pred             ------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          234 ------------SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       234 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                  .....+.+++++.+||.+||..||.+|||++++++||||+...+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                        01112367899999999999999999999999999999987644

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.3e-50  Score=346.10  Aligned_cols=259  Identities=21%  Similarity=0.247  Sum_probs=201.7

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHH---HHHHhCCCCccccee-------e
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM---EIQSSLRHPNILRLY-------G   86 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~---~~~~~l~h~~i~~~~-------~   86 (284)
                      ...+|++.+.||.|+||+||+|.+..+++.||+|++...........+.+++|+   +.++. +|||+++++       +
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence            345699999999999999999999999999999999876554445556777774   45555 799977744       4


Q ss_pred             EEecC-----------------CeEEEEEeecCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCccc
Q 023270           87 WFHDD-----------------ERIFLILEYAHRGELYRELRKH-RRFTEQQA------ATYIASLTNALAYCHENHVIH  142 (284)
Q Consensus        87 ~~~~~-----------------~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~------~~i~~~i~~~l~~lh~~gi~H  142 (284)
                      ++..+                 ..+++||||++ ++|.+++... ..++...+      +.++.||+.||.|||++|++|
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            44433                 34899999998 7999999874 34455555      677799999999999999999


Q ss_pred             cCCCCCCeEecCCCCEEEeecccccccCCCCccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCCCCCC
Q 023270          143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAES  220 (284)
Q Consensus       143 ~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~  220 (284)
                      +||||+|||++.++.+||+|||++...........+++.|+|||++.+  ..++.++||||||+++|+|++|..||....
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999999776655545567799999999987  678999999999999999999999998764


Q ss_pred             hHHHH-------HHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          221 QKDTF-------RRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       221 ~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .....       ..........+..+.+++++.+||.+||..||++|||++++|+||||++..+
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            32110       0001112233334578999999999999999999999999999999987643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-48  Score=331.75  Aligned_cols=270  Identities=22%  Similarity=0.364  Sum_probs=207.3

Q ss_pred             hHHHhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCc---eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc
Q 023270            5 TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI   81 (284)
Q Consensus         5 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i   81 (284)
                      ....+......+..++|++.+.||+|+||+||+|.+..++.   .||+|++....... ...+.+.+|+++++.++|+||
T Consensus         9 ~~~~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i   87 (323)
T 3qup_A            9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHV   87 (323)
T ss_dssp             -------CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTB
T ss_pred             HHHHHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCce
Confidence            34455666777888999999999999999999999887765   79999996643332 235678899999999999999


Q ss_pred             cceeeEEecCCeE------EEEEeecCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           82 LRLYGWFHDDERI------FLILEYAHRGELYRELRKHR------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        82 ~~~~~~~~~~~~~------~~v~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      +++++++...+..      ++|+||+++++|.+++....      .++...++.++.|++.||.|||+.|++|+||+|+|
T Consensus        88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~N  167 (323)
T 3qup_A           88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN  167 (323)
T ss_dssp             CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcce
Confidence            9999999877654      99999999999999996543      58999999999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      |+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+
T Consensus       168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~  247 (323)
T 3qup_A          168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE  247 (323)
T ss_dssp             EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999985433221     22345678999999999999999999999999999999 999999988888


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHhhhcCccccccC
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLS-------LQKIMEHPWIIKNA  276 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-------~~~il~~~~~~~~~  276 (284)
                      ....+.... .....+.+++++.+++.+||..||.+|||       ++++++|||+....
T Consensus       248 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          248 IYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             HHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             HHHHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            877776654 34445578999999999999999999999       89999999998753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-48  Score=321.66  Aligned_cols=252  Identities=22%  Similarity=0.372  Sum_probs=221.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+.+..++|++.+.||+|+||+||++.+. ++..|++|++.......    +.+.+|+.+++.++|+||+++++++.++
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            456788899999999999999999999986 57789999997654333    4678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      +..++||||+++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence            9999999999999999999765 468999999999999999999999999999999999999999999999999985443


Q ss_pred             CC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          171 SK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       171 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ..    .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+.... ....+...++++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHV  236 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHH
T ss_pred             ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCCCCCcCCHHH
Confidence            22    223445678999999998899999999999999999999 999999999988888877753 344455789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+++.+||..||++|||+++++++
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999976

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.3e-49  Score=340.07  Aligned_cols=267  Identities=25%  Similarity=0.400  Sum_probs=208.2

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      ..........+.+|++.+.||+|+||+||+|.+..++..||||++.......    ....++++.+..++|+||++++++
T Consensus        12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~   87 (360)
T 3e3p_A           12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSY   87 (360)
T ss_dssp             CBSSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             cChhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHh
Confidence            3344455677899999999999999999999999999999999885433221    234567777888899999999999


Q ss_pred             EecCC-------eEEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCeEecC
Q 023270           88 FHDDE-------RIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCH--ENHVIHRDIKPENLLLDH  154 (284)
Q Consensus        88 ~~~~~-------~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l~~lh--~~gi~H~dl~p~nil~~~  154 (284)
                      +...+       ..++||||+++ +|...+.    ....++...++.++.|++.||.|||  +.|++|+||+|+||+++.
T Consensus        88 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             EEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET
T ss_pred             hhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC
Confidence            86533       38999999986 5544443    4567899999999999999999999  999999999999999997


Q ss_pred             -CCCEEEeecccccccCC--CCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 023270          155 -EGRLKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK  230 (284)
Q Consensus       155 -~~~~~l~d~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~  230 (284)
                       ++.++|+|||++.....  ......+++.|+|||++.+.. ++.++||||||+++++|++|..||...+....+..+..
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence             89999999999865432  223456899999999987655 89999999999999999999999999888877777654


Q ss_pred             cCCCC------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          231 VDLSF------------------------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       231 ~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      .....                              ......++++.+||.+||+.||.+|||++++|+||||++..++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence            21111                              11123578999999999999999999999999999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-48  Score=336.20  Aligned_cols=270  Identities=23%  Similarity=0.378  Sum_probs=217.1

Q ss_pred             HHhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH--------HHHHHHHHHHHHHHHHHhCCC
Q 023270            7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--------EKYKIQHQLRREMEIQSSLRH   78 (284)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~~~~~~~~~~l~h   78 (284)
                      .++.........++|++.+.||+|+||.||++.+.. +..||+|++.....        ......+.+.+|+.+++.++|
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   88 (362)
T 3pg1_A           10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH   88 (362)
T ss_dssp             HHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC
Confidence            344445556667899999999999999999998854 89999998854221        223345788899999999999


Q ss_pred             CcccceeeEEec-----CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe
Q 023270           79 PNILRLYGWFHD-----DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL  152 (284)
Q Consensus        79 ~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~  152 (284)
                      +||+++++++..     ....++||||++ ++|.+.+... ..++...++.++.|++.||.|||+.|++|+||+|+||++
T Consensus        89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           89 PNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL  167 (362)
T ss_dssp             TTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             cCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE
Confidence            999999999843     347899999998 5888777654 479999999999999999999999999999999999999


Q ss_pred             cCCCCEEEeecccccccCC--CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 023270          153 DHEGRLKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM  229 (284)
Q Consensus       153 ~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~  229 (284)
                      +.++.++|+|||++.....  ......+++.|+|||++.+ ..++.++||||||+++++|++|..||...+..+....+.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999854322  2334567889999999877 668999999999999999999999999988877777665


Q ss_pred             hcCCCCC------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          230 KVDLSFP------------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       230 ~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      .......                              ..+..++.+.+||.+||..||.+|||++++|+||||++..+|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence            4211110                              013568899999999999999999999999999999987554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.3e-49  Score=332.78  Aligned_cols=257  Identities=32%  Similarity=0.595  Sum_probs=212.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH-----HHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+++.++|+||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46799999999999999999999999999999998654321     1222346788999999999999999999987665


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC---EEEeeccccccc
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQS  169 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~---~~l~d~~~~~~~  169 (284)
                       .++||||+++++|.+++.....++...++.++.|++.||.|||++|++|+||+|+||+++.++.   ++|+|||++...
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999988889999999999999999999999999999999999999987664   999999998654


Q ss_pred             CCCC--ccccCCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCC--CCCCC
Q 023270          170 RSKR--HTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFP--SAPSI  241 (284)
Q Consensus       170 ~~~~--~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~  241 (284)
                      ....  ....+++.|+|||++.   ...++.++||||||+++++|++|..||...... .....+..+.....  ....+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  247 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence            4322  2345889999999973   566889999999999999999999999765443 23333333332221  12467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ++++.+|+.+||..||.+|||++++|+||||++.
T Consensus       248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            8999999999999999999999999999999865

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=324.69  Aligned_cols=268  Identities=28%  Similarity=0.465  Sum_probs=217.8

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      .......+...+|.....||.|+||.||+|.+..++..|++|.+.....   ...+.+.+|+.+++.++|+||+++++++
T Consensus        12 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~   88 (295)
T 2clq_A           12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSF   88 (295)
T ss_dssp             --CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence            3444555666677777799999999999999999999999999865432   2346788999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-CCCEEEeecc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFG  164 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-~~~~~l~d~~  164 (284)
                      ...+..++|+|++++++|.+++....   .+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             EETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             EeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecc
Confidence            99999999999999999999998752   4678999999999999999999999999999999999987 8999999999


Q ss_pred             cccccCC---CCccccCCCcccCccccCCCC--CCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC
Q 023270          165 WSVQSRS---KRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSA  238 (284)
Q Consensus       165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~  238 (284)
                      .+.....   ......+++.|+|||++.+..  ++.++||||||+++++|++|..||...... ...............+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 2clq_A          169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP  248 (295)
T ss_dssp             TCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred             cccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence            9855432   223456889999999987653  789999999999999999999999764332 2222222223334445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          239 PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      ..+++++.+++.+||..||++|||++++++||||+.....+
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  289 (295)
T 2clq_A          249 ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK  289 (295)
T ss_dssp             TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence            57899999999999999999999999999999999876543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.4e-49  Score=341.53  Aligned_cols=255  Identities=22%  Similarity=0.349  Sum_probs=209.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC--------CCcccceee
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--------HPNILRLYG   86 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~--------h~~i~~~~~   86 (284)
                      .+...+|++.+.||+|+||+||+|.+..+++.||+|++.....    ..+.+.+|+.+++.+.        |+||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc----chHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            3345789999999999999999999999999999999965432    2356678888888875        788999999


Q ss_pred             EEe----cCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCC---
Q 023270           87 WFH----DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEG---  156 (284)
Q Consensus        87 ~~~----~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~---  156 (284)
                      ++.    .+...++|||+++ ++|.+.+...  ..++...++.++.||+.||.|||++ |++|+||||+|||++.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            987    5668999999996 4666666544  5699999999999999999999998 999999999999998775   


Q ss_pred             ----------------------------------------------CEEEeecccccccCCCCccccCCCcccCccccCC
Q 023270          157 ----------------------------------------------RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN  190 (284)
Q Consensus       157 ----------------------------------------------~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~  190 (284)
                                                                    .++|+|||++...........+++.|+|||++.+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHT
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcC
Confidence                                                          8999999999776666666778999999999999


Q ss_pred             CCCCchhhHhhHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCC-----------------------------
Q 023270          191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ------KDTFRRIMKVDLSF-----------------------------  235 (284)
Q Consensus       191 ~~~~~~~Di~slG~il~~l~tg~~p~~~~~~------~~~~~~~~~~~~~~-----------------------------  235 (284)
                      ..++.++||||||+++|+|++|..||...+.      ......+.......                             
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            9999999999999999999999999976542      22222222110000                             


Q ss_pred             -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          236 -----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       236 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                                 ......++++.+||.+||..||++|||++++|+||||+.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                       011223567899999999999999999999999999974

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.1e-48  Score=320.56  Aligned_cols=253  Identities=25%  Similarity=0.449  Sum_probs=213.2

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH-HHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .++...+|++.+.||+|+||.||++.+  .++.|++|++....... ....+.+.+|+.+++.++|+||+++++++..++
T Consensus         2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (271)
T 3dtc_A            2 LEIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP   79 (271)
T ss_dssp             CBCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred             CccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            367789999999999999999999997  47889999986544332 233467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCeEecC--------CCCEEEe
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH---VIHRDIKPENLLLDH--------EGRLKIG  161 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g---i~H~dl~p~nil~~~--------~~~~~l~  161 (284)
                      ..++||||+++++|.+++. .+.+++..++.++.|++.||.|||+.|   ++|+||+|+||+++.        ++.++|+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             ceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999999999998885 457899999999999999999999999   889999999999986        7789999


Q ss_pred             ecccccccCC-CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          162 DFGWSVQSRS-KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       162 d~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      |||++..... ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+...............+.+..
T Consensus       159 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3dtc_A          159 DFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST  238 (271)
T ss_dssp             CCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred             cCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence            9999854332 223456899999999999888999999999999999999999999999998888888887777777778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++++.+++.+||..||.+|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-49  Score=336.81  Aligned_cols=260  Identities=38%  Similarity=0.667  Sum_probs=217.4

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHH-HHHHHHHHHHHHHHHHhC-CCCcccceeeEE
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSL-RHPNILRLYGWF   88 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~   88 (284)
                      ..+...+|++.+.||+|+||+||++.+.   .+++.||+|++...... .......+.+|+++++.+ +|+||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3456689999999999999999999984   47899999998643211 011123456788888888 699999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ..++..++||||+++++|.+++.....++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999854


Q ss_pred             cCC----CCccccCCCcccCccccCCC--CCCchhhHhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCC
Q 023270          169 SRS----KRHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRRIMKVDLSFPSA  238 (284)
Q Consensus       169 ~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~  238 (284)
                      ...    ......|++.|+|||++.+.  .++.++||||||+++++|++|..||...    ..............  ..+
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYP  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCC
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCC
Confidence            321    22334689999999999863  4789999999999999999999999643    33445555554433  334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-----CHHhhhcCcccccc
Q 023270          239 PSISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      ..+++.+.+||.+||..||.+||     |++++++||||++.
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            57899999999999999999999     99999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.4e-48  Score=331.19  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=216.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----   91 (284)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++|+||+++++++..+     
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            4578999999999999999999999999999999985432  223345677899999999999999999987654     


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ...++|+|+++ ++|.+++.. +.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            67999999997 589998876 5689999999999999999999999999999999999999999999999999854332


Q ss_pred             C-------------CccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---
Q 023270          172 K-------------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS---  234 (284)
Q Consensus       172 ~-------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---  234 (284)
                      .             .....|++.|+|||++.+ ..++.++||||||+++++|++|..||.+.+.......+......   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            1             122357899999998754 67899999999999999999999999988876655544321111   


Q ss_pred             ---------------------CCC------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          235 ---------------------FPS------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       235 ---------------------~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                           .+.      .+.+++++.+|+.+||..||.+|||++++++||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence                                 000      13678999999999999999999999999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=329.13  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=213.1

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe----
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH----   89 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~----   89 (284)
                      ......+|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++|+||+++++++.    
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            3345688999999999999999999999999999999986543   233567889999999999999999999873    


Q ss_pred             ----------cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec-CCCCE
Q 023270           90 ----------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRL  158 (284)
Q Consensus        90 ----------~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~-~~~~~  158 (284)
                                ..+..++|+||++ ++|.+++.. +.++...++.++.|++.||.|||+.|++|+||+|+||+++ .++.+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence                      3468899999998 599998865 5689999999999999999999999999999999999997 56799


Q ss_pred             EEeecccccccCC------CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 023270          159 KIGDFGWSVQSRS------KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV  231 (284)
Q Consensus       159 ~l~d~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  231 (284)
                      +|+|||++.....      ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+..+....+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999864322      2233456888999998865 67899999999999999999999999998887777666543


Q ss_pred             CCCCC----------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          232 DLSFP----------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       232 ~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      .....                            ..+.+++++.+|+.+||..||.+|||++++|+||||+....|.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            21110                            0135799999999999999999999999999999999876554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.1e-48  Score=327.63  Aligned_cols=251  Identities=27%  Similarity=0.523  Sum_probs=209.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEec--CCe
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHD--DER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~--~~~   93 (284)
                      ...+|++.+.||+|+||+||+|.+..+++.||+|++....      .+.+.+|+.+++.+. |+||+++++++..  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            4578999999999999999999999999999999986433      246778999999997 9999999999987  668


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccC--
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSR--  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~--  170 (284)
                      .++||||+++++|..++..   ++...++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....  
T Consensus       108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            8999999999999988754   79999999999999999999999999999999999999777 89999999985433  


Q ss_pred             CCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHh-------------cCC--
Q 023270          171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDTFRRIMK-------------VDL--  233 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~-------------~~~--  233 (284)
                      .......+++.|+|||.+.+ ..++.++||||||+++++|++|..||... +..+.+..+..             ...  
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            23344568889999999877 66899999999999999999999999543 33222222111             110  


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          234 --------------------SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       234 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                          .......+++++.+||.+||..||.+|||++++|+||||++..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                                0111123789999999999999999999999999999999764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.7e-48  Score=321.29  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=219.8

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      ......+++..++|++.+.||.|+||+||++.+. ++..|++|++.......    +.+.+|+++++.++|+||++++++
T Consensus        13 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~   87 (283)
T 3gen_A           13 GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV   87 (283)
T ss_dssp             ---CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEE
Confidence            3344567788899999999999999999999775 66789999997654333    457889999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      +..++..++||||+++++|.+++.. ...++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             ECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             EecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence            9999999999999999999999977 467999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          167 VQSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       167 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      ......    .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+.... ....+...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  246 (283)
T 3gen_A          168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLA  246 (283)
T ss_dssp             GGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTC
T ss_pred             ccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-CCCCCCcC
Confidence            544322    223345678999999998889999999999999999998 999999999888888777653 34444578


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+.+++.+||..||.+|||++++++|
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.2e-48  Score=325.72  Aligned_cols=267  Identities=23%  Similarity=0.431  Sum_probs=219.1

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC--CCcccceee
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--HPNILRLYG   86 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~--h~~i~~~~~   86 (284)
                      -......+..++|++.+.||+|+||.||++.+. +++.||+|++....... ...+.+.+|+++++.++  |+||+++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEEEE
Confidence            344556778889999999999999999999884 58889999986543322 34567889999999997  599999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      ++..++..++|||+ .+++|.+++.....++...++.++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++
T Consensus        96 ~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~  173 (313)
T 3cek_A           96 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  173 (313)
T ss_dssp             EEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             EeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence            99999999999995 5679999999988999999999999999999999999999999999999995 589999999998


Q ss_pred             cccCCCC-----ccccCCCcccCccccCC-----------CCCCchhhHhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHH
Q 023270          167 VQSRSKR-----HTMCGTLDYLAPEMVEN-----------KEHDYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFRRIM  229 (284)
Q Consensus       167 ~~~~~~~-----~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~  229 (284)
                      .......     ....+++.|+|||.+.+           ..++.++||||||+++++|++|..||.... .........
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            5543221     23457999999999875           468889999999999999999999998754 344555555


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          230 KVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                      ........+...++++.+++.+||..||.+|||++++++||||+....|.
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  303 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  303 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence            55555555567789999999999999999999999999999999876654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-47  Score=320.67  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=219.5

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHH----HHHHHHHHHHHHHhCCCCcccc
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK----IQHQLRREMEIQSSLRHPNILR   83 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~----~~~~~~~~~~~~~~l~h~~i~~   83 (284)
                      ........+..++|++.+.||+|+||+||+|.+..+++.||+|++.........    ..+.+.+|+.+++.++|+||++
T Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   87 (287)
T 4f0f_A            8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK   87 (287)
T ss_dssp             ----CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred             CcchhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchh
Confidence            455566778899999999999999999999999999999999998653332211    1167889999999999999999


Q ss_pred             eeeEEecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCCCC---
Q 023270           84 LYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGR---  157 (284)
Q Consensus        84 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~~~---  157 (284)
                      +++++.+..  ++||||+++++|.+.+... ..+++..++.++.|++.||.|||++|  ++|+||+|+||+++.++.   
T Consensus        88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             EEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             hheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCc
Confidence            999987665  7999999999998888654 57999999999999999999999999  999999999999988776   


Q ss_pred             --EEEeecccccccCCCCccccCCCcccCccccC--CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHhc
Q 023270          158 --LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVE--NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--TFRRIMKV  231 (284)
Q Consensus       158 --~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~  231 (284)
                        ++|+|||++...........+++.|+|||.+.  ...++.++||||||+++++|++|..||...+...  ........
T Consensus       166 ~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             CCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             eeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence              99999999977666666677899999999984  4457899999999999999999999998755433  35555555


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ......+..+++++.+++.+||..||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            5566666789999999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-47  Score=331.92  Aligned_cols=253  Identities=25%  Similarity=0.454  Sum_probs=218.9

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEec-------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~   85 (284)
                      .++...+|++.+.||+|+||.||+|.+..       ++..||+|++.....  ....+.+.+|+.+++.+ +||||++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--HHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--HHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            35667899999999999999999998753       445699999965432  23356788999999999 899999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      +++..++.+|+||||+++++|.+++....                .++...++.++.||+.||.|||++|++|+||+|+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            99999999999999999999999998753                47899999999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      |+++.++.+||+|||++......     .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999998644322     223345778999999999999999999999999999999 999999988887


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....+..+. ....+..+++++.+++.+||..||.+|||+++++++
T Consensus       314 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            777666553 344455789999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-47  Score=323.54  Aligned_cols=257  Identities=22%  Similarity=0.375  Sum_probs=210.9

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .....+.+|++.+.||+|+||.||++.+..+++.|++|++...........+.+.+|+.+++.++|+||+++++++..++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            45566899999999999999999999999999999999997765555556678899999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..++|+||+++++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999987544322


Q ss_pred             ----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCCCCCHHHHH
Q 023270          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF-PSAPSISAEAKH  247 (284)
Q Consensus       173 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  247 (284)
                          .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+....... ...+.+|+++.+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence                223457899999999999899999999999999999999999999877664444443332211 223578999999


Q ss_pred             HHHHhcccCCCCCC-CHHhhhcC
Q 023270          248 LISRLLVKDSSKRL-SLQKIMEH  269 (284)
Q Consensus       248 li~~~l~~~p~~Rp-s~~~il~~  269 (284)
                      ++.+||..||++|| |++++++.
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~~  290 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSAA  290 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHHH
Confidence            99999999999999 78877753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.9e-48  Score=326.85  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=220.8

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCce---EEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~---v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ...++...+|++.+.||+|+||+||++.+..++..   ||||++......  ...+.+.+|+.+++.++|+||+++++++
T Consensus        42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~  119 (325)
T 3kul_A           42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPNIIRLEGVV  119 (325)
T ss_dssp             -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34577889999999999999999999999866554   999998654322  2346788999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ..++..++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            9999999999999999999999765 579999999999999999999999999999999999999999999999999985


Q ss_pred             ccCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          168 QSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       168 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      ......      ....+++.|+|||++.+..++.++||||||+++++|++ |..||...+..+....+... ...+.+..
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  278 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMG  278 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTT
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCC
Confidence            543221      12234667999999988889999999999999999999 99999999998888887765 34455568


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++++.+++..||..||.+|||+.++++.
T Consensus       279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          279 CPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.1e-48  Score=335.39  Aligned_cols=258  Identities=28%  Similarity=0.402  Sum_probs=214.6

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CC-----cccceeeEE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HP-----NILRLYGWF   88 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~-----~i~~~~~~~   88 (284)
                      +....+|++.+.||+|+||+||+|.+..+++.||||++.....    ....+..|+.+++.+. |+     +++++++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH----HHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            3446889999999999999999999999999999999865332    2345566777776664 44     599999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCeEecC--CCCEEEee
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCH--ENHVIHRDIKPENLLLDH--EGRLKIGD  162 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh--~~gi~H~dl~p~nil~~~--~~~~~l~d  162 (284)
                      ..++..++|||+++ ++|.+++...  ..++...++.++.|++.||.|||  +.||+|+||||+||+++.  ++.+||+|
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999999997 4999999876  46899999999999999999999  579999999999999954  67899999


Q ss_pred             cccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----
Q 023270          163 FGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS-----  237 (284)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----  237 (284)
                      ||++...........+++.|+|||++.+..++.++||||||+++++|++|..||.+.+..+.+..+.......+.     
T Consensus       205 FG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  284 (382)
T 2vx3_A          205 FGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ  284 (382)
T ss_dssp             CTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            999977766666778899999999999999999999999999999999999999998888777766542111100     


Q ss_pred             --------------------------------CCC-------------------------CCHHHHHHHHHhcccCCCCC
Q 023270          238 --------------------------------APS-------------------------ISAEAKHLISRLLVKDSSKR  260 (284)
Q Consensus       238 --------------------------------~~~-------------------------~~~~l~~li~~~l~~~p~~R  260 (284)
                                                      ...                         .++++.+||.+||..||++|
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  364 (382)
T 2vx3_A          285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR  364 (382)
T ss_dssp             CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred             hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence                                            000                         01478999999999999999


Q ss_pred             CCHHhhhcCccccccCC
Q 023270          261 LSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       261 ps~~~il~~~~~~~~~~  277 (284)
                      ||++++|+||||++..+
T Consensus       365 pta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          365 IQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             CCHHHHTTSGGGCC---
T ss_pred             CCHHHHhcCcccccCCC
Confidence            99999999999998643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.2e-48  Score=318.01  Aligned_cols=250  Identities=22%  Similarity=0.370  Sum_probs=219.5

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      .++...+|++.+.||+|+||.||++.+. ++..||+|++.......    +.+.+|+++++.++|+||+++++++..++.
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            5678899999999999999999999764 56779999987654333    457889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            999999999999999998764 5999999999999999999999999999999999999999999999999998544332


Q ss_pred             C----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+......... ....+...++++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQ  236 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTSCHHHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCCCcChHHHHH
Confidence            2    22335667999999988889999999999999999999 999999999888888777654 33344568999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+||..||.+|||+++++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=328.40  Aligned_cols=248  Identities=24%  Similarity=0.407  Sum_probs=211.4

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ..+...+|++.+.||+|+||+||++.+..++..|++|++....   ....+.+.+|+.+++.++|+||+++++++.+++.
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            3467889999999999999999999999999999999885432   2335678899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999999999988 467999999999999999999999999999999999999999999999999998543222


Q ss_pred             Cc-----------------cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH-----HHHHHHh
Q 023270          173 RH-----------------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-----TFRRIMK  230 (284)
Q Consensus       173 ~~-----------------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~-----~~~~~~~  230 (284)
                      ..                 ...|++.|+|||++.+..++.++||||||+++++|++|..|+.......     .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            11                 3468899999999999999999999999999999999999886532210     1111111


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .    ..++.+++++.+++.+||..||.+|||++++++
T Consensus       242 ~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 R----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             H----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1    123468899999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.5e-48  Score=330.63  Aligned_cols=260  Identities=23%  Similarity=0.433  Sum_probs=216.7

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCC-ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc------ccce
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN------ILRL   84 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~------i~~~   84 (284)
                      ....+...+|++.+.||+|+||+||+|.+..++ ..||+|++.....    ..+.+.+|+.+++.++|++      ++.+
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            345566789999999999999999999998776 6899999864322    2356667888888776554      8999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe----------
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----------  152 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~----------  152 (284)
                      .+++...+..++|||+++ +++.+.+...  ..++...++.++.||+.||.|||+.|++|+||+|+||++          
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            999999999999999995 5676666654  369999999999999999999999999999999999999          


Q ss_pred             ---------cCCCCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH
Q 023270          153 ---------DHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD  223 (284)
Q Consensus       153 ---------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~  223 (284)
                               +.++.++|+|||++...........+++.|+|||++.+..++.++||||||+++++|++|..||...+..+
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     56789999999999776666666789999999999999999999999999999999999999999888776


Q ss_pred             HHHHHHhcCCCCC------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCC
Q 023270          224 TFRRIMKVDLSFP------------------------------------------SAPSISAEAKHLISRLLVKDSSKRL  261 (284)
Q Consensus       224 ~~~~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rp  261 (284)
                      ....+.......+                                          .....+.++.+||.+||..||.+||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            5554433211111                                          0112245799999999999999999


Q ss_pred             CHHhhhcCccccccC
Q 023270          262 SLQKIMEHPWIIKNA  276 (284)
Q Consensus       262 s~~~il~~~~~~~~~  276 (284)
                      |++++|+||||++..
T Consensus       327 t~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          327 TLAEALLHPFFAGLT  341 (355)
T ss_dssp             CHHHHTTSGGGGGCC
T ss_pred             CHHHHhcChhhcCCC
Confidence            999999999999753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.1e-48  Score=334.93  Aligned_cols=258  Identities=24%  Similarity=0.441  Sum_probs=220.2

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEE-----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccc
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILR   83 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~   83 (284)
                      ....+++...+|++.+.||+|+||.||+|.     +..+++.||||++......  ...+.+.+|++++..+ +||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceee
Confidence            345567888999999999999999999998     4456688999999654322  2346788999999999 7899999


Q ss_pred             eeeEEecCC-eEEEEEeecCCCchHHHHHhcCC-----------------------------------------------
Q 023270           84 LYGWFHDDE-RIFLILEYAHRGELYRELRKHRR-----------------------------------------------  115 (284)
Q Consensus        84 ~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~-----------------------------------------------  115 (284)
                      +++++...+ ..++||||+++++|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999987755 58999999999999999976532                                               


Q ss_pred             -------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC----
Q 023270          116 -------------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----  172 (284)
Q Consensus       116 -------------------l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~----  172 (284)
                                         +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......    
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                               899999999999999999999999999999999999999999999999998543221    


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                       .....+++.|+|||++.+..++.++||||||+++++|++ |..||......+..............+..+++++.+++.
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML  330 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             123446788999999999999999999999999999998 999998877665555555555556666689999999999


Q ss_pred             HhcccCCCCCCCHHhhhcC
Q 023270          251 RLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~  269 (284)
                      +||..||.+|||++++++|
T Consensus       331 ~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHH
Confidence            9999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=332.28  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=221.0

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEE-----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      ..++..++|++.+.||+|+||+||+|.     +..++..||+|++......  .....+.+|+.+++.++|+||++++++
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh--hhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456777899999999999999999999     4456778999998643222  233567889999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC---C
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---R  157 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~---~  157 (284)
                      +..++..++||||+++++|.+++....       .++...++.++.|++.||.|||+.|++||||||+||+++.++   .
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999999998753       489999999999999999999999999999999999998555   5


Q ss_pred             EEEeeccccccc-----CCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 023270          158 LKIGDFGWSVQS-----RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKV  231 (284)
Q Consensus       158 ~~l~d~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  231 (284)
                      ++|+|||++...     ........+++.|+|||++.+..++.++||||||+++++|++ |..||...+..+....+..+
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998432     122234457889999999999999999999999999999998 99999999998888877765


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      . ....+..+++++.+|+.+||..||.+|||+++++++.++-.
T Consensus       303 ~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 G-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            4 33445578999999999999999999999999999876543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.4e-48  Score=327.26  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=214.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEe-cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHH---hCCCCcccceeeEEe----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREV-ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS---SLRHPNILRLYGWFH----   89 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~---~l~h~~i~~~~~~~~----   89 (284)
                      .++|++.+.||+|+||.||+|.+. .+++.||+|++........ ....+.+|+..++   .++|+||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            478999999999999999999985 6788999999864332210 0112334554444   458999999999987    


Q ss_pred             -cCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           90 -DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        90 -~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                       .....++|+|+++ ++|.+++....  .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5568999999998 59999998753  4899999999999999999999999999999999999999999999999998


Q ss_pred             cccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 023270          167 VQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF---------  235 (284)
Q Consensus       167 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------  235 (284)
                      .....  ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+.+..+.......         
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  247 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence            54432  2234567899999999999999999999999999999999999999998888777765421100         


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          236 ----------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       236 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                                      ...+.+++++.+|+.+||..||.+|||++++++||||++...+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence                            11245789999999999999999999999999999999876544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.1e-48  Score=337.11  Aligned_cols=257  Identities=32%  Similarity=0.488  Sum_probs=211.0

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ...++...+|++.+.||+|+||+||+|.+..++. +++|++.....       ...+|+++++.++|+||+++++++...
T Consensus        33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             SSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             CCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence            3456667789999999999999999999876665 88888754321       223689999999999999999998543


Q ss_pred             C------eEEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec-CCCCEEE
Q 023270           92 E------RIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKI  160 (284)
Q Consensus        92 ~------~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~-~~~~~~l  160 (284)
                      +      .+++||||++++ +...+.    ....++...++.++.|++.||.|||+.|++|+||||+||+++ .++.+||
T Consensus       105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL  183 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL  183 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE
Confidence            3      488999999864 443332    346799999999999999999999999999999999999998 7899999


Q ss_pred             eeccccccc--CCCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---
Q 023270          161 GDFGWSVQS--RSKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS---  234 (284)
Q Consensus       161 ~d~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---  234 (284)
                      +|||++...  ........+++.|+|||++.+. .++.++||||||+++++|++|..||.+.+..+.+..+.+....   
T Consensus       184 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             CCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999998543  3333456789999999998765 4899999999999999999999999998887777766542110   


Q ss_pred             --------------CC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          235 --------------FP----------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       235 --------------~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                    ++          ..+.+++++.+||.+||..||.+|||++++++||||++...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                          00          12247899999999999999999999999999999997644

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.7e-48  Score=337.99  Aligned_cols=253  Identities=32%  Similarity=0.489  Sum_probs=209.8

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------   91 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~------   91 (284)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+++++.++|+||+++++++...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            347999999999999999999999999999999985432       2234689999999999999999988432      


Q ss_pred             CeEEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeecccc
Q 023270           92 ERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS  166 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~~~  166 (284)
                      ..+++|+||+++ ++...+.    ....++...++.++.||+.||.|||+.||+|+||||+|||++.+ +.+||+|||++
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            247899999985 6666554    34679999999999999999999999999999999999999965 57899999998


Q ss_pred             cccC--CCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------
Q 023270          167 VQSR--SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-----------  232 (284)
Q Consensus       167 ~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----------  232 (284)
                      ....  .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+.++.+..           
T Consensus       205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            6432  233445789999999998765 68999999999999999999999999988777666655421           


Q ss_pred             ------CCCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          233 ------LSFP----------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       233 ------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                            ..++          ..+.+++++.+||++||..||.+|||++++++||||++..++
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                  0111          123568999999999999999999999999999999876544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=327.85  Aligned_cols=254  Identities=24%  Similarity=0.402  Sum_probs=212.2

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC--
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE--   92 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~--   92 (284)
                      .+.-++|++.+.||+|+||+||+|.+..+++.||+|++.......  ..+.+.+|+++++.++|+||+++++++...+  
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            345678999999999999999999999999999999987544322  2356678999999999999999999987665  


Q ss_pred             eEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe----cCCCCEEEeeccc
Q 023270           93 RIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGW  165 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~----~~~~~~~l~d~~~  165 (284)
                      ..++||||+++++|.+++....   .+++..++.++.|++.||.|||+.|++|+||+|+||++    +.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            7899999999999999998754   38999999999999999999999999999999999999    7778899999999


Q ss_pred             ccccCC--CCccccCCCcccCccccC--------CCCCCchhhHhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhc
Q 023270          166 SVQSRS--KRHTMCGTLDYLAPEMVE--------NKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRRIMKV  231 (284)
Q Consensus       166 ~~~~~~--~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~  231 (284)
                      +.....  ......+++.|+|||++.        +..++.++||||||+++++|++|..||...    ...+.+..+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            865433  223456899999999886        567899999999999999999999999643    334555555554


Q ss_pred             CCC-------------------CCC----CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCc
Q 023270          232 DLS-------------------FPS----APSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  270 (284)
Q Consensus       232 ~~~-------------------~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  270 (284)
                      ...                   .+.    ...+++.+.+++++||..||++|||++|+|+||
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            321                   111    123456789999999999999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=336.24  Aligned_cols=257  Identities=29%  Similarity=0.523  Sum_probs=197.1

Q ss_pred             ccCcEe-eeeeccCCCeEEEEEEEe--cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe--cCC
Q 023270           18 LQDFEI-GRPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH--DDE   92 (284)
Q Consensus        18 ~~~y~~-~~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~--~~~   92 (284)
                      -..|.+ .++||+|+||+||+|.+.  .++..||+|++......     ..+.+|+.+++.++|+||+++++++.  .+.
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            355777 457999999999999965  56889999999654332     35678999999999999999999995  467


Q ss_pred             eEEEEEeecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe----cCCCCEE
Q 023270           93 RIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLK  159 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~----~~~~~~~  159 (284)
                      ..++||||++ ++|.+++....         .+++..++.++.||+.||.|||+.||+|+||+|+|||+    +.++.++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            8999999997 48888775331         48999999999999999999999999999999999999    6778999


Q ss_pred             EeecccccccCC------CCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChH---------H
Q 023270          160 IGDFGWSVQSRS------KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------D  223 (284)
Q Consensus       160 l~d~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------~  223 (284)
                      |+|||++.....      ......|++.|+|||++.+. .++.++||||||+++++|++|..||......         +
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999855432      22345679999999999875 4899999999999999999999999765542         3


Q ss_pred             HHHHHHhcCCCCC--CC----------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHhhh
Q 023270          224 TFRRIMKVDLSFP--SA----------------------------------PSISAEAKHLISRLLVKDSSKRLSLQKIM  267 (284)
Q Consensus       224 ~~~~~~~~~~~~~--~~----------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il  267 (284)
                      .+..+......+.  .+                                  ...++++.+||.+||..||.+|||++++|
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            3333332111000  00                                  11267899999999999999999999999


Q ss_pred             cCccccccCCCCC
Q 023270          268 EHPWIIKNANPRG  280 (284)
Q Consensus       268 ~~~~~~~~~~~~~  280 (284)
                      +||||++.+.|..
T Consensus       333 ~hp~f~~~~~~~~  345 (405)
T 3rgf_A          333 QDPYFLEDPLPTS  345 (405)
T ss_dssp             TSGGGTSSSCCCS
T ss_pred             cChhhccCCCCcc
Confidence            9999998876644

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-47  Score=316.92  Aligned_cols=252  Identities=17%  Similarity=0.295  Sum_probs=222.0

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ...++.+++|++.+.||+|+||+||++.+  .++.|++|++....... ...+.+.+|+.+++.++|+||+++++++..+
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A            3 KHSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSP   79 (271)
T ss_dssp             -CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred             CcCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence            34678899999999999999999999997  47889999987654333 2346788999999999999999999999877


Q ss_pred             --CeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCCCCEEEeeccc
Q 023270           92 --ERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        92 --~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                        +..++|+||+++++|.+++....  .+++..++.++.|++.||.|||+.|  ++|+||+|+||+++.++.++++||++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~  159 (271)
T 3kmu_A           80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV  159 (271)
T ss_dssp             TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred             CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence              78899999999999999998765  4899999999999999999999999  99999999999999999999999888


Q ss_pred             ccccCCCCccccCCCcccCccccCCCCCCc---hhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          166 SVQSRSKRHTMCGTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      ......  ....+++.|+|||.+.+...+.   ++||||||+++++|++|..||...+.................+..++
T Consensus       160 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3kmu_A          160 KFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS  237 (271)
T ss_dssp             CCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCC
T ss_pred             eeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCC
Confidence            644322  2346789999999998765544   79999999999999999999999999888888887777777777899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +++.+++.+||..||.+|||++++++
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          238 PHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=322.26  Aligned_cols=262  Identities=25%  Similarity=0.443  Sum_probs=205.8

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ....+.+++|++.+.||+|+||.||+|.+..+++.|++|++....... ...+.+.++..+++.++|+||+++++++..+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            456678899999999999999999999999999999999986654332 2334555566678888999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..++||||+ ++.+..+... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999999999 4566665544 46799999999999999999999995 9999999999999999999999999988543


Q ss_pred             CC--CCccccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCC-CCCCCC
Q 023270          170 RS--KRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVDLS-FPSAPS  240 (284)
Q Consensus       170 ~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~  240 (284)
                      ..  ......+++.|+|||++.     +..++.++||||||+++++|++|..||.. ....+........... .+....
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence            32  223446889999999984     45688999999999999999999999987 4555666666554332 222346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +++++.+++.+||..||.+|||++++++||||++.
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            89999999999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-47  Score=324.31  Aligned_cols=257  Identities=25%  Similarity=0.420  Sum_probs=222.6

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEE-----ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~   84 (284)
                      ...+++..++|++.+.||+|+||.||+|.+     ..++..|++|++......  ...+.+.+|+.+++.+ +|+||+++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeE
Confidence            345677788999999999999999999985     346778999998754432  2346788999999999 89999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHR------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~  146 (284)
                      ++++..++..++||||+++++|.+++....                  .+++..++.++.|++.||.|||+.|++|+||+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  172 (313)
T 1t46_A           93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (313)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            999999999999999999999999998754                  48999999999999999999999999999999


Q ss_pred             CCCeEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCC
Q 023270          147 PENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES  220 (284)
Q Consensus       147 p~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~  220 (284)
                      |+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999999999999999999985543322     22345678999999998899999999999999999998 999998877


Q ss_pred             hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .................+..+++++.+++.+||..||.+|||+++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            6666666666555666666899999999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.9e-48  Score=329.39  Aligned_cols=255  Identities=29%  Similarity=0.536  Sum_probs=186.8

Q ss_pred             cccccCcEeee-eeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec---
Q 023270           15 EWSLQDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD---   90 (284)
Q Consensus        15 ~~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~---   90 (284)
                      .....+|++.+ .||.|+||+||+|.+..+++.||+|++.....       ...+....++.++|+|++++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            33557899965 69999999999999999999999999855321       11223344667799999999999875   


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeecc
Q 023270           91 -DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFG  164 (284)
Q Consensus        91 -~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~~  164 (284)
                       +...++||||+++++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.++|+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             456899999999999999998764  6999999999999999999999999999999999999976   4559999999


Q ss_pred             cccccCC-CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHH----HHHHhcCC--CCCC
Q 023270          165 WSVQSRS-KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----RRIMKVDL--SFPS  237 (284)
Q Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~--~~~~  237 (284)
                      ++..... ......+++.|+|||++.+..++.++||||||+++++|++|..||.........    ........  ..+.
T Consensus       177 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (336)
T 3fhr_A          177 FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE  256 (336)
T ss_dssp             TCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred             cceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence            9865433 233456789999999998888999999999999999999999999776654432    22222222  2223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ...+++++.+|+.+||..||.+|||++++|+||||++..
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            347899999999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-48  Score=330.22  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=220.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~   85 (284)
                      ..+++..++|.+.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+.+|+.+++.+ +||||++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            456778899999999999999999999973     356679999986543  223346788999999999 899999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHR-----------------------RFTEQQAATYIASLTNALAYCHENHVIH  142 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H  142 (284)
                      +++..++..++||||+++++|.+++....                       .+++..++.++.|++.||.|||+.|++|
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999999999999999999999997653                       2789999999999999999999999999


Q ss_pred             cCCCCCCeEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCC
Q 023270          143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPF  216 (284)
Q Consensus       143 ~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~  216 (284)
                      +||+|+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|+| |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            9999999999999999999999985433221     22345778999999998899999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCc
Q 023270          217 EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  270 (284)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  270 (284)
                      .....................+..+++++.+|+.+||..||.+|||+++++++-
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            888776666666666566666668899999999999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.9e-48  Score=334.20  Aligned_cols=259  Identities=23%  Similarity=0.398  Sum_probs=210.9

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-----------CCccc
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-----------HPNIL   82 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-----------h~~i~   82 (284)
                      ..+...+|++.+.||+|+||+||+|.+..+++.||+|++......    .+.+.+|+.+++.+.           |+||+
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            345678999999999999999999999999999999998654322    245667777777765           78999


Q ss_pred             ceeeEEecCC----eEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecC-
Q 023270           83 RLYGWFHDDE----RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDH-  154 (284)
Q Consensus        83 ~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~-  154 (284)
                      ++++++...+    ..++|+|++ +++|.+++...  ..++...++.++.||+.||.|||++ |++|+||+|+||+++. 
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            9999987654    789999999 68999999874  4599999999999999999999998 9999999999999953 


Q ss_pred             -----CCCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh------HH
Q 023270          155 -----EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ------KD  223 (284)
Q Consensus       155 -----~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~------~~  223 (284)
                           .+.++|+|||++...........+++.|+|||++.+..++.++||||||+++++|++|..||...+.      ..
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence                 3479999999997766666667789999999999999999999999999999999999999986542      22


Q ss_pred             HHHHHHhcCCC----------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023270          224 TFRRIMKVDLS----------------------------------------FPSAPSISAEAKHLISRLLVKDSSKRLSL  263 (284)
Q Consensus       224 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~  263 (284)
                      ...++......                                        ...+...++++.+||.+||..||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            22222211000                                        01112456789999999999999999999


Q ss_pred             HhhhcCccccccCC
Q 023270          264 QKIMEHPWIIKNAN  277 (284)
Q Consensus       264 ~~il~~~~~~~~~~  277 (284)
                      +++|+||||++...
T Consensus       329 ~ell~hp~f~~~~~  342 (373)
T 1q8y_A          329 GGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHTCGGGTTCTT
T ss_pred             HHHhhChhhhcccC
Confidence            99999999998643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-47  Score=325.87  Aligned_cols=256  Identities=23%  Similarity=0.366  Sum_probs=222.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      ....++..++|++.+.||+|+||.||++.+..     +++.||+|++......  ...+.+.+|+.+++.++|+||++++
T Consensus        39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~  116 (343)
T 1luf_A           39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLL  116 (343)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            34567788999999999999999999999873     4588999999754322  3456788999999999999999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKH------------------------RRFTEQQAATYIASLTNALAYCHENHVI  141 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~  141 (284)
                      +++..++..++||||+++++|.+++...                        ..+++..++.++.|++.||.|||++|++
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv  196 (343)
T 1luf_A          117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV  196 (343)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            9999999999999999999999999874                        5689999999999999999999999999


Q ss_pred             ccCCCCCCeEecCCCCEEEeecccccccCC-----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCC
Q 023270          142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPP  215 (284)
Q Consensus       142 H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p  215 (284)
                      |+||+|+||+++.++.++|+|||++.....     ......+++.|+|||.+.+..++.++||||||+++++|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999844321     2233456788999999998889999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          216 FEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      |...+..+....+..+.. ...+..+++++.+++.+||..||.+|||+++++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            999998888887776543 33445789999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-47  Score=328.90  Aligned_cols=254  Identities=24%  Similarity=0.462  Sum_probs=221.2

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCC-------ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESK-------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~   84 (284)
                      .+++...+|.+.+.||+|+||+||+|.+...+       ..||+|++......  ...+.+.+|+++++.+ +|+||+++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH--HHHHHHHHHHHHHHHhcCCchhhhh
Confidence            34667789999999999999999999976433       56999998664322  3356788999999999 89999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++++..++..++||||+++++|.+++....                .+++..++.++.|++.||.|||+.|++|+||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            999999999999999999999999998754                4899999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCC-----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.+||+|||++.....     ......+++.|+|||++.+..++.++||||||+++++|++ |..||...+..
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999864432     2233346788999999999999999999999999999999 99999999888


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +....+.... ....+..+++++.+|+.+||..||.+|||+++++++
T Consensus       301 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          301 ELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8777766653 444456799999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-47  Score=323.25  Aligned_cols=256  Identities=24%  Similarity=0.431  Sum_probs=221.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      ...+++..++|.+.+.||.|+||.||+|.+.     .++..|++|++.....  ....+.+.+|+++++.++||||++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~   92 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEFNVLKQVNHPHVIKLY   92 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCceeeEE
Confidence            3456777899999999999999999999884     3457899999965432  23356788999999999999999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcc
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHRR------------------------FTEQQAATYIASLTNALAYCHENHVI  141 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~~i~~~l~~lh~~gi~  141 (284)
                      +++..++..++||||+++++|.+++.....                        ++...++.++.|++.||.|||++|++
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  172 (314)
T 2ivs_A           93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV  172 (314)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            999999999999999999999999987543                        89999999999999999999999999


Q ss_pred             ccCCCCCCeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCC
Q 023270          142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPP  215 (284)
Q Consensus       142 H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p  215 (284)
                      |+||+|+||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998544322     123346778999999988889999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          216 FEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      |...+.......+.... ....+..+++++.+++.+||..||.+|||+++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             STTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99888877776665543 344556789999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-47  Score=332.37  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=220.5

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .+++...+|.+.+.||+|+||.||++.+..+++.||+|++.....  ....+.+.+|+++++.++||||+++++++..++
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            356677899999999999999999999998999999999865422  233457889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 RIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ..++||||+++++|.+++...+ .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            9999999999999999998754 689999999999999999999999999999999999999999999999999865432


Q ss_pred             CCc-----cccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          172 KRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       172 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ...     ...+++.|+|||.+.+..++.++||||||++++++++ |..||...+..+.......+ ...+.+..+++++
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  344 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAV  344 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCCCCCTTCCHHH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHH
Confidence            221     1224567999999988889999999999999999998 99999998888777666554 3455556789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .+|+.+||..||.+|||++++++
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-47  Score=319.76  Aligned_cols=251  Identities=26%  Similarity=0.500  Sum_probs=205.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-------   90 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-------   90 (284)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++....    ...+.+.+|+.+++.++|+||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            357999999999999999999999999999999985432    234678899999999999999999998754       


Q ss_pred             ------CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeec
Q 023270           91 ------DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        91 ------~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                            .+..++|+||+++++|.+++... ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence                  45789999999999999999865 36788999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-----------------CCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCC-ChHHH
Q 023270          164 GWSVQSRS-----------------KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDT  224 (284)
Q Consensus       164 ~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~-~~~~~  224 (284)
                      |++.....                 ......+++.|+|||.+.+. .++.++||||||+++++|++   ||... +....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            98854321                 12234578899999999765 68999999999999999998   55433 33344


Q ss_pred             HHHHHhcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          225 FRRIMKVDLSFP--SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       225 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ...+.......+  .....++.+.+++.+||..||.+|||++++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            444444332222  234677889999999999999999999999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-46  Score=317.73  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=209.4

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ...+.+|++.+.||.|+||.||+|.+..++..|++|++.............+.+|+.+++.++|+||+++++++..++..
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            44677899999999999999999999999999999998754333344557788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           95 FLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ++|+||+++++|.+++..    ...++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999999865    3568999999999999999999999999999999999999999999999999975433


Q ss_pred             CC---CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          171 SK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE--SQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       171 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ..   .....+++.|+|||.+.+..++.++||||||+++++|++|..||...  .....................+++++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  267 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence            22   23345789999999999999999999999999999999999999654  33455555555544444445789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+++.+||..||.+|||+++++++
T Consensus       268 ~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          268 RQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.6e-47  Score=317.57  Aligned_cols=253  Identities=21%  Similarity=0.374  Sum_probs=222.7

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++..++|++.+.||+|+||+||++.+..++..|++|++......    .+.+.+|+.+++.++|+||+++++++..+
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            45678889999999999999999999999999999999998654322    35678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..++||||+++++|.+++...  ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999999999874  35899999999999999999999999999999999999999999999999998654


Q ss_pred             CCCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ....    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+.......+... .....+..++++
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  240 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEK  240 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHH
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCCHH
Confidence            4322    22335678999999998899999999999999999999 99999988877766666554 344555689999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.+++.+||..||.+|||++++++.
T Consensus       241 l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          241 VYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhCCChhhCcCHHHHHHH
Confidence            9999999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.6e-47  Score=312.54  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=220.0

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      +.+..++|++.+.||+|+||.||++.+. ++..|++|++.......    +.+.+|+++++.++|+||+++++++..++.
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            5677889999999999999999999985 67789999997654333    467889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999999999876 56899999999999999999999999999999999999999999999999998654321


Q ss_pred             ----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       173 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                          .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+..+. ....+...++++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~  236 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQ  236 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCCccCcHHHHH
Confidence                123445678999999988889999999999999999999 999999998888888777653 33344578999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+||..||.+|||+++++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-47  Score=319.11  Aligned_cols=255  Identities=24%  Similarity=0.412  Sum_probs=210.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEE----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      ...++..++|++++.||+|+||+||++.    +..+++.||+|++....   ....+.+.+|+.+++.++|+||++++++
T Consensus         3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   79 (295)
T 3ugc_A            3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGV   79 (295)
T ss_dssp             ---CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3467888999999999999999999998    56688999999986543   2334678899999999999999999999


Q ss_pred             EecC--CeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecc
Q 023270           88 FHDD--ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        88 ~~~~--~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                      +...  ...++||||+++++|.+++...+ .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            8544  56899999999999999998764 59999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH---------------H
Q 023270          165 WSVQSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------------D  223 (284)
Q Consensus       165 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------------~  223 (284)
                      ++.......      ....++..|+|||.+.+..++.++||||||+++++|++|..|+......               .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            985443221      2233566799999999999999999999999999999999988653221               1


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...+........+.+..+++++.+++.+||..||.+|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            2222333344555566899999999999999999999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.3e-47  Score=315.22  Aligned_cols=254  Identities=25%  Similarity=0.435  Sum_probs=210.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecC---CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ...++..++|++.+.||+|+||.||+|.+..+   +..|++|++.....  ....+.+.+|+..++.++||||+++++++
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            45678889999999999999999999998654   44699999865432  23456788999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      . ++..++||||+++++|.+++...+ .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            4 567899999999999999998764 68999999999999999999999999999999999999999999999999985


Q ss_pred             ccCCCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          168 QSRSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       168 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      ......    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+.... ..+.++.++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~  243 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCP  243 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCC
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCC
Confidence            543221    22345678999999998889999999999999999996 999999888887777776653 344556899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++.+++.+||..||.+|||+++++++
T Consensus       244 ~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          244 PTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.8e-47  Score=324.03  Aligned_cols=263  Identities=27%  Similarity=0.431  Sum_probs=196.3

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHH-HHHhCCCCcccceeeEEe
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~-~~~~l~h~~i~~~~~~~~   89 (284)
                      ...+.+...+|++.+.||+|+||.||++.+..+++.||+|++....... . ...+..++. +++.++|+||+++++++.
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-E-QKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-H-HHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-H-HHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            3456788899999999999999999999999999999999986543222 2 233444444 778889999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEecCCCCEEEeec
Q 023270           90 DDERIFLILEYAHRGELYRELRK-----HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~-gi~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                      .++..++||||+++ +|.+++..     ...++...+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            99999999999985 88887764     46789999999999999999999999 9999999999999999999999999


Q ss_pred             ccccccCCC--CccccCCCcccCcccc----CCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCC--
Q 023270          164 GWSVQSRSK--RHTMCGTLDYLAPEMV----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLS--  234 (284)
Q Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~--  234 (284)
                      |++......  .....+++.|+|||++    .+..++.++||||||+++++|++|..||...... +.......+...  
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            998554322  2233688999999998    4566899999999999999999999999875432 222222222111  


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          235 -FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       235 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                       ......+++++.+|+.+||..||.+|||++++++||||.+..
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence             111235899999999999999999999999999999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.3e-48  Score=328.13  Aligned_cols=259  Identities=29%  Similarity=0.529  Sum_probs=216.6

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---HHHHHHHHHHHHHHhCC--CCcccceee
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLR--HPNILRLYG   86 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~~~~~~l~--h~~i~~~~~   86 (284)
                      ...+....+|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++.+.  |+|++++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            4455667889999999999999999999999999999999866532210   01134557888888886  599999999


Q ss_pred             EEecCCeEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec-CCCCEEEeecc
Q 023270           87 WFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFG  164 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~-~~~~~~l~d~~  164 (284)
                      ++..++..++|+|++.+ ++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            99999999999999975 89999999888999999999999999999999999999999999999998 67899999999


Q ss_pred             cccccCC-CCccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 023270          165 WSVQSRS-KRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSIS  242 (284)
Q Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
                      ++..... ......+++.|+|||++.+..+ +.++||||||+++++|++|..||....      ......  ......++
T Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~--~~~~~~~~  267 (320)
T 3a99_A          196 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ--VFFRQRVS  267 (320)
T ss_dssp             TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC--CCCSSCCC
T ss_pred             cccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccc--ccccccCC
Confidence            9865433 2334568999999999877765 688999999999999999999997532      122222  22334789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          243 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       243 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      +++.+|+.+||..||.+|||++++++||||++...+
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            999999999999999999999999999999987654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.8e-47  Score=323.24  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=221.0

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEE-----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccc
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL   82 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~   82 (284)
                      ++.....++..++|++.+.||.|+||.||++.     +..++..||+|++......  .....+.+|+.+++.++|+||+
T Consensus        19 ss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv   96 (327)
T 2yfx_A           19 SSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIV   96 (327)
T ss_dssp             ECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--hhHHHHHHHHHHHhhCCCCCCC
Confidence            44556678889999999999999999999998     5567889999998643322  2345778899999999999999


Q ss_pred             ceeeEEecCCeEEEEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-
Q 023270           83 RLYGWFHDDERIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-  154 (284)
Q Consensus        83 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-  154 (284)
                      ++++++..++..++||||+++++|.+++....       .++...++.++.|++.||.|||+.|++|+||+|+||+++. 
T Consensus        97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A           97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred             eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC
Confidence            99999999999999999999999999998763       4899999999999999999999999999999999999984 


Q ss_pred             --CCCEEEeecccccccC-----CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 023270          155 --EGRLKIGDFGWSVQSR-----SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR  226 (284)
Q Consensus       155 --~~~~~l~d~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~  226 (284)
                        +..++|+|||++....     .......+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+...
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  256 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  256 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence              4469999999874321     12233456889999999988889999999999999999998 999999988888777


Q ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          227 RIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      .+.... .......+++++.+++.+||..||.+|||+++++++.|+-.
T Consensus       257 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          257 FVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCC-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            766653 33444578999999999999999999999999999987643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.3e-47  Score=334.58  Aligned_cols=249  Identities=23%  Similarity=0.429  Sum_probs=217.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++...+|++.+.||+|+||.||++.+.  ++.||||++....     ..+.+.+|++++++++|+||+++++++...
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            456788999999999999999999999874  6799999986543     235788999999999999999999998766


Q ss_pred             C-eEEEEEeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           92 E-RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        92 ~-~~~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      + ..++||||+++++|.+++...+.  ++...++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            5 79999999999999999987643  79999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          169 SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                      .........+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+..+ .....+..+++++.+
T Consensus       339 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~  417 (450)
T 1k9a_A          339 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYD  417 (450)
T ss_dssp             CC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred             ccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence            5544444467889999999999999999999999999999998 99999988887777776655 345556689999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhc
Q 023270          248 LISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++.+||..||.+|||+.++++
T Consensus       418 li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          418 VMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-46  Score=321.47  Aligned_cols=254  Identities=25%  Similarity=0.470  Sum_probs=218.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe-------cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV-------ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~   84 (284)
                      .+++...+|++.+.||+|+||.||+|.+.       .++..||+|++......  ...+.+.+|+.+++.+ +|+||+++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--HHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            34455689999999999999999999975       35678999999654322  3356788999999999 89999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++++..++..++||||+++++|.+++....                .++...++.++.|++.||.|||+.|++|+||+|+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999999998754                3899999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.++|+|||++......     .....+++.|+|||++.+..++.++||||||+++++|++ |..||...+..
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            999999999999999998554332     223345778999999988889999999999999999999 99999998888


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +....+.... ....+..+++++.+++.+||..||.+|||+++++++
T Consensus       267 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          267 ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8777766654 334455789999999999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.7e-47  Score=322.63  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=219.9

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceE--EEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV--ALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v--~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      ......+..++|++.+.||+|+||.||+|.+..++..+  ++|.+....  .....+.+.+|+.+++.+ +||||+++++
T Consensus        16 ~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   93 (327)
T 1fvr_A           16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLG   93 (327)
T ss_dssp             CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             CcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhce
Confidence            44556688899999999999999999999999888865  888885422  223346788999999999 8999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~ni  150 (284)
                      ++..++..++||||+++++|.+++....                .++...++.++.|++.||.|||+.|++|+||+|+||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  173 (327)
T 1fvr_A           94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  173 (327)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             eeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceE
Confidence            9999999999999999999999997654                689999999999999999999999999999999999


Q ss_pred             EecCCCCEEEeecccccccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 023270          151 LLDHEGRLKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRR  227 (284)
Q Consensus       151 l~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~  227 (284)
                      +++.++.++|+|||++.....  ......+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....
T Consensus       174 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~  253 (327)
T 1fvr_A          174 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  253 (327)
T ss_dssp             EECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             EEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence            999999999999999854332  2223346788999999988889999999999999999998 9999999988887777


Q ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          228 IMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +..+ .....+..+++++.+++.+||..||.+|||+++++++
T Consensus       254 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          254 LPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6655 3344455789999999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5e-47  Score=316.89  Aligned_cols=249  Identities=22%  Similarity=0.350  Sum_probs=211.3

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCC-------ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceee
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESK-------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~   86 (284)
                      .++..++|++.+.||+|+||+||++.+..++       ..|++|++......   ..+.+.+|+.+++.++|+||+++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~   79 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYG   79 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            4677889999999999999999999998877       46999998654322   2357889999999999999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC--------
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--------  157 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~--------  157 (284)
                      ++..++..++||||+++++|.+++...+. ++...++.++.|++.||.|||+.|++|+||+|+||+++.++.        
T Consensus        80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999999999988754 999999999999999999999999999999999999998887        


Q ss_pred             EEEeecccccccCCCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 023270          158 LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSF  235 (284)
Q Consensus       158 ~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~  235 (284)
                      ++|+|||.+...... ....+++.|+|||.+.+ ..++.++||||||+++++|++ +.+||...+......... ...  
T Consensus       160 ~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~~~--  235 (289)
T 4fvq_A          160 IKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRH--  235 (289)
T ss_dssp             EEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTC--
T ss_pred             eeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-ccC--
Confidence            999999998544332 23457888999999987 668999999999999999999 555666555554444333 322  


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          236 PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ..+...++++.+++.+||..||.+|||+++++++
T Consensus       236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2333578899999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.4e-47  Score=315.06  Aligned_cols=250  Identities=23%  Similarity=0.417  Sum_probs=209.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      ...+.+..++|++.+.||.|++|+||++.+  +++.|++|++....     ..+.+.+|+.+++.++|+||+++++++..
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE   85 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            344567889999999999999999999986  47899999986543     23567889999999999999999998754


Q ss_pred             C-CeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           91 D-ERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        91 ~-~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      . +..++|+||+++++|.+++....  .++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence            4 57899999999999999998764  38999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Q 023270          168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK  246 (284)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (284)
                      ..........+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+..+ .....+..+++++.
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  244 (278)
T 1byg_A          166 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVY  244 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHH
T ss_pred             cccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCcccCCHHHH
Confidence            65555555567889999999998889999999999999999998 99999988877777666554 33445567899999


Q ss_pred             HHHHHhcccCCCCCCCHHhhhc
Q 023270          247 HLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       247 ~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +++.+||..||.+|||+.++++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=322.87  Aligned_cols=258  Identities=29%  Similarity=0.532  Sum_probs=205.3

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---HHHHHHHHHHHHHHhC----CCCccccee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSL----RHPNILRLY   85 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~~~~~~l----~h~~i~~~~   85 (284)
                      ..+...++|++.+.||+|+||.||+|.+..+++.|++|++........   .....+.+|+..+..+    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            345567889999999999999999999999999999999965443221   1223455688888888    899999999


Q ss_pred             eEEecCCeEEEEEee-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec-CCCCEEEeec
Q 023270           86 GWFHDDERIFLILEY-AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDF  163 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~-~~~~~~l~d~  163 (284)
                      +++...+..++|+|+ +.+++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            999999999999999 78899999999888899999999999999999999999999999999999999 7899999999


Q ss_pred             ccccccCC-CCccccCCCcccCccccCCCCCC-chhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          164 GWSVQSRS-KRHTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      |++..... ......+++.|+|||++.+..+. .++||||||+++++|++|..||....      .......  .....+
T Consensus       185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~--~~~~~~  256 (312)
T 2iwi_A          185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL--HFPAHV  256 (312)
T ss_dssp             SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC--CCCTTS
T ss_pred             chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc--CCcccC
Confidence            99855433 33445688999999998777664 58999999999999999999997532      1222222  233478


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ++++.+++.+||..||++|||++++++||||++..+.
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence            9999999999999999999999999999999987654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-46  Score=314.11  Aligned_cols=254  Identities=22%  Similarity=0.356  Sum_probs=215.6

Q ss_pred             hcccccccCcEeee-eeccCCCeEEEEEEE--ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           12 RKREWSLQDFEIGR-PLGKGKFGRVYLVRE--VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        12 ~~~~~~~~~y~~~~-~lg~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ....+...+|++.+ .||.|+||+||++.+  ..+++.|++|++...... ....+.+.+|+++++.++|+||+++++++
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34566778899999 999999999999954  556788999998765322 23456788999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                       ..+..++|+|++++++|.+++...+.++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence             5677899999999999999999988899999999999999999999999999999999999999999999999999855


Q ss_pred             cCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          169 SRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       169 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      .....      ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+.... ....+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  245 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGC  245 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Confidence            43222      12235678999999988889999999999999999999 999999988888777666543 34445578


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ++++.+++.+||..||.+|||++++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.4e-47  Score=322.99  Aligned_cols=255  Identities=23%  Similarity=0.403  Sum_probs=220.3

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCc-----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----PVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      ..++..++|++.+.||.|+||.||++.+..++.     .|++|.+......  ...+.+.+|+.+++.+ +||||+++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            467778899999999999999999999876654     6999998654322  2346788999999999 8999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKH--------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL  152 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~  152 (284)
                      ++..++..++||||+++++|.+++...              ..++...++.++.|++.||.|||+.|++|+||+|+||++
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL  197 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence            999999999999999999999999753              357999999999999999999999999999999999999


Q ss_pred             cCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 023270          153 DHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR  226 (284)
Q Consensus       153 ~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~  226 (284)
                      +.++.++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||..........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            999999999999985432221     22345678999999998889999999999999999998 999998877666666


Q ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          227 RIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...........+...++++.+++.+||..||.+|||+++++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            6666555666666789999999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.9e-47  Score=321.39  Aligned_cols=256  Identities=24%  Similarity=0.432  Sum_probs=216.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~   85 (284)
                      ..+++...+|++.+.||.|+||+||+|.+.     .+++.|++|++......  ...+.+.+|+.++..+ +|+||++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            345677889999999999999999999854     46688999998664322  2346788999999999 689999999


Q ss_pred             eEEecCC-eEEEEEeecCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           86 GWFHDDE-RIFLILEYAHRGELYRELRKHRR----------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        86 ~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      +++...+ ..++|+||+++++|.+++.....                ++...++.++.|++.||.|||+.|++|+||+|+
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~  177 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  177 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence            9987654 58999999999999999987653                899999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.++|+|||++.......     ....+++.|+|||++.+..++.++||||||+++++|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            9999999999999999985443221     23346788999999999999999999999999999998 99999887655


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...............+..+++++.+++.+||..||.+|||++++++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44444444444455556789999999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.2e-47  Score=315.78  Aligned_cols=257  Identities=23%  Similarity=0.373  Sum_probs=214.2

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecC-Cc--eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES-KH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~--~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ....+..++|++.+.||.|+||+||++.+..+ +.  .|++|++...........+.+.+|+++++.++|+||+++++++
T Consensus        11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            34567788999999999999999999987543 33  5899998765544445567889999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ..+. .++|+|++++++|.+++... ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence            7765 89999999999999999775 578999999999999999999999999999999999999999999999999985


Q ss_pred             ccCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          168 QSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       168 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      ......      ....+++.|+|||++.+..++.++||||||+++++|++ |..||...+..+....+.......+....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED  249 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence            543222      22345678999999988889999999999999999999 99999999999998888887767777778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +++++.+++.+||..||.+|||+++++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.3e-47  Score=326.21  Aligned_cols=254  Identities=24%  Similarity=0.396  Sum_probs=211.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ..++...+|++.+.||+|+||.||++.+.   .++..||||++.....  ....+.+.+|+.+++.++|+||+++++++.
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            45677789999999999999999999886   4677899999865432  233567889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      .++..++||||+++++|.+++...+ .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999999999998764 699999999999999999999999999999999999999999999999999854


Q ss_pred             cCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          169 SRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       169 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      .....      ....+++.|+|||++.+..++.++||||||++++++++ |..||...+..+....+.... ..+.+..+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~  275 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-RLPPPMDC  275 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-ECCCCTTC
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCccc
Confidence            43221      11234668999999998899999999999999999998 999999988888777766543 34445578


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.++.+++.+||..||.+||+++++++.
T Consensus       276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~  303 (373)
T 2qol_A          276 PAALYQLMLDCWQKDRNNRPKFEQIVSI  303 (373)
T ss_dssp             BHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence            9999999999999999999999998863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-46  Score=316.84  Aligned_cols=259  Identities=17%  Similarity=0.298  Sum_probs=213.0

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEec---CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      .......+..++|.+.+.||+|+||.||+|.+..   ++..|++|++....... ...+.+.+|+.+++.++|+||++++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~  102 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLL  102 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeee
Confidence            3445566778899999999999999999998776   44579999986554333 3346788999999999999999999


Q ss_pred             eEEecCC-----eEEEEEeecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC
Q 023270           86 GWFHDDE-----RIFLILEYAHRGELYRELRK------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (284)
Q Consensus        86 ~~~~~~~-----~~~~v~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~  154 (284)
                      +++...+     ..++|+||+++++|.+++..      ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence            9987655     45999999999999999843      356899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 023270          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRI  228 (284)
Q Consensus       155 ~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  228 (284)
                      ++.++|+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+.....
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            999999999998543321     123346778999999999999999999999999999999 99999998888877777


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ..+. ....+..+++++.+++.+||..||.+|||+.+++++
T Consensus       263 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          263 LHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HTTC-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HcCC-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6654 344455789999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-46  Score=319.40  Aligned_cols=253  Identities=20%  Similarity=0.345  Sum_probs=210.4

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceE----EEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV----ALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ...++..+|++.+.||+|+||+||+|.+..+++.+    ++|.+....  .....+.+.+|+.+++.++|+||+++++++
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   86 (327)
T 3poz_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            44567889999999999999999999988777654    777775432  223346788999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ..++ .++|++++.+++|.+++... ..++...++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus        87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence            8765 78899999999999999874 579999999999999999999999999999999999999999999999999985


Q ss_pred             ccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          168 QSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       168 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      ......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+... ...+.++..
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  244 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPIC  244 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTB
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-CCCCCCccC
Confidence            432221     22345778999999999999999999999999999999 99999988877766655554 345556679


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.++.+++.+||..||.+|||+.+++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-46  Score=310.99  Aligned_cols=265  Identities=21%  Similarity=0.346  Sum_probs=217.3

Q ss_pred             ChhhHHHhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCc---eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC
Q 023270            2 DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH   78 (284)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h   78 (284)
                      +++....-...........|.+.+.||+|+||+||+|.+..++.   .|++|.+....  .....+.+.+|+.+++.++|
T Consensus         4 ~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h   81 (298)
T 3pls_A            4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNH   81 (298)
T ss_dssp             CHHHHHHTGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCC
T ss_pred             cHHHHhhhhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCC
Confidence            34443444444445555567788999999999999999766555   69999986533  22345678899999999999


Q ss_pred             CcccceeeEEecCCeE-EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC
Q 023270           79 PNILRLYGWFHDDERI-FLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (284)
Q Consensus        79 ~~i~~~~~~~~~~~~~-~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~  156 (284)
                      +||+++++++...+.. ++|+|++.+++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus        82 ~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~  161 (298)
T 3pls_A           82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF  161 (298)
T ss_dssp             TTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             CCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            9999999999776655 9999999999999999874 5789999999999999999999999999999999999999999


Q ss_pred             CEEEeecccccccCC-------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 023270          157 RLKIGDFGWSVQSRS-------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRI  228 (284)
Q Consensus       157 ~~~l~d~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  228 (284)
                      .++|+|||++.....       ......+++.|.|||.+.+..++.++||||||+++++|++ +.+||...+..+.....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~  241 (298)
T 3pls_A          162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL  241 (298)
T ss_dssp             CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred             cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence            999999999853322       2233456788999999999999999999999999999999 55666666666666555


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .... ..+.+..+++++.+++.+||..||.+|||++++++.
T Consensus       242 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          242 AQGR-RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCC-CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5543 455556789999999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-46  Score=316.25  Aligned_cols=255  Identities=23%  Similarity=0.358  Sum_probs=215.3

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCC----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESK----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      -..++...+|++.+.||+|+||+||+|.+..++    ..|++|++......  .....+.+|+.+++.++|+||++++++
T Consensus        37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~  114 (333)
T 1mqb_A           37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGV  114 (333)
T ss_dssp             -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            345778899999999999999999999887654    35999998654322  234578899999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      +...+..++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             EecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence            99999999999999999999999775 57999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 023270          167 VQSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAP  239 (284)
Q Consensus       167 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
                      .......      ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+..+. ..+.+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~~  273 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLPTPM  273 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCT
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-cCCCcc
Confidence            5443221      12234678999999998899999999999999999998 999999988888877776653 344555


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+++++.+++.+||..||.+||++.+++++
T Consensus       274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          274 DCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3e-46  Score=316.92  Aligned_cols=255  Identities=20%  Similarity=0.348  Sum_probs=220.7

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceee
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~   86 (284)
                      ..+++..++|++.+.||+|+||.||+|.+.     .+++.|++|.+......  .....+.+|+.+++.++|+||+++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            345667789999999999999999999887     36788999999654322  23456889999999999999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~  156 (284)
                      ++..++..++||||+++++|.+++...          ..++...++.++.|++.||.|||++|++|+||+|+||+++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            999999999999999999999998753          3568999999999999999999999999999999999999999


Q ss_pred             CEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 023270          157 RLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMK  230 (284)
Q Consensus       157 ~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~  230 (284)
                      .++|+|||++.......     ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            99999999985433221     22345788999999998889999999999999999999 8999999988888877776


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ... ......+++++.+++.+||..||.+|||+++++++
T Consensus       256 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          256 GGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            543 33445789999999999999999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-46  Score=315.24  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=211.0

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~   91 (284)
                      ...+..++|++.+.||+|+||.||+|.+..+++.||+|++.....     .+.+.+|+..++.+ +|++++++++++..+
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            345677899999999999999999999999999999999854332     23567888999998 799999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC-----EEEeeccc
Q 023270           92 ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-----LKIGDFGW  165 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~-----~~l~d~~~  165 (284)
                      ...++|+||+ +++|.+++...+ .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.     ++|+|||+
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999999999 789999998754 6999999999999999999999999999999999999987775     99999999


Q ss_pred             ccccCCC----------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcC
Q 023270          166 SVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE---SQKDTFRRIMKVD  232 (284)
Q Consensus       166 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~  232 (284)
                      +......          .....|++.|+|||++.+..++.++||||||+++++|++|..||...   ........+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            8543322          23445889999999999999999999999999999999999999874   3444444433322


Q ss_pred             CCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          233 LSFP---SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       233 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...+   ..+.+++++.+++.+||..||.+|||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1111   123689999999999999999999999999764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.1e-47  Score=317.22  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=213.1

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEE----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      ......+..++|++.+.||+|+||.||+|.    +..+++.||+|++.....  ....+.+.+|+.+++.++|+||++++
T Consensus        12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (302)
T 4e5w_A           12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYK   89 (302)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeee
Confidence            344556677889999999999999999998    567889999999865432  22346788999999999999999999


Q ss_pred             eEEecC--CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           86 GWFHDD--ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        86 ~~~~~~--~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                      +++...  ...++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECc
Confidence            999876  6789999999999999999554 5799999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCC------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCC--------------CChH
Q 023270          163 FGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA--------------ESQK  222 (284)
Q Consensus       163 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~--------------~~~~  222 (284)
                      ||++......      .....++..|+|||.+.+..++.++||||||+++++|++|..|+..              ....
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            9998554332      2234567779999999988899999999999999999999887532              2223


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .............+.++.+++++.+++.+||..||.+|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            3333444444555666789999999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.5e-47  Score=320.14  Aligned_cols=256  Identities=22%  Similarity=0.311  Sum_probs=205.3

Q ss_pred             HHhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceee
Q 023270            7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (284)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~   86 (284)
                      +.+......+...+|++.+.||+|+||+||+|.+.  ++.||+|++.......    .....|+..++.++||||+++++
T Consensus        12 ~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~   85 (322)
T 3soc_A           12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS----WQNEYEVYSLPGMKHENILQFIG   85 (322)
T ss_dssp             --CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             cccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHH----HHHHHHHHHHhcCCCCCchhhcc
Confidence            34455667788889999999999999999999864  7899999996544322    34456888999999999999999


Q ss_pred             EEecCC----eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCCeEe
Q 023270           87 WFHDDE----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN----------HVIHRDIKPENLLL  152 (284)
Q Consensus        87 ~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~----------gi~H~dl~p~nil~  152 (284)
                      ++..+.    .+++||||+++++|.+++... .+++..++.++.|++.||.|||+.          |++|+||||+||++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill  164 (322)
T 3soc_A           86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL  164 (322)
T ss_dssp             EEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE
T ss_pred             eeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE
Confidence            997644    479999999999999999774 589999999999999999999999          99999999999999


Q ss_pred             cCCCCEEEeecccccccCC-----CCccccCCCcccCccccCCC-----CCCchhhHhhHHHHHHHHHhCCCCCCCC---
Q 023270          153 DHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENK-----EHDYAVDNWTLGILCYEFLYGAPPFEAE---  219 (284)
Q Consensus       153 ~~~~~~~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~---  219 (284)
                      +.++.+||+|||++.....     ......+++.|+|||++.+.     .++.++||||||+++|+|++|..||.+.   
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            9999999999999854322     12235689999999999863     4567889999999999999999999653   


Q ss_pred             -------------ChHHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          220 -------------SQKDTFRRIMKVDLSFPSAP-----SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       220 -------------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                                   ....................     ..++++.+|+.+||+.||.+|||++++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                         22233333333322222221     124569999999999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.4e-46  Score=310.83  Aligned_cols=257  Identities=23%  Similarity=0.456  Sum_probs=203.5

Q ss_pred             HhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      .......++...+|++.+.||+|+||+||++.+.   ..|++|++....... ...+.+.+|+.+++.++|+||++++++
T Consensus        13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             -----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            4455677899999999999999999999999854   359999986543332 345678899999999999999999996


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      . ..+..++|+||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence            5 566789999999999999999654 57899999999999999999999999999999999999999999999999998


Q ss_pred             cccCC-----CCccccCCCcccCccccC---CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCC-
Q 023270          167 VQSRS-----KRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-DLSFP-  236 (284)
Q Consensus       167 ~~~~~-----~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~-  236 (284)
                      .....     ......+++.|+|||.+.   +..++.++||||||+++++|++|..||......+...+.... ..... 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            54321     223346899999999986   566888999999999999999999999886665555544433 22222 


Q ss_pred             --CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          237 --SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                        ....+++++.+|+.+||..||.+|||++++++.
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence              123688999999999999999999999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-46  Score=334.70  Aligned_cols=252  Identities=21%  Similarity=0.372  Sum_probs=221.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .+++...+|++.+.||+|+||.||++.+..++..||||++......    .+.+.+|+.+++.++|+||+++++++..++
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            4567778999999999999999999999988999999999654322    356889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ..++||||+++++|.+++...  ..++...++.++.|++.||.|||++|++|+||+|+|||++.++.+||+|||++....
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999999999999874  458999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          171 SKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       171 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ...    ....++..|+|||++.+..++.++||||||+++++|++ |..||...+..+....+... .....+..+++++
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  448 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKV  448 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHH
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHH
Confidence            222    22335678999999998889999999999999999999 99999988877776665544 4455566899999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+|+.+||..||.+|||++++++.
T Consensus       449 ~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          449 YELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCcChhHCcCHHHHHHH
Confidence            999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-46  Score=310.90  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=217.5

Q ss_pred             cccccccCcEeee-eeccCCCeEEEEEEEe--cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           13 KREWSLQDFEIGR-PLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ..++...+|.+.+ .||+|+||.||++.+.  .++..|++|++.....  ....+.+.+|+++++.++|+||+++++++ 
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            4567778899988 9999999999999854  4677899999866432  23456788999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      ..+..++|+|++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            556799999999999999999754 5699999999999999999999999999999999999999999999999999855


Q ss_pred             cCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          169 SRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       169 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      .....      ....+++.|+|||++.+..++.++||||||+++++|++ |..||...+..+....+..+. ....++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~  238 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPEC  238 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCCCCc
Confidence            43221      22345788999999988889999999999999999998 999999988888777766653 33445589


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcCc
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEHP  270 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~~  270 (284)
                      ++++.+++.+||..||.+|||+++++++.
T Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999999999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=310.83  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=206.7

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      .+..++|++.+.||+|+||+||++.+  .++.|++|.+....     ..+.+.+|++.++.++|+||+++++++.+  ..
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PV   74 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence            46788999999999999999999986  46889999986432     23567889999999999999999998763  47


Q ss_pred             EEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCCeEecCCCC-EEEeeccccc
Q 023270           95 FLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHE---NHVIHRDIKPENLLLDHEGR-LKIGDFGWSV  167 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~gi~H~dl~p~nil~~~~~~-~~l~d~~~~~  167 (284)
                      ++||||+++++|.+++....   .++...++.++.|++.||.|||+   +|++|+||+|+||+++.++. ++|+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            99999999999999998764   47899999999999999999999   89999999999999998886 7999999986


Q ss_pred             ccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ--KDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ..........+++.|+|||++.+..++.++||||||+++++|++|..||.....  ......... .........+++++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  233 (307)
T 2eva_A          155 DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRPPLIKNLPKPI  233 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCCCCBTTCCHHH
T ss_pred             ccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCCCCcccccCHHH
Confidence            655555556789999999999999999999999999999999999999975432  223333333 23344455789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcC-----ccccccCCC
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEH-----PWIIKNANP  278 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~-----~~~~~~~~~  278 (284)
                      .+++.+||..||.+|||+++++++     .++....+|
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            999999999999999999999984     666555444

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.1e-46  Score=308.44  Aligned_cols=253  Identities=26%  Similarity=0.377  Sum_probs=214.6

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecC---CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ...+..++|.+.+.||+|+||+||++.+...   +..|++|.+......  ...+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            4577889999999999999999999987653   345999998764322  23467889999999999999999999886


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      + +..++|+|++++++|.+++... ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            5 4568999999999999999775 4599999999999999999999999999999999999999999999999999855


Q ss_pred             cCCCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          169 SRSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       169 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      .....    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+....+.... ..+.+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  241 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPP  241 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCCCCTTCCH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCCCCCCCCH
Confidence            43322    23345778999999988889999999999999999998 999998877777766665543 3444557899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+++.+||..||.+|||+++++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHH
Confidence            99999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-46  Score=319.88  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=207.6

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~   94 (284)
                      +...+|++.+.||+|+||+||+|.+..+++.||+|++.....     .+.+.+|+.+++.+ +|+||+++++++..++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            345789999999999999999999999999999999865432     23577899999999 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC-----EEEeecccccc
Q 023270           95 FLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-----LKIGDFGWSVQ  168 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~-----~~l~d~~~~~~  168 (284)
                      ++||||+ +++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.     ++|+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 78999999874 68999999999999999999999999999999999999998887     99999999854


Q ss_pred             cCCC----------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC
Q 023270          169 SRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE---SQKDTFRRIMKVDLSF  235 (284)
Q Consensus       169 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~  235 (284)
                      ....          .....|++.|+|||++.+..++.++||||||+++++|++|..||...   +..+.+..+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            3221          13456899999999999999999999999999999999999999874   3334444443322211


Q ss_pred             CC---CCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          236 PS---APSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       236 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.   ....| ++.+++..||..||.+||+++++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11   12345 9999999999999999999999887

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7e-46  Score=308.45  Aligned_cols=249  Identities=21%  Similarity=0.370  Sum_probs=215.7

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .+++..++|++.+.||+|+||.||++.+. ++..|++|++......    .+.+.+|+++++.++|+||+++++++. .+
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   80 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QE   80 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence            46677789999999999999999999864 5678999998654432    256788999999999999999999876 45


Q ss_pred             eEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 RIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ..++|+||+++++|.+++....  .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            6899999999999999997643  78999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          171 SKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       171 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ...    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+.... ....+..+++++
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  239 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-RMVRPDNCPEEL  239 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHH
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-CCCCcccccHHH
Confidence            322    23345678999999988889999999999999999999 999999988888877776653 344455789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .+++.+||..||++|||++++++
T Consensus       240 ~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          240 YQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccChhhCCCHHHHHH
Confidence            99999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.2e-46  Score=328.63  Aligned_cols=250  Identities=21%  Similarity=0.391  Sum_probs=218.0

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++...+|++.+.||+|+||+||++.+. ++..||||++......    .+.+.+|+.+++.++|+||+++++++. .
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            345777889999999999999999999874 5678999998764422    357889999999999999999999886 6


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..++||||+++++|.+++...  ..++...++.++.|++.||.|||++|++|+||+|+|||++.++.+||+|||++...
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            6789999999999999999754  36899999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ...    .....++..|+|||++....++.++||||||+++++|++ |..||.+.+..+....+..+ ...+.+..++++
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~  413 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEE  413 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTSCHH
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHH
Confidence            322    122345678999999998899999999999999999999 99999999988888877665 345556689999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.+|+.+||..||.+|||++++++
T Consensus       414 l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          414 LYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999999976

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.6e-46  Score=317.22  Aligned_cols=256  Identities=22%  Similarity=0.366  Sum_probs=215.4

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEE----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceee
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~   86 (284)
                      ....-+..++|++.+.||+|+||.||++.    +..++..|++|++.....   ...+.+.+|+++++.++|+||+++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~   91 (327)
T 3lxl_A           15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRG   91 (327)
T ss_dssp             --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEEEE
Confidence            34455778999999999999999999999    567888999999865432   23467889999999999999999999


Q ss_pred             EEe--cCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeec
Q 023270           87 WFH--DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        87 ~~~--~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                      ++.  +.+..++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A           92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred             EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence            886  456799999999999999999874 56999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH--------------H
Q 023270          164 GWSVQSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------D  223 (284)
Q Consensus       164 ~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~--------------~  223 (284)
                      |++.......      ....+++.|+|||.+.+..++.++||||||+++++|++|..||......              .
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence            9985443221      2334677799999998888999999999999999999999998654332              2


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...+........+.+..+++++.+|+.+||..||.+|||+++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333444445556667899999999999999999999999999765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-46  Score=319.63  Aligned_cols=253  Identities=19%  Similarity=0.320  Sum_probs=213.3

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCce----EEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP----VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      ...++..+|++.+.||+|+||+||+|.+..++..    |++|.+......  .....+.+|+.+++.++|+||+++++++
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A            7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            3567788999999999999999999999888876    667766432211  1124566788999999999999999988


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      . ++..++|+||+++++|.+++... +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence            6 56689999999999999999875 578999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 023270          168 QSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSI  241 (284)
Q Consensus       168 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
                      ......     ....++..|+|||.+.+..++.++||||||+++++|++ |..||......+....+.... ....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  242 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQPQIC  242 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-BCCCCTTB
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CCCCCCcC
Confidence            543221     23446778999999998899999999999999999999 999999888777766666543 34444568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          242 SAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       242 ~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.++.+++.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=316.76  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=208.0

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe---
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH---   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~---   89 (284)
                      ...+..++|++.+.||+|+||.||++.+..+++.||+|++.....   ...+.+.+|+.+++.++|+||+++++++.   
T Consensus        23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            345667889999999999999999999999999999999855332   23467889999999999999999999986   


Q ss_pred             -cCCeEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecc
Q 023270           90 -DDERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        90 -~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                       .....++|+||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence             34578999999999999999976    4679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC------------ccccCCCcccCccccCCCC---CCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 023270          165 WSVQSRSKR------------HTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRI  228 (284)
Q Consensus       165 ~~~~~~~~~------------~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~  228 (284)
                      ++.......            ....+++.|+|||.+.+..   ++.++||||||+++++|++|..||...... ......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            874432111            1234688999999987654   688999999999999999999999531110 011122


Q ss_pred             HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCc
Q 023270          229 MKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  270 (284)
Q Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  270 (284)
                      .......+..+.+++++.+++.+||..||.+|||+++++++-
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            223344555567899999999999999999999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-45  Score=307.62  Aligned_cols=257  Identities=19%  Similarity=0.321  Sum_probs=212.3

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEEEecCC---ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceee
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~   86 (284)
                      ......-...+|++.+.||+|+||+||+|.+..++   ..+++|.+....  .....+.+.+|+.+++.++|+||+++++
T Consensus        16 ~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~   93 (298)
T 3f66_A           16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLG   93 (298)
T ss_dssp             GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            34444555678999999999999999999875433   358899886533  2233567889999999999999999999


Q ss_pred             EE-ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecc
Q 023270           87 WF-HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (284)
Q Consensus        87 ~~-~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~  164 (284)
                      ++ ..++..++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        94 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A           94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             EECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             EEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccc
Confidence            85 4556889999999999999999764 568999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 023270          165 WSVQSRSK-------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFP  236 (284)
Q Consensus       165 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  236 (284)
                      ++......       .....+++.|+|||.+.+..++.++||||||+++++|++ +.+||...+..+......... ...
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~  252 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLL  252 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCC
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCC
Confidence            98543321       223345678999999999899999999999999999999 777888777777766666654 333


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+..+++++.+++.+||..||.+|||++++++.
T Consensus       253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            445789999999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=320.34  Aligned_cols=255  Identities=18%  Similarity=0.265  Sum_probs=201.0

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEec---CCceEEEEehhhhhHHHH--------HHHHHHHHHHHHHHhCCCCccc
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKY--------KIQHQLRREMEIQSSLRHPNIL   82 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~--------~~~~~~~~~~~~~~~l~h~~i~   82 (284)
                      ..+..++|++.+.||+|+||+||+|.+..   ++..+++|++........        .....+.+++..++.++|+||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            34556789999999999999999999987   788999999865432111        1123456788889999999999


Q ss_pred             ceeeEEec----CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC--
Q 023270           83 RLYGWFHD----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG--  156 (284)
Q Consensus        83 ~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~--  156 (284)
                      ++++++..    +...++||||+ +++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++  
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            99999887    77899999999 889999998888899999999999999999999999999999999999999887  


Q ss_pred             CEEEeecccccccCC----------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC--ChHHH
Q 023270          157 RLKIGDFGWSVQSRS----------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE--SQKDT  224 (284)
Q Consensus       157 ~~~l~d~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~--~~~~~  224 (284)
                      .++|+|||++.....          ......+++.|+|||++.+..++.++||||||+++|+|++|..||...  +....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999854321          113446899999999999999999999999999999999999999652  22222


Q ss_pred             HHHHHhcCCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          225 FRRIMKVDLSFP-------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       225 ~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...........+       ....+++++.+++.+||..||.+|||++++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            111111111111       112688999999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=314.34  Aligned_cols=254  Identities=20%  Similarity=0.338  Sum_probs=211.6

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceE----EEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV----ALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      ....+...+|++.+.||+|+||+||+|.+..+++.+    ++|.+.....  ....+.+.+|+.+++.++|+||++++++
T Consensus         8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~   85 (327)
T 3lzb_A            8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred             hhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            344577889999999999999999999998888776    5565533221  1224577889999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      +..+. .+++++++.+++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             EecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            98765 78899999999999999875 57999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          167 VQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       167 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      ......     .....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+... ...+.++.
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  243 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPI  243 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTT
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCcc
Confidence            543221     122345678999999999999999999999999999999 99999988887776666554 34555667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.++.+++.+||..||.+|||++++++.
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999999999974

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.7e-46  Score=309.09  Aligned_cols=248  Identities=24%  Similarity=0.410  Sum_probs=210.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec------
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD------   90 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~------   90 (284)
                      ...+|++.+.||+|+||.||++.+..+++.|++|++....       ..+.+|+++++.++|+||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3468999999999999999999999899999999986543       245689999999999999999998854      


Q ss_pred             ----------CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCE
Q 023270           91 ----------DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (284)
Q Consensus        91 ----------~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~  158 (284)
                                ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                      44689999999999999999764  579999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCC--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 023270          159 KIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP  236 (284)
Q Consensus       159 ~l~d~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  236 (284)
                      +|+|||++.....  ......+++.|+|||.+.+..++.++||||||+++++|++|..|+..  ............    
T Consensus       162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~~----  235 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDGI----  235 (284)
T ss_dssp             EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTTC----
T ss_pred             EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhccc----
Confidence            9999999855432  23345689999999999999999999999999999999999887642  222333333322    


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .+..+++++.+++.+||..||.+|||+.+++++.+.-+...
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            23468999999999999999999999999999988766543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-45  Score=326.06  Aligned_cols=256  Identities=21%  Similarity=0.395  Sum_probs=217.3

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++...+|++.+.||+|+||.||++.+.. +..||||++......    .+.+.+|+++++.++|+||+++++++.+ 
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            3466777889999999999999999999854 467999999764432    2467899999999999999999999866 


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..++||||+++++|.+++...  ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            6789999999999999999753  56899999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ...    .....++..|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+..+ ...+.++.++++
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~  409 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES  409 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHH
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHH
Confidence            322    122345678999999998899999999999999999999 99999999988888777665 344555689999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcC--ccccc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEH--PWIIK  274 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~--~~~~~  274 (284)
                      +.+++.+||..||.+|||++++++.  .++..
T Consensus       410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            9999999999999999999999874  55543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-45  Score=313.12  Aligned_cols=258  Identities=25%  Similarity=0.402  Sum_probs=209.5

Q ss_pred             HhhhhcccccccCc-EeeeeeccCCCeEEEEEE----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccc
Q 023270            8 REDNRKREWSLQDF-EIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL   82 (284)
Q Consensus         8 ~~~~~~~~~~~~~y-~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~   82 (284)
                      +.......+...+| ++++.||+|+||+||++.    +..+++.||+|++.....  ....+.+.+|+++++.++|+||+
T Consensus        19 ~~~pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv   96 (318)
T 3lxp_A           19 FQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHII   96 (318)
T ss_dssp             -----CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ecCCCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchh
Confidence            33444445455555 999999999999998775    345788899999976432  23356788999999999999999


Q ss_pred             ceeeEEecC--CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEE
Q 023270           83 RLYGWFHDD--ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI  160 (284)
Q Consensus        83 ~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l  160 (284)
                      ++++++...  ..+++||||+++++|.+++... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus        97 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A           97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             CEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             hEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEE
Confidence            999999874  6789999999999999998765 4899999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCC------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH------------
Q 023270          161 GDFGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK------------  222 (284)
Q Consensus       161 ~d~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~------------  222 (284)
                      +|||++......      .....+++.|+|||.+.+..++.++||||||+++++|++|..||......            
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  255 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM  255 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence            999998654332      12334677899999999888999999999999999999999998754322            


Q ss_pred             --HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          223 --DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                        ....+........+.+..+++++.+|+.+||..||.+|||++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              1233334444455566689999999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8e-46  Score=319.60  Aligned_cols=253  Identities=18%  Similarity=0.309  Sum_probs=199.6

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecC-----CceEEEEehhhhhHHHHHH--------HHHHHHHHHHHHhCCCCccc
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKI--------QHQLRREMEIQSSLRHPNIL   82 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~--------~~~~~~~~~~~~~l~h~~i~   82 (284)
                      +..++|++.+.||+|+||+||+|.+..+     ++.||+|++..........        ......++..++.++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3445899999999999999999988765     5789999976543221111        12233456677888999999


Q ss_pred             ceeeEEecC----CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec--CC
Q 023270           83 RLYGWFHDD----ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD--HE  155 (284)
Q Consensus        83 ~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~--~~  155 (284)
                      ++++++...    ...++||||+ +++|.+++... +.+++..++.++.||+.||.|||+.|++|+||||+||+++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    4689999999 88999999876 6799999999999999999999999999999999999999  88


Q ss_pred             CCEEEeecccccccCCC----------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH-HH
Q 023270          156 GRLKIGDFGWSVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DT  224 (284)
Q Consensus       156 ~~~~l~d~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~  224 (284)
                      +.++|+|||++......          .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            99999999998443211          12334899999999999999999999999999999999999999853222 21


Q ss_pred             HHHHHhc---CC-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          225 FRRIMKV---DL-----SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       225 ~~~~~~~---~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .......   ..     .......+|+++.+++..||..+|.+||+++++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            1111100   00     000123679999999999999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=312.80  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=193.4

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEe-
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFH-   89 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~-   89 (284)
                      ...++...+|++.+.||+|+||.||++.+..+++.||+|++.....   ...+.+.+|+..+..+. |+||+++++++. 
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            3455666789999999999999999999999999999999855432   23457788999999996 999999999983 


Q ss_pred             -------cCCeEEEEEeecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEecCCCC
Q 023270           90 -------DDERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGR  157 (284)
Q Consensus        90 -------~~~~~~~v~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~~~~~  157 (284)
                             ....+++|+||++ ++|.+++..   .+.+++..++.++.|++.||.|||+.|  ++|+||+|+||+++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence                   3446899999997 689888865   457999999999999999999999999  999999999999999999


Q ss_pred             EEEeecccccccCCCCc---------------cccCCCcccCcccc---CCCCCCchhhHhhHHHHHHHHHhCCCCCCCC
Q 023270          158 LKIGDFGWSVQSRSKRH---------------TMCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAE  219 (284)
Q Consensus       158 ~~l~d~~~~~~~~~~~~---------------~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~~l~tg~~p~~~~  219 (284)
                      ++|+|||++........               ...+++.|+|||++   .+..++.++||||||+++++|++|..||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            99999999855432211               34478899999998   5667899999999999999999999999876


Q ss_pred             ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCc
Q 023270          220 SQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  270 (284)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  270 (284)
                      .......    .....+.....++.+.+|+.+||..||.+|||+++++++-
T Consensus       257 ~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          257 AKLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             hHHHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            5544333    3334445557788999999999999999999999999884

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.8e-45  Score=307.16  Aligned_cols=241  Identities=28%  Similarity=0.539  Sum_probs=195.5

Q ss_pred             ccccccCcEee-eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHH-HhCCCCcccceeeEEec-
Q 023270           14 REWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHD-   90 (284)
Q Consensus        14 ~~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~-~~l~h~~i~~~~~~~~~-   90 (284)
                      ......+|.+. +.||.|+||.||++.+..+++.||+|++...        ..+.+|+..+ +..+|+||+++++++.. 
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            34567789888 7899999999999999999999999998542        2344666666 66789999999999876 


Q ss_pred             ---CCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEee
Q 023270           91 ---DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGD  162 (284)
Q Consensus        91 ---~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d  162 (284)
                         ++..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.++|+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999998764  6999999999999999999999999999999999999998   78999999


Q ss_pred             cccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCC--
Q 023270          163 FGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSA--  238 (284)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~--  238 (284)
                      ||++....                   +..++.++||||||+++++|++|..||...+...............  ..+  
T Consensus       164 fg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          164 FGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             CTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             cccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            99874332                   2446789999999999999999999998766544332222211111  111  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCCC
Q 023270          239 --PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  281 (284)
Q Consensus       239 --~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (284)
                        ..+++++.+++.+||..||.+|||++++++||||++......+
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~  269 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  269 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence              3578999999999999999999999999999999987655443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.4e-46  Score=317.53  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=207.0

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      +...++|++.+.||+|+||+||++.+ .++..|++|++......   ..+.+.+|+.+++.++|+||+++++++..++..
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            34568899999999999999999996 46889999998654322   245788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           95 FLILEYAHRGELYRELRKHR----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ++||||+++++|.+++....    .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999999999886543    58999999999999999999999999999999999999999999999999985432


Q ss_pred             CC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHH------HHH-HHhcCCC----
Q 023270          171 SK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------FRR-IMKVDLS----  234 (284)
Q Consensus       171 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~------~~~-~~~~~~~----  234 (284)
                      ..     .....|++.|+|||.+.+..++.++||||||+++++|++|..||......+.      ... .......    
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (321)
T 2qkw_B          191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD  270 (321)
T ss_dssp             SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred             cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence            21     1233478999999999888899999999999999999999999976433211      111 1111111    


Q ss_pred             ----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCc
Q 023270          235 ----FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  270 (284)
Q Consensus       235 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  270 (284)
                          ....+..+.++.+++.+||..||++|||+++++++.
T Consensus       271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                111123456799999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=323.52  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=198.3

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~   92 (284)
                      ..+.-.+|.+.+.||+|+||+|+. ....+++.||||++......      .+.+|+++++.+ +||||+++++++.+++
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            344445699999999999999763 44568899999998654322      345788999998 7999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-----CCEEEeecccc
Q 023270           93 RIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-----GRLKIGDFGWS  166 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-----~~~~l~d~~~~  166 (284)
                      ..++|||+++ ++|.+++.... .++...++.++.||+.||.|||+.|++|+||||+||+++.+     ..++|+|||++
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9999999997 59999997764 45566778999999999999999999999999999999542     25889999998


Q ss_pred             cccCC------CCccccCCCcccCccccC---CCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 023270          167 VQSRS------KRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFP  236 (284)
Q Consensus       167 ~~~~~------~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  236 (284)
                      .....      ......|++.|+|||++.   ...++.++||||||+++++|++ |..||....................
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL  250 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence            54432      223456899999999997   4567889999999999999999 9999976655544332222111111


Q ss_pred             C-CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          237 S-APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       237 ~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      . ....+..+.+||.+||..||.+|||++++++||||..
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            1 1234566899999999999999999999999999975

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.6e-45  Score=306.09  Aligned_cols=245  Identities=26%  Similarity=0.433  Sum_probs=195.3

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh--CCCCcccceeeEEec--
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS--LRHPNILRLYGWFHD--   90 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~--l~h~~i~~~~~~~~~--   90 (284)
                      ++..++|++.+.||+|+||+||++.+  +++.||+|++.....      ..+..|.+++..  ++|+||+++++++..  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            45678999999999999999999987  688999999865432      233345555555  799999999998643  


Q ss_pred             --CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCCeEecCCCCEEE
Q 023270           91 --DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH--------ENHVIHRDIKPENLLLDHEGRLKI  160 (284)
Q Consensus        91 --~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh--------~~gi~H~dl~p~nil~~~~~~~~l  160 (284)
                        ....++||||+++++|.++++. ..+++..++.++.|++.||.|||        +.|++|+||||+||+++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3568999999999999999955 56899999999999999999999        999999999999999999999999


Q ss_pred             eecccccccCCC-------CccccCCCcccCccccCCC------CCCchhhHhhHHHHHHHHHhC----------CCCCC
Q 023270          161 GDFGWSVQSRSK-------RHTMCGTLDYLAPEMVENK------EHDYAVDNWTLGILCYEFLYG----------APPFE  217 (284)
Q Consensus       161 ~d~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~tg----------~~p~~  217 (284)
                      +|||++......       .....|++.|+|||++.+.      .++.++||||||+++++|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999998433221       1233689999999999876      345799999999999999999          88885


Q ss_pred             CC----ChHHHHHHHHhcCCCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          218 AE----SQKDTFRRIMKVDLSFPSA------PSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       218 ~~----~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ..    ................+..      ...++++.+|+.+||..||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            42    2223333333222222221      124578999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=310.39  Aligned_cols=256  Identities=24%  Similarity=0.412  Sum_probs=210.0

Q ss_pred             hhhcccccccCcEeeeeeccCCCeEEEEEE----EecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      ......+...+|++++.||+|+||.||++.    +..++..|++|++.....   ...+.+.+|+.+++.++|+||++++
T Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~  108 (326)
T 2w1i_A           32 DRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYK  108 (326)
T ss_dssp             -----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            344567888999999999999999999998    456889999999865432   2346788999999999999999999


Q ss_pred             eEEecCC--eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEee
Q 023270           86 GWFHDDE--RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (284)
Q Consensus        86 ~~~~~~~--~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d  162 (284)
                      +++...+  ..++|+||+++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus       109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             EEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred             EEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEec
Confidence            9886554  789999999999999999876 4689999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH--------------
Q 023270          163 FGWSVQSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------  222 (284)
Q Consensus       163 ~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~--------------  222 (284)
                      ||++.......      ....++..|+|||.+.+..++.++||||||+++++|++|..|+......              
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence            99986543322      2234566799999998888999999999999999999999887643111              


Q ss_pred             -HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          223 -DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                       ..+.+........+.+..+++++.+++.+||..||.+|||++++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             1122233333344556679999999999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.2e-45  Score=306.07  Aligned_cols=245  Identities=20%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE-ecCCeEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF-HDDERIFL   96 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~-~~~~~~~~   96 (284)
                      .++|++.+.||+|+||+||++.+..+++.||+|++.....     .+.+.+|+.+++.++|++++..+..+ ..++..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            4689999999999999999999999999999998644332     23567888999999988777666655 66778899


Q ss_pred             EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe---cCCCCEEEeecccccccCCC
Q 023270           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~  172 (284)
                      |||++ +++|.+++.. ...++...++.++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 7899999985 4679999999999999999999999999999999999999   78899999999998543322


Q ss_pred             ----------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCC---
Q 023270          173 ----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---DTFRRIMKVDLSFP---  236 (284)
Q Consensus       173 ----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~---  236 (284)
                                .....+++.|+|||.+.+..++.++||||||+++++|++|..||...+..   .............+   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence                      22456899999999999999999999999999999999999999764321   22222222111111   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ....+|+++.+++.+||+.||.+|||++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            12467899999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-46  Score=319.40  Aligned_cols=257  Identities=23%  Similarity=0.322  Sum_probs=206.8

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .......+|++.+.||+|+||+||++.+ .+++.||+|++.......  ....+.+|+.+++.++|+||+++++++..++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            3455678999999999999999999985 468999999986543222  1235788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeEecCCCCEEEeeccc
Q 023270           93 RIFLILEYAHRGELYRELRKHR----RFTEQQAATYIASLTNALAYCHEN---HVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      ..++||||+++++|.+++....    .+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            9999999999999999998653    489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCC----CChHHHHHHHHhcCCCC--
Q 023270          166 SVQSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA----ESQKDTFRRIMKVDLSF--  235 (284)
Q Consensus       166 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~----~~~~~~~~~~~~~~~~~--  235 (284)
                      +......    .....|++.|+|||.+.+..++.++||||||+++++|++|..||..    .................  
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            8543322    2234489999999999888899999999999999999999999952    11111111111111110  


Q ss_pred             -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          236 -----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       236 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                                 ...+..++++.+++.+||..||.+|||+.++++|-.-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                       1111234679999999999999999999999998543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.1e-45  Score=305.14  Aligned_cols=246  Identities=20%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE-ecCCeEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF-HDDERIFL   96 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~-~~~~~~~~   96 (284)
                      .++|++.+.||+|+||.||++.+..+++.||+|++......     +.+.+|+.+++.++|++++..+..+ ..++..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            47899999999999999999999999999999997554322     3577899999999988766666554 66778899


Q ss_pred             EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec---CCCCEEEeecccccccCCC
Q 023270           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~  172 (284)
                      ||||+ +++|.+++.. ...++...++.++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 7899999974 45799999999999999999999999999999999999994   7889999999998543322


Q ss_pred             ----------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC---
Q 023270          173 ----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---KDTFRRIMKVDLSFP---  236 (284)
Q Consensus       173 ----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~---  236 (284)
                                .....+++.|+|||.+.+..++.++||||||+++++|++|..||.....   ......+.......+   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence                      2345689999999999999999999999999999999999999976332   222222222211111   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....+|+++.+++.+||+.||.+|||++++++.
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            124689999999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-44  Score=318.71  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=195.3

Q ss_pred             ccccccC-cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecC
Q 023270           14 REWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (284)
Q Consensus        14 ~~~~~~~-y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~   91 (284)
                      .+..+.+ |.+.+.||+|+||+||.+ ...+++.||||++....      .+.+.+|+.+++.+ +||||+++++++..+
T Consensus         9 ~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A            9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             CSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             hhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            3444445 555788999999999865 45679999999986543      13456788888875 899999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC---------
Q 023270           92 ERIFLILEYAHRGELYRELRKHRRF-------TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---------  155 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~~~l-------~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~---------  155 (284)
                      +..++|||+++ ++|.+++......       +...++.++.||+.||.|||+.|++|+||+|+||+++.+         
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence            99999999996 5999999875432       223456799999999999999999999999999999754         


Q ss_pred             ----CCEEEeecccccccCCCC-------ccccCCCcccCccccCC-------CCCCchhhHhhHHHHHHHHHh-CCCCC
Q 023270          156 ----GRLKIGDFGWSVQSRSKR-------HTMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYEFLY-GAPPF  216 (284)
Q Consensus       156 ----~~~~l~d~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t-g~~p~  216 (284)
                          +.++|+|||++.......       ....|++.|+|||++.+       ..++.++||||||+++++|++ |..||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                489999999986543321       23468999999999875       568999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          217 EAESQKDTFRRIMKVDLSFPSAP-----SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      .......  ..+.......+...     .+++++.+|+.+||..||.+|||++++++||||..
T Consensus       241 ~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            7665443  23333333322211     34578999999999999999999999999999974

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=312.19  Aligned_cols=243  Identities=17%  Similarity=0.271  Sum_probs=200.4

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEec--------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccc------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVE--------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR------   83 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~------   83 (284)
                      .++|++.+.||+|+||.||+|.+..        +++.||+|++...        +.+.+|+.+++.++|+|+++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            4799999999999999999999987        4889999998654        35668899999999999887      


Q ss_pred             ---------eeeEEec-CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 023270           84 ---------LYGWFHD-DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLL  151 (284)
Q Consensus        84 ---------~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil  151 (284)
                               +++++.. ++..++||||+ +++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5666665 67899999999 88999999886  78999999999999999999999999999999999999


Q ss_pred             ecCCC--CEEEeecccccccCCC----------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCC
Q 023270          152 LDHEG--RLKIGDFGWSVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE  219 (284)
Q Consensus       152 ~~~~~--~~~l~d~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~  219 (284)
                      ++.++  .++|+|||++......          .....+++.|+|||++.+..++.++||||||+++++|++|..||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999998543221          12346889999999999999999999999999999999999999875


Q ss_pred             C--hHHHHHHHH---hcCCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          220 S--QKDTFRRIM---KVDLSFPS----APSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       220 ~--~~~~~~~~~---~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .  .........   ........    ...+++++.+++.+||..||.+|||++++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            3  322222221   11111111    12468999999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=320.79  Aligned_cols=253  Identities=24%  Similarity=0.400  Sum_probs=209.5

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC--
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE--   92 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~--   92 (284)
                      .+.-++|++.+.||+|+||+||+|.+..+++.||+|++.......  ..+.+.+|+++++.++|+||+++++++...+  
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            355678999999999999999999999999999999997644332  2356678999999999999999999988665  


Q ss_pred             eEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe----cCCCCEEEeeccc
Q 023270           93 RIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGW  165 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~----~~~~~~~l~d~~~  165 (284)
                      ..++||||+++++|.+++....   .+++..++.++.|++.||.|||+.|++|+||+|+||++    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            7899999999999999997653   38999999999999999999999999999999999999    6777899999999


Q ss_pred             ccccCC--CCccccCCCcccCccccCC--------CCCCchhhHhhHHHHHHHHHhCCCCCCC----CChHHHHHHHHhc
Q 023270          166 SVQSRS--KRHTMCGTLDYLAPEMVEN--------KEHDYAVDNWTLGILCYEFLYGAPPFEA----ESQKDTFRRIMKV  231 (284)
Q Consensus       166 ~~~~~~--~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~tg~~p~~~----~~~~~~~~~~~~~  231 (284)
                      +.....  ......+++.|+|||++.+        ..++.++||||||+++|+|++|..||..    ....+.+..+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            855433  2234568999999999865        4567899999999999999999999964    3445566666654


Q ss_pred             CCCC-------------------CCC----CCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          232 DLSF-------------------PSA----PSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       232 ~~~~-------------------~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....                   +..    ..+++.+.+++.+||..||++|||+++++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            3221                   111    2345678999999999999999999998654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=326.84  Aligned_cols=255  Identities=21%  Similarity=0.392  Sum_probs=220.0

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++...+|++.+.||+|+||.||++.+.. +..||||++......    .+.+.+|+++++.++|+||+++++++.+ 
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            3466778899999999999999999998854 467999998764432    2467899999999999999999999866 


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..++||||+++++|.+++...  ..++...++.++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++...
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            6789999999999999999753  56899999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ...    .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+. ..+.+..++++
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~  492 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPES  492 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHH
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHH
Confidence            321    122345678999999998899999999999999999999 999999999888887776653 44455688999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcC--cccc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEH--PWII  273 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~--~~~~  273 (284)
                      +.+||.+||..||++|||+++|++.  .+|.
T Consensus       493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            9999999999999999999999875  4554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=313.00  Aligned_cols=256  Identities=22%  Similarity=0.349  Sum_probs=216.4

Q ss_pred             hhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      .....+++...+|++.+.||.|+||.||++.+..   .+++|++....... ...+.+.+|+.+++.++|+||+++++++
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            3457788899999999999999999999998743   59999986543211 1224566889999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      ..++..++|+||+++++|.+++...+ .++...++.++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             ecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            99999999999999999999998764 689999999999999999999999999999999999997 7899999999864


Q ss_pred             ccC--------CCCccccCCCcccCccccCC---------CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 023270          168 QSR--------SKRHTMCGTLDYLAPEMVEN---------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK  230 (284)
Q Consensus       168 ~~~--------~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~  230 (284)
                      ...        .......+++.|+|||.+.+         ..++.++||||||+++++|++|..||...+..........
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            321        12233457889999999864         3478899999999999999999999999998888888777


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ..........++.++.+++.+||..||.+|||++++++.
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            665555555789999999999999999999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-44  Score=330.48  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=210.1

Q ss_pred             cCcEee-eeeccCCCeEEEEEEE--ecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           19 QDFEIG-RPLGKGKFGRVYLVRE--VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        19 ~~y~~~-~~lg~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      ..+.+. +.||.|+||.||++.+  ..+++.||||++....... ...+.+.+|+++++.++|+||+++++++.. +..+
T Consensus       368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  445 (635)
T 4fl3_A          368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM  445 (635)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence            334443 4799999999999955  4566889999987643322 234678899999999999999999999864 5588


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC--
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--  173 (284)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......  
T Consensus       446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999999999999988899999999999999999999999999999999999999999999999999985432211  


Q ss_pred             ----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          174 ----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       174 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                          ....+++.|+|||++.+..++.++||||||+++++|++ |..||.+.+..+....+..+. ....+..+++++.+|
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~l  604 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDL  604 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHH
Confidence                22335678999999999999999999999999999998 999999999988887777654 444555799999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~  269 (284)
                      +..||..||++|||++++++.
T Consensus       605 i~~cl~~dP~~RPs~~~l~~~  625 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVELR  625 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-45  Score=314.47  Aligned_cols=249  Identities=19%  Similarity=0.329  Sum_probs=203.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCC---ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe-cCCe
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH-DDER   93 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~-~~~~   93 (284)
                      ..+|++.+.||+|+||+||++.+..++   ..|++|.+.....  ....+.+.+|+.+++.++||||+++++++. .++.
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            345889999999999999999876543   3589998854321  233567889999999999999999999865 4568


Q ss_pred             EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      .++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            89999999999999999765 46899999999999999999999999999999999999999999999999998543221


Q ss_pred             -------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          173 -------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       173 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                             .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+..+. ....+..++++
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~  324 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDP  324 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHH
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHH
Confidence                   122345678999999999999999999999999999999 788898877766666665543 33445578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.+++.+||..||.+|||+++++++
T Consensus       325 l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9e-46  Score=336.57  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec---
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD---   90 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~---   90 (284)
                      ......+|++.+.||.|+||+||++.+..++..||+|++.....  ....+.+.+|+.+++.++||||+++++++..   
T Consensus         9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A            9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS--PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC--HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            34556899999999999999999999999999999999865422  2334678899999999999999999998755   


Q ss_pred             ---CCeEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCC---EEEe
Q 023270           91 ---DERIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIG  161 (284)
Q Consensus        91 ---~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~---~~l~  161 (284)
                         ++..++||||+++++|.+++....   .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.   ++|+
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence               678899999999999999998754   6899999999999999999999999999999999999997765   9999


Q ss_pred             ecccccccCCC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHH-----------
Q 023270          162 DFGWSVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRI-----------  228 (284)
Q Consensus       162 d~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~-----------  228 (284)
                      |||++......  .....+++.|+|||.+.+..++.++||||||+++++|++|..||........+...           
T Consensus       167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99998654332  23456899999999999999999999999999999999999999765433221100           


Q ss_pred             ---HhcCCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          229 ---MKVDLSFP--------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       229 ---~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                         ..+...+.        ..+.+++++.+++..||.+||++|||++++++||||+..
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence               00000010        112367889999999999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=308.16  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=195.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe--
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH--   89 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~--   89 (284)
                      ....+.+.+|++.+.||+|+||.||++.+  +++.||+|++........    ....++..+..++|+||+++++.+.  
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~----~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNF----INEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHH----HHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhH----HHHHHHHHHHhccCcchhhheeccccc
Confidence            34578899999999999999999999975  688999999865443221    1224444455689999999997543  


Q ss_pred             ---cCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCCeEecCCCC
Q 023270           90 ---DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN---------HVIHRDIKPENLLLDHEGR  157 (284)
Q Consensus        90 ---~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~---------gi~H~dl~p~nil~~~~~~  157 (284)
                         ....+++||||+++++|.+++.... .+...++.++.|++.||.|||+.         |++|+||||+||+++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence               2336799999999999999997754 48899999999999999999999         9999999999999999999


Q ss_pred             EEEeecccccccCCC-----------CccccCCCcccCccccCC-------CCCCchhhHhhHHHHHHHHHhCCCCCCCC
Q 023270          158 LKIGDFGWSVQSRSK-----------RHTMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYEFLYGAPPFEAE  219 (284)
Q Consensus       158 ~~l~d~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~tg~~p~~~~  219 (284)
                      +||+|||++......           .....|++.|+|||++.+       ..++.++||||||+++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            999999998543221           123458999999999977       34567899999999999999997665321


Q ss_pred             -C----------------hHHHHHHHH-hcCCCCCCCC------CCCHHHHHHHHHhcccCCCCCCCHHhh------hcC
Q 023270          220 -S----------------QKDTFRRIM-KVDLSFPSAP------SISAEAKHLISRLLVKDSSKRLSLQKI------MEH  269 (284)
Q Consensus       220 -~----------------~~~~~~~~~-~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~i------l~~  269 (284)
                       .                ..+...... ........+.      ..++++.+||.+||..||.+|||++++      +-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence             1                111222222 2222222221      144579999999999999999999999      556


Q ss_pred             ccccccCCCC
Q 023270          270 PWIIKNANPR  279 (284)
Q Consensus       270 ~~~~~~~~~~  279 (284)
                      +|-+++--+.
T Consensus       319 ~~~~~~~~~~  328 (336)
T 3g2f_A          319 IWERNKSVSP  328 (336)
T ss_dssp             CCCC------
T ss_pred             HHHhcccCCC
Confidence            8888775443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=327.71  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=209.5

Q ss_pred             ccccCcEeee-eeccCCCeEEEEEEEec--CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           16 WSLQDFEIGR-PLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        16 ~~~~~y~~~~-~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      +...++.+.+ .||+|+||.||++.+..  ++..||||++......  ...+.+.+|+++++.++|+||+++++++.. +
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            4445566666 89999999999998764  4567999998654211  234678899999999999999999999876 5


Q ss_pred             eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      ..++||||+++++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+|||++.++.+||+|||++.....
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            699999999999999999754 4699999999999999999999999999999999999999999999999999865432


Q ss_pred             CC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          172 KR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       172 ~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ..      ....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..+. ....++.++++
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~  567 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPE  567 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-CCCCCTTCCHH
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHH
Confidence            21      12234578999999998999999999999999999998 999999998888887777654 44455679999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.+|+.+||..||.+||+++++++
T Consensus       568 l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          568 LYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999854

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.9e-44  Score=302.70  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-HHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      .|...+.||+|+||+||++.+  +++.|++|++..... ......+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            345558999999999999986  678999999854321 22234567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---
Q 023270           99 EYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---  172 (284)
                      ||+++++|.+++...   ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            999999999999743   46899999999999999999999999999999999999999999999999998544322   


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcC---------CCCCC
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRRIMKVD---------LSFPS  237 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~---------~~~~~  237 (284)
                        .....+++.|+|||.+.+ .++.++||||||+++++|++|..||.......    .........         .....
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence              223468899999998865 47899999999999999999999997654322    112111110         00111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ....+..+.+++.+||..||.+|||+++++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22345779999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=302.25  Aligned_cols=247  Identities=23%  Similarity=0.399  Sum_probs=195.3

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHH--hCCCCcccceeeEEecC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS--SLRHPNILRLYGWFHDD   91 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~--~l~h~~i~~~~~~~~~~   91 (284)
                      .....++|++.+.||+|+||.||++.+.  ++.||+|++......      ....+.+++.  .++|+||+++++++...
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccc------hhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3445578999999999999999999874  889999998554322      2223444444  34899999999998877


Q ss_pred             ----CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCeEecCCCCEE
Q 023270           92 ----ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--------HVIHRDIKPENLLLDHEGRLK  159 (284)
Q Consensus        92 ----~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------gi~H~dl~p~nil~~~~~~~~  159 (284)
                          ...++||||+++++|.+++... .++...++.++.|++.||.|||+.        |++|+||||+||+++.++.+|
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence                7899999999999999999764 689999999999999999999999        999999999999999999999


Q ss_pred             EeecccccccCCCC-------ccccCCCcccCccccCCCCCCch------hhHhhHHHHHHHHHhC----------CCCC
Q 023270          160 IGDFGWSVQSRSKR-------HTMCGTLDYLAPEMVENKEHDYA------VDNWTLGILCYEFLYG----------APPF  216 (284)
Q Consensus       160 l~d~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~il~~l~tg----------~~p~  216 (284)
                      |+|||++.......       ....|++.|+|||++.+...+..      +||||||+++|+|++|          ..||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999985432221       23468999999999987766654      9999999999999999          6777


Q ss_pred             CCC----ChHHHHHHHH-hcCCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          217 EAE----SQKDTFRRIM-KVDLSFPSA-----PSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       217 ~~~----~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...    .......... ........+     ..+++++.+++.+||..||.+|||+++++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            542    1222233322 222222222     1456779999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-45  Score=321.06  Aligned_cols=252  Identities=17%  Similarity=0.221  Sum_probs=200.7

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC-Ccc---------ccee
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNI---------LRLY   85 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h-~~i---------~~~~   85 (284)
                      ....+|.+.+.||+|+||+||+|.+..+++.||||++...........+.+++|+..++.+.| .+.         +...
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            344568999999999999999999999999999999874443333445678899999998876 221         1111


Q ss_pred             eE------------Eec-----CCeEEEEEeecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 023270           86 GW------------FHD-----DERIFLILEYAHRGELYRELRK-------HRRFTEQQAATYIASLTNALAYCHENHVI  141 (284)
Q Consensus        86 ~~------------~~~-----~~~~~~v~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~gi~  141 (284)
                      +.            +..     ...++++|+.+. ++|.++++.       ...+++..++.++.|++.||.|||++||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            11            111     124678888774 699988852       23467888999999999999999999999


Q ss_pred             ccCCCCCCeEecCCCCEEEeecccccccCCCCccccCCCcccCcccc----------CCCCCCchhhHhhHHHHHHHHHh
Q 023270          142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV----------ENKEHDYAVDNWTLGILCYEFLY  211 (284)
Q Consensus       142 H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~il~~l~t  211 (284)
                      |+||||+|||++.++.+||+|||++...........| +.|+|||++          .+..++.++||||||+++|+|++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999999998766655566677 999999999          55568899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          212 GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |..||...+..........      ....+|+++.+||.+||..||++|||+.++++||||++.
T Consensus       313 g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             SSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999987765443333222      223688999999999999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-43  Score=323.95  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=215.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecC---CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ..++...+|++.+.||+|+||.||+|.+..+   +..|++|.+.....  ....+.+.+|+.+++.++||||+++++++.
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3456678899999999999999999998654   34689999865332  233467889999999999999999999885


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                       ++..++||||+++++|.+++...+ .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence             566899999999999999998764 689999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          169 SRSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       169 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      .....    ....+++.|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+..+. ..+.++.+++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  619 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPP  619 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCH
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccH
Confidence            43322    22345678999999988899999999999999999997 999999998888887777653 3445567999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++.+++.+||..||.+|||+.++++.
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=306.60  Aligned_cols=251  Identities=16%  Similarity=0.265  Sum_probs=200.3

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEE-----EEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC---CCcccce
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLV-----REVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILRL   84 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~---h~~i~~~   84 (284)
                      ..++...+|.+.+.||+|+||+||+|     .+..+++.||+|++.....      ..+..+++.+..++   |+|++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhh
Confidence            34455678999999999999999999     4677899999999865432      24556666666676   8999999


Q ss_pred             eeEEecCCeEEEEEeecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-----
Q 023270           85 YGWFHDDERIFLILEYAHRGELYRELRK-----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-----  154 (284)
Q Consensus        85 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-----  154 (284)
                      ++++..++..++||||+++++|.+++..     ...+++..++.++.|++.||.|||+.||+|+||||+|||++.     
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence            9999999999999999999999999974     457999999999999999999999999999999999999998     


Q ss_pred             ------CCCEEEeecccccccC-----CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHH
Q 023270          155 ------EGRLKIGDFGWSVQSR-----SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD  223 (284)
Q Consensus       155 ------~~~~~l~d~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~  223 (284)
                            ++.+||+|||++....     .......|++.|+|||++.+..++.++||||||+++|+|+||..||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  8999999999985322     22234568999999999999999999999999999999999999986543311


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC---cccccc
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH---PWIIKN  275 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~---~~~~~~  275 (284)
                      ..     .. ........++.+.+++..||+.+|.+|++..+.+.+   .|+.+.
T Consensus       293 ~~-----~~-~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 CK-----PE-GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             EE-----EC-SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ee-----ec-hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            00     00 111111357789999999999999999765554443   444443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2e-43  Score=301.84  Aligned_cols=243  Identities=24%  Similarity=0.384  Sum_probs=199.3

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHh--CCCCcccceeeEEecCC---
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS--LRHPNILRLYGWFHDDE---   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~--l~h~~i~~~~~~~~~~~---   92 (284)
                      .++|++.+.||+|+||.||++.+  +++.||+|++....      ...+.+|.+++..  ++|+||+++++++...+   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            46899999999999999999987  58899999986543      2345567777777  78999999999998776   


Q ss_pred             -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCCeEecCCCCEEEeec
Q 023270           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH--------ENHVIHRDIKPENLLLDHEGRLKIGDF  163 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh--------~~gi~H~dl~p~nil~~~~~~~~l~d~  163 (284)
                       ..++||||+++++|.+++.+ ..+++..++.++.|++.||.|||        +.|++|+||+|+||+++.++.++|+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             89999999999999999976 46899999999999999999999        899999999999999999999999999


Q ss_pred             ccccccCCC-------CccccCCCcccCccccCCCC------CCchhhHhhHHHHHHHHHhC----------CCCCCCC-
Q 023270          164 GWSVQSRSK-------RHTMCGTLDYLAPEMVENKE------HDYAVDNWTLGILCYEFLYG----------APPFEAE-  219 (284)
Q Consensus       164 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~il~~l~tg----------~~p~~~~-  219 (284)
                      |++......       .....+++.|+|||++.+..      ++.++||||||+++++|++|          ..||... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            998543322       23446889999999997663      33689999999999999999          7888654 


Q ss_pred             ----ChHHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          220 ----SQKDTFRRIMKVDLSFPSAP-----SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       220 ----~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                          ..................+.     ..++.+.+++.+||..||.+|||+++++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                23344444433333332221     234679999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-43  Score=313.46  Aligned_cols=247  Identities=20%  Similarity=0.309  Sum_probs=203.9

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC-CcccceeeEEecCCeE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWFHDDERI   94 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h-~~i~~~~~~~~~~~~~   94 (284)
                      ...++|++.+.||.|+||.||++.+..+++.||||++......     ..+.+|+.+++.+.| +++..+..++..++..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999987544322     346788899999987 5566666667788899


Q ss_pred             EEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEe---cCCCCEEEeecccccccC
Q 023270           95 FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~  170 (284)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||+   +.++.++|+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 7899999986 4679999999999999999999999999999999999999   588999999999985443


Q ss_pred             CCC----------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC-
Q 023270          171 SKR----------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---KDTFRRIMKVDLSFP-  236 (284)
Q Consensus       171 ~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~-  236 (284)
                      ...          ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ...+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            221          245689999999999999999999999999999999999999987433   333333322211111 


Q ss_pred             --CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          237 --SAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                        ....+++++.+|+..||..+|.+||++++|++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              11367899999999999999999999998876

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-42  Score=290.50  Aligned_cols=227  Identities=13%  Similarity=0.101  Sum_probs=189.9

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      +...+|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+..+..++|+||+++++++..++..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999997765444455678889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcc
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  175 (284)
                      +||||+++++|.++++..  ....++..++.|++.||.|||++|++|+||||+||+++.+|.++|+++++          
T Consensus       108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----------  175 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------  175 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----------
Confidence            999999999999999653  36667899999999999999999999999999999999999999985432          


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCC--CCCCCCCHHHHHHHH
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---RIMKVDLSF--PSAPSISAEAKHLIS  250 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l~~li~  250 (284)
                             .+       .++.++||||||+++|+|++|..||...+..+.+.   .........  ...+.+++++.+++.
T Consensus       176 -------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  241 (286)
T 3uqc_A          176 -------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA  241 (286)
T ss_dssp             -------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred             -------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence                   22       36889999999999999999999998765533111   000111000  112468999999999


Q ss_pred             HhcccCCCCCCCHHhhhcC
Q 023270          251 RLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~  269 (284)
                      +||..||.+| |++++++.
T Consensus       242 ~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          242 RSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHCTTSSCC-CHHHHHHH
T ss_pred             HHcccCCccC-CHHHHHHH
Confidence            9999999999 99999874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-44  Score=307.08  Aligned_cols=247  Identities=19%  Similarity=0.280  Sum_probs=188.9

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHH-----HHHHHHHHHHHHHHHHhCC---------CCcc
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----KYKIQHQLRREMEIQSSLR---------HPNI   81 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~~~~~~~~l~---------h~~i   81 (284)
                      +...+|++.+.||+|+||+||+|.+  +++.||||++......     .....+.+.+|+.+++.++         |+|+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4568899999999999999999987  6799999999754321     1111245667777777765         5555


Q ss_pred             cce-----------------eeEEec-------------CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHH
Q 023270           82 LRL-----------------YGWFHD-------------DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA  131 (284)
Q Consensus        82 ~~~-----------------~~~~~~-------------~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~  131 (284)
                      +++                 ++++..             ++..++||||+++|++.+.+.. +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            554                 444443             6789999999998876666644 568999999999999999


Q ss_pred             HHHHH-hCCccccCCCCCCeEecCCC--------------------CEEEeecccccccCCCCccccCCCcccCccccCC
Q 023270          132 LAYCH-ENHVIHRDIKPENLLLDHEG--------------------RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN  190 (284)
Q Consensus       132 l~~lh-~~gi~H~dl~p~nil~~~~~--------------------~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~  190 (284)
                      |.||| +.||+|+||||+|||++.++                    .+||+|||++......  ...|++.|+|||++.+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCC
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcC
Confidence            99999 99999999999999999887                    8999999998655432  3478999999999987


Q ss_pred             CCCCchhhHhhHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhcC-CCCCC----CCCCCHHHHHHHHHhcccCCCCCCCH
Q 023270          191 KEHDYAVDNWTLGIL-CYEFLYGAPPFEAESQ-KDTFRRIMKVD-LSFPS----APSISAEAKHLISRLLVKDSSKRLSL  263 (284)
Q Consensus       191 ~~~~~~~Di~slG~i-l~~l~tg~~p~~~~~~-~~~~~~~~~~~-~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~  263 (284)
                      .. +.++||||++.+ .+++++|..||..... ......+.... .....    .+.+++++.+||++||..|     |+
T Consensus       252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa  325 (336)
T 2vuw_A          252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA  325 (336)
T ss_dssp             CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred             CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence            76 899999998777 6667788888843211 11222333211 11111    1246789999999999976     99


Q ss_pred             Hhhh-cCcccc
Q 023270          264 QKIM-EHPWII  273 (284)
Q Consensus       264 ~~il-~~~~~~  273 (284)
                      +++| +||||+
T Consensus       326 ~e~l~~Hp~f~  336 (336)
T 2vuw_A          326 TDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHCGGGC
T ss_pred             HHHHhcCCCcC
Confidence            9999 999996

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-42  Score=322.59  Aligned_cols=244  Identities=22%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEec-CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      .+...+|++.+.||+|+||+||++.+.. +++.|+||++.....  ......+.+|+.+++.++||||+++++++...+.
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            3455899999999999999999999976 789999999865332  2334677899999999999999999999987655


Q ss_pred             -----EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           94 -----IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        94 -----~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                           .|+||||+++++|.+++..  .+++..++.++.||+.+|.|||++||+|+||||+||+++.+ .+||+|||++..
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999987755  78999999999999999999999999999999999999875 999999999865


Q ss_pred             cCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 023270          169 SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL  248 (284)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (284)
                      .... ....|++.|+|||++.+.. +.++||||||+++++|++|..||......        ...........++.+.++
T Consensus       231 ~~~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~~l  300 (681)
T 2pzi_A          231 INSF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGRL  300 (681)
T ss_dssp             TTCC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHHHH
T ss_pred             cccC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHHHH
Confidence            5443 4556899999999987654 88999999999999999998887642111        000000001245789999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCcccc
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      |.+||..||.+||+..+.+.|+|+.
T Consensus       301 i~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          301 LRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HhhhccCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999998875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.1e-33  Score=256.03  Aligned_cols=184  Identities=13%  Similarity=0.103  Sum_probs=133.9

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhh-------HHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEecCCeEEE
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-------IEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ...+.|+.+....++....|+.|++|++....       .......+.+.+|+++|+++ .|+||+++++++++++..|+
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            34567788888888888889999999985431       12334567899999999999 69999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CC
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~  173 (284)
                      ||||++|++|.++|...++++..   .++.||+.||.|+|++||+||||||+|||++.+|++||+|||++.....   ..
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999998888765   4789999999999999999999999999999999999999999855432   22


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG  212 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg  212 (284)
                      ....||+.|+|||++.+. ....+|+|++|++++.+.++
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            345689999999998754 56789999999987766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.3e-27  Score=215.19  Aligned_cols=182  Identities=17%  Similarity=0.183  Sum_probs=142.5

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhh-----hHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKE-----QIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+.||+|+||+||++.  ..+..+++|+....     ........+.+.+|++++++++|+||+++..++..++..++|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35689999999999994  46778888875332     223333456789999999999999999766666677788999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC----
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~----  173 (284)
                      |||+++++|.+++..        +..++.|++.+|.|||++|++|+||||+||+++.  .+||+|||++.......    
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999998866        5689999999999999999999999999999988  99999999986655422    


Q ss_pred             ------ccccCCCcccCccccCC--CCCCchhhHhhHHHHHHHHHhCCCCC
Q 023270          174 ------HTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPF  216 (284)
Q Consensus       174 ------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~  216 (284)
                            ....|++.|+|||++..  ..++...|+|+..+-..+-..++.+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                  24468999999999976  55778889999888877776655444

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.1e-25  Score=184.03  Aligned_cols=143  Identities=22%  Similarity=0.239  Sum_probs=115.0

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH---------------HHHHHHHHHHHHHHHhCCCCcccceeeE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---------------YKIQHQLRREMEIQSSLRHPNILRLYGW   87 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~h~~i~~~~~~   87 (284)
                      +.+.||.|+||.||+|.+ .+++.||+|++.......               ......+.+|+.+++.++  | +++.++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            349999999999999999 889999999985432211               123567889999999999  5 777776


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      +.. +..++||||+++++|.+ +.      ......++.|++.|+.+||+.|++|+||+|+|||++ ++.++|+|||++.
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            543 56699999999999987 42      234557999999999999999999999999999999 9999999999985


Q ss_pred             ccCCCCccccCCCcccCcccc
Q 023270          168 QSRSKRHTMCGTLDYLAPEMV  188 (284)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~~  188 (284)
                      ..          ..+.|||.+
T Consensus       241 ~~----------~~~~a~e~l  251 (282)
T 1zar_A          241 EV----------GEEGWREIL  251 (282)
T ss_dssp             ET----------TSTTHHHHH
T ss_pred             EC----------CCCCHHHHH
Confidence            32          345778876

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=2.5e-21  Score=158.56  Aligned_cols=140  Identities=19%  Similarity=0.266  Sum_probs=108.0

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCce--EEEEehhhhhHH---------------------HHHHHHHHHHHHHHHHhCC
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHP--VALKIIFKEQIE---------------------KYKIQHQLRREMEIQSSLR   77 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~---------------------~~~~~~~~~~~~~~~~~l~   77 (284)
                      |.+.+.||+|+||.||+|.+..+|..  ||||++......                     .......+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999998788888  999986432111                     1122346788999999998


Q ss_pred             CCcc--cceeeEEecCCeEEEEEeecCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCC
Q 023270           78 HPNI--LRLYGWFHDDERIFLILEYAHR-G----ELYRELRKHRRFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPEN  149 (284)
Q Consensus        78 h~~i--~~~~~~~~~~~~~~~v~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh-~~gi~H~dl~p~n  149 (284)
                      |+++  ..+++.    +..++||||+++ |    +|.+....   .+...+..++.|++.++.+|| +.|++|+||+|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8764  333332    356899999942 3    66665432   234567889999999999999 9999999999999


Q ss_pred             eEecCCCCEEEeeccccccc
Q 023270          150 LLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~  169 (284)
                      ||++.  .++|+|||++...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999998544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=8.4e-19  Score=149.65  Aligned_cols=141  Identities=18%  Similarity=0.189  Sum_probs=101.6

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH-------------------HHHHHHHHHHHHHHHHHhCCCCcc
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-------------------EKYKIQHQLRREMEIQSSLRHPNI   81 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~h~~i   81 (284)
                      |.+.+.||.|++|.||+|.+ .+|+.||||++.....                   +.....-...+|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            89999999999999999987 5789999998642210                   001111223456666776655444


Q ss_pred             cceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-----
Q 023270           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----  156 (284)
Q Consensus        82 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-----  156 (284)
                      ....-+...  ..++||||+++.+|..+.      +......++.|++.++.+||+.|++||||||.|||++.+|     
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            322222222  237999999988886542      2234567889999999999999999999999999998876     


Q ss_pred             -----CEEEeecccccccC
Q 023270          157 -----RLKIGDFGWSVQSR  170 (284)
Q Consensus       157 -----~~~l~d~~~~~~~~  170 (284)
                           .+.|+||+.+....
T Consensus       248 ~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECCCTTCEETT
T ss_pred             cccccceEEEEeCCcccCC
Confidence                 38999999875543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=2.4e-13  Score=111.22  Aligned_cols=140  Identities=15%  Similarity=0.141  Sum_probs=109.2

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIF   95 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~   95 (284)
                      .+..|.+...++.|+.+.||++..  .+..+++|+........   ...+.+|++.++.+. +..+.++++++...+..|
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            456799999999999999999874  36789999986432111   134677888888774 567788999988888999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE--------------------------------------  137 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~--------------------------------------  137 (284)
                      +|||+++|.+|.+.+.     +......++.++..++..||+                                      
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999988876531     122334778889999999998                                      


Q ss_pred             ---------------------CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 ---------------------NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ---------------------~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                                           .+++|||++|.||+++.++.+.|+||+.+
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                 44889999999999987666779999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.41  E-value=1.1e-12  Score=106.99  Aligned_cols=150  Identities=13%  Similarity=0.109  Sum_probs=102.5

Q ss_pred             ChhhHHHhhhhcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc-
Q 023270            2 DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-   80 (284)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~-   80 (284)
                      ++.....+........+.+|.+....+.|..+.||++.. .++..+++|......      ...+..|+..++.+.+.+ 
T Consensus         3 ~~~~~~~~~p~~l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~   75 (264)
T 1nd4_A            3 EQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGV   75 (264)
T ss_dssp             -------CCCGGGTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTC
T ss_pred             ccCCccccCCHHHHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCC
Confidence            333333444445556677888876666777799999864 567789999975431      134566777777775434 


Q ss_pred             -ccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------
Q 023270           81 -ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--------------------  139 (284)
Q Consensus        81 -i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g--------------------  139 (284)
                       +.+++++...++..++|||+++|.++.  .   ...+.   ..++.++...+..||...                    
T Consensus        76 ~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~  147 (264)
T 1nd4_A           76 PCAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTR  147 (264)
T ss_dssp             CBCCEEEEEECSSCEEEEEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHH
T ss_pred             CCCeEEEeccCCCCCEEEEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHH
Confidence             556888888888899999999988874  1   11122   245566667777777543                    


Q ss_pred             --------------------------------------ccccCCCCCCeEecCCCCEEEeecccc
Q 023270          140 --------------------------------------VIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       140 --------------------------------------i~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                                                            ++|||++|.||+++.++.+.|+||+.+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          148 MEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             HHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             HhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                                                  899999999999987766779999975

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=3.7e-11  Score=102.74  Aligned_cols=142  Identities=15%  Similarity=0.281  Sum_probs=104.2

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehh--hhhHHHHHHHHHHHHHHHHHHhCCC--CcccceeeEEecC---C
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDD---E   92 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~--~~~~~~~~~~~~~~~~~~~~~~l~h--~~i~~~~~~~~~~---~   92 (284)
                      ....++.|+.|.++.+|++...  +..+++|+..  .....  .....+.+|+.+++.+..  ..+.+++.++.+.   +
T Consensus        39 ~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g  114 (359)
T 3dxp_A           39 GPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG  114 (359)
T ss_dssp             CCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred             CCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence            3445778999999999998753  4688899875  32211  113467788888888874  4567788877666   4


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-----------------------------------  137 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-----------------------------------  137 (284)
                      ..|+|||+++|.++.+.  ....++......++.++...|..||.                                   
T Consensus       115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            58999999998777431  12346788888999999999999997                                   


Q ss_pred             -----------------------CCccccCCCCCCeEecCCCC--EEEeeccccc
Q 023270          138 -----------------------NHVIHRDIKPENLLLDHEGR--LKIGDFGWSV  167 (284)
Q Consensus       138 -----------------------~gi~H~dl~p~nil~~~~~~--~~l~d~~~~~  167 (284)
                                             .+++|||++|.||+++.++.  +.++||+.+.
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                                   36899999999999987753  6899999764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=2.3e-10  Score=95.48  Aligned_cols=180  Identities=18%  Similarity=0.175  Sum_probs=117.0

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCc--ccceeeEEecCC---eEEEE
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPN--ILRLYGWFHDDE---RIFLI   97 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~--i~~~~~~~~~~~---~~~~v   97 (284)
                      ++.++.|..+.+|++.     ..+++|.....     .....+.+|.+.++.+. +..  +.+++.....++   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4558999999999763     56899986433     22356778888888773 333  334444433333   35889


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE----------------------------------------  137 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~----------------------------------------  137 (284)
                      |++.+|.++.....  ..++..+...++.++...+..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988875432  346777777888888888888885                                        


Q ss_pred             ------------------CCccccCCCCCCeEecC--CCCEEEeecccccccCCCCccccCCCcc---cCccccC----C
Q 023270          138 ------------------NHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSKRHTMCGTLDY---LAPEMVE----N  190 (284)
Q Consensus       138 ------------------~gi~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~y---~aPE~~~----~  190 (284)
                                        ..++|||++|.||+++.  ++.+.++||+.+....... ........   ..|+...    .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHH
Confidence                              13699999999999988  5668899999864332111 00000011   1222110    0


Q ss_pred             -CC---------CCchhhHhhHHHHHHHHHhCCCCC
Q 023270          191 -KE---------HDYAVDNWTLGILCYEFLYGAPPF  216 (284)
Q Consensus       191 -~~---------~~~~~Di~slG~il~~l~tg~~p~  216 (284)
                       +.         .....+.|+++.+++.+.+|+.+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             00         122368999999999999997654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.86  E-value=7.1e-08  Score=80.46  Aligned_cols=132  Identities=17%  Similarity=0.164  Sum_probs=88.2

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCC---cccceeeEEe-cCCeEEEEEe
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP---NILRLYGWFH-DDERIFLILE   99 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~---~i~~~~~~~~-~~~~~~~v~e   99 (284)
                      ++.++.|....+|++     +..+++|+....     .....+..|.+.++.+.+.   .+.+++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456788999999987     577899985322     2235678899999888652   3555666653 4556789999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE------------------------------------------  137 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~------------------------------------------  137 (284)
                      +.+|.++....-  ..++......++.++...+..||+                                          
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999888765321  122333444444444444444442                                          


Q ss_pred             ------------------CCccccCCCCCCeEecC---CCC-EEEeeccccc
Q 023270          138 ------------------NHVIHRDIKPENLLLDH---EGR-LKIGDFGWSV  167 (284)
Q Consensus       138 ------------------~gi~H~dl~p~nil~~~---~~~-~~l~d~~~~~  167 (284)
                                        ..++|||++|.||+++.   ++. +.|+||+.+.
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                              24589999999999987   355 5899999764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.85  E-value=9.3e-08  Score=78.12  Aligned_cols=136  Identities=15%  Similarity=0.163  Sum_probs=93.4

Q ss_pred             CcEeeeeeccCCC-eEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEEE
Q 023270           20 DFEIGRPLGKGKF-GRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        20 ~y~~~~~lg~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~v   97 (284)
                      .|+... +..|.. +.||+.....++..+++|+-....      ...+.+|...++.+. +-.+.+++.++.+++..++|
T Consensus        26 g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           26 GYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             TCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            344433 334444 468988887778889999974432      235667777777664 23467788888888999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN---------------------------------------  138 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~---------------------------------------  138 (284)
                      ||++++.++.+.....    ......+..++...+..||..                                       
T Consensus        99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            9999988877665432    122233444555555555521                                       


Q ss_pred             -------------------CccccCCCCCCeEecCCCCEEEeecccc
Q 023270          139 -------------------HVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       139 -------------------gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                                         .++|||+++.||+++.++.+-|+||+.+
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence                               1689999999999998877889999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.37  E-value=1.9e-06  Score=74.35  Aligned_cols=81  Identities=15%  Similarity=0.162  Sum_probs=46.7

Q ss_pred             EeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH--HHH--HHHHHHHHHHHHHHhCCC--Cc-ccceeeEEecCCeE
Q 023270           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKY--KIQHQLRREMEIQSSLRH--PN-ILRLYGWFHDDERI   94 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~--~~~~~~~~~~~~~~~l~h--~~-i~~~~~~~~~~~~~   94 (284)
                      ...+.||.|..+.||++....++..+++|.......  ...  .....+..|.+.++.+..  +. +.+++.+  +.+..
T Consensus        33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA  110 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred             eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence            346789999999999997766678899997542111  000  011234556666665532  33 3345443  34456


Q ss_pred             EEEEeecCCC
Q 023270           95 FLILEYAHRG  104 (284)
Q Consensus        95 ~~v~e~~~~~  104 (284)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.37  E-value=8.8e-06  Score=63.20  Aligned_cols=136  Identities=17%  Similarity=0.096  Sum_probs=92.1

Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCCC
Q 023270          103 RGELYRELRKH-RRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL  180 (284)
Q Consensus       103 ~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  180 (284)
                      ..+|.+.|... .+++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|.|.+.+-. +         .....
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~-s---------~~~~~  101 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAA-D---------DAGEP  101 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC-----------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccccc-c---------ccccc
Confidence            35899999765 689999999999999999887632 121233355789999999999886411 0         01123


Q ss_pred             cccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc-----
Q 023270          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK-----  255 (284)
Q Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-----  255 (284)
                      .+.|||... ...+.+.-|||||+++|..+---.                   ...-...+|++|.+||..|...     
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL-------------------~e~eE~eLS~~LE~LL~~Mt~~~~d~~  161 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL-------------------KENEERELSPPLEQLIDHMANTVEADG  161 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTC-------------------CTTEEECCCHHHHHHHHHHTTCCC---
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC-------------------CcccchhhCHHHHHHHHHHHhcccccc
Confidence            467888752 445688999999999999874211                   1122236899999999999865     


Q ss_pred             --------------------CCCCCCCHHhhhc
Q 023270          256 --------------------DSSKRLSLQKIME  268 (284)
Q Consensus       256 --------------------~p~~Rps~~~il~  268 (284)
                                          .+..|++.++|++
T Consensus       162 ~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          162 SNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             -----------------CCSCCCCCCSHHHHHH
T ss_pred             cccccccccccccccccccccccCcCCHHHHHH
Confidence                                2468888988875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.25  E-value=1.5e-05  Score=67.04  Aligned_cols=29  Identities=21%  Similarity=0.272  Sum_probs=26.7

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .+++|||+++.||+++.++.+.++||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            57999999999999988889999999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=2.6e-06  Score=72.43  Aligned_cols=82  Identities=7%  Similarity=0.118  Sum_probs=51.1

Q ss_pred             Eeeeee-ccCCCeEEEEEEEe--c----CCceEEEEehhhhh---HHHHHHHHHHHHHHHHHHhCCC---CcccceeeEE
Q 023270           22 EIGRPL-GKGKFGRVYLVREV--E----SKHPVALKIIFKEQ---IEKYKIQHQLRREMEIQSSLRH---PNILRLYGWF   88 (284)
Q Consensus        22 ~~~~~l-g~g~~~~v~~~~~~--~----~~~~v~iK~~~~~~---~~~~~~~~~~~~~~~~~~~l~h---~~i~~~~~~~   88 (284)
                      ...+.| +.|..+.+|++...  .    ++..+++|......   ...   ...+.+|...++.+..   -.+.+++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            345677 88999999988754  1    25678999875432   000   0234455666655532   3456677766


Q ss_pred             ecC---CeEEEEEeecCCCch
Q 023270           89 HDD---ERIFLILEYAHRGEL  106 (284)
Q Consensus        89 ~~~---~~~~~v~e~~~~~~L  106 (284)
                      .++   +..++|||+++|.++
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCC
T ss_pred             cCCCccCCceEEEEecCCCCh
Confidence            554   356899999987554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.98  E-value=0.00015  Score=60.28  Aligned_cols=76  Identities=21%  Similarity=0.305  Sum_probs=56.8

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC---CCcccceeeEEecCCeEEEEEe
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~---h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      -.+.|+.|..+.+|++..  ++..+++|+.....      ...+..|.+.++.+.   ...+.+++.+....+..++|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            456789999999999875  56789999875432      234566766666663   3567788888877888999999


Q ss_pred             ecCCCch
Q 023270          100 YAHRGEL  106 (284)
Q Consensus       100 ~~~~~~L  106 (284)
                      +.++.++
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.97  E-value=6.4e-05  Score=65.32  Aligned_cols=76  Identities=12%  Similarity=0.128  Sum_probs=44.0

Q ss_pred             HhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccc----cCCCcccCccccCCCC---CCchhhHhhHHHHHHH
Q 023270          136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM----CGTLDYLAPEMVENKE---HDYAVDNWTLGILCYE  208 (284)
Q Consensus       136 h~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~  208 (284)
                      +...++|||++|.|||++.++ +.++||+.+..........    .-...|++|+......   ......+......++.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            356799999999999998877 9999998764332111000    0012345554443111   1123455566666666


Q ss_pred             HHhC
Q 023270          209 FLYG  212 (284)
Q Consensus       209 l~tg  212 (284)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.90  E-value=1.5e-05  Score=66.13  Aligned_cols=71  Identities=13%  Similarity=0.027  Sum_probs=42.2

Q ss_pred             eeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeEEEEEeec-
Q 023270           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYA-  101 (284)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~~~v~e~~-  101 (284)
                      ++.|+.|....+|++      ..+++|+.......    .-...+|...++.+...++ .+++.+  +++.-++++||. 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            788999999999988      56889987542110    0111245555554432222 345543  343457899999 


Q ss_pred             CCCch
Q 023270          102 HRGEL  106 (284)
Q Consensus       102 ~~~~L  106 (284)
                      ++.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66544

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.67  E-value=0.00017  Score=59.26  Aligned_cols=80  Identities=16%  Similarity=0.186  Sum_probs=52.5

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCC---cccceeeEEecCCeE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP---NILRLYGWFHDDERI   94 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~---~i~~~~~~~~~~~~~   94 (284)
                      .....-++.+|.|..+.||++.. .+|+.|++|+........   ...+..|.+.|+.+...   .+.+++..  +  .-
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~   85 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DR   85 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TT
T ss_pred             CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--c--Cc
Confidence            34566788899999999999975 578899999865432211   12456777777777432   23334433  2  23


Q ss_pred             EEEEeecCCCc
Q 023270           95 FLILEYAHRGE  105 (284)
Q Consensus        95 ~~v~e~~~~~~  105 (284)
                      ++|||+.++..
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            78899987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.53  E-value=0.00025  Score=60.62  Aligned_cols=139  Identities=18%  Similarity=0.226  Sum_probs=77.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEec-------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEec
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHD   90 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~   90 (284)
                      ...+ ++.|..|-...+|++....       ++..|++|+.-... .   ....+.+|.++++.+...++ .++++.+.+
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-Q---GVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-c---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            4444 4567788889999988642       35789999963311 1   12344467777766643222 456665543


Q ss_pred             CCeEEEEEeecCCCchHH--------------HHH---hc-----CCCC--HHHHHHHHHHHHH----------------
Q 023270           91 DERIFLILEYAHRGELYR--------------ELR---KH-----RRFT--EQQAATYIASLTN----------------  130 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~--------------~l~---~~-----~~l~--~~~~~~i~~~i~~----------------  130 (284)
                          .+|+||.+|.++..              .++   ..     +...  ..++..++.++..                
T Consensus       126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence                28999998755421              111   11     0111  2344444433321                


Q ss_pred             ---HHHHH----Hh----CCccccCCCCCCeEecCC----CCEEEeecccc
Q 023270          131 ---ALAYC----HE----NHVIHRDIKPENLLLDHE----GRLKIGDFGWS  166 (284)
Q Consensus       131 ---~l~~l----h~----~gi~H~dl~p~nil~~~~----~~~~l~d~~~~  166 (284)
                         .+..|    ..    ..++|+|+.+.||+++.+    +.+.++||.++
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence               12222    22    248999999999999876    78999999986

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.51  E-value=0.0005  Score=57.36  Aligned_cols=75  Identities=16%  Similarity=0.247  Sum_probs=42.7

Q ss_pred             eeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc--ccceeeE-----EecCCeEEEE
Q 023270           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGW-----FHDDERIFLI   97 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~--i~~~~~~-----~~~~~~~~~v   97 (284)
                      ..++ |....+|++.. .+|+.+++|.........    ..+..|...++.+....  +.+++..     ...++..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~----~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH----HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 88889998764 346679999985332211    23334555554443211  3333332     1234567889


Q ss_pred             EeecCCCc
Q 023270           98 LEYAHRGE  105 (284)
Q Consensus        98 ~e~~~~~~  105 (284)
                      +++.+|.+
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998744

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.45  E-value=0.00021  Score=59.91  Aligned_cols=30  Identities=33%  Similarity=0.412  Sum_probs=26.0

Q ss_pred             CCccccCCCCCCeEecCC----CCEEEeeccccc
Q 023270          138 NHVIHRDIKPENLLLDHE----GRLKIGDFGWSV  167 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~----~~~~l~d~~~~~  167 (284)
                      .+++|||+++.||+++.+    +.+.++||+.+.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            468999999999999875    689999998763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00025  Score=61.76  Aligned_cols=74  Identities=23%  Similarity=0.298  Sum_probs=45.6

Q ss_pred             eeeeeccCCCeEEEEEEEec-------CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeE
Q 023270           23 IGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERI   94 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~   94 (284)
                      -++.|+.|....+|++....       ++..+++|+......     ...+.+|..+++.+...++ .++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            45678899999999997643       257899999843211     0123356666665543333 456665432    


Q ss_pred             EEEEeecCCCc
Q 023270           95 FLILEYAHRGE  105 (284)
Q Consensus        95 ~~v~e~~~~~~  105 (284)
                      .+|+||.+|.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            38899987644

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.43  E-value=0.00064  Score=56.55  Aligned_cols=140  Identities=13%  Similarity=0.133  Sum_probs=73.4

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc--ccceeeE------EecC
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGW------FHDD   91 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~--i~~~~~~------~~~~   91 (284)
                      +..-.+.|+.|....+|++...  +..+++|......  .   ...+..|..++..+...+  +.+++..      ...+
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             cceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            3344567888888999988753  3478899885521  1   122334445444442111  2233321      1234


Q ss_pred             CeEEEEEeecCCCchH----H-------H---HHhc-CC--------CCHHHHHHH---------------HHHHHHHHH
Q 023270           92 ERIFLILEYAHRGELY----R-------E---LRKH-RR--------FTEQQAATY---------------IASLTNALA  133 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~----~-------~---l~~~-~~--------l~~~~~~~i---------------~~~i~~~l~  133 (284)
                      +..++++++.+|.++.    .       .   +... ..        .....-...               -..+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            5678999999875431    0       0   1110 00        011000000               011333444


Q ss_pred             HHHh-------CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          134 YCHE-------NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       134 ~lh~-------~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .++.       .+++|||+++.||+++.++.+.++||+.+
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a  215 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA  215 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence            4442       36899999999999988766789999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.30  E-value=0.0029  Score=53.14  Aligned_cols=29  Identities=28%  Similarity=0.368  Sum_probs=26.2

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .+++|||+++.||+++.++.+.++||+.+
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~  234 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEP  234 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCC
Confidence            46899999999999998889999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.0011  Score=56.27  Aligned_cols=75  Identities=17%  Similarity=0.106  Sum_probs=40.7

Q ss_pred             eeeeeccCCCeEEEEEEEecC--------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc-ccceeeEEecCCe
Q 023270           23 IGRPLGKGKFGRVYLVREVES--------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDER   93 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~-i~~~~~~~~~~~~   93 (284)
                      -.+.++.|....+|++.....        +..+++|+........    .....|...++.+...+ ..++++..  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~----~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL----YNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT----SCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce----ecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            456778888899999976542        3678999875422110    01234555555553223 34555443  22 


Q ss_pred             EEEEEeecCCCc
Q 023270           94 IFLILEYAHRGE  105 (284)
Q Consensus        94 ~~~v~e~~~~~~  105 (284)
                       ++|+||.+|.+
T Consensus       110 -~~v~e~i~G~~  120 (369)
T 3c5i_A          110 -GRIEEWLYGDP  120 (369)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -cEEEEEecCCc
Confidence             68999998654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.84  E-value=0.0029  Score=55.43  Aligned_cols=76  Identities=17%  Similarity=0.195  Sum_probs=45.4

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeEEEEEeec
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYA  101 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~~~v~e~~  101 (284)
                      -++.|+.|-...+|++.....+..+++|+..... ..   .-....|..+++.+...++ .++++.+.  +  ..|+||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            4567888999999999865435789999874321 00   0011367777777765444 45666552  2  2499998


Q ss_pred             CCCch
Q 023270          102 HRGEL  106 (284)
Q Consensus       102 ~~~~L  106 (284)
                      ++.++
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            86443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=95.91  E-value=0.065  Score=41.63  Aligned_cols=114  Identities=14%  Similarity=0.112  Sum_probs=77.9

Q ss_pred             CCCcccceeeEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCCeEecCC
Q 023270           77 RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA-YCHENHVIHRDIKPENLLLDHE  155 (284)
Q Consensus        77 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~-~lh~~gi~H~dl~p~nil~~~~  155 (284)
                      .||++  ...+-..++.+.+.++.-+...-...+   ..++....++++.+|+.... ++  ..-+|--++|+|++++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57777  556667788888877775443333344   34689999999999888655 33  445678899999999999


Q ss_pred             CCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCC
Q 023270          156 GRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF  216 (284)
Q Consensus       156 ~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~  216 (284)
                      +.+++.-.|.-              .-++|.     ..+...=+-..-+++..++.++..|
T Consensus       121 ~~p~i~hRGi~--------------~~lpP~-----e~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          121 LEPFFLHVGVK--------------ESLPPD-----EWDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CCEEESCCEET--------------TTBSSC-----SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CcEEEEEcCCc--------------ccCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999877652              222332     2333444556778888888775543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.89  E-value=0.0096  Score=51.55  Aligned_cols=77  Identities=17%  Similarity=0.124  Sum_probs=45.1

Q ss_pred             EeeeeeccCCCeEEEEEEEecC-------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCc-ccceeeEEecCCe
Q 023270           22 EIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDER   93 (284)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~-i~~~~~~~~~~~~   93 (284)
                      .-++.+..|-...+|++.....       +..|++|+.......    .-...+|.++++.+...+ ..++++.+  .+ 
T Consensus        73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-  145 (424)
T 3mes_A           73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--PE-  145 (424)
T ss_dssp             EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC-
Confidence            3456678888999999986521       578999997432110    001234555555553222 34455433  22 


Q ss_pred             EEEEEeecCCCch
Q 023270           94 IFLILEYAHRGEL  106 (284)
Q Consensus        94 ~~~v~e~~~~~~L  106 (284)
                       +.|++|.+|.+|
T Consensus       146 -~~I~efI~G~~l  157 (424)
T 3mes_A          146 -GRIEEFIDGEPL  157 (424)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -CEEEEEeCCccC
Confidence             788999987553

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=95.83  E-value=0.043  Score=42.49  Aligned_cols=114  Identities=11%  Similarity=0.123  Sum_probs=79.6

Q ss_pred             CCCcccceeeEEecCCeEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC
Q 023270           77 RHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (284)
Q Consensus        77 ~h~~i~~~~~~~~~~~~~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~  155 (284)
                      .||++++. .+-..++.+.+.++.-+. -++.. +   +.++....++++.+|+....++  ..-+|--++|+|++++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence            57888876 677777777777776442 23332 3   3468899999999999877443  334678899999999999


Q ss_pred             CCEEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCC
Q 023270          156 GRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF  216 (284)
Q Consensus       156 ~~~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~  216 (284)
                      +.+++.-.|..              .-++|.     ..+...-+-..-+++..+++++..|
T Consensus       116 ~~p~i~~RGik--------------~~l~P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          116 GLPIAKTRGLQ--------------NVVDPL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             SCEEESCCEET--------------TTBSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCEEEEEccCc--------------cCCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999876642              112222     3344555666888999999887765

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.49  E-value=0.045  Score=46.96  Aligned_cols=28  Identities=32%  Similarity=0.532  Sum_probs=24.2

Q ss_pred             ccccCCCCCCeEe------cCCCCEEEeeccccc
Q 023270          140 VIHRDIKPENLLL------DHEGRLKIGDFGWSV  167 (284)
Q Consensus       140 i~H~dl~p~nil~------~~~~~~~l~d~~~~~  167 (284)
                      ++|+|+.+.||++      +.++.+.++||.++.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999      456789999999873

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	284
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-101
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-83
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-83
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-82
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-81
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-81
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-81
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-80
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-79
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-79
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-78
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-77
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-77
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-75
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-75
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-74
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-73
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-73
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-72
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-70
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-69
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-68
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-68
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-66
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-64
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-63
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-62
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-62
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-61
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-60
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-59
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-59
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-59
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-55
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-52
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-22

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  295 bits (756), Expect = e-101
 Identities = 161/265 (60%), Positives = 206/265 (77%), Gaps = 3/265 (1%)

Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 1   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV + S +R T+CGTLDYL PEM+E + 
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
           HD  VD W+LG+LCYEFL G PPFEA + ++T++RI +V+ +FP    ++  A+ LISRL
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRL 238

Query: 253 LVKDSSKRLSLQKIMEHPWIIKNAN 277
           L  + S+R  L++++EHPWI  N++
Sbjct: 239 LKHNPSQRPMLREVLEHPWITANSS 263

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (641), Expect = 1e-83
 Identities = 89/260 (34%), Positives = 147/260 (56%), Gaps = 7/260 (2%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
             ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPEMVENKEHD 194
           +IHRD+KPEN+LL+ +  ++I DFG +        +++ ++  GT  Y++PE++  K   
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLV 254
            + D W LG + Y+ + G PPF A ++   F++I+K++  FP       +A+ L+ +LLV
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLV 246

Query: 255 KDSSKRLSLQKIMEHPWIIK 274
            D++KRL  +++  +  +  
Sbjct: 247 LDATKRLGCEEMEGYGPLKA 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  249 bits (638), Expect = 6e-83
 Identities = 66/263 (25%), Positives = 120/263 (45%), Gaps = 4/263 (1%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F   R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PN ++  G +  +   +L++EY             +   E + A         LAY H +
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVE---NKEHDY 195
           ++IHRD+K  N+LL   G +K+GDFG +    +  ++  GT  ++APE++      ++D 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
            VD W+LGI C E     PP    +       I + +     +   S   ++ +   L K
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 256 DSSKRLSLQKIMEHPWIIKNANP 278
               R + + +++H ++++   P
Sbjct: 254 IPQDRPTSEVLLKHRFVLRERPP 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  248 bits (633), Expect = 4e-82
 Identities = 105/262 (40%), Positives = 157/262 (59%), Gaps = 7/262 (2%)

Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +SLQDF+I R LG G FGRV+L+R   +    A+K++ KE + + K       E  + S 
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I+R++G F D ++IF+I++Y   GEL+  LRK +RF    A  Y A +  AL Y 
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           H   +I+RD+KPEN+LLD  G +KI DFG++       +T+CGT DY+APE+V  K ++ 
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK 255
           ++D W+ GIL YE L G  PF   +   T+ +I+  +L FP  P  + + K L+SRL+ +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLITR 238

Query: 256 DSSKRL-----SLQKIMEHPWI 272
           D S+RL       + +  HPW 
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWF 260

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  246 bits (630), Expect = 3e-81
 Identities = 82/273 (30%), Positives = 140/273 (51%), Gaps = 10/273 (3%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           K +  L  ++I   LG G FG V+ V E  + +  A K +          +  +R+E++ 
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQT 76

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNA 131
            S LRHP ++ L+  F DD  + +I E+   GEL+ ++  +H + +E +A  Y+  +   
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 132 LAYCHENHVIHRDIKPENLLL--DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           L + HEN+ +H D+KPEN++        LK+ DFG +  +  +       GT ++ APE+
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEA 245
            E K   Y  D W++G+L Y  L G  PF  E+  +T R +   D +   +    IS + 
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
           K  I +LL+ D + R+++ + +EHPW+     P
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (623), Expect = 5e-81
 Identities = 78/279 (27%), Positives = 143/279 (51%), Gaps = 14/279 (5%)

Query: 10  DNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++  R+ + +D +EI   LG G FG+VY  +  E+    A K+I  +  E+ +       
Sbjct: 2   EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMV 58

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIAS 127
           E++I +S  HPNI++L   F+ +  +++++E+   G +   +    R  TE Q       
Sbjct: 59  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 118

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S    ++  +R +  GT  ++A
Sbjct: 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 185 PEMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP 239
           PE+V     +++ +DY  D W+LGI   E     PP    +      +I K +    + P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 240 S-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 277
           S  S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (620), Expect = 8e-81
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 9/265 (3%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  ++         +++E+ I   L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 61

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +            + MCGTL Y+APE+++ +E
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-FRRIMKVDLSFPSAPSISAEAKHLIS 250
            H   VD W+ GI+    L G  P++  S     +    +          I +    L+ 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKN 275
           ++LV++ S R+++  I +  W  K 
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKP 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  241 bits (616), Expect = 9e-80
 Identities = 87/268 (32%), Positives = 143/268 (53%), Gaps = 9/268 (3%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           ++ E     ++    LG G F  V L  +  ++  VA+K I K+ +E    +  +  E+ 
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIA 59

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +   ++HPNI+ L   +     ++LI++    GEL+  + +   +TE+ A+  I  + +A
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
           + Y H+  ++HRD+KPENLL    D + ++ I DFG S      S   T CGT  Y+APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAE 244
           ++  K +  AVD W++G++ Y  L G PPF  E+    F +I+K +  F S     IS  
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 245 AKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           AK  I  L+ KD  KR + ++ ++HPWI
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  242 bits (618), Expect = 2e-79
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 10/262 (3%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
              ++I   LG G FG V+   E  +      K I          ++ ++ E+ I + L 
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLH 84

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           HP ++ L+  F D   + LILE+   GEL+  +     + +E +   Y+      L + H
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 137 ENHVIHRDIKPENLLLD--HEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKE 192
           E+ ++H DIKPEN++ +      +KI DFG +  +           T ++ APE+V+ + 
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLIS 250
             +  D W +G+L Y  L G  PF  E   +T + + + D  F      S+S EAK  I 
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

Query: 251 RLLVKDSSKRLSLQKIMEHPWI 272
            LL K+  KRL++   +EHPW+
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWL 286

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 5e-79
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 9/264 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + +     +G+G  G VY   +V +   VA++ +  +Q  K   +  +  E+ +    ++
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKN 76

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+     +   + +++++EY   G L  ++       E Q A        AL + H N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDY 195
            VIHRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVD-LSFPSAPSISAEAKHLISRLLV 254
            VD W+LGI+  E + G PP+  E+       I         +   +SA  +  ++R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 255 KDSSKRLSLQKIMEHPWIIKNANP 278
            D  KR S +++++H + +K A P
Sbjct: 256 MDVEKRGSAKELLQHQF-LKIAKP 278

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 9e-78
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 11/266 (4%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + I   LG+G+FG V+   E  SK     K +  +  +    Q  +++E+ I +  RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHR 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NIL L+  F   E + +I E+    +++  +        E++  +Y+  +  AL + H +
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 139 HVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHD 194
           ++ H DI+PEN++        +KI +FG + Q +       +    +Y APE+ ++    
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLISRL 252
            A D W+LG L Y  L G  PF AE+ +     IM  + +F       IS EA   + RL
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241

Query: 253 LVKDSSKRLSLQKIMEHPWIIKNANP 278
           LVK+   R++  + ++HPW+ +    
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIER 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 1e-77
 Identities = 77/260 (29%), Positives = 145/260 (55%), Gaps = 7/260 (2%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           ++DF + + LGKG FG+V+L    ++    A+K + K+ +     ++  +  +  +  + 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKEH 193
              +++RD+K +N+LLD +G +KI DFG   ++    +K +T CGT DY+APE++  +++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
           +++VD W+ G+L YE L G  PF  + +++ F  I   +  +P    +  EAK L+ +L 
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEAKDLLVKLF 238

Query: 254 VKDSSKRLSL-QKIMEHPWI 272
           V++  KRL +   I +HP  
Sbjct: 239 VREPEKRLGVRGDIRQHPLF 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  233 bits (595), Expect = 5e-77
 Identities = 77/271 (28%), Positives = 132/271 (48%), Gaps = 17/271 (6%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY------KIQHQLRREMEI 72
           +++E    LG+G    V       +    A+KII       +      +++    +E++I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 73  QSSLR-HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
              +  HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE 189
           +   H+ +++HRD+KPEN+LLD +  +K+ DFG+S  +    K   +CGT  YLAPE++E
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 190 NKE------HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSI 241
                    +   VD W+ G++ Y  L G+PPF    Q    R IM  +  F  P     
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 242 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
           S   K L+SR LV    KR + ++ + HP+ 
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 1e-76
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 16/267 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D+E+   +G G +GR   +R       +  K +    + + + Q  L  E+ +   L+HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHP 63

Query: 80  NILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALA 133
           NI+R Y    D  +  +++++EY   G+L   + K  +      E+     +  LT AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 134 YCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAP 185
            CH      + V+HRD+KP N+ LD +  +K+GDFG +       S      GT  Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
           E +    ++   D W+LG L YE     PPF A SQK+   +I +           S E 
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-YRYSDEL 242

Query: 246 KHLISRLLVKDSSKRLSLQKIMEHPWI 272
             +I+R+L      R S+++I+E+P I
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILENPLI 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 2e-75
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 46/297 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E     +  +Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSP 64

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD---------------------------------- 223
           D W++G+   E   G  P      K+                                  
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 224 --------TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                       I+        +   S E +  +++ L+K+ ++R  L+++M H +I
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 4e-75
 Identities = 101/264 (38%), Positives = 152/264 (57%), Gaps = 10/264 (3%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I           E  +  + 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEH 193
              V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
             AVD W LG++ YE + G  PF  +  +  F  I+  ++ FP   ++S EAK L++ LL
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLL 240

Query: 254 VKDSSKRLS-----LQKIMEHPWI 272
            KD  +RL       +++MEH + 
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFF 264

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  227 bits (580), Expect = 8e-74
 Identities = 91/271 (33%), Positives = 149/271 (54%), Gaps = 7/271 (2%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           + E   +    L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K     
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             E  I  ++  P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
            +     Y H   +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT + LAPE
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPE 208

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAK 246
           ++ +K ++ AVD W LG+L YE   G PPF A+     + +I+   + FP     S++ K
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLK 266

Query: 247 HLISRLLVKDSSKRL-----SLQKIMEHPWI 272
            L+  LL  D +KR       +  I  H W 
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 2e-73
 Identities = 82/264 (31%), Positives = 140/264 (53%), Gaps = 11/264 (4%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSL 76
            ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 137 ENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVEN 190
              + H D+KPEN++L        R+KI DFG +  +   ++   + GT +++APE+V  
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL 248
           +      D W++G++ Y  L GA PF  +++++T   +  V+  F      + SA AK  
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250

Query: 249 ISRLLVKDSSKRLSLQKIMEHPWI 272
           I RLLVKD  KR+++Q  ++HPWI
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWI 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 7e-73
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 11/261 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
            +    +G+G F  VY   + E+   VA   +   ++ K + Q + + E E+   L+HPN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQHPN 69

Query: 81  ILRLYGWFHD----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+R Y  +       + I L+ E    G L   L++ +    +   ++   +   L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 137 ENH--VIHRDIKPENLLLDHE-GRLKIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENKE 192
                +IHRD+K +N+ +    G +KIGD G +   R S    + GT +++APEM E K 
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK- 188

Query: 193 HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           +D +VD +  G+   E      P+ E ++    +RR+               E K +I  
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248

Query: 252 LLVKDSSKRLSLQKIMEHPWI 272
            + ++  +R S++ ++ H + 
Sbjct: 249 CIRQNKDERYSIKDLLNHAFF 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  225 bits (574), Expect = 1e-72
 Identities = 78/269 (28%), Positives = 139/269 (51%), Gaps = 15/269 (5%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE---MEIQ 73
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I+  + +     E   + + 
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVE-NK 191
           + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++   
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---FRRIMKVDLSFPSAPSISAEAKHL 248
            +D + D ++LG + ++ L G  PF     KD     R  + + +  P   S S E + L
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSL 239

Query: 249 ISRLLVKDSSKRLSL-----QKIMEHPWI 272
           +  LL +D ++RL       Q++ E P+ 
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  217 bits (553), Expect = 1e-70
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 12/265 (4%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 80  NILRLYGWFHDDE----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG------WSVQSRSKRHTMCGTLDYLAPEMVE 189
           H+N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE   
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKH 247
               D   D ++LG + YE L G PPF  +S      + ++ D   PSA    +SA+   
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247

Query: 248 LISRLLVKDSSKRLSLQKIMEHPWI 272
           ++ + L K+   R      M    +
Sbjct: 248 VVLKALAKNPENRYQTAAEMRADLV 272

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 7e-69
 Identities = 58/280 (20%), Positives = 118/280 (42%), Gaps = 20/280 (7%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W +      +G+ +G G FG VY  +       VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
               RH NIL   G +    ++ ++ ++     LY  L     +F   +           
Sbjct: 58  LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG +          +   + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 187 MVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSI-- 241
           ++  ++   + +  D +  GI+ YE + G  P+   + +D    ++      P    +  
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 242 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 279
                 K L++  L K   +R    +I+    ++  + P+
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-68
 Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 17/274 (6%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSL 76
            +++G  LG G FG VY    V    PVA+K + K++I  +       ++  E+ +   +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 77  R--HPNILRLYGWFHDDERIFLILEYAH-RGELYRELRKHRRFTEQQAATYIASLTNALA 133
                 ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 134 YCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENK 191
           +CH   V+HRDIK EN+L+D   G LK+ DFG     + +      GT  Y  PE +   
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184

Query: 192 E-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
             H  +   W+LGIL Y+ + G  PFE + +      I++  + F     +S+E +HLI 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR--QRVSSECQHLIR 236

Query: 251 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 284
             L    S R + ++I  HPW+     P+ T +I
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 3e-68
 Identities = 76/285 (26%), Positives = 145/285 (50%), Gaps = 27/285 (9%)

Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 56

Query: 72  IQSSL-RHPNILRLYGWFHD----DERIFLILEYAHRGELYRELRKH--RRFTEQQAATY 124
           +     + P+I+R+   + +     + + +++E    GEL+  ++    + FTE++A+  
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL         LK+ DFG++    S +   T C T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM------KVDL 233
             Y+APE++  +++D + D W+LG++ Y  L G PPF +         +       + + 
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
             P    +S E K LI  LL  + ++R+++ + M HPWI+++   
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 5e-68
 Identities = 59/259 (22%), Positives = 115/259 (44%), Gaps = 12/259 (4%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             ++++ ++ + +GKG+FG V L       + VA+K I  +   +         E  + +
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-----AFLAEASVMT 55

Query: 75  SLRHPNILRLYGWFHDDE-RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNA 131
            LRH N+++L G   +++  ++++ EY  +G L   LR   R          +   +  A
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK 191
           + Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  K
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK 175

Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
           +     D W+ GIL +E   +G  P+     KD   R+ K      +          ++ 
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMK 234

Query: 251 RLLVKDSSKRLSLQKIMEH 269
                D++ R S  ++ E 
Sbjct: 235 NCWHLDAAMRPSFLQLREQ 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 7e-66
 Identities = 67/283 (23%), Positives = 107/283 (37%), Gaps = 32/283 (11%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRHP 79
           E    LG+G+F  VY  R+  +   VA+K I      + K  I     RE+++   L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+ L   F     I L+ ++                T      Y+      L Y H++ 
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVEN-KEHDY 195
           ++HRD+KP NLLLD  G LK+ DFG +    S          T  Y APE++   + +  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA----------------- 238
            VD W +G +  E L   P    +S  D   RI +   +                     
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 239 ---------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                     +   +   LI  L + +   R++  + ++  + 
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-64
 Identities = 60/264 (22%), Positives = 99/264 (37%), Gaps = 12/264 (4%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQ 73
             +D  +   LG G FG V              VA+K +  + + + +      RE+   
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
            SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   +
Sbjct: 66  HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPE 186
            Y      IHRD+   NLLL     +KIGDFG              +        + APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 187 MVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEA 245
            ++ +   +A D W  G+  +E   YG  P+   +      +I K     P       + 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244

Query: 246 KHLISRLLVKDSSKRLSLQKIMEH 269
            +++ +        R +   + + 
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 1e-63
 Identities = 97/274 (35%), Positives = 153/274 (55%), Gaps = 18/274 (6%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQI-EKYKIQHQLRREMEI 72
            +++FE+ + LG G +G+V+LVR++         A+K++ K  I +K K     R E ++
Sbjct: 22  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81

Query: 73  QSSLRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
              +R  P ++ L+  F  + ++ LIL+Y + GEL+  L +  RFTE +   Y+  +  A
Sbjct: 82  LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT----MCGTLDYLAPEM 187
           L + H+  +I+RDIK EN+LLD  G + + DFG S +  +         CGT++Y+AP++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

Query: 188 VENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF--PSAPSISA 243
           V   +  HD AVD W+LG+L YE L GA PF  + +K++   I +  L    P    +SA
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261

Query: 244 EAKHLISRLLVKDSSKRLSL-----QKIMEHPWI 272
            AK LI RLL+KD  KRL        +I EH + 
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-63
 Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 12/257 (4%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR    RF  QQ       +  A+ Y   
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT----MCGTLDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T        + +  PE++   + 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL 252
               D W  G+L +E    G  P+E  +  +T   I +  L        S +   ++   
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSC 237

Query: 253 LVKDSSKRLSLQKIMEH 269
             + + +R + + ++ +
Sbjct: 238 WHEKADERPTFKILLSN 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  197 bits (502), Expect = 9e-63
 Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 23/285 (8%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQL 66
               +E  +   +I + +G G+FG V         + +  VA+K +     EK +     
Sbjct: 17  REFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDF 74

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYI 125
             E  I     HPN++ L G       + +I E+   G L     +   +FT  Q    +
Sbjct: 75  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------SRSKRHTMC 177
             +   + Y  + + +HRD+   N+L++     K+ DFG S          + +      
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFP 236
             + + APE ++ ++   A D W+ GI+ +E + YG  P+   + +D    I + D   P
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLP 253

Query: 237 SAPSISAEAKHLISRLLVKDSSKRLS-------LQKIMEHPWIIK 274
                 +    L+     KD + R         L K++ +P  +K
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 1e-62
 Identities = 66/308 (21%), Positives = 116/308 (37%), Gaps = 47/308 (15%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            +  +E    +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLL 66

Query: 77  RHPNILRLYGWFHDDE--------RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           +H N++ L                 I+L+ ++              +FT  +    +  L
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-------HTMCGTLD 181
            N L Y H N ++HRD+K  N+L+  +G LK+ DFG +      +            TL 
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 182 YLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP---- 236
           Y  PE++   +++   +D W  G +  E    +P  +  +++     I ++  S      
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 237 --------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
                                      A      A  LI +LLV D ++R+     + H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 271 WIIKNANP 278
           +   +  P
Sbjct: 307 FFWSDPMP 314

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 2e-62
 Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 37/299 (12%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----PVALKIIFKEQIEKY 60
            E E + K E+  ++ E G+ LG G FG+V                VA+K++ ++     
Sbjct: 24  REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83

Query: 61  KIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---- 115
           +    L  E+++ + L  H NI+ L G       I+LI EY   G+L   LR  R     
Sbjct: 84  R--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141

Query: 116 -------------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG 156
                               T +    +   +   + +      +HRD+   N+L+ H  
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201

Query: 157 RLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL- 210
            +KI DFG +       +   R      + ++APE +    +    D W+ GIL +E   
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261

Query: 211 YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
            G  P+        F ++++           + E   ++      DS KR S   +   
Sbjct: 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 3e-62
 Identities = 75/293 (25%), Positives = 133/293 (45%), Gaps = 33/293 (11%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I  +   +  +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELN 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HPNI++L    H + +++L+ E+ H+  + + +             +Y+  L   LA+CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV-ENKE 192
            + V+HRD+KP+NLL++ EG +K+ DFG +               TL Y APE++   K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA-------------- 238
           +  AVD W+LG +  E +     F  +S+ D   RI +   +                  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 239 -------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P +  + + L+S++L  D +KR+S +  + HP+      P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  195 bits (497), Expect = 4e-62
 Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 33/286 (11%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +     +G+G +G VY  +        ALK I  E+ ++  I     RE+ I   L+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELK 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H NI++LY   H  +R+ L+ E+  +                 A +++  L N +AYCH+
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAPEMVENKE-H 193
             V+HRD+KP+NLL++ EG LKI DFG +        K      TL Y AP+++   + +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--------------- 238
              +D W++G +  E + G P F   S+ D   RI ++  +  S                
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 239 ------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                         +      L+S++L  D ++R++ ++ +EH + 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-61
 Identities = 73/302 (24%), Positives = 134/302 (44%), Gaps = 40/302 (13%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           R++  K  W ++  +   +P+G G +G V    +  +   VA+K +++    +     + 
Sbjct: 6   RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRA 64

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDER------IFLILEYAHRGELYRELRKHRRFTEQQ 120
            RE+ +   +RH N++ L   F  DE        +L++ +   G    +L KH +  E +
Sbjct: 65  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDR 122

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL 180
               +  +   L Y H   +IHRD+KP NL ++ +  LKI DFG + Q+ S+      T 
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182

Query: 181 DYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA- 238
            Y APE++ N   +   VD W++G +  E + G   F+     D  + IMKV  + P+  
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242

Query: 239 ----------------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 270
                                        + S  A +L+ ++LV D+ +R++  + + HP
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302

Query: 271 WI 272
           + 
Sbjct: 303 YF 304

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-61
 Identities = 63/292 (21%), Positives = 120/292 (41%), Gaps = 36/292 (12%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVES-KHPVALKIIFKEQIEKYKIQHQLR--REMEIQ 73
           + Q +E    +G+G +G+V+  R++++    VALK +  +  E+      +R    +   
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 74  SSLRHPNILRLYGWFHDDE-----RIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIAS 127
            +  HPN++RL+            ++ L+ E+  +    Y +         +     +  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
           L   L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y AP
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA------- 238
           E++    +   VD W++G +  E     P F   S  D   +I+ V              
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 239 ------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                               I    K L+ + L  + +KR+S    + HP+ 
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 5e-61
 Identities = 57/271 (21%), Positives = 110/271 (40%), Gaps = 19/271 (7%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++  +L+D    + LG G FG V     +  +    VA+KI+  E  +   ++ +L  E 
Sbjct: 5   RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEA 59

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            +   L +P I+R+ G    +    L++E A  G L + L+++R   ++     +  ++ 
Sbjct: 60  NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLA 184
            + Y  E++ +HRD+   N+LL  +   KI DFG S            +      + + A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           PE +   +     D W+ G+L +E   YG  P+      +    + K             
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPR 237

Query: 244 EAKHLISRLLVKDSSKRLSLQKI---MEHPW 271
           E   L++     D   R     +   + + +
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 8e-61
 Identities = 52/271 (19%), Positives = 105/271 (38%), Gaps = 18/271 (6%)

Query: 13  KREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W    +   +   LG+G FG V++     +   VA+K +    +          +E 
Sbjct: 9   KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEA 63

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL--YRELRKHRRFTEQQAATYIASL 128
           ++   LRH  +++LY    ++  I+++ EY  +G L  + +    +     Q     A +
Sbjct: 64  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLA 184
            + +AY    + +HRD++  N+L+      K+ DFG +        + R      + + A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           PE           D W+ GIL  E    G  P+     ++   ++ +     P  P    
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPE 241

Query: 244 EAKHLISRLLVKDSSKRLSLQKIME--HPWI 272
               L+ +   K+  +R + + +      + 
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 8e-61
 Identities = 54/256 (21%), Positives = 100/256 (39%), Gaps = 12/256 (4%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +    + +G G+FG V+L     +K  VA+K I +  + +         E E+   L HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYR-ELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            +++LYG   +   I L+ E+   G L      +   F  +        +   +AY  E 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM----CGTLDYLAPEMVENKEHD 194
            VIHRD+   N L+     +K+ DFG +      ++T        + + +PE+     + 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL 253
              D W+ G+L +E    G  P+E  S  +    I             S     +++   
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHCW 239

Query: 254 VKDSSKRLSLQKIMEH 269
            +    R +  +++  
Sbjct: 240 KERPEDRPAFSRLLRQ 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-60
 Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 16/265 (6%)

Query: 13  KREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           + EW    +  ++   LG G+FG V++         VA+K + +  +           E 
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEA 59

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASL 128
            +   L+H  ++RLY     +  I++I EY   G L   L+     + T  +     A +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLA 184
              +A+  E + IHRD++  N+L+      KI DFG +        + R      + + A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA 243
           PE +         D W+ GIL  E + +G  P+   +  +  + + +         +   
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPE 237

Query: 244 EAKHLISRLLVKDSSKRLSLQKIME 268
           E   L+     +    R +   +  
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRS 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (483), Expect = 6e-60
 Identities = 53/260 (20%), Positives = 102/260 (39%), Gaps = 10/260 (3%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E    D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +  
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMK 68

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNAL 132
            ++HPN+++L G    +   ++I E+   G L   LR+  R   +          +++A+
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPEMV 188
            Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHL 248
              +     D W  G+L +E                   +++ D           +   L
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248

Query: 249 ISRLLVKDSSKRLSLQKIME 268
           +      + S R S  +I +
Sbjct: 249 MRACWQWNPSDRPSFAEIHQ 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 7e-60
 Identities = 65/299 (21%), Positives = 122/299 (40%), Gaps = 45/299 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +     +G+G +G V    +  +K  VA+K I   + + Y    +  RE++I    RH N
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFRHEN 67

Query: 81  ILRLYGWFHDD-----ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           I+ +            + ++L+      G    +L K +  +      ++  +   L Y 
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------HTMCGTLDYLAPEMVE 189
           H  +V+HRD+KP NLLL+    LKI DFG +  +               T  Y APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 190 NKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA---------- 238
           N +    ++D W++G +  E L   P F  +   D    I+ +  S              
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 239 -------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                              P+  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 1e-59
 Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 21/273 (7%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
              D +    +G+G FG+V   R  +    +   I   ++            E+E+   L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 77  -RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQ 119
             HPNI+ L G       ++L +EYA  G L   LRK                    + Q
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC 177
           Q   + A +   + Y  +   IHRD+   N+L+      KI DFG S   +   K+    
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFP 236
             + ++A E +    +    D W+ G+L +E +  G  P+   +  + + ++ +      
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLE 246

Query: 237 SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
              +   E   L+ +   +   +R S  +I+  
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-59
 Identities = 65/293 (22%), Positives = 128/293 (43%), Gaps = 33/293 (11%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  ++  +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H NI+RL+   H D+++ L+ E+  +         +     +   +++  L   L +CH 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVEN-KEH 193
            +V+HRD+KP+NLL++  G LK+ +FG +               TL Y  P+++   K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 194 DYAVDNWTLGILCYEFLYG-APPFEAESQKDTFRRIMKVDLSFPS--------------- 237
             ++D W+ G +  E      P F      D  +RI ++  +                  
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 238 ------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
                        P ++A  + L+  LL  +  +R+S ++ ++HP+      P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-59
 Identities = 66/306 (21%), Positives = 125/306 (40%), Gaps = 36/306 (11%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           R++  K  W + + ++   P+G G +G V    + ++   VA+K + +        + + 
Sbjct: 6   RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RT 64

Query: 67  RREMEIQSSLRHPNILRLYGWFHDD----ERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
            RE+ +   ++H N++ L   F       E   + L     G     + K ++ T+    
Sbjct: 65  YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY 182
             I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +      T  Y
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY 184

Query: 183 LAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--- 238
            APE M+    ++  VD W++G +  E L G   F      D  + I+++  +  +    
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 239 --------------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 272
                                        +  A  L+ ++LV DS KR++  + + H + 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

Query: 273 IKNANP 278
            +  +P
Sbjct: 305 AQYHDP 310

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-59
 Identities = 78/299 (26%), Positives = 124/299 (41%), Gaps = 47/299 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +   + +G G FG VY  +  +S   VA+K + +++  K        RE++I   L H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHC 73

Query: 80  NILRLYGWFH------DDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTN 130
           NI+RL  +F+      D+  + L+L+Y             R  +         Y+  L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP-E 186
           +LAY H   + HRDIKP+NLLLD +   LK+ DFG +  +       +   +  Y AP  
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV--------------- 231
           +    ++  ++D W+ G +  E L G P F  +S  D    I+KV               
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 232 --DLSFPS----------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 278
             +  FP            P    EA  L SRLL    + RL+  +   H +  +  +P
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 5e-58
 Identities = 45/268 (16%), Positives = 103/268 (38%), Gaps = 9/268 (3%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           +P++ RL G         +         L            Q    +   +   + Y  +
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPEMVENKE 192
             ++HRD+   N+L+     +KI DFG +      +           + ++A E + ++ 
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR 251
           + +  D W+ G+  +E + +G+ P++     +    + K     P  P  + +   ++ +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTIDVYMIMVK 248

Query: 252 LLVKDSSKRLSLQKIMEHPWIIKNANPR 279
             + D+  R   ++++     +     R
Sbjct: 249 CWMIDADSRPKFRELIIEFSKMARDPQR 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-57
 Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 21/274 (7%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           ++    + D E+G     G FG V     R  + +  VA+K++ +   +      ++ RE
Sbjct: 6   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMRE 59

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASL 128
            +I   L +P I+RL G    +  + L++E A  G L++ L   R        A  +  +
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ------SRSKRHTMCGTLDY 182
           +  + Y  E + +HRD+   N+LL +    KI DFG S          + R      L +
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSI 241
            APE +  ++     D W+ G+  +E L YG  P++     +    I +        P  
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPEC 237

Query: 242 SAEAKHLISRLLVKDSSKRLS---LQKIMEHPWI 272
             E   L+S   +     R     +++ M   + 
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-57
 Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 32/288 (11%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V         + ++   VA+K++        +    
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EA 72

Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---------- 114
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R          
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 115 --------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                       +   ++   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 167 VQSRSKRHTM-----CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E    G+ P+    
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
               F +++K      S     AE   ++      D  KR + ++I++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 7e-57
 Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 9/262 (3%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E    
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYR-ELRKHRRFTEQQAATYIASLTNAL 132
               HP+I++L G   ++  +++I+E    GEL      +           Y   L+ AL
Sbjct: 63  RQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMV 188
           AY      +HRDI   N+L+     +K+GDFG S      +  K       + ++APE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
             +    A D W  G+  +E L +G  PF+     D   RI   +   P  P+       
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYS 240

Query: 248 LISRLLVKDSSKRLSLQKIMEH 269
           L+++    D S+R    ++   
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-55
 Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 20/270 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVES----KHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
                 + +G G+FG VY      S    + PVA+K +     EK ++      E  I  
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMG 64

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALA 133
              H NI+RL G     + + +I EY   G        K   F+  Q    +  +   + 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEM 187
           Y    + +HRD+   N+L++     K+ DFG S       ++          + + APE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH 247
           +  ++   A D W+ GI+ +E +        E       + +      P+     +    
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 248 LISRLLVKDSSKRLS-------LQKIMEHP 270
           L+ +   ++ ++R         L K++  P
Sbjct: 245 LMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  179 bits (455), Expect = 3e-55
 Identities = 72/306 (23%), Positives = 137/306 (44%), Gaps = 53/306 (17%)

Query: 10  DNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++   EW  QD +++ R LG+GK+  V+    + +   V +KI+   + +      +++R
Sbjct: 25  ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK------KIKR 78

Query: 69  EMEIQSSLR-HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           E++I  +LR  PNI+ L     D       L+ E+ +  +     + ++  T+     Y+
Sbjct: 79  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK---QLYQTLTDYDIRFYM 135

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDY 182
             +  AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +
Sbjct: 136 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195

Query: 183 LAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKV--------- 231
             PE++ + + +DY++D W+LG +    ++   PF       D   RI KV         
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255

Query: 232 --------------------------DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQK 265
                                      +   +   +S EA   + +LL  D   RL+ ++
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

Query: 266 IMEHPW 271
            MEHP+
Sbjct: 316 AMEHPY 321

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (452), Expect = 3e-55
 Identities = 49/286 (17%), Positives = 103/286 (36%), Gaps = 28/286 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +GR +G G FG +YL  ++ +   VA+K+   +         QL  E +I   ++   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63

Query: 81  ILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            +    W   + +   +++E              R+F+ +        + + + Y H  +
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 140 VIHRDIKPENLL---LDHEGRLKIGDFGWSVQSRS----------KRHTMCGTLDYLAPE 186
            IHRD+KP+N L         + I DFG + + R           +   + GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP------S 240
                E     D  +LG +   F  G+ P++        ++  ++     S P       
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 241 ISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKNANPRGTCD 283
             +E    ++         +     L+++  + +  +  +     D
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (447), Expect = 2e-54
 Identities = 60/291 (20%), Positives = 108/291 (37%), Gaps = 38/291 (13%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLR 67
             E+   + E  R +G+G FGRV+  R       E    VA+K++ +E      +Q   +
Sbjct: 7   SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQ 64

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR------------ 115
           RE  + +   +PNI++L G     + + L+ EY   G+L   LR                
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 116 ------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
                        +  +       +   +AY  E   +HRD+   N L+     +KI DF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184

Query: 164 GWSVQSRSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFE 217
           G S    S  +          + ++ PE +    +    D W  G++ +E   YG  P+ 
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244

Query: 218 AESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
             + ++    +   ++      +   E  +L+     K  + R S   I  
Sbjct: 245 GMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-53
 Identities = 61/289 (21%), Positives = 122/289 (42%), Gaps = 33/289 (11%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-------PVALKIIFKEQIEKYKIQ 63
           + + E       +G+PLG+G FG+V L   +            VA+K++  +  EK    
Sbjct: 5   DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--L 62

Query: 64  HQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-------- 114
             L  EME+   + +H NI+ L G    D  +++I+EYA +G L   L+  R        
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122

Query: 115 --------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                   + + +   +    +   + Y      IHRD+   N+L+  +  +KI DFG +
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 167 -----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAES 220
                +    K       + ++APE + ++ + +  D W+ G+L +E    G  P+    
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 221 QKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
            ++ F+ + +         + + E   ++        S+R + ++++E 
Sbjct: 243 VEELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 8e-52
 Identities = 56/278 (20%), Positives = 109/278 (39%), Gaps = 26/278 (9%)

Query: 15  EW--SLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  + +   + R LG+G FG VY        + E +  VA+K + +    + +I+    
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 71

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRF----------T 117
            E  +       +++RL G     +   +I+E   RG+L   LR  R            +
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-----SVQSRSK 172
             +       + + +AY + N  +HRD+   N ++  +  +KIGDFG            K
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKV 231
                  + +++PE +++       D W+ G++ +E       P++  S +   R +M+ 
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251

Query: 232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
            L      +       L+      +   R S  +I+  
Sbjct: 252 GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  169 bits (429), Expect = 8e-52
 Identities = 47/270 (17%), Positives = 93/270 (34%), Gaps = 27/270 (10%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-P 79
           +++GR +G+G FG ++    + +   VA+K   +          QLR E      L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCT 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I  +Y +  +     L+++              R+F+ +  A     +   +   HE  
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 140 VIHRDIKPENLLLD-----HEGRLKIGDFGWSVQSRS----------KRHTMCGTLDYLA 184
           +++RDIKP+N L+      +   + + DFG     R           ++  + GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAP----- 239
                 +E     D   LG +   FL G+ P++        ++  ++     S P     
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 240 -SISAEAKHLISRLLVKDSSKRLSLQKIME 268
                E    +                +  
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-52
 Identities = 57/309 (18%), Positives = 120/309 (38%), Gaps = 52/309 (16%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L+ ++  +P+G G  G V    +      VA+K + +    +     +  RE+ +   + 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVN 74

Query: 78  HPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           H NI+ L   F       + + ++L++E                   ++ +  +  +   
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCG 131

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE 189
           + + H   +IHRD+KP N+++  +  LKI DFG +    +         T  Y APE++ 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP------------- 236
              +   VD W++G +  E +     F      D + ++++   +               
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 237 ---------------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
                                           +++A+ L+S++LV D +KR+S+   ++H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 270 PWIIKNANP 278
           P+I    +P
Sbjct: 312 PYINVWYDP 320

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 7e-50
 Identities = 48/259 (18%), Positives = 98/259 (37%), Gaps = 16/259 (6%)

Query: 24  GRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
              +G+G FG VY    +++       A+K + +  I       Q   E  I     HPN
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 81  ILRLYG-WFHDDERIFLILEYAHRGELYR-ELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           +L L G     +    ++L Y   G+L      +    T +    +   +   + +    
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS-------VQSRSKRHTMCGTLDYLAPEMVENK 191
             +HRD+   N +LD +  +K+ DFG +         S   +      + ++A E ++ +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS 250
           +     D W+ G+L +E +  GAPP+   +  D    +++                 ++ 
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVML 268

Query: 251 RLLVKDSSKRLSLQKIMEH 269
           +     +  R S  +++  
Sbjct: 269 KCWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-49
 Identities = 58/288 (20%), Positives = 112/288 (38%), Gaps = 29/288 (10%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V         +  +   VA+K++ +      + + 
Sbjct: 4   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRA 62

Query: 65  QLRREMEIQSSLRHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR-------- 115
            +     +     H N++ L G        + +I+E+   G L   LR  R         
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 116 --------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS- 166
                    T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG + 
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182

Query: 167 ----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQ 221
                    ++      L ++APE + ++ +    D W+ G+L +E     A P+     
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 222 KDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH 269
            + F R +K      +    + E    +      + S+R +  +++EH
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-46
 Identities = 51/293 (17%), Positives = 104/293 (35%), Gaps = 50/293 (17%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
              +   +GKG+FG V+  +       VA+KI    +   +  +     E+     LRH 
Sbjct: 4   TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE----AEIYQTVMLRHE 57

Query: 80  NILRLYGWFHDDE----RIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASL 128
           NIL      + D     +++L+ +Y   G L+  L ++        +     A+      
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-------CGTLD 181
              +    +  + HRD+K +N+L+   G   I D G +V+  S   T+        GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 182 YLAPEMVENKEH------DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM------ 229
           Y+APE++++  +          D + +G++ +E                    +      
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 230 -----------KVDLSFP---SAPSISAEAKHLISRLLVKDSSKRLSLQKIME 268
                      K+  + P    +         ++      + + RL+  +I +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (369), Expect = 3e-42
 Identities = 59/317 (18%), Positives = 110/317 (34%), Gaps = 65/317 (20%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ------- 73
           + + R LG G F  V+L +++ +   VA+KI+  +++     + +++    +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 74  SSLRHPNILRLYGWFHDDERIFLIL-----EYAHRGELYRELRKHRRFTEQQAATYIASL 128
            S+   +IL+L   F+      + +               +  +HR             L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 129 TNALAYCHENH-VIHRDIKPENLLLDHEG------RLKIGDFGWSVQSRSKRHTMCGTLD 181
              L Y H    +IH DIKPEN+L++         ++KI D G +            T +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK------DTFRRIMKVDLSF 235
           Y +PE++         D W+   L +E + G   FE +         D   +I+++    
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 236 PS----------------------------------------APSISAEAKHLISRLLVK 255
           PS                                        +   + E    +S +L  
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 256 DSSKRLSLQKIMEHPWI 272
           D  KR     ++ HPW+
Sbjct: 315 DPRKRADAGGLVNHPWL 331

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.2 bits (223), Expect = 1e-22
 Identities = 28/193 (14%), Positives = 61/193 (31%), Gaps = 20/193 (10%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQS 74
            IG+ +G+GK   V+     E      +K          K++ +               +
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 75  SLRHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
                 + +L G      +  E   +++E            +  R   +     +  +  
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILE 114

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
            +A  +   ++H D+   N+L+  EG + I DF  SV+   +        D        +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 191 KEHDYAVDNWTLG 203
           + +    D  +  
Sbjct: 174 RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	284
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.66
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.41
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.48
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.11

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-65  Score=418.75  Aligned_cols=260  Identities=62%  Similarity=1.122  Sum_probs=239.6

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ++|++.+|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+++++.++||||+++++++.+++.
T Consensus         1 r~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   80 (263)
T d2j4za1           1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   80 (263)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence            47889999999999999999999999999999999999977665555556788899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-C
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-K  172 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~  172 (284)
                      .|+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..... .
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            999999999999999999989999999999999999999999999999999999999999999999999999865433 3


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHh
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRL  252 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (284)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+  +.+|+++++||.+|
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~  238 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRL  238 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--ccCCHHHHHHHHHH
Confidence            3455789999999999999999999999999999999999999999999999988887765444  47999999999999


Q ss_pred             cccCCCCCCCHHhhhcCcccccc
Q 023270          253 LVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       253 l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      |.+||.+|||++|+|+||||+.+
T Consensus       239 L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         239 LKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             TCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ccCCHhHCcCHHHHHcCcCcCCc
Confidence            99999999999999999999865

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-62  Score=405.02  Aligned_cols=261  Identities=35%  Similarity=0.635  Sum_probs=235.2

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      +.+.+..+|++.+.||+|+||+||+|.+..+++.||||++...........+.+.+|++++++++||||+++++++.+++
T Consensus         2 P~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            34556789999999999999999999999999999999997766555455678899999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC-
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-  171 (284)
                      .+|+||||+++|+|.+++...+.+++..++.++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..... 
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999854321 


Q ss_pred             ----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 023270          172 ----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKH  247 (284)
Q Consensus       172 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (284)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++......++  ..+++++++
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~  239 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKARD  239 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--TTCCHHHHH
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC--ccCCHHHHH
Confidence                22345689999999999999999999999999999999999999999999999999888765544  479999999


Q ss_pred             HHHHhcccCCCCCCCHHh------hhcCcccccc
Q 023270          248 LISRLLVKDSSKRLSLQK------IMEHPWIIKN  275 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~------il~~~~~~~~  275 (284)
                      ||++||+.||++|||++|      +++||||+.-
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999999998      5889999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-61  Score=406.73  Aligned_cols=258  Identities=40%  Similarity=0.729  Sum_probs=240.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      |++++|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            57899999999999999999999999999999999997766555555678889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCcc
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  175 (284)
                      +||||+++++|..++.....++...++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++.........
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~  160 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  160 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999877777777


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      ..|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+..+....  ++.+++++.+++.+||..
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~  238 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVKDLLSRLITR  238 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCS
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhh
Confidence            889999999999999999999999999999999999999999999999999988876544  347999999999999999


Q ss_pred             CCCCCC-----CHHhhhcCcccccc
Q 023270          256 DSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       256 ~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      ||.+|+     |++++++||||++-
T Consensus       239 dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         239 DLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CHHhccccchhhHHHHHcCcccccC
Confidence            999996     99999999999863

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-62  Score=403.06  Aligned_cols=261  Identities=30%  Similarity=0.562  Sum_probs=223.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      ..+|++++.||+|+||+||+|.+..+++.||||++......  ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            46899999999999999999999999999999998654322  2345788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-----CC
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----SK  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-----~~  172 (284)
                      ||||++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....     ..
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999985432     12


Q ss_pred             CccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                      .....||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...... ..................+++++.+||+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            244579999999999988876 57899999999999999999999776543 3334444444444444578999999999


Q ss_pred             HhcccCCCCCCCHHhhhcCccccccCCCCCC
Q 023270          251 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  281 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (284)
                      +||+.||++|||++|+|+||||++. .++|+
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~-l~kg~  271 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKP-LKKGA  271 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCC-CCCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcC-CCCCC
Confidence            9999999999999999999999864 55553

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-61  Score=400.56  Aligned_cols=253  Identities=29%  Similarity=0.484  Sum_probs=226.4

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.......   .+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            47999999999999999999999999999999986554332   356889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCCcc
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~~~  175 (284)
                      |||++++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.+|++||+|||++....   .....
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999987765 569999999999999999999999999999999999999999999999999986532   23345


Q ss_pred             ccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHhcc
Q 023270          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKV-DLSFPSAPSISAEAKHLISRLLV  254 (284)
Q Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~  254 (284)
                      ..||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+...... ......++.+++++++||.+||.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            56999999999999999999999999999999999999999998887777666554 33445556789999999999999


Q ss_pred             cCCCCCCCHHhhhcCcccccc
Q 023270          255 KDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       255 ~~p~~Rps~~~il~~~~~~~~  275 (284)
                      +||++|||++|+|+||||+..
T Consensus       256 ~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         256 MDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGC
T ss_pred             CChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999865

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-61  Score=404.79  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=233.6

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|++++.||+|+||+||+|.+..+++.||||++...........+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            39999999999999999999999999999999876655555556788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCCccccCC
Q 023270          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT  179 (284)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  179 (284)
                      ||++++|..++...+++++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..... .....||
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~~~GT  174 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANSFVGT  174 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCCCCSC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-CCccccC
Confidence            999999988888888999999999999999999999999999999999999999999999999999865443 3456799


Q ss_pred             CcccCccccCC---CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 023270          180 LDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKD  256 (284)
Q Consensus       180 ~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (284)
                      +.|+|||++.+   ..++.++||||||+++|+|++|..||.+.+..+.+..+............+|+++.+||.+||+.|
T Consensus       175 ~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d  254 (309)
T d1u5ra_         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI  254 (309)
T ss_dssp             GGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSS
T ss_pred             ccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCC
Confidence            99999999864   458899999999999999999999999999988888888877666666679999999999999999


Q ss_pred             CCCCCCHHhhhcCccccccCC
Q 023270          257 SSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       257 p~~Rps~~~il~~~~~~~~~~  277 (284)
                      |.+|||++++|+||||++...
T Consensus       255 P~~Rpt~~ell~Hp~~~~~~~  275 (309)
T d1u5ra_         255 PQDRPTSEVLLKHRFVLRERP  275 (309)
T ss_dssp             GGGSCCHHHHTTCHHHHSCCC
T ss_pred             hhHCcCHHHHHhCHHhcCCCC
Confidence            999999999999999987643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-61  Score=404.99  Aligned_cols=259  Identities=38%  Similarity=0.644  Sum_probs=238.1

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      ++.+++|++++.||.|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+
T Consensus         1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            46789999999999999999999999999999999999876655545567788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---C
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---S  171 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~  171 (284)
                      |+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++....   .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986533   2


Q ss_pred             CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      ......||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..++...+......++  ..+|+++++||++
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~dli~~  238 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC--ccCCHHHHHHHHh
Confidence            33456789999999999999999999999999999999999999999999999999988776554  4799999999999


Q ss_pred             hcccCCCCCCC-----HHhhhcCcccccc
Q 023270          252 LLVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      ||++||.+|++     ++++++||||++.
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             hccCCchhhcccccccHHHHHcCcccccC
Confidence            99999999995     8999999999763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-60  Score=403.61  Aligned_cols=260  Identities=35%  Similarity=0.639  Sum_probs=240.4

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCe
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~   93 (284)
                      ....+.+|++++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+++++.++||||+++++++...+.
T Consensus        36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  115 (350)
T d1rdqe_          36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence            34557899999999999999999999999999999999977665554556778899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  173 (284)
                      .++|+|++.+++|...+...+.+++..++.++.||+.||.|||++||+|+||||+|||++.+|++||+|||++.......
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998777777


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ....|++.|+|||++.+..++.++|||||||++|+|+||..||.+.+....+..+.......+  ..+++++.+||++||
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTCCHHHHHHHHHHS
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC--ccCCHHHHHHHHHHh
Confidence            777899999999999999999999999999999999999999999999999999888765544  479999999999999


Q ss_pred             ccCCCCCC-----CHHhhhcCcccccc
Q 023270          254 VKDSSKRL-----SLQKIMEHPWIIKN  275 (284)
Q Consensus       254 ~~~p~~Rp-----s~~~il~~~~~~~~  275 (284)
                      ..||.+|+     |++++++||||+..
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhCHHhccccccccHHHHHcCccccCC
Confidence            99999994     99999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-60  Score=399.61  Aligned_cols=255  Identities=33%  Similarity=0.629  Sum_probs=216.2

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~   98 (284)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.......  ....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45999999999999999999999999999999997654433  2356789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec---CCCCEEEeecccccccCC--CC
Q 023270           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRS--KR  173 (284)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~--~~  173 (284)
                      |||++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||||+||++.   .++.+||+|||++.....  ..
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999999988999999999999999999999999999999999999995   478999999999864432  23


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHH
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLISR  251 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  251 (284)
                      ....||+.|+|||++.+..+++++|||||||++|+|++|..||.+.+..+....+.......+.  .+.+|+++.+||.+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            4557999999999999999999999999999999999999999999999999988887655443  35789999999999


Q ss_pred             hcccCCCCCCCHHhhhcCcccccc
Q 023270          252 LLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ||..||.+|||++|+++||||++.
T Consensus       247 ~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-60  Score=388.17  Aligned_cols=251  Identities=24%  Similarity=0.451  Sum_probs=218.3

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec----CCeEEE
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----DERIFL   96 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~----~~~~~~   96 (284)
                      |++.++||+|+||+||+|.+..++..||+|++....... ...+.+.+|++++++++||||+++++++..    +..+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            478889999999999999999999999999987655433 235678899999999999999999999864    457899


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEec-CCCCEEEeecccccccCC-C
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRS-K  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~g--i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~-~  172 (284)
                      ||||+++++|.+++.+...+++..++.++.||+.||.|||++|  |+|+||||+|||++ .++.+||+|||++..... .
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~  169 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  169 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence            9999999999999999889999999999999999999999999  99999999999996 578999999999965433 3


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFRRIMKVDLSFPSAPSISAEAKHLISR  251 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (284)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ..+...+..+......+...++++.+||.+
T Consensus       170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  248 (270)
T d1t4ha_         170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG  248 (270)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred             cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence            345679999999999865 599999999999999999999999976554 445555555544444445688999999999


Q ss_pred             hcccCCCCCCCHHhhhcCcccc
Q 023270          252 LLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       252 ~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      ||.+||++|||++|+|+|||||
T Consensus       249 ~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         249 CIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999997

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-60  Score=391.08  Aligned_cols=253  Identities=30%  Similarity=0.507  Sum_probs=215.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec--CCeEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERIF   95 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~--~~~~~   95 (284)
                      ..+|++++.||+|+||+||+|++..+|+.||+|++....... ...+.+.+|++++++++||||+++++++.+  ++.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            568999999999999999999999999999999987655443 335678899999999999999999998864  45789


Q ss_pred             EEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCCeEecCCCCEEEeecccc
Q 023270           96 LILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENH-----VIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~lh~~g-----i~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      +|||||++|+|.+++..    .+.+++..++.++.|++.||.|||+.|     |+|+||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999999864    357999999999999999999999876     999999999999999999999999998


Q ss_pred             cccCC---CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          167 VQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       167 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      .....   ......||+.|+|||++.+..++.++||||||+++|+|+||..||...+..++...+..+... ..+..+|+
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~  240 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSD  240 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCH
Confidence            55332   223457899999999999999999999999999999999999999999999888888776544 34457999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcCccc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEHPWI  272 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~~~~  272 (284)
                      ++.+|+++||..||.+|||++|+|+|||+
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.6e-60  Score=401.86  Aligned_cols=260  Identities=32%  Similarity=0.631  Sum_probs=232.4

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      ..+.+|++.+.||+|+||+||+|.+..+|+.||||++......   ..+.+.+|+.++++++||||+++++++.+++.+|
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4567999999999999999999999999999999998665433   2467889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC--CCCEEEeecccccccCCC
Q 023270           96 LILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~  172 (284)
                      +|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||+|||++.  ++.+||+|||++......
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999999999854 467999999999999999999999999999999999999964  578999999998654433


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCCHHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHL  248 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l  248 (284)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++..  +.+|+++++|
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence              234678999999999999999999999999999999999999999999999999988876554432  4689999999


Q ss_pred             HHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          249 ISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      |.+||..||++|||++|+|+||||++...+
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            999999999999999999999999987554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=394.90  Aligned_cols=253  Identities=29%  Similarity=0.508  Sum_probs=224.0

Q ss_pred             CcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEe
Q 023270           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (284)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e   99 (284)
                      .|++++.||+|+||+||+|.+..++..||+|++......   ..+.+.+|++++++++||||+++++++.+++.+++|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            489999999999999999999999999999998654322   24577899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCcc
Q 023270          100 YAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (284)
Q Consensus       100 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~  175 (284)
                      ||++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....   ....
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            9999999998765 46799999999999999999999999999999999999999999999999999854322   2235


Q ss_pred             ccCCCcccCccccC-----CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCCCCCHHHHHHH
Q 023270          176 MCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS-FPSAPSISAEAKHLI  249 (284)
Q Consensus       176 ~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  249 (284)
                      ..|++.|+|||++.     +..++.++|||||||++|+|+||..||.+.+..+.+.++...... ...+..+|+++.+||
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  249 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL  249 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            67899999999984     455789999999999999999999999999888888888776433 333457899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCcccccc
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                      ++||+.||++|||++|+|+||||+..
T Consensus       250 ~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-61  Score=403.68  Aligned_cols=261  Identities=28%  Similarity=0.448  Sum_probs=222.0

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeE
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~   94 (284)
                      +++-++|++++.||+|+||+||+|.+..+++.||+|++......  ...+.+.+|+.++++++||||+++++++.+++.+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            56778999999999999999999999999999999998654222  2346788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCCEEEeecccccccC-CC
Q 023270           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SK  172 (284)
Q Consensus        95 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-~~  172 (284)
                      |+||||+++++|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||++.... ..
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            9999999999999999998899999999999999999999997 599999999999999999999999999985432 23


Q ss_pred             CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHH----------------------------
Q 023270          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------------  224 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~----------------------------  224 (284)
                      .....||+.|+|||++.+..++.++||||+||++++|++|..||.+.+..+.                            
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            3456899999999999999999999999999999999999999976543321                            


Q ss_pred             --------------HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          225 --------------FRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       225 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                                    ................++.++.+||.+||..||++|||++|+|+||||++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                          11111111111112346889999999999999999999999999999998643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-60  Score=393.89  Aligned_cols=258  Identities=32%  Similarity=0.584  Sum_probs=229.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH---HHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++.......   ....+.+.+|++++++++||||+++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46999999999999999999999999999999986543321   112467889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC----CEEEeecccccccC-
Q 023270           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSR-  170 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~-  170 (284)
                      +|||||++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++    .+|++|||++.... 
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999988999999999999999999999999999999999999998776    59999999985543 


Q ss_pred             -CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHH
Q 023270          171 -SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKH  247 (284)
Q Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  247 (284)
                       .......+++.|+|||++.+..++.++||||+|+++|+|++|..||.+.+..+.+..+......++.  .+.+|+++++
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  249 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence             3334567899999999999999999999999999999999999999999999999988887655443  2478999999


Q ss_pred             HHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          248 LISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ||++||+.||.+|||++++|+||||++.+
T Consensus       250 li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         250 FIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.2e-59  Score=398.46  Aligned_cols=258  Identities=29%  Similarity=0.547  Sum_probs=230.9

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .+.+|++++.||+|+||+||+|.+..+++.||||++.......   ...+.+|+.++++++||||+++++++.+++.+|+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3567999999999999999999999999999999986644332   3567899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEec--CCCCEEEeecccccccCCC-
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~--~~~~~~l~d~~~~~~~~~~-  172 (284)
                      |||||++++|.+.+... .++++.+++.++.||+.||.|||++||+|+||||+|||++  .++.+||+|||++...... 
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999999999887665 4699999999999999999999999999999999999997  5689999999998655432 


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--APSISAEAKHLI  249 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  249 (284)
                       .....+++.|+|||++.+..++.++|||||||++|+|+||..||.+.+..+.+..+......++.  .+.+|+++.+||
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence             33457899999999999999999999999999999999999999999999999998887655443  357999999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                      .+||..||.+|||++|+|+||||++...
T Consensus       264 ~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            9999999999999999999999987543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.6e-59  Score=382.44  Aligned_cols=257  Identities=31%  Similarity=0.536  Sum_probs=229.2

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH------HHHHHHHHHHHHHHHHHhCC-CCcccceeeEEec
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI------EKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHD   90 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~   90 (284)
                      ..+|++.+.||+|+||+||+|++..+++.||||++.....      ......+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4789999999999999999999999999999999865432      12334467889999999997 9999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ++..|+||||+++++|.+++...+++++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999986543


Q ss_pred             C--CCccccCCCcccCccccC------CCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CC
Q 023270          171 S--KRHTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PS  240 (284)
Q Consensus       171 ~--~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  240 (284)
                      .  ......|++.|.|||.+.      ...++.++||||+|+++++|++|..||.+.+..+....+..+...++..  +.
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            2  334566899999999885      3346889999999999999999999999999999888888876554433  47


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      +|+++++|+.+||++||++|||++++|+||||++
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            8999999999999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-59  Score=391.90  Aligned_cols=256  Identities=30%  Similarity=0.593  Sum_probs=228.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHH-HhCCCCcccceeeEEecCCeEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~-~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      +.+|.+.+.||+|+||+||+|++..+++.||||++.+.........+.+..|..++ +.++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            46899999999999999999999999999999999765544433344555666655 47899999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCC
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKR  173 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~  173 (284)
                      ||||+++|+|..++.....+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++....   ...
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999999998999999999999999999999999999999999999999999999999999985432   233


Q ss_pred             ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 023270          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLL  253 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (284)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.......+  ..+|+++.+||++||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~dli~~~L  238 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEAKDLLVKLF  238 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--ccCCHHHHHHHHHhc
Confidence            445689999999999999999999999999999999999999999999999998887765443  478999999999999


Q ss_pred             ccCCCCCCCHH-hhhcCcccccc
Q 023270          254 VKDSSKRLSLQ-KIMEHPWIIKN  275 (284)
Q Consensus       254 ~~~p~~Rps~~-~il~~~~~~~~  275 (284)
                      ..||.+|||++ ++++||||++-
T Consensus       239 ~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         239 VREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             CSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             ccCCCCCcCHHHHHHhCchhccC
Confidence            99999999995 89999999863

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-58  Score=395.06  Aligned_cols=260  Identities=29%  Similarity=0.489  Sum_probs=221.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHH---HHHHHHHHhCCCCcccceeeEEecCC
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL---RREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~---~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .++++|++.+.||+|+||+||+|++..+|+.||||++.............+   ..++++++.++||||+++++++..++
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            368899999999999999999999999999999999876554433222233   34577788889999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC-C
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-S  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~-~  171 (284)
                      .+|+||||+++++|.+++.+...+++..++.++.||+.||.|||+.|++|+||||+|||++.+|.+||+|||++.... .
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            999999999999999999998999999999999999999999999999999999999999999999999999986543 3


Q ss_pred             CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCCCCCCHHHHHHH
Q 023270          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM-KVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li  249 (284)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|+||..||...+..+...-.. ........++.+|+++++||
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence            4455679999999999875 568999999999999999999999998755433222111 12233344557999999999


Q ss_pred             HHhcccCCCCCCC-----HHhhhcCcccccc
Q 023270          250 SRLLVKDSSKRLS-----LQKIMEHPWIIKN  275 (284)
Q Consensus       250 ~~~l~~~p~~Rps-----~~~il~~~~~~~~  275 (284)
                      .+||..||++|||     ++++++||||++.
T Consensus       241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999     7999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-59  Score=391.12  Aligned_cols=256  Identities=28%  Similarity=0.526  Sum_probs=230.0

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      .+.+|.+++.||+|+||+||+|.+..+++.||+|++.......    ..+.+|+++++.++||||+++++++.+++.+|+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH----HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH----HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            4678999999999999999999999999999999997654332    457789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC--CCEEEeecccccccCCC-
Q 023270           97 ILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE--GRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~--~~~~l~d~~~~~~~~~~-  172 (284)
                      |||||++++|.+++...+ .+++.+++.++.||+.||.|||+.||+|+||||+|||++.+  +.++|+|||++...... 
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            999999999999998765 79999999999999999999999999999999999999865  48999999998654432 


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--CCCCHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--PSISAEAKHLI  249 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li  249 (284)
                       .....+++.|+|||...+..++.++||||+||++|+|++|..||...+..+.+..+......++..  +.+|+++++||
T Consensus       159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence             344568899999999999999999999999999999999999999999999999998876555432  36899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      ++||..||.+|||++++|+||||++..
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccCc
Confidence            999999999999999999999998754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=380.68  Aligned_cols=260  Identities=26%  Similarity=0.392  Sum_probs=218.7

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHH--HHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEee
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK--YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~  100 (284)
                      .++.||+|+||+||+|.+..+++.||||++.......  ....+.+.+|+.++++++||||+++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999999999999999986544322  12235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCcccc
Q 023270          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMC  177 (284)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~~~~  177 (284)
                      +.++++..+......+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.....   ......
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            99887777766667899999999999999999999999999999999999999999999999999855433   223456


Q ss_pred             CCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-------------------
Q 023270          178 GTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS-------------------  237 (284)
Q Consensus       178 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------------  237 (284)
                      +++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......+..                   
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            89999999998654 5799999999999999999999999999998888776653111100                   


Q ss_pred             -------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCCCCC
Q 023270          238 -------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC  282 (284)
Q Consensus       238 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  282 (284)
                             .+.+++++.+||++||..||++|||++|+|+||||++.+.|--.|
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~  293 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC  293 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCC
Confidence                   124688999999999999999999999999999999987765555

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=373.68  Aligned_cols=260  Identities=28%  Similarity=0.489  Sum_probs=217.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.+|++++.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+++.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            46899999999999999999999999999999999654432 23356788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---CCC
Q 023270           98 LEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKR  173 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---~~~  173 (284)
                      |||++++.+...... ...+++..++.++.|++.||.|||+.||+|+||||+|||++.++.+||+|||.+....   ...
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            999976444433333 3579999999999999999999999999999999999999999999999999985443   233


Q ss_pred             ccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------------
Q 023270          174 HTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS---------------  237 (284)
Q Consensus       174 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------  237 (284)
                      ....+++.|+|||.+.... .+.++||||+|+++|+|++|+.||.+.+..+.+..+.........               
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            4457899999999877665 578999999999999999999999998888777765542111100               


Q ss_pred             ------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          238 ------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       238 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                  .+.+++++.+|+++||..||.+|||++|+|+||||++..+|
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                        12467899999999999999999999999999999988776

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-56  Score=370.65  Aligned_cols=251  Identities=21%  Similarity=0.355  Sum_probs=218.7

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .+++..++|++.+.||+|+||+||+|.+..++..||||++......    .+.+.+|++++++++||||+++++++.+++
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            4677889999999999999999999999999999999998654432    356889999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      .+++||||+++|+|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            999999999999999999764  578999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCCCCCCCCCCCHHH
Q 023270          171 SKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLSFPSAPSISAEA  245 (284)
Q Consensus       171 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (284)
                      ...    ....+++.|+|||++.+..++.++||||||+++|+|++|..|+ ...+...... ........+.++.+|+++
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l  245 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEKV  245 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHHTTCCCCCCTTCCHHH
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH-HHhcCCCCCCCccchHHH
Confidence            322    2234678899999999999999999999999999999965554 5555555444 444445666667899999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .+|+.+||+.||++|||++++++
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999976

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-57  Score=372.70  Aligned_cols=252  Identities=30%  Similarity=0.543  Sum_probs=214.8

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHH---HHHHHHHHHHHHHHhCC--CCcccceeeEEecCCe
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLR--HPNILRLYGWFHDDER   93 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~~~~~~l~--h~~i~~~~~~~~~~~~   93 (284)
                      ++|++.+.||+|+||+||+|.+..+++.||||++........   .....+.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            589999999999999999999999999999999865433211   11123567899999886  8999999999999999


Q ss_pred             EEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCC-CCEEEeecccccccCC
Q 023270           94 IFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRS  171 (284)
Q Consensus        94 ~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~  171 (284)
                      .++|||++.+ +++.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.+ +.+||+|||++.....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999975 6788888888899999999999999999999999999999999999999865 7999999999865433


Q ss_pred             -CCccccCCCcccCccccCCCCC-CchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          172 -KRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                       ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+      ++......  .+..+|+++++||
T Consensus       164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~--~~~~~s~~~~~li  235 (273)
T d1xwsa_         164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF--FRQRVSSECQHLI  235 (273)
T ss_dssp             SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC--CSSCCCHHHHHHH
T ss_pred             ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC--CCCCCCHHHHHHH
Confidence             3345679999999999987765 577999999999999999999997532      23344333  3447999999999


Q ss_pred             HHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          250 SRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                      ++||..||++|||++|+|+||||++...|
T Consensus       236 ~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         236 RWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            99999999999999999999999987554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-56  Score=375.50  Aligned_cols=254  Identities=30%  Similarity=0.583  Sum_probs=210.3

Q ss_pred             cccccCcEeee-eeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHH-hCCCCcccceeeEEec--
Q 023270           15 EWSLQDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS-SLRHPNILRLYGWFHD--   90 (284)
Q Consensus        15 ~~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~-~l~h~~i~~~~~~~~~--   90 (284)
                      ...+.+|.+.. .||+|+||+||+|.+..+++.||||++...        ..+.+|+.++. ..+||||+++++++.+  
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            34567999885 599999999999999999999999998542        24557887754 5589999999999865  


Q ss_pred             --CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeec
Q 023270           91 --DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDF  163 (284)
Q Consensus        91 --~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~  163 (284)
                        +..+|+|||||++|+|.+++.+.  ..+++.+++.++.||+.||.|||+.|++||||||+||+++.   ++.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46789999999999999999875  46999999999999999999999999999999999999975   467999999


Q ss_pred             ccccccC--CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCC
Q 023270          164 GWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMK----VDLSFPS  237 (284)
Q Consensus       164 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~~  237 (284)
                      |++....  .......|++.|+|||++.+..++.++|||||||++|+|+||..||.+.+.......+..    ....++.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            9985433  334556799999999999999999999999999999999999999987665544443332    2222222


Q ss_pred             C--CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          238 A--PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       238 ~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                      .  ..+|+++.+||++||+.||.+|||++|+|+||||++..
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            1  25789999999999999999999999999999997653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.6e-56  Score=367.34  Aligned_cols=255  Identities=28%  Similarity=0.478  Sum_probs=216.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +.+|+++++||+|+||+||+|++. +++.||||++....... ...+.+.+|+.++++++||||+++++.+..++..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            479999999999999999999884 78999999986654332 2346788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~  174 (284)
                      +|++.++.+..+....+.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+|++|||.+.....   ...
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            99998877777667678899999999999999999999999999999999999999999999999999854432   233


Q ss_pred             cccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------------
Q 023270          175 TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP-----------------  236 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------------  236 (284)
                      ...+++.|.|||.+.+.. ++.++||||||+++++|++|..||.+.+..+.+.++........                 
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            445788999999987654 68999999999999999999999999888777776543211110                 


Q ss_pred             ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          237 ----------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       237 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                                ..+.+++++.+||++||.+||++|||++|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      12346889999999999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.1e-56  Score=365.99  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=219.0

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC----e
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----R   93 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~----~   93 (284)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357999999999999999999999999999999997665555555678999999999999999999999987543    4


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC---
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~---  170 (284)
                      .|+||||+++++|..++...+.+++.+++.++.||+.||.|||++|++|+||||+||+++.++..+++|||.+....   
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            89999999999999999998999999999999999999999999999999999999999999999999999864322   


Q ss_pred             ---CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHH
Q 023270          171 ---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--SAPSISAEA  245 (284)
Q Consensus       171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  245 (284)
                         .......|++.|+|||++.+..+++++||||||+++|+|+||.+||...+..+...+.......++  ..+.+|+++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence               122345689999999999999999999999999999999999999999999888888777654433  235789999


Q ss_pred             HHHHHHhcccCCCCCCCHHhhhcCcccc
Q 023270          246 KHLISRLLVKDSSKRLSLQKIMEHPWII  273 (284)
Q Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (284)
                      .++|.+||.+||.+||+..+.|.|+|++
T Consensus       246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999999555555677654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=358.44  Aligned_cols=247  Identities=23%  Similarity=0.395  Sum_probs=220.3

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~   96 (284)
                      ..++|++.+.||+|+||+||++++ .++..||||++.......    +.+.+|+.++++++||||+++++++.+++.+++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            568999999999999999999997 477889999987654433    468899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC---
Q 023270           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---  172 (284)
                      ||||+++|+|..++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......   
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            99999999999886554 57899999999999999999999999999999999999999999999999998543322   


Q ss_pred             -CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 023270          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLIS  250 (284)
Q Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (284)
                       .....+++.|+|||.+.+..++.++||||||+++|+|+| |..||...+..++...+..+. ..+.+...++++.+|++
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccccHHHHHHHH
Confidence             223557889999999999999999999999999999998 899999999999888877653 55666789999999999


Q ss_pred             HhcccCCCCCCCHHhhhcC
Q 023270          251 RLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       251 ~~l~~~p~~Rps~~~il~~  269 (284)
                      +||+.||++|||+++|++|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-56  Score=373.11  Aligned_cols=255  Identities=24%  Similarity=0.401  Sum_probs=220.5

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCc-----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----PVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      .+++...+|++.+.||+|+||+||+|.+...++     .||+|.+......  .....+.+|+.++.++ +||||+++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            456777899999999999999999999876554     5899988554322  2346788899999988 8999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHR-----------------------RFTEQQAATYIASLTNALAYCHENHVIHR  143 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~  143 (284)
                      ++.+.+.+++|||||++|+|.+++.+..                       .+++..++.++.|++.||.|||++||+||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999997542                       48999999999999999999999999999


Q ss_pred             CCCCCCeEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCC
Q 023270          144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFE  217 (284)
Q Consensus       144 dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~  217 (284)
                      ||||+||+++.++++||+|||++.......     ....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            999999999999999999999985443322     23446899999999999999999999999999999997 899999


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          218 AESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.+....+.++......++.+..+|+++.+||.+||+.||++|||+++|++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8877777777777777777777899999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-55  Score=363.40  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=213.2

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCc---eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEe
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~   89 (284)
                      ..++...+|++.+.||+|+||+||+|.+..+++   .||||.+......  ...+.+.+|++++++++||||+++++++.
T Consensus        20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   97 (299)
T d1jpaa_          20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVT   97 (299)
T ss_dssp             SCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             chhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            346778999999999999999999999877665   4888887553322  23467889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccc
Q 023270           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (284)
Q Consensus        90 ~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~  168 (284)
                      .++.+++|||||++|+|.+++... +.+++.+++.++.|++.||.|||++|++||||||+|||++.++++||+|||++..
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence            999999999999999999988775 5799999999999999999999999999999999999999999999999999854


Q ss_pred             cCCCC--------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 023270          169 SRSKR--------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAP  239 (284)
Q Consensus       169 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
                      .....        ....+++.|+|||.+.+..++.++||||||+++|+|+| |..||...+..+....+..+ ...+.+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~  256 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLPPPM  256 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCT
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCc
Confidence            33211        12346889999999999999999999999999999998 89999999998888877665 3455566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+++++.+|+.+||+.||++|||+.+++++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            899999999999999999999999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=362.69  Aligned_cols=252  Identities=22%  Similarity=0.421  Sum_probs=210.8

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~   92 (284)
                      .+++...+|++.+.||+|+||+||+|+..   ..||||++....... ...+.+.+|+.++++++||||+++++++. ++
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~   76 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP   76 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence            36788899999999999999999999753   359999986543332 23568889999999999999999999875 45


Q ss_pred             eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                      .+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            689999999999999999765 5699999999999999999999999999999999999999999999999999854322


Q ss_pred             -----CCccccCCCcccCccccCCC---CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCC
Q 023270          172 -----KRHTMCGTLDYLAPEMVENK---EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP----SAP  239 (284)
Q Consensus       172 -----~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~  239 (284)
                           ......||+.|+|||++.+.   .++.++||||||+++|+|+||..||.+.+...............+    .+.
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence                 22345689999999998643   478999999999999999999999998776655555444332222    244


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          240 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       240 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+|+++.+|+.+||..||.+|||+++++++
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            689999999999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=363.15  Aligned_cols=256  Identities=21%  Similarity=0.370  Sum_probs=220.7

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++..++|++.+.||+|+||+||+|.+. ++..||||++.......    +.+.+|++++++++||||+++++++.+ 
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH----HHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            356778899999999999999999999974 67789999986544332    568899999999999999999998754 


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..++||||+++|+|.+++...  .++++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence            5679999999999999877544  36999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ...    .....+++.|+|||++.+..++.++||||||+++|+|+| |.+|+...+..+....+..+ .....++.++++
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~  238 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEE  238 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCcccChHH
Confidence            322    233457889999999998889999999999999999999 56667777777777777665 345556689999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhc--Cccccc
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIME--HPWIIK  274 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~--~~~~~~  274 (284)
                      +.+|+.+||+.||++|||++++++  ++||..
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999999999999999999999  788864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-55  Score=358.07  Aligned_cols=248  Identities=22%  Similarity=0.380  Sum_probs=211.2

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEE
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~   95 (284)
                      +..++|++.+.||+|+||+||+|.+. ++..||||++.......    +.+.+|++++++++||||+++++++..++..+
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            35679999999999999999999875 56789999987544333    46889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC--
Q 023270           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  172 (284)
                      +||||+++|+|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++++||+|||++......  
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999999988765 56899999999999999999999999999999999999999999999999998544322  


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                        .....|++.|+|||++.+..++.++||||||+++|+|+| |.+||...+..+....+..+. ....+...++++.+|+
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQIM  235 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-CCCCCTTSCHHHHHHH
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-CCCCccccCHHHHHHH
Confidence              223457899999999999999999999999999999998 678888888888888776653 4444557899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcC
Q 023270          250 SRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~  269 (284)
                      .+||+.||++|||++++++|
T Consensus       236 ~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=368.09  Aligned_cols=261  Identities=24%  Similarity=0.390  Sum_probs=212.3

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecC-CceEEEEehhhhhHHHHHHHHHHHHHHHH---HHhCCCCcccceeeEEec---
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEI---QSSLRHPNILRLYGWFHD---   90 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~~~~~~---~~~l~h~~i~~~~~~~~~---   90 (284)
                      -++|++++.||+|+||+||+|.+..+ ++.||||++........ ....+.+|+.+   ++..+||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            36899999999999999999999765 56789999865332211 11223345554   445589999999999853   


Q ss_pred             --CCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           91 --DERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        91 --~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                        +...++++|+++++.+...... ...+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              3578999999998766544443 3578999999999999999999999999999999999999999999999999975


Q ss_pred             ccC--CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 023270          168 QSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSF----------  235 (284)
Q Consensus       168 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------  235 (284)
                      ...  .......||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+..+.+..+.......          
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            433  33345678999999999999999999999999999999999999999999888877765421110          


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCCC
Q 023270          236 ---------------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  279 (284)
Q Consensus       236 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (284)
                                     .....+++++.+||++||.+||++|||++|+|+||||++...++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence                           01235788999999999999999999999999999999875543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-55  Score=361.17  Aligned_cols=246  Identities=23%  Similarity=0.375  Sum_probs=209.7

Q ss_pred             eeeccCCCeEEEEEEEec--CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEEEeecC
Q 023270           25 RPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (284)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v~e~~~  102 (284)
                      +.||+|+||+||+|.+..  +++.||||++.....+ ....+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            469999999999998654  4568999998654432 3445788999999999999999999999865 45789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCCC------ccc
Q 023270          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------HTM  176 (284)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~------~~~  176 (284)
                      +|+|.+++.+...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......      ...
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999985433221      234


Q ss_pred             cCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 023270          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVK  255 (284)
Q Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (284)
                      .|++.|+|||.+.+..++.++||||||+++|+|+| |..||.+.+..+....+..+. ..+.+..+|+++.+|+.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcccCHHHHHHHHHHcCC
Confidence            57899999999999999999999999999999997 899999998888777776653 4455568999999999999999


Q ss_pred             CCCCCCCHHhh---hcCcccc
Q 023270          256 DSSKRLSLQKI---MEHPWII  273 (284)
Q Consensus       256 ~p~~Rps~~~i---l~~~~~~  273 (284)
                      ||++|||+++|   |+|+|+.
T Consensus       250 dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHhh
Confidence            99999999998   4566653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=358.89  Aligned_cols=260  Identities=20%  Similarity=0.378  Sum_probs=219.6

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ..+++...+|++.+.||+|+||+||+|.+..+ ..||||++.......    +.+.+|+.++++++|+||+++++++.+ 
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            34678889999999999999999999988544 679999996554332    568899999999999999999999854 


Q ss_pred             CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      +..++||||+++|+|.+++...  +.+++.+++.++.||+.||.|||+.|++||||||+|||++.++++||+|||++...
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence            5678999999999999888653  57999999999999999999999999999999999999999999999999998543


Q ss_pred             CC----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RS----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ..    ......+++.|+|||++.+..++.++||||||+++|+|++| .+|+......+.+..+..+ ...+.++.++++
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~  242 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES  242 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHH
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCCcccCHH
Confidence            22    22235578999999999999999999999999999999994 5666777777777766654 345566789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhc--CccccccCCC
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIME--HPWIIKNANP  278 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~~  278 (284)
                      +.+|+.+||+.||++|||+++|++  ++||+..+.+
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            999999999999999999999998  8999876543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=368.90  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=215.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----   92 (284)
                      -++|++++.||+|+||+||+|.+..+++.||||++....... ...+.+.+|+++++.++||||+++++++...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            578999999999999999999999999999999997544333 34567889999999999999999999997654     


Q ss_pred             -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC
Q 023270           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (284)
Q Consensus        93 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~  171 (284)
                       .+|+||||+ +.+|..+++. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++++|||++.....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 4577776654 6799999999999999999999999999999999999999999999999999988777


Q ss_pred             CCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------------
Q 023270          172 KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP--------------  236 (284)
Q Consensus       172 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------  236 (284)
                      ......+++.|+|||.+.+. .++.++||||+||++++|++|..||.+.+....+..........+              
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence            77778899999999998764 578999999999999999999999999887776655444221111              


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCcccccc
Q 023270          237 ---------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  275 (284)
Q Consensus       237 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (284)
                                     ..+.+++++.+||++||..||.+|||++|+|+||||++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                           123578999999999999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=358.73  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=217.2

Q ss_pred             cccccCcEeeee-eccCCCeEEEEEEEec--CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           15 EWSLQDFEIGRP-LGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        15 ~~~~~~y~~~~~-lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      .+.-.+|.+... ||+|+||+||+|.+..  ++..||||++.....  ....+.+.+|++++++++||||+++++++.. 
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-   80 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   80 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence            345567888885 9999999999997754  344799999865432  2335678899999999999999999998865 


Q ss_pred             CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      +.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            4689999999999999988654 579999999999999999999999999999999999999999999999999985443


Q ss_pred             CCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          171 SKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       171 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ...      ....+++.|+|||++.+..++.++||||||+++|+++| |..||...+..+....+..+. ..+.++.+|+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~  239 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPP  239 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCH
Confidence            221      23457889999999998899999999999999999998 999999988888877776654 4455668999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhh---hcCcccc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKI---MEHPWII  273 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~i---l~~~~~~  273 (284)
                      ++.+|+.+||+.||++|||+.+|   |+|+|+.
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999988   6678774

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=364.39  Aligned_cols=260  Identities=25%  Similarity=0.415  Sum_probs=214.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-------   90 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-------   90 (284)
                      ..+|+++++||+|+||+||+|.+..+++.||||++....... .....+.+|+.++++++|+|++++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            689999999999999999999999999999999986543322 233567789999999999999999998754       


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 -DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 -~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                       ++..++|||+++++.+.........+++..++.++.|++.||.|||+.||+||||||+|||++.++.++++|||++...
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             3468999999987766655555678999999999999999999999999999999999999999999999999998432


Q ss_pred             C-------CCCccccCCCcccCccccCCC-CCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--C
Q 023270          170 R-------SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPSA--P  239 (284)
Q Consensus       170 ~-------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~  239 (284)
                      .       .......||+.|+|||++.+. .++.++||||+|+++++|++|..||.+.+..+....+......+...  .
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            2       222335689999999998765 58999999999999999999999999988877766655532222111  0


Q ss_pred             ----------------------------CCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          240 ----------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       240 ----------------------------~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                                  ..++++.+||.+||.+||++|||++|+|+||||+..+.|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p  314 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  314 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence                                        126678899999999999999999999999999987554

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-54  Score=356.33  Aligned_cols=259  Identities=24%  Similarity=0.453  Sum_probs=220.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCCeEEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~~~~~v   97 (284)
                      +++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            57999999999999999999999999999999998654432 23456788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC---CCc
Q 023270           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (284)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~---~~~  174 (284)
                      ++++.++++..++...+.+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||.+.....   ...
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            99999999998888888999999999999999999999999999999999999999999999999999865433   223


Q ss_pred             cccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCCC------------------
Q 023270          175 TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRRIMKVDLS------------------  234 (284)
Q Consensus       175 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~~~------------------  234 (284)
                      ...+++.|.|||.+.+.. ++.++||||+||++++|++|..|| .+.+..+....+......                  
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            345678899999987665 689999999999999999999885 556666665554332111                  


Q ss_pred             ---------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          235 ---------FPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       235 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                               ....+.+++++.+||++||++||++|||++|+|+||||++--.
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                     1112356889999999999999999999999999999987533

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=352.25  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=212.7

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEecCC----ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESK----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~   88 (284)
                      +.++..+.|++.+.||+|+||+||+|.+..++    ..||||++.......  ....+.+|++++++++||||+++++++
T Consensus         1 ~~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~~~g~~   78 (283)
T d1mqba_           1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVI   78 (283)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence            35788899999999999999999999987655    369999986543322  345688999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        89 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      .+++..++|+||+.++++.+.+... +.+++..++.++.|++.|+.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence            9999999999999999999888765 579999999999999999999999999999999999999999999999999985


Q ss_pred             ccCCC------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 023270          168 QSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTFRRIMKVDLSFPSAPS  240 (284)
Q Consensus       168 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
                      .....      .....|++.|+|||++.+..++.++||||||+++|+|+++ .+|+...+..+....+..+ ...+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~  237 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMD  237 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTT
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCCCCchh
Confidence            43221      1234578899999999999999999999999999999985 5556666777776666554 45556668


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          241 ISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       241 ~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +++++.+|+.+||..||++|||+.+|++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=353.35  Aligned_cols=248  Identities=23%  Similarity=0.422  Sum_probs=211.7

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-CC
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DE   92 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-~~   92 (284)
                      +++++++|++.+.||+|+||.||+|.+  .++.||||++....     ..+.+.+|++++++++||||+++++++.+ .+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            688999999999999999999999987  46789999996543     23568899999999999999999998854 46


Q ss_pred             eEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           93 RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      .+++||||+++|+|.+++...  ..+++..++.++.||+.|+.|||+.+++|+||+|+||+++.++.++++|||++....
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence            789999999999999999664  358999999999999999999999999999999999999999999999999997766


Q ss_pred             CCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                      .......+++.|+|||++.+..+++++||||||+++|+|+| |.+||...+..+....+..+ ..++.++.+++++.+|+
T Consensus       155 ~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHH
T ss_pred             CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHHH
Confidence            66666678899999999999999999999999999999998 79999988888888777664 34555668999999999


Q ss_pred             HHhcccCCCCCCCHHhhhcC
Q 023270          250 SRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~  269 (284)
                      ++||..||.+|||+.+++++
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=353.47  Aligned_cols=257  Identities=23%  Similarity=0.386  Sum_probs=214.6

Q ss_pred             cccccCcEeeeeeccCCCeEEEEEEEecCC---ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      -+..+||++.+.||+|+||+||+|++..+.   ..||||++...........+.+.+|+.+++.++||||+++++++.+ 
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            466789999999999999999999876443   3589999977665555666789999999999999999999999965 


Q ss_pred             CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      +..++|+||++++++.+.+... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            4678999999999999877654 579999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC------ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Q 023270          171 SKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISA  243 (284)
Q Consensus       171 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
                      ...      ....++..|+|||++.+..++.++||||||+++|+|+| |..||.+.+..+....+......++.++.+|+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            322      22346788999999999999999999999999999998 89999999999999999888777777788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHhhhcCccccc
Q 023270          244 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  274 (284)
Q Consensus       244 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (284)
                      ++.+|+.+||..||++|||+++|+  +++++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~--~~L~~  271 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALR--DFLLE  271 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHH--HHHHh
Confidence            999999999999999999999996  45544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=363.28  Aligned_cols=254  Identities=30%  Similarity=0.439  Sum_probs=210.9

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC------
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------   91 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~------   91 (284)
                      ..+|+.+++||.|+||+||+|++..+++.||||++....       ....+|++++++++|+||+++++++...      
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            447999999999999999999999999999999986543       1234789999999999999999998532      


Q ss_pred             CeEEEEEeecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeeccccc
Q 023270           92 ERIFLILEYAHRGELYREL---RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSV  167 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~  167 (284)
                      .++++||||++++.+..+.   .....+++..++.++.||+.||.|||++||+|+||||+|||++.++ .+||+|||++.
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            3589999999865433322   3345799999999999999999999999999999999999999875 89999999985


Q ss_pred             ccC--CCCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 023270          168 QSR--SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDL-----------  233 (284)
Q Consensus       168 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----------  233 (284)
                      ...  .......|++.|+|||.+.+ ..++.++||||+||++|+|++|..||...+..+.+..+.+...           
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            443  33445678999999998765 4689999999999999999999999998888777766543110           


Q ss_pred             ------CC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          234 ------SF----------PSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       234 ------~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                            ..          ...+.+++++.+||++||..||++|||++|+|+||||++..++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                  00          1123578999999999999999999999999999999987554

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=350.53  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=210.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCC---ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~   90 (284)
                      +++...+|++.+.||+|+||+||+|.+..++   ..||||.+.....  ....+.+.+|+.++++++||||+++++++. 
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            5677789999999999999999999886543   4588888854332  233567889999999999999999999985 


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccccc
Q 023270           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~  169 (284)
                      ++.+++||||+++++|..++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence            56789999999999999987654 57999999999999999999999999999999999999999999999999998553


Q ss_pred             CC----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          170 RS----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       170 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ..    ......+++.|+|||.+.+..++.++||||||+++|+|+| |.+||...+..+....+..+. ..+.++.+|++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~  237 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPT  237 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHH
Confidence            32    2233457889999999999999999999999999999997 899999999988888877654 34556689999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.+||.+||..||++|||+++|+++
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=362.17  Aligned_cols=259  Identities=23%  Similarity=0.379  Sum_probs=217.7

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC-----C
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----E   92 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~-----~   92 (284)
                      ..+|++++.||+|+||+||+|.+..+++.||||++....... ...+.+.+|+++++.++|+|++++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            468999999999999999999999999999999997654333 2345778999999999999999999998533     3


Q ss_pred             eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC
Q 023270           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (284)
Q Consensus        93 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  172 (284)
                      ..+++++++.+++|.+++.. +.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++++|||.+......
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence            34555666778899998855 57999999999999999999999999999999999999999999999999999777777


Q ss_pred             CccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------------
Q 023270          173 RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFPS--------------  237 (284)
Q Consensus       173 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------------  237 (284)
                      .....|++.|+|||...+.. ++.++||||||+++|+|++|..||.+.+.......+.........              
T Consensus       175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  254 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred             cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence            77778899999999877654 689999999999999999999999998887777666553222111              


Q ss_pred             ---------------CCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          238 ---------------APSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       238 ---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                     ...+++++.+||++||..||.+|||++|+|+||||++..++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence                           13578999999999999999999999999999999986543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=358.11  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC-----e
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----R   93 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~-----~   93 (284)
                      .+|+++++||+|+||+||+|.+..+++.||||++.....  ....+.+.+|+.++++++|||++++++++....     .
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            569999999999999999999999999999999865432  233467889999999999999999999986553     3


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCC--
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~--  171 (284)
                      +++++ ++.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        86 ~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          86 VYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            55555 4557899999976 4699999999999999999999999999999999999999999999999999854322  


Q ss_pred             ----CCccccCCCcccCccccCC-CCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 023270          172 ----KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLSFP----------  236 (284)
Q Consensus       172 ----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  236 (284)
                          ......+++.|+|||++.. ..++.++||||+|+++++|++|..||...+..+.............          
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence                1234558899999999854 4578899999999999999999999998877655554433211110          


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCCC
Q 023270          237 -------------------SAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  278 (284)
Q Consensus       237 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (284)
                                         ..+.+++++.+|+.+||..||.+|||++++|+||||++...+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                               123578899999999999999999999999999999966543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=361.48  Aligned_cols=257  Identities=22%  Similarity=0.379  Sum_probs=207.5

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec------
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD------   90 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~------   90 (284)
                      .+++|+++++||+|+||+||+|.+..+|+.||||++....... .....+.+|+.++++++||||+++++++..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH-HHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            3578999999999999999999999999999999997654433 334678899999999999999999999853      


Q ss_pred             CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                      ...+|+||||+.++ +...+  ...+++..++.++.|++.||.|||+.||+|+||||+|||++.++.++++|||++....
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            36899999999764 44444  3568999999999999999999999999999999999999999999999999874433


Q ss_pred             C--CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------------
Q 023270          171 S--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIMKVDLS--------------  234 (284)
Q Consensus       171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------------  234 (284)
                      .  ......+++.|+|||++.+..+++++||||+||++++|++|+.||.+.+.......+......              
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            2  334456889999999999999999999999999999999999999988877766655432111              


Q ss_pred             --------CCCC------------------CCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccCC
Q 023270          235 --------FPSA------------------PSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  277 (284)
Q Consensus       235 --------~~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (284)
                              ....                  ...++++.+||++||.+||++|||++|+|+||||++..+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence                    0000                  013567899999999999999999999999999998653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=361.29  Aligned_cols=260  Identities=38%  Similarity=0.673  Sum_probs=217.7

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe---cCCceEEEEehhhhhHH-HHHHHHHHHHHHHHHHhCCC-CcccceeeE
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSLRH-PNILRLYGW   87 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~~~~~~~~~~~l~h-~~i~~~~~~   87 (284)
                      ..++.+.+|++++.||+|+||+||+|.+.   .+|+.||||++...... .....+.+.+|++++++++| +||++++++
T Consensus        18 ~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             CcccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            34467899999999999999999999874   36889999998643321 11123467789999999976 899999999


Q ss_pred             EecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccccc
Q 023270           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (284)
Q Consensus        88 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~  167 (284)
                      +.+....++++||+.+++|.+++...+.+++..+..++.||+.||.|+|+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999985


Q ss_pred             ccC----CCCccccCCCcccCccccCCC--CCCchhhHhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCCCC
Q 023270          168 QSR----SKRHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRRIMKVDLSFPS  237 (284)
Q Consensus       168 ~~~----~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~  237 (284)
                      ...    .......+++.|+|||.+.+.  .++.++|||||||++|+|++|..||...+..+    .........  .+.
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~  255 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY  255 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--CCC
Confidence            432    223445689999999998754  36889999999999999999999997754433    333333333  333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC-----CHHhhhcCccccc
Q 023270          238 APSISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPWIIK  274 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~  274 (284)
                      +..+++++.+|+++||++||.+||     +++|+++||||++
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            447999999999999999999999     4899999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.9e-52  Score=350.92  Aligned_cols=251  Identities=27%  Similarity=0.515  Sum_probs=207.4

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecC--Ce
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDD--ER   93 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~--~~   93 (284)
                      ..++|+++++||.|+||+||+|++..+++.||||++....      .+.+.+|+++++++. |+||+++++++...  ..
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            4567999999999999999999999999999999986533      245778999999985 99999999998743  57


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC-CEEEeecccccccC--
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSR--  170 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~--  170 (284)
                      +++||||+++++|....   +.+++..++.++.||+.||.|||++||+|+||||+|||++.++ .++|+|||++....  
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999999987653   5689999999999999999999999999999999999998765 69999999985543  


Q ss_pred             CCCccccCCCcccCccccCCCC-CCchhhHhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHh-------------c----
Q 023270          171 SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRRIMK-------------V----  231 (284)
Q Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~-------------~----  231 (284)
                      .......+++.|+|||.+.+.. ++.++||||+|++++++++|..||...... .....+..             .    
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            3344556899999999987655 799999999999999999999999765432 22111111             0    


Q ss_pred             ------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcCccccccC
Q 023270          232 ------------------DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  276 (284)
Q Consensus       232 ------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (284)
                                        .........+++++.+||++||..||++|||++|+|+||||+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                              001111234788999999999999999999999999999999763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-52  Score=345.72  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=220.0

Q ss_pred             hhcccccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      ....++-.++|++.+.||+|+||+||+|+...     +++.||||++......  ...+.+.+|++++++++|+|+++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCcccce
Confidence            34466777889999999999999999999764     4578999998654432  2356789999999999999999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHR------------------------RFTEQQAATYIASLTNALAYCHENHVI  141 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~  141 (284)
                      +++...+..++++|++++++|.+++....                        .++...++.++.|++.||+|||+.|++
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv  162 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV  162 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence            99999999999999999999999986432                        378999999999999999999999999


Q ss_pred             ccCCCCCCeEecCCCCEEEeecccccccCC-----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC-CCC
Q 023270          142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APP  215 (284)
Q Consensus       142 H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p  215 (284)
                      ||||||+||+++.++++||+|||++.....     ......+++.|+|||.+.+..++.++||||||+++|+|++| .+|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999999999843321     22234578899999999999999999999999999999998 478


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          216 FEAESQKDTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      |...+..+....+..+. .++.+..+++++.+|+.+||+.||++|||+.+|++
T Consensus       243 ~~~~~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999888877765 34455689999999999999999999999999965

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=350.31  Aligned_cols=253  Identities=22%  Similarity=0.360  Sum_probs=216.8

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCCce--EEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceeeEEec
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHP--VALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD   90 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~~~~~   90 (284)
                      ..+++++|++.+.||+|+||+||+|.+..++..  |+||.+....  .....+.+.+|+++++++ +||||+++++++.+
T Consensus         5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_           5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             CccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            467889999999999999999999999888775  6677764322  223356788999999998 79999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC
Q 023270           91 DERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~  154 (284)
                      ++.+++||||+++|+|.+++...                ..+++..++.++.||+.|+.|+|+.|++||||+|+|||++.
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence            99999999999999999998643                46899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCC--CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhc
Q 023270          155 EGRLKIGDFGWSVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTFRRIMKV  231 (284)
Q Consensus       155 ~~~~~l~d~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~  231 (284)
                      ++.+||+|||++......  .....++..|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+..+
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            999999999998544322  2334578999999999999999999999999999999996 5679988888888877665


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          232 DLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                       ..+..+..+++++.+||.+||+.||++|||+++++++
T Consensus       243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             3455566899999999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=350.07  Aligned_cols=250  Identities=20%  Similarity=0.359  Sum_probs=209.5

Q ss_pred             ccccCcEeeeeeccCCCeEEEEEEEecCCc----eEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecC
Q 023270           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (284)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~   91 (284)
                      ++-.+|++++.||+|+||+||+|.+..+++    +||+|.+....  .....+.+.+|+.++++++||||+++++++.++
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            455789999999999999999999987776    47888775332  223356789999999999999999999999765


Q ss_pred             CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccC
Q 023270           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (284)
Q Consensus        92 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~  170 (284)
                       ..+++++++.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++++||+|||++....
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             466778888888998887765 579999999999999999999999999999999999999999999999999985432


Q ss_pred             CC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Q 023270          171 SK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRRIMKVDLSFPSAPSISAE  244 (284)
Q Consensus       171 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
                      ..     .....|++.|+|||++.++.++.++||||||+++|+|+| |.+||...+..+....+..+ ...+.++.++++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~  241 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTID  241 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCCCCCTTBCHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHH
Confidence            21     123357899999999999999999999999999999998 89999998888777666654 345556689999


Q ss_pred             HHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          245 AKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       245 l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +.+|+.+||..||.+|||+.++++|
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=346.56  Aligned_cols=256  Identities=23%  Similarity=0.413  Sum_probs=206.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEecC-----CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~   85 (284)
                      ..+++...+|++.+.||+|+||.||+|.+...     ++.||||++.......  ..+.+.++...+.++ +|+||+.++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEee
Confidence            34567778999999999999999999997653     4579999986543322  235566677766665 689999999


Q ss_pred             eEEecC-CeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           86 GWFHDD-ERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        86 ~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      +++..+ +.+++|||||++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            987654 57899999999999999997542                4889999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC-CCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~  222 (284)
                      |||++.++++||+|||++......     .....||+.|+|||++.+..++.++||||||+++|+|+|+ .+||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998543221     2234688999999999999999999999999999999986 5788877665


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      +...........+..++.+++++.+++.+||+.||++|||++++++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55555555445566667899999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=342.52  Aligned_cols=252  Identities=24%  Similarity=0.453  Sum_probs=213.1

Q ss_pred             ccccccCcEeeeeeccCCCeEEEEEEEecCC-------ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 023270           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESK-------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (284)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~   85 (284)
                      +++..++|.+.+.||+|+||.||+|++..++       ..||||++.......  ....+.+|...+.++ +||||++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH--HHHHHHHHHHHHHHhcCCCeEEecc
Confidence            5566799999999999999999999876554       469999996644322  245677788878777 799999999


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~n  149 (284)
                      +++.+++..++||||+++|+|.+++...                ..+++..++.++.||+.||+|||+.|++||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            9999999999999999999999999654                358999999999999999999999999999999999


Q ss_pred             eEecCCCCEEEeecccccccCC-----CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChHH
Q 023270          150 LLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (284)
Q Consensus       150 il~~~~~~~~l~d~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  223 (284)
                      ||++.++.+||+|||.+.....     ......+++.|+|||.+.++.+++++||||||+++|+|++ |.+||...+...
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999999854332     2233567889999999999999999999999999999998 799999988888


Q ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          224 TFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      ....+..+ ..++.+..+++++.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcC-CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            77766654 456666789999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=345.20  Aligned_cols=261  Identities=20%  Similarity=0.322  Sum_probs=226.1

Q ss_pred             hcccccccCcEeeeeeccCCCeEEEEEEEec-----CCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceee
Q 023270           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (284)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~   86 (284)
                      ..+++...+|++.++||+|+||+||+|.+..     ++..||||++......  .....+.+|+.++++++|+||+++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            3467888999999999999999999998753     4578999999754322  23457889999999999999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCC
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~  156 (284)
                      ++..++..++||||+++|+|.+++...          ..++...+..++.+++.||.|||+++++||||||+|||++.++
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            999999999999999999999988643          2468999999999999999999999999999999999999999


Q ss_pred             CEEEeecccccccCCC-----CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHh
Q 023270          157 RLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTFRRIMK  230 (284)
Q Consensus       157 ~~~l~d~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~  230 (284)
                      ++||+|||++......     .....+++.|+|||.+.+..++.++||||||+++++|+|| .+||.+.+..+.+..+..
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            9999999998543322     2233578999999999999999999999999999999997 588999999988888777


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc------Ccccccc
Q 023270          231 VDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME------HPWIIKN  275 (284)
Q Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~------~~~~~~~  275 (284)
                      +. ..+.++.+++.+.+++.+||+.||.+|||++++++      +|+|++.
T Consensus       251 ~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         251 GG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            54 35555689999999999999999999999999998      6777653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=342.78  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=221.1

Q ss_pred             cccccccCcEeeeeeccCCCeEEEEEEEe-----cCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhC-CCCcccceee
Q 023270           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYG   86 (284)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l-~h~~i~~~~~   86 (284)
                      .+++.-++|++.+.||+|+||.||+|++.     .+++.||||++.......  ....+.+|+.+++.+ +||||+++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH--HHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            45667799999999999999999999864     456789999987654332  345788999999998 6999999999


Q ss_pred             EEecCCeEEEEEeecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023270           87 WFHDDERIFLILEYAHRGELYRELRKHR------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (284)
Q Consensus        87 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~  148 (284)
                      ++.+++..++|||||++++|.+++....                  .+++..++.++.||+.|+.|||++|++|+||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999987543                  5899999999999999999999999999999999


Q ss_pred             CeEecCCCCEEEeecccccccCCCC-----ccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHh-CCCCCCCCChH
Q 023270          149 NLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (284)
Q Consensus       149 nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  222 (284)
                      ||+++.++.++++|||.+.......     ....+++.|+|||.+.+..++.++||||||+++|+|+| |.+||...+..
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999986544322     23457889999999999999999999999999999998 77878887777


Q ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          223 DTFRRIMKVDLSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      +.+.++.........+...|+++.+||.+||+.||++|||+++|++
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7777777666677777789999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-50  Score=334.32  Aligned_cols=251  Identities=18%  Similarity=0.306  Sum_probs=205.3

Q ss_pred             eeeeeccCCCeEEEEEEEecCC---ceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEec-CCeEEEEE
Q 023270           23 IGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DERIFLIL   98 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~-~~~~~~v~   98 (284)
                      ..++||+|+||+||+|.+..++   ..||||++....  .....+.+.+|++++++++||||+++++++.. ++..++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            3678999999999999986543   358999985432  22345789999999999999999999999765 56899999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeecccccccCCC-----
Q 023270           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (284)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-----  172 (284)
                      |||++++|.+++... ..++...++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......     
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999988765 46788899999999999999999999999999999999999999999999998543221     


Q ss_pred             --CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 023270          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRRIMKVDLSFPSAPSISAEAKHLI  249 (284)
Q Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (284)
                        .....+++.|+|||.+.+..++.++||||||+++|+|+||..||.. .+..+....+..+ .....++.+++++.+|+
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~~li  267 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLYEVM  267 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHHHHHHH
Confidence              1224578899999999999999999999999999999997666654 4444455555554 35555668899999999


Q ss_pred             HHhcccCCCCCCCHHhhhcC------ccccccC
Q 023270          250 SRLLVKDSSKRLSLQKIMEH------PWIIKNA  276 (284)
Q Consensus       250 ~~~l~~~p~~Rps~~~il~~------~~~~~~~  276 (284)
                      .+||..||++|||+.|+++|      +|+.+..
T Consensus       268 ~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~  300 (311)
T d1r0pa_         268 LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  300 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence            99999999999999999998      6665543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-48  Score=326.68  Aligned_cols=254  Identities=18%  Similarity=0.247  Sum_probs=200.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEecCCeEEEE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLI   97 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~~~~~~~v   97 (284)
                      ++|++.+.||+|+||+||+|.+..+++.||||++......     ..+..|+++++.++|+++ +.+.+++.+++..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999999999999999987554322     356789999999987665 4555666788899999


Q ss_pred             EeecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC---CCCEEEeecccccccCCC-
Q 023270           98 LEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWSVQSRSK-  172 (284)
Q Consensus        98 ~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~-  172 (284)
                      ||++++ ++...+. ....++...++.++.|++.||+|||++||+|+||||+||+++.   +..++|+|||++...... 
T Consensus        82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            999965 6655554 4568999999999999999999999999999999999999864   457999999998543221 


Q ss_pred             ---------CccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChHHHHHHHH---hc---CCCCCC
Q 023270          173 ---------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRRIM---KV---DLSFPS  237 (284)
Q Consensus       173 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~---~~~~~~  237 (284)
                               .....||+.|+|||.+.+..++.++||||||+++++|+||..||.............   ..   ......
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence                     233468999999999999999999999999999999999999998765543322211   11   111112


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHH---hhhcCccccccCCC
Q 023270          238 APSISAEAKHLISRLLVKDSSKRLSLQ---KIMEHPWIIKNANP  278 (284)
Q Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rps~~---~il~~~~~~~~~~~  278 (284)
                      .+.+|+++.+++..||..+|.+||+++   ++|+++|.+++...
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~  284 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  284 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence            346899999999999999999999987   55788877665443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=320.23  Aligned_cols=245  Identities=22%  Similarity=0.326  Sum_probs=192.6

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcccceeeEEecCC----e
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----R   93 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~~~~~~~~~~~----~   93 (284)
                      .++|.+.+.||+|+||+||+|+.  +|+.||||++.......    ...+.|+..+..++||||+++++++..++    .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            36899999999999999999985  68899999986554222    22234566667789999999999987553    6


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCCeEecCCCCEEEeeccc
Q 023270           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE--------NHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        94 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~--------~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      +++||||+++++|.+++.+. ++++..++.++.+++.|+.|+|.        .||+|+||||+|||++.++++||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            89999999999999999874 68999999999999999999996        5999999999999999999999999998


Q ss_pred             ccccCC-------CCccccCCCcccCccccCCCC------CCchhhHhhHHHHHHHHHhCCCCCCC--------------
Q 023270          166 SVQSRS-------KRHTMCGTLDYLAPEMVENKE------HDYAVDNWTLGILCYEFLYGAPPFEA--------------  218 (284)
Q Consensus       166 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~il~~l~tg~~p~~~--------------  218 (284)
                      +.....       ......|++.|+|||++.+..      ++.++||||||+++|+|+||..||..              
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            743321       223456899999999987643      56789999999999999999877632              


Q ss_pred             -CChHHHHHHHHhcCCCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          219 -ESQKDTFRRIMKVDLSFPSAPS-----ISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                       ................+..+..     .+..+.+|+.+||..||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             1223333333333332222211     23458999999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-47  Score=318.70  Aligned_cols=246  Identities=20%  Similarity=0.282  Sum_probs=203.4

Q ss_pred             cccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC-CcccceeeEEecCCeEE
Q 023270           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWFHDDERIF   95 (284)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h-~~i~~~~~~~~~~~~~~   95 (284)
                      ..++|++.+.||+|+||+||+|++..+++.||||++......     ..+++|++.++.+.| +|++.+++++..+...+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            357899999999999999999999999999999987543321     346678888888875 89999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecC-----CCCEEEeeccccccc
Q 023270           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-----EGRLKIGDFGWSVQS  169 (284)
Q Consensus        96 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~-----~~~~~l~d~~~~~~~  169 (284)
                      +|||+++ ++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.     ++.++|+|||++...
T Consensus        78 ~vme~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9999994 7999888765 47999999999999999999999999999999999999974     578999999998543


Q ss_pred             CC----------CCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCC---
Q 023270          170 RS----------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES---QKDTFRRIMKVDL---  233 (284)
Q Consensus       170 ~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~---  233 (284)
                      ..          ......||+.|+|||++.+..+++++||||||+++++|+||..||.+..   .......+.....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            21          1223468999999999999999999999999999999999999997543   3333333222111   


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhc
Q 023270          234 SFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIME  268 (284)
Q Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  268 (284)
                      .....+.+|+++.+++..|+..+|.+||+++.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            11122468999999999999999999999887755

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-46  Score=321.71  Aligned_cols=254  Identities=24%  Similarity=0.428  Sum_probs=196.2

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-----------CCcccceeeE
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-----------HPNILRLYGW   87 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-----------h~~i~~~~~~   87 (284)
                      .+|+++++||+|+||+||+|++..+++.||||++.......    +.+.+|+++++.+.           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~----~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccch----HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            56999999999999999999999999999999997654322    35566777766664           5789999988


Q ss_pred             EecC--CeEEEEEeecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEecCCCC----
Q 023270           88 FHDD--ERIFLILEYAHRG-ELYRELRK--HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGR----  157 (284)
Q Consensus        88 ~~~~--~~~~~v~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~lh~-~gi~H~dl~p~nil~~~~~~----  157 (284)
                      +...  ...+++++++... ........  ...++...++.++.|++.|+.|||+ .||+|+||||+|||++.++.    
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            7543  4566666655433 33333332  3578999999999999999999997 89999999999999987653    


Q ss_pred             --EEEeecccccccCCCCccccCCCcccCccccCCCCCCchhhHhhHHHHHHHHHhCCCCCCCCChH------HHHHHHH
Q 023270          158 --LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK------DTFRRIM  229 (284)
Q Consensus       158 --~~l~d~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~------~~~~~~~  229 (284)
                        ++++|||.+...........+++.|+|||++.+..++.++|+||+|+++++|++|+.||......      +.+....
T Consensus       169 ~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~  248 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  248 (362)
T ss_dssp             EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             ceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence              99999999977776667778999999999999999999999999999999999999999754321      1111111


Q ss_pred             hcC----------------------------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHhhhcC
Q 023270          230 KVD----------------------------------------LSFPSAPSISAEAKHLISRLLVKDSSKRLSLQKIMEH  269 (284)
Q Consensus       230 ~~~----------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  269 (284)
                      ...                                        .........++++.+||.+||..||.+|||++|+|+|
T Consensus       249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000                                        0000112346789999999999999999999999999


Q ss_pred             ccccccC
Q 023270          270 PWIIKNA  276 (284)
Q Consensus       270 ~~~~~~~  276 (284)
                      |||++..
T Consensus       329 p~f~~~~  335 (362)
T d1q8ya_         329 PWLKDTL  335 (362)
T ss_dssp             GGGTTCT
T ss_pred             cccCCCC
Confidence            9999664

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=8.3e-26  Score=175.12  Aligned_cols=168  Identities=19%  Similarity=0.215  Sum_probs=121.9

Q ss_pred             cEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhH---------------HHHHHHHHHHHHHHHHHhCCCCccccee
Q 023270           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---------------EKYKIQHQLRREMEIQSSLRHPNILRLY   85 (284)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~h~~i~~~~   85 (284)
                      +.+.++||+|+||+||+|.+ .+|+.||||++.....               ...........|...+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            46889999999999999987 4788999998643211               1112234556788889999999988877


Q ss_pred             eEEecCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEecCCCCEEEeeccc
Q 023270           86 GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (284)
Q Consensus        86 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh~~gi~H~dl~p~nil~~~~~~~~l~d~~~  165 (284)
                      ++.    ..+++||++++..+..       ++...+..++.|++.++.+||++|++|+||||+|||+++++ ++|+|||.
T Consensus        81 ~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             Eec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence            653    2379999998765543       45566778999999999999999999999999999998655 88999999


Q ss_pred             ccccCCCCccccCCCcccCcc-----ccCCCCCCchhhHhhHHHHH
Q 023270          166 SVQSRSKRHTMCGTLDYLAPE-----MVENKEHDYAVDNWTLGILC  206 (284)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~Di~slG~il  206 (284)
                      +.....+...     .|....     .+....++.++|+||+.--+
T Consensus       149 a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             cccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            8655433211     111110     11235567889999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.66  E-value=9e-08  Score=75.84  Aligned_cols=139  Identities=14%  Similarity=0.147  Sum_probs=89.1

Q ss_pred             ccCcEeeeeeccCCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCC-CCcccceeeEEecCCeEEE
Q 023270           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFL   96 (284)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~-h~~i~~~~~~~~~~~~~~~   96 (284)
                      +..|+.++..+.++.+.||++.  .++..+++|+........   ...+.+|...+..+. +-.+.+++.+...++..++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            4578888877666678899875  466678888875433221   123455666666553 3335677888888899999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 023270           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH----------------------------------------  136 (284)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~lh----------------------------------------  136 (284)
                      ||++.++.++.+......  ..   ..++.++...+..||                                        
T Consensus        88 v~~~l~G~~~~~~~~~~~--~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ--SP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS--CH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEecccccccccccccc--cH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            999999877754332111  11   112222222222222                                        


Q ss_pred             -------------hC------CccccCCCCCCeEecCCCCEEEeecccc
Q 023270          137 -------------EN------HVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       137 -------------~~------gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                                   +.      .++|||++|.||+++.++.+-|+||+.+
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence                         11      2689999999999987777779999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.41  E-value=9e-07  Score=74.28  Aligned_cols=82  Identities=15%  Similarity=0.174  Sum_probs=45.7

Q ss_pred             eeeeeccCCCeEEEEEEEecCCceEEEEehhhhh--HHH--HHHHHHHHHHHHHHHhCC-C--CcccceeeEEecCCeEE
Q 023270           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEK--YKIQHQLRREMEIQSSLR-H--PNILRLYGWFHDDERIF   95 (284)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~--~~~~~~~~~~~~~~~~l~-h--~~i~~~~~~~~~~~~~~   95 (284)
                      ..+.||.|....||++.+..+++.+++|......  .+.  .........|...++.+. +  ..+.+++.+  +++..+
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            4567999999999999987778889999643210  000  000122334555555442 2  234445443  455568


Q ss_pred             EEEeecCCCch
Q 023270           96 LILEYAHRGEL  106 (284)
Q Consensus        96 ~v~e~~~~~~L  106 (284)
                      +|||+.++..+
T Consensus       108 lvmE~L~~~~~  118 (392)
T d2pula1         108 TVMEDLSHLKI  118 (392)
T ss_dssp             EEECCCTTSEE
T ss_pred             EEEeccCCccc
Confidence            89999876543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=1.3e-05  Score=62.55  Aligned_cols=73  Identities=15%  Similarity=0.128  Sum_probs=47.2

Q ss_pred             eccCC-CeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCC--CcccceeeEEecCCeEEEEEeecCC
Q 023270           27 LGKGK-FGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYAHR  103 (284)
Q Consensus        27 lg~g~-~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~  103 (284)
                      +..|. .+.||++.. .++..+++|........      .+..|...++.+..  -.+.+++.+..+++..++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            34444 467898875 45666888986544322      24455555554432  3356678888888899999999987


Q ss_pred             Cch
Q 023270          104 GEL  106 (284)
Q Consensus       104 ~~L  106 (284)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.48  E-value=0.00018  Score=58.15  Aligned_cols=71  Identities=14%  Similarity=0.173  Sum_probs=42.6

Q ss_pred             CCCeEEEEEEEecCCceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCccc--cee-----eEEecCCeEEEEEeecC
Q 023270           30 GKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL--RLY-----GWFHDDERIFLILEYAH  102 (284)
Q Consensus        30 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i~--~~~-----~~~~~~~~~~~v~e~~~  102 (284)
                      +....||++.. .+|..|++|+........    +.+..|...+..+...++.  ..+     ..+..++..+.++++.+
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            44568998876 578889999986543222    3455566666655422221  111     12345567889999887


Q ss_pred             CCc
Q 023270          103 RGE  105 (284)
Q Consensus       103 ~~~  105 (284)
                      |..
T Consensus       108 G~~  110 (325)
T d1zyla1         108 GRQ  110 (325)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.32  E-value=0.00029  Score=58.54  Aligned_cols=78  Identities=24%  Similarity=0.360  Sum_probs=47.6

Q ss_pred             cCcEeeeeeccCCCeEEEEEEEecC-------CceEEEEehhhhhHHHHHHHHHHHHHHHHHHhCCCCcc-cceeeEEec
Q 023270           19 QDFEIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHD   90 (284)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~~~~~~~~~l~h~~i-~~~~~~~~~   90 (284)
                      .+.++ +.|+.|-...+|++.....       ++.|++++.-... ..    ....+|..+++.+...++ .++++++.+
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~----idr~~E~~i~~~ls~~gl~Pkll~~~~~  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE----SHLVAESVIFTLLSERHLGPKLYGIFSG  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH----HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh----hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence            44444 6788999999999987542       3568888764221 11    123356666666543343 466666532


Q ss_pred             CCeEEEEEeecCCCch
Q 023270           91 DERIFLILEYAHRGEL  106 (284)
Q Consensus        91 ~~~~~~v~e~~~~~~L  106 (284)
                          .+|+||.++.++
T Consensus       117 ----g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ----GRLEEYIPSRPL  128 (395)
T ss_dssp             ----EEEECCCCEEEC
T ss_pred             ----ceEEEEeccccC
Confidence                678899876543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.11  E-value=0.00067  Score=54.35  Aligned_cols=29  Identities=24%  Similarity=0.337  Sum_probs=26.3

Q ss_pred             CCccccCCCCCCeEecCCCCEEEeecccc
Q 023270          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (284)
Q Consensus       138 ~gi~H~dl~p~nil~~~~~~~~l~d~~~~  166 (284)
                      .|++|||+.++||+++.+...-++||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            47999999999999998888899999976